<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6445942\results\search\zoonosis\results.xml">
   <result pre="diseases such as HIV/AIDS, severe acute respiratory syndrome (SARS), and" exact="Nipah virus infection," post="among others have emerged. Well-known diseases also have reemerged"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6711314\results\search\zoonosis\results.xml">
   <result pre="emerged viruses in humans, this appears to be true for" exact="Ebola" post="virus, Marburg virus, Severe Acute Respiratory Syndrome (SARS) and"/>
   <result pre="have caused epidemics or pandemics. virus host combinations review references" exact="Influenza" post="A virus avian to human, swine, horse, seal, dog."/>
   <result pre="immunodeficiency virus non-human primate to human, two major events [12]" exact="Ebola" post="virus bat to human, outbreaks, some extended epidemicsbat to"/>
   <result pre="epidemicsbat to gorilla (to human)bat to duiker (to human) [13]" exact="MERS coronavirus" post="camel to human, mostly spillover, some outbreaks [14] SARS"/>
   <result pre="reviews; many specific references are contained within those reviews. 2." exact="Influenza" post="A virus spillover and epidemic emergence IAVs are often"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6745427\results\search\zoonosis\results.xml">
   <result pre="other arboviral infections. Keywords: Mosquito Vectors Aedes Zika Virus Arboviruses" exact="Dengue" post="Information Dissemination Saudi Arabia Introduction With people in Saudi"/>
   <result pre="feed indoors and outdoors, which increases transmission in Saudi Arabia.1-3" exact="Dengue" post="is closely related to other mosquito-borne flaviviruses within the"/>
   <result pre="of mosquito vectors: past, present, and future.Insects2016 Oct;7(4):E52. 10.3390/insects704005227706105 2WHO." exact="Dengue" post="control. Biological control. 2016 [cited 2016 October 24]. Available"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6832525\results\search\zoonosis\results.xml">
   <result pre="acute infections, including dengue virus (DENV), West Nile virus (WNV)," exact="Japanese encephalitis" post="virus (JEV) and Zika virus (ZIKV) (Figure 1). Transmission"/>
   <result pre="an antigen delivery platform for other experimental vaccines including HIV-1," exact="Lassa fever," post="malaria and DENV [175,176,177,178,179,180]. After early successes in outbreak"/>
   <result pre="can emerge in humans sporadically, complicating initial diagnosis. These include" exact="Ebola" post="viruses (EBOV), Marburg virus (MARV), Rift Valley fever virus"/>
   <result pre="initial diagnosis. These include Ebola viruses (EBOV), Marburg virus (MARV)," exact="Rift Valley fever" post="virus (RVFV), Junin virus (JUNV) and Crimean-Congo hemorrhagic fever"/>
   <result pre="including the West African 2013-16 EBOV outbreak [228] and the" exact="Lassa fever" post="virus (LASV) outbreak in Nigeria in 2018 [229]. This"/>
   <result pre="replicationSci. Rep.201774092010.1038/srep4092028098253 35.XuH.-T.Colby-GerminarioS.P.HassounahS.A.FogartyC.OsmanN.PalanisamyN.HanY.OliveiraM.QuanY.WainbergM.A.Evaluation of Sofosbuvir (Î²-D-2â€™-deoxy-2â€™-Î±-fluoro-2â€™-Î²-C-methyluridine) as an inhibitor of" exact="Dengue" post="virus replicationSci. Rep.20177634510.1038/s41598-017-06612-228740124 36.De FreitasC.S.HigaL.M.SacramentoC.Q.FerreiraA.C.ReisP.A.DelvecchioR.MonteiroF.L.Barbosa-LimaG.James WestgarthH.VieiraY.R.et al.Yellow fever virus"/>
   <result pre="virus host factorsNature20094581047105010.1038/nature0796719396146 76.LiuK.QianY.JungY.-S.ZhouB.CaoR.ShenT.ShaoD.WeiJ.MaZ.ChenP.et al.mosGCTL-7, a C-Type Lectin Protein, Mediates" exact="Japanese Encephalitis" post="Virus Infection in MosquitoesJ. Virol.201791e01348-1610.1128/JVI.01348-16 77.ChengG.CoxJ.WangP.KrishnanM.N.DaiJ.QianF.AndersonJ.F.FikrigE.A C-type lectin collaborates"/>
   <result pre="protease-helicase as a target for antiviral drug developmentAntivir. Res.201511814815810.1016/j.antiviral.2015.03.01425842996 97.TanB.-H.FuJ.SugrueR.J.YapE.-H.ChanY.-C.TanY.H.Recombinant" exact="Dengue" post="Type 1 Virus NS5 Protein Expressed inEscherichia coliExhibits RNA-Dependent"/>
   <result pre="through IPS-1J. Virol.20088260961610.1128/JVI.01305-0717977974 130.NazmiA.MukhopadhyayR.DuttaK.BasuA.STING mediates neuronal innate immune response following" exact="Japanese encephalitis" post="virus infectionSci. Rep.2012234710.1038/srep0034722470840 131.IshikawaH.BarberG.N.STING is an endoplasmic reticulum adaptor"/>
   <result pre="new roles for cGAS in innate immunityNature201450569169510.1038/nature1286224284630 135.van GentM.GackM.U.Viral pathogenesis:" exact="Dengue" post="virus takes on cGASNat. Microbiol.201721705010.1038/nmicrobiol.2017.5028346454 136.AguirreS.LuthraP.Sanchez-AparicioM.T.MaestreA.M.PatelJ.LamotheF.FredericksA.C.TripathiS.ZhuT.Pintado-SilvaJ.et al.Dengue virus NS2B"/>
   <result pre="of YFV 17D-based chimeric vaccines against dengue, West Nile and" exact="Japanese encephalitis" post="virusesVaccine20102863264910.1016/j.vaccine.2009.09.09819808029 179.StoyanovC.T.BoscardinS.B.DeroubaixS.Barba-SpaethG.FrancoD.NussenzweigR.S.NussenzweigM.RiceC.M.Immunogenicity and protective efficacy of a recombinant yellow"/>
   <result pre="ModelsAm. J. Trop. Med. Hyg.20189842043110.4269/ajtmh.16-029329231157 206.TripathiN.K.ShrivastavaA.Recent Developments in Recombinant Protein-Based" exact="Dengue" post="VaccinesFront. Immunol.20189191910.3389/fimmu.2018.0191930190720 207.KheraT.BehrendtP.BankwitzD.BrownR.J.P.TodtD.DoepkeM.KhanA.G.SchulzeK.LawJ.LoganM.et al.Functional and immunogenic characterization of diverse"/>
   <result pre="Markers and Mechanisms of Rapid Protection Conferred by the VSV-Vectored" exact="Ebola" post="Virus VaccineMBio20191010.1128/mBio.01597-19 209.MonathT.P.LeeC.K.JulanderJ.G.BrownA.BeasleyD.W.WattsD.M.HaymanE.GuertinP.MakowieckiJ.CrowellJ.et al.Inactivated yellow fever 17D vaccine: Development"/>
   <result pre="fever virus in UgandaVirology20124221510.1016/j.virol.2011.08.02421962764 228.QuickJ.LomanN.J.DuraffourS.SimpsonJ.T.SeveriE.CowleyL.BoreJ.A.KoundounoR.DudasG.MikhailA.et al.Real-time, portable genome sequencing for" exact="Ebola" post="surveillanceNature201653022823210.1038/nature1699626840485 229.KafetzopoulouL.E.PullanS.T.LemeyP.SuchardM.A.EhichioyaD.U.PahlmannM.ThielebeinA.HinzmannJ.OestereichL.WozniakD.M.et al.Metagenomic sequencing at the epicenter of the"/>
   <result pre="229.KafetzopoulouL.E.PullanS.T.LemeyP.SuchardM.A.EhichioyaD.U.PahlmannM.ThielebeinA.HinzmannJ.OestereichL.WozniakD.M.et al.Metagenomic sequencing at the epicenter of the Nigeria 2018" exact="Lassa fever" post="outbreakScience2019363747710.1126/science.aau934330606844 230.JainM.OlsenH.E.PatenB.AkesonM.The Oxford Nanopore MinION: Delivery of nanopore sequencing"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6857389\results\search\zoonosis\results.xml">
   <result pre="JFMPC-8-3125 doi: 10.4103/jfmpc.jfmpc_716_19 : Review Article A notorious vector-borne disease:" exact="Dengue fever," post="its evolution as public health threat PathakVineet K.1MohanM1[1], Department"/>
   <result pre="the new creations are licensed under the identical terms. Abstract" exact="Dengue fever," post="the most notorious of vector borne diseases is under"/>
   <result pre="is available in India. Aedes dengue epidemiology surveillance urbanization Background" exact="Dengue" post="virus (DENV) is a positive-stranded encapsulated RNA virus of"/>
   <result pre="Aedes Aegypti also transmits Chikungunya, yellow fever, and Zika infections.[1]" exact="Dengue" post="also referred to as â€œwater poison,â€� â€œcramp-like seizure,â€� or"/>
   <result pre="importance Government of India has named 16th May 2019 â€œNational" exact="Dengue" post="day.â€� The theme was â€œFight the bite: Prevent Dengueâ€�"/>
   <result pre="of prevention and role of primary healthcare providers.[6] Epidemiology of" exact="Dengue" post="Virus The epidemiology of dengue significantly changed in south-east"/>
   <result pre="Borne Disease Control Program (NVBDCP) covers malaria, dengue, Chikungunya, and" exact="Japanese encephalitis," post="and also works for the elimination of Kala-azar and"/>
   <result pre="5KutsunaSKatoYMoiMLKotakiAOtaMShinoharaKet al.Autochthonous dengue fever, Tokyo, Japan, 2014Emerg Infect Dis2015215172025695200 6National" exact="Dengue" post="Day 2019 | National Health Portal of India [Internet]cited"/>
   <result pre="from: https://linkinghub.elsevier.com/retrieve/pii/S1201971219300153 35RajapakseSRodrigoCRajapakseTreatment of dengue feverInfect Drug Resist201251031222870039 36WHO |" exact="Dengue" post="guidelines for diagnosis, treatment, prevention and control: New edition"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6893414\results\search\zoonosis\results.xml">
   <result pre="virus (DENV), yellow fever virus (YFV), West Nile virus, and" exact="Japanese encephalitis" post="virus, which have resulted in epidemics and threatened public"/>
   <result pre="therapy have been utilized to treat respiratory syncytial virus and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) infection respectively, and ivermectin and azithromycin (Azi)"/>
   <result pre="infection by inhibiting cell bindingAntivir. Res.201714214815710.1016/j.antiviral.2017.03.01428343845 31.LuL.LiuQ.ZhuY.ChanK.H.QinL.LiY.WangQ.ChanJ.F.JiangS.YuF.et al.Structure-based discovery of" exact="Middle East respiratory syndrome" post="coronavirus fusion inhibitorNat. Commun.20145306710.1038/ncomms406724473083 32.ZhaoG.DuL.MaC.LiY.LiL.PoonV.K.WangL.ZhengB.J.JiangS.ZhouY.et al.A safe and convenient"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6896946\results\search\zoonosis\results.xml">
   <result pre="10.3389/fimmu.2019.02804 : Immunology: Editorial Editorial: Understanding the Limitations of Current" exact="Influenza" post="Vaccine Strategies and Future Development of More Efficacious Preventative"/>
   <result pre="terms.Editorial on the Research Topic Understanding the Limitations of Current" exact="Influenza" post="Vaccine Strategies and Future Development of More Efficacious Preventative"/>
   <result pre="vaccine efficacy therapeutics prevention fig-count: table-count: equation-count: ref-count: page-count: word-count:" exact="Influenza" post="viruses pose a substantial threat to human health. Recent"/>
   <result pre="Rimmelzwaan lab on â€œResponse Modifiers: Tweaking the Immune Response Against" exact="Influenza" post="A Virus,â€� the authors address the potential therapeutic use"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6904818\results\search\zoonosis\results.xml">
   <result pre="related flaviviruses, such as dengue, yellow fever, West Nile, and" exact="Japanese encephalitis" post="viruses. Nevertheless, the authors have established the antiviral activity"/>
   <result pre="and NNRTI-resistant HIV-1Antimicrob. Agents Chemother.54201071872719933797 13NobleC.G.LimS.P.AroraR.YokokawaF.NilarS.SehC.C.WrightS.K.BensonT.E.SmithP.W.ShiP.Y.A Conserved Pocket in the" exact="Dengue" post="Virus Polymerase Identified through Fragment-based ScreeningJ.Â Biol. Chem.29120168541854826872970 14RichnerJ.M.JaggerB.W.ShanC.FontesC.R.DowdK.A.CaoB.HimansuS.CaineE.A.NunesB.T.D.MedeirosD.B.A.Vaccine"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6913311\results\search\zoonosis\results.xml">
   <result pre="of Traditional Kampo Drugs and Their Constituent Crude Drugs on" exact="Influenza" post="Virus Replication In Vitro: Suppression of Viral Protein Synthesis"/>
   <result pre="broad range of Kampo drugs. Funding Hiroshima University 1. Introduction" exact="Influenza" post="viruses, which belong to the family Orthomyxoviridae, are enveloped"/>
   <result pre="(70%) was used for an inactivating control. 2.5. Investigation of" exact="Influenza" post="Virus Replication In Vitro MDCK(+) cells were infected with"/>
   <result pre="Effects of Kampo Drugs with Indications for Respiratory Symptoms on" exact="Influenza" post="Virus Replication The Kampo drugs used in this study"/>
   <result pre="Mao-to, a Japanese herbal medicine, for treatment of type A" exact="influenza infection" post="in childrenPhytomedicine2007142-39610110.1016/j.phymed.2006.09.01517141491 6ToriumiY.KameiT.MurataK.TakahashiI.SuzukiN.MazdaO.Utility of maoto in an influenza season"/>
   <result pre="of influenza virusesFolia Pharmacologica Japonica20121402626510.1254/fpj.140.6222878568 8NomaK.KiyotaniK.KouchiH.et al.Endogenous protease-dependent replication of" exact="human influenza" post="viruses in two MDCK cell linesArchives of Virology1998143101893190910.1007/s0070500504289856079 9KawaharaT.AkibaI.SakouM.SakaguchiT.TaniguchiH.Inactivation"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6943894\results\search\zoonosis\results.xml">
   <result pre="made available in this article, unless otherwise stated. Abstract Background" exact="Influenza" post="A viruses cause epidemics/severe pandemics that pose a great"/>
   <result pre="H3N2 viruses in Taiwan and 14,220 NP sequences collected from" exact="Influenza" post="Research Database. The identified genetic variations were further analyzed"/>
   <result pre="variations of NP during virus evolution deserves future attention. Keywords" exact="Influenza" post="virus Nucleoprotein Evolution H3N2 Ferret study Viral replication Viral"/>
   <result pre="and Technology, Taiwan Funding National Health Research Institutes, Taiwan Background" exact="Influenza" post="A viruses are common respiratory infectious pathogens which cause"/>
   <result pre="have continuously circulated in human population since the 1968 pandemic." exact="Influenza" post="A viruses contain eight gene segments, which include PB2,"/>
   <result pre="National Cheng Kung University Hospital (NCKUH) between 1999 and 2017." exact="Influenza" post="isolates were cultured in MDCK cells; the virus culture"/>
   <result pre="we collected 14,220 H3N2 NP sequences obtained from the NIAID" exact="Influenza" post="Research Database (IRD) (http://www.fludb.org) [20]. In this database, the"/>
   <result pre="The IF stain was done using D3 Ultra DFA Reagent" exact="Influenza" post="A (Diagnostic Hybrids). Virus growth kinetics To analyze the"/>
   <result pre="ferrets have not been exposed to human seasonal influenza viruses." exact="Influenza" post="virus strains used in HI assay were A/Hong Kong/4801/2014"/>
   <result pre="is required to better understand the role of NP in" exact="human influenza" post="evolution and fitness. Avian influenza infection is a great"/>
   <result pre="role of NP in human influenza evolution and fitness. Avian" exact="influenza infection" post="is a great threat to humans and it is"/>
   <result pre="of influenza A(H3N2) viruses, we analyzed the NP gene of" exact="human influenza" post="A H3N2 viruses that have circulated from 1999 to"/>
   <result pre="reference strains were compared. Abbreviations IF stain immunofluorescence stain IRD" exact="Influenza" post="Research Database NCKUH National Cheng Kung University Hospital NLS"/>
   <result pre="influenza A viruses in mammalsEmerg Microbes Infect20143e910.1038/emi.2014.926038511 2.WendelIMatrosovichMKlenkHDSnapShot: evolution of" exact="human influenza" post="A virusesCell Host Microbe201517416.e41110.1016/j.chom.2015.02.00125766297 3.Song W, Wang P, Mok"/>
   <result pre="determinants of influenza evolutionNature200342242843310.1038/nature0150912660783 14.RambautAPybusOGNelsonMIViboudCTaubenbergerJKHolmesECThe genomic and epidemiological dynamics of" exact="human influenza" post="A virusNature200845361561910.1038/nature0694518418375 15.JohnsonBFWilsonLEEllisJElliotAJBarclayWSPebodyRGMcMenaminJFlemingDMZambonMCFatal cases of influenza a in childhoodPLoS"/>
   <result pre="37.WestgeestKBRussellCALinXSpronkenMIBestebroerTMBahlJvan BeekRSkepnerEHalpinRAde JongJCRimmelzwaanGFOsterhausADSmithDJWentworthDEFouchierRAde GraafMGenomewide analysis of reassortment and evolution of" exact="human influenza" post="A(H3N2) viruses circulating between 1968 and 2011J Virol2014882844285710.1128/JVI.02163-1324371052 38.HutchinsonECDenhamEMThomasBTrudgianDCHesterSSRidlovaGYorkATurrellLFodorEMapping"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6958409\results\search\zoonosis\results.xml">
   <result pre="(Basel)pharmaceuticalsPharmaceuticals1424-8247MDPI doi: 10.3390/ph12040147pharmaceuticals-12-00147 : Review Alternative Experimental Models for Studying" exact="Influenza" post="Proteins, Hostâ€&quot;Virus Interactions and Anti-Influenza Drugs ChuaSonja C. J."/>
   <result pre="cells 1. Introduction 1.1. Ninety Years after Its Identification, the" exact="Influenza" post="Virus Has Not Been Eradicated Almost ninety years after"/>
   <result pre="local epidemics or global pandemics, such as the 2005 H5N1" exact="Bird flu" post="and the 2009 H1N1 Swine flu [3]. This situation"/>
   <result pre="Multiple reasons for this inefficiency in vaccination and therapy exist." exact="Influenza" post="viruses have high mutation rates and this seems to"/>
   <result pre="devising novel anti-influenza therapies. 1.2. The Life Cycle of the" exact="Influenza" post="Virus The Influenza virus belongs the Orthomyxoviridae family, which"/>
   <result pre="therapies. 1.2. The Life Cycle of the Influenza Virus The" exact="Influenza" post="virus belongs the Orthomyxoviridae family, which are negative-sense single-stranded"/>
   <result pre="named A, B and C. The most prolific member is" exact="Influenza" post="A, which infects a large number of hosts and"/>
   <result pre="membrane to infect other cells [6]. 1.3. The Disease of" exact="Influenza" post="and Available Therapies The Influenza virus is transmitted by"/>
   <result pre="[6]. 1.3. The Disease of Influenza and Available Therapies The" exact="Influenza" post="virus is transmitted by respiratory droplets and causes acute"/>
   <result pre="complications such as acute bronchitis and secondary bacterial pneumonia [21]." exact="Influenza" post="viruses evolve constantly with antigenic shifts (reassortment of viral"/>
   <result pre="pandemics such as the 1918 H1N1 Spanish pandemic, 2005 H5N1" exact="Bird flu" post="and the 2009 H1N1 Swine flu [3]. To date,"/>
   <result pre="virus in egg culture [28]. 2. Traditional Models to Study" exact="Influenza" post="2.1. No Current Laboratory Model Has Fully Reproduced All"/>
   <result pre="first animals that investigators were able to infect with the" exact="human influenza" post="virus were ferrets [1] and this model remains in"/>
   <result pre="human), isolated systems, including in vitro systems have been applied." exact="Influenza" post="proteins have been expressed and purified as recombinant proteins"/>
   <result pre="current models and elaborate on new models. 2.2. Cell Lines" exact="Influenza" post="was initially shown to infect human embryo lung and"/>
   <result pre="mice and is now approved in Japan for treatment of" exact="influenza infection" post="[62]. 2.2.2. Immortalized Lung Cells, e.g., A549 and Calu-3"/>
   <result pre="mice strains do not display disease following infection with primary" exact="human influenza" post="virus isolates [30]. This is, in part, due to"/>
   <result pre="[30]. This is, in part, due to the preference of" exact="human influenza" post="A virus for Î±2,6-linked sialic acid receptors on the"/>
   <result pre="share many of the clinical symptoms presented by humans following" exact="influenza infection" post="and are susceptible to the human influenza virus [88]."/>
   <result pre="by humans following influenza infection and are susceptible to the" exact="human influenza" post="virus [88]. Thus, no prior adaptation of the virus"/>
   <result pre="macaques) have similar immune responses to humans in regard to" exact="influenza infection" post="([99] and reviewed in Bouvier et al., 2010 [30])."/>
   <result pre="animals compared to mice. 3. Novel, Alternative Models for Studying" exact="Influenza" post="As mentioned above, mammalian models, animals and cell lines,"/>
   <result pre="through studying viruses in the fly [216,220,221,222,223,224,225]. 3.2.3. Drosophila and" exact="Influenza" post="Virus Infection Several of the influenza proteins have been"/>
   <result pre="bafilomycin, a drug that targets the V1V0 ATPase, prior to" exact="influenza infection" post="and this reduced infectivity [226]. Thus, this shows that"/>
   <result pre="phenotype. Different Hh modulation among various viral strains exists (Udorn," exact="swine flu" post="and PR8), with the PR8 strain having the highest"/>
   <result pre="levels of Hh target gene induction may be protective against" exact="influenza infection" post="[231]. An RNAi screen in Drosophila cell culture was"/>
   <result pre="only way in which responses of smokers and patients to" exact="influenza infection" post="could have been tested. Adult human nasal epithelial stem/progenitor"/>
   <result pre="revealed perturbations in homeostasis and metabolic pathways in response to" exact="influenza infection" post="[262]. Other interesting observations using patient-derived NECs include the"/>
   <result pre="to provide a better understanding of the host response to" exact="influenza infection" post="in the bronchial tissues. Proteomic studies performed with human"/>
   <result pre="associated with host cell defense response, endocytosis and GTPase activity." exact="Influenza" post="virus was also found to increase apoptosis and pyroptosis"/>
   <result pre="to test DAS181 efficacy in removing sialic acid and inhibiting" exact="influenza infection" post="[286]. Given these results, DAS181 has currently reached phase"/>
   <result pre="from human lungs, and these cells were shown to support" exact="influenza infection" post="with PR8 and A/Philippines/1982 (H3N2) [296]. ATII cells produced"/>
   <result pre="SP-D [302]. While some of these processes are known in" exact="influenza infection," post="these studies with AECs confirm the role of these"/>
   <result pre="not relevant on a first glance, when studying aspects of" exact="influenza infection" post="in yeast, Drosophila and zebrafish provide knowledge and a"/>
   <result pre="first monovalent vaccine to universal vaccinesJ. Prev. Med. Hyg.201657E115E12027980374 8.DavidsonS.Treating" exact="Influenza" post="Infection, From Now and Into the FutureFront. Immunol.20189194610.3389/fimmu.2018.0194630250466 9.SanjuÃ¡nR.Domingo-CalapP.Mechanisms"/>
   <result pre="human virusesVirology20124231510.1016/j.virol.2011.11.01622177780 12.PowellJ.D.StraubT.M.Advances and Remaining Challenges in the Study of" exact="Influenza" post="and Anthrax Infection in Lung Cell CultureChallenges20189210.3390/challe9010002 13.MacLachlanN.J.DuboviE.J.Chapter 21â€&quot;OrthomyxoviridaeFennerâ€™s"/>
   <result pre="Microbiol.2012226910.3389/fmicb.2011.0026922291683 15.McCauleyJ.HongoS.KaverinN.KochsG.LambR.MatrosovichM.PerezD.PaleseP.PrestiR.RimstadE.Familyâ€&quot;OrthomyxoviridaeVirus TaxonomyKingA.M.Q.AdamsM.J.CarstensE.B.LefkowitzE.J.ElsevierSan Diego, CA, USA201274976110.1016/B978-0-12-384684-6.00061-6 16.KlemmC.BoergelingY.LudwigS.EhrhardtC.Immunomodulatory Nonstructural Proteins of" exact="Influenza" post="A VirusesTrends Microbiol.20182662463610.1016/j.tim.2017.12.00629373257 17.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et al.New World Bats Harbor Diverse"/>
   <result pre="Influenza A VirusesTrends Microbiol.20182662463610.1016/j.tim.2017.12.00629373257 17.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et al.New World Bats Harbor Diverse" exact="Influenza" post="A VirusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 18.BouvierN.M.PaleseP.The biology of influenza virusesVaccine200826Suppl. 4D49D5310.1016/j.vaccine.2008.07.03919230160"/>
   <result pre="during epidemics: Implications for preventionArch. Intern. Med.1982142858910.1001/archinte.1982.003401400870167053739 21.TaubenbergerJ.K.MorensD.M.The Pathology of" exact="Influenza" post="Virus InfectionsAnnu. Rev. Pathol.2008349952210.1146/annurev.pathmechdis.3.121806.15431618039138 22.AriasC.F.Escalera-ZamudioM.Soto-Del Rio MdeL.Cobian-GuemesA.G.IsaP.LopezS.Molecular anatomy of"/>
   <result pre="transmission studies: A historical perspectiveCurr. Opin. Virol.20151310110810.1016/j.coviro.2015.06.00226126082 30.BouvierN.M.LowenA.C.Animal Models for" exact="Influenza" post="Virus Pathogenesis and TransmissionViruses201021530156310.3390/v2080153021442033 31.RajaoD.S.VincentA.L.Swine as a Model for"/>
   <result pre="Influenza Virus Pathogenesis and TransmissionViruses201021530156310.3390/v2080153021442033 31.RajaoD.S.VincentA.L.Swine as a Model for" exact="Influenza" post="A Virus Infection and ImmunityILAR J.201556445210.1093/ilar/ilv00225991697 32.ParrishC.R.MurciaP.R.HolmesE.C.Influenza Virus Reservoirs"/>
   <result pre="Reservoirs and Intermediate Hosts: Dogs, Horses, and New Possibilities for" exact="Influenza" post="Virus Exposure of HumansJ. Virol.2015892990299410.1128/JVI.03146-1425540375 33.ThangavelR.R.BouvierN.M.Animal models for influenza"/>
   <result pre="34.ZhongL.WangX.LiQ.LiuD.ChenH.ZhaoM.GuX.HeL.LiuX.GuM.et al.Molecular Mechanism of the Airborne Transmissibility of H9N2 Avian" exact="Influenza" post="A Viruses in ChickensJ. Virol.2014889568957810.1128/JVI.00943-1424920791 35.BelserJ.A.KatzJ.M.TumpeyT.M.The ferret as a"/>
   <result pre="Insights into Replication and Host Adaptation MechanismsJ. Biol. Chem.2010285284112841710.1074/jbc.R110.11753120538599 37.CarrilloB.ChoiJ.-M.BornholdtZ.A.SankaranB.RiceA.P.PrasadB.V.V.The" exact="Influenza" post="A Virus Protein NS1 Displays Structural PolymorphismJ. Virol.2014884113412210.1128/JVI.03692-1324478439 38.ConstantinidesA.E.SeverinC.C.GumpperR.H.ZhengX.LuoM.Characterization"/>
   <result pre="influenza A2 virus in monkey kidney cellsVirology19621833233410.1016/0042-6822(62)90023-514021004 42.GreenI.J.LiebermanM.MogabgabW.J.PeterkinW.G.PhillipsI.A.The Behavior of" exact="Influenza" post="Viruses in Various Tissue Culture SystemsJ. Immunol.19577823323913429092 43.NogalesA.MartÃ­nez-SobridoL.Reverse Genetics"/>
   <result pre="Culture SystemsJ. Immunol.19577823323913429092 43.NogalesA.MartÃ­nez-SobridoL.Reverse Genetics Approaches for the Development of" exact="Influenza" post="VaccinesInt. J. Mol. Sci.2016182010.3390/ijms1801002028025504 44.MiliÃ¡nE.KamenA.A.Current and emerging cell culture"/>
   <result pre="MDCK cell line for the efficient isolation and propagation of" exact="human influenza" post="virusesNat. Microbiol.201910.1038/s41564-019-0433-6 51.TsaiH.C.LehmanC.W.LinC.C.TsaiS.W.ChenC.M.Functional evaluation for adequacy of MDCK-lineage cells"/>
   <result pre="cells in influenza researchBMC Res. Notes20191210110.1186/s13104-019-4134-230808400 52.HamamotoI.TakakuH.TashiroM.YamamotoN.High Yield Production of" exact="Influenza" post="Virus in Madin Darby Canine Kidney (MDCK) Cells with"/>
   <result pre="55.LugovtsevV.Y.MelnykD.WeirJ.P.Heterogeneity of the MDCK Cell Line and Its Applicability for" exact="Influenza" post="Virus ResearchPLoS ONE20138e7501410.1371/journal.pone.007501424058646 56.KimE.H.KwonH.I.ParkS.J.KimY.I.SiY.J.LeeI.W.KimS.M.KimS.I.AhnD.H.ChoiY.K.Generation of a High-Growth Influenza Vaccine"/>
   <result pre="Applicability for Influenza Virus ResearchPLoS ONE20138e7501410.1371/journal.pone.007501424058646 56.KimE.H.KwonH.I.ParkS.J.KimY.I.SiY.J.LeeI.W.KimS.M.KimS.I.AhnD.H.ChoiY.K.Generation of a High-Growth" exact="Influenza" post="Vaccine Strain in MDCK Cells for Vaccine PreparednessJ. Microbiol."/>
   <result pre="InfluenzaJ. Biomol. Screen.20141993694610.1177/108705711351806824464431 64.BakreA.AndersenL.E.MeliopoulosV.ColemanK.YanX.BrooksP.CrabtreeJ.TompkinsS.M.TrippR.A.Identification of Host Kinase Genes Required for" exact="Influenza" post="Virus Replication and the Regulatory Role of MicroRNAsPLoS ONE20138e6679610.1371/journal.pone.006679623805279"/>
   <result pre="antiviral responseBiochem. Biophys. Res. Commun.20174821107111310.1016/j.bbrc.2016.11.16627914808 67.JiangW.ShengC.GuX.LiuD.YaoC.GaoS.ChenS.HuangY.HuangW.FangM.Suppression of Rac1 Signaling by" exact="Influenza" post="A Virus NS1 Facilitates Viral ReplicationSci. Rep.201663504110.1038/srep3504127869202 68.KumarD.TiwariK.RajalaM.S.Analysis of"/>
   <result pre="Approach Identifies Vpr Binding Protein as Novel Host Factor Supporting" exact="Influenza" post="A Virus Infections in Human CellsMol. Cell. Proteom.20171672874210.1074/mcp.M116.065904 73.SeongR.K.ChoiY.K.ShinO.S.MDA7/IL-24"/>
   <result pre="from MEK1 SUMOylation to Phosphorylation of the ERK Pathway in" exact="Influenza" post="A Virus-Infected Cells and Facilitates Its InfectionFront. Cell. Infect."/>
   <result pre="Virus-Infected Cells and Facilitates Its InfectionFront. Cell. Infect. Microbiol.201772710.3389/fcimb.2017.0002728224114 77.ZhuC.PengG.YiW.SongH.LiuF.LiuX.The" exact="Influenza" post="A Virus Non-structural Protein NS1 Upregulates The Expression of"/>
   <result pre="ProteinScand. J. Immunol.20168436536910.1111/sji.1249627718266 78.HeatonB.E.KennedyE.M.DummR.E.HardingA.T.SaccoM.T.SachsD.HeatonN.S.A CRISPR Activation Screen Identifies a Pan-avian" exact="Influenza" post="Virus Inhibitory Host FactorCell Rep.2017201503151210.1016/j.celrep.2017.07.06028813663 79.GerlachT.HensenL.MatrosovichT.BergmannJ.WinklerM.PeteranderlC.KlenkH.D.WeberF.HeroldS.PohlmannS.et al.pH Optimum of"/>
   <result pre="79.GerlachT.HensenL.MatrosovichT.BergmannJ.WinklerM.PeteranderlC.KlenkH.D.WeberF.HeroldS.PohlmannS.et al.pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of" exact="Influenza" post="A Viruses to the Interferon-Induced Antiviral State and IFITMsJ."/>
   <result pre="compared to standard of care in vivoAntivir. Res.201714217818410.1016/j.antiviral.2017.03.02428377100 83.BÃ¶ttcher-FriebertshÃ¤userE.SteinD.A.KlenkH.-D.GartenW.Inhibition of" exact="Influenza" post="Virus Infection in Human Airway Cell Cultures by an"/>
   <result pre="developmentPathogens2014384587410.3390/pathogens304084525436508 88.OhD.Y.HurtA.C.Using the Ferret as an Animal Model for Investigating" exact="Influenza" post="Antiviral EffectivenessFront. Microbiol.201678010.3389/fmicb.2016.0008026870031 89.MifsudE.J.TaiC.M.K.HurtA.C.Animal models used to assess influenza"/>
   <result pre="Rep.201662313810.1038/srep2313826988202 94.ImaiH.ShinyaK.TakanoR.KisoM.MuramotoY.SakabeS.MurakamiS.ItoM.YamadaS.LeM.t.Q.et al.The HA and NS Genes of Human H5N1" exact="Influenza" post="A Virus Contribute to High Virulence in FerretsPLoS Pathog.20106e100110610.1371/journal.ppat.100110620862325"/>
   <result pre="Oseltamivir Therapy in Ferrets Inoculated with Different Clades of H5N1" exact="Influenza" post="VirusAntimicrob. Agents Chemother.200751141410.1128/AAC.01312-0617296744 97.MarriottA.C.DoveB.K.WhittakerC.J.BruceC.RyanK.A.BeanT.J.RaynerE.PearsonG.TaylorI.DowallS.et al.Low Dose Influenza Virus Challenge"/>
   <result pre="Clades of H5N1 Influenza VirusAntimicrob. Agents Chemother.200751141410.1128/AAC.01312-0617296744 97.MarriottA.C.DoveB.K.WhittakerC.J.BruceC.RyanK.A.BeanT.J.RaynerE.PearsonG.TaylorI.DowallS.et al.Low Dose" exact="Influenza" post="Virus Challenge in the Ferret Leads to Increased Virus"/>
   <result pre="perspectives for heterologous protein productionAppl. Microbiol. Biotechnol.2014985301531710.1007/s00253-014-5732-524743983 124.HwangJ.-S.YamadaK.HondaA.NakadeK.IshihamaA.Expression of Functional" exact="Influenza" post="Virus RNA Polymerase in the Methylotrophic Yeast Pichia pastorisJ."/>
   <result pre="JabbarM.NayakD.P.Signal processing, glycosylation, and secretion of mutant hemagglutinins of a" exact="human influenza" post="virus by Saccharomyces cerevisiaeMol. Cell Biol.198771476148510.1128/MCB.7.4.14763037322 128.WardA.C.AzadA.A.MacreadieI.G.Expression and characterisation"/>
   <result pre="screening inhibitors of mutated influenza virus neuraminidasesFEBS Open Bio2013348448910.1016/j.fob.2013.10.007 133.BasuD.WalkiewiczM.P.FriemanM.BaricR.S.AubleD.T.EngelD.A.Novel" exact="Influenza" post="Virus NS1 Antagonists Block Replication and Restore Innate Immune"/>
   <result pre="inhibitor of influenza virusAntimicrob. Agents Chemother.1995392204220910.1128/AAC.39.10.22048619568 135.BalgiA.D.WangJ.ChengD.Y.H.MaC.PfeiferT.A.ShimizuY.AndersonH.J.PintoL.H.LambR.A.DeGradoW.F.et al.Inhibitors of the" exact="Influenza" post="A Virus M2 Proton Channel Discovered Using a High-Throughput"/>
   <result pre="subtypes expressed in yeastSci. China Ser. C Life Sci.20095254555010.1007/s11427-009-0072-x19557332 147.NemeroffM.E.QianX.-Y.KrugR.M.The" exact="Influenza" post="Virus NS1 Protein Forms Multimers in Vitro and in"/>
   <result pre="in Vitro and in VivoVirology199521242242810.1006/viro.1995.14997571411 148.NgamurulertS.LimjindapornT.AuewarakuP.Identification of cellular partners of" exact="Influenza" post="A virus (H5N1) non-structural protein NS1 by yeast two-hybrid"/>
   <result pre="A virus by SUMO1J. Virol.2011851086109810.1128/JVI.00877-1021047957 158.FournierG.ChiangC.MunierS.TomoiuA.DemeretC.VidalainP.O.JacobY.NaffakhN.Recruitment of RED-SMU1 complex by" exact="Influenza" post="A Virus RNA polymerase to control Viral mRNA splicingPLoS"/>
   <result pre="protein Aly/REFPLoS ONE20138e7242910.1371/journal.pone.007242924073193 163.GenerousA.ThorsonM.BarcusJ.JacherJ.BuschM.SleisterH.Identification of putative interactions between swine and" exact="human influenza" post="A virus nucleoprotein and human host proteinsVirol. J.20141122810.1186/s12985-014-0228-625547032 164.MomoseF.BaslerC.F.Oâ€™NeillR.E.IwamatsuA.PaleseP.NagataK.Cellular"/>
   <result pre="virus replicationSci. China Life Sci.2010531098110510.1007/s11427-010-4048-721104370 182.MaH.KienF.ManiÃ¨reM.ZhangY.LagardeN.TseK.S.PoonL.L.M.NalB.Human Annexin A6 Interacts with" exact="Influenza" post="A Virus Protein M2 and Negatively Modulates InfectionJ. Virol.2012861789180110.1128/JVI.06003-1122114333"/>
   <result pre="183.FanY.MokC.K.ChanM.C.ZhangY.NalB.KienF.BruzzoneR.SanyalS.Cell Cycle-independent Role of Cyclin D3 in Host Restriction of" exact="Influenza" post="Virus InfectionJ. Biol. Chem.20172925070508810.1074/jbc.M117.77611228130444 184.ZhuP.LiangL.ShaoX.LuoW.JiangS.ZhaoQ.SunN.ZhaoY.LiJ.WangJ.et al.Host Cellular Protein TRAPPC6ADelta"/>
   <result pre="InfectionJ. Biol. Chem.20172925070508810.1074/jbc.M117.77611228130444 184.ZhuP.LiangL.ShaoX.LuoW.JiangS.ZhaoQ.SunN.ZhaoY.LiJ.WangJ.et al.Host Cellular Protein TRAPPC6ADelta Interacts with" exact="Influenza" post="A Virus M2 Protein and Regulates Viral Propagation by"/>
   <result pre="antibodies in bacteria and yeastJ. Biosci. Bioeng.201512048349010.1016/j.jbiosc.2015.03.00925912450 195.LeeY.-N.KimM.-C.LeeY.-T.HwangH.S.LeeJ.KimC.KangS.-M.Cross Protection against" exact="Influenza" post="A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular"/>
   <result pre="Tandem Repeat M2 Extracellular ProteinsPLoS ONE201510e013782210.1371/journal.pone.013782226366729 196.LeiH.JinS.KarlssonE.Schultz-CherryS.YeK.Yeast Surface-Displayed H5N1 Avian" exact="Influenza" post="VaccinesJ. Immunol. Res.20162016413132410.1155/2016/413132428078309 197.JenningsB.H.Drosophilaâ€&quot;A versatile model in biology &amp;amp;"/>
   <result pre="of RNA Silencing by an Animal VirusScience20022961319132110.1126/science.107094812016316 229.MostafaA.AbdelwhabE.M.MettenleiterT.C.PleschkaS.Zoonotic Potential of" exact="Influenza" post="A Viruses: A Comprehensive OverviewViruses20181049710.3390/v1009049730217093 230.KokK.H.JinD.-Y.Influenza A virus NS1"/>
   <result pre="cell culture systems for asthma researchJ. Allergy2012201294398210.1155/2012/94398222287976 249.RamosI.Fernandez-SesmaA.Cell Receptors for" exact="Influenza" post="a Viruses and the Innate Immune ResponseFront. Microbiol.2012311710.3389/fmicb.2012.0011722536196 250.ChanM.C.ChanR.W.YuW.C.HoC.C.YuenK.M.FongJ.H.TangL.L.LaiW.W.LoA.C.ChuiW.H.et"/>
   <result pre="and Role for Future Cell TherapyCurr. Allergy Asthma Rep.20141549010.1007/s11882-014-0490-0 254.ScullM.A.Gillim-RossL.SantosC.RobertsK.L.BordonaliE.SubbaraoK.BarclayW.S.PicklesR.J.Avian" exact="Influenza" post="virus glycoproteins restrict virus replication and spread through human"/>
   <result pre="Allergy Clin. Immunol.20013187388010.1046/j.1365-2222.2001.01103.x 256.KimH.J.KimC.H.KimM.J.RyuJ.H.SeongS.Y.KimS.LimS.J.HoltzmanM.J.YoonJ.H.The Induction of Pattern-Recognition Receptor Expression against" exact="Influenza" post="A Virus through Duox2-Derived Reactive Oxygen Species in Nasal"/>
   <result pre="cells (hNECs)Exp. Cell Res.201735218419210.1016/j.yexcr.2017.01.01128131813 262.TanK.S.YanY.KohW.L.H.LiL.ChoiH.TranT.SugrueR.WangD.Y.ChowV.T.Comparative Transcriptomic and Metagenomic Analyses of" exact="Influenza" post="Virus-Infected Nasal Epithelial Cells From Multiple Individuals Reveal Specific"/>
   <result pre="of Normal Human Bronchial Epithelial Cells as a Model for" exact="Influenza" post="A Infections in Human Distal TracheaJ. Histochem. Cytochem.20156331232810.1369/002215541557096825604814 265.ThompsonC.I.BarclayW.S.ZambonM.C.PicklesR.J.Infection"/>
   <result pre="human and avian strains of influenza a virusJ. Virol.2006808060806810.1128/JVI.00384-0616873262 266.OshanskyC.M.PickensJ.A.BradleyK.C.JonesL.P.Saavedra-EbnerG.M.BarberJ.P.CrabtreeJ.M.SteinhauerD.A.TompkinsS.M.TrippR.A.Avian" exact="Influenza" post="Viruses Infect Primary Human Bronchial Epithelial Cells Unconstrained by"/>
   <result pre="type 1 and avian influenza viruses, and sialyl(alpha2-6)Gal receptor for" exact="human influenza" post="virusesGlycoconj. J.20062310110610.1007/s10719-006-5442-z16575527 270.NichollsJ.M.BourneA.J.ChenH.GuanY.PeirisJ.S.M.Sialic acid receptor detection in the human"/>
   <result pre="Bull.20052839940810.1248/bpb.28.39915744059 272.DanzyS.StuddardL.R.ManicassamyB.SolorzanoA.MarshallN.GarcÃ­a-SastreA.SteelJ.LowenA.C.Mutations to PB2 and NP Proteins of an Avian" exact="Influenza" post="Virus Combine To Confer Efficient Growth in Primary Human"/>
   <result pre="that confer binding to human tracheal airway epitheliumPLoS ONE20094e783610.1371/journal.pone.000783619924306 276.DavisA.S.ChertowD.S.KindrachukJ.QiL.SchwartzmanL.M.SuzichJ.AlsaatyS.LogunC.ShelhamerJ.H.TaubenbergerJ.K.1918" exact="Influenza" post="receptor binding domain variants bind and replicate in primary"/>
   <result pre="role in organizing the actin cytoskeletonJ. Cell Sci.201112467968310.1242/jcs.06496421321325 280.MindayeS.T.IlyushinaN.A.FantoniG.AltermanM.A.DonnellyR.P.EichelbergerM.C.Impact of" exact="Influenza" post="A Virus Infection on the Proteomes of Human Bronchoepithelial"/>
   <result pre="a mutually exclusive mannerJ. Virol.201810.1128/JVI.00396-1829743359 283.SmallwoodH.S.DuanS.MorfouaceM.RezinciucS.ShulkinB.L.ShelatA.ZinkE.E.MilastaS.BajracharyaR.OluwaseumA.J.et al.Targeting Metabolic Reprogramming by" exact="Influenza" post="Infection for Therapeutic InterventionCell Rep.2017191640165310.1016/j.celrep.2017.04.03928538182 284.NicholasB.StaplesK.J.MoeseS.MeldrumE.WardJ.DennisonP.HavelockT.HinksT.S.C.AmerK.WooE.et al.A novel lung"/>
   <result pre="Type II Cells Secrete Antiviral IL-29 (IFN-Î»1) in Response to" exact="Influenza" post="A InfectionJ. Immunol.20091821296130410.4049/jimmunol.182.3.129619155475 297.TravantyE.ZhouB.ZhangH.DiY.P.AlcornJ.F.WentworthD.E.MasonR.WangJ.Differential Susceptibilities of Human Lung Primary"/>
   <result pre="InfectionJ. Immunol.20091821296130410.4049/jimmunol.182.3.129619155475 297.TravantyE.ZhouB.ZhangH.DiY.P.AlcornJ.F.WentworthD.E.MasonR.WangJ.Differential Susceptibilities of Human Lung Primary Cells to" exact="H1N1 Influenza" post="VirusesJ. Virol.201589119351194410.1128/JVI.01792-1526378172 298.YuW.C.L.ChanR.W.Y.WangJ.TravantyE.A.NichollsJ.M.PeirisJ.S.M.MasonR.J.ChanM.C.W.Viral Replication and Innate Host Responses in"/>
   <result pre="Immunol.20091821296130410.4049/jimmunol.182.3.129619155475 297.TravantyE.ZhouB.ZhangH.DiY.P.AlcornJ.F.WentworthD.E.MasonR.WangJ.Differential Susceptibilities of Human Lung Primary Cells to H1N1" exact="Influenza" post="VirusesJ. Virol.201589119351194410.1128/JVI.01792-1526378172 298.YuW.C.L.ChanR.W.Y.WangJ.TravantyE.A.NichollsJ.M.PeirisJ.S.M.MasonR.J.ChanM.C.W.Viral Replication and Innate Host Responses in"/>
   <result pre="Primary Human Alveolar Epithelial Cells and Alveolar Macrophages Infected with" exact="Influenza" post="H5N1 and H1N1 VirusesJ. Virol.2011856844685510.1128/JVI.02200-1021543489 299.ItoY.CorrellK.ZemansR.L.LeslieC.C.MurphyR.C.MasonR.J.Influenza induces IL-8 and"/>
   <result pre="proviral role for CEACAM1Sci. Rep.201881546810.1038/s41598-018-33605-630341336 302.WangJ.NikradM.P.PhangT.GaoB.AlfordT.ItoY.EdeenK.TravantyE.A.KosmiderB.HartshornK.et al.Innate Immune Response to" exact="Influenza" post="A Virus in Differentiated Human Alveolar Type II CellsAm."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6958466\results\search\zoonosis\results.xml">
   <result pre="Flaviviridae family. Some important disease-causing viruses of this genus are" exact="Dengue fever" post="virus, Tick-borne encephalitis virus, West Nile virus, Japanese encephalitis"/>
   <result pre="are Dengue fever virus, Tick-borne encephalitis virus, West Nile virus," exact="Japanese encephalitis" post="virus, and Zika virus [10]. These viruses possess a"/>
   <result pre="and came through rodents in ships carrying grain to Rome." exact="Smallpox" post="infections that decimated the native populations of the New"/>
   <result pre="vaccines are available for the yellow fever virus (YFV) and" exact="Japanese encephalitis" post="virus (JEV). There are two types of JEV vaccine"/>
   <result pre="weakened YFV strain [47]. None exist for the Zika or" exact="Dengue" post="viruses. An important point to note is that vaccines,"/>
   <result pre="dependent enhancement or ADE. Reportedly, in cases of a secondary" exact="Dengue" post="infection, it has been seen that the disease severity"/>
   <result pre="probable cause is an abnormal behavior of the antibodies against" exact="Dengue" post="virusâ€&quot;they aid in the virulence of this arbovirus resulting"/>
   <result pre="virusâ€&quot;they aid in the virulence of this arbovirus resulting in" exact="Dengue" post="Shock Syndrome or Dengue Hemorrhagic Fever [49]. Since Zika"/>
   <result pre="virulence of this arbovirus resulting in Dengue Shock Syndrome or" exact="Dengue" post="Hemorrhagic Fever [49]. Since Zika is closely related to"/>
   <result pre="NS5-based peptide vaccines that targets both Zika as well as" exact="Dengue" post="viruses. Furthermore, Richner et al. (2017) [58] assembled modified"/>
   <result pre="of YFV 17D-based chimeric vaccines against dengue, West Nile and" exact="Japanese encephalitis" post="virusesVaccine20102863264910.1016/j.vaccine.2009.09.09819808029 48.WHO Vaccine Pipeline TrackerAvailable online: https://docs.google.com/spreadsheets/d/19otvINcayJURCMg76xWO4KvuyedYbMZDcXqbyJGdcZM/pubhtml#(accessed on 15"/>
   <result pre="through in silico screeningAntivir. Res.2018151788610.1016/j.antiviral.2017.12.01629274845 131.YangS.XuM.LeeE.M.ShiryaevS.A.HeS.SunW.ChengY.-S.HuX.TharappelA.M.LuB.et al.Emetine inhibits Zika and" exact="Ebola" post="virus infections through two molecular mechanisms: Inhibiting viral replication"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6977312\results\search\zoonosis\results.xml">
   <result pre="keratitis â€&quot; Topical or oral corticosteroids on bullous retinal detachment" exact="Influenza" post="virus Retinal edema, shiny vesicular dots at the termination"/>
   <result pre="to moderate vitreous reaction No No â€&quot; Doxycycline Systemic corticosteroids" exact="Dengue" post="virus Maculopathy with macular edema, focal chorioretinitis, yellow subretinal"/>
   <result pre="while waiting for the exclusion of other HVFs such as" exact="Ebola" post="virus disease or Crimean-Congo hemorrhagic fever [39, 98]. Standard"/>
   <result pre="[104] and was successfully used to cure and prevent from" exact="Lassa fever" post="[105]. To date, its use is not indicated when"/>
   <result pre="east AfricaJ Pathol Bacteriol19313454557910.1002/path.1700340418 2.TantelyLMBoyerSFontenilleDA review of mosquitoes associated with" exact="Rift Valley fever" post="virus in MadagascarAm J Trop Med Hyg20159272272910.4269/ajtmh.14-042125732680 3.MonacoFPinoniCCossedduGMKhaisebSCalistriPMoliniUet al.Rift"/>
   <result pre="from Mali to Europe and other countries, 2016Eurosurveillance.201924180021310.2807/1560-7917.ES.2019.24.8.1800213 10.ChevalierVRelevance of" exact="Rift Valley fever" post="to public health in the European UnionClin Microbiol Infect20131970570810.1111/1469-0691.1216323517372"/>
   <result pre="European UnionClin Microbiol Infect20131970570810.1111/1469-0691.1216323517372 11.LiuJSunYShiWTanSPanYCuiSet al.The first imported case of" exact="Rift Valley fever" post="in China reveals a genetic reassortment of different viral"/>
   <result pre="a genetic reassortment of different viral lineagesEmerg Microbes Infect.20176e410.1038/emi.2016.13628096531 12.WiwanitkitSEmerging" exact="Rift Valley fever" post="in China: what should be known?Asian Pac J Trop"/>
   <result pre="to the United Kingdom to support replication and transmission of" exact="Rift Valley fever" post="virusParasite Vectors.20181130810.1186/s13071-018-2884-7 14.HartleyDMRinderknechtJLNippTLClarkeNPSnowderGDcollab: National Center for Foreign Animal and"/>
   <result pre="Disease Defense Advisory Group on Rift Valley FeverPotential effects of" exact="Rift Valley fever" post="in the United StatesEmerging Infect Dis.201117e121801607 15.HartmanDARiceLMDeMariaJBorlandEMBergrenNAFagreACet al.Entomological risk"/>
   <result pre="Infect Dis.201117e121801607 15.HartmanDARiceLMDeMariaJBorlandEMBergrenNAFagreACet al.Entomological risk factors for potential transmission of" exact="Rift Valley fever" post="virus around concentrations of livestock in ColoradoTransbound Emerg Dis.2019661709171731002468"/>
   <result pre="research and development for zoonotic disease controlEmerging Infect Dis.20131918919310.3201/eid1902.12094123347653 17.LaughlinLWMeeganJMStrausbaughLJMorensDMWattenRHEpidemic" exact="Rift Valley fever" post="in Egypt: observations of the spectrum of human illnessTrans"/>
   <result pre="human illnessTrans R Soc Trop Med Hyg19797363063310.1016/0035-9203(79)90006-3575446 18.AhmadKMore deaths from" exact="Rift Valley fever" post="in Saudi Arabia and YemenLancet2000356142210.1016/S0140-6736(05)74068-X11052595 19.MohamedMMoshaFMghambaJZakiSRShiehW-JPaweskaJet al.Epidemiologic and clinical"/>
   <result pre="Arabia and YemenLancet2000356142210.1016/S0140-6736(05)74068-X11052595 19.MohamedMMoshaFMghambaJZakiSRShiehW-JPaweskaJet al.Epidemiologic and clinical aspects of a" exact="Rift Valley fever" post="outbreak in humans in Tanzania, 2007Am J Trop Med"/>
   <result pre="meta-analysis protocols (PRISMA-P) 2015 statementSyst Rev.201520154 23.World Health Organization (WHO)." exact="Rift Valley fever." post="https://www.who.int/news-room/fact-sheets/detail/rift-valley-fever. Accessed 31 Dec 2019. 24.Centers for Disease Control"/>
   <result pre="Rift Valley FeverElectron J Diff Eq.2007115112 33.NiuTGaffHDPapelisYEHartleyDMAn epidemiological model of" exact="Rift Valley fever" post="with spatial dynamicsComput Math Methods Med.2012201213875710.1155/2012/13875722924058 34.LiJBlakeleyDSmithRJThe failure of"/>
   <result pre="Arabia, August-November 2000. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4943a3.htm. Accessed 29 June 2019. 43.KahlonSSPetersCJLeducJMuchiriEMMuiruriSNjengaMKet al.Severe" exact="Rift Valley fever" post="may present with a characteristic clinical syndromeAm J Trop"/>
   <result pre="of Rift Valley Fever in MadagascarMed Mal Infect.20114131832110.1016/j.medmal.2010.12.00721295426 47.Al-HazmiMAyoolaEAAbdurahmanMBanzalSAshrafJEl-BushraAet al.Epidemic" exact="Rift Valley fever" post="in Saudi Arabia: a clinical study of severe illness"/>
   <result pre="study of severe illness in humansClin Infect Dis20033624525210.1086/34567112539063 48.NderituLLeeJSOmoloJOmuloSOâ€™GuinnMLHightowerAet al.Sequential" exact="Rift Valley fever" post="outbreaks in eastern Africa caused by multiple lineages of"/>
   <result pre="caused by multiple lineages of the virusJ Infect Dis201120365566510.1093/infdis/jiq00421282193 49.BabaMMasigaDKSangRVillingerJHas" exact="Rift Valley fever" post="virus evolved with increasing severity in human populations in"/>
   <result pre="virus: unanswered questionsAntiviral Res201613227428010.1016/j.antiviral.2016.07.00527400990 53.LaBeaudADPfeilSMuiruriSDahirSSutherlandLJTraylorZet al.Factors associated with severe human" exact="Rift Valley fever" post="in Sangailu, Garissa County, KenyaPLoS Negl Trop Dis.20159e000354810.1371/journal.pntd.000354825764399 54.NjengaMKPaweskaJWanjalaRRaoCYWeinerMOmballaVet"/>
   <result pre="FeverRev Sci Tech Off Int Epiz20153437538910.20506/rst.34.2.2364 57.SmithDRSteeleKEShamblinJHonkoAJohnsonJReedCet al.The pathogenesis of" exact="Rift Valley fever" post="virus in the mouse modelVirology201040725626710.1016/j.virol.2010.08.01620850165 58.AyoolaAEAl-HazmiMHMichailNTAderojuAHafezMMBanzalSBLiver involvement in patients"/>
   <result pre="60.ShiehW-JPaddockCDLedermanERaoCYGouldLHMohamedMet al.Pathologic studies on suspect animal and human cases of" exact="Rift Valley fever" post="from an outbreak in Eastern Africa, 2006â€&quot;2007Am J Trop"/>
   <result pre="in Mauritania, 2015Open Forum Infect Dis.2016320010.1093/ofid/ofw200 62.PhilippeBJouanARiouOCoulibalyILeguennoBMeeganJet al.Hemorrhagic forms of" exact="Rift Valley fever" post="in MauritaniaBull Soc Pathol Exot198982611619 63.StrausbaughLJLaughlinLWMeeganJMWattenRHClinical studies on Rift"/>
   <result pre="Valley fever in MauritaniaBull Soc Pathol Exot198982611619 63.StrausbaughLJLaughlinLWMeeganJMWattenRHClinical studies on" exact="Rift Valley fever," post="Part I: acute febrile and hemorrhagic-like diseasesJ Egypt Public"/>
   <result pre="Valley feverBull Soc Pathol Exot198982628636 65.JouanAPhilippeBRiouOCoulibalyILeguennoBMeeganJet al.Mild clinical forms of" exact="Rift Valley fever" post="during the epidemic in MauritaniaBull Soc Pathol Exot198982620627 66.Al-KhuwaitirTSAl-MoghairiAMSherbeeniSMAl-GhamdiASRift"/>
   <result pre="and hepatorenal syndromeSaudi Med J20042552853115083233 67.AnyanguASGouldLHSharifSKNgukuPMOmoloJOMutongaDet al.Risk factors for severe" exact="Rift Valley fever" post="infection in Kenya, 2007Am J Trop Med Hyg201083142110.4269/ajtmh.2010.09-029320682901 68.SalemMLOBabaSEWOFall-MalickFZBoushabBMGhaberSMMokhtarASevere"/>
   <result pre="Valley fever encephalitisEmerging Infect Dis.20041055455510.3201/eid1003.02081715116716 71.RiouOPhilippeBJouanACoulibalyIMondoMDigoutteJPNeurologic and neurosensory forms of" exact="Rift Valley fever" post="in MauritaniaBull Soc Pathol Exot198982605610 72.MaarSASwanepoelRGelfandMRift Valley fever encephalitis."/>
   <result pre="description of a caseCent Afr J Med.197925811421266 73.LaughlinLWGirgisNIMeeganJMStrausbaughLJYassinMWWattenRHClinical studies on" exact="Rift Valley fever." post="Part 2: Ophthalmologic and central nervous system complicationsJ Egypt"/>
   <result pre="from symptom onset, France, autumn 2015Eurosurveillance.201610.2807/1560-7917.ES.2016.21.18.3022227172608 75.ReedCLinKWilhelmsenCFriedrichBNalcaAKeeneyAet al.Aerosol exposure to" exact="Rift Valley fever" post="virus causes earlier and more severe neuropathology in the"/>
   <result pre="into the central nervous system are inflammatory components of lethal" exact="Rift Valley fever" post="encephalitis in ratsPLoS Pathog201915e100783310.1371/journal.ppat.100783331220182 79.WonderlichERCarolineALMcMillenCMWaltersAWReedDSBarratt-BoyesSMet al.Peripheral blood biomarkers of"/>
   <result pre="permeability in the brain is a late pathogenic event during" exact="Rift Valley fever" post="virus encephalitis in ratsVirology201952617317910.1016/j.virol.2018.10.02130396029 81.El ImamMEl SabiqMOmranMAbdalkareemAEl Gaili MohamedMAElbashirAet"/>
   <result pre="rift valley feverS Afr Med J19512592693014892952 84.Al-HazmiAAl-RajhiAAAbboudEBAyoolaEAAl-HazmiMSaadiRet al.Ocular complications of" exact="Rift Valley fever" post="outbreak in Saudi ArabiaOphthalmology200511231331810.1016/j.ophtha.2004.09.01815691569 85.YoserSLForsterDJRaoNASystemic viral infections and their"/>
   <result pre="human abortionsTrans R Soc Trop Med Hyg19807468568610.1016/0035-9203(80)90167-47193926 93.BaudinMJumaaAMJommaHJEKarsanyMSBuchtGNÃ¤slundJet al.Association of" exact="Rift Valley fever" post="virus infection with miscarriage in Sudanese women: a cross-sectional"/>
   <result pre="pregnant Sudanese womanJ Med Virol20088092910.1002/jmv.2113218360907 95.ArishiHMAqeelAYAl HazmiMMVertical transmission of fatal" exact="Rift Valley fever" post="in a newbornAnn Trop Paediatr20062625125310.1179/146532806X12036316925964 96.WoodsCWKarpatiAMGreinTMcCarthyNGaturukuPMuchiriEet al.An outbreak of"/>
   <result pre="Accessed 30 June 2019. 102.KendeMAlvingCRRillWLSwartzGMCanonicoPGEnhanced efficacy of liposome-encapsulated ribavirin against" exact="Rift Valley fever" post="virus infection in miceAntimicrob Agents Chemother19852790390710.1128/AAC.27.6.9034026264 103.HugginsJWProspects for treatment"/>
   <result pre="antiviral compoundSci Rep.20188192510.1038/s41598-018-20362-929386590 107.SchartonDBaileyKWVestZWestoverJBKumakiYVan WettereAet al.Favipiravir (T-705) protects against peracute" exact="Rift Valley fever" post="virus infection and reduces delayed-onset neurologic disease observed with"/>
   <result pre="Chemother.201963e00669-1910.1128/AAC.00669-1931085519 110.AtkinsCFreibergANRecent advances in the development of antiviral therapeutics for" exact="Rift Valley fever" post="virus infectionFuture Virol.20171265166510.2217/fvl-2017-006029181086 111.AllenERKrummSARaghwaniJHalldorssonSElliottAGrahamVAet al.A protective monoclonal antibody targets"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6993835\results\search\zoonosis\results.xml">
   <result pre="cause in the West is herpes simplex virus, but globally" exact="Japanese encephalitis" post="(JE) remains the single largest cause. Etiologic diagnosis is"/>
   <result pre="forms of immunotherapy are used for AIE. Acute encephalitis syndrome" exact="Japanese encephalitis" post="autoimmune encephalitis Funding The author(s) declared that no grants"/>
   <result pre="virus Flaviviruses (mosquito-borne) Â Â Â Â â€¢Â Â Â" exact="Japanese encephalitis" post="virus Â Â Â Â â€¢Â Â Â St"/>
   <result pre="rubella virus Bunyaviruses Â Â Â Â â€¢Â Â Â" exact="California encephalitis" post="virus Reoviruses Â Â Â Â â€¢Â Â Â"/>
   <result pre="and 71 Orthomyxoviruses Â Â Â Â â€¢Â Â Â" exact="Influenza" post="viruses Paramyxoviruses Â Â Â Â â€¢Â Â Â"/>
   <result pre="Â Shigella encephalopathy Â Â Â Â â€¢Â Â Â" exact="Dengue" post="encephalopathy Â Â Â Â â€¢Â Â Â Sepsis"/>
   <result pre="infectious encephalitisis is herpes simplex virus encephalitis (HSVE) 11. The" exact="California Encephalitis" post="Project enrolled 1570 patients with suspected encephalitis over a"/>
   <result pre="and occurs in epidemics, especially in the south and east." exact="Rabies" post="is another form of VE which poses a public"/>
   <result pre="of encephalitis in the southern state of Kerela 19, 20." exact="Dengue" post="infection was known to produce neurologic manifestations, including encephalopathy,"/>
   <result pre="characteristic of influenza. Patients with rabies may have the characteristic" exact="hydrophobia" post="or aerophobia. Neurologic signs in acute encephalitis do not"/>
   <result pre="multifocal or diffuse brain involvement have been described 37, 38." exact="Rabies" post="may present as an ascending paralysis simulating Guillainâ€&quot;BarrÃ© syndrome"/>
   <result pre="Clinical features in children hospitalized during the 2005 epidemic of" exact="Japanese encephalitis" post="in Uttar Pradesh, India.Clin Infect Dis.2006;43(2):123â€&quot;31. 10.1086/50512116779737 F1000 Recommendation"/>
   <result pre="India.Clin Infect Dis.2006;43(2):123â€&quot;31. 10.1086/50512116779737 F1000 Recommendation 14JainPSinghAKKhanDNet al.: Trend of" exact="Japanese encephalitis" post="in Uttar Pradesh, India from 2011 to 2013.Epidemiol Infect.2016;144(2):363â€&quot;70."/>
   <result pre="in India.PLoS Negl Trop Dis.2019;13(6):e0007393. 10.1371/journal.pntd.000739331246966 F1000 Recommendation 21LumLCLamSKChoyYSet al.:" exact="Dengue" post="encephalitis: a true entity?Am J Trop Med Hyg.1996;54(3):256â€&quot;9. 10.4269/ajtmh.1996.54.2568600761"/>
   <result pre="a true entity?Am J Trop Med Hyg.1996;54(3):256â€&quot;9. 10.4269/ajtmh.1996.54.2568600761 22KumarRTripathiSTambeJJet al.:" exact="Dengue" post="encephalopathy in children in Northern India: clinical features and"/>
   <result pre="approach to diagnosis of autoimmune encephalitis.Lancet Neurol.2016;15(4):391â€&quot;404. 10.1016/S1474-4422(15)00401-926906964 45ParidaMDashPKTripathiNKet al.:" exact="Japanese Encephalitis" post="Outbreak, India, 2005.Emerg Infect Dis.2006;12(9):1427â€&quot;30. 10.3201/eid1209.06020017073095 46SaxenaVMishraVKDholeTN: Evaluation of"/>
   <result pre="Evaluation of reverse-transcriptase PCR as a diagnostic tool to confirm" exact="Japanese encephalitis" post="virus infection.Trans R Soc Trop Med Hyg.2009;103(4):403â€&quot;6. 10.1016/j.trstmh.2009.01.02119249068 47SarkarATaraphdarDMukhopadhyaySKet"/>
   <result pre="Hyg.2009;103(4):403â€&quot;6. 10.1016/j.trstmh.2009.01.02119249068 47SarkarATaraphdarDMukhopadhyaySKet al.: Molecular evidence for the occurrence of" exact="Japanese encephalitis" post="virus genotype I and III infection associated with acute"/>
   <result pre="high-dose dexamethasone on the outcome of acute encephalitis due to" exact="Japanese encephalitis" post="virus.J Infect Dis.1992;165(4):631â€&quot;7. 10.1093/infdis/165.4.6311313068 56StanberryLR: Herpes simplex virus. In:"/>
   <result pre="10.1016/s0140-6736(03)12709-212642049 62KumarRTripathiPBaranwalMet al.: Randomized, controlled trial of oral ribavirin for" exact="Japanese encephalitis" post="in children in Uttar Pradesh, India.Clin Infect Dis.2009;48(4):400â€&quot;6. 10.1086/59630919143532"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7019949\results\search\zoonosis\results.xml">
   <result pre="migration is important in the spread of disease. Similarly, the" exact="Ebola" post="outbreak in west Africa in 2014â€&quot;2016 spread rapidly regionally"/>
   <result pre="which modeling studies showed was vital for preventing dissemination of" exact="Ebola" post="to the rest of the world [18]. However, even"/>
   <result pre="Travel Med.20162310.1093/jtm/taw019 18.WiratsudakulA.TriampoW.LaosiritawornY.ModchangC.A one-year effective reproduction number of the 2014â€&quot;2015" exact="Ebola" post="outbreaks in the widespread West African countries and quantitative"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7020194\results\search\zoonosis\results.xml">
   <result pre="airway inflammation, is yet to be established. Host Factor in" exact="Influenza" post="Viral Export An estimated 5% of adults develop influenza"/>
   <result pre="epidemics are largely due to influenza viruses A and B." exact="Influenza" post="viruses are segmented, negative-sense RNA viruses within a lipid"/>
   <result pre="cytoskeletal reorganization.J. Cell Biol.163165â€&quot;176. 10.1083/jcb.20030107514557253 ShimJ. M.KimJ.TensonT.MinJ. Y.KainovD. E. (2017)." exact="Influenza" post="virus infection, interferon response, viral counter-response, and apoptosis.Viruses9:E223. 10.3390/v908022328805681"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7029158\results\search\zoonosis\results.xml">
   <result pre="GS-734 (Remdesivir), a nucleotide analogue pro-drug, originally developed against the" exact="Ebola" post="and the Marburg viruses, has been recently suggested to"/>
   <result pre="of ChinaAvailable at:http://www.nhc.gov.cn/2020 PellB.KuangY.ViboudC.ChowellG.Using phenomenological models for forecasting the 2015" exact="Ebola" post="challengeEpidemics222018627027913131 ReadJ.M.BridgenJ.R.CummingsD.A.HoA.JewellC.P.Novel coronavirus 2019-nCoV: Early estimation of epidemiological parameters"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7054940\results\search\zoonosis\results.xml">
   <result pre="Kennel coughPneumonia Equine Equine coronavirus Betacoronavirus GI Tract Gastroenteritis Camel" exact="Middle East respiratory syndrome" post="(MERS) coronavirus Betacoronavirus Respiratory tract Mild respiratory signs Chicken"/>
   <result pre="that was intended to be used for the treatment of" exact="Ebola" post="virus disease. It also has anti-coronavirus activity due to"/>
   <result pre="and Nipah viruses, as well as earlier emergencies posed by" exact="Bird flu" post="and Swine flu viruses. The emerging novel coronavirus (2019-nCoV)"/>
   <result pre="CormanVM, CottontailVM, RichardsLR, SchoemanMC, DrostenC, DrexlerJF, PreiserW2013Close relative of human" exact="Middle East respiratory syndrome" post="coronavirus in bat, South Africa. Emerg Infect Dis. 19(10):1697â€&quot;1699."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7057477\results\search\zoonosis\results.xml">
   <result pre="Other members of this family include arboviruses, dengue virus and" exact="Japanese encephalitis" post="viruses [11]. ZIKV antibodies were also detected in animal"/>
   <result pre="with Zika virus Dissimilarities with Zika virus Diagnostic test 1" exact="Dengue fever" post="High fever, severe muscle pain, and headache and may"/>
   <result pre="in ZIKV infection as it proved to be effective in" exact="Japanese encephalitis" post="virus which is included in the same genus like"/>
   <result pre="virus [33]. Treatment with belladonna efficaciously reduced the severity of" exact="Japanese encephalitis" post="virus infection [58]. Atropa belladonna plant belongs to family"/>
   <result pre="infections available for use of human are yellow fever vaccine," exact="Japanese encephalitis" post="vaccine, tick-borne encephalitis vaccines and dengue vaccine, so the"/>
   <result pre="could trigger Guillainâ€&quot;BarrÃ© syndromeNat Rev Neurol.201610.1038/nrneurol.2016.3027982042 58.BandyopadhyayBDasSSenguptaMSahaCDasKCSarkarDet al.Decreased intensity of" exact="Japanese encephalitis" post="virus infection in chick chorioallantoic membrane under influence of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7061886\results\search\zoonosis\results.xml">
   <result pre="10.1136/bmjgh-2019-001955 : Original Research: 1506 Forty-two years of responding to" exact="Ebola" post="virus outbreaks in Sub-Saharan Africa: a review RugarabamuSima12MboeraLeonard1RweyemamuMark1MwanyikaGaspary13LutwamaJulius4PaweskaJanusz5MisinzoGerald1[1], SACIDS"/>
   <result pre="indicated, and the use is non-commercial. See:Â http://creativecommons.org/licenses/by-nc/4.0/.bmjgh-2019-001955.pdf Abstract Introduction" exact="Ebola" post="virus disease (EVD) is one of the deadliest haemorrhagic"/>
   <result pre="questions What is already known? The unprecedented scale of recent" exact="Ebola" post="virus disease (EVD) epidemics is attributed to a combination"/>
   <result pre="systems need to be addressed to prevent future outbreaks. Introduction" exact="Ebola" post="virus disease (EVD) is a severe, often fatal, illness"/>
   <result pre="EVD epidemics. This review aimed to analyse 42 years of" exact="Ebola" post="virus outbreak reports, identify challenges and opportunities in its"/>
   <result pre="some of the affected countries. The keywords used were Ebola," exact="Ebola" post="haemorrhagic fever, EVD, outbreaks, epidemics, challenges, diagnosis, case management,"/>
   <result pre="were included in the final review (figure 1). Trends in" exact="Ebola" post="outbreaks Since 1976, when EVD was first detected in"/>
   <result pre="Figure 2 Map showing the 11 African countries affected by" exact="Ebola" post="virus disease since 1976. Ebola is endemic in East-Central"/>
   <result pre="11 African countries affected by Ebola virus disease since 1976." exact="Ebola" post="is endemic in East-Central and West Africa and is"/>
   <result pre="going outbreak BDBV, Bundibugyo ebolavirus; CFR, case fatality rate; EBOV," exact="Ebola" post="virus; EVD, Ebola virus disease; SUDV, Sudan Ebola virus;"/>
   <result pre="Bundibugyo ebolavirus; CFR, case fatality rate; EBOV, Ebola virus; EVD," exact="Ebola" post="virus disease; SUDV, Sudan Ebola virus; TAFV, TaÃ¯ Forest"/>
   <result pre="rate; EBOV, Ebola virus; EVD, Ebola virus disease; SUDV, Sudan" exact="Ebola" post="virus; TAFV, TaÃ¯ Forest ebolavirus. Context of EVD Different"/>
   <result pre="due to their occupational and domestic caregiving role.24 In most" exact="Ebola" post="outbreaks, the transmission rate has been higher in the"/>
   <result pre="morbidity and mortality caused by EVD. Control strategies during an" exact="Ebola" post="outbreak include proactive case detection, contact tracing and management,"/>
   <result pre="(table 2). All the sources of known index cases of" exact="Ebola" post="have been traced to the hunting of bushmeat or"/>
   <result pre="20 614 Occupation Healthcare worker CFR, case fatality rate; EVD," exact="Ebola" post="virus disease. Case fatality rates varied from 71% during"/>
   <result pre="over time (table 3, figure 3). Figure 3 Number of" exact="Ebola" post="cases and case fatality rate (CFR) in Sub-Saharan Africa,"/>
   <result pre="Africa, 1976â€&quot;2019. Table 3 OR for case fatality rate of" exact="Ebola" post="virus disease according to period Year of outbreak 1976â€&quot;1986"/>
   <result pre="EVD outbreak Factor Challenge Opportunity Action Epidemiological and ecological factors" exact="Ebola" post="viruses are endemic in central and western African rainforests."/>
   <result pre="various channels, including social media. Empowering individuals and communities. EVD," exact="Ebola" post="virus disease. Epidemiological and ecological factors While the specific"/>
   <result pre="other infected animal species, and then spread through human-to-human transmission.30" exact="Ebola" post="viruses are endemic in central and western African rainforests,"/>
   <result pre="equator.30 31 Consequently, the sporadic emergency and spillover of the" exact="Ebola" post="virus are supported by and likely to be associated"/>
   <result pre="some intrinsic factors related to these forest systems.28 Outbreaks of" exact="Ebola" post="virus since 1976 have been occurring in what is"/>
   <result pre="between human population and wildlife, leading to enhanced contacts with" exact="Ebola" post="virus-carrying natural hosts. Humans continuously interact with the biotic"/>
   <result pre="compared with women within the African context.26 The increase in" exact="Ebola" post="outbreaks in DRC since 1994 has been associated with"/>
   <result pre="to conduct trials.6 Testing these drugs in animals infected with" exact="Ebola" post="is hampered by the fact that they must be"/>
   <result pre="in Africa. A major issue surrounding this and other potential" exact="Ebola" post="therapeutics is ensuring the availability and affordability of any"/>
   <result pre="which only direct and indirect contacts of probable and confirmed" exact="Ebola" post="cases, or front-line health workers and humanitarian staff, are"/>
   <result pre="than a year only a quarter of known and probable" exact="Ebola" post="contacts were traced by national surveillance teams. The current"/>
   <result pre="challenges for vaccination uptake.10 Health system vulnerability Long before the" exact="Ebola" post="crisis, access to healthcare services and safe drinking water"/>
   <result pre="difficulties in identifying and following up cases and contacts of" exact="Ebola" post="are the main challenges. In the recent outbreak in"/>
   <result pre="seek healthcare service. Over 3â€‰months, only a third of new" exact="Ebola" post="cases were identified and monitored as contacts of previously"/>
   <result pre="maternity admissions, and attendance in the community.3 New patients with" exact="Ebola" post="are confirmed and isolated with an average delay of"/>
   <result pre="from forest-dwelling fauna to forest interfacing humans, which will enable" exact="Ebola" post="prevention and control at source. To reduce the risk"/>
   <result pre="primates that are found in the region and on the" exact="Ebola" post="virus activity in animals and humans should also be"/>
   <result pre="disease: an overview. Ann Glob Health2014;80:444â€&quot;51.10.1016/j.aogh.2015.02.00525960093 2collab: WHOWorld Health Organization." exact="Ebola hemorrhagic fever" post="in Zaire, 1976. Bull World Health Organ1978;56:271â€&quot;93.307456 3collab: World"/>
   <result pre="External situation report2019;b:52. 4OkwareSI, OmaswaFG, ZarambaS, et al.An outbreak of" exact="Ebola" post="in Uganda. Trop Med Int Health2002;7:1068â€&quot;75.10.1046/j.1365-3156.2002.00944.x12460399 5TownerJS, SealyTK, KhristovaML,"/>
   <result pre="Trop Med Int Health2002;7:1068â€&quot;75.10.1046/j.1365-3156.2002.00944.x12460399 5TownerJS, SealyTK, KhristovaML, et al.Newly discovered" exact="Ebola" post="virus associated with hemorrhagic fever outbreak in Uganda. PLoS"/>
   <result pre="Uganda. PLoS Pathog2008;4:e100021210.1371/journal.ppat.100021219023410 6BaizeS, PannetierD, OestereichL, et al.Emergence of Zaire" exact="Ebola" post="virus disease in guinea. N Engl J Med2014;371:1418â€&quot;25.10.1056/NEJMoa140450524738640 7MagangaGD,"/>
   <result pre="J Med2014;371:2083â€&quot;91.10.1056/NEJMoa141109925317743 8AurelieKK, GuyMM, BonaNF, et al.A historical review of" exact="Ebola" post="outbreaks. Advances in Ebola control. InTech Open2017;2:1â€&quot;27. 9Muyembe-TamfumJJ, MulanguS,"/>
   <result pre="BonaNF, et al.A historical review of Ebola outbreaks. Advances in" exact="Ebola" post="control. InTech Open2017;2:1â€&quot;27. 9Muyembe-TamfumJJ, MulanguS, MasumuJ, et al.Ebola virus"/>
   <result pre="present. Onderstepoort J Vet Res2012;79:810.4102/ojvr.v79i2.451 10ColtartCEM, LindseyB, GhinaiI, et al.The" exact="Ebola" post="outbreak, 2013-2016: old lessons for new epidemics. Philos Trans"/>
   <result pre="J Med2018;379:1198â€&quot;201.10.1056/NEJMp180769130134126 12MajidMU, TahirMS, AliQ, et al.Nature and history of" exact="Ebola" post="virus: an overview. Arch Neurosci2016;3:e3502710.5812/archneurosci.35027 13SheskinDJHandbook of parametric and"/>
   <result pre="et al.What factors might have led to the emergence of" exact="Ebola" post="in West Africa?PLoS Negl Trop Dis2015;9:e000365210.1371/journal.pntd.000365226042592 15GrosethA, FeldmannH, StrongJEThe"/>
   <result pre="West Africa?PLoS Negl Trop Dis2015;9:e000365210.1371/journal.pntd.000365226042592 15GrosethA, FeldmannH, StrongJEThe ecology of" exact="Ebola" post="virus. Trends Microbiol2007;15:408â€&quot;16.10.1016/j.tim.2007.08.00117698361 16MacNeilA, RollinPEEbola and Marburg hemorrhagic fevers:"/>
   <result pre="tropical diseases?PLoS Negl Trop Dis2012;6:e154610.1371/journal.pntd.000154622761967 17SanchezA, GeisbertTW, FeldmannHFiloviridae: Marburg and" exact="Ebola" post="Viruses : KnipeDM, HowleyPM, Fields virology. Philadelphia: Lippincott Williams"/>
   <result pre="19TongY-G, ShiW-F, LiuD, et al.Genetic diversity and evolutionary dynamics of" exact="Ebola" post="virus in Sierra Leone. Nature2015;524:93â€&quot;6.10.1038/nature1449025970247 20CarrollSA, TownerJS, SealyTK, et"/>
   <result pre="based on 97 whole-genome sequences. J Virol2013;87:2608â€&quot;16.10.1128/JVI.03118-1223255795 21Check HaydenE, HaydenEThe" exact="Ebola" post="questions. Nature2014;514:554â€&quot;7.10.1038/514554a25355344 22OleribeOO, SalakoBL, KaMM, et al.Ebola virus disease"/>
   <result pre="countries. Clin Med2015;15:54â€&quot;7.10.7861/clinmedicine.15-1-54 23Centers for Disease Control and Prevention, 2014-2016" exact="Ebola" post="Outbreak in West Africa | History | Ebola (Ebola"/>
   <result pre="Prevention, 2014-2016 Ebola Outbreak in West Africa | History |" exact="Ebola" post="(Ebola Virus Disease) | CDC [Internet]. Cdc.gov, 2019 Available:"/>
   <result pre="rates and risk factors for infection among health workers during" exact="Ebola" post="and Marburg virus outbreaks: a systematic review. J Infect"/>
   <result pre="Marburg virus outbreaks: a systematic review. J Infect Dis2018;218:S679â€&quot;89.10.1093/infdis/jiy43530202878 27DyerOTwo" exact="Ebola" post="treatments halve deaths in trial in DRC outbreak. BMJ2019;366:l514010.1136/bmj.l514031409588"/>
   <result pre="outbreak. BMJ2019;366:l514010.1136/bmj.l514031409588 28NkanguMN, OlatundeOA, YayaSThe perspective of gender on the" exact="Ebola" post="virus using a risk management and population health framework:"/>
   <result pre="Poverty2017;610.1186/s40249-017-0346-7 29WonderlyB, JonesS, GattonML, et al.Comparative performance of four rapid" exact="Ebola" post="antigen-detection lateral flow immunoassays during the 2014-2016 Ebola epidemic"/>
   <result pre="four rapid Ebola antigen-detection lateral flow immunoassays during the 2014-2016" exact="Ebola" post="epidemic in West Africa. PLoS One2019;14:e021211310.1371/journal.pone.021211330845203 30NsioJ, KapetshiJ, MakialaS,"/>
   <result pre="Africa. PLoS One2019;14:e021211310.1371/journal.pone.021211330845203 30NsioJ, KapetshiJ, MakialaS, et al.2017 outbreak of" exact="Ebola" post="virus disease in northern Democratic Republic of Congo. J"/>
   <result pre="RealR, et al.Recent loss of closed forests is associated with" exact="Ebola" post="virus disease outbreaks. Sci Rep2017;7:1429110.1038/s41598-017-14727-929085050 35CappsB, LedermanZOne health, vaccines"/>
   <result pre="opportunities for shared benefits. J Agric Environ Ethics2015;28:1011â€&quot;32.10.1007/s10806-015-9574-7 36ChippauxJ-POutbreaks of" exact="Ebola" post="virus disease in Africa: the beginnings of a tragic"/>
   <result pre="Dis2013;7:e260010.1371/journal.pntd.000260024367715 43HoulihanCF, YoukeeD, BrownCSNovel surveillance methods for the control of" exact="Ebola" post="virus disease. Int Health2017;9:139â€&quot;41.10.1093/inthealth/ihx01028582554 44JonesKE, PatelNG, LevyMA, et al.Global"/>
   <result pre="Expert Rev Vaccines2014;13:521â€&quot;31.10.1586/14760584.2014.88584124575870 46ElstonJW, Moosa AJM, et al.Impact of the" exact="Ebola" post="outbreak on health systems and population health in Sierra"/>
   <result pre="Health2016;38:673â€&quot;8. 47PinzonJE, WilsonJM, TuckerCJ, et al.Trigger events: enviroclimatic coupling of" exact="Ebola hemorrhagic fever" post="outbreaks. Am J Trop Med Hyg2004;71:664â€&quot;74.10.4269/ajtmh.2004.71.66415569802 48MadelainV, NguyenTHT, OlivoA,"/>
   <result pre="Clin Pharmacokinet2016;55:907â€&quot;23.10.1007/s40262-015-0364-126798032 49ThiamS, DelamouA, CamaraS, et al.Challenges in controlling the" exact="Ebola" post="outbreak in two prefectures in guinea: why did communities"/>
   <result pre="impact of traditional and religious practices on the spread of" exact="Ebola" post="in West Africa: time for a strategic shift. Pan"/>
   <result pre="time for a strategic shift. Pan Afr Med J2015;22:9. 52MoranBFighting" exact="Ebola" post="in conflict in the Dr Congo. Lancet2018;392:1295â€&quot;6.10.1016/S0140-6736(18)32512-130322568 53MarÃ­ SaÃ©zA,"/>
   <result pre="NowakK, et al.Investigating the zoonotic origin of the West African" exact="Ebola" post="epidemic. EMBO Mol Med2015;7:17â€&quot;23.10.15252/emmm.20140479225550396 54SwanepoelR, LemanPA, BurtFJExperimental inoculation of"/>
   <result pre="Med2015;7:17â€&quot;23.10.15252/emmm.20140479225550396 54SwanepoelR, LemanPA, BurtFJExperimental inoculation of plants and animals with" exact="Ebola" post="virus. Emerg Infect Dis1996;2:321â€&quot;5.10.3201/eid0204.9604078969248 55PathmanathanI, O'ConnorKA, AdamsML, et al.Rapid"/>
   <result pre="Emerg Infect Dis1996;2:321â€&quot;5.10.3201/eid0204.9604078969248 55PathmanathanI, O'ConnorKA, AdamsML, et al.Rapid assessment of" exact="Ebola" post="infection prevention and control needs-six districts, Sierra Leone. MMWR"/>
   <result pre="56collab: World Health OrganizationInfection prevention and control (IPC) guidance summary:" exact="Ebola" post="guidance package. Geneva, Switzerland: World Health Organization, 2014 Available:"/>
   <result pre="and practice of medical laboratory practitioners in the fight against" exact="Ebola" post="virus disease. J Virus Erad2018;4:1â€&quot;5. 58ChanMEbola virus disease in"/>
   <result pre="N Engl J Med2014;371:1177â€&quot;80.10.1056/NEJMp140990325140858 60WilkinsonA, FairheadJComparison of social resistance to" exact="Ebola" post="response in Sierra Leone and guinea suggests explanations lie"/>
   <result pre="not culture. Crit Public Health2017;27:14â€&quot;27.10.1080/09581596.2016.125203428366999 61DhillonRS, KellyJDCommunity trust and the" exact="Ebola" post="endgame. N Engl J Med2015;373:787â€&quot;9.10.1056/NEJMp150841326222382 62PetherickAEbola in West Africa:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7064018\results\search\zoonosis\results.xml">
   <result pre="dealt with more scaring emerging agents. For example, the 2014-2015" exact="Ebola hemorrhagic fever" post="outbreak was successfully contained, and specific experience accrued during"/>
   <result pre="epidemic, permitting to implement new vaccination strategies and therapeutic interventions" exact="Ebola" post="outbreak (2014-2016) [5]. The study of respiratory viral infections"/>
   <result pre="(SARS-CoV now named SARS-CoV-1) discovered in November, 2002 [9], the" exact="Middle East respiratory syndrome" post="(MERS) coronavirus (MERS-CoV) in June, 2012 [10]; and SARS-CoV-2,"/>
   <result pre="of SARS-CoV-2 replication including chloroquine are clinical efficient against declared" exact="SARS-CoV-2 infection" post="[62â€&quot;64]. If these findings are confirmed, chloroquine might be"/>
   <result pre="Dis2012121291491510.1016/s1473-3099(12)70304-323316491 4SuttonTCThe Pandemic Threat of Emerging H5 and H7 Avian" exact="Influenza" post="Viruses.Viruses201810946110.3390/v10090461 5collab: WHO.Ebola 2014-2016.Available at: https://www.who.int/csr/disease/ebola/en/. [Accessed: 29.02.2020] 6Le-VietNLeVNChungHPhanDTPhanQDCaoTVAbatCRaoult"/>
   <result pre="East Respiratory Syndrome.J Virol201791110.1128/jvi.01825-16 53ZhaoJAlshukairiANBaharoonSAAhmedWABokhariAANehdiAMLayqahLAAlghamdiMGAl GethamyMMDadaAMKhalidIBoujelalMAl JohaniSMet al.Recovery from the" exact="Middle East respiratory syndrome" post="is associated with antibody and T-cell responses.Sci Immunol2017214eaan539310.1126/sciimmunol.aan539328778905 54MullerMAMeyerBCormanVMAl-MasriMTurkestaniARitzDSiebergAAldabbaghSBoschBJLattweinEAlhakeemRFAssiriAMAlbarrakAMet"/>
   <result pre="associated with antibody and T-cell responses.Sci Immunol2017214eaan539310.1126/sciimmunol.aan539328778905 54MullerMAMeyerBCormanVMAl-MasriMTurkestaniARitzDSiebergAAldabbaghSBoschBJLattweinEAlhakeemRFAssiriAMAlbarrakAMet al.Presence of" exact="Middle East respiratory syndrome" post="coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological"/>
   <result pre="Infect Dis201515555956410.1016/s1473-3099(15)70090-325863564 55KayaliGPeirisMA more detailed picture of the epidemiology of" exact="Middle East respiratory syndrome" post="coronavirus.Lancet Infect Dis201515549549710.1016/s1473-3099(15)70128-325863563 56Al KahloutRANasrallahGKFaragEAWangLLattweinEMullerMAEl ZowalatyMEAl RomaihiHEGrahamBSAl Thani AA"/>
   <result pre="â€&quot; acute respiratory distress syndrome; CoV â€&quot; coronavirus; COVID-19 â€&quot;" exact="coronavirus disease 2019;" post="HCoV â€&quot; human coronavirus; MERS â€&quot; Middle-East respiratory syndrome;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7073332\results\search\zoonosis\results.xml">
   <result pre="CoVs (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), emerging from animal reservoirs, have led to"/>
   <result pre="HCoV, named 2019 novel coronavirus (2019-nCoV/SARS-CoV-2), as the cause of" exact="coronavirus disease 2019" post="(abbreviated as COVID-19)5, was found in Wuhan, China. As"/>
   <result pre="development of effective treatments for viral infections1, including SARS-CoV17, MERS-CoV17," exact="Ebola" post="virus18, and Zika virus14,19â€&quot;21. We recently presented an integrated"/>
   <result pre="This methodology allows to identify several candidate repurposable drugs for" exact="Ebola" post="virus11,14. Our work over the last decade has demonstrated"/>
   <result pre="virus, HCV hepatitis C virus, HDV hepatitis delta virus, EBOV" exact="Ebola" post="viruses, ZEBOV-GP Zaire Ebola virus glycoprotein, HIV human immunodeficiency"/>
   <result pre="virus, HDV hepatitis delta virus, EBOV Ebola viruses, ZEBOV-GP Zaire" exact="Ebola" post="virus glycoprotein, HIV human immunodeficiency virus, EBV Epstein-Barr virus,"/>
   <result pre="effects in blocking various viral infections, including MERS-CoV, SARS-CoV, and" exact="Ebola" post="virus in established cell lines17,38. Compared to the classical"/>
   <result pre="to have moderate activity in inhibiting the entry of Zaire" exact="Ebola" post="virus glycoprotein and human immunodeficiency virus (ZEBOV-GP/HIV)18. Altogether, network-predicted"/>
   <result pre="the treatment of metastatic breast cancer68. SERMs (including toremifene) inhibited" exact="Ebola" post="virus infection18 by interacting with and destabilizing the Ebola"/>
   <result pre="inhibited Ebola virus infection18 by interacting with and destabilizing the" exact="Ebola" post="virus glycoprotein39. In vitro assays have demonstrated that toremifene"/>
   <result pre="Immunol.201841914228643204 5.ChenNet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 6.Li, Q. et"/>
   <result pre="Reports202084616610.1016/j.physrep.2019.12.004 17.DyallJet al.Repurposing of clinically developed drugs for treatment of" exact="Middle East respiratory syndrome" post="coronavirus infectionAntimicrob. Agents Chemother.2014584885489310.1128/AAC.03036-1424841273 18.JohansenLMet al.FDA-approved selective estrogen receptor"/>
   <result pre="infectionAntimicrob. Agents Chemother.2014584885489310.1128/AAC.03036-1424841273 18.JohansenLMet al.FDA-approved selective estrogen receptor modulators inhibit" exact="Ebola" post="virus infectionSci. Transl. Med.20135190ra17910.1126/scitranslmed.3005471 19.HeSet al.Repurposing of the antihistamine"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob. Agents Chemother.2014584875488410.1128/AAC.03011-1424841269 39.ZhaoYet al.Toremifene"/>
   <result pre="cultureAntimicrob. Agents Chemother.2014584875488410.1128/AAC.03011-1424841269 39.ZhaoYet al.Toremifene interacts with and destabilizes the" exact="Ebola" post="virus glycoproteinNature201653516917210.1038/nature1861527362232 40.EmmottEet al.The cellular interactome of the coronavirus"/>
   <result pre="analogs and mycophenolic acid synergistically inhibit the papain-like protease of" exact="Middle East respiratory syndrome" post="coronavirusAntivir. Res.201511591610.1016/j.antiviral.2014.12.01125542975 55.ChenHWurmTBrittonPBrooksGHiscoxJAInteraction of the coronavirus nucleoprotein with nucleolar"/>
   <result pre="66.KindrachukJet al.Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for" exact="Middle East respiratory syndrome" post="coronavirus infection as identified by temporal kinome analysisAntimicrob. Agents"/>
   <result pre="75.BiedenkopfNet al.The natural compound silvestrol is a potent inhibitor of" exact="Ebola" post="virus replicationAntivir. Res.2017137768110.1016/j.antiviral.2016.11.01127864075 76.MullerCet al.Broad-spectrum antiviral activity of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7089181\results\search\zoonosis\results.xml">
   <result pre="affected by climate change. Large-scale outbreaks were first described for" exact="Monkeypox" post="virus in central Africa in the 1970s [117], while"/>
   <result pre="1970s [117], while outbreaks of mosquito-borne Chikungunya virus [85] and" exact="Dengue" post="virus infections in the Indian Ocean islands were seen"/>
   <result pre="were seen mostly in the twenty-first century [124]. The historic" exact="Ebola" post="outbreak in West Africa in 2013â€&quot;2014, followed by a"/>
   <result pre="attracted extensive media attention. The rapid and uncontrolled spread of" exact="Ebola" post="fever in Africa has been considered as a threat"/>
   <result pre="Microbiology (IMB) was involved in the international effort to contain" exact="Ebola" post="fever in West Africa during the 2014â€&quot;2016 outbreak [120]."/>
   <result pre="for several reasons, one of them being the risk that" exact="variola" post="virus might be brought back with the methods of"/>
   <result pre="drug was available at the time to treat infections with" exact="variola" post="virus, a drug effective against orthopoxviruses, tecovirimat, has recently"/>
   <result pre="been approved by the United States Federal Drug Administration [55]." exact="Smallpox" post="as an exclusively human infection was eradicated by vaccination,"/>
   <result pre="system and classic quarantine approaches was demonstrated in the recent" exact="Ebola" post="outbreaks in West- and Central Africa. However, the need"/>
   <result pre="worldwide. As a result, there are no FDA-approved antivirals for" exact="Ebola" post="or the causative viral agents of many other viral"/>
   <result pre="in only two designated laboratories in Russia and the US." exact="Monkeypox" post="virus (BSL-3), a zoonotic agent causing sequelae similar to"/>
   <result pre="respiratory tract, causing a systemic infection in humans and animals." exact="Smallpox" post="virus infection leads to a fatal multiorgan failure syndrome"/>
   <result pre="in complicated cases with a hemorrhagic syndrome and CNS involvement." exact="Smallpox" post="has played a role in large-scale epidemics in history"/>
   <result pre="to infected bush meat and body fluids of human patients." exact="Ebola" post="and Marburg viruses (EBOV/MARV) cause severe viral hemorrhagic fevers"/>
   <result pre="in October 2019 in the EU as the worldâ€™s first" exact="Ebola" post="vaccine [19]. Filoviruses are filamentous enveloped viruses with Group"/>
   <result pre="[8], CM-10-18-type glycan processing inhibitors, active against Marburg virus and" exact="Ebola" post="virus in mouse models [25], a number of kinase"/>
   <result pre="for Chagas disease, which has additional activity against SARS-CoV and" exact="Ebola" post="virus [154]. Alphaviridae Alphaviruses are mosquito-borne viruses, but some"/>
   <result pre="the broad-spectrum antiviral candidate favipiravir (T-705), initially developed to treat" exact="human influenza," post="which shows a potent antiviral effect in small animal"/>
   <result pre="Lassa virus (LassaV) requires BSL-4 containment. Annual case numbers of" exact="Lassa fever" post="(LassaF) are estimated to be between 100.000 and 300.000"/>
   <result pre="in rodent models [53, 54, 59], galidesivir (BCX4430), effective against" exact="Rift Valley fever" post="virus (RVFV) infection in a hamster model and investigated"/>
   <result pre="Flaviviruses causing hemorrhagic fever or severe encephalitis (Omsk hemorrhagic fever," exact="Dengue" post="and Yellow fever, Russian springâ€&quot;summer encephalitis/Tick Borne Encephalitis (TBEV))"/>
   <result pre="up to 30%) or affect the CNS, causing encephalitis (e.g.," exact="Japanese encephalitis," post="tick borne encephalitis with case fatality rates up to"/>
   <result pre="is not effective. Live vaccines against yellow fever (17D) and" exact="Japanese Encephalitis" post="(JE), a number of inactivated TBEV vaccines, and most"/>
   <result pre="number of inactivated TBEV vaccines, and most recently a live" exact="Dengue" post="virus vaccine are available. Flaviviruses are a large family"/>
   <result pre="animal models for the treatment of infections with Usutu (UsutuV)," exact="Dengue" post="(DENV) and Zika viruses (ZikaV) is their rather low"/>
   <result pre="hemodialysis and both morbidity and mortality in the case of" exact="Lassa fever" post="(LassaF). Ribavirin (Copegusâ&quot;¢, Rebetolâ&quot;¢, VirazoleÂ® ICN/Valeant (IND)) is used"/>
   <result pre="Clin Microbiol201856e01875-1710.1128/JCM.01875-1729643201 8.AmanMJKinchMSWarfieldKWarrenTYunusAEnterleinSStavaleEWangPChangSTangQPorterKGoldblattMBavariSDevelopment of a broad-spectrum antiviral with activity against" exact="Ebola" post="virusAntivir Res20098324525110.1016/j.antiviral.2009.06.00119523489 9.BassettoMDe BurghgraeveTDelangLMassarottiAColucciaAZontaNGattiVColombanoGSorbaGSilvestriRTronGCNeytsJLeyssenPBrancaleAComputer-aided identification, design and synthesis of"/>
   <result pre="prevent oseltamivir resistance in immunodeficient mice infected with pandemic A(H1N1)" exact="Influenza" post="virusViruses201810.3390/v1011061030400276 11.Andreas BeinekeABaumgÃ¤rtnerWWohlseinPCross-species transmission of canine distemper virusâ€&quot;an updateOne"/>
   <result pre="13.BixlerSLBocanTMWellsJWetzelKSVan TongerenSADongLGarzaNLDonnellyGCazaresLHNussJSolovevaVKoistinenKAWelchLEpsteinCLiangL-FGiesingDLenkRBavariSWarrenTKEfficacy of favipiravir (T-705) in nonhuman primates infected with" exact="Ebola" post="virus or Marburg virusAntivir Res20181519710410.1016/j.antiviral.2017.12.02129289666 14.BixlerSLBocanTMWellsJWetzelKSVan TongerenSAGarzaNLDonnellyGCazaresLHSolovevaVWelchLEpsteinCLiangL-FGiesingDLenkRBavariSWarrenTKIntracellular conversion and"/>
   <result pre="vivo dose response of favipiravir (T-705) in rodents infected with" exact="Ebola" post="virusAntivir Res2018151505410.1016/j.antiviral.2017.12.02029289664 15.BrayMParagasJExperimental therapy of filovirus infectionsAntivir Res200210.1016/S0166-3542(02)00005-012076759 16.BrayMDefense"/>
   <result pre="18.Bullard-FeibelmanKMGoveroJZhuZSalazarVVeselinovicMDiamondMSGeissBJThe FDA-approved drug sofosbuvir inhibits Zika virus infectionAntivir Res201713713414010.1016/j.antiviral.2016.11.02327902933 19.CallawayEâ€˜Make" exact="Ebola" post="a thing of the pastâ€™: first vaccine against deadly"/>
   <result pre="(1986) MEASLES: a dangerous illness. https://www.encephalitis.info/Handlers/Download.ashx?IDMF=9ea058b7-fd6f-493e-8589-34d56e9ac164 29.DawesBEKalveramBIkegamiTJuelichTSmithJKZhangLParkALeeBKomenoTFurutaYFreibergANFavipiravir (T-705) protects against" exact="Nipah virus infection" post="in the hamster modelSci Rep20188760410.1038/s41598-018-25780-329765101 30.De BurghgraeveTSeliskoBKapteinSChatelainGLeyssenPDebingYJacobsMVan AerschotACanardBNeytsJ3â€²,5â€²Di-O-trityluridine inhibits"/>
   <result pre="British Empire in North America2005NormanUniversity of Oklahoma Press 37.DyerOEscalating Congo" exact="Ebola" post="epidemic passes 2000 cases amid violence and suspicionBMJ2019365l406210.1136/bmj.l406231167752 38.European"/>
   <result pre="Zealand White rabbitsAntivir Res201714327828610.1016/j.antiviral.2017.04.00228392420 57.GubarevaLVBesselaarTGDanielsRSFryAGregoryVHuangWHurtACJorqueraPALackenbyALeangS-KLoJPereyaslovDRebelo-de-AndradeHSiqueiraMMTakashitaEOdagiriTWangDZhangWMeijerAGlobal update on the susceptibility of" exact="human influenza" post="viruses to neuraminidase inhibitors, 2015-2016Antivir Res2017146122010.1016/j.antiviral.2017.08.00428802866 58.HawleyRJEitzenEMBiological weapons-a primer"/>
   <result pre="64.HugginsJZhangZXBrayMAntiviral drug therapy of filovirus infections: s-adenosylhomocysteine hydrolase inhibitors inhibit" exact="Ebola" post="virus In vitro and in a lethal mouse modelJ"/>
   <result pre="4S750S76110.1093/clinids/11.Supplement_4.S7502546248 66.HwangJJiangAFikrigEA potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and" exact="Dengue" post="virusesAntivir Res201916116316810.1016/j.antiviral.2018.11.01730521835 67.IppolitoGFeldmannHLaniniSVairoFDi CaroACapobianchiMRNicastriEViral hemorrhagic fevers: advancing the level"/>
   <result pre="Res20087811612410.1016/j.antiviral.2007.10.00918061688 104.MuckerEMGoffAJShamblinJDGrosenbachDWDamonIKMehalJMHolmanRCCarrollDGallardoNOlsonVAClemmonsCJHudsonPHrubyDEEfficacy of Tecovirimat (ST-246) in Nonhuman primates infected with" exact="variola" post="virus (smallpox)Antimicrob Agents Chemother201357126246625310.1128/aac.00977-1324100494 105.MumtazNJimmersonLCBushmanLRKiserJJAronGReuskenCBEMKoopmansMPGvan KampenJJACell-line dependent antiviral activity"/>
   <result pre="of nordihydroguaiaretic acidAntivir Res20108828729510.1016/j.antiviral.2010.09.01720888364 120.QuickJLomanNJDuraffourSSimpsonJTSeveriECowleyLBoreJAKoundounoRDudasGMikhailAOuÃ©draogoNAfroughBBahABaumJHBecker-ZiajaBBoettcherJ-PCabeza-CabrerizoMCamino-SanchezACarterLLDoerrbeckerJEnkirchTDorivalIGGHetzeltNHinzmannJHolmTKafetzopoulouLEKoropoguiMKosgeyAKuismaELogueCHMazzarelliAMeiselSMertensMMichelJNgaboDNitzscheKPallashEPatronoLVPortmannJRepitsJGRickettNYSachseASingethanKVitorianoIYemanaberhanRLZekengEGTrinaRBelloASallAAFayeOusmaneFayeOumarMagassoubaNWilliamsCVAmburgeyVWinonaLDavisEGerlachJWashingtonFMonteilVJourdainMBererdMCamaraAlimouSomlareHCamaraAbdoulayeGerardMBadoGBailletBDelauneDNebieKYDiarraASavaneYPallawoRBGutierrezGJMilhanoNRogerIWilliamsCJYattaraFLewandowskiKTaylorJRachwalPTurnerDPollakisGHiscoxJAMatthewsDAOâ€™SheaMKJohnstonAMWilsonDHutleyESmitEDi CaroAWoelfelRStoeckerKFleischmannEGabrielMWellerSAKoivoguiLDialloBKeitaSRambautAFormentyPGuntherSCarrollMWReal-time, portable genome sequencing for" exact="Ebola" post="surveillanceNature201653022823210.1038/nature1699626840485 121.RavichandranRManianMRibavirin therapy for Chikungunya arthritisJ Infect Dev Ctries2008214014210.3855/T2.2.14019738340"/>
   <result pre="antiviral adenosine nucleoside analog under development for the treatment of" exact="Ebola" post="virus diseaseJ Infect Public Health20169322022610.1016/j.jiph.2016.04.00227095300 137.TchesnokovEPFengJYPorterDPGÃ¶tteMMechanism of inhibition of"/>
   <result pre="Ebola virus diseaseJ Infect Public Health20169322022610.1016/j.jiph.2016.04.00227095300 137.TchesnokovEPFengJYPorterDPGÃ¶tteMMechanism of inhibition of" exact="Ebola" post="virus RNA-dependent RNA polymerase by remdesivirViruses201910.3390/v1104032630987343 138.TilmanisDvan BaalenCOhDYRossignolJ-FHurtACThe susceptibility"/>
   <result pre="RNA-dependent RNA polymerase by remdesivirViruses201910.3390/v1104032630987343 138.TilmanisDvan BaalenCOhDYRossignolJ-FHurtACThe susceptibility of circulating" exact="human influenza" post="viruses to tizoxanide, the active metabolite of nitazoxanideAntivir Res201714714214810.1016/j.antiviral.2017.10.00228986103"/>
   <result pre="BCX4430Nature201450840240510.1038/nature1302724590073 144.WarrenTKJordanRLoMKRayASMackmanRLSolovevaVSiegelDPerronMBannisterRHuiHCLarsonNStrickleyRWellsJStuthmanKSVan TongerenSAGarzaNLDonnellyGShurtleffACRettererCJGharaibehDZamaniRKennyTEatonBPGrimesEWelchLSGombaLWilhelmsenCLNicholsDKNussJENagleERKugelmanJRPalaciosGDoerfflerENevilleSCarraEClarkeMOZhangLLewWRossBWangQChunKWolfeLBabusisDParkYStrayKMTranchevaIFengJYBarauskasOXuYWongPBraunMRFlintMMcMullanLKChenSSFearnsRSwaminathanSMayersDLSpiropoulouCFLeeWANicholSTCihlarTBavariSTherapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature201653138138510.1038/nature1718026934220 145.WestoverJBMathisATaylorRWanderseeLBaileyKWSefingEJHickersonBTJungK-HSheridanWPGowenBBGalidesivir limits Rift Valley fever"/>
   <result pre="molecule GS-5734 against Ebola virus in rhesus monkeysNature201653138138510.1038/nature1718026934220 145.WestoverJBMathisATaylorRWanderseeLBaileyKWSefingEJHickersonBTJungK-HSheridanWPGowenBBGalidesivir limits" exact="Rift Valley fever" post="virus infection and disease in Syrian golden hamstersAntivir Res2018156384510.1016/j.antiviral.2018.05.01329864447"/>
   <result pre="147.WHO Roadmap to Nectected Tropical Diseases (2012) https://unitingtocombatntds.org/wp-content/uploads/2017/11/who_ntd_roadmap.pdf 148.WHO (2016)" exact="Lassa fever" post="in Germany. https://www.who.int/csr/don/23-march-2016-lassa-fever-germany/en/ 149.collab: WHOA global strategy to eliminate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7090748\results\search\zoonosis\results.xml">
   <result pre="with gross public concern were recorded in different regions, including" exact="Ebola" post="in western Africa, Zika in South America, H7N9 in"/>
   <result pre="century, can cause severe diseases with high fatality and morbidity." exact="Severe acute respiratory syndrome" post="(SARS) coronavirus (SARS-CoV) emerged in November 2002 in Guangdong,"/>
   <result pre="globally 8098 human infections with 774 deaths (9.6%), and the" exact="Middle East respiratory syndrome" post="(MERS) coronavirus (MERS-CoV) emerged in 2012 in Saudi Arabia"/>
   <result pre="a diverse panel of RNA viruses such as SARS-CoV, MERS-CoV," exact="Ebola" post="virus (EBOV), Marburg virus, Nipah virus, Hendra virus, and"/>
   <result pre="it is in clinical trials to evaluate its efficacy against" exact="Ebola" post="virus infections. The study by Wang et al. (2020)"/>
   <result pre="virus, human immunodeficiency virus, dengue virus, West Nile virus, Crimean" exact="Congo hemorrhagic fever" post="virus, and hepatitis A virus (GarcÃ­a-Serradilla et al.2019). It"/>
   <result pre="Res202010.1038/s41422-020-0282-032612199 WarrenTKJordanRLoMKRayASMackmanRLSolovevaVSiegelDPerronMBannisterRHuiHCet al.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature201653138138510.1038/nature1718026934220 World Health Organization (WHO) (2020a)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7090771\results\search\zoonosis\results.xml">
   <result pre="ChinaLancet202010.1016/S0140-6736(20)30183-532007192 7.ChenNSZhouMDongXQuJMGongFYHanYet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet202010.1016/S0140-6736(20)30211-732007192 8.LiZZShenKLWeiXMWangHLLuJTianHet al.Clinical analysis"/>
   <result pre="Immunol20194310130010.1016/j.smim.2019.10130031771760 17.Al-TawfiqJAMomattinHDibJMemishZARibavirin and interferon therapy in patients infected with the" exact="Middle East respiratory syndrome" post="coronavirus: an observational studyInt J Infect Dis201420424610.1016/j.ijid.2013.12.00324406736 18.WangHQMaLLJiangJDPangRChenYJLiYHRecombinant human"/>
   <result pre="and therapeutic effects of recombinant IFN -Î±2b nasal spray on" exact="SARS-CoV infection" post="in Macaca mulataChin J Exp Clin Virol200519207211 28.YuDXChenQZhangLLLiuYYuZALiZFet al.A"/>
   <result pre="Chin PLA200420274276 32.National Health Commission of People's Republic of China." exact="Influenza" post="diagnosis and treatment protocol (revised edition 2019). https://wenku.baidu.com/view/00f0d41d2079168884868762caaedd3383c4b57f.html. Access"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7091034\results\search\zoonosis\results.xml">
   <result pre="Pediatrics0019-54560973-7693Springer IndiaNew Delhi pmcid: 70910343214 doi: 10.1007/s12098-020-03214-1 : Review Article" exact="Influenza" post="http://orcid.org/0000-0002-6691-1435DharmapalanDhanyadrdhanyaroshan@gmail.com[], grid.464529.80000 0004 1802 3059Department of Pediatric Infectious Diseases,"/>
   <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. Abstract" exact="Influenza" post="continues to baffle humans by its constantly changing nature."/>
   <result pre="is capable to hit at any moment in time. Keywords" exact="Influenza" post="Pandemic Hemagglutinin Neuraminidase Influenza vaccines Oseltamivir Introduction A century"/>
   <result pre="at any moment in time. Keywords Influenza Pandemic Hemagglutinin Neuraminidase" exact="Influenza" post="vaccines Oseltamivir Introduction A century has elapsed since the"/>
   <result pre="a severe pandemic like 1918 looms large as the novel" exact="Influenza" post="A viruses of avian or swine origin continue to"/>
   <result pre="swine origin continue to infect the humans. Sporadic cases of" exact="Influenza" post="occur throughout the year. Transmission of the virus depends"/>
   <result pre="year even when the peak season had just begun [5]." exact="Influenza" post="surveillance studies from India have identified three major patterns"/>
   <result pre="more likely to cause infection in the lower respiratory tract." exact="Influenza" post="Virus Influenza viruses A, B and C belong to"/>
   <result pre="to cause infection in the lower respiratory tract. Influenza Virus" exact="Influenza" post="viruses A, B and C belong to Orthomyxoviridae family"/>
   <result pre="of origin; number of lineage; year of isolation and, for" exact="Influenza" post="A viruses only, HA and NA subtype, described by"/>
   <result pre="date, and N1 to N9 [8]. For example, the pandemic" exact="Influenza" post="A of 2009 is denoted as A/California/04/2009(H1N1) for Influenza"/>
   <result pre="pandemic Influenza A of 2009 is denoted as A/California/04/2009(H1N1) for" exact="Influenza" post="type A, isolated first in California, lineage number 04,"/>
   <result pre="on alveolar type II cells and ocular epithelium [9] while" exact="human influenza" post="viruses bind to 2,6 linked sialic acids present in"/>
   <result pre="the upper respiratory tract epithelium. Due to localisation of the" exact="human influenza" post="virus mainly to the upper respiratory tract, there is"/>
   <result pre="upper respiratory tract, there is greater risk of transmission of" exact="human influenza" post="viruses than Avian flu [10]. However strains that are"/>
   <result pre="the virion entry into the host nucleus for replication. The" exact="Influenza" post="A viruses carry 8 negative sense RNA segments. These"/>
   <result pre="phenomenon is referred to as antigenic drift and occurs in" exact="Influenza" post="A, B and C viruses. When a sudden genetic"/>
   <result pre="called as an antigenic shift. This phenomenon occurs only in" exact="Influenza" post="A. For example antigenic shift took place with swine"/>
   <result pre="annually. Co-infection with bacteria increases the severity of the infection." exact="Influenza" post="associated myositis presents with severe bilateral myaligia in the"/>
   <result pre="febrile seizures, reported in about 5% infants and young children." exact="Influenza" post="associated encephalopathy can occur due to direct infection of"/>
   <result pre="is the high cost in resource-limited settings. The cheaper, Rapid" exact="Influenza" post="Diagnostic tests (RIDT) using monoclonal antibodies are available for"/>
   <result pre="H1N1 when compared to the PCR results. These can differentiate" exact="Influenza" post="A and B viruses but cannot be used for"/>
   <result pre="influenza in children. It is less efficacious in treatment of" exact="Influenza" post="B than A. The indications for initiating treatment are"/>
   <result pre="for use in severe patients are some of these challenges." exact="Influenza" post="A (H1N1) viruses resistant to Oseltamivir have been reported"/>
   <result pre="adults due to relatively higher viral load [19]. The Global" exact="Influenza" post="Surveillance and Response System (GISRS) tested 27,000 H1N1 viruses"/>
   <result pre="has shown broad antiviral activity against all known types of" exact="Influenza" post="(A, B, C and D) and the Influenza A"/>
   <result pre="types of Influenza (A, B, C and D) and the" exact="Influenza" post="A viruses of avian and swine origin which have"/>
   <result pre="an H1N1 strain, an H3N2 strain and one or two" exact="Influenza" post="B strains belonging to evolutionarily diverging lineages â€&quot; B/Victoria"/>
   <result pre="sneezing etiquettes and hand hygiene are important for control of" exact="influenza infection" post="both in the community and the health care settings."/>
   <result pre="of any case of human infection due to a new" exact="Influenza" post="A virus subtype within 24Â h of its detection."/>
   <result pre="many of these challenges, in 2019, WHO established the Global" exact="Influenza" post="Strategy 2019â€&quot;2030. The four strategic objectives outlined are to"/>
   <result pre="the tropicsCurr Epidemiol Rep201528910010.1007/s40471-015-0038-425938010 5.National Centre for Disease Control. Seasonal" exact="Influenza" post="H1N1. Available at: https://ncdc.gov.in/index4.php?lang=1&amp;amp;level=0&amp;amp;linkid=119&amp;amp;lid=276. Accessed 2nd August 2019. 6.ChadhaMSPotdarVASahaSet"/>
   <result pre="Other Respir Viruses2008214715410.1111/j.1750-2659.2008.00051.x19453419 10.MansfieldKeith G.Viral Tropism and the Pathogenesis of" exact="Influenza" post="in the Mammalian HostThe American Journal of Pathology200717141089109210.2353/ajpath.2007.07069517717138 11.CampJeremy"/>
   <result pre="Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic" exact="Influenza" post="A Virus Triggers Biphasic, Systemic, and Local Recruitment of"/>
   <result pre="public health, laboratory, and clinical perspectivesThe Lancet Infectious Diseases201212324024810.1016/S1473-3099(11)70318-822186145 21.CDC." exact="Influenza" post="Antiviral Medications: Summary for Clinicians. Available at: https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm. Accessed"/>
   <result pre="institutional outbreak management of seasonal influenzaClin Infect Dis201968e14710.1093/cid/ciy866 27.WHO. Global" exact="Influenza" post="Strategy 2019-2030. Geneva: World Health Organization; 2019. Available at:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7091691\results\search\zoonosis\results.xml">
   <result pre="outbreak, drugs like remdesivir â€&quot; an experimental drug developed against" exact="Ebola" post="and recently held up by WHO Assistant Director-general Bruce"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7093024\results\search\zoonosis\results.xml">
   <result pre="Research Identification of Chebulinic Acid and Chebulagic Acid as Novel" exact="Influenza" post="Viral Neuraminidase Inhibitors LiPing1â€ DuRuikun123â€ WangYanyan1HouXuewen1WangLin1ZhaoXiujuan1ZhanPeng4LiuXinyong4RongLijun5*CuiQinghua123*[], 1College of Pharmacy,"/>
   <result pre="neuraminidase neuraminidase inhibitor fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction" exact="Influenza" post="vaccines and antiviral drugs are effective in preventing infection"/>
   <result pre="infection or ameliorating disease severity (Vasileiou et al., 2017). However," exact="influenza infection," post="as an acute respiratory disease caused by seasonal outbreaks"/>
   <result pre="here for additional data file. References References AirG. M. (2012)." exact="Influenza" post="neuraminidase.Influenza Other Respir. Viruses6245â€&quot;256. 10.1111/j.1750-2659.2011.00304.x22085243 AlameM. M.MassaadE.ZaraketH. (2016). Peramivir:"/>
   <result pre="and gallic acid.J. Food Drug Anal.23116â€&quot;123. 10.1016/j.jfda.2014.07.00728911434 ColmanP. M. (1994)." exact="Influenza" post="virus neuraminidase: structure, antibodies, and inhibitors.Protein Sci.31687â€&quot;1696. 10.1002/pro.55600310077849585 de"/>
   <result pre="influenza a virus entry.Viruses11:E458. 10.3390/v1105045831137516 GrienkeU.SchmidtkeM.von GrafensteinS.KirchmairJ.LiedlK. R.RollingerJ. M. (2012)." exact="Influenza" post="neuraminidase: a druggable target for natural products.Nat. Prod. Rep.2911â€&quot;36."/>
   <result pre="S.FryA.GregoryV.GubarevaL. V.et al. (2018). Global update on the susceptibility of" exact="human influenza" post="viruses to neuraminidase inhibitors and status of novel antivirals,"/>
   <result pre="neuraminidase suggests new opportunities for drug design.Nature44345â€&quot;49. 10.1038/nature0511416915235 SamsonM.PizzornoA.AbedY.BoivinG. (2013)." exact="Influenza" post="virus resistance to neuraminidase inhibitors.Antivir. Res.98174â€&quot;185. 10.1016/j.antiviral.2013.03.01423523943 ShobugawaY.SaitoR.SatoI.KawashimaT.DapatC.DapatI. C.et"/>
   <result pre="neuraminidase by mass spectrometry.Anal. Bioanal. Chem.4056563â€&quot;6572. 10.1007/s00216-013-7068-x23748498 TakashitaE.KawakamiC.OgawaR.MoritaH.FujisakiS.ShirakuraM.et al. (2019)." exact="Influenza" post="A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to"/>
   <result pre="diverse influenza A viruses.PLoS Pathog.9:e1003657. 10.1371/journal.ppat.100365724130481 van der VriesE.SchuttenM.FraaijP.BoucherC.OsterhausA. (2013)." exact="Influenza" post="virus resistance to antiviral therapy.Adv. Pharmacol.67217â€&quot;246. 10.1016/b978-0-12-405880-4.00006-823886002 VasileiouE.SheikhA.ButlerC.El FerkhK.von"/>
   <result pre="gaussia luciferase.Viruses11:665. 10.3390/v1107066531330768 collab: World Health Organization [WHO] (2018). 2018" exact="Influenza" post="(seasonal) Fact Sheet.Geneva: WHO. WuY.QinG.GaoF.LiuY.VavrickaC. J.QiJ.et al. (2013). Induced"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7098069\results\search\zoonosis\results.xml">
   <result pre="COVID-19 as a global pandemic. Abstract The recent outbreak of" exact="coronavirus disease 2019" post="(COVID-19) highlights an urgent need for therapeutics. Through a"/>
   <result pre="antiviral agents coronavirus SARS-CoV MERS-CoV SARS-CoV-2 (COVID-19) flavivirus Zika virus" exact="Ebola" post="virus human adenovirus This article is made available for"/>
   <result pre="the article for non-commercial scholarly purposes. The recent outbreak of" exact="coronavirus disease 2019" post="(COVID-19) first detected in Wuhan, China, was caused by"/>
   <result pre="and rarely associated with severe diseases. However, the epidemics of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV)"/>
   <result pre="viral infections, such as severe acute respiratory syndrome coronavirus (SARS-CoV)," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), Zika virus (ZIKV), Japanese encephalitis virus (JEV),"/>
   <result pre="(SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), Zika virus (ZIKV)," exact="Japanese encephalitis" post="virus (JEV), hepatitis C virus (HCV), Ebola virus (EBOV),"/>
   <result pre="virus (ZIKV), Japanese encephalitis virus (JEV), hepatitis C virus (HCV)," exact="Ebola" post="virus (EBOV), human rhinoviruses (HRVs), Chikungunya virus (CHIKV), human"/>
   <result pre="offer the therapeutic potential to be extended to combat fast-spreading" exact="coronavirus disease 2019" post="(COVID-19), given its inexpensive and low in vivo toxicity"/>
   <result pre="1â€&quot;4), West Nile virus (WNV), yellow fever virus (YFV), and" exact="Japanese encephalitis" post="virus (JEV). Many of these viruses are significant human"/>
   <result pre="which may make a host-targeted approach less attractive. Niclosamide and" exact="Ebola" post="Virus Ebola virus (EBOV) is an enveloped negative-sense single-stranded"/>
   <result pre="make a host-targeted approach less attractive. Niclosamide and Ebola Virus" exact="Ebola" post="virus (EBOV) is an enveloped negative-sense single-stranded RNA virus"/>
   <result pre="animals and spreads in the human population through person-to-person transmission." exact="Ebola" post="virus disease (EVD), known as Ebola hemorrhagic fever, has"/>
   <result pre="population through person-to-person transmission. Ebola virus disease (EVD), known as" exact="Ebola hemorrhagic fever," post="has a high fatality rate, ranging from 25 to"/>
   <result pre="RNA-dependent RNA polymerase (RdRp) inhibitor, and lopinavir/ritonavir (protease inhibitors) against" exact="Ebola" post="or HIV may be repurposed through fast-track human clinical"/>
   <result pre="(PDB ID: 6LU7). Abbreviations Used WHO World Health Organization COVID-19" exact="coronavirus disease 2019" post="2019-nCoV the 2019 novel coronavirus MERS-CoV Middle East respiratory"/>
   <result pre="COVID-19 coronavirus disease 2019 2019-nCoV the 2019 novel coronavirus MERS-CoV" exact="Middle East respiratory syndrome" post="coronavirus SARS-CoV severe acute respiratory syndrome coronavirus HCV hepatitis"/>
   <result pre="hepatitis C virus DENV dengue virus ZIKV Zika virus JEV" exact="Japanese encephalitis" post="virus WNV West Nile virus YFV yellow fever virus"/>
   <result pre="virus WNV West Nile virus YFV yellow fever virus EBOV" exact="Ebola" post="virus HRV human rhinovirus CHIKV Chikungunya virus HAdV human"/>
   <result pre="2003. https://www.who.int/csr/sars/country/table2004_04_21/en/ (accessed Feb 26, 2020). collab: World Health Organization." exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). January, 2020. https://www.who.int/emergencies/mers-cov/en/ (acessed Feb 26, 2020)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7099677\results\search\zoonosis\results.xml">
   <result pre="Ebola), novel coronaviruses including severe acute respiratory syndrome CoV (SARS-CoV)," exact="Middle East respiratory syndrome" post="MERS-CoV), and highly pathogenic influenza. Coronaviruses (CoVs), as a"/>
   <result pre="novel Î²CoVs, severe acute respiratory syndrome CoV (SARS- CoV) and" exact="Middle East respiratory syndrome" post="CoV (MERS-CoV), have recently emerged and can induce a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7102556\results\search\zoonosis\results.xml">
   <result pre="emerging CoVs, including severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), both belonging to beta coronavirus, have caused"/>
   <result pre="samples [23]. The method can detect hCoVs, and Zika and" exact="Ebola" post="viruses. The last one, the paper-based colorimetric assay, uses"/>
   <result pre="target, implying that neutralizing antibodies that were so effective against" exact="SARS-CoV infection" post="may fail to recognize the 2019-nCoV, and that multiple"/>
   <result pre="RBD-based vaccine could induce neutralizing antibody responses and protection against" exact="SARS-CoV infection" post="in the immunized animals, while it did not elicit"/>
   <result pre="six-helical bundle (6-HB), blocking S protein-mediated membrane fusion and inhibiting" exact="SARS-CoV infection" post="[59]. When MERS-CoV was circulating in human populations in"/>
   <result pre="screened out from non-immune humans [72,73]. Antibodies effective at inhibiting" exact="SARS-CoV infection" post="should also have the potential for treatment of 2019-nCoV"/>
   <result pre="https://www.who.int/docs/default-source/coronaviruse/20200114-interim-laboratory-guidance-version.pdf?sfvrsn=6967c39b_4&amp;amp;download=true. 10https://www.gisaid.org/. 11http://virological.org/t/initial-assessment-of-the-ability-of-published-coronavirus-primers-sets-to-detect-the-wuhan-coronavirus/321. 12NohJ.Y.YoonS.W.KimD.J.LeeM.S.KimJ.H.NaW.Simultaneous detection of severe acute respiratory syndrome," exact="Middle East respiratory syndrome," post="and related bat coronaviruses by real-time reverse transcription PCRArch"/>
   <result pre="respiratory syndrome-coronavirusJÂ Mol Diagn19201781782728807812 14LuX.WhitakerB.SakthivelS.K.KamiliS.RoseL.E.LoweL.Real-time reverse transcription-PCR assay panel for" exact="Middle East respiratory syndrome" post="coronavirusJÂ Clin Microbiol522014677524153118 15CormanV.M.EckerleI.BleickerT.ZakiA.LandtO.Eschbach-BludauM.Detection of a novel human coronavirus"/>
   <result pre="Hajj pilgrimageIran Red Crescent Med J182016e2387428191331 17WHO: https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf?sfvrsn=d381fc88_2. 18ShiratoK.YanoT.SenbaS.AkachiS.KobayashiT.NishinakaT.Detection of" exact="Middle East respiratory syndrome" post="coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP)Virol J11201413925103205"/>
   <result pre="SARS-CoVVaccine2920116606661321762752 34VolzA.KupkeA.SongF.JanyS.FuxR.Shams-EldinH.Protective efficacy of recombinant modified vaccinia virus Ankara delivering" exact="Middle East respiratory syndrome" post="coronavirus spike glycoproteinJÂ Virol8920158651865626018172 35MunsterV.J.WellsD.Protective efficacy of a novel"/>
   <result pre="cross-neutralize the novel human coronavirus hCoV-EMCJÂ Infect67201334835023685240 37ChiH.ZhengX.WangX.WangC.WangH.GaiW.DNA vaccine encoding" exact="Middle East respiratory syndrome" post="coronavirus S1 protein induces protective immune responses in miceVaccine3520172069207528314561"/>
   <result pre="of neutralizing monoclonal antibodies targeting multiple antigenic sites on the" exact="Middle East respiratory syndrome" post="coronavirus spike glycoprotein to avoid neutralization escapeJÂ Virol922018e02002e0201729514901 46OlsenC.W.AÂ"/>
   <result pre="fusogenic mechanism and identification of fusion inhibitorsLancet363200493894715043961 60LuL.LiuQ.ZhuY.ChanK.H.QinL.LiY.Structure-based discovery of" exact="Middle East respiratory syndrome" post="coronavirus fusion inhibitorNat Commun52014306724473083 61XiaS.YanL.AÂ pan-coronavirus fusion inhibitor targeting"/>
   <result pre="full protection of a human transgenic mouse model from lethal" exact="Middle East respiratory syndrome" post="(MERS)-coronavirus infectionAntivir Res132201614114827312105 66PascalK.E.ColemanC.M.MujicaA.O.KamatV.BaditheA.FairhurstJ.Pre- and postexposure efficacy of fully"/>
   <result pre="Sci U S A1122015104731047826216974 69ChenZ.BaoL.ChenC.ZouT.XueY.LiF.Human neutralizing monoclonal antibody inhibition of" exact="Middle East respiratory syndrome" post="coronavirus replication in the common MarmosetJÂ Infect Dis21520171807181528472421 70XuJ.JiaW.WangP.ZhangS.ShiX.WangX.Antibodies"/>
   <result pre="in the common MarmosetJÂ Infect Dis21520171807181528472421 70XuJ.JiaW.WangP.ZhangS.ShiX.WangX.Antibodies and vaccines against" exact="Middle East respiratory syndrome" post="coronavirusEmerg Microb Infect82019841856 71CoughlinM.M.PrabhakarB.S.Neutralizing human monoclonal antibodies to severe"/>
   <result pre="SARS-coronavirus evolution pathwayPLoS Pathog42008e100019718989460 74OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: a retrospective cohort studyLancet Infect Dis1420141090109525278221 75SheahanT.P.SimsA.C.Broad-spectrum"/>
   <result pre="initial virological and clinical findingsThorax59200425225614985565 78ChanJ.F.ChanK.H.KaoR.Y.ToK.K.ZhengB.J.LiC.P.Broad-spectrum antivirals for the emerging" exact="Middle East respiratory syndrome" post="coronavirusJÂ Infect67201360661624096239 79LoutfyM.R.BlattL.M.SiminovitchK.A.WardS.WolffB.LhoH.Interferon alfacon-1 plus corticosteroids in severe acute"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7102570\results\search\zoonosis\results.xml">
   <result pre="the viral load. Favipiravir cures all mice in a lethal" exact="influenza infection" post="model, while oseltamivir fails to cure the animals. Thus,"/>
   <result pre="has been used for treatment of human infection with life-threatening" exact="Ebola" post="virus, Lassa virus, rabies, and severe fever with thrombocytopenia"/>
   <result pre="infections for which standard treatments are not available. Keywords Favipiravir" exact="Influenza" post="Antiviral agent Ebola Chain termination Resistant virus Abbreviations baloxavir,"/>
   <result pre="standard treatments are not available. Keywords Favipiravir Influenza Antiviral agent" exact="Ebola" post="Chain termination Resistant virus Abbreviations baloxavir, baloxavir marboxil G-string,"/>
   <result pre="Japan. Favipiravir was highlighted as a treatment during the lethal" exact="Ebola" post="virus epidemic in West Africa in 2014 because a"/>
   <result pre="West Africa in 2014 because a standard treatment for lethal" exact="Ebola" post="virus infection is not available. Favipiravir has been reported"/>
   <result pre="been reported to be effective for prophylaxis and treating lethal" exact="Ebola" post="virus infection in animal models (Oestereich et al., 2014;"/>
   <result pre="used for the post-exposure prophylaxis and treatment of patients with" exact="Ebola" post="virus infection (Bai et al., 2016; Jacobs et al.,"/>
   <result pre="was confirmed by analyzing its efficacy in animal models of" exact="influenza infection," post="as described below, which led to drug development. Favipiravir"/>
   <result pre="infections, as shown in Table 1 . Patients with an" exact="Ebola" post="virus infection in West Africa in 2014 and patients"/>
   <result pre="2008), and gWest Nile fever (Philpott et al., 2019). 2.3" exact="Influenza" post="infection model We have identified two antipyretic steps in"/>
   <result pre="steps in influenza infections, as shown in Fig. 2 ." exact="Influenza" post="infection and its replication in the epithelium of the"/>
   <result pre="by cinnamyl compounds and NSAIDs in the fever cascade in" exact="influenza infection." post="Fig. 2 Cascade of fever induction by influenza and"/>
   <result pre="by influenza and antipyretic action of cinnamyl compounds and NSAIDs." exact="Influenza" post="infection induces interferon (IFN) production that subsequently induces interleukin"/>
   <result pre="of favipiravir were conducted in mice and ferrets using the" exact="influenza infection" post="system described above in our laboratory. 2.4 Efficacy of"/>
   <result pre="favipiravir in influenza-infected animals Since our laboratory had established an" exact="influenza infection" post="model to investigate the cytokine cascade that induces fever"/>
   <result pre="be confirmed. We first observed the prevention of a lethal" exact="influenza infection." post="Oral administration of favipiravir was significantly effective in alleviating"/>
   <result pre="infection. Oral administration of favipiravir was significantly effective in alleviating" exact="influenza infection" post="in mice (Furuta et al., 2002), and its efficacy"/>
   <result pre="oseltamivir was observed in an animal with a severe lethal" exact="influenza infection" post="with a high viral load (Takahashi et al., 2003)."/>
   <result pre="infection model and is considered to correspond to a novel" exact="influenza infection" post="in humans. Although oseltamivir is ineffective in this model,"/>
   <result pre="al., 2019; Wong et al., 2009), respectively, in infected cells." exact="Influenza" post="infection induces TNF-Î± production in mouse macrophage-derived P388D1 cells,"/>
   <result pre="contribute to the enhanced effects of favipiravir treatment on alleviating" exact="influenza infection" post="compared with oseltamivir treatment. Favipiravir displays superior properties to"/>
   <result pre="cycle of influenza and sites of action of anti-influenza drugs." exact="Influenza" post="virus hemagglutinin (HA) binds to its receptor, sialic acid"/>
   <result pre="inoculation of a wild-type A(H1N1) virus (Doyle et al., 1994)." exact="Influenza" post="causes dry cough (90%), fever (83.8%), and headache (82.5%),"/>
   <result pre="Oseltamivir, an NAI, has been the treatment of choice for" exact="influenza infection." post="The emergence of a resistant virus (after day 1)"/>
   <result pre="to an influenza pandemic and spread globally, such as A(H1N1)pdm09." exact="Influenza" post="pandemics can cause severe pneumonia, generate a drug-resistant virus,"/>
   <result pre="has been used to treat humans with diseases such as" exact="Ebola" post="virus infection (Bai et al., 2016; Jacobs et al.,"/>
   <result pre="al., 2016; Jacobs et al., 2015; Sissoko et al., 2016)," exact="Lassa fever" post="(Raabe et al., 2017), norovirus (Ruis et al., 2018),"/>
   <result pre="Furuta et al., 2013; Furuta, Komeno, &amp;amp; Nakamura, 2017). 5.2" exact="Ebola" post="virus infection Concerning Ebola virus infection, the efficacy of"/>
   <result pre="Furuta, Komeno, &amp;amp; Nakamura, 2017). 5.2 Ebola virus infection Concerning" exact="Ebola" post="virus infection, the efficacy of favipiravir in post-exposure prophylaxis"/>
   <result pre="(Smither et al., 2014) and a therapeutic mouse model of" exact="Ebola" post="virus disease (Oestereich, Ludtke, et al., 2014). Treatment with"/>
   <result pre="favipiravir from 6 to 13Â days after lethal infection with" exact="Ebola" post="virus cured all mice when the treatment was started"/>
   <result pre="irreversible levels. Thus, favipiravir may be able to cure an" exact="Ebola" post="virus infection in the early phase of infection, but"/>
   <result pre="dose of favipiravir used to treat a human with an" exact="Ebola" post="virus infection is 6000Â mg on the first day"/>
   <result pre="or favipiravir with other anti-Ebola agents and did not develop" exact="Ebola" post="virus disease (Jacobs et al., 2015). Although the needle"/>
   <result pre="PEP using a mouse model (Smither et al., 2014). An" exact="Ebola" post="study conducted in Guinea included 126 patients, and 111"/>
   <result pre="rate was not statistically significant (Sissoko et al., 2016). An" exact="Ebola" post="study conducted in Sierra Leone included 39 favipiravir-treated patients"/>
   <result pre=".027). (Bai et al., 2016). During the 2014 epidemic of" exact="Ebola" post="virus infection in West Africa, patients who were treated"/>
   <result pre="has been used as an emergency or compassionate treatment for" exact="Lassa fever," post="norovirus, and rabies cases. This review focuses on human"/>
   <result pre="Table 1. Favipiravir has been used in human therapy for" exact="Ebola hemorrhagic fever" post="(Bai et al., 2016, Jacobs et al., 2015; Sissoko"/>
   <result pre="al., 2016, Jacobs et al., 2015; Sissoko et al., 2016)," exact="Lassa fever" post="(Raabe et al., 2017), norovirus (Ruis et al., 2018),"/>
   <result pre="al., 2019). 5.4 The dose of favipiravir for influenza and" exact="Ebola" post="virus infection The antiviral activity (EC50) of favipiravir against"/>
   <result pre="infection The antiviral activity (EC50) of favipiravir against influenza and" exact="Ebola" post="viruses is different from the range of 0.014â€&quot;0.55Â Î¼g/mL"/>
   <result pre="by diffusion from the blood, and in the case of" exact="Ebola" post="virus infection, direct perfusion of blood reaches target tissues,"/>
   <result pre="that promotes polymerase-induced mutation synthesis (Wheeler, Rajagopal, &amp;amp; Mathews, 2005)." exact="Influenza" post="RdRp complex is composed of PB1, PB2, and PA"/>
   <result pre="ATP, GTP, CTP, and UTP, as substrates for RNA synthesis." exact="Influenza" post="RdRp incorporates mismatched nucleotides in a primer-extension-based misincorporation assay"/>
   <result pre="biased nucleotide pool conditions as if the mutagen is present." exact="Influenza" post="RdRp displays a significantly higher fidelity than human immunodeficiency"/>
   <result pre="may be liver failure, renal failure, respiratory failure and encephalitis." exact="Ebola" post="virus infection seemed to be difficult for patients when"/>
   <result pre="2014), indicating the importance of early diagnosis and treatment. In" exact="Ebola" post="virus infection, other than the direct cause of death"/>
   <result pre="compare historical control patients and patients treated with favipiravir for" exact="Ebola" post="virus infection (Bai et al., 2016; Jacobs et al.,"/>
   <result pre="virus replication in vivoElife32014e03679 BaiC.Q.MuJ.S.KargboD.SongY.B.NiuW.K.NieW.M. â€¦JiangJ.F.Clinical and Virological characteristics of" exact="Ebola" post="virus disease patients treated with Favipiravir (T-705)-Sierra Leone, 2014Clinical"/>
   <result pre="TongerenS.A.DongL. â€¦WarrenT.K.Efficacy of favipiravir (T-705) in nonhuman primates infected with" exact="Ebola" post="virus or Marburg virusAntiviral Research15120189710429289666 CaoB.A Pharmacokinetics Study of"/>
   <result pre="genetic analysis of acyclovir-resistant variantsAntiviral Research40199915516610027650 JacobsM.AaronsE.BhaganiS.BuchananR.CropleyI.HopkinsS. â€¦RodgerA.Post-exposure prophylaxis against" exact="Ebola" post="virus disease with experimental antiviral agents: A case-series of"/>
   <result pre="United States of America107201088288720080770 KuA.S.ChanL.T.The first case of H5N1 avian" exact="influenza infection" post="in a human with complications of adult respiratory distress"/>
   <result pre="KurokawaM.ImakitaM.KumedaC.A.YukawaT.A.ShirakiK.Kakkon-to suppressed interleukin 1Î± production responsive to interferon and alleviated" exact="influenza infection" post="in miceJ Traditional Med131996201209 KurokawaM.KumedaC.A.YamamuraJ.KamiyamaT.ShirakiK.Antipyretic activity of cinnamyl derivatives"/>
   <result pre="by Kakkon-to, a herbal medicine, on the early stage of" exact="influenza infection" post="in miceAntiviral Research56200218318812367723 KurokawaM.WatanabeW.ShimizuT.SawamuraR.ShirakiK.Modulation of cytokine production by 7-hydroxycoumarin"/>
   <result pre="cytokine production by 7-hydroxycoumarin in vitro and its efficacy against" exact="influenza infection" post="in miceAntiviral Research85201037338019913056 KurokawaM.YamamuraJ.LiZ.SatoH.HitomiN.TatsumiY.ShirakiK.Antipyretic activity of gingyo-san, a traditional"/>
   <result pre="Europe, 2007-08 seasonEmerging Infectious Diseases15200955256019331731 MemoliM.J.AthotaR.ReedS.CzajkowskiL.BristolT.ProudfootK. â€¦TaubenbergerJ.K.The natural history of" exact="influenza infection" post="in the severely immunocompromised vs nonimmunocompromised hostsClinical Infectious Diseases58201421422424186906"/>
   <result pre="National Kidney FoundationHemodialysis2019National Kidney FoundationNew Yorkhttps://www.kidney.org/atoz/content/hemodialysis OestereichL.LudtkeA.WurrS.RiegerT.Munoz-FontelaC.GuntherS.Successful treatment of advanced" exact="Ebola" post="virus infection with T-705 (favipiravir) in a small animal"/>
   <result pre="Agents and Chemotherapy5720135202520823917318 SchartonD.BaileyK.W.VestZ.WestoverJ.B.KumakiY.Van WettereA. â€¦GowenB.B.Favipiravir (T-705) protects against peracute" exact="Rift Valley fever" post="virus infection and reduces delayed-onset neurologic disease observed with"/>
   <result pre="due to thymidine kinase-deficient/temperature-sensitive virusJournal of Medical Virology7920071731174017854045 ShinyaK.EbinaM.YamadaS.OnoM.KasaiN.KawaokaY.Avian flu:" exact="Influenza" post="virus receptors in the human airwayNature440200643543616554799 ShirakiK.Helicase-primase inhibitor amenamevir"/>
   <result pre="miceAntimicrobial Agents and Chemotherapy51200784585117194832 SissokoD.LaouenanC.FolkessonE.Mâ€™LebingA.B.BeavoguiA.H.BaizeS. â€¦GroupJ.S.Experimental treatment with Favipiravir for" exact="Ebola" post="virus disease (the JIKI trial): A historically controlled, single-arm"/>
   <result pre="therapeuticsPLoS Pathogens92013e1003565 SmitherS.J.EastaughL.S.StewardJ.A.NelsonM.LenkR.P.LeverM.S.Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational" exact="Ebola" post="virus infection in a mouse modelAntiviral Research104201415315524462697 SpicklerA.R.Eastern, Western"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7102582\results\search\zoonosis\results.xml">
   <result pre="different parts of the globe. 2 Diabetes, respiratory infections and" exact="COVID19" post="Individuals with diabetes are at risk of infections, especially"/>
   <result pre="important risk factor for mortality in patients infected with Pandemic" exact="Influenza" post="A 2009 (H1N1), Severe Acute Respiratory Syndrome (SARS) coronavirus"/>
   <result pre="spread of infection. 4 Measures in Patients of diabetes with" exact="COVID 19" post="infection a.In case a person with diabetes develops fever,"/>
   <result pre="3GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.LiuL.ShanH.LeiC.L.HuiD.S.C.DuB.LiL.J.ZengG.YuenK.Y.ChenR.C.TangC.L.WangT.ChenP.Y.XiangJ.LiS.Y.WangJ.L.LiangZ.J.PengY.X.WeiL.LiuY.HuY.H.PengP.WangJ.M.LiuJ.Y.ChenZ.LiG.ZhengZ.J.QiuS.Q.LuoJ.YeC.J.ZhuS.Y.ZhongN.S.China medical treatment expert group for covid-19. Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaNÂ Engl J Med2020 Feb 2810.1056/NEJMoa2002032 4FauciA.S.LaneH.C.RedfieldR.R.Covid-19 -"/>
   <result pre="Jan 1411E59 8DengS.Q.PengH.J.Characteristics of and public health responses to the" exact="coronavirus disease 2019" post="outbreak in ChinaJÂ Clin Med22020 Feb 20910.3390/jcm9020575E575 9ZhangJ.J.DongX.CaoY.Y.YuanY.D.YangY.B.YanY.Q.AkdisC.A.GaoY.D.Clinical characteristics"/>
   <result pre="ChinaIntensive Care Med2020 Mar 310.1007/s00134-020-05991-x 11LippiG.PlebaniM.Laboratory abnormalities in patients with" exact="COVID-2019" post="infectionClin Chem Lab Med2020 Mar 310.1515/cclm-2020-0198pii:/j/cclm.ahead-of-print/cclm-2020-0198/cclm-2020-0198.xml 12WuZ.McGooganJ.M.Characteristics of and"/>
   <result pre="Med2020 Mar 310.1515/cclm-2020-0198pii:/j/cclm.ahead-of-print/cclm-2020-0198/cclm-2020-0198.xml 12WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7102591\results\search\zoonosis\results.xml">
   <result pre="immunosuppressive drugs. However, the increasing knowledge about the pathophysiology of" exact="SARS-CoV-2 infection" post="is leading to consider some anti-rheumatic drugs as potential"/>
   <result pre="the other hand, the growing knowledge about the pathogenesis of" exact="SARS-CoV-2 infection" post="is leading to the introduction of drugs commonly used"/>
   <result pre="the consequent ARDS occurring in the most aggressive patterns of" exact="SARS-CoV infection" post="[11]. Therefore, waiting for observational data on the incidence"/>
   <result pre="epithelial cells, which are particularly prone to viral infection [13]." exact="SARS-CoV-2 infection" post="leads to the downregulation of ACE2 expression, thus resulting"/>
   <result pre="role of the genetic predisposition for an increased risk of" exact="SARS-CoV-2 infection" post="due to ACE2 polymorphisms that have been linked to"/>
   <result pre="for the widely use of CS for the management of" exact="Middle East respiratory syndrome" post="(MERS)-CoV [44] and SARS-CoV [45] outbreaks, both histologically characterized"/>
   <result pre="and approved targeted therapeutics for the treatment of the new" exact="SARS-CoV-2 infection" post="are still lacking and the management of COVID-19 is"/>
   <result pre="an adenosine analogue currently under development for the management of" exact="Ebola" post="virus infection [78], has been recently recognized as a"/>
   <result pre="showed good preliminary in vitro results in the control of" exact="SARS-CoV-2 infection" post="[80]. Consequently, lopinavir-ritonavir and remdesevir are currently the only"/>
   <result pre="seems to be the best option for the management of" exact="SARS-CoV-2 infection" post="[93]. 5.2 IL-6 and IL-1 blockers As already described,"/>
   <result pre="requiring immunosuppressive treatment [22]. 5.3 TNF inhibitors As previously described," exact="SARS-CoV infection" post="is associated with a downregulation of ACE2 expression coupled"/>
   <result pre="have all been demonstrated to inhibit infection of cells by" exact="Dengue" post="virus, Ebola virus, and respiratory syncytial virus [103]. Unfortunately,"/>
   <result pre="been demonstrated to inhibit infection of cells by Dengue virus," exact="Ebola" post="virus, and respiratory syncytial virus [103]. Unfortunately, all these"/>
   <result pre="JAK/STAT pathway are crucial determinants of virulence [113]. In particular," exact="Influenza" post="A viruses disrupt JAK/STAT signaling by reducing the expression"/>
   <result pre="SARS-CoV-2Natl Sci Rev202010.1093/nsr/nwaa036 3WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="patients infected by SARS-CoV-2 in Wuhan, ChinaAllergy202010.1111/all.14238 5GuanW.-J.NiZ.-Y.HuY.LiangW.-H.OuC.-Q.HeJ.-X.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaNew Engl J Medicine202010.1056/nejmoa2002032 6HuangC.WangY.LiX.RenL.ZhaoJ.HuY.Clinical features of patients"/>
   <result pre="and cytokines in peripheral blood of 123 hospitalized patients with" exact="2019 novel coronavirus pneumonia" post="(NCP)Medrxiv202010.1101/2020.02.10.20021832 22MehtaP.McAuleyD.F.BrownM.SanchezE.TattersallR.S.MansonJ.J.COVID-19: consider cytokine storm syndromes and immunosuppressionLancet202010.1016/S0140-6736(20)30628-0 23MathewA.J.RavindranV.Infections"/>
   <result pre="quantitative RT-PCRJ Korean Med Sci352020e7910.3346/jkms.2020.35.e79 78MulanguS.DoddL.E.DaveyR.T.MbayaO.T.ProschanM.MukadiD.A randomized, controlled trial of" exact="Ebola" post="virus disease therapeuticsNew Engl J Medicine38120192293230310.1056/nejmoa1910993 79SheahanT.P.SimsA.C.GrahamR.L.MenacheryV.D.GralinskiL.E.CaseJ.B.Broad-spectrum antiviral GS-5734"/>
   <result pre="94DiaoB.WangC.TanY.ChenX.LiuY.NingL.Reduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVID-19)Medrxiv202010.1101/2020.02.18.20024364 95ShakooryB.CarcilloJ.A.ChathamW.W.AmdurR.L.ZhaoH.DinarelloC.A.Interleukin-1 receptor blockade is associated with reduced mortality"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7108526\results\search\zoonosis\results.xml">
   <result pre="infections and pneumonia 9-O-acetylsialic acids SARS-CoV Bats Masked palmes civetes" exact="Severe acute respiratory syndrome" post="Angiotensin converting enzyme 2 MERS-CoV Bats Camelids Severe acute"/>
   <result pre="acute respiratory syndrome Angiotensin converting enzyme 2 MERS-CoV Bats Camelids" exact="Severe acute respiratory syndrome" post="Dipeptidyl peptidase-4 2019-nCoV Bats Unknown Severe acute respiratory syndrome"/>
   <result pre="Camelids Severe acute respiratory syndrome Dipeptidyl peptidase-4 2019-nCoV Bats Unknown" exact="Severe acute respiratory syndrome" post="Angiotensin converting enzyme 2 Until 2002, CoVs were considered"/>
   <result pre="a nucleotide analogue prodrug initially developed for the treatment of" exact="Ebola" post="and Marburg virus infection, and the anti-malarial drug chloroquine"/>
   <result pre="from viral challenges (Jin etÂ al.2017). Thus, as reported for" exact="Ebola" post="virus, the use of monoclonal antibodies to treat severe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7110270\results\search\zoonosis\results.xml">
   <result pre="control of severe acute respiratory syndromeScience20033001966197010.1126/science.108661612766207 MizumotoKSaitohMChowellGMiyamatsuYNishiuraHEstimating the risk of" exact="Middle East respiratory syndrome" post="(MERS) death during the course of the outbreak in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7111068\results\search\zoonosis\results.xml">
   <result pre="that the nucleotide analog remdesivir had a better activity against" exact="MERS coronavirus" post="than the protease inhibitor lopinavir combined with ritonavir, and"/>
   <result pre="al (2020) Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet395: 507â€&quot;513.32007143 Danchin,"/>
   <result pre="J. M., (2020) Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVIDâ€�19) Outbreak in china: summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7113379\results\search\zoonosis\results.xml">
   <result pre="with 2019-nCoV infectionJ Med Virol2020 3.WangYXJLiuWHYangMChenWThe role of CT for" exact="Covid-19" post="patientâ€™s management remains poorly definedAnn Transl Med2020814510.21037/atm.2020.02.7132175437 4.LiuYYangYZhangCet al.Clinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7117553\results\search\zoonosis\results.xml">
   <result pre="resources such as mechanical ventilation2. The severe nature of the" exact="SARS-CoV-2 infection" post="also exacerbates resource limitations, asÂ patients often need 15â€&quot;20"/>
   <result pre="patients receiving JAK inhibitors5. However, extrapolation of this data to" exact="SARS-CoV-2 infection" post="is problematic given the heterogeneity in specific drug-associated adverse"/>
   <result pre="Engl. J. Med.2020 3.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="outcome in patients hospitalised with acute respiratory disease due to" exact="MERS coronavirus" post="or other causesPLoS One201611e016597827812197 8.LeeNet al.A major outbreak of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7117787\results\search\zoonosis\results.xml">
   <result pre="history of underlying diseases and/or co-infection with other infections like" exact="Influenza" post="virus and Klebsiella may accelerate the progress of symptoms"/>
   <result pre="against the COVID-19 virus and its safety was proven in" exact="Ebola" post="trials. Another proposed treatment is Chloroquine, an old drug"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7118644\results\search\zoonosis\results.xml">
   <result pre="development and regulatory body approved therapies. In particular, the current" exact="coronavirus disease 2019" post="(COVID-19) pandemic has quickly intensified interest in developing treatment"/>
   <result pre="November 2019, there were 2494 laboratory-confirmed cases of infection with" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) that reached 27 countries and had a"/>
   <result pre="generated intense interest in vaccine development and treatment options for" exact="coronavirus disease 2019" post="(COVID-19) [6,7]. Remdesivir (GS-5734, Fig. 1a) is an investigational"/>
   <result pre="respiratory syncytial virus, and Hendra virus), and Filoviridae (such as" exact="Ebola" post="virus) [[8], [9], [10], [11], [12]]. Originally developed to"/>
   <result pre="virus) [[8], [9], [10], [11], [12]]. Originally developed to treat" exact="Ebola" post="virus infection [8], remdesivir is a prodrug of the"/>
   <result pre="African green monkeys [21]. In a Ces1c-knockout mouse model of" exact="SARS-CoV infection," post="prophylactic and therapeutic remdesivir treatment resulted in lower lung"/>
   <result pre="that randomized 175 patients to be treated with remdesivir for" exact="Ebola" post="[39]. Incidentally, randomization to remdesivir treatment was discontinued in"/>
   <result pre="compassionate use data having been favorable for remdesivir against the" exact="Ebola" post="virus prior to the trial [9]. Interestingly, patients who"/>
   <result pre="Summary, November 2019Available from:https://www.who.int/emergencies/mers-cov/en/(accessed on 9 March 2020) 5MullerM.A.MeyerB.CormanV.M.Al-MasriM.TurkestaniA.RitzD.Presence of" exact="Middle East respiratory syndrome" post="coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological"/>
   <result pre="approachOne Health9202010012432195311 8WarrenT.K.JordanR.LoM.K.RayA.S.MackmanR.L.SolovevaV.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature.5317594201638138526934220 9LoM.K.JordanR.ArveyA.SudhamsuJ.Shrivastava-RanjanP.HotardA.L.GS-5734 and its parent nucleoside"/>
   <result pre="32GordonC.J.TchesnokovE.P.FengJ.Y.PorterD.P.GotteM.The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirusJ. Biol. Chem.2020 33KirchdoerferR.N.WardA.B.Structure of the SARS-CoV nsp12 polymerase"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7126217\results\search\zoonosis\results.xml">
   <result pre="adjunct to pharmacotherapy for influenza virus infection. Graphical abstract Keywords" exact="Influenza" post="Antivirals Glucosinolate Isomer Isatidis Radix Abbreviations AAF amnio-allantoic fluid"/>
   <result pre="tissue culture infective dose TPCK N-p-Tosyl-L-phenylalanine chloromethyl ketone 1 Introduction" exact="Influenza" post="viruses are enveloped RNA viruses which can cause morbidity"/>
   <result pre="Â°C in a sterilized container. 2.2 Virus, cell and animal" exact="Influenza" post="virus strain A/California/7/2009 (H1N1) NYMC X-179A was from Shanghai"/>
   <result pre="by hemagglutination inhibition (HAI) assay and neuraminidase inhibition (NA) assay." exact="Influenza" post="virus is an enveloped RNA virus with hemagglutinin (HA)"/>
   <result pre="envelope. Viral adsorption to cells is the initial step of" exact="influenza infection," post="which is performed via the binding between sialic acid"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7127009\results\search\zoonosis\results.xml">
   <result pre="their altered production has been demonstrated in both SARS and" exact="MERS coronavirus" post="infections. Such altered levels have been shown to be"/>
   <result pre="comprehensive reviewJ. Infect.S0163â€&quot;445320202030087-6 4WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7129715\results\search\zoonosis\results.xml">
   <result pre="the third major coronavirus epidemic of the 21st century after" exact="Middle East respiratory syndrome" post="(MERS) and severe acute respiratory syndrome (SARS). COVID-19 is"/>
   <result pre="clinical trial of chloroquine found that it did not prevent" exact="influenza infection" post="[5]. 2 Tocilizumab/Sarilumab The clinical presentation of COVID-19 is"/>
   <result pre="consider their possible adverse effects. The people most affected by" exact="SARS-CoV-2 infection" post="are adults aged &amp;gt;60Â years with one or more"/>
   <result pre="16Actemra (tocilizumab)Prescribing information2019GenentechAccessed March 22, 2020https://www.actemrahcp.com/?_ga=2.137041460.509331555.1584929819-505112783.1584929819 17VardenyO.MadjidM.SolomonS.D.Applying the Lessons of" exact="Influenza" post="to Coronavirus During a Time of UncertaintyAvailable from http://ahajournals.org"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7134984\results\search\zoonosis\results.xml">
   <result pre="century, severe acute respiratory syndrome (SARS), 2009 A(H1N1) influenza, and" exact="Ebola" post="have all placed strains on critical care systems. In"/>
   <result pre="for triage and prioritization of care when necessary. Keywords Pandemic" exact="Influenza" post="Disaster preparedness Key points â€¢In a globalized world where"/>
   <result pre="2001 to 2002 and the 2013 to 2014 West African" exact="Ebola" post="epidemic showed the risks of highly contagious disease to"/>
   <result pre="to epidemics with global pandemic potential, as dramatically demonstrated by" exact="Ebola" post="and related viruses. The unique infection prevention requirements, the"/>
   <result pre="pandemic, and the limited number of Western patients infected with" exact="Ebola" post="virus in 2014 to 2015 serve as a useful"/>
   <result pre="due to relaxed infection control practices later in the epidemic.11" exact="Influenza" post="A(H1N1) pandemic, 2009 to 2010 Critical care services were"/>
   <result pre="increased resources that could be brought to bear. West Africa" exact="Ebola" post="virus disease epidemic, 2014 to 2016 In March 2014,"/>
   <result pre="West African nations of Guinea and Liberia reported outbreaks of" exact="Ebola" post="virus disease (EVD) that rapidly spread to nearby countries"/>
   <result pre="not be feasible in a generalized outbreak. Beyond the hospital," exact="Ebola" post="produced a unique public response. Widespread media reporting on"/>
   <result pre="(eg, brincidofovir for a poxvirus outbreak).31 High-containment pathogens, such as" exact="Ebola" post="have special supply requirements. Ventilators, laboratory equipment, and other"/>
   <result pre="the proper use of these devices is necessary in advance." exact="Ebola" post="and other high-containment pathogens require higher levels of expertise"/>
   <result pre="and the use of PAPRs are routine in most US" exact="Ebola" post="treatment units (ETUs). Training for hospital staff is available"/>
   <result pre="(ETUs). Training for hospital staff is available through the National" exact="Ebola" post="Training and Education Center (www.netec.org). Although having an adequate"/>
   <result pre="surgical units as auxiliary ICUs and step-down units, for example.)" exact="Ebola" post="and other high-containment pathogens require even-more specific dedicated space."/>
   <result pre="16LeligdowiczA.FischerW.A.2ndUyekiT.M.Ebola virus disease and critical illnessCrit Care20201621727468829 17UyekiT.M.MehtaA.K.DaveyR.T.Jr.Clinical management of" exact="Ebola" post="virus disease in the United States and EuropeNÂ Engl"/>
   <result pre="Engl J Med374201663664626886522 18SellT.K.BoddieC.McGintyE.E.Media messages and perception of risk for" exact="Ebola" post="virus infection, United StatesEmerg Infect Dis23201710811127983495 19GeeS.SkovdalM.Public discourses of"/>
   <result pre="Ebola virus infection, United StatesEmerg Infect Dis23201710811127983495 19GeeS.SkovdalM.Public discourses of" exact="Ebola" post="contagion and courtesy stigma: the real risk to international"/>
   <result pre="international health care workers returning home from the West Africa" exact="Ebola" post="outbreak?Qual Health Res2820181499150829484966 20MorrisA.M.RicciK.A.GriffinA.R.Personal and professional challenges confronted by"/>
   <result pre="hemorrhagic fever patients and experience gained from admission of an" exact="Ebola" post="patientEmerg Infect Dis22201618419126812146 34LeA.B.HoboyS.GermainA.AÂ pilot survey of the U.S."/>
   <result pre="March 02, 2019 41HersteinJ.J.BiddingerP.D.GibbsS.G.Sustainability of high-level isolation capabilities among US" exact="Ebola" post="treatment centersEmerg Infect Dis23201796596728518036 42HersteinJ.J.BiddingerP.D.KraftC.S.Current capabilities and capacity of"/>
   <result pre="Ebola treatment centersEmerg Infect Dis23201796596728518036 42HersteinJ.J.BiddingerP.D.KraftC.S.Current capabilities and capacity of" exact="Ebola" post="treatment centers in the United StatesInfect Control Hosp Epidemiol37201631331826641267"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7138017\results\search\zoonosis\results.xml">
   <result pre="Jan 2410.1016/S0140-6736(20)30183-5 12ChenNZhouMDongXEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet2020published online Jan 2910.1016/S0140-6736(20)30211-7"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7138145\results\search\zoonosis\results.xml">
   <result pre="doi: 10.1016/j.ijcard.2020.03.074 : Article Commentary: What is the relationship between" exact="Covid-19" post="and cardiovascular disease? FerrariR.fri@unife.itabâ�ŽDi PasqualeG.cRapezziC.ab[a], [b], [c], â�ŽCorresponding author"/>
   <result pre="as long as the COVID-19 resource centre remains active. Keywords" exact="Covid-19" post="Cardiovascular disease Infections Compared to other sections of medicine,"/>
   <result pre="number of cardiovascular diseases may increase mortality among affected patients." exact="Covid-19" post="appears less pathogenic than previous viruses such as SARS-COV"/>
   <result pre="or MERS-COV. But, deaths in the Wuhan Province where the" exact="Covid-19" post="epidemic started were between 0.5% to 2.5% [1]. In"/>
   <result pre="in 19% of COVID-19 patients [2]. A report on 136" exact="Covid-19" post="patients shows that 26% of them required cardiovascular intensive"/>
   <result pre="Although the vulnerability of the patients with heart diseases to" exact="Covid-19" post="is quite evident in these reports, the single study"/>
   <result pre="respiratory symptoms. Only later are they diagnosed as positive for" exact="Covid-19" post="[6]. Some Covid-19 patients have high sensitivity cardiac troponin"/>
   <result pre="later are they diagnosed as positive for Covid-19 [6]. Some" exact="Covid-19" post="patients have high sensitivity cardiac troponin 1 levels, suggesting"/>
   <result pre="It is unclear whether these cardiac conditions are provoked by" exact="Covid-19" post="or are just comorbidities or non-specific complications of infection."/>
   <result pre="MI were shown for more recent epidemics of SARS and" exact="Covid-19" post="[8]. Only future studies will establish a possible relationship"/>
   <result pre="[8]. Only future studies will establish a possible relationship between" exact="Covid-19" post="and coronary artery disease. Only the awareness of such"/>
   <result pre="for the SARS-COV infection, the receptor for the new 2019" exact="Covid-19" post="is human angiotensin-converting enzyme 2 (ACE2), a homologue of"/>
   <result pre="few upper respiratory tract symptoms typical of flu and why" exact="Covid-19" post="is not just a common cold [9]. Contrary to"/>
   <result pre="angiotensin 2 plasma levels could activate ACE2 and an adverse" exact="Covid-19" post="pandemic [10]. ARBs are mainly prescribed for hypertension and"/>
   <result pre="to ARBs should be used to treat hypertension during the" exact="Covid-19" post="pandemic [10]. The caveats here are a) there is"/>
   <result pre="side effects of the current drugs empirically used for the" exact="Covid-19" post="infection and now tested in experimental protocols (such as"/>
   <result pre="surveillance is mandatory. In conclusion, besides the possible impact of" exact="Covid-19" post="on cardiology, the pandemic has created a perfect storm"/>
   <result pre="4GuanW.NiZ.HuY.China Medical Treatment Expert Group for Covid-19. Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med3821820201708172032109013 5WuZ.McGooganJ.M.Characteristics of and important"/>
   <result pre="Engl J Med3821820201708172032109013 5WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="acute coronary syndromesLancet Infect. Dis.102010839220113977 8HalhogbaniT.Acute myocarditis associated with novel" exact="Middle East respiratory syndrome" post="coronavirusAnn Saudi Med362016788026922692 9GurwitzD.Angiotensin receptor blockers as tentative SARS-CoV-2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7138156\results\search\zoonosis\results.xml">
   <result pre="and includes those that cause severe acute respiratory syndrome (SARS)," exact="Middle East respiratory syndrome" post="(MERS) and now the COVID-19 pandemic. In an uncertain"/>
   <result pre="considered be at a higher risk of develping complications from" exact="COVID19" post="infection. Low Natalizumab Tysabri Anti-VLA4, selective adhesion molecule inhibitor"/>
   <result pre="GuanW.-J.NiZ.-Y.HuY.LiangW.-H.OuC.-Q.HeJ.-X.LiuL.ShanH.LeiC.-L.HuiD.S.C.DuB.LiL.-J.ZengG.YuenK.-Y.ChenR.-C.TangC.-L.WangT.ChenP.-Y.XiangJ.LiS.-Y.WangJ.-L.LiangZ.-J.PengY.-X.WeiL.LiuY.HuY.-H.PengP.WangJ.-M.LiuJ.-Y.ChenZ.LiG.ZhengZ.-J.QiuS.-Q.LuoJ.YeC.-J.ZhuS.-Y.ZhongN.-S.collab: China Medical Treatment Expert Group for Covid-19Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN. Engl. J. Med.202010.1056/NEJMoa2002032https://doi.org/ HauserS.L.Bar-OrA.ComiG.GiovannoniG.HartungH.-P.HemmerB.LublinF.MontalbanX.RammohanK.W.SelmajK.TraboulseeA.WolinskyJ.S.ArnoldD.L.KlingelschmittG.MastermanD.FontouraP.BelachewS.ChinP.MaironN.GarrenH.KapposL.OPERAIcollab: OPERA II Clinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7138334\results\search\zoonosis\results.xml">
   <result pre="risks of the collision of the COVID-19 and addiction epidemics." exact="Coronavirus disease 2019" post="(COVID-19) is causing untold challenges to health care and"/>
   <result pre="other coronaviruses, including those causing severe acute respiratory syndrome and" exact="Middle East respiratory syndrome" post="(2). Persons whose lungs may be compromised from vaping"/>
   <result pre="Z, McGoogan JM. Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7138382\results\search\zoonosis\results.xml">
   <result pre="References Al-TawfiqJ.A.MomattinH.DibJ.MemishZ.A.Ribavirin and interferon therapy in patients infected with the" exact="Middle East respiratory syndrome" post="coronavirus: an observational studyInt. J. Infect. Dis.202014424610.1016/j.ijid.2013.12.00324406736 ArabiY.M.ShalhoubS.Al-OmariA.MandourahY.Al-HameedF.SindiA.AlraddadiB.Al-MotairiA.Al-KhatibK.Abdul-MomminA.QushmaqI.A.MadyA.SolaimanO.Al-AithanA.BalkhyH.H.Al-RaddadiR.RajabA.Al-MekhlafiG.A.Al-HarthyA.KharabaA.Al-JabbaryA.PintoR.SadatM.Al-MutairiH.Al-QasimE.JoseJ.DeebA.M.MersonL.HaydenF.G.FowlerR.AldawoodA.S.Effect of"/>
   <result pre="clinical trials for COVID-19. medRxivJanuary202010.1101/2020.03.18.200381902020.03.18.20038190 ChanJ.F.W.ChanK.H.KaoR.Y.T.ToK.K.W.ZhengB.J.LiC.P.Y.LiP.T.W.DaiJ.MokF.K.Y.ChenH.HaydenF.G.YuenK.Y.Broad-spectrum antivirals for the emerging" exact="Middle East respiratory syndrome" post="coronavirusJ. Infect.67201360661610.1016/j.jinf.2013.09.02924096239 ChanJ.F.W.YaoY.YeungM.L.DengW.BaoL.JiaL.LiF.XiaoC.GaoH.YuP.CaiJ.P.ChuH.ZhouJ.ChenH.QinC.YuenK.Y.Treatment with lopinavir/ritonavir or interferon-Î²1b improves outcome"/>
   <result pre="Infect. Dis.21220151904191310.1093/infdis/jiv39226198719 ChannappanavarR.FehrA.R.ZhengJ.Wohlford-LenaneC.AbrahanteJ.E.MackM.SompallaeR.McCrayP.B.MeyerholzD.K.PerlmanS.IFN-I response timing relative to virus replication determines" exact="MERS coronavirus" post="infection outcomesJ. Clin. Invest.12920193625363910.1172/JCI12636331355779 ChenF.ChanK.H.JiangY.KaoR.Y.T.LuH.T.FanK.W.ChengV.C.C.TsuiW.H.W.HungI.F.N.LeeT.S.W.GuanY.PeirisJ.S.M.YuenK.Y.In vitro susceptibility of 10"/>
   <result pre="to selected antiviral compoundsJ. Clin. Virol.312004697510.1016/j.jcv.2004.03.00315288617 DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov. Ther.142020586010.5582/ddt.2020.0101232147628 FalzaranoD.De WitE.MartellaroC.CallisonJ.MunsterV.J.FeldmannH.Inhibition of novel Î² coronavirus"/>
   <result pre="linesBiochem. Biophys. Res. Commun.326200590590810.1016/j.bbrc.2004.11.12815607755 OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.AlmakhlafiG.A.AlbarrakM.M.MemishZ.A.AlbarrakA.M.Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: a retrospective cohort studyLancet Infect. Dis.1420141090109510.1016/S1473-3099(14)70920-X25278221 RanieriV.M.PettilÃ¤V.KarvonenM.K.JalkanenJ.NightingaleP.BrealeyD.ManceboJ.FerrerR.MercatA.PatronitiN.QuintelM.VincentJ.L.OkkonenM.MezianiF.BellaniG.MacCallumN.CreteurJ.KlugeS.Artigas-RaventosA.MaksimowM.PiippoI.ElimaK.JalkanenS.JalkanenM.BellinganG.Effect"/>
   <result pre="Immunol.32201451354510.1146/annurev-immunol-032713-12023124555472 ShalhoubS.FarahatF.Al-JiffriA.SimhairiR.ShammaO.SiddiqiN.MushtaqA.IFN-Î±2a or IFN-Î²1a in combination with ribavirin to treat" exact="Middle East respiratory syndrome" post="coronavirus pneumonia: a retrospective studyJ. Antimicrob. Chemother.7020152129213210.1093/jac/dkv08525900158 SheahanT.P.SimsA.C.LeistS.R.SchÃ¤ferA.WonJ.BrownA.J.MontgomeryS.A.HoggA.BabusisD.ClarkeM.O.SpahnJ.E.BauerL.SellersS.PorterD.FengJ.Y.CihlarT.JordanR.DenisonM.R.BaricR.S.Comparative therapeutic"/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the perspectives of clinical immunologists from ChinaClin. Immunol.214202010839310.1016/j.clim.2020.10839332222466"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7144238\results\search\zoonosis\results.xml">
   <result pre="IAV replication and provided us novel therapeutic targets for combating" exact="influenza infection." post="KEYWORDS Influenza A virus autophagy HIF-1Î± glycolysis AMPKÎ± ULK1"/>
   <result pre="provided us novel therapeutic targets for combating influenza infection. KEYWORDS" exact="Influenza" post="A virus autophagy HIF-1Î± glycolysis AMPKÎ± ULK1 Funding National"/>
   <result pre="Local Universities in Shanghai. fig-count: table-count: equation-count: ref-count: page-count: Introduction" exact="Influenza" post="A virus (IAV) is an enveloped virus with a"/>
   <result pre="antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA)." exact="Influenza" post="A Virus Nucleoprotein (ab128193), HIF-1-alpha (ab113642) and Influenza A"/>
   <result pre="CA, USA). Influenza A Virus Nucleoprotein (ab128193), HIF-1-alpha (ab113642) and" exact="Influenza" post="A Virus Nucleoprotein (FITC) (ab20921) antibodies were from ABCAM"/>
   <result pre="alpha (APC) antibody was from R&amp;amp;D (R&amp;amp;D Systems, Minneapolis, USA)." exact="Influenza" post="A Virus PB2 antibody (PA532220) was from Pierce (Dallas,"/>
   <result pre="replication in vitro. Figure 6. Autophagy inhibition reduces replication of" exact="Influenza" post="A Virus in vitro. (A-D) A549 cells were pretreated"/>
   <result pre="IAV replication. Requirement for the development of host-factor-directed antiviral drugs" exact="Influenza" post="viruses are a major cause of morbidity and mortality"/>
   <result pre="which resulted in decreased mortality in the mouse model of" exact="influenza infection" post="[29]. This is controversial to our findings in this"/>
   <result pre="doi: 10.1186/1752-0509-4-6120465796 29SmallwoodHS, DuanS, MorfouaceM, et al.Targeting metabolic reprogramming by" exact="influenza infection" post="for therapeutic intervention. Cell Rep. 2017 May;19(8):1640â€&quot;1653. doi: 10.1016/j.celrep.2017.04.03928538182"/>
   <result pre="systems analysis identifies a feedforward inflammatory circuit leading to lethal" exact="influenza infection." post="Cell. 2013 Jul;154(1):197â€&quot;212. doi: 10.1016/j.cell.2013.06.01323827683"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7144545\results\search\zoonosis\results.xml">
   <result pre="in COVID-19 patients suggests the existence of a relationship between" exact="SARS-CoV-2 infection" post="and cardiac disease. The Notch signalling is a major"/>
   <result pre="we discuss the possibility to target Notch signalling to prevent" exact="SARS-CoV-2 infection" post="and interfere with the progression of COVID-19- associated heart"/>
   <result pre="other complications [51]. Furthermore, patients diagnosed with pneumonia due to" exact="SARS-CoV-2 infection" post="showed an increase in high-sensitivity cardiac troponin I levels,"/>
   <result pre="of furin could then be a possible approach to prevent" exact="SARS-CoV-2 infection" post="(Fig.Â 1a, b). Of relevance in this context, nanomolar"/>
   <result pre="of therapeutic targets to treat COVID-19. Targeting Notch to prevent" exact="SARS-CoV-2 infection" post="The Notch signalling pathway plays a major role in"/>
   <result pre="serious vasoplegic shocks were observed. Nevertheless, the cytokine storm in" exact="COVID19" post="patients is characterised not only by hyperinnate immune response"/>
   <result pre="also to fight heart and lung disease caused directly by" exact="SARS-CoV-2 infection" post="and by the cytokine storm in response to the"/>
   <result pre="Thorac Oncol202010.1016/j.jtho.2020.02.02432151778 7.ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYXiaJYuTZhangXZhangLEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 8.ChengJKoenigSNKuivaniemiHSGargVHansCPPharmacological inhibitor of"/>
   <result pre="role of the Notch pathwayJ Steroid Biochem Mol Biol20191898710010.1016/j.jsbmb.2019.02.00830817989 19.GuanWJNiZYHuYLiangWHOuCQHeJXLiuLShanHLeiCLHuiDSCDuBLiLJZengGYuenKYChenRCTangCLWangTChenPYXiangJLiSYWangJLLiangZJPengYXWeiLLiuYHuYHPengPWangJMLiuJYChenZLiGZhengZJQiuSQLuoJYeCJZhuSYZhongNScollab:" exact="Covid-19" post="CMTEGfClinical Characteristics of Coronavirus Disease 2019 in ChinaN Engl"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7146687\results\search\zoonosis\results.xml">
   <result pre="the COVID-19 resource centre remains active. Global responses to the" exact="coronavirus disease 2019" post="(COVID-19) pandemic are converging with pervasive, existing sexual and"/>
   <result pre="be at risk of pregnancy-related complications during the COVID-19 pandemic.7" exact="Severe acute respiratory syndrome" post="and Middle East respiratory syndrome were associated with increased"/>
   <result pre="complications during the COVID-19 pandemic.7 Severe acute respiratory syndrome and" exact="Middle East respiratory syndrome" post="were associated with increased risk of pregnancy-related morbidity and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7147535\results\search\zoonosis\results.xml">
   <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. Abstract" exact="Coronavirus disease 2019" post="(COVID-19) is a clinical syndrome caused by a novel"/>
   <result pre="pandemic by the World Health Organization on 11 March, 2020." exact="SARS-CoV-2 infection" post="in severe cases involves the host response as an"/>
   <result pre="the COVID-19 pandemic is discussed. Key message The outbreak of" exact="coronavirus disease 2019" post="(COVID-19) affects the management of several cutaneous immune-mediated chronic"/>
   <result pre="the â€œcytokine stormâ€� associated with a poor outcome of COVID-19." exact="Coronavirus disease 2019" post="(COVID-19) is a clinical syndrome caused by a novel"/>
   <result pre="exacerbating disease progression [5]. In line with SARS and MERS," exact="SARS-CoV-2 infection" post="in severe cases involves the host response as an"/>
   <result pre="risk/benefit on a case-by-case basis depending on the risk of" exact="SARS-CoV-2 infection." post="There is no available evidence that supports discontinuation of"/>
   <result pre="corticosteroids might contribute to viral replication in the event of" exact="SARS-CoV-2 infection" post="[30]. Immunosuppressive medications in transplanted patients increase the risk"/>
   <result pre="1.European Centre for Disease Prevention and Control. Rapid risk assessment:" exact="coronavirus disease 2019" post="(COVID-19) pandemic: increased transmission in the EU/EEA and the"/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the experience of clinical immunologists from ChinaClin Immunol20202521410839310.1016/j.clim.2020.108393"/>
   <result pre="outbreak. https://www.eular.org/eular_guidance_for_patients_covid19_outbreak.cfm. Accessed 1 Apr 2020. 23.IOIBD. IOIBD update on" exact="COVID19" post="for patients with Crohnâ€™s disease and ulcerative colitis. https://www.ioibd.org/ioibd-update-on-covid19-for-patients-with-crohns-disease-and-ulcerative-colitis/."/>
   <result pre="for actionDermatol Ther202011e1329810.1111/dth.13298 28.ShahPZampellaJGUse of systemic immunomodulatory therapies during the" exact="coronavirus disease 2019" post="(COVID-19) pandemicJ Am Acad Dermatol.202010.1016/j.jaad.2020.03.05632244021 29.FavalliEGIngegnoliFDe LuciaOet al.COVID-19 infection"/>
   <result pre="44.HuiDSSystemic corticosteroid therapy may delay viral clearance in patients with" exact="Middle East respiratory syndrome" post="coronavirus infectionAm J Respir Crit Care Med201819770070110.1164/rccm.201712-2371ED29227752 45.World Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7151436\results\search\zoonosis\results.xml">
   <result pre="doi: 10.1016/j.ajog.2020.04.005 : Article Care of the pregnant woman with" exact="coronavirus disease 2019" post="in labor and delivery: anesthesia, emergencyÂ cesarean delivery, differential"/>
   <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Coronavirus disease 2019," post="caused by the severe acute respiratory syndrome coronavirus 2,"/>
   <result pre="data emerging to suggest that pregnant women diagnosed as having" exact="coronavirus disease 2019" post="can have severe morbidities (up to 9%). This is"/>
   <result pre="that showed good maternal and neonatal outcomes. Clinical manifestations of" exact="coronavirus disease 2019" post="include features of acute respiratory illnesses. Typical radiologic findings"/>
   <result pre="the absence of fever as well as leukocytosis. Confirmation of" exact="coronavirus disease 2019" post="is by reverse transcriptase-polymerized chain reaction from upper airway"/>
   <result pre="cases, chest imaging should be considered. A pregnant woman with" exact="coronavirus disease 2019" post="is at the greatest risk when she is in"/>
   <result pre="screened donated breast milk from mothers who are free of" exact="coronavirus disease 2019." post="We present management strategies derived from best available evidence"/>
   <result pre="These include protection of the healthcare workers caring for the" exact="coronavirus disease 2019" post="gravida, establishing a diagnosis in symptomatic cases, deciding between"/>
   <result pre="words ACE2 acute respiratory distress syndrome acutely ill ARDS coronavirus" exact="coronavirus disease 2019" post="COVID-19 maternal morbidity MERS obstetric management pandemic pregnancy SARS-CoV-2"/>
   <result pre="pregnancy SARS-CoV-2 SARS severe acute respiratory syndrome vertical transmission virus" exact="Coronavirus disease 2019" post="(COVID-19) is caused by severe acute respiratory syndrome coronavirus"/>
   <result pre="25% as observed in other coronavirus infections such as the" exact="Middle East respiratory syndrome" post="(MERS) and SARS.1,7 Moreover, SARS-CoV-2 has been shown to"/>
   <result pre="shown to have 85% similarity with SARS coronavirus (SARS-CoV) and" exact="MERS coronavirus" post="(MERS-CoV). Both the SARS and MERS epidemics had significant"/>
   <result pre="aminotransferase, bilirubin, creatinine, procalcitonin, troponin, D-dimer, and lactate dehydrogenase.15,16,18 Diagnosing" exact="coronavirus disease 2019" post="Confirmation of the disease is done using nucleic acid"/>
   <result pre="may be seen in other viral and atypical pneumonias. COVID-19," exact="coronavirus disease 2019;" post="CT, computed tomography; GGO, ground glass opacity. Ashokka. Care"/>
   <result pre="ground glass opacity. Ashokka. Care of the pregnant woman with" exact="coronavirus disease 2019" post="in labor and delivery. Am J Obstet GynecolÂ 2020."/>
   <result pre="imaging includes chest x-ray, chest CT, and lung ultrasound. COVID-19," exact="coronavirus disease 2019;" post="CT, computed tomography; RT-PCR, reverse transcription polymerized chain reaction."/>
   <result pre="polymerized chain reaction. Ashokka. Care of the pregnant woman with" exact="coronavirus disease 2019" post="in labor and delivery. Am J Obstet GynecolÂ 2020."/>
   <result pre="splash-resistant gown, and gloves should be sufficient. Managing patients with" exact="coronavirus disease 2019" post="in labor A pregnant woman presenting to the delivery"/>
   <result pre="ill parturient. Anesthesia in emergency cesareans for pregnant women with" exact="coronavirus disease 2019" post="An emergency cesarean delivery (30-min decision-to-incision interval) mandates a"/>
   <result pre="systemic vascular resistance. Ashokka. Care of the pregnant woman with" exact="coronavirus disease 2019" post="in labor and delivery. Am J Obstet GynecolÂ 2020."/>
   <result pre="tertiary institutions needs meticulous planning. Drugs and evolving therapy for" exact="coronavirus disease 2019" post="Antiviral treatment Much of the early information on COVID-19"/>
   <result pre="coronavirus infectionsViruses122020194 2ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 3RasmussenS.A.SmulianJ.C.LednickyJ.A.WenT.S.JamiesonD.J.Coronavirus disease 2019"/>
   <result pre="ahead of print] 12WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="women and childrenJÂ Infect2020[Epub ahead of print] 17GuanW.J.NiZ.Y.HuY.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaNÂ Engl J Med2020[Epub ahead of print] 18WangD.HuB.HuC.Clinical"/>
   <result pre="Public HealthSSHSPH COVID-19 science reports: diagnosticsAvailable at:https://sph.nus.edu.sg/wp-content/uploads/2020/03/COVID-19-Science-Report-Diagnostics-23-Mar.pdf 20HosseinyM.KoorakiS.GholamrezanezhadA.ReddyS.MyersL.Radiology perspective of" exact="coronavirus disease 2019" post="(COVID-19): lessons from severe acute respiratory syndrome and Middle"/>
   <result pre="of print] 23AiT.YangZ.HouH.Correlation of chest CT and RT-PCR testing in" exact="coronavirus disease 2019" post="(COVID-19) in China: a report of 1014 casesRadiology2020[Epub ahead"/>
   <result pre="appearances and pattern of progression in 138 patientsRadiology228200340140612759474 27DasK.M.LeeE.Y.Al JawderS.E.Acute" exact="Middle East respiratory syndrome" post="coronavirus: temporal lung changes observed on the chest radiographs"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="inÂ vitroCell Discov620201632194981 57GautretP.LagierJ.C.ParolaP.Hydroxychloroquine and azithromycin as a treatment"/>
   <result pre="by noninvasive pulse contour methodology from intra-arterial waveform analysis COVID-19:" exact="coronavirus disease 2019" post="(previously called 2019 novel coronavirus [2019-nCoV]) CT: computed tomography"/>
   <result pre="chemoattractant protein 1 MIP1Î±: macrophage inflammatory protein 1 alfa MERS:" exact="Middle East respiratory syndrome" post="MERS-CoV: Middle East respiratory syndrome coronavirus MODS: multiorgan dysfunction"/>
   <result pre="inflammatory protein 1 alfa MERS: Middle East respiratory syndrome MERS-CoV:" exact="Middle East respiratory syndrome" post="coronavirus MODS: multiorgan dysfunction syndrome NAAT: nucleic acid amplification"/>
   <result pre="to 3 hours for the next availability of bed). COVID-19," exact="coronavirus disease 2019;" post="EDTA, ethylenediamine tetraacetic acid; ICU, intensive care unit; PAPR,"/>
   <result pre="personal protective equipment. Ashokka. Care of the pregnant woman with" exact="coronavirus disease 2019" post="in labor and delivery. Am J Obstet Gynecol 2020."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7151540\results\search\zoonosis\results.xml">
   <result pre="patient during an infectious outbreak can have potentially severe consequences." exact="Coronavirus disease 2019" post="(COVID-19) is already known to be associated with a"/>
   <result pre="be more transmissible than severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS).5 Within the ICU, potentially aerosol generating procedures such"/>
   <result pre="using simulationSimul Healthc62011S24S2921817860 4WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7154513\results\search\zoonosis\results.xml">
   <result pre="Previous work with pathogenic severe acute respiratory syndrome (SARS-CoV) and" exact="Middle East respiratory syndrome" post="(MERS-CoV) coronaviruses provides insight and platforms that can help"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7155909\results\search\zoonosis\results.xml">
   <result pre="hygiene in the treatment of COVID-19. The full ramifications of" exact="SARS-CoV-2 infection" post="are yet to be understood. Early work points to"/>
   <result pre="precautions when caring for any patients with confirmed or suspected" exact="SARS-CoV-2 infection," post="with the addition of airborne precautions when any aerosol-generating"/>
   <result pre="particular, remdesivir is a nucleotide analog developed for use with" exact="Ebola" post="infection. The drug inhibits the RNA-dependent RNA polymerase used"/>
   <result pre="readily evades cellular and humoral immunity, sharply limiting vaccination approaches,101" exact="SARS-CoV infection" post="appeared to induce broad and long-lasting immunity with less"/>
   <result pre="727â€&quot;33. DOI: 10.1056/NEJMoa200101731978945 2.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: Summary of a report of"/>
   <result pre="6, 2020. 22.ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYXiaJYuTZhangXZhangLEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: A descriptive study.Lancet2020; 395:507â€&quot;13. DOI: 10.1016/S0140-6736(20)30211-732007143"/>
   <result pre="China Medical Treatment Expert Group for C: Clinical characteristics of" exact="coronavirus disease 2019" post="in China.N Engl J Med2020DOI: 10.1056/NEJMoa2002032 24.WangDHuBHuCZhuFLiuXZhangJWangBXiangHChengZXiongYZhaoYLiYWangXPengZClinical characteristics of"/>
   <result pre="200463DOI: 10.1148/radiol.202020046332077789 29.AiTYangZHouHZhanCChenCLvWTaoQSunZXiaLCorrelation of chest CT and RT-PCR testing in" exact="coronavirus disease 2019" post="(COVID-19) in China: A report of 1014 cases.Radiology2020: 200642DOI:"/>
   <result pre="65.ArabiYMArifiAABalkhyHHNajmHAldawoodASGhabashiAHawaHAlothmanAKhaldiAAl RaiyBClinical course and outcomes of critically ill patients with" exact="Middle East respiratory syndrome" post="coronavirus infection.Ann Intern Med2014; 160:389â€&quot;9724474051 66.TranKCimonKSevernMPessoa-SilvaCLConlyJAerosol generating procedures and"/>
   <result pre="randomized clinical trial.JAMA2018; 320:2251â€&quot;930347031 85.AlshahraniMSSindiAAlshamsiFAl-OmariAEl TahanMAlahmadiBZeinAKhataniNAl-HameedFAlamriSAbdelzaherMAlghamdiAAlfousanFTashATashkandiWAlraddadiRLewisKBadaweeMArabiYMFanEAlhazzaniWExtracorporeal membrane oxygenation for severe" exact="Middle East respiratory syndrome" post="coronavirus.Ann Intensive Care2018; 8:329330690 86.GordonCJTchesnokovEPFengJYPorterDPGotteMThe antiviral compound remdesivir potently"/>
   <result pre="86.GordonCJTchesnokovEPFengJYPorterDPGotteMThe antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus.J Biol Chem2020DOI: 10.1074/jbc.AC120.013056 87.WangMCaoRZhangLYangXLiuJXuMShiZHuZZhongWXiaoGRemdesivir and chloroquine effectively inhibit"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, China.JAMA Intern Med2020:e200994DOI: 10.1001/jamainternmed.2020.0994 100.AgostiniMLAndresELSimsACGrahamRLSheahanTPLuXSmithECCaseJBFengJYJordanRRayASCihlarTSiegelDMackmanRLClarkeMOBaricRSDenisonMRCoronavirus susceptibility"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7156260\results\search\zoonosis\results.xml">
   <result pre="occurred in 2012 and 2015 due to the spread of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), another virus from the same family (5,"/>
   <result pre="query COVID-19 antiviral therapy Coronavirus[tiab] OR COVID19[tiab] OR 2019-nCoV[tiab] OR" exact="COVID19" post="virus[tiab] OR COVID-19 virus[tiab] OR 2019-nCoV disease[tiab] OR 2019"/>
   <result pre="2019 novel coronavirus disease[tiab] OR 2019-nCoV infection[tiab] OR 2019-nCoV[tiab] OR" exact="Coronavirus disease 2019" post="virus[tiab] OR SARS-CoV-2[tiab] OR SARS2[tiab] OR 2019 novel coronavirus[tiab]"/>
   <result pre="coronavirus disease-19[tiab] OR new coronavirus[tiab] OR Wuhan coronavirus[tiab] OR Wuhan" exact="seafood market pneumonia" post="virus[tiab] OR &quot;severe acute respiratory syndrome coronavirus 2&quot;[Supplementary Concept]"/>
   <result pre="OR Viruses, MERS[tiab] OR Middle East respiratory syndrome-related coronavirus[tiab] OR" exact="Middle East respiratory syndrome" post="related coronavirus[tiab] OR SARS Virus[tiab] OR Severe Acute Respiratory"/>
   <result pre="OR Coronavirus,Â SARS[tiab] OR Severe acute respiratory syndrome-related coronavirus[tiab] OR" exact="Severe acute respiratory syndrome" post="related coronavirus[tiab] OR SARS-Associated Coronavirus[tiab] OR Coronavirus,Â SARS-Associated[tiab] OR"/>
   <result pre="publication. References References 1WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="of SARS coronavirus Infection, Genetics and Evolution.2019712130 5ChenXChughtaiAADydaAMacIntyreCRComparative epidemiology of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in Saudi Arabia and South Korea Emerging"/>
   <result pre="10CaoBWangYWenDLiuWWangJFanGet al.A Trial of Lopinavirâ€&quot;Ritonavir in Adults Hospitalized with Severe" exact="Covid-19" post="New England Journal of Medicine2020[In press] 11ChenNZhouMDongXQuJGongFHanYet al.Epidemiological and"/>
   <result pre="press] 11ChenNZhouMDongXQuJGongFHanYet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study The Lancet20203951022350713 12ChenQQuanBLiXGaoGZhengWZhangJet"/>
   <result pre="report of clinical diagnosis and treatment of 9 cases of" exact="coronavirus disease 2019" post="Journal of medical virology2020[In press] 13GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical Characteristics of"/>
   <result pre="Jama20203231110619 24WangZChenXLuYChenFZhangWClinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatment Bioscience trends202014164832037389"/>
   <result pre="Have Failed Low-Dose Therapy2020Pre-prints. 2020:Available at: https://www.preprints.org/manuscript/202003.0065/v1 32ArabiYMAsiriAYAssiriAMJokhdarHAAAlothmanABalkhyHHet al.Treatment of" exact="Middle East respiratory syndrome" post="with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE trial):"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7158580\results\search\zoonosis\results.xml">
   <result pre="to cover these topics in future publications. Introduction The 2014â€&quot;16" exact="Ebola" post="epidemic had mostly waned before successful medical countermeasures were"/>
   <result pre="H1N1 and H5H1, severe acute respiratory syndrome coronavirus, Lassa virus," exact="Ebola" post="virus, and Middle East respiratory syndrome coronavirusâ€&quot;have involved RNA"/>
   <result pre="severe acute respiratory syndrome coronavirus, Lassa virus, Ebola virus, and" exact="Middle East respiratory syndrome" post="coronavirusâ€&quot;have involved RNA viruses.3, 4 They can replicate in"/>
   <result pre="and diagnostic platforms before outbreaks occur.16 For example, the Pandemic" exact="Influenza" post="Preparedness Framework17 was negotiated over 4 years and resulted"/>
   <result pre="been more open sharing of influenza samples. Although the Pandemic" exact="Influenza" post="Preparedness Framework is limited by its inability to address"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7162395\results\search\zoonosis\results.xml">
   <result pre="8,096 laboratoryâ€�confirmed cases 9. The second was due to the" exact="Middle East respiratory syndrome" post="(MERS)â€�CoV that, in 2012, was first described in a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7162773\results\search\zoonosis\results.xml">
   <result pre="Clinical classification Physicians classified the disease severity of patients with" exact="SARS-CoV-2 infection" post="according to the â€œDiagnosis and Treatment Protocol for Novel"/>
   <result pre="inÂ vitro studies, chloroquine and hydroxychloroquine were found to inhibit" exact="SARS-CoV-2 infection" post="efficiently,40,44 and several clinical trials have been quickly conducted"/>
   <result pre="treatment of COVID-19 in China. Monteil etÂ al. found that" exact="SARS-CoV-2 infection" post="in engineered human blood vessel organoids and human kidney"/>
   <result pre="conflicts of interest to disclose. References References 1GuanW.-J.NiZ.-Y.HuY.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med38220201708172032109013 2Sun P, Qie S,"/>
   <result pre="28LiuY.SunW.LiJ.Clinical features and progression of acute respiratory distress syndrome in" exact="coronavirus disease 2019" post="[preprint]medRxiv202002.17.20024166 29MachW.J.ThimmeschA.R.PierceJ.T.PierceJ.D.Consequences of hyperoxia and the toxicity of oxygen"/>
   <result pre="experts' consensus on diagnosis and treatment of severe and critical" exact="coronavirus disease 2019" post="(Revised Edition)]. Zhonghua Wei Zhong Bing Ji Jiu Yi"/>
   <result pre="case seriesBMJ3682020m60632075786 38ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 39CaoB.WangY.WenD.A trial of"/>
   <result pre="for the 2019-new coronavirus (2019-nCoV)Biosci Trends142020697131996494 42DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov Ther142020586032147628 43collab: China National Health CommissionPress conference"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="inÂ vitroCell Discov620201632194981 45GaoJ.TianZ.YangX.Breakthrough: chloroquine phosphate has shown apparent"/>
   <result pre="Z, McGoogan JM. Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7166105\results\search\zoonosis\results.xml">
   <result pre="this century to include severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS). How Does COVID-19 Affect Patients? This viral illness"/>
   <result pre="cases, Wenzhou, China, 2020Emerg Infect Dis26202010.1016/S1473-3099(20)30195-X 7LauerS.A.GrantzK.H.BiQ.JonesF.K.ZhengQ.MeredithH.R.The incubation period of" exact="coronavirus disease 2019" post="(COVID-19) from publicly reported confirmed cases: estimation and applicationAnn"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7167217\results\search\zoonosis\results.xml">
   <result pre="approximately 1 decade after SARS-CoV, when another highly pathogenic CoV," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), emerged in Middle Eastern countries such as"/>
   <result pre="found to be &amp;lt; 200 cells/mm3 in three patients with" exact="SARS-CoV infection" post="(Cui et al. 2019; Luk et al. 2019; Paraskevis"/>
   <result pre="was present in about 20â€&quot;25% of patients with MERS-CoV or" exact="SARS-CoV infection" post="(Yin and Wunderink 2018), intestinal symptoms have rarely been"/>
   <result pre="being tested for COVID-19 in in-vitro and human-based SARS-CoV, and" exact="MERS-Cov" post="trials, and studies evaluating the antiviral activity of types"/>
   <result pre="have no competing interests. References References ArabiYMAlothmanABalkhyHHAl-DawoodAAlJohaniSAl HarbiSet al.Treatment of" exact="Middle East respiratory syndrome" post="with a combination of lopinavir-ritonavir and interferon-Î²1b (MIRACLE trial):"/>
   <result pre="al (2020) Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet 395(10223):507â€&quot;513 CockrellASYountBLScobeyTJensenKDouglasMBeallAet"/>
   <result pre="S, Machin N, Hesketh L, Guiver M et al (2020)" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) â€&quot; surveillance and testing in North England"/>
   <result pre="coronavirus outbreak in China. bioRxiv. 10.1101/2020.01.23.916726 StoecklinSBRollandPSilueYMaillesACampeseCSimondonAet al.First cases of" exact="coronavirus disease 2019" post="(COVID-19) in France: surveillance, investigations and control measures, January"/>
   <result pre="R, Watts A, Fisman DN, Khan K (2020) Estimation of" exact="COVID-2019" post="burden and potential for international dissemination of infection from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7169770\results\search\zoonosis\results.xml">
   <result pre="the expense of primary healthcare requirements. The impact of the" exact="Ebola" post="epidemic on the economy and healthcare structures is still"/>
   <result pre="Lancet1966: 1: 76â€&quot;77.4158999 3collab: GISAID Global Initiative on Sharing All" exact="Influenza" post="Data . Phylogeny of SARSâ€�like betacoronaviruses including novel coronavirus"/>
   <result pre="(Available from: http://www.who.int/csr/sars/country/en/.) 12collab: World Health Organization . WHO 2019," exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV). (Available from: https://www.who.int/emergencies/mers-cov/en/.) 13RichardsonP, GriffinI, TuckerC et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7171518\results\search\zoonosis\results.xml">
   <result pre="primarily the human respiratory system. Earlier coronaviral outbreaks (CoVs) include" exact="Middle East respiratory syndrome" post="(MERS)-CoV and severe acute respiratory syndrome (SARS)-CoV which have"/>
   <result pre="revealed the presence of a new beta-CoV strain [5]. The" exact="COVID19" post="genetic sequence showed more than 50 % identity to"/>
   <result pre="References References 1ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 2LuH.StrattonC.W.TangY.W.Outbreak of pneumonia"/>
   <result pre="pneumoniaRadiology202020023610.1148/radiol.2020200236 15AssiriA.Al-TawfiqJ.A.Al-RabeeahA.A.Al-RabiahF.A.Al-HajjarS.AlBarrakA.Epidemiological, demographic, and clinical characteristics of 47 cases of" exact="Middle East respiratory syndrome" post="coronavirus disease from Saudi Arabia: a descriptive studyLancet Infect"/>
   <result pre="74CockrellA.S.PeckK.M.YountB.L.AgnihothramS.S.ScobeyT.CurnesN.R.Mouse dipeptidyl peptidase 4 is not a functional receptor for" exact="Middle East respiratory syndrome" post="coronavirus infectionJÂ Virol88920145195519924574399 75NagataN.IwataN.HasegawaH.FukushiS.YokoyamaM.HarashimaA.Participation of both host and virus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7171523\results\search\zoonosis\results.xml">
   <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Covid-19" post="disease is caused by SARS-CoV-2, a virus belonging to"/>
   <result pre="caused by SARS-CoV-2, a virus belonging to the coronavirus family." exact="Covid-19" post="is so new that there is currently no specific"/>
   <result pre="change and modification as the epidemic progresses. Keywords Chloroquine coronavirus" exact="Covid-19" post="epidemic hydroxychloroquine treatment Introduction In mid-December 2019, in the"/>
   <result pre="throughout this review. What is a coronavirus? What is COVID-19?" exact="Covid-19" post="disease, which appeared in China in late 2019, is"/>
   <result pre="was the case with Sras or Mers and now with" exact="Covid-19" post="(for Coronavirus Disease) [1]. COVID-19 is the infectious disease"/>
   <result pre="countries remain, until 28th March, still little affected by the" exact="Covid-19" post="in comparison with Europe, even if the number of"/>
   <result pre="the effectiveness of chloroquine on treatment of pneumonia associated with" exact="Covid-19" post="[13]. In this study, it was confirmed that the"/>
   <result pre="is carefully administered in Switzerland as a treatment against the" exact="Covid-19" post="pandemic. The clinical effect is encouraging since the severity"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7174188\results\search\zoonosis\results.xml">
   <result pre="(0.7%).3 New research suggests that the estimated cumulative frequency of" exact="coronavirus disease 2019" post="(COVID-19) cases among adults experiencing homelessness in Boston were"/>
   <result pre="guidance for homeless service providers to plan and respond to" exact="coronavirus disease 2019" post="(COVID-19). Centers for Disease Control and Prevention.www.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/plan-prepare-respond.html. Updated April"/>
   <result pre="for Disease Control and Prevention (CDC)Interim guidance on management of" exact="coronavirus disease 2019" post="(COVID-19) in correctional and detention facilities2020Centers for Disease Control"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7174922\results\search\zoonosis\results.xml">
   <result pre="date, several drugs targeting RdRp enzymes are being employed for" exact="SARS-CoV-2 infection" post="treatment. Some of them have a predicted binding moiety"/>
   <result pre="a given day by the number of patients with confirmed" exact="SARS-CoV-2 infection" post="14Â days before, considering the WHO data relative to"/>
   <result pre="January 2020 by Wu and coworkers [11] formerly called â€œWuhan" exact="seafood market pneumonia" post="virusâ€� (WSM, NC_045512) (https://www.ncbi.nlm.nih.gov/nuccore/NC_045512). GISAID database (https://www.gisaid.org/) filtered from"/>
   <result pre="mechanisms. Abbreviations RdRp RNA-dependent RNA polymerase nsp Non-structural protein SARS-CoV" exact="Severe acute respiratory syndrome" post="coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (COVID-19)"/>
   <result pre="nsp Non-structural protein SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2" exact="Severe acute respiratory syndrome" post="coronavirus 2 (COVID-19) MERS-CoV Middle east respiratory syndrome coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7174982\results\search\zoonosis\results.xml">
   <result pre="active. Abstract Since December 2019, a respiratory pandemic named as" exact="coronavirus disease 2019" post="(Covid-19) caused by a new coronavirus named as SARS-CoV-2,"/>
   <result pre="acute respiratory syndrome coronavirus MERS-CoV, Middle-East respiratory syndrome coronavirus Covid-19," exact="coronavirus disease 2019" post="WHO, World Health Organization SARS-CoV-2, SARS coronavirus-2 NSAIDs, non-steroidal"/>
   <result pre="Unani, Siddha, and Homeopathy RNA, ribose nucleic acid Keywords SARS-CoV-2" exact="Covid-19" post="Unani medicine Waba Influenza Nazla-e-wabaiya 1 Introduction Since the"/>
   <result pre="RNA, ribose nucleic acid Keywords SARS-CoV-2 Covid-19 Unani medicine Waba" exact="Influenza" post="Nazla-e-wabaiya 1 Introduction Since the beginning of the 21st"/>
   <result pre="coronaviruses have caused disastrous outbreaks of pneumonia in human beings:" exact="Severe acute respiratory syndrome" post="coronavirus (SARS-CoV) in 2002â€&quot;03 and Middle-East respiratory syndrome coronavirus"/>
   <result pre="coronavirus (MERS-CoV) in 2012 (ÄŒivljak et al., 2020). The ongoing" exact="Covid-19" post="(Coronavirus disease 2019) is the third coronavirus epidemic of"/>
   <result pre="â€˜all continents except Antarcticaâ€™ (Acharya, 2020). On 12th March 2020," exact="Covid-19" post="was declared a pandemic by the World Health Organization"/>
   <result pre="been 2,074,529 confirmed cases and 139,378 deaths worldwide due to" exact="Covid-19" post="as reported by the WHO (WHO, 2020). In India,"/>
   <result pre="the WHO (WHO, 2020). In India, the first case of" exact="Covid-19" post="was a student who returned from Wuhan, China on"/>
   <result pre="cases have been identified (WHO, 2020). The causative agent of" exact="Covid-19" post="was tentatively named as 2019 n-CoV (2019 novel coronavirus)"/>
   <result pre="etc. are also being used as a tentative treatment for" exact="Covid-19" post="(Dong et al., 2020). Yet, as of now, there"/>
   <result pre="scientific studies. In this paper, we present an overview of" exact="Covid-19" post="and SARS-CoV-2, Unani concept of infectious and epidemic diseases"/>
   <result pre="preventive measures, and a possible approach to the management of" exact="Covid-19" post="with Unani medicine. 2 Methodology The authors searched the"/>
   <result pre="during 2005â€&quot;2020 were hence included in the final manuscript. 3" exact="Coronavirus disease 2019" post="3.1 Causative agent SARS-CoV-2 is a coronavirus belonging to"/>
   <result pre="et al., 2020). 3.3 Disease spectrum The incubation period of" exact="Covid-19" post="ranges from 1 to 14Â days, averaging 5â€&quot;6Â days"/>
   <result pre="Zakariya Razi (865â€&quot;925Â CE), Kitab fi al-jadari wa-al-hasbah (Book on" exact="Smallpox" post="and Measles) describes the modes of spread of the"/>
   <result pre="Rushd, 1987) 5 Possible approach to prevention and management of" exact="Covid-19" post="in the light of Unani medicine In light of"/>
   <result pre="medicine In light of the above-summarized information, the symptoms of" exact="Covid-19" post="closely resemble those of nazla-e-wabaiya described in Unani books."/>
   <result pre="mortality. There is also speculation that close to two-thirds of" exact="Covid-19" post="cases from China may have gone undetected (Menkir et"/>
   <result pre="university hospital in BrazilJ. Crit. Care42201739910.1016/j.jcrc.2017.09.091 DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov. Ther.142020586010.5582/ddt.2020.0101232147628 Ezz EldinH.M.SarhanR.M.KhayyalA.E.The impact of vinegar on"/>
   <result pre="Antimicrob. Agents105949202010.1016/j.ijantimicag.2020.105949 GuoY.R.CaoQ.D.HongZ.S.TanY.Y.ChenS.D.JinH.J.TanK. SenWangD.Y.YanY.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak - an update on the statusMil. Med."/>
   <result pre="Report-882020World Health Organization WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7179500\results\search\zoonosis\results.xml">
   <result pre="on the management of patients with respiratory failure. During the" exact="Ebola" post="outbreak in Sierra Leone in 2016, a decrease in"/>
   <result pre="J Med382202097097132003551 9ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet39510223202050751332007143 10JaillonS.BerthenetK.GarlandaC.Sexual dimorphism in"/>
   <result pre="woman with preterm deliveryDis, ciaa200202010.1093/cid/ciaa200 21LiuY.ChenH.TangK.GuoY.Clinical manifestations and outcome of" exact="SARS-CoV-2 infection" post="during pregnancyJ Infect202010.1016/j.jinf.2020.02.028 22RasmussenS.A.SmulianJ.C.LednickyJ.A.WenT.S.JamiesonD.J.Coronavirus disease 2019 (COVID-19) and pregnancy:"/>
   <result pre="Available at: https://icmanaesthesiacovid-19.org/ppe-guidance. Accessed April 4, 2020. 31GuanW.J.NiZ.Y.HuY.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med202010.1056/NEJMoa2002032 32RuanQ.YangK.WangW.JiangL.SongJ.Clinical predictors of mortality"/>
   <result pre="are dying but not of Ebola': the effect of the" exact="Ebola" post="virus epidemic on the availability, uptake and outcomes of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7180007\results\search\zoonosis\results.xml">
   <result pre="thought to be the continuation of serious epidemics caused by" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) and severe acute respiratory syndrome (SARS) in"/>
   <result pre="Saudi Arabia.N Engl J Med. 2012;367:1814-20. 10.1056/NEJMoa121172123075143 7World Health Organization." exact="Coronavirus disease 2019" post="(COVID-19) situation report. February 28, 2020. Geneva: WHO; 2020."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7180238\results\search\zoonosis\results.xml">
   <result pre="transmissible coronavirus after severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) emerged in humans. The source of origin,"/>
   <result pre="transmissible coronavirus after severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) emerged in humans. The source of origin,"/>
   <result pre="later, the world witnessed another outbreak in the form of" exact="Middle East respiratory syndrome" post="(MERS) caused by MERS-CoV in the Middle East (4,"/>
   <result pre="second country after China, bearing the highest fatalities due to" exact="SARS-CoV-2 infection." post="(38). The spread of SARS-CoV-2 in Iran poses a"/>
   <result pre="Moreover, asymptomatic persons are thought to be potential sources of" exact="SARS-CoV-2 infection" post="(40), which may have caused the rapid spread of"/>
   <result pre="17). Pneumonia appears to be the most frequent manifestation of" exact="SARS-CoV-2 infection," post="characterized primarily by fever, cough, dyspnea, and bilateral infiltrates"/>
   <result pre="MERS-CoV, thus could be a suitable choice for treatment of" exact="SARS-CoV-2 infection." post="(60) Remdesivir Terminates transcription of viral RNA transcription at"/>
   <result pre="CormanVM, CottontailVM, RichardsLR, SchoemanMC, DrostenC, DrexlerJF, PreiserW2013Close relative of human" exact="Middle East respiratory syndrome" post="coronavirus in bat, South Africa. Emerg Infect Dis19:1697â€&quot;1699. doi:10.3201/eid1910.130946.24050621"/>
   <result pre="GerberSI, Al HosaniFI, TongS, Al MuhairiSSM2018Zoonotic origin and transmission of" exact="Middle East respiratory syndrome" post="coronavirus in the UAE. Zoonoses Public Health65:322â€&quot;333. doi:10.1111/zph.12435.29239118 26.ChuDKW,"/>
   <result pre="in Japanese pipistrelle: implications for the origin of the novel" exact="Middle East respiratory syndrome" post="coronavirus. J Virol87:8638â€&quot;8650. doi:10.1128/JVI.01055-13.23720729 28.LauSKP, ZhangL, LukHKH, XiongL, PengX,"/>
   <result pre="disease. Clin Microbiol Rev28:465â€&quot;522. doi:10.1128/CMR.00102-14.25810418 47.MilletJK, WhittakerGR2014Host cell entry of" exact="Middle East respiratory syndrome" post="coronavirus after two-step, furin-mediated activation of the spike protein."/>
   <result pre="RNA synthesis reveals potent inhibition of diverse coronaviruses including the" exact="Middle East respiratory syndrome" post="virus. PLoS Pathog10:e1004166. doi:10.1371/journal.ppat.1004166.24874215 50.RiderTH, ZookCE, BoettcherTL, WickST, PancoastJS,"/>
   <result pre="SubbaraoK2015Development of animal models against emerging coronaviruses: from SARS to" exact="MERS coronavirus." post="Virology479â€&quot;480:247â€&quot;258. doi:10.1016/j.virol.2015.02.030. 58.MomattinH, Al-AliAY, Al-TawfiqJA2019A systematic review of therapeutic"/>
   <result pre="systematic review of therapeutic agents for the treatment of the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). Travel Med Infect Dis30:9â€&quot;18. doi:10.1016/j.tmaid.2019.06.012.31252170 59.MielechAM, KilianskiA,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7180381\results\search\zoonosis\results.xml">
   <result pre="and strong prevention programs. Keywords Zika virus Yellow fever virus" exact="Dengue" post="virus Chikungunya virus West Nile virus Aedes mosquitoes Flaviviruses"/>
   <result pre="can be effective [12]. Vaccines are available to protect against" exact="Japanese encephalitis" post="and yellow fever [13], and the first dengue vaccine,"/>
   <result pre="influenza, other arbovirus diseases such as Chikungunya, Zika, West Nile," exact="Japanese encephalitis" post="or yellow fever, and even from typhoid/paratyphoid (Salmonella typhi"/>
   <result pre="tests, unfortunately none of which are available in resource-limited areas." exact="Dengue" post="diagnostics will greatly benefit from a Dengue POC test"/>
   <result pre="in resource-limited areas. Dengue diagnostics will greatly benefit from a" exact="Dengue" post="POC test that meets the WHO ASSURED criteria (Affordable,"/>
   <result pre="capture viruses with a glycoprotein-rich envelope such as influenza virus," exact="Ebola" post="virus, DENV and other arboviruses, or even HCV. The"/>
   <result pre="the rainy season, occurring 6â€&quot;8Â weeks after the peak of" exact="dengue disease." post="A total of 1698 confirmed cases of ZIKV infection"/>
   <result pre="result, vaccine refusal has been rising in the population! 5.2" exact="Dengue" post="As reviewed by Dr In-Kyu Yoon (International Vaccine Institute,"/>
   <result pre="need for a pre-vaccination screening strategy [30]. The WHO SAGE" exact="Dengue" post="Working Group reviewed these data and, in April 2018,"/>
   <result pre="there also is now an increased risk of urban epidemics." exact="Dengue" post="epidemics have recently seen their amplitude increase dramatically: in"/>
   <result pre="distribution and burden of dengueNature496201350450723563266 10WHO Report. Global Strategy for" exact="Dengue" post="prevention and control, 2012- 2020. 11SamuelM.MaozD.ManriqueP.Community effectiveness of indoor"/>
   <result pre="dengue vector control method: A systematic reviewPLoS NeglTrop Dis1182017e000583710.1371/journal.pntd.0005837 12WHO," exact="Dengue" post="haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd edition."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7182166\results\search\zoonosis\results.xml">
   <result pre="CoV 2: severe acute respiratory syndrome coronavirus 2; MERS CoV," exact="Middle East respiratory syndrome" post="coronavirus; RNA, ribonucleic acid A novel member ofÂ CoV"/>
   <result pre="the infection with SARS-CoV-2, which was initially called as novel" exact="coronavirus disease 2019" post="(nCOVID-19), could result in a human infection that presents"/>
   <result pre="either of its predecessors that include the SARS-CoV and theÂ" exact="Middle East respiratory syndrome" post="virusÂ (MERS)Â [16]. Numerous factors have contributed to the"/>
   <result pre="on the viability of the SARS coronavirusAdv VirolChanKHPeirisJSLamSYPoonLLYuenKYSetoWH7346902011201122312351 32Stability of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) under different environmental conditionsEuro Surveillvan DoremalenNBushmakerTMunsterVJ0182013 33Preliminary"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7184357\results\search\zoonosis\results.xml">
   <result pre="the Major Article by Chu et al on pages 1400â€&quot;9.)" exact="Coronavirus disease 2019" post="(COVID-19), a respiratory illness caused by a novel coronavirus,"/>
   <result pre="the much more limited SARS outbreak of 2002â€&quot;2003, and to" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), the etiologic agent for MERS. SARS-CoV-2 differs"/>
   <result pre="IFN production likely hampers the early innate immune response to" exact="SARS-CoV-2 infection." post="The authors obtained human lung tissue samples from 6"/>
   <result pre="for SARS-CoV-2 than SARS-CoV. The higher viral levels associated with" exact="SARS-CoV-2 infection" post="may reflect an even more striking observation from this"/>
   <result pre="In previous work from Professor Yuenâ€™s group, neither MERS-CoV nor" exact="SARS-CoV infection" post="induced significant expression of type I IFNs in human"/>
   <result pre="are as yet no data with respect to treatment of" exact="SARS-CoV-2 infection" post="with IFN-Î»; however, there are relevant data concerning SARS-CoV"/>
   <result pre="hepatitis, where pegylated IFN-Î»1 has been tested so far, and" exact="SARS-CoV-2 infection" post="is that patients with severe COVID-19 have a high"/>
   <result pre="and, ideally, should be first studied in patients with early" exact="SARS-CoV-2 infection" post="or as prophylaxis. Possible trials of pegylated IFN-Î»1 for"/>
   <result pre="J Virol2013; 87:6604â€&quot;14.23552422 13.ZhouJ, ChuH, LiC, et al.Active replication of" exact="Middle East respiratory syndrome" post="coronavirus and aberrant induction of inflammatory cytokines and chemokines"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7185310\results\search\zoonosis\results.xml">
   <result pre="10801USA pmid: 3228617610.1089/vim.2019.0167 doi: 10.1089/vim.2019.0167 : Opinions and Reviews Slowing" exact="Influenza" post="Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities"/>
   <result pre="typically observed for acute infections. In contrast, in immunocompromised individuals," exact="influenza infection" post="becomes more protracted, lasts for weeks, and is associated"/>
   <result pre="to limit the effect of immune-induced selection of specificity-selected variants." exact="Influenza" post="infection in the airways results in frequent superinfection of"/>
   <result pre="immunity to influenza A viruses. Expert Rev Vaccines2010;9:1325â€&quot;134121087110 11.EpsteinSLPrior H1N1" exact="influenza infection" post="and susceptibility of Cleveland Family Study participants during the"/>
   <result pre="27. United States of America, Presidential Executive Order on Modernizing" exact="Influenza" post="Vaccines in the United States to Promote National Security"/>
   <result pre="epidemiological significance. Virology1980;104:139â€&quot;1486156537 31.XueKS, MonclaLH, BedfordT, et al.Within-host evolution of" exact="human influenza" post="virus. Trends Microbiol2018;26:781â€&quot;79329534854 32.XueKS, Stevens-AyersT, CampbellAP, et al.Parallel evolution"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7186945\results\search\zoonosis\results.xml">
   <result pre="recent epidemics, severe acute respiratory syndrome CoV (SARS-CoV and SARS-CoV-2)," exact="Middle East respiratory syndrome" post="CoV (MERS-CoV) HCoV-229E, and other identified coronaviruses, i.e. HCoV-OC43,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7187878\results\search\zoonosis\results.xml">
   <result pre="to the Editor: Mechanisms of increased morbidity and mortality of" exact="SARS-CoV-2 infection" post="in individuals with diabetes: what this means for an"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7189021\results\search\zoonosis\results.xml">
   <result pre="during the Second World War, and a new antiviral against" exact="Ebola" post="last year whose promise waned. On March 20, 2020,"/>
   <result pre="in animal studies, causing severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS) (Kupferschmidt and Cohen 2020). Will the approved or"/>
   <result pre="(10Â Î¼M) and offered 100% protection against the most feared" exact="Ebola" post="virus infection (Warren et al. 2016). In an in"/>
   <result pre="pneumoniaN Engl J Med2020382131199120710.1056/NEJMoa200131631995857 MulanguSDoddLEDaveyRTJret al.A randomized, controlled trial of" exact="Ebola" post="virus disease therapeuticsN Engl J Med20193812293230310.1056/NEJMoa191099331774950 PatonNIAboulhabJHydroxychloroquine, hydroxyurea and"/>
   <result pre="Res202030326927110.1038/s41422-020-0282-032020029 WarrenTKJordanRLoMKet al.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature201653138138510.1038/nature1718026934220 World Health Organization (WHO) (2020)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7189412\results\search\zoonosis\results.xml">
   <result pre="a novel human-infecting coronavirus (Huang etÂ al., 2020), officially named" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) (World Health Organization, 2020a). Also, the"/>
   <result pre="(WHO) has officially named the disease caused by SARS-CoV-2 as" exact="coronavirus disease 2019" post="(COVID-19) (World Health Organization, 2020a). As of 29 March"/>
   <result pre="Disease Control and Prevention. (2020). Severe outcomes among patients with" exact="coronavirus disease 2019" post="(COVID-19) â€&quot; United States, February 12â€&quot;March 16, 2020. ChenH.,"/>
   <result pre="28, 2020 from http://www.who.int/csr/sars/country/table2004_04_21/en/index.html collab: World Health Organization. (2019, November)." exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) Retrieved March 28, 2020 from https://www.who.int/emergencies/mers-cov/en/ collab:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7190301\results\search\zoonosis\results.xml">
   <result pre="pandemic of severe acute respiratory coronavirus 2 (SARS-CoV-2), which causes" exact="coronavirus disease 2019" post="(COVID-19), continues to spread around the world, having infected"/>
   <result pre="or pandemics emerge, including previous coronavirus outbreaksâ€&quot;SARS in 2002â€&quot;04 and" exact="Middle East respiratory syndrome" post="in 2012. Promise was shown for SARS, with a"/>
   <result pre="to publish guidance on the use of the treatment for" exact="Ebola" post="virus disease, and treatment benefits have been shown in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7190393\results\search\zoonosis\results.xml">
   <result pre="are dying from heart attacks, as a possible complication of" exact="SARS-CoV-2 infection." post="High expression of the ACE2 receptor, via which COVID-19"/>
   <result pre="cells should be considered as a potential high risk for" exact="SARS-CoV-2 infection" post="[9]. Investigations suggest that the spike glycoprotein of SARS-CoV-2"/>
   <result pre="century, following severe acute respiratory syndrome (SARS) in 2002â€&quot;2003 and" exact="Middle East respiratory syndrome" post="(MERS) in 2011. Both SARS-CoV and MERS-CoV were newly"/>
   <result pre="for virus-specific memory T-cells in broad and long-term protection against" exact="SARS-CoV infection" post="was elucidated [21, 22]. Indeed, the crucial protective role"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7191286\results\search\zoonosis\results.xml">
   <result pre="for as long as the COVID-19 resource centre remains active." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), the cause of the coronavirus disease"/>
   <result pre="acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the" exact="coronavirus disease 2019" post="(COVID-19) pandemic, is the worst challenge for a century"/>
   <result pre="for Covid-19. Comorbidity and its impact on 1590 patients with" exact="Covid-19" post="in China: a Nationwide AnalysisEur Respir J2020 Mar 2610.1183/13993003.00547-2020pii:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7194560\results\search\zoonosis\results.xml">
   <result pre="approved safe drugs for potential use in COVID-treatment. Abbreviations COVID-19," exact="Coronavirus disease 2019" post="2019-nCoV, 2019 New Coronavirus MERS CoV, Middle East Respiratory"/>
   <result pre="was detected to be a new coronavirus and termed as" exact="Coronavirus disease 2019" post="(COVID-19). Coronavirus has been associated with several infectious epidemics"/>
   <result pre="C virus RNA-dependent RNA polymerase [21], dengue virus [22] and" exact="Ebola" post="virus [23]. In this work, we cover a knowledge"/>
   <result pre="Chem. Biol.3200876577519053243 23RajU.VaradwajP.K.Flavonoids as multi-target inhibitors for proteins associated with" exact="Ebola" post="virus: in silico discovery using virtual screening and molecular"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7194707\results\search\zoonosis\results.xml">
   <result pre="viruses were termed severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV); both have resulted in more than 10,000"/>
   <result pre="previous outbreaks of similar types of infection such as the" exact="Middle East respiratory syndrome" post="(MERS)-CoV.48 However, although there appeared to be some evidence"/>
   <result pre="care providersAm J Pharmaceut Educ74102010S710.5688/aj7410s7 40Improving Pharmacist Involvement in Pandemic" exact="Influenza" post="Planning and Response in Australia2018Australian Healthcare and Hospital AssociationAvailable"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7194797\results\search\zoonosis\results.xml">
   <result pre="different coronaviruses in the different parts of the world namely;" exact="Severe acute respiratory syndrome" post="cornonavirus-1 (SARS-CoV-1), Middle East respiratory syndrome (MERS-CoV) and Severe"/>
   <result pre="of the world namely; Severe acute respiratory syndrome cornonavirus-1 (SARS-CoV-1)," exact="Middle East respiratory syndrome" post="(MERS-CoV) and Severe acute respiratory syndrome cornonavirus-2 (SARS-CoV-2). We"/>
   <result pre="respiratory syndrome cornonavirus-1 (SARS-CoV-1), Middle East respiratory syndrome (MERS-CoV) and" exact="Severe acute respiratory syndrome" post="cornonavirus-2 (SARS-CoV-2). We aimed to delineate the differences in"/>
   <result pre="coronavirus (SARS-CoV-1) in 2003, H1N1 influenza in 2009 and the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012. Recently, an outbreak of pneumonia"/>
   <result pre="epidemiological and transmission difference in characteristics between SARS-CoV1, MERS and" exact="Covid-19" post="has been summarized in TableÂ 1 . TableÂ 1"/>
   <result pre="and futureEpidemiology166200579180116222170 16WangYixuanUnique epidemiological and clinical features of the emerging" exact="2019 novel coronavirus pneumonia" post="(COVID-19) implicate special control measures2020 17LaiC.C.Asymptomatic carrier state, acute"/>
   <result pre="(SARS-CoV-2): facts and mythsJÂ Microbiol Immunol Infect2020 18ChengS.-C.First case of" exact="coronavirus disease 2019" post="(COVID-19) pneumonia in TaiwanJÂ Formos Med Assoc1193202074775132113824 19ZhaoS.L.QRanJ.Preliminary estimation"/>
   <result pre="clinical application of A rapid IgM-IgG combined antibody test for" exact="SARS-CoV-2 infection" post="diagnosisJÂ Med Virol2020 Feb 2710.1002/jmv.25727[Epub ahead of print] 27Guo"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7194918\results\search\zoonosis\results.xml">
   <result pre="control is achieved. One of the most disturbing issues is" exact="Covid-19" post="treatment; although a large number of medications, previously used"/>
   <result pre="Authorities. Remdesivir remains the most promising drug to treat the" exact="Ebola" post="virus [6] infection and has the ability to inhibit"/>
   <result pre="to a recent press release, the last patient suffering from" exact="Ebola" post="virus in Democratic Republic of Congo has been released"/>
   <result pre="for the prevention, diagnosis and treatment of pneumonia induced by" exact="Covid-19" post="virus [5]. It is furthermore requested that the scientific"/>
   <result pre="Med Infect Dis202010161510.1016/j.tmaid.2020.101615[Epub ahead of Print] 4DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov14120204860 5GaoJ.TianZ.YangX.Breakthrough: chloroquine phosphate has shown apparent efficacy"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7195043\results\search\zoonosis\results.xml">
   <result pre="to develop a new diagnosis and management system for the" exact="COVID 19" post="cases, through useful algorithms. AI is helpful in the"/>
   <result pre="development. Declaration of competing interest None. References References 1HaleemA.JavaidM.VaishyaEffects of" exact="COVID 19" post="pandemic in daily lifeCurr Med Res Pract202010.1016/j.cmrp.2020.03.011 2BaiH.X.HsiehB.XiongZ.HalseyK.ChoiJ.W.TranT.M.PanI.ShiL.B.WangD.C.MeiJ.JiangX.L.Performance of"/>
   <result pre="Feb 17. 4AiT.YangZ.HouH.ZhanC.ChenC.LvW.TaoQ.SunZ.XiaL.Correlation of chest CT and RT-PCR testing in" exact="coronavirus disease 2019" post="(COVID-19) in China: a report of 1014 casesRadiology202010.1148/radiol.2020200642 5LuoH.TangQ.L.ShangY.X.LiangS.B.YangM.RobinsonN.LiuJ.P.Can"/>
   <result pre="1014 casesRadiology202010.1148/radiol.2020200642 5LuoH.TangQ.L.ShangY.X.LiangS.B.YangM.RobinsonN.LiuJ.P.Can Chinese medicine be used for prevention of" exact="coronavirus disease 2019" post="(COVID-19)? A review of historical classics, research evidence and"/>
   <result pre="271331932805 15WanK.H.HuangS.S.YoungA.LamD.S.Precautionary measures needed for ophthalmologists during pandemic of the" exact="coronavirus disease 2019" post="(COVID-19)Acta Ophthalmol2020 Mar 29 16LiL.QinL.XuZ.YinY.WangX.KongB.BaiJ.LuY.FangZ.SongQ.CaoK.Artificial intelligence distinguishes COVID-19 from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7195149\results\search\zoonosis\results.xml">
   <result pre="this itty-bitty virus. And we have nothing Preliminary trials against" exact="Ebola" post="yielded promising results, and in 2018 Gilead tested the"/>
   <result pre="tested the drug in a large-scale clinical trial during an" exact="Ebola" post="outbreak in the Democratic Republic of the Congo. When"/>
   <result pre="same infection. The strategy has saved lives during polio and" exact="Ebola" post="epidemics, measles outbreaks and even during the SARS epidemic"/>
   <result pre="Foundation. Last month, the organisation launched an endeavour called the" exact="Covid-19" post="Therapeutics Accelerator, which will contribute up to $125 million"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7196187\results\search\zoonosis\results.xml">
   <result pre="Convalescent plasma (CP) COVID-19 Current diagnostics SARS-CoV-2 INTRODUCTION The novel" exact="coronavirus disease 2019" post="(COVID-19), an outbreak caused by the Severe Acute Respiratory"/>
   <result pre="This is the third coronavirus epidemic after the SARS and" exact="MERS coronavirus" post="outbreaks. Structural studies revealed that there is a close"/>
   <result pre="important specimen recommended by the WHO and CDC to detect" exact="SARS-CoV-2 infection" post="is the OP. This swab is collected from the"/>
   <result pre="single vial for more sensitive and appropriate results of the" exact="SARS-CoV-2 infection." post="Bronchoalveolar lavage and tracheal aspirate: For patients who are"/>
   <result pre="and IgG antibodies produced by the patient in response to" exact="SARS-CoV-2 infection" post="(9). Likewise, ICMR has also issued some guidelines for"/>
   <result pre="beta-1a, chloroquine, and hydroxychloroquine. Remdesivir has been previously tested for" exact="Ebola" post="treatment (15). According to a recent study, an inflammatory"/>
   <result pre="therapy appears as a shaft of light to combat the" exact="SARS-CoV-2 infection." post="Doctors and scientists are claiming that CP therapy was"/>
   <result pre="treat several infectious diseases, including Spanish flu (1917-1918) (32), the" exact="Ebola" post="epidemic in West Africa (33), human coronaviruses (34), influenza"/>
   <result pre="(37, 38). In a meta-analysis from 32 studies conducted on" exact="SARS-CoV infection," post="the mortality rate was significantly decreased when compared to"/>
   <result pre="be approved soon as the one-stop remedy to treat the" exact="SARS-CoV-2 infection." post="As per the government order, more state hospitals should"/>
   <result pre="mild symptom associated with this disease. Containing the spread of" exact="SARS-CoV-2 infection" post="will potentially reduce the stress and strain on the"/>
   <result pre="are working rigorously to find the solution to treat the" exact="SARS-CoV-2 infection" post="at a rapid pace. Hence, more research is needed"/>
   <result pre="for collecting, handling, and testing clinical specimens from persons for" exact="coronavirus disease 2019" post="(COVID-19)https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.htmlaccessed on 16 April, 2020 9collab: World Health Organization"/>
   <result pre="Intern Med14559960910.7326/0003-4819-145-8-200610170-0013916940336 33Van GriensvenJEdwardsTde LamballerieXet al.2016Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in GuineaN Engl J Med374334210.1056/NEJMoa151181226735992 34ZhouBZhongNGuanY2007Treatment with"/>
   <result pre="Infect Dis5244745610.1093/cid/ciq10621248066 37ChengZLuYCaoQet al.2020Clinical features and chest CT manifestations of" exact="coronavirus disease 2019" post="(COVID-19) in a single-center study in Shanghai, ChinaAm J"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov61610.1038/s41421-020-0156-032194981 Fig. 1 Collection of Specimens/samples and"/>
   <result pre="Ninth Hospital of Nanchang Nanchang, Jiangxi, China Eculizumab (Soliris) in" exact="Covid-19" post="Infected Patients Eculizumab Initiated - Norwegian Coronavirus Disease 2019"/>
   <result pre="Acyclovir SARS, MERS, Coronavirus 229E and COVID-19 Nitazoxanide SARS, MERSand" exact="Influenza" post="Influenza drugs MERS Remdesivir COVID-19, SARS, MERS Favipiravir COVID-19"/>
   <result pre="SARS, MERS, Coronavirus 229E and COVID-19 Nitazoxanide SARS, MERSand Influenza" exact="Influenza" post="drugs MERS Remdesivir COVID-19, SARS, MERS Favipiravir COVID-19 Darunavir"/>
   <result pre="Ruxolitinib COVID-19 Saquinavir SARS and Feline Coronavirus Relenza, Tamiflu, Amantadine" exact="Influenza" post="virus Indinavir SARS and COVID-19 Carfilzomib COVID-19 Oseltamivir COVID-19"/>
   <result pre="investigation in clinical trials for pre-exposure or post-exposure prophylaxis of" exact="SARS-CoV-2 infection," post="and treatment of patients with mild, moderate, and severe"/>
   <result pre="al., 2020) Two drugs, remdesivir and chloroquine phosphate, efficiently inhibited" exact="SARS-CoV-2 infection" post="in vitro Remdesivir + chloroquine phosphate Not specified 27"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7196535\results\search\zoonosis\results.xml">
   <result pre="Med. Virol.3951022320205075130â€&quot;2 ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.XiaJ.YuT.ZhangX.ZhangL.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet39510223202050751310.1016/S0140-6736(20)30211-732007143 CSBTS (State Bureau"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7196844\results\search\zoonosis\results.xml">
   <result pre="2020-3-3pmc-release: 2020-3-311713213219received: 2020-3-4accepted: 2020-3-13 Background With the worldwide spread of" exact="SARS-CoV-2 infection," post="it is becoming increasingly urgent to develop a vaccine"/>
   <result pre="respiratory syndrome (SARS) spread outwards from China. Ten years later," exact="Middle East respiratory syndrome" post="(MERS) hit the headlines. MERS was first diagnosed in"/>
   <result pre="viruses (19). It was developed as a substance to treat" exact="Ebola" post="infection. It was effective in an experiment on non-human"/>
   <result pre="but the results of a clinical trial in patients with" exact="Ebola" post="were not convincing. After a preliminary analysis revealed that"/>
   <result pre="treated with remdesivir. The reasons for remdesivirâ€™s poor efficacy against" exact="Ebola" post="in this clinical trial remain unexplained (20). Clinical trials"/>
   <result pre="Hepatol20095178779119665816 18WarrenTKJordanRLoMKet al.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature201653138138526934220 19SheahanTPSimsACGrahamRLet al.Broad-spectrum antiviral GS-5734 inhibits"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7196923\results\search\zoonosis\results.xml">
   <result pre="decades, the world has faced several infectious disease outbreaks. Ebola," exact="Influenza" post="A (H1N1), SARS, MERS, and Zika virus have had"/>
   <result pre="(Centers for Desease Control &amp;amp; Prevention, 2005; World Health Organization." exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), 2019). Coronavirus is a family of the"/>
   <result pre="the common cold, severe acute respiratory syndrome (SARS) and the" exact="Middle East respiratory syndrome" post="(MERS) (Amanat &amp;amp; Krammer, 2020). In 2019, a new"/>
   <result pre="In 2019, a new virus identified in china namely novel" exact="coronavirus disease 2019" post="(COVID-19). On 11 March 2020, the World Health Organization"/>
   <result pre="(2019) have conducted a trial of four investigational therapies for" exact="Ebola" post="virus diseased patients. A total of 681 patients were"/>
   <result pre="inhibitor), Mab114 (a single human monoclonal antibody derived from an" exact="Ebola" post="survivor), and REGN-EB3 (a coformulated mixture of three human"/>
   <result pre="superior than ZMAP and remdesivir group in reducing mortality for" exact="Ebola" post="patients, primary groups have faster rate of viral clearance"/>
   <result pre="et al., 2017). It is under the clinical development for" exact="Ebola" post="virus treatment and typically it is distributed in the"/>
   <result pre="(2017) tested a Remdesivir inhibitor that has shown activity against" exact="Ebola" post="virus as a potential agent to be used to"/>
   <result pre="to combat coronaviruses. Unfortunately, it could not be help to" exact="Ebola" post="patients during the 2019 outbreak in the Democratic Republic"/>
   <result pre="Azithromycin has been displayed an antiviral property against Zika and" exact="Ebola" post="virus in vitro (Bosseboeuf et al., 2018; Madrid et"/>
   <result pre="Association, 314(19), 2034â€&quot;2044. 10.1001/jama.2015.1389626575060 BadenL. R., &amp;amp; RubinE. J. (2020)." exact="Covid-19" post="- The search for effective therapy. The New England"/>
   <result pre="MangerI. D., GilfillanL., BavariS., &amp;amp; TangaM. J. (2015). Evaluation of" exact="Ebola" post="virus inhibitors for drug repurposing. ACS Infectious Diseases, 1(7),"/>
   <result pre="the PALM Writing Group (2019). A randomized, controlled trial of" exact="Ebola" post="virus disease therapeutics. New England Journal of Medicine, 381,"/>
   <result pre="channels. Virology, 330(1), 322â€&quot;331. 10.1016/j.virol.2004.09.03315527857 collab: World Health Organization (2019)." exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). https://www.who.int/emergencies/mers-cov/en. WrappD., WangN., CorbettK. S., GoldsmithJ. A.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7197577\results\search\zoonosis\results.xml">
   <result pre="and pandemics, including the severe acute respiratory syndrome (SARS), the" exact="Middle East respiratory syndrome" post="(MERS), influenza H1N1, and the novel severe acute respiratory"/>
   <result pre="RemigioC, MilliganT, DelineCAcute necrotizing encephalopathy in a child with H1N1" exact="influenza infection." post="Pediatr Radiol. 2010;40(2):200-205.20020117 5.UmapathiT, KorAC, VenketasubramanianNet al..Large artery ischaemic"/>
   <result pre="post-influenza cerebellitis. Intern Med. 1997;36(10):747-749.9372341 8.AlgahtaniH, SubahiA, ShirahBNeurological complications of" exact="Middle East respiratory syndrome" post="coronavirus: a report of two cases and review of"/>
   <result pre="19.FrobertE, SarretC, BillaudGet al..Pediatric neurological complications associated with the A(H1N1)pdm09" exact="influenza infection." post="J Clin Virol. 2011;52(4):307-313.21920811 20.EkstrandJJ, HerbenerA, RawlingsJet al..Heightened neurologic"/>
   <result pre="BalkhyHHet al..Clinical course and outcomes of critically ill patients with" exact="Middle East respiratory syndrome" post="coronavirus infection. Ann Intern Med. 2014;160(6):389-397.24474051 35.NoorwaliAA, TurkistaniAM, AsiriSIet"/>
   <result pre="TurkistaniAM, AsiriSIet al..Descriptive epidemiology and characteristics of confirmed cases of" exact="Middle East respiratory syndrome" post="coronavirus infection in the Makkah region of Saudi Arabia,"/>
   <result pre="OmraniAS, BaigKet al..Clinical aspects and outcomes of 70 patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a single-center experience in Saudi Arabia. Int"/>
   <result pre="Med. 2017;45(10):1683-1695.28787295 38.ChoiWS, KangCI, KimYet al..Clinical presentation and outcomes of" exact="Middle East respiratory syndrome" post="in the Republic of Korea. Infect Chemother. 2016;48(2):118-126.27433382 39.AssiriA,"/>
   <result pre="Al-RabeeahAAet al..Epidemiological, demographic, and clinical characteristics of 47 cases of" exact="Middle East respiratory syndrome" post="coronavirus disease from Saudi Arabia: a descriptive study. Lancet"/>
   <result pre="2013;13(9):752-761.23891402 40.ShalhoubS, Al-HameedF, MandourahYet al..Critically ill healthcare workers with the" exact="Middle East respiratory syndrome" post="(MERS): a multicenter study. PLoS One. 2018;13(11):e0206831.30439974 41.AleanizyFS, MohmedN,"/>
   <result pre="PLoS One. 2018;13(11):e0206831.30439974 41.AleanizyFS, MohmedN, AlqahtaniFY, El Hadi MohamedRAOutbreak of" exact="Middle East respiratory syndrome" post="coronavirus in Saudi Arabia: a retrospective study. BMC Infect"/>
   <result pre="51.WangZ, YangB, LiQ, WenL, ZhangRClinical features of 69 cases with" exact="coronavirus disease 2019" post="in Wuhan, China. Clin Infect Dis. published online: March"/>
   <result pre="LiangWH, ZhaoYet al..Comorbidity and its impact on 1590 patients with" exact="Covid-19" post="in China: a nationwide analysis. Eur Respir J. published"/>
   <result pre="TuM, WangSet al..Clinical characteristics of laboratory confirmed positive cases of" exact="SARS-CoV-2 infection" post="in Wuhan, China: a retrospective single center analysis. Travel"/>
   <result pre="February 24, 2020 (doi:10.1016/S2213-2600(20)30079-5). 59.GuanWJ, NiZY, HuYet al..Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. published online: February"/>
   <result pre="Engl J Med. published online: February 28, 2020 (doi:10.1056/NEJMoa2002032). 60.collab:" exact="Covid-19" post="National Emergency Response Center, Epidemiology Case Management Team, Korea"/>
   <result pre="Ed. 2020;395(10223):497-506. 62.ZhengF, LiaoC, FanQHet al..Clinical characteristics of children with" exact="coronavirus disease 2019" post="in Hubei, China. Curr Med Sci. published online: March"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7197622\results\search\zoonosis\results.xml">
   <result pre="via PMC and Europe PMC, consistent with existing copyright protections.pvaa042.pdfpage-count:" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) is the causal agent of the"/>
   <result pre="(SARS-CoV-2) is the causal agent of the current pandemic of" exact="coronavirus disease 2019" post="(COVID-19). SARS-CoV-2 is a positive-sense single-stranded RNA betacoronavirus sharing"/>
   <result pre="response and preventing endothelial barrier damage in patients infected with" exact="Ebola" post="virus during the recent Ebola outbreak in West Africa.5"/>
   <result pre="damage in patients infected with Ebola virus during the recent" exact="Ebola" post="outbreak in West Africa.5 Similar to avian influenza viruses,"/>
   <result pre="mechanism of actions and proposed advantages of statins in COVID-19." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), the causal agent of coronavirus disease"/>
   <result pre="acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of" exact="coronavirus disease 2019" post="(COVID-19), enters the cell through angiotensin-converting enzyme 2 (ACE2)."/>
   <result pre="should also be taken into consideration in the setting of" exact="SARS-CoV-2 infection." post="Observational studies have found that elderly people with cardiovascular"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7198433\results\search\zoonosis\results.xml">
   <result pre="this last paper were performed as a way to model" exact="Ebola" post="presence in sewage. The inactivation kinetics of enveloped viruses"/>
   <result pre="sources and/or cure the sources. The pathway it clear too:" exact="Covid-19" post="spreads via aerosols, sneezed our coughed out by infected"/>
   <result pre="based on current evidenceInt. J. Antimicrob. Agents202010.1016/j.ijantimicag.2020.105948 3LaiChih-ChengWangCheng-YiWangYa-HuiHsuehShun-ChungKoWen-ChienHsuehPo-RenGlobal epidemiology of" exact="coronavirus disease 2019" post="(COVID-19): disease incidence, daily cumulative index, mortality, and their"/>
   <result pre="COVID-19 in Wuhan, ChinaSci. Total Environ.7242020138226 10RamadhanTosepuCorrelation between weather and" exact="Covid-19" post="pandemic in Jakarta, IndonesiaSci. Total Environ.725202010.1016/j.scitotenv.2020.138436138436 11CocciaMarioDetermining the diffusion"/>
   <result pre="pandemic in Jakarta, IndonesiaSci. Total Environ.725202010.1016/j.scitotenv.2020.138436138436 11CocciaMarioDetermining the diffusion of" exact="Covid-19" post="and suggest to prevent future accelerated viral infectivity such"/>
   <result pre="Environ.727202010.1016/j.scitotenv.2020.138543138543 16DaugthonChristianThe international imperative to rapidly and inexpensively monitor community-wide" exact="Covid-19" post="infection status and trendsSci. Total Environ.726202010.1016/j.scitotenv.2020.138149138149 17MaoKangZhangHuaYangZhugenCan a paper-based"/>
   <result pre="air measurement of SARS-CoV-2 in the patient rooms with confirmed" exact="Covid-19" post="in the largest hospital in IranSci. Total Environ.7252020138401 25RowanNeilLaffeyJohn"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7199720\results\search\zoonosis\results.xml">
   <result pre="the COVID-19 resource centre remains active. Since December 2019, the" exact="SARS-CoV-2 infection" post="has worldwide affected thousands of people and is life-threatening"/>
   <result pre="properly to fight this century virus. Since the outbreak of" exact="SARS-CoV-2 infection," post="Chinese Government initiated a policy that the COVID-19 patients"/>
   <result pre="treasure box together with modern technological investigation to combat the" exact="SARS-CoV-2 infection" post="powerfully, together with internationals."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7199731\results\search\zoonosis\results.xml">
   <result pre="potential drugs. Keywords Coronavirus SARS-CoV-2 COVID-19 Epitopes Immune-informatics Abbreviations COVID-19," exact="Coronavirus disease 2019" post="ssRNA, single-stranded RNA MERS-CoV, Middle East respiratory syndrome coronavirus"/>
   <result pre="Immune-informatics Abbreviations COVID-19, Coronavirus disease 2019 ssRNA, single-stranded RNA MERS-CoV," exact="Middle East respiratory syndrome" post="coronavirus SARS-CoV, severe acute respiratory syndrome coronavirus BtCoV, bat"/>
   <result pre="of Sars-CoV-2, there are 6 known human coronaviruses, including the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV)."/>
   <result pre="enhancement (ADE) effects of S protein antibodies are found in" exact="MERS coronavirus" post="[41], there are several limitations on targeting S protein"/>
   <result pre="S protein to ACE2 is important for the treatment of" exact="SARS-CoV infection" post="[102]. One recombinant human monoclonal antibody (mAb) (single-chain variable"/>
   <result pre="coronavirus Reducing oxidative stress (Beck, Kolbeck et al., 1994) PUFAa" exact="Influenza" post="virus, human immunodeficiency virus Antiâ€�inflammatory and proâ€�inflammatory effects. (Morita,"/>
   <result pre="Antiâ€�inflammatory and proâ€�inflammatory effects. (Morita, Kuba et al., 2013) Selenium" exact="Influenza" post="virus, avian coronavirus; viral mutations Defense against infectious diseases"/>
   <result pre="HIV infection (Tsang and Zhong 2003) Remdesivir SARSâ€�CoV/MERSâ€�CoV Treatment of" exact="Ebola" post="virus disease and Marburg virus (Yamamoto, Yang et al.,"/>
   <result pre="of HIV (Mohanasundaram and Sekhar 2018) Arbidol SARSâ€�CoV Treatment for" exact="influenza infection" post="(Khamitov, Loginova et al., 2008) Nitric oxide SARSâ€�CoV Treatment"/>
   <result pre="are no licensed therapeutic or vaccine for the treatment of" exact="SARS-CoV-2 infection" post="available in the market. Developing an effective treatment for"/>
   <result pre="J. Infect. Dis.91202026426631953166 6GuoY.-R.CaoQ.-D.HongZ.-S.TanY.-Y.ChenS.-D.JinH.-J.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;an update on the statusMil. Med. Res.7202011031928528 7ChanJ.F.-W.KokK.-H.ZhuZ.ChuH.ToK.K.-W.YuanS.Genomic"/>
   <result pre="dynamic receptor binding domainsNat. Commun.820171509228393837 12CottenM.WatsonS.J.KellamP.Al-RabeeahA.A.MakhdoomH.Q.AssiriA.Transmission and evolution of the" exact="Middle East respiratory syndrome" post="coronavirus in Saudi Arabia: a descriptive genomic studyLancet38220131993200224055451 13FathizadehH.MaroufiP.Momen-HeraviM.DaoS.KÃ¶seÅž.GanbarovK.Protection"/>
   <result pre="East respiratory syndrome coronavirus transmissionEmerg. Infect. Dis.26202019131961300 15ChoC.-C.LinM.-H.ChuangC.-Y.HsuC.-H.Macro domain from" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) is an efficient ADP-ribose binding module crystal"/>
   <result pre="genome projectNat. Genet.23199915115710508510 22WichapongK.PianwanitS.SipplW.KokpolS.Homology modeling and molecular dynamics simulations of" exact="Dengue" post="virus NS2B/NS3 protease: insight into molecular interactionJ. Mol. Recogn.:"/>
   <result pre="syndrome coronavirusJ. Virol.782004120901209515479853 75PeckK.M.ScobeyT.SwanstromJ.JensenK.L.BurchC.L.BaricR.S.Permissivity of dipeptidyl peptidase 4 orthologs to" exact="Middle East respiratory syndrome" post="coronavirus is governed by glycosylation and other complex determinantsJ."/>
   <result pre="staff of Imam Reza Hospital for all they did during" exact="Covid-19" post="pandemic and in memorial of all our colleagues lost"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7200052\results\search\zoonosis\results.xml">
   <result pre="in December 2019. On March 11 2020, WHO declared the" exact="SARS-CoV-2 infection" post="to be a pandemic, based on the involvement of"/>
   <result pre="Wuhan, China in December 2019 [1, 2]. Since then, the" exact="SARS-CoV-2 infection" post="has become a pandemic, reaching almost every Country in"/>
   <result pre="namely the severe acute respiratory syndrome CoV (SARS-CoV) and the" exact="Middle East respiratory syndrome" post="CoV (MERS-CoV) [3], also the current SARS-CoV-2 is suggested"/>
   <result pre="C is not present in the negative-sense RNA viruses. The" exact="Influenza" post="virus is the only one showing the two aspartates"/>
   <result pre="a RdRp structures were derived from PDB databank: SARS-CoV-2 (6M71)," exact="Influenza" post="virus (6QCT); HCV (3MWV). The whole molecules are presented"/>
   <result pre="RdRps were compared. b SARS-CoV-2 RdRp; c HCV RdRp; d" exact="Influenza" post="RdRp, zoomingin the channel in which the Motif C"/>
   <result pre="the optimal nucleoside analog to be repositioned to treatment of" exact="SARS-CoV-2 infection." post="Indeed, it has been developed for the positive-sense HCV"/>
   <result pre="USA20071047385739010.1073/pnas.061159910417456597 18.WarrenTKJordanRLoMKRayASMackmanRLSolovevaVet al.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature201653138138510.1038/nature1718026934220 19.FurutaYKomenoTNakamuraTFavipiravir (T-705), a broad spectrum"/>
   <result pre="Phys Biol Sci20179344946310.2183/pjab.93.027 20.ReynardONguyenXNAlazard-DanyNBarateauVCimarelliAVolchkovVEIdentification of a new ribonucleoside inhibitor of" exact="Ebola" post="virus replicationViruses201576233624010.3390/v712293426633464 21.BourliereMPietriOHepatitis C virus therapy: no one will"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7202545\results\search\zoonosis\results.xml">
   <result pre="with BMI&amp;gt;40, are believed to be at higher risk for" exact="influenza infection" post="due to a weakened immune response [31]. Similarly, vaccines"/>
   <result pre="of all hospitalised patients, even prior to laboratory confirmation of" exact="influenza infection." post="Evidence shows that the greatest benefit is seen when"/>
   <result pre="the betacoronavirus that caused the SARS epidemic of 2003. The" exact="Middle East respiratory syndrome" post="(MERS) epidemic was also caused by a betacoronavirus that"/>
   <result pre="Actuarial Life Table. https://www.ssa.gov/oact/STATS/table4c6.html 19collab: Centers for Disease Control. Estimated" exact="Influenza" post="Illnesses, Medical visits, Hospitalizations, and Deaths in the United"/>
   <result pre="List Results - ClinicalTrials.gov.https://clinicaltrials.gov/search/open/condition=%22Coronavirus+Infections%22 31collab: Centers for Disease Control andPrevention.." exact="Influenza" post="Antiviral Medications: Clinician Summary. 2020https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm 32MontoAS, RotthoffJ, TeichE, HerlocherML,"/>
   <result pre="home populations.Clin Infect Dis. 2004; 39:459â€&quot;64. 10.1086/42264615356805 33ChowEJ, DoyleJD, UyekiTM." exact="Influenza" post="virus-related critical illness: prevention, diagnosis, treatment.Crit Care. 2019; 23:214â€&quot;11."/>
   <result pre="and collab: Baloxavir Marboxil Investigators Group. Baloxavir Marboxil for Uncomplicated" exact="Influenza" post="in Adults and Adolescents.N Engl J Med. 2018; 379:913â€&quot;23."/>
   <result pre="BezrukovDS, PolykovskiyD, ShayakhmetovR, FilimonovA, OrekhovP, YanY, PopovaOlga, VanhaelenQ, et al.Potential" exact="COVID-2019" post="3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches.ChemRxiv."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7202626\results\search\zoonosis\results.xml">
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Influenza" post=": Biology and life sciences : Organisms : Viruses"/>
   <result pre=": Organisms : Viruses : RNA viruses : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza A virus : Biology and life sciences"/>
   <result pre=": Viruses : RNA viruses : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="A virus : Biology and life sciences : Microbiology"/>
   <result pre="microbiology : Microbial pathogens : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza A virus : Medicine and health sciences"/>
   <result pre="Microbial pathogens : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="A virus : Medicine and health sciences : Pathology"/>
   <result pre="Pathogens : Microbial pathogens : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza A virus : Biology and life sciences"/>
   <result pre="Microbial pathogens : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="A virus : Biology and life sciences : Organisms"/>
   <result pre=": Organisms : Viruses : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza A virus : Biology and Life Sciences"/>
   <result pre=": Viruses : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="A virus : Biology and Life Sciences : Molecular"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Orthomyxoviruses:" exact="Influenza" post="Viruses : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Orthomyxoviruses:" exact="Influenza" post="Viruses : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Orthomyxoviruses:" exact="Influenza" post="Viruses : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Orthomyxoviruses:" exact="Influenza" post="Viruses : Medicine and Health Sciences: Diagnostic Medicine :"/>
   <result pre="The potential benefits of a rapid and accurate diagnosis of" exact="influenza infection" post="include prompt initiation of antiviral therapy [7], fewer ancillary"/>
   <result pre="peak during the first 1â€&quot;2 days after the onset of" exact="influenza infection," post="and decline to undetectable levels within a week [11]."/>
   <result pre="Î¼L of remaining samples after performing the ImuoAce Flu test." exact="Influenza" post="A and B virus detection and the identification of"/>
   <result pre="was performed according to the Manual for the Diagnosis of" exact="Influenza" post="Virus, Version 4 by the National Institute of Infectious"/>
   <result pre="95%CI: 87.4â€&quot;99.9). 10.1371/journal.pone.0231217.t004Table 4 Sensitivity and specificity of Linjudge FluA/pdm." exact="Influenza" post="A Positive Negative TPa FPb TNc FNd % Sensitivity"/>
   <result pre="had been on the market until several years ago, Clearline" exact="Influenza" post="A/B/(H1N1) 2009 [30]; however, it has since been withdrawn"/>
   <result pre="HirotsuN, LeeN, de JongMD, HurtAC, et al.Baloxavir Marboxil for Uncomplicated" exact="Influenza" post="in Adults and Adolescents. N Engl J Med. 2018;379(10):913â€&quot;23."/>
   <result pre="10.1016/j.jinf.2011.06.00821722665 6HaversF, ThakerS, ClippardJR, JacksonM, McLeanHQ, GaglaniM, et al.Use of" exact="Influenza" post="Antiviral Agents by Ambulatory Care Clinicians During the 2012â€&quot;2013"/>
   <result pre="Influenza Antiviral Agents by Ambulatory Care Clinicians During the 2012â€&quot;2013" exact="Influenza" post="Season. Clin Infect Dis. 2014;59(6): 774â€&quot;82. 10.1093/cid/ciu42225034419 7Benito-FernandezJ, Vazquez-RoncoMA,"/>
   <result pre="et al.Diagnostic Accuracy of Novel and Traditional Rapid Tests for" exact="Influenza" post="Infection Compared With Reverse Transcriptase Polymerase Chain Reaction: A"/>
   <result pre="Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic" exact="Influenza" post="Virus Infections. Clin Infect Dis. 2016;62(4):431â€&quot;7. 10.1093/cid/civ90926518469 12ReedC, ChavesSS,"/>
   <result pre="16National Institute of Infectious Diseases. Manual for the Diagnosis of" exact="Influenza" post="Virus (in Japanese) 2018 [Available from: https://www.niid.go.jp/niid/images/lab-manual/influenza20190116.pdf. 17FluNet. Influenza"/>
   <result pre="of Influenza Virus (in Japanese) 2018 [Available from: https://www.niid.go.jp/niid/images/lab-manual/influenza20190116.pdf. 17FluNet." exact="Influenza" post="Laboratory Information by the GISRS. 2019 [http://apps.who.int/flumart/Default?ReportNo=1&amp;amp;CountryCode=JP 18UyekiTM, BernsteinHH,"/>
   <result pre="20ChengCK, CowlingBJ, ChanKH, FangVJ, SetoWH, YungR, et al.Factors affecting QuickVue" exact="Influenza" post="A + B rapid test performance in the community"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7202804\results\search\zoonosis\results.xml">
   <result pre="these changes in lifestyles occur now, during this phase of" exact="Covid-19" post="pandemics, but their effects are expected to translate into"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7202810\results\search\zoonosis\results.xml">
   <result pre="been controversy over discussions about injecting disinfectants into patients with" exact="SARS-CoV-2 infection" post="or treating them with ultraviolet rays [6]. Disinfectants are"/>
   <result pre="increased media coverage for â€œalternativeâ€� remedies to prevent and treat" exact="SARS-CoV-2 infection." post="For example, it is common in China to use"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7202902\results\search\zoonosis\results.xml">
   <result pre="Severe Acute Respiratory Syndrome corona virus 2 (SARS-CoV-2), so called," exact="coronavirus disease 2019" post="(COVID-19) are posing a similar challenge in which the"/>
   <result pre="in lung epithelial cells. In SARS-CoV-1 infection and presumably in" exact="SARS-CoV-2 infection," post="binding of spike protein to ACE2 together with lysosome"/>
   <result pre="WH, Ou CQ, He JX, et al. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. 2020. 12.HammingITimensWBulthuisMLLelyATNavisGvan GoorHTissue"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7203261\results\search\zoonosis\results.xml">
   <result pre="Clinical Pharmacy2210-77032210-7711Springer International PublishingCham pmcid: 72032611049 doi: 10.1007/s11096-020-01049-6 : Commentary" exact="Covid-19" post="and drug therapy, what we learned http://orcid.org/0000-0001-7132-000XProvenzaniAlessioaprovenzani@ismett.eduPolidoriPiera[], grid.419663.f0000 0001"/>
   <result pre="activities against RNA viruses like filoviruses, paramyxoviruses, pneumoviruses, SARS and" exact="MERS coronavirus" post="[10]. Based on pre-clinical studies in Ebola virus, remdesivir"/>
   <result pre="SARS and MERS coronavirus [10]. Based on pre-clinical studies in" exact="Ebola" post="virus, remdesivir act as an inhibitor of RNA polymerase,"/>
   <result pre="with severe Covid-19N Engl J Med202010.1056/NEJMoa200128232369286 13.DongLHuSGaoJDiscovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov Ther2020141586010.5582/ddt.2020.0101232147628 14.https://www.chinalawtranslate.com/coronavirus-treatment-plan-7/?lang=en. Accessed 17 Apr 2020. 15.ZhangQWangYQiCShenLLiJClinical"/>
   <result pre="Accessed 17 Apr 2020. 26.MulanguSDoddLEDaveyRTJret al.A randomized, controlled trial of" exact="Ebola" post="virus disease therapeuticsN Engl J Med2019381242293230310.1056/NEJMoa191099331774950 27.MalikYSSircarSBhatSet al.Emerging novel"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7203543\results\search\zoonosis\results.xml">
   <result pre="declaration of COVID-19 as a global pandemic. The pandemic of" exact="coronavirus disease 2019" post="(COVID-19) has led to unprecedented disruption in peopleâ€™s lives"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7207128\results\search\zoonosis\results.xml">
   <result pre="used against Betacoronaviruses associated with previous epidemics of SARS-CoV and" exact="MERS-Cov" post="(HIV drugs or Ebola frizzled drug) as well as"/>
   <result pre="with previous epidemics of SARS-CoV and MERS-Cov (HIV drugs or" exact="Ebola" post="frizzled drug) as well as promising malaria drugs chloroquine"/>
   <result pre="influence the work reported in this paper. References References 1WHO." exact="Coronavirus disease 2019" post="(COVID-19) Situation Report â€&quot; 67. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200327-sitrep-67-covid-19.pdf?sfvrsn=b65f68eb_4. 2YangX.YuY.XuJ.Clinical course and"/>
   <result pre="Epstein-Barr virus-associated hemophagocytic lymphohistiocytosisJ Clin Oncol1920012665267311352958 19HenterJ.I.Palmkvist-KaijserK.HolzgraefeB.BrycesonY.T.PalmerK.Cytotoxic therapy for severe" exact="swine flu" post="A/H1N1Lancet3762010211621168053 20AleemA.Al AmoudiS.Al-MashhadaniS.SiddiquiN.Haemophagocytic syndrome associated with hepatitis-B virus infection"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7207154\results\search\zoonosis\results.xml">
   <result pre="emerging viruses, such as corona. This was the case with" exact="Ebola" post="in Africa, and with the Nipah virus in Malaysia,"/>
   <result pre="References References MalvyD, McElroyAK, de ClerckH, GÃ¼ntherS, van GriensvenJ (2019)" exact="Ebola" post="virus disease. Lancet393: 936â€&quot;94830777297 MarÃ­ SaÃ©zA, WeissS, NowakK, LapeyreV,"/>
   <result pre="al (2015) Investigating the zoonotic origin of the West African" exact="Ebola" post="epidemic. EMBO Mol Med7: 17â€&quot;2325550396 WangH, FengZ, ShuY, YuH,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7207156\results\search\zoonosis\results.xml">
   <result pre="For COVIDâ€�19, the new technologies and the experience gained with" exact="Ebola" post="are going to help to further accelerate the development"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7210461\results\search\zoonosis\results.xml">
   <result pre="more relevant than those seen in the first phase of" exact="SARS-CoV-2 infection." post="In these cases, patients are advised not to go"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7211516\results\search\zoonosis\results.xml">
   <result pre="original work is properly cited. Abstract The global fight against" exact="coronavirus disease 2019" post="(COVID-19) is largely based on strategies to boost immune"/>
   <result pre="Vaccination Convalescent Serum Antibodies Immunotherapy INTRODUCTION The global fight against" exact="coronavirus disease 2019" post="(COVID-19) requires concerted efforts of all specialists with advanced"/>
   <result pre="be associated with aging, reduced cardiopulmonary reserves, and immune dysregulations.2" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), the cause of the current pandemic,"/>
   <result pre="for the paediatric rheumatologistClin Immunol202021410842032283324 8TagarroAEpalzaCSantosMSanz-SantaeufemiaFJOtheoEMoraledaCet al.Screening and severity of" exact="coronavirus disease 2019" post="(COVID-19) in children in Madrid, SpainJAMA PediatrForthcoming 2020 9DashraathPWongJLLimMXLimLMLiSBiswasAet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7211730\results\search\zoonosis\results.xml">
   <result pre="to imunodeficiency â€¢Immunodeficiency contributes to chronic diseases and the current" exact="Covid-19" post="pandemics. â€¢Environmental chemicals and microorganisms share similar molecular pathomechanisms"/>
   <result pre="respiratory syndrome coronavirus (SARS)-CoV in 2002â€&quot;2003 (Ksiazek et al., 2003)," exact="Middle East respiratory syndrome" post="(MERS)-CoV in 2012 (Zaki et al., 2012) and, in"/>
   <result pre="colitis, asthma, dengue virus disease (Jain et al., 2013), and" exact="swine flu" post="determined by pandemic H1N1 influenza virus (Bermejo-Martin et al.,"/>
   <result pre="and ARBs are unlikely to be harmful in patients with" exact="Covid-19" post="(Jarcho et al., 2020 1). Conversely, because of the"/>
   <result pre="and chemokines (Yang, 2020). The excessive immune reaction produced by" exact="SARS-CoV-2 infection" post="in the host can lead in some cases to"/>
   <result pre="drugs, such as ACE-inhibitors and angiotensin-receptor blockers (ARBs) to increase" exact="Covid-19" post="severity and case fatality rate (Day, 2020). This is"/>
   <result pre="i.e. both high and low ACE2 activity could theoretically increase" exact="Covid-19" post="severity (Guo et al., 2020). Therefore, more research is"/>
   <result pre="interaction between the ACE-inhibitor/ARB use and the susceptibility to increased" exact="Covid-19" post="severity. Observational studies are currently underway on this issue,"/>
   <result pre="of convincing clinical evidence of their benefits against severity of" exact="Covid-19" post="(Fang et al., 2020; ESC, 2020). It has been"/>
   <result pre="GS-441524. Its clinical significance was proved during the West African" exact="Ebola" post="virus epidemic of 2013â€&quot;2016 and the Kivu Ebola epidemic"/>
   <result pre="West African Ebola virus epidemic of 2013â€&quot;2016 and the Kivu" exact="Ebola" post="epidemic in 2018 (Warren et al., 2015). Given its"/>
   <result pre="Although Remdesivir has led to quick recoveries in symptoms of" exact="Covid-19" post="patients in a clinical trial, results from its Phase"/>
   <result pre="clinical trial, results from its Phase III trial involving severe" exact="Covid-19" post="patients are expected to be available soon. 6 Approaches"/>
   <result pre="be available soon. 6 Approaches and challenges to tackle the" exact="Covid-19" post="epidemics/pandemics It is well understood that COVID-19 outbreak and"/>
   <result pre="and 2) avoiding hospitals (and Intensive Care Units) overwhelmed by" exact="Covid-19" post="cases. The global spending on cancer therapies, cholesterol-lowering drugs,"/>
   <result pre="the non-observance of individual protection measures and treatment of mild" exact="Covid-19" post="cases in new temporary hospitals, the intensified competition and"/>
   <result pre="inhibitor that provides complete therapeutic protection against the development of" exact="Ebola" post="virus disease (EVD) in infected non-human primatesOpen Forum Infectious"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7212074\results\search\zoonosis\results.xml">
   <result pre="outbreak originating in Wuhan, China. The disease was later named" exact="coronavirus disease 2019" post="(COVID-19) in February 2020, by WHO (1). The epidemiological"/>
   <result pre="is noteworthy that there are reports of atypical presentation of" exact="Middle East respiratory syndrome" post="virus (MERS-CoV) in patients who received immunosuppressive drugs; therefore,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7212248\results\search\zoonosis\results.xml">
   <result pre="pneumonia and tumour progression all which can mask an underlying" exact="SARS-CoV-2 infection." post="CT imaging is essential for the diagnosis of SARS-CoV-2"/>
   <result pre="SARS-CoV-2 infection. CT imaging is essential for the diagnosis of" exact="SARS-CoV-2 infection" post="in the absence of microbiological tests and the CT"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov2020611610.1038/s41421-020-0156-032194981 9.BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalAGlobal cancer statistics 2018: GLOBOCAN estimates"/>
   <result pre="patients during a COVID â€�19 epidemicAnaesthesia202075682382410.1111/anae.1505332221974 33.SorbelloM.Elâ€�BoghdadlyK.Di GiacintoI.CataldoR.EspositoC.FalcettaS.MerliG.CorteseG.CorsoR. M.BressanF.PintaudiS.GreifR.DonatiA.PetriniF.The Italian" exact="coronavirus disease 2019" post="outbreak: recommendations from clinical practiceAnaesthesia202075672473210.1111/anae.1504932221973 34.CookT. M.Elâ€�BoghdadlyK.McGuireB.McNarryA. F.PatelA.HiggsA.Consensus guidelines"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7212283\results\search\zoonosis\results.xml">
   <result pre="common symptoms; GI symptoms were more common with more severe" exact="Covid-19" post="disease (23% vs. 8.1%) and family clustering (31.1% vs."/>
   <result pre="cross-sectional, multicenter studyAm J GastroenterolMarch 5, 202010.14309/ajg.0000000000000620 8GuanWei-jieNiZ.Y.HuY.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med2020 Feb 2810.1056/NEJMoa2002032[Epub ahead of"/>
   <result pre="Wuhan, ChinaLancet395202049750631986264 17ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 18ShiH.HanX.JiangN.Radiological findings from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7213034\results\search\zoonosis\results.xml">
   <result pre="Commentary The Socially Distanced Social Animal â€&quot; In The New" exact="Covid-19" post="Era RanganathanLakshmi NarasimhanShivaramanM.M Arun1RamamurthyGuhanShrivarthanR.[], [1], Address for correspondence: Dr."/>
   <result pre="rapid IgG/IgM combined antibody test for SARS-CoV-2medRxiv2020doi:10.1101/2020.03.26.20044883 22HosseinyMKoorakiSGholamrezanezhadAReddySMyersLRadiology perspective of" exact="coronavirus disease 2019" post="(COVID-19):Lessons from severe acute respiratory syndrome and Middle East"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7213617\results\search\zoonosis\results.xml">
   <result pre="Editor: At the end of 2019, an outbreak of novel" exact="coronavirus disease 2019" post="(COVID-19), caused by 2019-nCov, causing widespread novel coronavirus disease."/>
   <result pre="similar to the severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), which also belong to the Coronaviridae family"/>
   <result pre="6, 2020] 2.KimUJWonEJKeeSJJungSIJangHCCombination therapy with lopinavir/ritonavir, ribavirin and interferon-Î± for" exact="Middle East respiratory syndrome." post="Antivir Ther2016; 21:455â€&quot;459. doi: 10.3851/IMP3002.26492219 3.SpanakisNTsiodrasSHaagmansBLRajVSPontikisKKoutsoukouAet al.Virological and serological"/>
   <result pre="doi: 10.3851/IMP3002.26492219 3.SpanakisNTsiodrasSHaagmansBLRajVSPontikisKKoutsoukouAet al.Virological and serological analysis of a recent" exact="Middle East respiratory syndrome" post="coronavirus infection case on a triple combination antiviral regimen."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7214230\results\search\zoonosis\results.xml">
   <result pre="the beginning of severe acute respiratory syndrome human coronavirus (SARS-HCoV)," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) and now the (COVID-19) have driven the"/>
   <result pre="b-CoVs, the severe acute respiratory syndrome CoV (SARS-CoV) and the" exact="Middle East respiratory syndrome" post="CoV (MERS-CoV), have caused serious epidemics [19]. In November"/>
   <result pre="MERS-CoV is dromedary camels (Reusken et al. 2016). In 2012," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV causes mild to severe fever, cough, diarrhea"/>
   <result pre="McGoogan, J. M. Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7214343\results\search\zoonosis\results.xml">
   <result pre="Introduction The 2019â€&quot;20 coronavirus outbreak is an ongoing pandemic of" exact="coronavirus disease 2019" post="(COVID-19), caused by severe acute respiratory syndrome coronavirus 2"/>
   <result pre="11 patients with liver cirrhosis developed acute liver failure during" exact="influenza infection" post="[12]. No data available on the impact of COVID-19"/>
   <result pre="15World Health Organization: Rational use of personal protective equipment for" exact="coronavirus disease 2019" post="(COVID-19). Interim guidance. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/infection-prevention-and-control. Accessed April 12,"/>
   <result pre="COVID-19J Clin Microbiol202010.1128/JCM.00297-20 43WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in ChinaJAMA2020[Internet] available from : https://jamanetwork.com/journals/jama/fullarticle/2762130external accessed"/>
   <result pre="Med3821320201199120710.1056/NEJMoa200131631995857 49Al-DorziH.M.AldawoodA.S.KhanR.The critical care response to a hospital outbreak of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) infection: an observational studyAnn Intensive Care61201610110.1186/s13613-016-0203-z27778310 50FeltraccoP.BarbieriS.GalligioniH.MichielettoE.CarolloC.OriC.Intensive"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7214347\results\search\zoonosis\results.xml">
   <result pre="therefore increase the risk for a more severe expression of" exact="SARS-CoV-2 infection" post="in people with diabetes [40]. Corticosteroid utilization also requires"/>
   <result pre="infection advises against the use of corticosteroids upon suspicion of" exact="SARS-CoV-2 infection" post="outside clinical trials [45], yet corticosteroids were extensively utilized"/>
   <result pre="by the ISS, https://www.iss.it/coronavirus) [12]. Fig. 5 Territorial differences in" exact="SARS-CoV-2 infection" post="within Italy as of April 16, 2020 (Source: Data"/>
   <result pre="fully aware that: â€¢a strikingly different trend was observed for" exact="SARS-CoV-2 infection" post="between Northern and Southern Italy; â€¢strict containment rules are"/>
   <result pre="to and strengthened; â€¢people with T2DM are more susceptible to" exact="SARS-CoV-2 infection," post="with twice as high mortality risk as metabolically healthy"/>
   <result pre="legumes typical of the Mediterranean diet might help to stop" exact="SARS-CoV-2 infection" post="from spreading. To borrow from Plutarch, the conditions described"/>
   <result pre="work reported in this paper. References References 1Chinaâ€™s first confirmed" exact="Covid-19" post="case traced back to November 17, inÂ South China"/>
   <result pre="Y, Liang WH, Ou CQ, He JX. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. 2020:1â€&quot;13. Epub 2020/02/29."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7215132\results\search\zoonosis\results.xml">
   <result pre="pests, diseases, climate change and now as demonstrated by the" exact="COVID19" post="pandemic prone to a complete shut down by unforeseen"/>
   <result pre="a complete shut down by unforeseen crisis. Like never before," exact="COVID19" post="has revealed how closely linked human, animal and ecological"/>
   <result pre="countries dependent on migrant farmworkers who are particularly vulnerable to" exact="COVID19" post="and if they get sick they cannot get to"/>
   <result pre="schools, stadiums, theme parks and cruise ships has plummeted. Clearly" exact="COVID19" post="has revealed the socio-ecological fragility of current industrial-globalized food"/>
   <result pre="farms canÂ fortify peopleâ€™s immune systems. In the face of" exact="COVID 19," post="agroecology is positioning itself as the only agricultural path"/>
   <result pre="The key point here is whether the crisis unfolded by" exact="COVID19" post="will provide the impetus to change industrial agriculture for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7215134\results\search\zoonosis\results.xml">
   <result pre="aligned with those from negative-sense RNA viruses, namely Ebola, Influenza," exact="Rabies" post="and Vesicular Stomatitis viruses [16]. The structure modeling shows"/>
   <result pre="to the one from HCV than the one from negative-sense" exact="Influenza" post="and Ebola RNA viruses. Therefore, repositioning of Sofosbuvir (SovaldiÂ®;"/>
   <result pre="one from HCV than the one from negative-sense Influenza and" exact="Ebola" post="RNA viruses. Therefore, repositioning of Sofosbuvir (SovaldiÂ®; EpclusaÂ® by"/>
   <result pre="NS5B RdRp protein, as antiviral in the treatment of the" exact="SARS-CoV-2 infection" post="has an extremely high potentiality of success, as recently"/>
   <result pre="the molecular structure of the Sofosbuvir and the inhibitors of" exact="Influenza" post="and Ebola viruses currently evaluated in clinical trials (Fig.Â"/>
   <result pre="structure of the Sofosbuvir and the inhibitors of Influenza and" exact="Ebola" post="viruses currently evaluated in clinical trials (Fig.Â 1). Fig."/>
   <result pre="(developed for the influenza virus) and Remdesivir (developed for the" exact="Ebola" post="virus) are shown together with Sofosbuvir (developed for the"/>
   <result pre="lead compound with the highest potential of antiviral efficacy in" exact="SARS-CoV-2 infection." post="In addition, the long-lasting use in patients for treating"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7216567\results\search\zoonosis\results.xml">
   <result pre="(Lond)Eye0950-222X1476-5454Nature Publishing Group UKLondon pmcid: 7216567956 doi: 10.1038/s41433-020-0956-3 : Comment" exact="COVID19" post="and ophthalmology: a brief summary of the literature http://orcid.org/0000-0002-2634-9775ChandraShrutishruti.chandra@nhs.net1FlanaganDeclan1HingoraniMelanie1http://orcid.org/0000-0001-5541-4305LoteryAndrew2SivaprasadSobha1[1],"/>
   <result pre="This literature review aims to address the available evidence on" exact="COVID19" post="related issues faced in ophthalmology practice. Methods: Information was"/>
   <result pre="sudden vision loss. Evidence on testing of health workers for" exact="COVID19" post="Nosocomial transmission has been recognised as an important amplifier"/>
   <result pre="as an important amplifier in epidemics of both SARS and" exact="Middle East respiratory syndrome." post="Although hospital settings are the most common sites for"/>
   <result pre="SARS and MERS virus, it is not the case for" exact="COVID 19" post="and considerable transmission occur through close contacts [23]. The"/>
   <result pre="[11%]). However, comparison yielded no significant difference in rate of" exact="SARS-CoV-2 infection" post="among the groups. They concluded that nosocomial infection from"/>
   <result pre="RdRp assay which has low sensitivity [24]. Potential treatments for" exact="COVID19" post="New or re-purposed drugs are being explored for treatment"/>
   <result pre="as of 30 April 2020, evidence on the implications of" exact="COVID19" post="in ophthalmology practice are limited to Level 2 or"/>
   <result pre="of coronavirus in tears and conjunctival secretions of patients with" exact="SARS-CoV-2 infection." post="J Med Virol. 2020. 10.1002/jmv.25725. 5.Asadi S, Bouvier N,"/>
   <result pre="of Respirators and Medical Masks.â€� Reusability of Facemasks During an" exact="Influenza" post="Pandemic: Facing the Flu. Washington, DC: The National Academies"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7216760\results\search\zoonosis\results.xml">
   <result pre="and renal function as well as fertility. Surprisingly, the 2003" exact="SARS-CoV infection" post="was shown to downregulate the expression of ACE2 in"/>
   <result pre="anti-influenza drug faviprivir.8 Remdesivir was previously tested in humans with" exact="Ebola" post="virus disease and also in animal models of MERS"/>
   <result pre="J. J. (2020) Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="CheungC. W.; XiaZ. (2020) Review of the clinical characteristics of" exact="coronavirus disease 2019" post="(COVID-19). J. Gen Intern Med.1â€&quot;5. 10.1007/s11606-020-05762-w.31625040 KubaK.; ImaiY.; RaoS.;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7217781\results\search\zoonosis\results.xml">
   <result pre="coronavirusesJ. Virol.93122019e000231930918074 11DyallJ.Repurposing of clinically developed drugs for treatment of" exact="Middle East respiratory syndrome" post="coronavirus infectionAntimicrob. Agents Chemother.58820144885489324841273 Acknowledgments This work was supported"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7217786\results\search\zoonosis\results.xml">
   <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) continues to sweep the world, causing"/>
   <result pre="with other two CoV diseases, severe acute respiratory syndrome and" exact="Middle East respiratory syndrome" post="(SARS and MERS), of which causative viruses are SARS-CoV"/>
   <result pre="in the medical field during the epidemic season. Keywords Coronaviruses" exact="Influenza" post="A viruses Transmission Diagnosis Therapy Prevention In December 2019,"/>
   <result pre="nucleoside analog that mimics adenosine for previously treatment of the" exact="Ebola" post="virus infection [110]. Health authorities in China have initiated"/>
   <result pre="for treatment of COVID-19 [116]. Currently, for clinical treatment of" exact="influenza infection," post="there are only three classes of FDA (Food and"/>
   <result pre="and see 7.9 million hospitalised in the UKBMJ3682020m107132179567 4KhodamoradiZ.MoghadamiM.LotfiM.Co-infection of" exact="coronavirus disease 2019" post="and influenza A: a report from IranArch Iran Med23202023924332271596"/>
   <result pre="between a swine H3N2 influenza A virus and a prior" exact="human influenza" post="vaccine virus: a possible immune pressure-driven cross-species transmissionBiochem Biophys"/>
   <result pre="avian influenza A(H7N9) virus: a reviewEpidemiol Infect14320153359337426205078 43AlgahtaniH.SubahiA.ShirahB.Neurological complications of" exact="Middle East respiratory syndrome" post="coronavirus: a report of two cases and review of"/>
   <result pre="J Med38220201199120731995857 58ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 59SengaM.ArabiY.M.FowlerR.A.Clinical spectrum of"/>
   <result pre="in Wuhan, China: a descriptive studyLancet395202050751332007143 59SengaM.ArabiY.M.FowlerR.A.Clinical spectrum of the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV)JÂ Infect Public Health10201719119427140697 60MemishZ.A.PerlmanS.Van KerkhoveM.D.ZumlaA.Middle East respiratory"/>
   <result pre="syndromeLancet39520201063107732145185 61AssiriA.Al-TawfiqJ.A.Al-RabeeahA.A.Al-RabiahF.A.Al-HajjarS.Al-BarrakA.Epidemiological, demographic, and clinical characteristics of 47 cases of" exact="Middle East respiratory syndrome" post="coronavirus disease from Saudi Arabia: a descriptive studyLancet Infect"/>
   <result pre="factors associated with outcomes of patients infected with a Novel" exact="Influenza" post="A (H7N9) virus: a preliminary studyPloS One82013e73362 70PoepplW.HellM.HerknerH.StoiserB.FritscheG.Schurz-BamiehN.Clinical aspects"/>
   <result pre="(S-OIV) H1N1 virus in humansJÂ Clin Virol45200916917319540800 75LiemN.T.TungC.V.HienN.D.HienT.T.ChauN.Q.LongH.T.Clinical features of" exact="human influenza" post="A (H5N1) infection in Vietnam: 2004-2006Clin Infect Dis4820091639164619435433 76HuiD.S.Review"/>
   <result pre="HosaniF.KeatingM.K.GerberS.I.JonesT.L.MetcalfeM.G.Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of" exact="Middle East respiratory syndrome" post="coronavirus infection in the United Arab Emirates, April 2014Am"/>
   <result pre="virus infection in 2009-2010Histopathology60201232633522211291 97MauadT.HajjarL.A.CallegariG.D.da SilvaL.F.SchoutD.GalasF.R.Lung pathology in fatal novel" exact="human influenza" post="A (H1N1) infectionAm J Respir Crit Care Med1812010727919875682 98BaiL.GuL.CaoB.ZhaiX.L.LuM.LuY.Clinical"/>
   <result pre="A (H5N1) virus in humansEmerg Infect Dis13200770871217553248 102PeirisJ.S.YuW.C.LeungC.W.CheungC.Y.NgW.F.NichollsJ.M.Re-emergence of fatal" exact="human influenza" post="A subtype H5N1 diseaseLancet363200461761914987888 103WooP.C.LauS.K.TsoiH.W.HuangY.PoonR.W.ChuC.M.Clinical and molecular epidemiological features"/>
   <result pre="rational use of chloroquine and hydroxychloroquine in the management of" exact="coronavirus disease 2019" post="(COVID-19) pandemic: a timely reviewJÂ Toxicol Environ Health B"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7218355\results\search\zoonosis\results.xml">
   <result pre="Jung https://orcid.org/0000-0002-4980-3264 References References 1GuanWJNiZYHuY, et al. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. New Engl J Med2020 Available at: www.nejm.org/doi/full/10.1056/NEJMoa2002032."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7219411\results\search\zoonosis\results.xml">
   <result pre="a supposed antiviral activity: remdesivir, a molecule originally tested against" exact="Ebola" post="virus, shows in vivo activity against MERS-CoV5 but there"/>
   <result pre="ACE inhibitors in favouring the onset of severe forms of" exact="SARS-CoV-2 infection" post="induced a massive change in antihypertensive drugs prescription that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7219724\results\search\zoonosis\results.xml">
   <result pre="as COVID-19 in February 2020. A new respiratory disease -" exact="Coronavirus disease 2019" post="(COVID-19) - is spreading globally and there have been"/>
   <result pre="ON CVD AND OTHER COMMON CHRONIC DISEASES Cardiovascular complications of" exact="influenza infection," post="including myocarditis, acute myocardial infarction, and exacerbation of heart"/>
   <result pre="Global ThreatJ Assoc Physicians India2020686771 6.BadawiARyooSGPrevalence of comorbidities in the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV): a systematic review and meta-analysisInt J Infect"/>
   <result pre="echocardio-graphic follow-up studyCirculation20031081798180314504188 8.HarrisJEShahPJKorimilliVWinHFrequency of troponin elevations in patients with" exact="influenza infection" post="during the 2017-2018 influenza seasonInt J Cardiol Heart Vasc20192214514730740511"/>
   <result pre="25.March 15th, 2020https://www.bing.com/search?q=prevention+covid-19&amp;amp;form=PREXEN 26.SalihefendicNZildzicMAhmetagicSAcute Respiratory Distress Syndrome (ARDS) from Endemic" exact="Influenza" post="A/H1N1: Prehospital ManagementMed Arh201526916263 27.HassanSJawadJMAhjelWSSingBRSingJAwadMSHadiRNThe Nrf2 Activator (DMF) and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7219859\results\search\zoonosis\results.xml">
   <result pre="of clinical trials during the coronavirus 2019 (COVID-19) pandemic. Abstract" exact="Coronavirus disease 2019" post="(COVID-19) is a novel infectious disease that started in"/>
   <result pre="on the concepts of justice, equity, autonomy, and informed consent." exact="Coronavirus disease 2019" post="(COVID-19) is a novel infectious disease that started in"/>
   <result pre="2019, with the first human-to-human transmission reported in mid-January 2020.1,2" exact="Coronavirus disease 2019" post="is caused by a novel coronavirus (severe acute respiratory"/>
   <result pre="not new or limited to emerging infections.3,4 Even during the" exact="Ebola" post="virus epidemic, pregnant women were excluded from all therapeutic"/>
   <result pre="from all therapeutic and vaccine-development trials. This occurred even with" exact="Ebola" post="being a highly lethal virusâ€&quot;the vast majority of cases"/>
   <result pre="being a highly lethal virusâ€&quot;the vast majority of cases of" exact="Ebola" post="virus infection in pregnancy resulted in the death of"/>
   <result pre="La Fuente-NunezVSaxwnaAKueselACProtected to death: systematic exclusion of pregnant women from" exact="Ebola" post="virus disease trials. Reprod Health2017, 14; 47â€&quot;55.28351407 6.BleharMCSpongCGradyCGoldkindSFSahinLClaytonJAEnrolling pregnant"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7220586\results\search\zoonosis\results.xml">
   <result pre="as a global pandemic. Abstract Patients with diabetes who get" exact="coronavirus disease 2019" post="(COVID-19) are at risk of a severe disease course"/>
   <result pre="from previous viral epidemics. DPP4 is the prime receptor for" exact="Middle East respiratory syndrome" post="coronavirus responsible for its entry into cell [19]. Hence"/>
   <result pre="[26]. Treatment with ARBs was reported to reduce mortality in" exact="Ebola" post="virus infection [27]. Previously, a small study in ten"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, China. JAMA Intern Med. 2020. 10.1001/jamainternmed.2020.0994."/>
   <result pre="Z, McGoogan JM. Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="A systematic review and meta-analysisClin Immunol2020210108313.10.1016/j.clim.2019.10831331765833 9.Maddaloni E, Buzzetti R." exact="Covid-19" post="and diabetes mellitus: unveiling the interaction of two pandemics."/>
   <result pre="H7N9 virus-induced acute lunginjurySci Rep20144702710.1038/srep0702725391767 27.FedsonDSJacobsonJRRordamOMOpalSMTreating the host response to" exact="Ebola" post="virus disease with generic statins and angiotensin receptor blockersmBio20156e0071610.1128/mBio.00716-1526106080"/>
   <result pre="Zhi202048E00410.3760/cma.j.cn112148-20200220-0010532120458 30.GuoTFanYChenMWuXZhangLHeTet al.Cardiovascular Implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol202027e20101710.1001/jamacardio.2020.1017 31.Richardson S, Hirsch JS, Narasimhan M, Crawford"/>
   <result pre="J, et al. Hypokalemia and clinical implications in patients with" exact="coronavirus disease 2019" post="(COVID-19). 2020. 10.1101/2020.02.27.20028530. 34.Zhang, Zhu L, Cai L, Lei"/>
   <result pre="analysisDiabetes Metab Syndr2020143192310.1016/j.dsx.2020.03.01432298984 42.GhoshAGuptaRMisraATelemedicine for diabetes care in India during" exact="COVID19" post="pandemic and national lockdown period: guidelines for physiciansDiabetes Metab"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7221333\results\search\zoonosis\results.xml">
   <result pre="Asian house shrew, ChinaSci China Life Sci20196270170410.1007/s11427-018-9435-730701456 HolmesECDudasGRambautAAndersenKGThe evolution of" exact="Ebola" post="virus: Insights from the 2013â€&quot;2016 epidemicNature201653819320010.1038/nature1979027734858 LingwoodDSimonsKLipid rafts as"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7222554\results\search\zoonosis\results.xml">
   <result pre="pandemic of the disease once it has been acquired [26,28]." exact="SARS-CoV-2 infection" post="is primarily thought to transmit from human-to-human among individuals"/>
   <result pre="review, there are no specific therapeutic regimens approved for treating" exact="SARS-CoV-2 infection." post="The development of novel compounds or vaccines that work"/>
   <result pre="the moment in the standard clinical practices of China for" exact="SARS-CoV-2 infection" post="[27]. However, the validity of using these compounds should"/>
   <result pre="the fast solution to act against the invasive spread of" exact="SARS-CoV-2 infection." post="Several drugs have been used before to control and"/>
   <result pre="in improving patients' survival and reducing the viral load of" exact="SARS-CoV-2 infection" post="[77]. The investigations include antiviral drugs such as lopinavir,"/>
   <result pre="Jin Yin-Tan Hospital, Wuhan, on 199 seriously ill patients of" exact="SARS-CoV-2 infection" post="[80]. Male and nonpregnant patients of 18Â years or"/>
   <result pre="validate further the role of FPV in the management of" exact="SARS-CoV-2 infection" post="(NCT04303299, NCT04310228 and NCT04273763). FPV is being investigated as"/>
   <result pre="A clinical case study for the first patient diagnosed with" exact="SARS-CoV-2 infection" post="in USA has shown promising effectiveness of RDV [74]."/>
   <result pre="currently one of the most promising antiviral agents for reversing" exact="SARS-CoV-2 infection." post="Currently, about seven clinical trials are registered for investigating"/>
   <result pre="is recruiting patients to determine the efficacy of RBV for" exact="SARS-CoV-2 infection" post="at the University of Hong Kong, Queen Mary Hospital."/>
   <result pre="[91]. Arbidol is another antiviral that is being considered for" exact="SARS-CoV-2 infection." post="A retrospective study from the Fifth Affiliated Hospital of"/>
   <result pre="is currently being investigated extensively for its promising activity against" exact="SARS-CoV-2 infection" post="[96,97]. CQ is an old antimalarial drug with limited"/>
   <result pre="Trial Registry to test the CQ or HCQ efficiency on" exact="SARS-CoV-2 infection" post="[97]. The clinical outcomes include time to clinical recovery,"/>
   <result pre="and tolerability of tocilizumab in the treatment of patients with" exact="SARS-CoV-2 infection." post="Tocilizumab is to be injected as two doses, 8Â"/>
   <result pre="tocilizumab versus FPV alone versus tocilizumab alone for treatment of" exact="SARS-CoV-2 infection" post="[117]. Sarilumab is another IL-6 blocker that is used"/>
   <result pre="be considered while repurposing the use of this drug for" exact="SARS-CoV-2 infection." post="Other immunomodulators are being considered, including adalimumab. As mentioned"/>
   <result pre="response that is the main factor inducing lung damage in" exact="SARS-CoV-2 infection." post="On the other hand, corticosteroids may suppress the immune"/>
   <result pre="and died [27]. A study included 80 patients with confirmed" exact="SARS-CoV-2 infection" post="received treatment of a single antibiotic (moxifloxacin) and RBV"/>
   <result pre="[28]. Another study was conducted on 46 patients with confirmed" exact="SARS-CoV-2 infection" post="who received standard care of oxygen, cough relief, antiviral"/>
   <result pre="trials yet) The discovery and development of new molecules against" exact="SARS-CoV-2 infection" post="need time [129]. Besides, in silico discovery of molecules"/>
   <result pre="several research groups and pharmaceutical companies from the beginning of" exact="SARS-CoV-2 infection." post="The selection of these potential therapies was based on"/>
   <result pre="the anti-inflammatory drug is a choice for viral infections, including" exact="SARS-CoV-2 infection." post="Few studies discussed anti-inflammatory therapies as an option to"/>
   <result pre="anti-inflammatory therapies as an option to reduce the symptoms of" exact="SARS-CoV-2 infection" post="with baricitinib, and melatonin being the most related [131]."/>
   <result pre="screening for anti-inflammatory drugs that could be potential therapies for" exact="SARS-CoV-2 infection" post="[132]. SAR-COV-2 enters lung cells by ACE2-mediated invasion. AP2-associated"/>
   <result pre="as a potential anti-inflammatory drug to relieve the symptoms of" exact="SARS-CoV-2 infection." post="Viral infections cause injury of the immune system that"/>
   <result pre="effect and has been previously encouraged to be used for" exact="Ebola" post="viral infection [134]. As suggested by ChengÂ et al.,"/>
   <result pre="ChengÂ et al., melatonin could reduce the clinical symptoms of" exact="SARS-CoV-2 infection" post="and prolong the survival time for the patient. Angiotensin"/>
   <result pre="studies, it is still unclear how ACE2 is modified in" exact="SARS-CoV-2 infection" post="[32,135]. Kruse has suggested that therapies that block the"/>
   <result pre="receptor domain could be studied for their potential effectiveness against" exact="SARS-CoV-2 infection" post="[136]. For example, using the small receptor-binding domain (RBD)"/>
   <result pre="emodin or promazine could be considered as potential therapeutics for" exact="SARS-CoV-2 infection." post="Protease inhibitors Having coronaviral principal protease (3CLpro) as the"/>
   <result pre="effect for the function of proteases 3CLpro and Plpro in" exact="SARS-CoV infection" post="[141]. These candidates are also undergoing studies in research"/>
   <result pre="Î±-ketoamide inhibitor and considered Î±-ketoamide inhibitors as promising agents for" exact="SARS-CoV-2 infection" post="[140]. Traditional Chinese medicines therapy Traditional Chinese medicines (TCMs)"/>
   <result pre="infections, could be potential therapies for relieving the symptoms of" exact="SARS-CoV-2 infection," post="as proposed in the literature by different research groups"/>
   <result pre="confirmed the use of TCM as a preventive therapy for" exact="SARS-CoV-2 infection." post="Another trial study that is under process is also"/>
   <result pre="pharmaceutical companies enter the race to find a treatment for" exact="SARS-CoV-2 infection," post="relieve its symptoms or to reduce the risk of"/>
   <result pre="2. Therapies in research and development as potential therapies for" exact="SARS-CoV-2 infection." post="Therapies Type Pharmaceutical company Website TJM2 Neutralizing antibody I-Mab"/>
   <result pre="beneficial against certain RNA viruses such as SARS-CoV, MERS-CoV, influenza," exact="Ebola" post="and counter inflammatory medications, as well as product reuse"/>
   <result pre="Med.36(5), 450â€&quot;456 (2016).27374710 35.ShiratoK , YanoT , SenbaSet al.Detection of" exact="Middle East respiratory syndrome" post="coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol."/>
   <result pre="2020 (2020). www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected 70.NicholasJ , BeechingTEF , FowlerRobertBMJ Best Practice:" exact="coronavirus disease 2019" post="(COVID-19) (2020). https://bestpractice.bmj.com/topics/en-gb/3000168 71.FavalliEG , IngegnoliF , DeLucia O"/>
   <result pre=", DongXet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet395(10223), 507â€&quot;513 (2020).32007143"/>
   <result pre="(COVID-19). ww.hse.ie/eng/about/who/acute-hospitals-division/drugs-management-programme/guidelines/specific-antiviral-therapy-in-the-clinical-management-of-acute-respiratory-infection-with-sars-cov-2-covid-19.pdf 78.DongL , HuS , GaoJDiscovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19). Search Results Featured snippet from the web Drug"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitro. Cell. Dis.6(1), 1â€&quot;4 (2020). 101.YaoX , YeF"/>
   <result pre="of Protease Inhibitors, Oseltamivir, Favipiravir, and Chloroquin for Treatment of" exact="COVID19" post=": A Randomized Control Trial (THDMS-COVID19). (2020). https://clinicaltrials.gov/ct2/show/NCT04303299 106.GordonDE"/>
   <result pre="132.RichardsonP , GriffinI , TuckerCet al.Baricitinib as potential treatment for" exact="2019-nCoV acute respiratory disease." post="Lancet395(10223), e30â€&quot;e31 (2020).32032529 133.TanD-X , KorkmazA , ReiterRJ ,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7223264\results\search\zoonosis\results.xml">
   <result pre="antirheumatic agents interferon type I Dear editor, The rapidly expanding" exact="coronavirus disease 2019" post="(COVID-19) is a global health challenge and a source"/>
   <result pre="inadequate inflammatory response with immunosuppressants to prevent ARDS in COVID-19." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) uses the ACE 2 as a"/>
   <result pre="clinical trials have shown an antiviral effect of antimalarials in" exact="COVID19" post="contributing to the growing interest of the health authorities,"/>
   <result pre="09 Apr 2020]. 2GuanW-jie, NiZ-yi, HuY, et al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med202010.1056/NEJMoa2002032 3RuscittiP, CiprianiP, Di"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7224629\results\search\zoonosis\results.xml">
   <result pre="the new creations are licensed under the identical terms. The" exact="coronavirus disease 2019" post="(COVID-19) pandemic is not the first, and certainly not"/>
   <result pre="already made us confront severe acute respiratory syndrome coronavirus (SARS-CoV)," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), avian flu, HINI flu pandemic and SARS-CoV-2"/>
   <result pre="respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV)," exact="avian flu," post="HINI flu pandemic and SARS-CoV-2 - all of which"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7227507\results\search\zoonosis\results.xml">
   <result pre="experiment concept to accelerate the Re-purposing of existing therapeutics for" exact="Covid-19" post="DaughtonChristian G.daughton.etox@gmail.comâ�Ž[], â�ŽCorresponding author. daughton.etox@gmail.com pmc-release: 2020-5-5ppub: 2020-11epub: 2020-5-52100026100026received:"/>
   <result pre="can be re-purposed (re-positioned) for the prevention or treatment of" exact="Covid-19" post="- or for any future epidemic. The usefulness of"/>
   <result pre="treatment. The objective would be to also collect for each" exact="Covid-19" post="case the patient's prior usage of existing therapeutic drugs."/>
   <result pre="major test groups - those who test positive for active" exact="SARS-CoV-2 infection" post="(using molecular methods) and those who test negative for"/>
   <result pre="for further discussion and evaluation. 1 Introduction Drug treatments for" exact="Covid-19" post="are urgently needed. Discovery and development of new molecular"/>
   <result pre="- in this case, those that could adversely interact with" exact="Covid-19" post="or with co-administered drugs. Computational approaches are also unable"/>
   <result pre="initial selection of potential candidates (including combinations) for repurposing with" exact="Covid-19" post="(and also avoiding contraindications) could greatly streamline the conventional"/>
   <result pre="to be effective treatments actually have any potential. During the" exact="Covid-19" post="epidemic, one of the best examples was hydroxychloroquine and"/>
   <result pre="in the ongoing clinical treatment and epidemiological examination of the" exact="Covid-19" post="epidemic. This approach would also be applicable to any"/>
   <result pre="this proposed approach, termed â€œNatural Experiment for Repurposing Drugs for" exact="Covid-19" post="Therapyâ€� - or â€œNERDâ€� as shorthand. NERD would essentially"/>
   <result pre="the prior and current drug usage among several combinations of" exact="Covid-19" post="case groups, primarily: (1) those known to have been"/>
   <result pre="might be contraindicated or actually potentiate the progression of adverse" exact="Covid-19" post="outcomes. Many different scenarios can be hypothesized for how"/>
   <result pre="be hypothesized for how drug usage might be associated with" exact="Covid-19" post="clinical outcomes. Consider the two bookend case outcomes for"/>
   <result pre="have adverse effects. To explain the lower incidence of serious" exact="Covid-19" post="outcomes compared with favorable outcomes, perhaps it is the"/>
   <result pre="no apparent underlying risk factors. It is likely that widespread" exact="Covid-19" post="testing among the general asymptomatic population will reveal that"/>
   <result pre="3 Outline of the approach for the NERD concept (1)As" exact="Covid-19" post="epidemiological surveillance screening and diagnostic testing proceeds, a national"/>
   <result pre="based upon whether they tested positive or negative for active" exact="SARS-CoV-2 infection" post="or tested positive for past SARS-CoV-2 infection (see Table"/>
   <result pre="negative for active SARS-CoV-2 infection or tested positive for past" exact="SARS-CoV-2 infection" post="(see Table 1 ). Patients would provide a list"/>
   <result pre="avoiding cognitive bias is shown by the evolving knowledge of" exact="SARS-CoV-2 infection," post="where a major route of infection is believed to"/>
   <result pre="critical, and death. Note that the population-wide incidence of â€œasymptomaticâ€�" exact="Covid-19" post="cases (where no symptoms are noted over the entire"/>
   <result pre="in real time. (5)Interpretation of NERD data and defining the" exact="Covid-19" post="test groups of most use to NERD. There are"/>
   <result pre="2020 was the first Emergency Use Authorization (EUA) for a" exact="Covid-19" post="serological test (for use in clinical laboratories) issued by"/>
   <result pre="There are many unknowns and problems surrounding serologic tests for" exact="Covid-19" post="[10,20]. A positive test using RT-PCR or antigen testing"/>
   <result pre="interpreting negative-test data. Drugs with PROTECTIVE or THERAPEUTIC POTENTIAL for" exact="Covid-19" post="(with minimal adverse effects) would have a DxUR distribution"/>
   <result pre="potential contraindications and warn of those drugs to AVOID for" exact="Covid-19" post="treatment, (ii) potential for increasing the risk of developing"/>
   <result pre="widespread epidemiologic surveillance screening of the general population for asymptomatic" exact="Covid-19" post="has been done in very few countries - Iceland"/>
   <result pre="and modulation of disease outcomes. But this important aspect of" exact="Covid-19" post="is ignored in the concept of NERD developed here"/>
   <result pre="potential contraindications and warn of those drugs to AVOID during" exact="Covid-19" post="treatment.    Additional potential advantages of NERD include â€¢"/>
   <result pre="include the use of IL-6 inhibitors and steroids for end-stage" exact="Covid-19" post="(e.g., see: [13]). Furthermore, by revealing combinations of drugs"/>
   <result pre="needed drug usage information from each patient during or after" exact="Covid-19" post="testing. Collecting drug usage information has long been the"/>
   <result pre="efficacy is determined by the timing of administration. Examples for" exact="Covid-19" post="are drugs used for reducing lung inflammation and damage,"/>
   <result pre="that additional opportunities with the natural experiment presented by the" exact="Covid-19" post="epidemic (as well as any future epidemic) include epidemiologic"/>
   <result pre="non-drug exposures increase the susceptibility or vulnerability to more serious" exact="Covid-19" post="outcomes. This might be especially germane to explaining cases"/>
   <result pre="This might be especially germane to explaining cases of serious" exact="Covid-19" post="disease among healthy younger adults and reported gender and"/>
   <result pre="to be predominantly associated with asymptomatic or mild cases of" exact="Covid-19" post="could be targeted for WBE monitoring in communities suspected"/>
   <result pre="to be predominantly associated with severe or critical cases of" exact="Covid-19" post="could be targeted for WBE monitoring in communities suspected"/>
   <result pre="5DaughtonC.The international imperative to rapidly and inexpensively monitor community- wide" exact="Covid-19" post="infection status and trendsSci. Total Environ.138149202010.1016/j.scitotenv.2020.138149 6BakerN.C.EkinsS.WilliamsA.J.TropshaA.A bibliometric review"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7228272\results\search\zoonosis\results.xml">
   <result pre="Wuhan, Hubei Province, China. This infectious disease was designated as" exact="coronavirus disease 2019" post="(COVIDâ€�19). It rapidly spreads throughout the world. More than"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7228359\results\search\zoonosis\results.xml">
   <result pre="already resulted in more fatalities compared with the SARS and" exact="MERS coronavirus" post="epidemics combined. Therapeutics that may assist to contain its"/>
   <result pre="epidemics, as virus mutations could make them futile. Indeed, new" exact="Influenza" post="virus strains emerge every year, requiring new immunizations. A"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7228735\results\search\zoonosis\results.xml">
   <result pre="related viruses that cause severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome," post="it has higher infectivity and rates of transmission.1 SARS-CoV-2"/>
   <result pre="and subsequent care puts health-care workers at increased risk of" exact="SARS-CoV-2 infection." post="Patients and surrogates need information and discussion in the"/>
   <result pre="sputum.19 A timeline of the typical clinical course of severe" exact="SARS-CoV-2 infection" post="is shown in figure 1 , based on authors'"/>
   <result pre="viral PCR, and antiviral antibody detection and infectivity of severe" exact="SARS-CoV-2 infection" post="The transparent red box shows the suggested window for"/>
   <result pre="who do not have COVID-19 are at unknown risk of" exact="SARS-CoV-2 infection" post="from visitors and staff. Safe locations need to be"/>
   <result pre="March 23.10.1056/NEJMp2005689 12WangJZhouMLiuFReasons for healthcare workers becoming infected with novel" exact="coronavirus disease 2019" post="(COVID-19) in ChinaJ Hosp Infect2020published online March 6.10.1016/j.jhin.2020.03.002 13GuanWJNiZYHuYClinical"/>
   <result pre="in ChinaJ Hosp Infect2020published online March 6.10.1016/j.jhin.2020.03.002 13GuanWJNiZYHuYClinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med38220201708172032109013 14WangDHuBHuCClinical characteristics of 138"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7229764\results\search\zoonosis\results.xml">
   <result pre="shortage of detection resource. Keywords Coronavirus Pandemic outbreak Limited resources" exact="Influenza" post="season Influenza vaccination 1 Introduction An emerging coronavirus, currently"/>
   <result pre="detection resource. Keywords Coronavirus Pandemic outbreak Limited resources Influenza season" exact="Influenza" post="vaccination 1 Introduction An emerging coronavirus, currently known as"/>
   <result pre="workers and, subsequently, among people under investigation for their disease." exact="Influenza" post="generates a relevant burden worldwide, both in terms of"/>
   <result pre="influenza, potentially threatening their own health and compromising patientsâ€™ safety." exact="Influenza" post="vaccine uptake is suboptimal also among other targeted categories,"/>
   <result pre="and alleged side-effects are among the drivers of vaccine hesitancy." exact="Influenza" post="vaccination would enable to better control and contain the"/>
   <result pre="planning: a modelling impact assessmentLancet3951023320201382139332277878 3LinQ.Y.ZhaoS.GaoD.Z.WangW.M.YangL.HeD.H.A conceptual model for the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in Wuhan, China with individual reaction and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7229974\results\search\zoonosis\results.xml">
   <result pre="currently the country with the highest number of cases of" exact="SARS-CoV-2 infection" post="after USA and this has generated an unprecedented health"/>
   <result pre="2012 Middle East Respiratory Syndrome (MERS)-CoV epidemic, and the 2014" exact="Ebola" post="epidemic [5]. Pertaining to the respiratory CoV infections, a"/>
   <result pre="All the patients (including a pregnant woman) recovered from the" exact="SARS-CoV-2 infection." post="Finally, Zeng and colleagues tested the role of convalescent"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7230338\results\search\zoonosis\results.xml">
   <result pre="current work, we discovered and analyzed the epidemiological paradox between" exact="coronavirus disease 2019" post="(COVID-19) and malaria in the initial phase of the"/>
   <result pre="ACE-2 receptor epidemiological paradox 1. Introduction The recent spread of" exact="coronavirus disease 2019" post="(COVID-19) constitutes an important and unsolved public health problem"/>
   <result pre="COVID-19. Therefore, the involuntary achievement of an indirect protection from" exact="SARS-CoV-2 infection" post="(similar to &quot;herd immunity&quot;) for individuals who are not"/>
   <result pre="of COVID-19: A modelling studyLancet202039587187710.1016/S0140-6736(20)30411-632087820 3.AltamimiA.AhmedA.E.Climate factors and incidence of" exact="Middle East respiratory syndrome" post="coronavirusJ. Infect. Public Health201910.1016/j.jiph.2019.11.01131813836 4.GuarnerJ.Three emerging Coronaviruses in two"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov.2020610.1038/s41421-020-0156-032194981 Figure 1 Distribution maps of betacoronaviruses"/>
   <result pre="data source) [9].In panel D is shown the distribution of" exact="coronavirus disease 2019" post="(COVID-19) cases as of 25 March 2020 (WHO data"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7231470\results\search\zoonosis\results.xml">
   <result pre="of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for" exact="Influenza" post="Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for"/>
   <result pre="original work is properly cited. Abstract The ongoing pandemic of" exact="coronavirus disease 2019" post="(COVID-19), caused by infection with human coronavirus 2019 (HCoV-19"/>
   <result pre="Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), or" exact="Coronavirus disease 2019" post="(COVID-19), the diseases caused by infection with SARS-CoV, MERS-CoV"/>
   <result pre="Memish ZAEpidemiological, demographic, and clinical characteristics of 47 cases of" exact="Middle East respiratory syndrome" post="coronavirus disease from Saudi Arabia: a descriptive studyThe Lancet"/>
   <result pre="DKW, Perera RAPM, Peiris MDromedary camels and the transmission of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV)Transboundary and Emerging Diseases201764234435310.1111/tbed.1240126256102 12Hijawi B, Abdallat M,"/>
   <result pre="MC, Drosten C, Drexler JF, Preiser WClose relative of human" exact="Middle East respiratory syndrome" post="coronavirus in bat, South AfricaEmerging Infectious Diseases201319101697169910.3201/eid1910.13094624050621 17Jiang SB,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7232076\results\search\zoonosis\results.xml">
   <result pre="of which cause mild infections. However, the epidemics caused by" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV)"/>
   <result pre="These suppress inflammation and this phenomenon is not seen with" exact="SARS-CoV infection" post="[11]. The role of the arachidonic acid related prostaglandin"/>
   <result pre="T-cell defects that could account for the increased susceptibility of" exact="SARS-CoV infection" post="in the elderly [12]. The mechanism involves respiratory dendritic"/>
   <result pre="no proven agent that can eliminate life-threatening pulmonary complications of" exact="SARS-CoV-2 infection" post="completely. Several research groups have searched for therapies for"/>
   <result pre="and therapeutic optionsNat Rev Drug Discov15201632734726868298 4DongLiyingShashaHuGaoJianjunDiscovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov Ther1412020586010.5582/ddt.2020.0101232147628 5XuJ.ShiP.Y.LiH.ZhouJ.Broad spectrum antiviral agent niclosamide and"/>
   <result pre="potentialACS Infect Dis202010.1021/acsinfecdis.0c00052 6GuoYan-RongCaoQing-DongHongZhong-SiThe origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak â€&quot; an update on the statusMilitary Med"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7232149\results\search\zoonosis\results.xml">
   <result pre="italic;} VirusesVirusesvirusesViruses1999-4915MDPI doi: 10.3390/v12040470viruses-12-00470 : Article Experimental Infection Using Mouse-Adapted" exact="Influenza" post="B Virus in a Mouse Model ProkopyevaElena12*KurskayaOlga1https://orcid.org/0000-0002-4561-6517SobolevIvan1SolomatinaMariia1MurashkinaTatyana1SuvorovaAnastasia1https://orcid.org/0000-0003-0015-9305AlekseevAlexander1https://orcid.org/0000-0001-6174-0836DanilenkoDaria3https://orcid.org/0000-0003-1733-1255KomissarovAndrey3https://orcid.org/0000-0003-3558-3261FadeevArtem3RamsayEdward3ShestopalovAlexander1DygaiAlexander4SharshovKirill1[1], kurskaya_og@mail.rusobolev_i@hotmail.comMariaza@ngs.rumurashkinatatiana89@gmail.comasuvorova153@gmail.comal-alexok@ngs.rushestopalov2@ngs.rusharshov@yandex.ru[2], [3],"/>
   <result pre="pathogenicity influenza model virulence antiviral drugs influenza vaccine 1. Introduction" exact="Influenza" post="B viruses (IBVs) belong to the family Orthomyxoviridae [1]."/>
   <result pre="mouse-adapted B virus. 3.4. Assessment of Vaccine Efficiency Against Mouse-Adapted" exact="Influenza" post="B Virus In Vivo We assessed vaccine efficiency against"/>
   <result pre="6 after challenge in vaccinated mice (Figure 3D). 4. Discussion" exact="Influenza" post="B viruses have real epidemiological significance, especially among children."/>
   <result pre="not provide an opportunity to study the pathological process of" exact="influenza infection" post="and makes it difficult to perform studies of anti-influenza"/>
   <result pre="not provide an opportunity to study the pathological process of" exact="influenza infection." post="Moreover, many of the presented recombinant strains have lost"/>
   <result pre="are long-acting neuraminidase inhibitors for the treatment and prophylaxis of" exact="human influenza" post="virus infection [39,40]. Between the NA inhibitors of oseltamivir"/>
   <result pre="mouse adaptation and virulenceVirology200533631832610.1016/j.virol.2005.03.02815892972 6.SheuT.G.DeydeV.M.Okomo-AdhiamboM.GartenR.J.XuX.BrightR.A.ButlerE.N.WallisT.R.KlimovA.I.GubarevaL.V.Surveillance for neuraminidase inhibitor resistance among" exact="human influenza" post="A and B viruses circulating worldwide from 2004 to"/>
   <result pre="2004 to 2008Antimicrob. Agents Chemother.2008523284329210.1128/AAC.00555-0818625765 7.XuX.LindstromS.E.ShawM.W.SmithC.B.HallH.E.MungallB.A.SubbaraoK.CoxN.J.KlimovA.Reassortment and evolution of current" exact="human influenza" post="A and B virusesVirus Res.2004103556010.1016/j.virusres.2004.02.01315163489 8.SheuT.G.DeydeV.M.GartenR.J.KlimovA.I.GubarevaL.V.Detection of antiviral resistance"/>
   <result pre="Wkly. Rep.2011601233123821918492 11.TranD.VaudryW.MooreD.BettingerJ.A.HalperinS.A.ScheifeleD.W.JadvjiT.LeeL.MersereauT.Hospitalization for influenza A versus BPediatrics2016138e2015464310.1542/peds.2015-464327535144 12.AdlhochC.SnackenR.MelidouA.IonescuS.PenttinenP.The European" exact="Influenza" post="Surveillance Network. Dominant influenza A(H3N2) and B/Yamagata virus circulation"/>
   <result pre="online: https://www.cdc.gov/flu/professionals/vaccination/vax-summary.htm(accessed on 26 March 2020) 16.collab: WHORecommended Composition of" exact="Influenza" post="Virus Vaccines for Use in the 2017â€&quot;2018 Northern Hemisphere"/>
   <result pre="Influenza Virus Vaccines for Use in the 2017â€&quot;2018 Northern Hemisphere" exact="Influenza" post="SeasonAvailable online: https://www.who.int/influenza/vaccines/virus/recommendations/201703_recommendation.pdf(accessed on 26 March 2020) 17.ShawM.W.XuX.LiY.NormandS.UekiR.T.KunimotoG.Y.HallH.KlimovA.CoxN.J.SubbaraoK.Reappearance and"/>
   <result pre="Health and Human ServicesCenters for Disease Control and Prevention. Seasonal" exact="Influenza" post="Vaccine Effectiveness, 2017â€&quot;2018Available online: https://www.cdc.gov/flu/vaccines-work/2017-2018.html(accessed on 26 March 2020)"/>
   <result pre="for the Laboratory Diagnosis and Virological Surveillance of InfluenzaWHO Global" exact="Influenza" post="Surveillance NetworkGeneva, Switzerland2011153 21.ProkopyevaE.A.Strain of Influenza Virus B/Novosibirsk/40/2017-MA for"/>
   <result pre="Surveillance of InfluenzaWHO Global Influenza Surveillance NetworkGeneva, Switzerland2011153 21.ProkopyevaE.A.Strain of" exact="Influenza" post="Virus B/Novosibirsk/40/2017-MA for Study of Therapeutic and Preventive Efficacy"/>
   <result pre="and in VivoAvailable online: https://yandex.ru/patents/doc/RU2703024C1_20191015(accessed on 21 April 2020) 22.ZhouB.LinX.WangW.HalpinR.A.BeraJ.StockwellT.B.BarrI.G.WentworthD.E.Universal" exact="Influenza" post="B Virus Genomic Amplification Facilitates Sequencing, Diagnostics, and Reverse"/>
   <result pre="27.AshmarinA.VorobyovStatisticheskie Metody v Mikrobiologicheskich IssledovanijachMedgizLeningrad, Russia1962180 28.collab: FlusurverReal-Time Surveillance of" exact="Influenza" post="MutationsAvailable online: https://flusurver.bii.a-star.edu.sg(accessed on 26 March 2020) 29.GavrilovA.A.Strain of"/>
   <result pre="MutationsAvailable online: https://flusurver.bii.a-star.edu.sg(accessed on 26 March 2020) 29.GavrilovA.A.Strain of Virus" exact="Influenza" post="B (Leningrad) 14/76/50 Designed for Preparing Harmless and Highly"/>
   <result pre="B (Leningrad) 14/76/50 Designed for Preparing Harmless and Highly Productive" exact="Influenza" post="Virus B for Inactivated and Live Influenza Vaccine ProductionAvailable"/>
   <result pre="and Highly Productive Influenza Virus B for Inactivated and Live" exact="Influenza" post="Vaccine ProductionAvailable online: https://yandex.ru/patents/doc/RU2105063C1_19980220(accessed on 21 April 2020) 30.DeshevaJ.A.Strain"/>
   <result pre="Vaccine ProductionAvailable online: https://yandex.ru/patents/doc/RU2105063C1_19980220(accessed on 21 April 2020) 30.DeshevaJ.A.Strain of" exact="Influenza" post="Virus B/60/Johannesburg/99/50 for Production of Live (anti)-influenza Intranasal Vaccine"/>
   <result pre="https://yandex.ru/patents/doc/RU2215786C1_20031110(accessed on 21 April 2020) 31.RudenkoL.G.Influenza Virus Strain for Living" exact="Influenza" post="Intranasal Vaccine for Infants and AdultsAvailable online: https://yandex.ru/patents/doc/RU2307161C2_20070927(accessed on"/>
   <result pre="21 April 2020) 32.KiselevaI.V.Influenza Virus Strain V/60/Phuket/2013/26 for Preparing Live" exact="Influenza" post="Intranasal Vaccine for Adults and ChildrenAvailable online: https://yandex.ru/patents/doc/RU2605926C1_20161227(accessed on"/>
   <result pre="ChildrenAvailable online: https://yandex.ru/patents/doc/RU2605926C1_20161227(accessed on 21 April 2020) 33.GendonY.Z.Cold-adapted Strain of" exact="Influenza" post="Virus B B/Victoria/2/63/87, Intended for the Quality of the"/>
   <result pre="Strain, Attenuation to Obtain Reassortants of Cold-adapted Strains for Live" exact="Influenza" post="VaccineAvailable online: https://yandex.ru/patents/doc/RU2529772C1_20140927(accessed on 21 April 2020) 34.AleksandrovaG.I.Attenuated Cold-adapted"/>
   <result pre="Influenza VaccineAvailable online: https://yandex.ru/patents/doc/RU2529772C1_20140927(accessed on 21 April 2020) 34.AleksandrovaG.I.Attenuated Cold-adapted" exact="Influenza" post="Virus Strain Used for Preparing Live Intranasal Influenza VaccineRU"/>
   <result pre="34.AleksandrovaG.I.Attenuated Cold-adapted Influenza Virus Strain Used for Preparing Live Intranasal" exact="Influenza" post="VaccineRU 2076817 C1Available online: https://yandex.ru/patents/doc/RU2529772C1_20140927(accessed on 21 April 2020)"/>
   <result pre="online: https://yandex.ru/patents/doc/RU2529772C1_20140927(accessed on 21 April 2020) 35.AleksandrovaG.I.Attenuated Cold-adapted Strain of" exact="Influenza" post="Virus B/Leningrad/14/17/55 for Living Influenza Vaccine Strain PreparingAvailable online:"/>
   <result pre="2020) 35.AleksandrovaG.I.Attenuated Cold-adapted Strain of Influenza Virus B/Leningrad/14/17/55 for Living" exact="Influenza" post="Vaccine Strain PreparingAvailable online: https://yandex.ru/patents/doc/RU2068271C1_19961027(accessed on 21 April 2020)"/>
   <result pre="ProphylaxisAvailable online: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm(accessed on 26 March 2020) 37.NodaT.Native Morphology of" exact="Influenza" post="VirionsFront. Microbiol.2011226910.3389/fmicb.2011.0026922291683 38.MaenoK.Replication of influenza B viruses: Biological functions"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7233228\results\search\zoonosis\results.xml">
   <result pre="PCR in upper respiratory samples or antibody evidence of past" exact="SARS-CoV-2 infection." post="References References 1World Health Organization WHO Director-generalâ€™s remarks at"/>
   <result pre="2020Available at:https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---3-march-2020 6WuZunyouMcGooganJennifer M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China. Summary of a report of"/>
   <result pre="Med Assoc1192020670e67332139299 10QiuH.WuJ.HongL.LuoY.SongQ.ChenD.Clinical and epidemiological features of 36 children with" exact="coronavirus disease 2019" post="(COVID-19) in Zhejiang, China: an observational cohort studyLancet Infect"/>
   <result pre="610.1001/jama.2020.8259[Epub ahead of print] 22KamK.Q.YungC.F.CuiL.Tzer Pin LinR.MakT.M.MaiwaldM.A well infant with" exact="coronavirus disease 2019" post="with high viral load2020Clinical Infectious Diseases 23LudvigssonJ.F.Systemic review of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7233243\results\search\zoonosis\results.xml">
   <result pre="for serious diseases, such as HIV-1, Hepatitis B and C," exact="Ebola" post="viruses, to cite a few. In this chapter, we"/>
   <result pre="including emerging and re-emerging arboviruses of global significance, such as" exact="Japanese encephalitis" post="(JEV), West Nile (WNV), Zika (ZIKV), dengue (DENV), yellow"/>
   <result pre="comprises five genera of viruses, including deadly pathogens such as" exact="Ebola" post="(EBOV) and Marburg (MARV) viruses, which cause fatal hemorrhagic"/>
   <result pre="Chem. Soc.1411320195182519110.1021/jacs.8b1026530860368 53WangS.R.ZhangQ.Y.WangJ.Q.GeX.Y.SongY.Y.WangY.F.LiX.D.FuB.S.XuG.H.ShuB.Chemical Targeting of a G-Quadruplex RNA in the" exact="Ebola" post="Virus L GeneCell Chem. Biol.23920161113112210.1016/j.chembiol.2016.07.01927617851 54KrafcikovaP.DemkovicovaE.ViglaskyV.Ebola Virus Derived G-Quadruplexes:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7235275\results\search\zoonosis\results.xml">
   <result pre="at the currently employed 800 mg dosage, does not prevent" exact="SARS-CoV-2 infection" post="HIV-infected individuals (16). It must be stressed that Janssen"/>
   <result pre="might be beneficial. Perhaps antiretrovirals might also help to prevent" exact="SARS-CoV-2 infection," post="as suggested for SARS-1 (19) and MERS (20). However,"/>
   <result pre="other ARVs improve clinical outcomes in severe COVID-19 or prevent" exact="SARS-CoV-2 infection" post="in patients at high risk of acquiring it (21)."/>
   <result pre="influenza (29). Hence, a serious illness might develop during a" exact="SARS-CoV-2 infection" post="not only in patients with TB but also in"/>
   <result pre="may avoid to seek hospital treatment for fear to get" exact="SARS-CoV-2 infection," post="as happened during the 2003 SARS epidemic (33). The"/>
   <result pre="lockdowns, enforced in an attempt to curb the spread of" exact="SARS-CoV-2 infection," post="lead to patients' job losses, difficulties in reaching the"/>
   <result pre="it will be extremely important to describe the features of" exact="SARS-CoV-2 infection" post="and the evolution of COVID-19 in HIV-infected patients, including"/>
   <result pre="2020). 11.ChenJChengXWangRZengX. Computed tomography imaging of an HIV-infected patient with" exact="coronavirus disease 2019" post="(COVID-19). J Med Virol. (2020) 14. 10.1002/jmv.2587932285949 12.WangMLuoLBuHXiaHOne case"/>
   <result pre="(COVID-19). J Med Virol. (2020) 14. 10.1002/jmv.2587932285949 12.WangMLuoLBuHXiaHOne case of" exact="Coronavirus disease 2019" post="(COVID-19) in a patient co-infected by HIV with a"/>
   <result pre="10.1016/S2352-3018(20)30111-9. [Epub ahead of print].32304642 16.RivaAContiFBernacchiaDPezzatiLSollimaSMerliSet al.Darunavir does not prevent" exact="SARS-CoV-2 infection" post="in HIV patients. Pharmacol Res. (2020) 157:10482610.1016/j.phrs.2020.10482632325127 17.ZhouYVedanthamPLuKAgudeloJCarrionRJrNunneleyJWet al.."/>
   <result pre="Defic Syndr. (2003) 34:242â€&quot;3. 10.1097/00126334-200310010-0001614526215 20.ParkSYLeeJSSonJSKoJHPeckKRJungYet al.. Post-exposure prophylaxis for" exact="Middle East respiratory syndrome" post="in healthcare workers. J Hosp Infect. (2019) 101:42â€&quot;46. 10.1016/j.jhin.2018.09.00530240813"/>
   <result pre="of respiratory viral infection in persons with human immunodeficiency virus." exact="Influenza" post="Other Respir Viruses. (2020). 10.1111/irv.12734. [Epub ahead of print].32153113"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7235487\results\search\zoonosis\results.xml">
   <result pre="adaptations are made.file:ADTP-9999-2000034.pdf Abstract Abstract In 2019/2020, the emergence of" exact="coronavirus disease 2019" post="(COVIDâ€�19) resulted in rapid increases in infection rates as"/>
   <result pre="syndrome (SARS),[2] H1N1,[3] H7N9,[4] Middle East Respiratory Syndrome (MERS),[5] and" exact="Ebola" post="Virus Disease (EVD),[6] among others. When addressing infectious diseases"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7235633\results\search\zoonosis\results.xml">
   <result pre="SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Abstract Therapeutic options for" exact="coronavirus disease 2019" post="are desperately needed to respond to the ongoing severe"/>
   <result pre="and immunomodulators might have their place in the management of" exact="coronavirus disease 2019." post="Unfortunately, no drugs have been approved yet to treat"/>
   <result pre="discuss the potential of these therapies for the treatment of" exact="coronavirus disease 2019." post="SARS-CoV-2 COVID-19 treatment antiviral drugs immunomodulators Introduction Approximately 15%"/>
   <result pre="SARS-CoV-2 COVID-19 treatment antiviral drugs immunomodulators Introduction Approximately 15% of" exact="coronavirus disease 2019" post="(COVID-19) patients will develop severe lung disease. It is"/>
   <result pre="that showed antiviral activity in animal models for SARS-CoV-1 and/or" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), two other coronaviruses causing severe disease, are"/>
   <result pre="experimental drug that was under development for the treatment of" exact="Ebola" post="virus-infected patients.14 Remdesivir is a nucleotide prodrug that inhibits"/>
   <result pre="and therefore halt viral RNA replication. Despite potent efficacy in" exact="Ebola" post="virus animal models, remdesivir was less efficacious in a"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell culture. Antimicrob Agents Chemother2014; 58:"/>
   <result pre="collab: the PALM Writing Group. A randomized, controlled trial of" exact="Ebola" post="virus disease therapeutics. N Engl J Med2019; 381: 2293â€&quot;2303.31774950"/>
   <result pre="Virol2004; 31: 69â€&quot;75.15288617 21ChanJFWChanKHKaoRYT, et al.Broad-spectrum antivirals for the emerging" exact="Middle East respiratory syndrome" post="coronavirus. J Infect2013; 67: 606â€&quot;616.24096239 22ChanJF-WYaoYYeungM-L, et al.Treatment with"/>
   <result pre="399â€&quot;406.14660806 24SpanakisNTsiodrasSHaagmansBL, et al.Virological and serological analysis of a recent" exact="Middle East respiratory syndrome" post="coronavirus infection case on a triple combination antiviral regimen."/>
   <result pre="25KimUJWonEJKeeSJ, et al.Combination therapy with lopinavir/ritonavir, ribavirin and interferon-a for" exact="Middle East respiratory syndrome." post="Antivir Ther2016; 21: 455â€&quot;459.26492219 26LimJJeonSShinHY, et al.Case of the"/>
   <result pre="al.Case of the index patient who caused tertiary transmission of" exact="coronavirus disease 2019" post="in Korea: the application of lopinavir/ritonavir for the treatment"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7236586\results\search\zoonosis\results.xml">
   <result pre="study was to review the current state of knowledge about" exact="SARS-CoV-2 infection" post="and COVID-19 disease in pregnant women. Because the epidemic"/>
   <result pre="[2]. At present, the entire world is struggling with the" exact="SARS-CoV-2 infection" post="pandemic. It has been observed that some types of"/>
   <result pre="health and life appear periodically and unpredictably and spread rapidly." exact="SARS-CoV-2 infection" post="and COVID-19 disease were first identified in Wuhan, Hubei"/>
   <result pre="study was to review the current state of knowledge about" exact="SARS-CoV-2 infection" post="and COVID-19 disease in pregnant women. Since the beginning"/>
   <result pre="response against viruses. Similar mechanisms of immune response occur during" exact="SARS-CoV-2 infection," post="causing pulmonary and systemic inflammatory responses [4]. The viral"/>
   <result pre="any viral symptoms associated with COVID-19 at the time when" exact="SARS-CoV-2 infection" post="was detected. Among them, 10 (71.4%) developed symptoms or"/>
   <result pre="during maternal virulence [19]. The suspicions that the course of" exact="SARS-CoV-2 infection" post="and COVID-19 disease may be more severe in pregnant"/>
   <result pre="Chinese][Epub ahead of print] 12LiuYChenHTangKet al.Clinical manifestations and outcome of" exact="SARS-CoV-2 infection" post="during pregnancyJ Infect2020[Epub ahead of print] 13WangXZhouZZhangJet al.A case"/>
   <result pre="Chinese]32051071 21ChenYLiZZhangYYet al.Maternal health care management during the outbreak of" exact="coronavirus disease 2019" post="(COVID-19)J Med Virol2020[Epub ahead of print] 22ChenDYangHCaoYet al.Expert consensus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7236639\results\search\zoonosis\results.xml">
   <result pre="Keywords Coronavirus COVID-19 Complex problems Collaboration Interdisciplinarity Public health Background" exact="Coronavirus disease 2019" post="(COVID-19), the outbreak due to severe acute respiratory syndrome"/>
   <result pre="interdisciplinary focus can help achieve such a goal [4, 5]." exact="Covid-19" post="Coronaviruses (CoVs) are human and vertebrate pathogens [6]. They"/>
   <result pre="of virus-like particle mimetic nanovesicles displaying the S protein of" exact="Middle East respiratory syndrome" post="coronavirus using insect cellsJ Biotechnol201930617718431614169 57.KimJWHaTKChoHKimEShimSHYangJLet al.Antiviral escin derivatives"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7236853\results\search\zoonosis\results.xml">
   <result pre="consistent with existing copyright protections.jhype-publish-ahead-of-print-10.1097.hjh.0000000000002515.pdf COVID-19, the disease associated with" exact="SARS-CoV-2 infection," post="is in some 20% of acutely affected patients associated"/>
   <result pre="consensus [4,6] recommends not changing RASi treatment in patients with" exact="SARS-CoV-2 infection." post="Whereas we found other heart failure medication to be"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7236857\results\search\zoonosis\results.xml">
   <result pre="and Europe PMC, consistent with existing copyright protections.adm-publish-ahead-of-print-10.1097.adm.0000000000000684.pdf Abstract The" exact="COVID19" post="crisis has created many additional challenges for patients with"/>
   <result pre="we providers all continue to learn to coexist with the" exact="COVID19" post="pandemic, we worry about what this means for our"/>
   <result pre="challenges in the coming months. Predictions of escalating deaths from" exact="COVID19" post="abound in every newspaper and medical journal and, in"/>
   <result pre="cannot isolate at all and will be cohorted with other" exact="COVID19" post="patients in shelters if they do become ill. Additionally,"/>
   <result pre="on 4 April 2020. 5.AkiyamaMJSpauldingACRichJDFlattening the Curve for Incarcerated Populations" exact="Covid-19" post="in Jails and Prisons. New England Journal of Medicine2020."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7236962\results\search\zoonosis\results.xml">
   <result pre="in countries endemic to flaviviruses, the first diagnostic impression is" exact="Dengue" post="and recently Zika. Despite having had an epidemic peak"/>
   <result pre="human use, such as is the case of yellow fever," exact="Japanese encephalitis," post="and dengue. But for VEEV only vaccines for animals"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7237358\results\search\zoonosis\results.xml">
   <result pre="scrambling to cope with the COVID-19 pandemic. COVID-19, short for" exact="Coronavirus disease 2019," post="is an infectious disease caused by the severe acute"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7237932\results\search\zoonosis\results.xml">
   <result pre="as a means of spread differs among the respiratory viruses." exact="Influenza" post="viruses are spread by contact as well as by"/>
   <result pre="example, avian influenza A viruses infect ciliated epithelial cells, whereas" exact="human influenza" post="viruses infect non-ciliated epithelial cells. The presence of specific"/>
   <result pre="well as for human coronavirus NL63. The receptor for the" exact="Middle East respiratory syndrome" post="(MERS) coronavirus is human dipeptidyl peptidase 4 (DPP4), and"/>
   <result pre="sialic acid as their receptor, but there is added subtlety;" exact="human influenza" post="viruses bind sialic acids with Î±2,6-linked oligosaccharides, whereas avian"/>
   <result pre="RSV and parainfluenza viruses, occurs in the nucleus and cytoplasm." exact="Influenza" post="viruses are replicated entirely within the nucleus, and they"/>
   <result pre="to the cytokine storm seen in severe influenza A/H5N1 and" exact="SARS-CoV-2 infection." post="Virus-encoded peptides stimulate activation, proliferation, and differentiation of naive"/>
   <result pre="whether this is true for SARS-CoV-2; notably, asymptomatic patients with" exact="coronavirus disease 2019" post="(COVID-19; 10%â€&quot;50% of infections) can excrete large quantities of"/>
   <result pre="and procalcitonin (Gandhi etÂ al., 2020). The pathogenesis of severe" exact="SARS-CoV-2 infection" post="is complex, and we are still learning about it"/>
   <result pre="feature of severe SARS-CoV-2 infections is the cytokine release syndrome." exact="SARS-CoV-2 infection" post="of respiratory epithelial cells activates monocytes, macrophages, and dendritic"/>
   <result pre="It is becoming clear that the pathogenetic cascade triggered by" exact="SARS-CoV-2 infection" post="damages many organs in the body, from the kidneys"/>
   <result pre="References BeigelJ.H.TomashekK.M.DoddL.E.MehtaA.K.ZingmanB.S.KalilA.C.HohmannE.ChuH.Y.LuetkemeyerA.KlineS.collab: ACTT-1 Study Group MembersRemdesivir for the Treatment of" exact="Covid-19" post="â€&quot; Preliminary ReportThe New England Journal of Medicine202010.1056/NEJMoa2007764 BlankC.U.HainingW.N.HeldW.HoganP.G.KalliesA.LugliE.LynnR.C.PhilipM.RaoA.RestifoN.P.Defining"/>
   <result pre="The Melbourne WHO Collaborating Centre for Reference and Research on" exact="Influenza" post="is supported by the 10.13039/501100003921Australian Government Department of Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7238163\results\search\zoonosis\results.xml">
   <result pre="well as, at least potentially, many other tropical viruses like" exact="Japanese encephalitis" post="and Rift Valley fever, with variable success depending on"/>
   <result pre="least potentially, many other tropical viruses like Japanese encephalitis and" exact="Rift Valley fever," post="with variable success depending on species and environments [13]."/>
   <result pre="environment. (4)Via zoonotic cycles. For example, many viruses (West Nile," exact="Japanese encephalitis," post="St Louis encephalitis virus, Murray valley, usutu) which are"/>
   <result pre="seldom actually arise. However, they happen regularly and the recent" exact="Covid-19" post="pandemic, which was not caused by an arbovirus, reminds"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7238722\results\search\zoonosis\results.xml">
   <result pre="the causative agents of severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS). The first human coronaviruses identified cause approximately one"/>
   <result pre="hosts and then cause novel severe disease. In 2012, the" exact="MERS coronavirus" post="was discovered in Saudi Arabia, isolated from the sputum"/>
   <result pre="and combination lopinavir,ritonavir, and interferon beta against MERS-CoVNat Comm202010.1038/s41467-019-13940-6/www.nature.com/nature 4.WHO." exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). 2018. https://www.who.intemergencies/mers-cov/en/. Accessed 21 Feb 2020. 5.ChoJKangJHaYet"/>
   <result pre="for the 2019-new coronavirus (2019-nCoV)Biosci Trends202010.5582/bst.2020.0102032389941 26.SandersJMonogueMJodlowskiTet al.Pharmacologic treatments for" exact="Coronavirus disease 2019" post="(COVID-19) A reviewJAMA202010.1001/jama2020.601932282022"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7239338\results\search\zoonosis\results.xml">
   <result pre="in the evaluation of favipiravir, an antiâ€�influenza polymerase inhibitor, against" exact="Ebola" post="virus. In this review, we discuss how mathematical modeling"/>
   <result pre="in NHPs were finally used to develop a model of" exact="Ebola" post="pathogenesis integrating the interactions among the virus, the innate"/>
   <result pre="of relevance for future human studies in the context of" exact="Ebola" post="virus, but also for other emerging viral diseases for"/>
   <result pre="years by the large outbreaks of Zika, Chikungunya, Lassa, or" exact="Ebola" post="viruses. Besides these iconic examples, about 200 human pathogenic"/>
   <result pre="in development recently showed encouraging results in animal models against" exact="Ebola" post="virus (EBOV)4, 5 or Zika virus,6 there are no"/>
   <result pre="against a variety of other RNA viruses, in particular Ebola," exact="Lassa fever," post="Marburg, Nipah, and Zika viruses.7, 8, 9 The main"/>
   <result pre="modeling have been instrumental to better understand the immuneâ€�pathogenesis of" exact="Ebola" post="virus disease (EVD) and to optimize the use of"/>
   <result pre="viral clearance. FAVIPIRAVIR IN HUMANS INFECTED WITH EVD The 2013â€&quot;2016" exact="Ebola" post="epidemic has been the largest outbreak of the virus"/>
   <result pre="with the efforts of a global response against the spreading" exact="Ebola" post="epidemic, a European consortium, Reaction! (horizon 2020 grant 666092),"/>
   <result pre="infected intramuscularly with 10 to 1,000 focus forming units with" exact="Ebola" post="virus Gabon 2001 strain, belonging to Zaire ebolavirus species."/>
   <result pre="various emerging viruses. CCHFV, Crimea Congo haemorrhagic fever virus; EBOV," exact="Ebola" post="virus; JUNV, Junin virus; LAV, Lassa fever virus; MARV,"/>
   <result pre="haemorrhagic fever virus; EBOV, Ebola virus; JUNV, Junin virus; LAV," exact="Lassa fever" post="virus; MARV, Marburg virus; RVFV, Rift valley fever virus;"/>
   <result pre="collected in NHPs to elaborate a simplified mathematical model of" exact="Ebola" post="viral dynamics where we assumed no target cell replenishment"/>
   <result pre="in 26 nonhuman primates infected with 1,000 focus forming units" exact="Ebola" post="virus and treated with ascending doses of favipiravir. Left:"/>
   <result pre="a compartment of refractory cells (R). (c) Integrated model of" exact="Ebola" post="virus (EBOV) infection. In addition to compartments presented in"/>
   <result pre="in vitro or in vivo. Combining favipiravir and ribavirin in" exact="Lassa fever" post="Favipiravir was also reported to have antiviral effect on"/>
   <result pre="fever Favipiravir was also reported to have antiviral effect on" exact="Lassa fever" post="virus, providing 100% protection in the lethal NHP model"/>
   <result pre="which prompted its use to treat several patients with severe" exact="Lassa fever" post="virus infection.78 In order to better understand how ribavirin"/>
   <result pre="immunity. Using these models, we consistently estimated an R0 of" exact="Lassa fever" post="virus of about 5â€&quot;6, and an efficacy of favipiravir"/>
   <result pre="at all doses considered, consistent with our results obtained for" exact="Ebola" post="infection in mice.80 Our analyses did not find a"/>
   <result pre="outbreak, the time from symptom onset to admission in the" exact="Ebola" post="treatment centers was between 3 and 5Â days37, 86"/>
   <result pre="the promising effects on favipiravir in the NHP model of" exact="Marburg disease" post="encouraged the implementation of a clinical trial targeting exposed"/>
   <result pre="4Warren, T.K.et alTherapeutic efficacy of the small molecule GSâ€�5734 against" exact="Ebola" post="virus in rhesus monkeys. Nature531, 381â€&quot;385 (2016).26934220 5Warren, T.et"/>
   <result pre="monkeys. Nature531, 381â€&quot;385 (2016).26934220 5Warren, T.et alEfficacy of galidesivir against" exact="Ebola" post="virus disease in rhesus monkeys. Open Forum Infect. Dis.4,"/>
   <result pre="combination with ribavirin in a lethal, immunocompetent mouse model for" exact="Lassa fever." post="J. Infect. Dis.213, 934â€&quot;938 (2016).26531247 10Pushpakom, S.et alDrug repurposing:"/>
   <result pre="(2019).30777297 17Schieffelin, J.S.et alClinical illness and outcomes in patients with" exact="Ebola" post="in Sierra Leone. N. Engl. J. Med.371, 2092â€&quot;2100 (2014).25353969"/>
   <result pre="D.S., Johnson, K.M., Feldmann, H. &amp;amp; Morens, D.M.The pathogenesis of" exact="Ebola" post="virus disease. Annu. Rev. Pathol.12, 387â€&quot;418 (2017).27959626 20Towner, J.S.et"/>
   <result pre="Groseth, A., Callison, J., Takada, A. &amp;amp; Feldmann, H.A novel" exact="Ebola" post="virus expressing luciferase allows for rapid and quantitative testing"/>
   <result pre="of antivirals. Antiviral Res.99, 207â€&quot;213 (2013).23751367 22Caballero, I.S.et alIn vivo" exact="Ebola" post="virus infection leads to a strong innate response in"/>
   <result pre="cells. BMC Genom.17, 707 (2016). 23Baize, S.et alInflammatory responses in" exact="Ebola" post="virusâ€�infected patients. Clin. Exp. Immunol.128, 163â€&quot;168 (2002).11982604 24Wauquier, N.,"/>
   <result pre="P., Padilla, C., Baize, S. &amp;amp; Leroy, E.M.Human fatal Zaire" exact="Ebola" post="virus infection is associated with an aberrant innate immunity"/>
   <result pre="Dis.4, e837 (2010).20957152 25Ruibal, P.et alUnique human immune signature of" exact="Ebola" post="virus disease in Guinea. Nature533, 100â€&quot;104 (2016).27147028 26Vernet, M.â€�A.et"/>
   <result pre="M.â€�A.et alClinical, virological, and biological parameters associated with outcomes of" exact="Ebola" post="virus infection in Macenta, Guinea. JCI Insight2, e88864 (2017).28352651"/>
   <result pre="Insight2, e88864 (2017).28352651 27Reynard, S.et alImmune parameters and outcomes during" exact="Ebola" post="virus disease. JCI Insight4, pii: 125106 (2019). 28McElroy, A.K.et"/>
   <result pre="virus disease. JCI Insight4, pii: 125106 (2019). 28McElroy, A.K.et alHuman" exact="Ebola" post="virus infection results in substantial immune activation. Proc. Natl."/>
   <result pre="for testing or use in patients infected with Ebola. In:" exact="Ebola" post="treatments and interventions. &amp;lt;http://www.who.int/medicines/ebola-treatment/2015_0703TablesofEbolaDrugs.pdf?ua=1&amp;gt; (2015). Accessed September 7, 2015."/>
   <result pre="Results (English version). &amp;lt;https://www.pmda.go.jp/files/000210319.pdf&amp;gt;. 33Oestereich, L.et alSuccessful treatment of advanced" exact="Ebola" post="virus infection with Tâ€�705 (favipiravir) in a small animal"/>
   <result pre="34Smither, S.J.et alPostâ€�exposure efficacy of oral Tâ€�705 (Favipiravir) against inhalational" exact="Ebola" post="virus infection in a mouse model. Antiviral Res.104, 153â€&quot;155"/>
   <result pre="Res.104, 153â€&quot;155 (2014).24462697 35MentrÃ©, F.et alDose regimen of favipiravir for" exact="Ebola" post="virus disease. Lancet Infect Dis.15, 150â€&quot;151 (2015).25435054 36Bouazza, N.et"/>
   <result pre="Lancet385, 603â€&quot;604 (2015). 37Sissoko, D.et alExperimental treatment with favipiravir for" exact="Ebola" post="virus disease (the JIKI Trial): a historically controlled, singleâ€�arm"/>
   <result pre="findings, compassionate use of favipiravir, and outcome in patients with" exact="Ebola" post="virus disease, Guinea, 2015â€�a retrospective observational study. J. Infect."/>
   <result pre="R.W., Mire, C.E., Feldmann, H. &amp;amp; Geisbert, T.W.Postâ€�exposure treatments for" exact="Ebola" post="and Marburg virus infections. Nat. Rev. Drug Discov.17, 413â€&quot;434"/>
   <result pre="(2017).28231247 42Piorkowski, G.et alImplementation of a nonâ€�human primate model of" exact="Ebola" post="disease: Infection of Mauritian cynomolgus macaques and analysis of"/>
   <result pre="of viremia to evaluate the baseline case fatality ratio of" exact="Ebola" post="virus disease and inform treatment studies: a retrospective cohort"/>
   <result pre="Sci.93, 449â€&quot;463 (2017). 47Guedj, J.et alAntiviral efficacy of favipiravir against" exact="Ebola" post="virus: a translational study in cynomolgus macaques. PLoS Med.15,"/>
   <result pre="(2012).22311616 62Hayden, F.G.et alLocal and systemic cytokine responses during experimental" exact="human influenza" post="A virus infection. Relation to symptom formation and host"/>
   <result pre="V.N.et alFavipiravir and ribavirin treatment of epidemiologically linked cases of" exact="Lassa fever." post="Clin. Infect. Dis.65, 855â€&quot;859 (2017).29017278 79Ribeiro, R.M., Laydenâ€�Almer, J.,"/>
   <result pre="S.L.et alEfficacy of favipiravir (Tâ€�705) in nonhuman primates infected with" exact="Ebola" post="virus or Marburg virus. Antiviral Res.151, 97â€&quot;104 (2018).29289666 86Prevail,"/>
   <result pre="Study Team . A randomized, controlled trial of ZMapp for" exact="Ebola" post="virus infection. N. Engl. J. Med.375, 1448 (2016).27732819 87Investigational"/>
   <result pre="1448 (2016).27732819 87Investigational Therapeutics for the Treatment of People with" exact="Ebola" post="Virus Disease â€&quot; Full Text View â€&quot; ClinicalTrials.gov. &amp;lt;https://clinicaltrials.gov/ct2/show/NCT03719586&amp;gt;."/>
   <result pre="â€&quot; ClinicalTrials.gov. &amp;lt;https://clinicaltrials.gov/ct2/show/NCT03719586&amp;gt;. 88Mulangu, S.et alA randomized, controlled trial of" exact="Ebola" post="virus disease therapeutics. N. Engl. J. Med.381, 2293â€&quot;2303 (2019).31774950"/>
   <result pre="90Henaoâ€�Restrepo, A.M.et alEfficacy and effectiveness of an rVSVâ€�vectored vaccine expressing" exact="Ebola" post="surface glycoprotein: interim results from the Guinea ring vaccination"/>
   <result pre="A.et alVSVâ€�EBOV rapidly protects macaques against infection with the 2014/15" exact="Ebola" post="virus outbreak strain. Science349, 739â€&quot;742 (2015).26249231 92Fischer, W.A.et alEbola"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7239775\results\search\zoonosis\results.xml">
   <result pre="Abstract Passive immunotherapy with plasma derived from patients convalescent from" exact="SARS-CoV-2 infection" post="can be a promising approach in the treatment of"/>
   <result pre="immunotherapy with plasma derived from patients that have recovered from" exact="SARS-CoV-2 infection" post="can be a promising approach in the treatment of"/>
   <result pre="recommend collection of any data from donors, possibly related to" exact="SARS-CoV-2 infection," post="that could be useful for subsequent epidemiological analysis (e.g."/>
   <result pre="and laboratory effects of convalescent plasma therapy for patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a study protocolSpringerplus4201570926618098 17ChengY.WongR.SooY.O.Use of convalescent plasma"/>
   <result pre="Convalescent Whole Blood or Plasma Collected from Patients Recovered from" exact="Ebola" post="Virus Disease for Transfusion, as an Empirical Treatment During"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7241406\results\search\zoonosis\results.xml">
   <result pre="[101], blocking viral replication. For this reason, combination treatment for" exact="Covid-19" post="with chloroquine and zinc has been suggested [102], although"/>
   <result pre="major acute SARS outbreak: an experience from Hong KongEye20200628328915877099 20LiJ.O.LamD.S.C.ChenY.TingD.S.W.Novel" exact="Coronavirus disease 2019" post="(COVID-19): the importance of recognising possible early ocular manifestation"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother5820144875488424841269 72WangM.CaoR.ZhangL.Remdesivir and"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discovery62020161932194981 93GautretP.LagierJ.C.ParolaP.Clinical and microbiological effect of a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7242729\results\search\zoonosis\results.xml">
   <result pre="leading to ~8,000 cases and 800 deaths. In 2002 the" exact="Middle East respiratory syndrome" post="coronavirus produced 2,500 cases with infection and caused 800"/>
   <result pre="produced 2,500 cases with infection and caused 800 deaths. The" exact="coronavirus disease 2019" post="(COVID-19) is highly contagious and has quickly spread globally"/>
   <result pre="and more recently in the US (46). In the 2014" exact="Ebola" post="outbreak, a randomized clinical trial was implemented and successfully"/>
   <result pre="https://www.ecdc.europa.eu/en/novel-coronavirus-china (accessed March 31, 2020). 4.GuanWJNiZYHuYLiangWHOuCQHeJXet al.. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. (2020) 382:1708â€&quot;20. 10.1056/NEJMoa200203232109013"/>
   <result pre="campaign: guidelines on the management of critically ill adults with" exact="coronavirus disease 2019" post="(COVID-19). Intensive Care Med. (2020). 10.1007/s00134-020-06022-5. [Epub ahead of"/>
   <result pre="al.Reduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVID-19). Front. Immunol. (2020) 11:82710.3389/fimmu.2020.0082732425950 10.ChannappanavarRFehrARVijayRMackMZhaoJMeyerholzDKet al.. Dysregulated type"/>
   <result pre="10.1016/j.chom.2016.01.00726867177 11.ChenGWuDGuoWCaoYHuangDWangHet al.Clinical and immunologic features in severe and moderate" exact="coronavirus disease 2019." post="J Clin Invest. (2020) 130:2620â€&quot;29. 10.1172/JCI13724432217835 12.LiaoMYangLYuanJWenYXuGZhaoJet al.The landscape"/>
   <result pre="regulator: a review. J Pineal Res. (2019) 66:e12534. 10.1111/jpi.1253430329173 18.AndersonGMaesMMarkusRPRodriguezM." exact="Ebola" post="virus: melatonin as a readily available treatment option. J"/>
   <result pre="47.DaveyRTJrDoddLProschanMANeatonJNeuhaus NordwallJKoopmeinersJSet al.. A randomized, controlled trial of ZMapp for" exact="Ebola" post="Virus infection. N Engl J Med. (2016) 375:1448â€&quot;56. 10.1056/NEJMoa160433027732819"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7242950\results\search\zoonosis\results.xml">
   <result pre="what to expect for COVID-19?Int. J. Antimicrob. Agents202010593810.1016/j.ijantimicag.2020.10593832171740 4SahraeiZ.ShabaniM.ShokouhiS.SaffaeiA.Aminoquinolines against" exact="coronavirus disease 2019" post="(COVID-19): chloroquine or hydroxychloroquineInt. J. Antimicrob. Agents202010594510.1016/j.ijantimicag.2020.10594532194152 5YaoX.YeF.ZhangM.CuiC.HuangB.NiuP.In vitro"/>
   <result pre="Opin Drug Metab Toxicol720111153116710.1517/17425255.2011.59850621736423 21ChorinE.DaiM.ShulmanE.WadhwainL.CohenR.B.BarbhaiyaC.The QT interval in patients with" exact="SARS-CoV-2 infection" post="treated with hydroxychloroquine/azithromycinmedRxiv212020202010.1101/2020.04.02.20047050 22Generalitat de CatalunyaNota Informativa Sobre lâ€™"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7243793\results\search\zoonosis\results.xml">
   <result pre="caused by SARS-CoV-2 is called COVID-19. The symptoms of the" exact="SARS-CoV-2 infection" post="range from asymptomatic to mild to severe to death.1"/>
   <result pre="generally less pathogenic than SARS-CoV, much less pathogenic than the" exact="Middle East respiratory syndrome" post="MERS-CoV, but more pathogenic than practically harmless HCoV-OC43, HCoV-HKU1,"/>
   <result pre="500 million 40â€&quot;100 million SARS (SARS-CoV)2002â€&quot;2003 N/A 30% 8,000 800" exact="Covid-19" post="(SARS-CoV-2)Since November 2019 &amp;gt;2% â‰¤3% &amp;gt;4,500,000 &amp;gt;300,000 Swine flu"/>
   <result pre="attachment step that primarily determines which host is susceptible to" exact="SARS-CoV infection." post="The SARS-CoV-2 entry through receptor bindingÂ was elucidated independently"/>
   <result pre="of novel mutations at the 501 position in SARS-CoV-2-infected and" exact="Covid-19" post="patients have to be closely monitored.34 Mutations in the"/>
   <result pre="in China.39 FigureÂ 7 Structures of Four Promising Drugs for" exact="Covid-19" post="Treatment and an Aristeromycin Derivative Favipiravir 24 is now"/>
   <result pre="Favipiravir 24 is now the first approved drug to treat" exact="Covid-19" post="The broad-spectrum antiviral drug remdesivir together with chloroquine effectively"/>
   <result pre="recently emerged novel CoV (SARS-CoV-2) inÂ vitro.40,41 Remdesivir (25) reduced" exact="SARS-CoV-2 infection" post="of monkey kidney cells with an EC50 of 0.77Â"/>
   <result pre="to inhibit multiple RNA viruses on a cellular level, including" exact="Ebola" post="and SARS. The presumed mode of action of the"/>
   <result pre="It is an adenosine analog and is currently developed for" exact="Ebola" post="virus disease and Marburg virus disease. It also shows"/>
   <result pre="analog and is currently developed for Ebola virus disease and" exact="Marburg virus disease." post="It also shows broad-spectrum antiviral activity against RNA virus"/>
   <result pre="COVID-19Nat. Nanotechnol.15202024724932203437 42WarrenT.K.JordanR.LoM.K.RayA.S.MackmanR.L.SolovevaV.SiegelD.PerronM.BannisterR.HuiH.C.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature531201638138526934220 43WestoverJ.B.MathisA.TaylorR.WanderseeL.BaileyK.W.SefingE.J.HickersonB.T.JungK.H.SheridanW.P.GowenB.B.Galidesivir limits Rift Valley fever"/>
   <result pre="molecule GS-5734 against Ebola virus in rhesus monkeysNature531201638138526934220 43WestoverJ.B.MathisA.TaylorR.WanderseeL.BaileyK.W.SefingE.J.HickersonB.T.JungK.H.SheridanW.P.GowenB.B.Galidesivir limits" exact="Rift Valley fever" post="virus infection and disease in Syrian golden hamstersAntiviral Res.1562018384529864447"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7246053\results\search\zoonosis\results.xml">
   <result pre="conduct our clinical, didactic, business, and social activities as the" exact="coronavirus disease 2019" post="(COVID-19) global pandemic abates and social distancing guidelines are"/>
   <result pre="acute respiratory syndrome (SARS)-associated coronavirus (CoV) in 2002 to 2003," exact="Middle East respiratory syndrome" post="(MERS)-CoV in 2012 and, more recently, SARS-CoV2 in 2019"/>
   <result pre="event.1 Unlike the previous 2 outbreaks, which were regional epidemics," exact="coronavirus disease 2019" post="(COVID-19), caused by SARS-CoV2, spread within a few weeks"/>
   <result pre="curriculum for students and residents Abbreviations: AGPs, aerosol-generating procedures; COVID-19," exact="coronavirus disease 2019;" post="HCP, healthcare personnel; PPE, personal protective equipment. Evolution of"/>
   <result pre="of PPE and mask fitting Abbreviations: AGPs, aerosol-generating procedures; COVID-19," exact="coronavirus disease 2019;" post="HCP, healthcare personnel; PAPR, powered air-purifying respirator; PPE, personal"/>
   <result pre="and Washington.48 FigureÂ 2 Comorbid risk factors in patients with" exact="coronavirus disease 2019" post="(COVID-19). Outpatient OMS clinics, especially in hospital settings, will"/>
   <result pre="Infect Dis20202053332087114 12ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: A descriptive studyLancet395202050732007143 13GuanW.J.NiZ.HuY.Clinical characteristics of"/>
   <result pre="pneumonia in Wuhan, China: A descriptive studyLancet395202050732007143 13GuanW.J.NiZ.HuY.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med3822020170832109013 14LauerS.A.GrantzK.H.BiQ.The incubation period of"/>
   <result pre="2019 in ChinaN Engl J Med3822020170832109013 14LauerS.A.GrantzK.H.BiQ.The incubation period of" exact="coronavirus disease 2019" post="(COVID-19) from publicly reported confirmed cases: Estimation and applicationAnn"/>
   <result pre="Zhi552020E001 27LuD.WangH.YuR.Integrated infection control strategy to minimize nosocomial infection of" exact="coronavirus disease 2019" post="among ENT healthcare workersJ Hosp Infect104202045432114056 28TayJ.K.KhooM.L.LohW.S.Surgical considerations for"/>
   <result pre="Dishttps://doi.org/10.1016/S1473-3099(20)30237-1accessed April 2, 2020 32LiuS.ChanT.-C.ChuY.-T.Comparative epidemiology of human infections with" exact="Middle East respiratory syndrome" post="and severe acute respiratory syndrome coronaviruses among healthcare personnelPLoS"/>
   <result pre="1200611916490989 43EggersM.EickmannM.ZornJ.Rapid and effective virucidal activity of povidone-iodine products against" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) and modified vaccinia virus Ankara (MVA)Infect Dis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7246824\results\search\zoonosis\results.xml">
   <result pre="curbing the spreadLancet Digit. Health20202e166e16710.1016/S2589-7500(20)30054-632289116 15.SunK.ChenJ.ViboudC.Early epidemiological analysis of the" exact="coronavirus disease 2019" post="outbreak based on crowdsourced data: A population-level observational studyLancet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7247743\results\search\zoonosis\results.xml">
   <result pre="SARS and MERS almost exclusively (2). Ritonavir/lopinavir, remdesivir (repurposed from" exact="Ebola" post="and FDA emergency approved), chloroquine and hydroxychloroquine (both now"/>
   <result pre="co-authors have no conflicts of interest. References References 1.GatesBResponding to" exact="Covid-19" post="- a once-in-a-century pandemic?N Engl J Med20203821677167910.1056/NEJMp200376232109012 2.Ekins S,"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov202061610.1038/s41421-020-0156-032194981 7.WangMCaoRZhangLYangXLiuJXuMShiZHuZZhongWXiaoGRemdesivir and chloroquine effectively inhibit the"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother20145884875488410.1128/AAC.03011-1424841269 10.DyallJColemanCMHartBJVenkataramanTHolbrookMRKindrachukJJohnsonRFOlingerGGJrJahrlingPBLaidlawMJohansenLMLear-RooneyCMGlassPJHensleyLEFriemanMBRepurposing of"/>
   <result pre="Agents Chemother20145884875488410.1128/AAC.03011-1424841269 10.DyallJColemanCMHartBJVenkataramanTHolbrookMRKindrachukJJohnsonRFOlingerGGJrJahrlingPBLaidlawMJohansenLMLear-RooneyCMGlassPJHensleyLEFriemanMBRepurposing of clinically developed drugs for treatment of" exact="Middle East respiratory syndrome" post="coronavirus infectionAntimicrob Agents Chemother20145884885489310.1128/AAC.03036-1424841273 11.BakerNCEkinsSWilliamsAJTropshaAA bibliometric review of drug"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7249458\results\search\zoonosis\results.xml">
   <result pre="than 1,500,000 patients worldwide have been diagnosed with the novel" exact="coronavirus disease 2019" post="(COVID-2019) caused by a laboratory-confirmed infection of the Severe"/>
   <result pre="outbreaks (including the 2003 Severe Acute Respiratory Syndrome Coronavirus,2 2014" exact="Ebola" post="virus,3 2015 Middle Eastern Respiratory Syndrome Coronavirus,4 and 2015"/>
   <result pre="sertraline was found to have potent in vitro activity against" exact="Ebola" post="in the Vero cell model,26 later testing in an"/>
   <result pre="class of medication, given their success in the treatment of" exact="Ebola" post="virus.49 Antibodies are a natural part of humoral immunity"/>
   <result pre="need to be delivered intravenously to be successful. In the" exact="Ebola" post="virus studies, for example, patients required one to three"/>
   <result pre="the international spreading risk associated with the 2014 West African" exact="Ebola" post="outbreak. PLoS Curr6,2014 4.ChoS.Y., KangJ.M., HaY.E., et al.MERS-CoV outbreak"/>
   <result pre="CaoQ.-D., HongZ.-S., et al.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;an update on the status. Mil Med Res7,11,"/>
   <result pre="DOI: 10.1111/all.14238 20.LippiG., and PlebaniM. Laboratory abnormalities in patients with" exact="COVID-2019" post="infection. Clin Chem Lab Med 2020 [Epub ahead of"/>
   <result pre="monotherapy fails to protect rhesus macaques from lethal challenge with" exact="Ebola" post="virus Makona. Sci Rep7,5886, 201728725019 30.Schwegmann-WeÃŸelsC., and HerrlerG.Sialic acids"/>
   <result pre="Le GuenP., VilleretB., et al.Silver nanoparticle-adjuvanted vaccine protects against lethal" exact="influenza infection" post="through inducing BALT and IgA-mediated mucosal immunity. Biomaterials217,119308, 201931279103"/>
   <result pre="201020187802 49.MulanguS., DoddL.E., DaveyR.T.Jr., et al.A randomized, controlled trial of" exact="Ebola" post="virus disease therapeutics. New Engl J Med381,2293, 201931774950 50.TianX.,"/>
   <result pre="Infect Dis Clin Pract27,328, 2019 59.PooleP.J., ChackoE., Wood-BakerR.W., and CatesC.J." exact="Influenza" post="vaccine for patients with chronic obstructive pulmonary disease. Cochrane"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7249615\results\search\zoonosis\results.xml">
   <result pre="in recent memory. These include SARS, MERS, the Zika virus," exact="swine flu," post="and Ebola. This is the third documented coronavirus (CoV)"/>
   <result pre="did not work [71â€&quot;73]. Treatment with chloroquine did not prevent" exact="influenza infection" post="in a randomized, double-blind, placebo-controlled clinical trial [74]. Conversely,"/>
   <result pre="respiratory treatment for different phenotypes?Intensive Care Med202010.1007/s00134-020-06033-232291463 23.Craven J (2020)" exact="Covid-19" post="vaccine tracker. Regulatory affairs professionals society. https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker. Accessed 30"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov2020611610.1038/s41421-020-0156-032194981 47.KubaKImaiYRaoSGaoHGuoFGuanBet al.A crucial role of angiotensin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7250076\results\search\zoonosis\results.xml">
   <result pre="MarchantR.SamiaN.I.RosenO.TannerM.A.CrippsS.Learning as we go-an examination of the statistical accuracy of" exact="COVID19" post="daily death count predictions202010.1101/2020.04.11.20062257 MeyersL.A.Contact network epidemiology: bond percolation"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7250111\results\search\zoonosis\results.xml">
   <result pre="is beneficial in COVID-19 infection. Keywords Antivirals Chikungunya Chloroquine COVID-19" exact="Dengue" post="Hydroxychloroquine Pneumonia Editor: M. Paul Introduction With the advent"/>
   <result pre="calculation is unclearRebound of viral RNA noted after stopping CQ" exact="Dengue" post="Tricou etÂ al., 2010, Vietnam [28] Randomized, double-blind, placebo-controlled"/>
   <result pre="nor CQ has been evaluated in combination with these agents." exact="Dengue" post="Two studies had assessed CQ for dengue infection (none"/>
   <result pre="an acidic pH for infectivityCell Biochem Funct34201619119627001679 12BarclayW.LongJ.WrightE.MolestiE.TempertonN.Antiviral therapies against" exact="Ebola" post="and other emerging viral diseases using existing medicines that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7250768\results\search\zoonosis\results.xml">
   <result pre="10.1016/j.mjafi.2020.05.004 : Review Article Cardiovascular comorbidities and complications associated with" exact="coronavirus disease 2019" post="MahajanKunalkunalmahajan442@gmail.comaâˆ—ChandraK.Saratb[a], [b], âˆ—Corresponding author. kunalmahajan442@gmail.com ppub: 2020-7epub: 2020-5-5763253260received: 2020-4-8accepted:"/>
   <result pre="author. kunalmahajan442@gmail.com ppub: 2020-7epub: 2020-5-5763253260received: 2020-4-8accepted: 2020-5-6(C) , 2020 Abstract" exact="Coronavirus disease 2019" post="(COVID-19) has caused a devastating global pandemic and continues"/>
   <result pre="the SARSÂ in 2002 by SARS-CoV, in 2012 by the" exact="Middle East respiratory syndrome" post="coronavirus (MERS)-CoV, and now COVID-19, a global pandemic in"/>
   <result pre="for patients, health care workers, and health systems during the" exact="coronavirus disease 2019" post="(COVID-19) pandemicJ Am Coll Cardiol2020 Mar 1810.1016/j.jacc.2020.03.031pii: S0735-1097(20)34637-4 4FauciA.S.LaneH.C.RedfieldR.R.Covid-19:"/>
   <result pre="in the greater Toronto areaJama28920032801280912734147 11BadawiA.RyooS.G.Prevalence of comorbidities in the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV): a systematic review and meta-analysisInt J Infect"/>
   <result pre="systematic review and meta-analysisInt J Infect Dis49201612913310.1016/j.ijid.2016.06.01527352628 12GuanW.J.NiZ.Y.HuY.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med2020 Feb 2810.1056/NEJMoa2002032 13ShiS.QinM.ShenB.Association of"/>
   <result pre="the prevalence of selected underlying health conditions among patients with" exact="coronavirus disease 2019" post="â€&quot; United States, february 12â€&quot;march 28, 2020MMWR Morb Mortal"/>
   <result pre="2020MMWR Morb Mortal Wkly Rep69202038238632240123 18lhogbaniT.Acute myocarditis associated with novel" exact="Middle East respiratory syndrome" post="coronavirusAnn Saudi Med362016788026922692 19WuQ.ZhouL.SunX.Altered lipid metabolism in recovered SARS"/>
   <result pre="Aug 22911010.1038/s41598-017-09536-z28831119 20GuoT.FanY.ChenM.Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol27202010.1001/jamacardio.2020.1017Published online March 21RaliA.S.SauerA.J.COVID-19 pandemic and cardiovascular diseaseUS"/>
   <result pre="and cardiovascular diseaseUS Cardiol142020e01 22LippiG.LavieC.J.Sanchis-GomarF.Cardiac troponin I in patients with" exact="coronavirus disease 2019" post="(COVID-19): evidence from a meta-analysisProg Cardiovasc Dis2020 23ZhouF.YuT.DuR.Clinical course"/>
   <result pre="March16202010.1093/eurheartj/ehaa190[epub ahead of print] 25InciardiR.M.LupiL.ZacconeG.Cardiac involvement in a patient with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol27202010.1001/jamacardio.2020.1096Published online March 26SalaS.PerettoG.GramegnaM.Acute myocarditis presenting as a"/>
   <result pre="ahead of print, 2020 Apr 16]Eur Heart J2020ehaa314 36TamC.F.CheungK.S.LamS.Impact of" exact="coronavirus disease 2019" post="(COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7251044\results\search\zoonosis\results.xml">
   <result pre="persons with low CD4 counts are at greater risk for" exact="influenza infection" post="and its complications including pneumococcal co-infection, longer hospital stays"/>
   <result pre="catch-up will be calamitous. We have seen how the recent" exact="Ebola" post="epidemic greatly undermined malaria control efforts, resulting in an"/>
   <result pre="know so far. J Chin Med Assoc. 10.1097/JCMA.0000000000000318 9.GatesBillResponding to" exact="Covid-19" post="â€&quot; A Once-in-a-Century Pandemic?New England Journal of Medicine2020382181677167910.1056/NEJMp200376232109012 10.MayosiBMFlisherAJLallooUGSitasFTollmanSMBradshawDThe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7251277\results\search\zoonosis\results.xml">
   <result pre="the spread of the novel coronavirus. COVID-19 SARS-CoV-2 whole-genome sequencing" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19), was"/>
   <result pre="whole-genome sequencing Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing" exact="coronavirus disease 2019" post="(COVID-19), was first detected in Wuhan, China, around mid-December"/>
   <result pre="research were deposited in the Global Initiative on Sharing All" exact="Influenza" post="Data (GISAID; www.gisaid.org), with accession numbers EPI_ISL_427391, EPI_ISL_428346, and"/>
   <result pre="infections (COVID-19)Int J Infect Dis202094154532179137 11MizumotoKKagayaKZarebskiAChowellGEstimating the asymptomatic proportion of" exact="coronavirus disease 2019" post="(COVID-19) cases on board the Diamond Princess cruise ship,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7252029\results\search\zoonosis\results.xml">
   <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Coronavirus disease 2019" post="(SARS-CoV2) is an active global health threat for which"/>
   <result pre="(sHLH) all have clinical and laboratory characteristics in common with" exact="COVID19" post="and associated therapies that could be worth testing in"/>
   <result pre="COVID-19 CRS cytokine release HLH hyperimmune response immunotherapy IRIS SARS-CoV-2" exact="Coronavirus disease 2019" post="(COVID-19) is an infectious illness caused by a novel"/>
   <result pre="to viruses responsible for severe acute respiratory syndrome (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). These coronavirus strains have been responsible for"/>
   <result pre="interleukin (IL)-6, high C-reactive protein and soluble CD25 suggest that" exact="SARS-CoV-2 infection" post="may trigger cytokine storm syndrome. This hyper-reactive cytokine release"/>
   <result pre="for shared therapeutic interventions. CCLÂ =Â chemokine ligand, COVID-19Â =Â" exact="coronavirus disease 2019," post="CRPÂ =Â C-reactive protein, CRSÂ =Â Cytokine release syndrome,"/>
   <result pre="in vitroAntiviral Res1782020104787 49Rome B.N., Avorn J.Drug evaluation during the" exact="Covid-19" post="pandemic [published online ahead of print April 14, 2020]."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7252082\results\search\zoonosis\results.xml">
   <result pre="with drugs metabolised by CYP3A and CYP2C19 RemdesivirExperimental drug for" exact="Ebola" post="virus infection A broad-spectrum antiviral agent (investigational nucleoside analogue"/>
   <result pre="to the clinically achievable concentration in humans reduced mortality following" exact="SARS-CoV infection" post="from 100% to 30â€&quot;35%. â€¢In vitro studies demonstrated that"/>
   <result pre="drugs being investigated range from repurposed flu treatments to failed" exact="Ebola" post="drugs, to antimalarial agents to immunosuppressants that have been"/>
   <result pre="of interest. References References 1JiangF.DengL.ZhangL.CaiY.CheungC.W.XiaZ.Review of the clinical characteristics of" exact="coronavirus disease 2019" post="(COVID-19)J Gen Intern Med20201531625040 2CascellaM.RajnikM.CuomoA.DulebohnS.C.Di NapoliR.Features, evaluation and treatment"/>
   <result pre="and treatment coronavirus (COVID-19)StatPearls2020StatPearls Publishing[Internet] 3COVIDC.Severe outcomes among patients with" exact="coronavirus disease 2019" post="(COVID-19)â€&quot;United States, february 12â€&quot;march 16, 2020MMWR Morb Mortal Wkly"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7252421\results\search\zoonosis\results.xml">
   <result pre="likely play a pivotal role for the deleterious consequences of" exact="SARS-CoV-2 infection" post="in addition to the severe acute respiratory distress syndrome"/>
   <result pre="cardiovascular conditions. COVID-19 and myocardial injury The cardiac manifestations of" exact="SARS-CoV-2 infection" post="include acute myocardial injury, heart failure, myocarditis, and ventricular"/>
   <result pre="injury related to COVID-19 Based on findings from Corona and" exact="Influenza" post="infections in the past, it has been speculated that"/>
   <result pre="on the incidence of myocardial infarction after the outbreak of" exact="Influenza" post="infections in Ontario reported a sixfold higher incidence ratio"/>
   <result pre="incidence ratio of AMI within 6Â days after a positive" exact="Influenza" post="test as compared to a negative test during the"/>
   <result pre="that an exaggerated inflammatory response mediated by viral infection with" exact="Influenza" post="A or B, respiratory syncytial virus (RSV) or other"/>
   <result pre="subclinical diastolic left ventricular impairment that was reported in acute" exact="SARS-CoV-2 infection" post="and was attributed to the cytokine storm syndrome that"/>
   <result pre="of pre-existing structural heart disease on long-term outcomes. Similar to" exact="SARS-CoV-2 infection," post="an impairment of right and left ventricular function on"/>
   <result pre="of cytokines by adsorbent polymer beads (â€œCytosorbâ€�) are sparse. Perspectives" exact="Coronavirus disease 2019" post="(COVID-19) is a pandemic after an outbreak of pneumonia"/>
   <result pre="crisisBr J Surg202010.1002/bjs.1162732363596 3.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="in a perfect stormCirculation20191391658166030933612 17.ThienemannFPintoFGrobbeeDEBoehmMBazarganiNGeJSliwaKWorld heart federation briefing on prevention:" exact="coronavirus disease 2019" post="(COVID-19) in low-income countriesGlob Heart20201513110.5334/gh.778 18.WilliamsBManciaGSpieringWAgabiti RoseiEAziziMBurnierMClementDLCocaAde SimoneGDominiczakAKahanTMahfoudFRedonJRuilopeLZanchettiAKerinsMKjeldsenSEKreutzRLaurentSLipGYHMcManusRNarkiewiczKRuschitzkaFSchmiederREShlyakhtoETsioufisCAboyansVDesormaisIcollab: ESC"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern Med202010.1001/jamainternmed.2020.099432338717 47.GrasselliGZangrilloAZanellaAAntonelliMCabriniLCastelliACeredaDColuccelloAFotiGFumagalliRIottiGLatronicoNLoriniLMerlerSNataliniGPiattiARanieriMVScandroglioAMStortiECecconiMPesentiAcollab: COVID-19 Lombardy"/>
   <result pre="J202010.1093/eurheartj/ehaa23132186331 60.ChenNZhouMDongXet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet20203951022350751310.1016/S0140-6736(20)30211-732007143 61.ThygesenKAlpertJSJaffeASet al.Fourth universal"/>
   <result pre="syndrome: a meta-analysis of randomised trialsLancet20173901009673774610.1016/S0140-6736(17)31490-328778541 84.(2020) ACC Clinical Bulletin:" exact="COVID 19" post="Clinical Guidance For the CV Care Team. https://www.acc.org/~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/2020/02/S20028-ACC-Clinical-Bulletin-Coronavirus.pdf. Accessed"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7253763\results\search\zoonosis\results.xml">
   <result pre="5.ArabiYM, DeebAM, Al-HameedF, et al.Macrolides in critically ill patients with" exact="Middle East respiratory syndrome." post="Int J Infect Dis2019;81:184â€&quot;190.30690213 6.JangTN, YehDY, ShenSH, HuangCH, JiangJS,"/>
   <result pre="Int J Infect Dis2019;81:184â€&quot;190.30690213 6.JangTN, YehDY, ShenSH, HuangCH, JiangJS, KaoSJ." exact="Severe acute respiratory syndrome" post="in Taiwan: analysis of epidemiological characteristics in 29 cases."/>
   <result pre="or without concomitant azithromycin among hospitalized patients testing positive for" exact="coronavirus disease 2019" post="(COVID-19). JAMA Cardiol2020. doi: 10.1001/jamacardio.2020.1834. 9.LippiG, PlebaniM. Procalcitonin in"/>
   <result pre="Cardiol2020. doi: 10.1001/jamacardio.2020.1834. 9.LippiG, PlebaniM. Procalcitonin in patients with severe" exact="coronavirus disease 2019" post="(COVID-19): a meta-analysis. Clin Chim Acta2020;505:190â€&quot;191.32145275 10.LiL, HuangQ, WangDC,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7254006\results\search\zoonosis\results.xml">
   <result pre="human, including severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) since 2012, and most recently SARS-CoV-2 since"/>
   <result pre="[4]]. Within just 4 months, the number of patients with" exact="SARS-CoV-2 infection," post="or Coronavirus Disease 2019 (COVID-19), has exceeded the total"/>
   <result pre="to evaluate the individual drug compoundsâ€™ cell protection effects against" exact="SARS-CoV-2 infection" post="[21]. Briefly, VeroE6 cells seeded in 96-well plates were"/>
   <result pre="multiplicities of infection (MOI) (1.000, 0.250, 0.063, 0.016, and 0.004)." exact="SARS-CoV-2 infection" post="(MOI = 1.000) caused significant CPE in VeroE6 cells"/>
   <result pre="Infect. Dis.202010.1016/S1473-3099(20)30243-7pii: S1473-3099(20)30243-7. [Epub ahead of print] 9GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.LiuL.ShanH.LeiC.L.HuiD.S.C.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN. Engl. J. Med.202010.1056/NEJMoa2002032[Epub ahead of print] 10HuangC.WangY.LiX.RenL.ZhaoJ.HuY.ZhangL.FanG.XuJ.GuX.Clinical"/>
   <result pre="Infect. Dis.2020ciaa32510.1093/cid/ciaa325[Epub ahead of print]32215622 24ChanJ.F.ChanK.H.KaoR.Y.ToK.K.ZhengB.J.LiC.P.LiC.P.T.DaiJ.MokF.K.ChenH.Broad-spectrum antivirals for the emerging" exact="Middle East respiratory syndrome" post="coronavirusJ. Infect.67201360661624096239 25YuanS.ChuH.ZhaoH.ZhangK.SinghK.ChowB.K.KaoR.Y.ZhouJ.ZhengB.J.Identification of a small-molecule inhibitor of influenza"/>
   <result pre="the treatment of obesityCurr. Opin. Investig. Drugs92008414421 31CheungK.S.HungI.F.ChanP.P.LungK.C.TsoE.LiuR.NgY.Y.ChuM.Y.ChungT.W.TamA.R.Gastrointestinal manifestations of" exact="SARS-CoV-2 infection" post="and virus load in fecal samples from the Hong"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7255394\results\search\zoonosis\results.xml">
   <result pre="been one of the countries most severely affected by the" exact="coronavirus disease 2019." post="This study aims to describe a series of children"/>
   <result pre="a series of children admitted to a PICU due to" exact="coronavirus disease 2019" post="infection. Design: Prospective observational study. Setting: Tertiary hospital in"/>
   <result pre="therapy. Eleven children were admitted to the PICU, with suspected" exact="coronavirus disease 2019;" post="the polymerase chain reaction test was positive in seven."/>
   <result pre="to require close monitoring, and multicenter studies are necessary. children" exact="coronavirus disease 2019" post="mechanical ventilation noninvasive ventilation pediatric critical care severe acute"/>
   <result pre="(SARS-CoV-2) was described in Wuhan, China. This virus causes the" exact="coronavirus disease 2019" post="(COVID-19), and its rapid spread has led to the"/>
   <result pre="by coronaviruses, such as severe acute respiratory syndrome and the" exact="Middle East respiratory syndrome," post="scant data on pediatric patients were published. Similarly, COVID-19"/>
   <result pre="two criteria. First, patients were required to have a confirmed" exact="SARS-CoV-2 infection" post="based on nasopharyngeal swab specimens, using real-time reverse-transcriptase polymerase"/>
   <result pre="seven children; three patients with a clinical presentation compatible with" exact="SARS-CoV-2 infection" post="were excluded due to two negative PCR test results."/>
   <result pre="J Epidemiol2020222[online ahead of print] 2.TagarroAEpalzaCSantosMet al.Screening and severity of" exact="coronavirus disease 2019" post="(COVID-19) in children in Madrid, Spain.JAMA Pediatr202048[online ahead of"/>
   <result pre="infection: Clinical and epidemiological features.Clin Infect Dis2020228 7.LiuWZhangQChenJet al.Detection of" exact="Covid-19" post="in children in early January 2020 in Wuhan, China.N"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7256352\results\search\zoonosis\results.xml">
   <result pre="and Europe PMC, consistent with existing copyright protections.TBSD_A_1767210.pdf Abstract Abstract" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) is the causative representative of a"/>
   <result pre="since late 2019. There is no therapeutic FDA-approved drug against" exact="SARS-CoV-2 infection," post="although a combination of anti-viral drugs is directly being"/>
   <result pre="application of Remdesivir (RVD) as a potential anti-viral compound against" exact="Middle East respiratory syndrome" post="(MERS) -CoV, SARS-CoV and SARS-CoV-2. First, we overview the"/>
   <result pre="the new CoV, including severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS) have originated from animals (Gretebeck &amp;amp; Subbarao, 2015;"/>
   <result pre="There is currently no drug or vaccine to prevent the" exact="SARS-CoV-2 infection," post="but the use of widespread antivirals can be effective"/>
   <result pre="(GS-5734) as a nucleotide analogue was originally developed to treat" exact="Ebola" post="(Tchesnokov etÂ al., 2019). The laboratory assessments has shown"/>
   <result pre="be used as a potential candidate for the treatment of" exact="Ebola" post="and emerging CoV. Agostini etÂ al. (2018) reported that"/>
   <result pre="Tchesnokov etÂ al. (2019) declared that the significant inhibition of" exact="Ebola" post="virus RNA polymerase can be attributed to the anti-viral"/>
   <result pre="2019). Lo etÂ al. (2019) also displayed that RDV prevent" exact="Nipah virus infection" post="in monkeys. Furthermore, to assess the reduction of MERS-CoV"/>
   <result pre="S., WooH., &amp;amp; KimY.-S. (2016). Clinical presentation and outcomes of" exact="Middle East respiratory syndrome" post="in the Republic of Korea. Infection &amp;amp; Chemotherapy, 48(2),"/>
   <result pre="The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus. The Journal of Biological Chemistry, 295(15), 4773â€&quot;4779. 10.1074/jbc.AC120.01305632094225"/>
   <result pre="&amp;amp; YanY. (2020). The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;an update on the status. Military Medical Research,"/>
   <result pre="ZhengW., &amp;amp; GarcÃ­a-SastreA. (2014). Identification of 53 compounds that block" exact="Ebola" post="virus-like particle entry via a repurposing screen of approved"/>
   <result pre="Infections,3(1), 1â€&quot;7. 10.1038/emi.2014.88 LaiC.-C., ShihT.-P., KoW.-C., TangH.-J., &amp;amp; HsuehP.-R. (2020)." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the"/>
   <result pre="tract. Paediatric Respiratory Reviews, 4(2), 84â€&quot;90. 10.1016/S1526-0542(03)00031-912758044 MahaseE. (2020). Coronavirus:" exact="Covid-19" post="has killed more people than SARS and MERS combined,"/>
   <result pre="ParkS. W., &amp;amp; KimN. J. (2016). Viral load kinetics of" exact="MERS coronavirus" post="infection. The New England Journal of Medicine, 375(13), 1303â€&quot;1305."/>
   <result pre="pyrrolo [2, 1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of" exact="Ebola" post="and emerging viruses. ACS Publications. SongZ., XuY., BaoL., ZhangL.,"/>
   <result pre="Y., PorterD. P., &amp;amp; GÃ¶tteM. (2019). Mechanism of inhibition of" exact="Ebola" post="virus RNA-dependent RNA polymerase by remdesivir. Viruses, 11(4), 32610.3390/v11040326"/>
   <result pre="QinQ. (2020). Unique epidemiological and clinical features of the emerging" exact="2019 novel coronavirus pneumonia" post="(COVIDâ€�19) implicate special control measures. Journal of Medical Virology,"/>
   <result pre="BavariS. (2016). Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeys. Nature, 531(7594), 381â€&quot;385. 10.1038/nature1718026934220 WooP."/>
   <result pre="model of MERS produced by infection of rhesus macaques with" exact="MERS coronavirus." post="The Journal of Infectious Diseases, 209(2), 236â€&quot;242. 10.1093/infdis/jit59024218506 ZhuZ.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7256451\results\search\zoonosis\results.xml">
   <result pre="not cause the acute respiratory distress syndrome (ARDS) characteristic of" exact="SARS-CoV-2 infection." post="The differences in the severity of illness caused by"/>
   <result pre="blockers on death and severity of disease in patients with" exact="coronavirus disease 2019" post="(COVID-19): a meta-analysis. medRxiv [Preprint]. (2020). 10.1101/2020.04.23.20076661 10.UhalBDAbdul-HafezA. Angiotensin"/>
   <result pre="(2020). 10.1111/all.14238. [Epub ahead of print]. 24.GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. (2020) 382:1708â€&quot;20. 10.1101/2020.02.06.2002097432109013"/>
   <result pre="216:762â€&quot;6. 10.1038/216762a04294626 48.InciardiRMLupiLZacconeGItaliaLRaffoMTomasoniDet al.. Cardiac involvement in a patient with" exact="coronavirus disease 2019" post="(COVID-19). JAMA Cardiol. (2020). 10.1001/jamacardio.2020.1096. [Epub ahead of print].32219357"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7256510\results\search\zoonosis\results.xml">
   <result pre="the world. A mathematical model examined whether the control of" exact="SARS-CoV-2 infection" post="could be achieved by isolating affected patients, and tracking"/>
   <result pre="was present in about 20â€&quot;25% of patients with MERS-CoV or" exact="SARS-CoV infection," post="intestinal symptoms are rarely seen in patients with COVID-19."/>
   <result pre="Chinese government carried out [47]. 6 Temperature and humidity and" exact="SARS-CoV-2 infection" post="One study investigated the relationship between the mean daily"/>
   <result pre="washing of hands is the best way to protect against" exact="SARS-CoV-2 infection" post="[55]. A study in six departments of a hospital"/>
   <result pre="polymerase of RNA viruses such as Influenza, Yellow fever, Chikungunya," exact="Ebola" post="[68], Norovirus, and Enterovirus [67]. Besides, in one recent"/>
   <result pre="plus Interferon-Î± (ChiCTR2000029600), and Favipiravir plus Baloxavir marboxil (an approved" exact="Influenza" post="inhibitor targeting the cap-dependent endonuclease) (ChiCTR2000029544). 8.1.1.2 Favilavir Favilavir"/>
   <result pre="zoonotic bat CoVs, and pre-pandemic zoonotic CoVs, in addition to" exact="Ebola" post="in cell culture and animal models [75]. The results"/>
   <result pre="CQ is an anti-malarial drug [100] with practical activity against" exact="SARS-CoV-2 infection" post="[101], which could help in the treatment of COVID-19."/>
   <result pre="Trial) (PHYDRA) NCT04318015 Not yet recruiting Safety and Immunity of" exact="Covid-19" post="aAPC Vaccine NCT04299724 Recruiting China Immunity and Safety of"/>
   <result pre="Covid-19 aAPC Vaccine NCT04299724 Recruiting China Immunity and Safety of" exact="Covid-19" post="Synthetic Minigene Vaccine NCT04276896 Recruiting China A Phase I"/>
   <result pre="GanovoÂ +Â ritonavir+/-Interferon nebulization NCT04291729 Completed China Eculizumab (Soliris) in" exact="Covid-19" post="Infected Patients NCT04288713 Available Severe 2019-nCoV Remdesivir RCT NCT04257656"/>
   <result pre="Not yet recruiting Nitric Oxide Gas Inhalation Therapy for Mild/Moderate" exact="COVID19" post="Infection NCT04290858 Withdrawn Nitric Oxide Gas Inhalation for Severe"/>
   <result pre="health concernThe Lancet.395102232020470473 3GuoY.-R.CaoQ.-D.HongZ.-S.TanY.-Y.ChenS.-D.JinH.-J.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;an update on the statusMil. Med. Res.71202011031928528 4Riou"/>
   <result pre="Diseases. 2020;91:264-6. 16ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyThe Lancet.395102232020507513 17CascellaM.RajnikM.CuomoA.DulebohnS.C.Di NapoliR.Features,"/>
   <result pre="Medical Center. medRxiv. 2020. 30McIntosh K, Hirsch MS, Bloom A." exact="Coronavirus disease 2019" post="(COVID-19). UpToDate Hirsch MS, Bloom A (Eds) Accessed Mar."/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan2020ChinaJAMA internal medicine 66Li H, Wang Y,"/>
   <result pre="Virus Infections. Chemistryâ€&quot;An Asian Journal. 2019;14(22):3962-8. 68OestereichL.LÃ¼dtkeA.WurrS.RiegerT.MuÃ±oz-FontelaC.GÃ¼ntherS.Successful treatment of advanced" exact="Ebola" post="virus infection with T-705 (favipiravir) in a small animal"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discovery6120201431934347 78(FDA) FaDA. Coronavirus (COVID-19) Update: FDA"/>
   <result pre="the Newly Emerged Coronavirus (2019-nCoV). 2020. 92DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discoveries &amp;amp; Therapeutics.1412020586032147628 93AryaR.DasA.PrasharV.KumarM.Potential inhibitors against papain-like protease"/>
   <result pre="autophagosome-lysosome fusionAutophagy.14820181435145529940786 105ARENA CT. Coronavirus: Chloroquine yields positive data in" exact="Covid-19" post="trial 2020 FEBRUARY 18 [Available from: https://www.clinicaltrialsarena.com/news/coronavirus-covid-19-choroquine-data/. 106McChesneyE.W.Animal toxicity"/>
   <result pre="Clinical features and progression of acute respiratory distress syndrome in" exact="coronavirus disease 2019." post="MedRxiv. 2020. 119BarrettD.M.TeacheyD.T.GruppS.A.Toxicity management for patients receiving novel T-cell"/>
   <result pre="role for Fc function in therapeutic monoclonal antibody-mediated protection against" exact="Ebola" post="virus. Cell host &amp;amp; microbe. 2018;24(2):221-33. e5. 137YehK.-M.ChiuehT.-S.SiuL.LinJ.-C.ChanP.K.PengM.-Y.Experience of"/>
   <result pre="Dis.105200481815200814 163ArabiY.M.ArifiA.A.BalkhyH.H.NajmH.AldawoodA.S.GhabashiA.Clinical course and outcomes of critically ill patients with" exact="Middle East respiratory syndrome" post="coronavirus infectionAnn. Intern. Med.1606201438939724474051 164CaoW.LiuX.BaiT.FanH.HongK.SongH.editors. High-dose intravenous immunoglobulin as"/>
   <result pre="intravenous immunoglobulin as a therapeutic option for deteriorating patients with" exact="coronavirus disease 2019." post="Open forum infectious diseases2020Oxford University Press US 165CavalliG.De LucaG.CampochiaroC.Della-TorreE.RipaM.CanettiD.Interleukin-1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7256539\results\search\zoonosis\results.xml">
   <result pre="centre remains active. Abstract Given the rapid spread of the" exact="coronavirus disease 2019" post="(COVID-19) pandemic and its overwhelming effect on health care"/>
   <result pre="Ang II, angiotensin II AT1R, type 1 angiotensin receptor COVID-19," exact="coronavirus disease 2019" post="IL-1/6/8, interleukin-1/6/8 NF-ÎºB, nuclear factor ÎºB SARS-CoV-2, severe acute"/>
   <result pre="acute respiratory syndrome coronavirus 2 TNF-Î±, tumor necrosis factor Î±" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) continues to rapidly spread worldwide. To"/>
   <result pre="worldwide. To date, no specific therapeutic agents or vaccines for" exact="coronavirus disease 2019" post="(COVID-19) are available, and much information on the causative"/>
   <result pre="well as in both the 2003 SARS-CoV and the 2012" exact="Middle East respiratory syndrome" post="epidemics, women have substantially lower case-fatality rates than do"/>
   <result pre="had a worse prognosis than did female mice. Specifically, after" exact="SARS-CoV infection," post="male mice had higher viral titers, more pulmonary vascular"/>
   <result pre="COVID-19. References References 1WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="perspectives on immune responsesCell Death Differ27520201451145432205856 12de JongM.D.SimmonsC.P.ThanhT.T.Fatal outcome of" exact="human influenza" post="A (H5N1) is associated with high viral load and"/>
   <result pre="increased risk for COVID-19 infection?Lancet Respir Med842020e2132171062 33SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a review [published online ahead of print April"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7258628\results\search\zoonosis\results.xml">
   <result pre="that often is complicating the weaning of intubated patients with" exact="SARS-CoV-2 infection." post="Patients and their families have a clear right to"/>
   <result pre="on compassionate use of remdesivir among 53 patients with severe" exact="SARS-CoV-2 infection" post="showed an improvement in oxygen support in 36 (68%)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7261908\results\search\zoonosis\results.xml">
   <result pre="enveloped viruses, such as those described below. Protein- and Peptide-Based" exact="Influenza" post="Virus Inactivators Influenza viruses belong to the Orthomyxoviridae family"/>
   <result pre="as those described below. Protein- and Peptide-Based Influenza Virus Inactivators" exact="Influenza" post="viruses belong to the Orthomyxoviridae family having segmented negative-sense,"/>
   <result pre="having segmented negative-sense, single-stranded RNA genomes (Palese and Shaw, 2007)." exact="Influenza" post="virus infection can lead to a high fever, cough,"/>
   <result pre="fever, cough, headache, sore throat etc. after 1â€&quot;3-day incubation period." exact="Influenza" post="viruses are classified as types A, B, C, and"/>
   <result pre="gp41 28.3 nM (HIV-1 Bal.01 pseudovirus) Parajuli et al., 2018" exact="Influenza" post="virus inactivators Urumin IPLRGAFINGRWDSQCHRFSNGAIACA H1 HA conserved stem HNBD#"/>
   <result pre="of the highly pathogenic emerging and re-emerging virus infections, e.g.," exact="Ebola" post="virus or Middle East respiratory syndrome coronavirus (MERS-CoV) infection."/>
   <result pre="pathogenic emerging and re-emerging virus infections, e.g., Ebola virus or" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) infection. Drugs are especially key in the"/>
   <result pre="D bound to the human receptor nectin-1.PLoS Pathog.7:e100227710.1371/journal.ppat.1002277 DouD.RevolR.OstbyeH.WangH.DanielsR. (2018)." exact="Influenza" post="A virus cell entry, replication, virion assembly and movement.Front."/>
   <result pre="fusion-activating interfaces on gD.J. Virol.8712656â€&quot;12666. 10.1128/JVI.01727-1324049165 GamblinS. J.SkehelJ. J. (2010)." exact="Influenza" post="hemagglutinin and neuraminidase membrane glycoproteins.J. Biol. Chem.28528403â€&quot;28409. 10.1074/jbc.R110.12980920538598 GanzT."/>
   <result pre="virucidal for human H1 hemagglutinin-bearing influenza viruses.Immunity46587â€&quot;595. 10.1016/j.immuni.2017.03.01828423338 HouserK.SubbaraoK. (2015)." exact="Influenza" post="vaccines: challenges and solutions.Cell Host Microbe17295â€&quot;300. 10.1016/j.chom.2015.02.01225766291 HrobowskiY. M.GarryR."/>
   <result pre="Structural and functional bases for broad-spectrum neutralization of avian and" exact="human influenza" post="A viruses.Nat. Struct. Mol. Biol.16265â€&quot;273. 10.1038/nsmb.156619234466 SullivanN.SunY.BinleyJ.LeeJ.BarbasC. F.IIIParrenP. W.et"/>
   <result pre="of influenza virus.Adv. Exp. Med. Biol.79072â€&quot;82. 10.1007/978-1-4614-7651-1_423884586 TakashitaE.KawakamiC.OgawaR.MoritaH.FujisakiS.ShirakuraM.et al. (2019)." exact="Influenza" post="A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to"/>
   <result pre="prior baloxavir treatment, Japan, January 2019.Euro Surveill.24:190017010.2807/1560-7917.ES.2019.24.12.1900170 TianY. S.ZhouY.TakagiT.KameokaM.KawashitaN. (2018)." exact="Dengue" post="virus and its inhibitors: a brief review.Chem. Pharm. Bull.66191â€&quot;206."/>
   <result pre="against a lethal H5N1 challenge in mice.Front. Microbiol.10:203110.3389/fmicb.2019.02031 YangJ.LiM.ShenX.LiuS. (2013)." exact="Influenza" post="A virus entry inhibitors targeting the hemagglutinin.Viruses5352â€&quot;373. 10.3390/v501035223340380 YuY.DengY."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7262150\results\search\zoonosis\results.xml">
   <result pre="parallel, makes an appraisal of other virus epidemics as SARSâ€�CoV," exact="Middle East respiratory syndrome" post="coronavirus, and H1N1 influenza. arrhythmia COVIDâ€�19 myocardial damage myocarditis"/>
   <result pre="ICU intensive care unit LVEF left ventricular ejection fraction MERSâ€�CoV" exact="Middle East respiratory syndrome" post="coronavirus NHC National Health Commission of China OR odds"/>
   <result pre="risk of cardiovascular death (Pâ€‰ Pâ€‰=â€‰.009). According to this study," exact="influenza infection" post="may result in increased metabolic demand, hypoxia, and adrenergic"/>
   <result pre="pain (44%) ND 22% Pericarditis (1â€‰pt) VT (1â€‰pt) SVT (1â€‰pt)" exact="H1N1 Influenza" post="Schoen et al42 160 Chest pain (5%) ND Zero"/>
   <result pre="(44%) ND 22% Pericarditis (1â€‰pt) VT (1â€‰pt) SVT (1â€‰pt) H1N1" exact="Influenza" post="Schoen et al42 160 Chest pain (5%) ND Zero"/>
   <result pre="EF, ejection fraction; HF, heart failure; HR, heart rate; MERSâ€�CoV," exact="Middle East respiratory syndrome" post="coronavirus; ND, not disclosed; pt, patient; LVEF, left ventricular"/>
   <result pre="burden of influenza: a review of the extraâ€�pulmonary complications of" exact="influenza infection." post="Influenza Other Respir Viruses. 2017;11:372â€�393.28745014 5AlexanderLK, SmallJD, EdwardsS, BaricRS."/>
   <result pre="influenza: a review of the extraâ€�pulmonary complications of influenza infection." exact="Influenza" post="Other Respir Viruses. 2017;11:372â€�393.28745014 5AlexanderLK, SmallJD, EdwardsS, BaricRS. An"/>
   <result pre="and Prevention (CDC) . Update: severe respiratory illness associated with" exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV)â€�worldwide, 2012â€�2013. MMWR Morb Mortal Wkly Rep. 2013;62:480â€�483.23760190"/>
   <result pre="Rep. 2013;62:480â€�483.23760190 11MaslowJN. Vaccines for emerging infectious diseases: lessons from" exact="MERS coronavirus" post="and Zika virus. Hum Vaccin Immunother. 2017;13:2918â€�2930.28846484 12BadawiA, RyooSG."/>
   <result pre="Vaccin Immunother. 2017;13:2918â€�2930.28846484 12BadawiA, RyooSG. Prevalence of comorbidities in the" exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV): a systematic review and metaâ€�analysis. Int J"/>
   <result pre="et al. Clinical aspects and outcomes of 70 patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a singleâ€�center experience in Saudi Arabia. Int"/>
   <result pre="Dis. 2014;29:301â€�306.25303830 14Alâ€�AbdallatMM, PayneDC, AlqasrawiS, et al. Hospitalâ€�associated outbreak of" exact="Middle East respiratory syndrome" post="coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect"/>
   <result pre="description. Clin Infect Dis. 2014;59:1225â€�1233.24829216 15AlhogbaniT.Acute myocarditis associated with novel" exact="Middle East respiratory syndrome" post="coronavirus. Ann Saudi Med. 2016;36:78â€�80.26922692 16NguyenJL, YangW, ItoK, MatteTD,"/>
   <result pre="tropics. Am J Epidemiol. 2017;186:202â€�209.28338806 19ModinD, JÃ¸rgensenME, GislasonG, et al." exact="Influenza" post="vaccine in heart failure. Circulation. 2019;139:575â€�586.30586760 20HuangC, WangY, LiX,"/>
   <result pre="et al. Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVIDâ€�19). JAMA Cardiol. 202010.1001/jamacardio.2020.1017 22ZhouF, YuT, DuR, et al."/>
   <result pre="24HarrisJE, ShahPJ, KorimilliV, WinH.Frequency of troponin elevations in patients with" exact="influenza infection" post="during the 2017â€�2018 influenza season. Int J Cardiol Heart"/>
   <result pre="greater Toronto area. JAMA. 2003;289:2801â€�2809.12734147 41Alâ€�TawfiqJA, HinediK, GhandourJ, et al." exact="Middle East respiratory syndrome" post="coronavirus: a caseâ€�control study of hospitalized patients. Clin Infect"/>
   <result pre="al. Epidemiological, demographic, and clinical characteristics of 47 cases of" exact="Middle East respiratory syndrome" post="coronavirus disease from Saudi Arabia: a descriptive study. Lancet"/>
   <result pre="LupiL, ZacconeG, et al. Cardiac involvement in a patient with" exact="coronavirus disease 2019" post="(COVIDâ€�19). JAMA Cardiol. 202010.1001/jamacardio.2020.1096"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7262202\results\search\zoonosis\results.xml">
   <result pre="lung cancer (2018PT31035). References References 1LaiCC, ShihTP, KoWC, TangHJ, HsuehPR." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARSâ€�CoVâ€�2) and coronavirus diseaseâ€�2019 (COVIDâ€�19): The epidemic"/>
   <result pre="of clinical trials. Cancer Chemother Pharmacol2011; 68: 1575â€&quot;83.21547571 26LiY, XiaL." exact="Coronavirus disease 2019" post="(COVIDâ€�19): Role of chest CT in diagnosis and management."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7262305\results\search\zoonosis\results.xml">
   <result pre="have been there before with severe acute respiratory syndrome (SARS)," exact="Middle East respiratory syndrome" post="(MERS), as well as the seasonal flu. In each"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7263255\results\search\zoonosis\results.xml">
   <result pre="(Î²-CoV) emerged in Guangdong province of China in 2002â€&quot;2003, and" exact="Middle East respiratory syndrome" post="(MERS) caused by MERS-CoV (Î²-CoV) emerged in Saudi Arabia"/>
   <result pre="Later on, the 11th February, WHO termed the disease as" exact="coronavirus disease 2019" post="(COVID-19) and CSG (Coronavirus Study Group) of the International"/>
   <result pre="to be addressed by the therapeutics development. Drugs to combat" exact="SARS-CoV-2 infection" post="are in search. In particular, proteins of SARS-CoV-2 such"/>
   <result pre="of CQ, may function as a safer treatment method for" exact="COVID 19," post="as it demonstrates anti-SARS-CoV activity in vitro [68] with"/>
   <result pre="Gilad Sciences. Inc in 2015 primarily for the treatment of" exact="Ebola" post="and it is in Phase -II trials for its"/>
   <result pre="is in Phase -II trials for its activity against the" exact="Ebola" post="virus-induced hemorrhagic fever [75]. In vivo and in vitro"/>
   <result pre="viral load in primary human epithelial cell cultures. RDV blocks" exact="SARS-CoV infection" post="at a micromolecular and at a half cytotoxic concentration"/>
   <result pre="against many other viruses like the Lassa virus, zika virus," exact="Ebola" post="virus, flavivirus, herpes simplex and in food â€&quot; mouth"/>
   <result pre="A study conducted in China reveals that ARB effectively inhibits" exact="SARS-CoV-2 infection" post="at low concentration of 10â€&quot;30Â Î¼M in vitro. The"/>
   <result pre="any mortality or significant adverse effect [109]. Evidently, FPV in" exact="Influenza" post="could contribute to positive treatment interventions. FPV may also"/>
   <result pre="declared on 4 February 2020 that DRV prevented in vitro" exact="SARS-CoV-2 infection." post="Cell research demonstrated that DRV reported to inhibit viral"/>
   <result pre="Studies showed that AZ is also effective against zika and" exact="Ebola" post="virus. AZ acts against the virus by a host"/>
   <result pre="aids in decreasing the viral load [160]. Cytokine storm in" exact="SARS-CoV-2 infection" post="is mainly caused due to SHL and cyclosporine is"/>
   <result pre="failed to offer an advantage in many viral epidemics, including" exact="influenza infection," post="respiratory syncytial virus (RSV) infection, MERS and SARS [176]."/>
   <result pre="future perspectivesInt. J. Antimicrob. Agents202010595110.1016/j.ijantimicag.2020.105951 20Severe outcomes among patients with" exact="coronavirus disease 2019" post="(COVID-19) â€&quot; United States, February 12â€&quot;March 16, 2020 |"/>
   <result pre="10, 2020). 21ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.XiaJ.YuT.ZhangX.ZhangL.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751310.1016/S0140-6736(20)30211-732007143 22ChaR.JohJ.-S.JeongI.LeeJ.Y.ShinH.-S.KimG.KimY.C.C.T. of N.M."/>
   <result pre="acute respiratory syndrome coronavirusJ. Virol.7920055288529510.1128/JVI.79.9.5288-5295.200515827143 30PerrierA.BonninA.DesmaretsL.DanneelsA.GoffardA.RouillÃ©Y.DubuissonJ.BelouzardS.The C-terminal domain of the" exact="MERS coronavirus" post="M protein contains a trans-Golgi network localization signalJ. Biol."/>
   <result pre="74LimJ.JeonS.ShinH.-Y.KimM.J.SeongY.M.LeeW.J.ChoeK.-W.KangY.M.LeeB.ParkS.-J.Case of the index patient who caused tertiary transmission of" exact="coronavirus disease 2019" post="in Korea: the application of lopinavir/ritonavir for the treatment"/>
   <result pre="quantitative RT-PCRJ. Korean Med. Sci.35202010.3346/jkms.2020.35.e79 75HoenenT.GrosethA.FeldmannH.Therapeutic strategies to target the" exact="Ebola" post="virus life cycleNat Rev Microbiol17201959360610.1038/s41579-019-0233-231341272 76LoM.K.FeldmannF.GaryJ.M.JordanR.BannisterR.CroninJ.PatelN.R.KlenaJ.D.NicholS.T.CihlarT.ZakiS.R.FeldmannH.SpiropoulouC.F.de WitE.Remdesivir (GS-5734) protects"/>
   <result pre="Med.92017eaal365310.1126/scitranslmed.aal365328659436 80WarrenT.K.JordanR.LoM.K.RayA.S.MackmanR.L.SolovevaV.SiegelD.PerronM.BannisterR.HuiH.C.LarsonN.StrickleyR.WellsJ.StuthmanK.S.Van TongerenS.A.GarzaN.L.DonnellyG.ShurtleffA.C.RettererC.J.GharaibehD.ZamaniR.KennyT.EatonB.P.GrimesE.WelchL.S.GombaL.WilhelmsenC.L.NicholsD.K.NussJ.E.NagleE.R.KugelmanJ.R.PalaciosG.DoerfflerE.NevilleS.CarraE.ClarkeM.O.ZhangL.LewW.RossB.WangQ.ChunK.WolfeL.BabusisD.ParkY.StrayK.M.TranchevaI.FengJ.Y.BarauskasO.XuY.WongP.BraunM.R.FlintM.McMullanL.K.ChenS.-S.FearnsR.SwaminathanS.MayersD.L.SpiropoulouC.F.LeeW.A.NicholS.T.CihlarT.BavariS.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature531201638138510.1038/nature1718026934220 81MadelainV.NguyenT.H.T.OlivoA.de LamballerieX.GuedjJ.TaburetA.-M.MentrÃ©F.Ebola virus infection: review"/>
   <result pre="combination of interferon-Î±2b and ribavirinSci. Rep.32013168610.1038/srep0168623594967 91DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discoveries &amp;amp; Therapeutics142020586010.5582/ddt.2020.0101232147628 92KnowlesS.R.PhillipsE.J.DresserL.MatukasL.Common adverse events associated with"/>
   <result pre="host defensesAnnu. Rev. Immunol.32201451354510.1146/annurev-immunol-032713-12023124555472 122OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.AlmakhlafiG.A.AlbarrakM.M.MemishZ.A.AlbarrakA.M.Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: a retrospective cohort studyLancet Infect. Dis.1420141090109510.1016/S1473-3099(14)70920-X25278221 123HensleyL.E.FritzE.A.JahrlingP.B.KarpC.HugginsJ.W.GeisbertT.W.Interferon-Î²"/>
   <result pre="SARS coronavirus replicationEmerg. Infect. Dis.10200431731910.3201/eid1002.03048215030704 124ChanJ.F.W.ChanK.-H.KaoR.Y.T.ToK.K.W.ZhengB.-J.LiC.P.Y.LiP.T.W.DaiJ.MokF.K.Y.ChenH.HaydenF.G.YuenK.-Y.Broad-spectrum antivirals for the emerging" exact="Middle East respiratory syndrome" post="coronavirusJ. Infect.67201360661610.1016/j.jinf.2013.09.02924096239 125ShenK.-L.YangY.-H.Diagnosis and treatment of 2019 novel coronavirus"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern. Med.202010.1001/jamainternmed.2020.0994 179ZhouY.-H.QinY.-Y.LuY.-Q.SunF.YangS.HarypursatV.TangS.-Q.HuangY.-Q.HeX.-Q.ZengY.-M.LiY.XuX.-L.ZhaoT.ChenY.-K.Effectiveness of glucocorticoid"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264504\results\search\zoonosis\results.xml">
   <result pre="the public health emergency.file:UOG-55-841.pdffig-count: table-count: page-count: word-count: During the current" exact="coronavirus disease 2019" post="(COVIDâ€�19) pandemic, several questions have arisen relating to the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264535\results\search\zoonosis\results.xml">
   <result pre="diseases in the last 3 decades, ranging from rotavirus to" exact="Middle East respiratory syndrome" post="coronavirus.1 The increasing human population, people movement across diverse"/>
   <result pre="it was distinct from SARSâ€�CoV (sequence homology 79%) and the" exact="Middle East respiratory syndrome" post="(MERS)â€�CoV (sequence homology 50%).3 The sequences were deposited in"/>
   <result pre="et al. Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507â€�513.32007143 9WangD,"/>
   <result pre="of mice. J Immunol. 2004;173:4030â€�4039.15356152 12LiK, Wohlfordâ€�LenaneC, PerlmanS, et al." exact="Middle East respiratory syndrome" post="coronavirus causes multiple organ damage and lethal disâ€�ease in"/>
   <result pre="kidney cells. Arch Virol. 1976;52:101â€�111.187144 29NetlandJ, MeyerholzDK, MooreS, CassellM, PerlmanS." exact="Severe acute respiratory syndrome" post="coronavirus infection causes neuronal death in the absence of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264541\results\search\zoonosis\results.xml">
   <result pre="use in six pregnant women in a randomised trial during" exact="Ebola" post="epidemics. The authors reported no adverse effect.27 The historical"/>
   <result pre="18 April 2020. 12The efficacy of different antiâ€�viral drugs in" exact="COVID 19" post="infected patients â€&quot; Full Text View â€&quot; ClinicalTrials.gov [https://clinicaltrials.gov/ct2/show/NCT04321616]."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264656\results\search\zoonosis\results.xml">
   <result pre="Although greatly resembled pathological features of COVIDâ€�19 with SARS and" exact="MERS coronavirus" post="infection, COVIDâ€�19 patients were found to have the unique"/>
   <result pre="the relative risk of mortality significantly.96 During the outbreak of" exact="Ebola" post="virus disease (EVD) in 2014, the use of convalescent"/>
   <result pre="the laboratory effect of convalescent plasma therapy for patients with" exact="Middle East respiratory syndrome" post="coronavirus infection was reported98 and no severe adverse events"/>
   <result pre="et al. Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507â€�513.32007143 7WuZ,"/>
   <result pre="Med. 2020;382(13):1199â€�1207.31995857 9GuanWJ, NiZY, HuY, et al. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. 2020. 10VerityR, OkellLC,"/>
   <result pre="Infect Dis. 2020;26(7). 10.3201/eid2607.200282 12BrebanR, RiouJ, FontanetA. Interhuman transmissibility of" exact="Middle East respiratory syndrome" post="coronavirus: estimation of pandemic risk. Lancet. 2013;382(9893):694â€�699.23831141 13FangY, NieY,"/>
   <result pre="WuX, ZengW, et al. Chest CT findings in patients with" exact="coronavirus disease 2019" post="and its relationship with clinical features. Invest Radiol. 2020;55(5):257â€�261.32091414"/>
   <result pre="of the ID now influenza A &amp;amp; B 2, Cobas" exact="Influenza" post="A/B, and Xpert Xpress Flu pointâ€�ofâ€�care nucleic acid amplification"/>
   <result pre="Cell Res. 2020;30(3):269â€�271.32020029 82DongL, HuS, GaoJ. Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVIDâ€�19). Drug Discov Ther. 2020;14(1):58â€�60.32147628 83GaoY, YanL, HuangY, et"/>
   <result pre="Antimicrob Agents. 2020;105949.32205204 89GuastalegnameM, ValloneA. Could chloroquine/hydroxychloroquine be harmful in" exact="coronavirus disease 2019" post="(COVIDâ€�19) treatment?Clin Infect Dis. 2020. 90GbinigieK, FrieK. Should chloroquine"/>
   <result pre="Convalescent Whole Blood or Plasma Collected from Patients Recovered from" exact="Ebola" post="Virus Disease for Transfusion, as an Empirical Treatment During"/>
   <result pre="and laboratory effects of convalescent plasma therapy for patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a study protocol. SpringerPlus. 2015;4:709.26618098 99LuCL, MurakowskiDK,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264879\results\search\zoonosis\results.xml">
   <result pre="are still lacking for SARSâ€�CoVâ€�2, but when using data from" exact="Middle East respiratory syndrome" post="(MERS) coronavirus, the daily mean risk of infection was"/>
   <result pre="limited evidence for the efficiency of surgical masks against seasonal" exact="influenza infection" post="in healthcare personnel, while some evidence exists for mask"/>
   <result pre="Staiger, D.O. (2020) Older clinicians and the surge in novel" exact="coronavirus disease 2019" post="(COVIDâ€�19). JAMA [Epub ahead of print]. 10.1001/jama.2020.4978 Bunyan, D.,"/>
   <result pre="and Vallone, A. (2020) Could Chloroquine /hydroxychloroquine be harmful in" exact="Coronavirus disease 2019" post="(COVIDâ€�19) treatment?Clin Infect Dis pii: ciaa321 [Epub ahead of"/>
   <result pre="Maiwald, M., and Li, J. (2020) A well infant with" exact="coronavirus disease 2019" post="(COVIDâ€�19) with high viral load. Clin Infect Dis pii:"/>
   <result pre="D. (2020) Clinical and epidemiological features of 36 children with" exact="coronavirus disease 2019" post="(COVIDâ€�19) in Zhejiang, China: an observational cohort study. Lancet"/>
   <result pre="X., et al (2020b) Evolving epidemiology and transmission dynamics of" exact="coronavirus disease 2019" post="outside Hubei province, China: a descriptive and modelling study."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264920\results\search\zoonosis\results.xml">
   <result pre="CancerMol. CancerMolecular Cancer1476-4598BioMed CentralLondon pmcid: 72649201218 doi: 10.1186/s12943-020-01218-1 : Review" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2): a review FengWei2412276155@qq.comZongWei526336268@qq.comWangFengrichardwangf@163.comJuShaoqingjsq814@hotmail.com[], grid.440642.00000 0004 0644"/>
   <result pre="critically ill patients) [30, 31]. Diarrhea, a common symptom of" exact="SARS-CoV-2 infection," post="also accounts for a high proportion of SARS-CoV-2 infections"/>
   <result pre="hospital in Wuhan was reported to have been diagnosed with" exact="SARS-CoV-2 infection" post="30â€‰h after birth, and it was considered that SARS-CoV-2"/>
   <result pre="and IgM can be detected in the second week after" exact="SARS-CoV-2 infection" post="[81]. At present, SARS-CoV-2 nucleic acid detection kit approved"/>
   <result pre="difficulties and restore prosperity as soon as possible. Abbreviations SARS-CoV" exact="Severe acute respiratory syndrome" post="coronavirus MERS-CoV East respiratory syndrome coronavirus SARS-CoV-2 Severe acute"/>
   <result pre="acute respiratory syndrome coronavirus MERS-CoV East respiratory syndrome coronavirus SARS-CoV-2" exact="Severe acute respiratory syndrome" post="coronavirus2 WHO The world health organization ICTV The international"/>
   <result pre="Microbiol2003120921810.1038/nrmicro77515035025 3.Memish ZA, Perlman S, Van Kerkhove MD, Zumla A." exact="Middle East respiratory syndrome." post="Lancet. 2020;Â 395:1063â€&quot;77. 4.Zhu N, Zhang D, Wang W,"/>
   <result pre="Azman AS, Reich NG, Lessler J. The incubation period of" exact="coronavirus disease 2019" post="(COVID-19) from publicly reported confirmed cases: estimation and application."/>
   <result pre="Dis. 2020;26(6):1337â€&quot;39. 45.Cao Q, Chen YC, Chen CL, Chiu CH." exact="SARS-CoV-2 infection" post="in children: transmission dynamics and clinical characteristics. J Formos"/>
   <result pre="infection control response to the rapidly evolving epidemiology of the" exact="Coronavirus disease 2019" post="(COVID-19) due to SARS-CoV-2 in Hong Kong. Infect Control"/>
   <result pre="Italy: a retrospective analysis. Bjog. 2020. 10.1111/1471-0528.16278. 71.ZhangXChenXChenLDengCZouXLiuWYuHChenBSunXThe evidence of" exact="SARS-CoV-2 infection" post="on ocular surfaceOcul Surf20201836036210.1016/j.jtos.2020.03.010 72.BrebanRRiouJFontanetAInterhuman transmissibility of Middle East"/>
   <result pre="of SARS-CoV-2 infection on ocular surfaceOcul Surf20201836036210.1016/j.jtos.2020.03.010 72.BrebanRRiouJFontanetAInterhuman transmissibility of" exact="Middle East respiratory syndrome" post="coronavirus: estimation of pandemic riskLancet201338269469910.1016/S0140-6736(13)61492-023831141 73.Hellewell J, Abbott S,"/>
   <result pre="Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of" exact="coronavirus disease 2019" post="(COVID-19). Clin Chem Lab Med. 2020. 10.1515/cclm-2020-0285. 85.Pan Y,"/>
   <result pre="J Roentgenol. 2020. 10.2214/AJR.20.22959. 87.Al-Tawfiq JA, Memish ZA. Diagnosis of" exact="SARS-CoV-2 infection" post="based on CT scan vs. RT-PCR: Reflecting on Experience"/>
   <result pre="2019 coronavirus. Antimicrob Agents Chemother. 2020;64(5):e00399â€&quot;20. 90.DongLHuSGaoJDiscovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov Ther202014586010.5582/ddt.2020.0101232147628 91.BatlleDWysockiJSatchellKSoluble angiotensin-converting enzyme 2: a potential"/>
   <result pre="Epidemiological characteristics and incubation period of 7,015 confirmed cases with" exact="coronavirus disease 2019" post="outside Hubei Province in China. J Infect Dis. 2020;"/>
   <result pre="support on sleep quality of medical staff treating patients with" exact="coronavirus disease 2019" post="(COVID-19) in January and February 2020 in ChinaMed Sci"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7266420\results\search\zoonosis\results.xml">
   <result pre="rights that occurred during previous pandemic responses, including the 2014â€&quot;2016" exact="Ebola" post="outbreak, whereby women were denied access to violence support"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7266578\results\search\zoonosis\results.xml">
   <result pre="which originated in China in 2002 [3] and the ongoing" exact="Middle East respiratory syndrome" post="(MERS),) first recorded in 2012 in the Middle East"/>
   <result pre="[22]. Epidemiological evidence suggests that during first month of winter," exact="influenza infection" post="is most common worldwide when Vit D levels are"/>
   <result pre="Peopleâ€™s Republic of China, in February, 2003Lancet36220031353135814585636 4AssiriA.McGeerA.PerlT.M.Hospital outbreak of" exact="Middle East respiratory syndrome" post="coronavirusN Engl J Med369201340741623782161 5YinY.WunderinkR.G.MERS, SARS and other coronaviruses"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7266583\results\search\zoonosis\results.xml">
   <result pre="long as the COVID-19 resource centre remains active. Abstract Aim" exact="Coronavirus disease 2019" post="(COVID-19) is a novel highly contagious infection caused by"/>
   <result pre="system Acute respiratory distress syndrome Hyperinflammation Cytokine storm 1 Introduction" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19),"/>
   <result pre="Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the" exact="coronavirus disease 2019" post="(COVID-19), and has affected people's lives globally, since first"/>
   <result pre="Biol. Chem.275432000332383324310924499 11ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet39510223202050751332007143 12SaghazadehA.RezaeiN.Immune-epidemiological parameters of"/>
   <result pre="25DiaoB.WangC.TanY.ChenX.LiuY.NingL.Reduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVID-19)medRxiv20202020.02.18.20024364 26ZhangC.WuZ.LiJ.-W.ZhaoH.WangG.-Q.The cytokine release syndrome (CRS) of severe COVID-19"/>
   <result pre="COVID -19Arthritis Rheum.202010.1002/art.41285 33LiuB.LiM.ZhouZ.GuanX.XiangY.Can we use interleukin-6 (IL-6) blockade for" exact="coronavirus disease 2019" post="(COVID-19)-induced cytokine release syndrome (CRS)?J. Autoimmun.202010245232291137 34WangX.FangX.CaiZ.WuX.GaoX.MinJ.Comorbid chronic diseases"/>
   <result pre="setupCurrent Protocols in Microbiology5712020 49JuB.ZhangQ.GeX.WangR.YuJ.ShanS.Potent human neutralizing antibodies elicited by" exact="SARS-CoV-2 infection" post="bioRxiv20202020.03.21.990770 50Md Insiat IslamR.Current drugs with potential for treatment"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7266750\results\search\zoonosis\results.xml">
   <result pre="(2020). All measures taken by the Judiciary to deal with" exact="Covid-19" post="in prisons; granting furlough to 70,000 prisinors[in persian] [Press"/>
   <result pre="Addiction EpidemicsAnnals of Internal Medicine202010.7326/M20-1212 World Health Organization, WHO. (2020a)." exact="Coronavirus disease 2019" post="(COVID-19): Situation report, 67. collab: World Health Organization, WHOMental"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7266814\results\search\zoonosis\results.xml">
   <result pre="To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract" exact="Influenza" post="epidemics and pandemics are constant threats to global public"/>
   <result pre="https://doi.org/10.13039/501100002920Research Grants Council, University Grants Committee (RGC, UGC) 17115015171212141712631717122519TuWenwei Introduction" exact="Influenza" post="is an acute respiratory virus infection that continues to"/>
   <result pre="immunity was recently thought to have obvious advantages in controlling" exact="influenza infection" post="without the risks of viral mutation and antiviral resistance.6â€&quot;8"/>
   <result pre="to improve the antiviral activity of human VÎ³9VÎ´2-T cells. Results" exact="Influenza" post="virus induced CD137 and CD137L expression on VÎ³9VÎ´2-T cells"/>
   <result pre="to promote the antiviral activity of VÎ³9VÎ´2-T cells. Fig. 1" exact="Influenza" post="virus induced CD137 and CD137L expression on VÎ³9VÎ´2-T cells"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267113\results\search\zoonosis\results.xml">
   <result pre="the public health emergency.file:JMV-9999-na.pdf Abstract Abstract The recent emergence of" exact="coronavirus disease 2019" post="(COVIDâ€�19) pandemic has reassessed the usefulness of historic convalescent"/>
   <result pre="review. J Med Virol. 2020;1â€&quot;9. 10.1002/jmv.2596131502247 1 INTRODUCTION The recent" exact="coronavirus disease 2019" post="(COVIDâ€�19) epidemic developed into an unprecedented global public health"/>
   <result pre="acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; COVIDâ€�19," exact="coronavirus disease 2019;" post="CP, convalescent plasma; CT, computed tomography; Ct, computed tomography;"/>
   <result pre="the outbreak of many diseases at various periods, including spanish" exact="Influenza" post="A (H1N1) infections in 1915 to 1917,11 severe acute"/>
   <result pre="Government of India. References REFERENCES 1collab: World Health Organization ." exact="Coronavirus disease 2019" post="(COVIDâ€�19) â€� Situation Repor â€� 90 (April 19, 2020)."/>
   <result pre="convalescent whole blood or plasma collected from patients recovered from" exact="Ebola" post="virus disease for transfusion, as an empirical treatment during"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267115\results\search\zoonosis\results.xml">
   <result pre="2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf 17GuanWJ, NiZY, HuY, et al. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. 2020. 18GuJ, HanB,"/>
   <result pre="2020;395:922. 34LauerSA, GrantzKH, BiQ, et al. The incubation period of" exact="coronavirus disease 2019" post="(COVIDâ€�19) from publicly reported confirmed cases: estimation and application."/>
   <result pre="2020. 36WuZ, McGooganJM. Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVIDâ€�19) outbreak in China: summary of a report of"/>
   <result pre="analogs and mycophenolic acid synergistically inhibit the papainâ€�like protease of" exact="Middle East respiratory syndrome" post="coronavirus. Antiviral Res. 2015;115:9â€&quot;16.25542975 73IbrahimA, AhmedM, ConwayR, CareyJJ. Risk"/>
   <result pre="metaâ€�analysis. Int J Clin Pract. 2014;68:520â€&quot;528.24548627 79ChengVC, LauSK, WooPC, YuenKY." exact="Severe acute respiratory syndrome" post="coronavirus as an agent of emerging and reemerging infection."/>
   <result pre="Registry 2020. http://www.chictr.org.cn/searchprojen.aspx?title=COVID-19%26officialname=%26subjectid=%26secondaryid=%26applier=%26studyleader=%26ethicalcommitteesanction=%26sponsor=%26studyailment=%26studyailmentcode=%26studytype=0%26studystage=0%26studydesign=0%26minstudyexecutetime=%26maxstudyexecutetime=%26recruitmentstatus=0%26gender=0%26agreetosign=%26secsponsor=%26regno=%26regstatus=0%26country=%26province=%26city=%26institution=%26institutionlevel=%26measure=%26intercode=%26sourceofspends=%26createyear=0%26isuploadrf=%26whetherpublic=%26btngo=btn%26verifycode=%26page=1 115SchwartzJ, KingCâ€�C, YenMâ€�Y.Protecting healthcare workers during the" exact="coronavirus disease 2019" post="(COVIDâ€�19) outbreak: lessons from Taiwanâ€™s severe acute respiratory syndrome"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267122\results\search\zoonosis\results.xml">
   <result pre="coronavirus (SARSâ€�CoV). The clinical illness it causes is termed as" exact="coronavirus disease 2019" post="(COVIDâ€�19).2 While several other human coronaviruses such as HCoVâ€�NL63,"/>
   <result pre="and HCoVâ€�HKU1 cause mild respiratory disease, others like the zoonotic" exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV) and SARSâ€�CoV tend to have a higher"/>
   <result pre="Engl J Med. 2020;382:1199â€�1207. 10.1056/NEJMoa2001316.31995857 5LaiCC, ShihTP, KoWC, TangHJ, HsuehPR." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARSâ€�CoVâ€�2) and corona virus diseaseâ€�2019 (COVIDâ€�19): the"/>
   <result pre="Lancet. 2020;S0140â€�6736(20):30154â€�30159. 22GuanWJ, NiZY, HuY, et al. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. 2020;382:1708â€�1720. 10.1056/NEJMoa2002032.32109013 23YangX,"/>
   <result pre="Commun. 2020;11(1):222 1â€&quot;4.31924756 34DongL, HuS, GaoJ. Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVIDâ€�19). Drug Discov Ther. 2020;14(1):58â€�60.32147628 35AdaljaAA. Oseltamivir protective against"/>
   <result pre="are potent inhibitors of severe acute respiratory syndrome coronavirus and" exact="Middle East respiratory syndrome" post="coronavirus fusion. J Virol. 2016;90:8924â€�8933.27466418 46Shanghai Institute of Materia"/>
   <result pre="of recombinant nucleocapsid and spice protein serological diagnosis of novel" exact="coronavirus disease 2019" post="(COVIDâ€�19). medxriv. 202010.1101/2020.03.17.20036954v1. 52PanY, LiX, et al. Serological immunochromatographic"/>
   <result pre="66LinQ, ZhaoS, GaoD, et al. A conceptual model for the" exact="coronavirus disease 2019" post="(COVIDâ€�19) outbreak in Wuhan, China with individual reaction and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267399\results\search\zoonosis\results.xml">
   <result pre="cathepsin B and L CC50 halfâ€�cytotoxic concentration COVIDâ€�19 SARSâ€�CoVâ€�2 caused" exact="coronavirus disease 2019" post="CoVs coronaviruses DPPâ€�4 dipeptidyl peptidaseâ€�4 ECMO extracorporeal membrane oxygenation"/>
   <result pre="IP10 IFNâ€�Î³â€�inducible protein 10 IRF3 IFN regulatory factor 3 MERSâ€�CoV" exact="Middle East respiratory syndrome" post="coronavirus Mpro main protease nsps nonstructural proteins PARP1 polyâ€�ADPâ€�ribose"/>
   <result pre="2020, the World Health Organization (WHO) declared that SARSâ€�CoVâ€�2 caused" exact="coronavirus disease 2019" post="(COVIDâ€�19), a public health emergency of international concern, and"/>
   <result pre="severe acute respiratory syndrome coronavirus (SARSâ€�CoV, 2002, southern China) and" exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV, 2012, Saudi Arabia), which mainly infect the"/>
   <result pre="and prevent new rounds of infection. During the outbreak of" exact="Ebola" post="in 2014â€&quot;2015, this rationale was used to treat Ebola"/>
   <result pre="of Ebola in 2014â€&quot;2015, this rationale was used to treat" exact="Ebola" post="patients with convalescent serum and achieved very good results"/>
   <result pre="L., Enjuanes, L., Weiss, S., &amp;amp; Sarafianos, S. G. (2012)." exact="Severe acute respiratory syndrome" post="coronavirus replication inhibitor that interferes with the nucleic acid"/>
   <result pre="replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and" exact="Middle East respiratory syndrome" post="coronaviruses. Antimicrobial Agents and Chemotherapy, 58(8), 4894â€&quot;4898. 10.1128/AAC.02994-1424841268 Ahmed,"/>
   <result pre="L. (2020). Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: A descriptive study. Lancet, 395(10223), 507â€&quot;513."/>
   <result pre="analogs and mycophenolic acid synergistically inhibit the papainâ€�like protease of" exact="Middle East respiratory syndrome" post="coronavirus. Antiviral Research, 115, 9â€&quot;16. 10.1016/j.antiviral.2014.12.01125542975 Clasman, J. R.,"/>
   <result pre="Hu, S., &amp;amp; Gao, J. (2020). Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVIDâ€�19). Drug Discov Ther, 14(1), 58â€&quot;60. 10.5582/ddt.2020.0101232147628 Fung, T."/>
   <result pre="of clinical diagnosis and treatment of a case infected with" exact="coronavirus disease 2019." post="Journal of Medical Virology, 92(5), 461â€&quot;463. 10.1002/jmv.2571132073161 Harding, S."/>
   <result pre="use of TKMâ€�100802 and convalescent plasma in 2 patients with" exact="Ebola" post="virus disease in the United States. Clinical Infectious Diseases,"/>
   <result pre="Bucher, K., &amp;amp; Rekito, A. (2020). Coronavirus Disease 2019 and" exact="Influenza" post="2019â€�2020. JAMA, 323(12), 1122â€&quot;1122. 10.1001/jama.2020.263332207769 Lu, M., Wu, J.,"/>
   <result pre="T. W. (2016). Passive immunotherapy: Assessment of convalescent serum against" exact="Ebola" post="virus Makona infection in nonhuman primates. The Journal of"/>
   <result pre="Dai, Y. (2020). Controversial treatments: An updated understanding of the" exact="coronavirus disease 2019." post="Journal of Medical Virology, 1â€&quot;22. 10.1002/jmv.2578831502247 Zhang, D. H.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267548\results\search\zoonosis\results.xml">
   <result pre="10.1111/trf.15797TRF15797 : Review: Reviews Convalescent plasma: possible therapy for novel" exact="coronavirus disease 2019" post="CONVALESENT PLASMA: POSSIBLE THERAPY FOR COVIDâ€�19 Cao and Shi"/>
   <result pre="of the public health emergency.file:TRF-60-1078.pdffig-count: table-count: page-count: word-count: ABBREVIATIONS COVIDâ€�19" exact="coronavirus disease 2019" post="MERS Middle East respiratory syndrome SARS severe acute respiratory"/>
   <result pre="emergency.file:TRF-60-1078.pdffig-count: table-count: page-count: word-count: ABBREVIATIONS COVIDâ€�19 coronavirus disease 2019 MERS" exact="Middle East respiratory syndrome" post="SARS severe acute respiratory syndrome WHO World Health Organization"/>
   <result pre="severe acute respiratory syndrome WHO World Health Organization The recent" exact="coronavirus disease 2019" post="(COVIDâ€�19) epidemic is spreading all over the world. By"/>
   <result pre="delay in the peak of viral replication in a lethal" exact="Ebola" post="virusâ€&quot;infected mouse model.3 Another assumption is that convalescent plasma"/>
   <result pre="flu epidemics (2005â€�2015), A (H1N1) flu epidemics (2009â€�2010), and the" exact="Ebola" post="virus epidemics (2013â€�2015) have been proved exceedingly lethal and"/>
   <result pre="convalescent plasma could be a promising specific treatment for serious" exact="Middle East respiratory syndrome" post="(MERS), and further evaluation is needed in human clinical"/>
   <result pre="serum from people who are convalescing from infection with the" exact="Ebola" post="virus can be used to treat new patients.19 PRINCIPLE"/>
   <result pre="after being discharged and who have twice tested negative for" exact="Ebola" post="virus RNA by molecular techniques (the two samples for"/>
   <result pre="Ebola virus RNA by molecular techniques (the two samples for" exact="Ebola" post="virus RNA testing should be taken at least 48â€‰hours"/>
   <result pre="SARS, avian influenza A (H5N1), influenza A (H1N1), MERS, and" exact="Ebola" post="virus. Although many studies have reported the efficacy and"/>
   <result pre="decrease the viral load and increase Antiâ€�SARSâ€�CoV IgM and IgG" exact="Influenza" post="A/B Wu22 International Journal of Infectious Diseases 10â€‰days after"/>
   <result pre="viral load of patients can be quickly removed after transfusion." exact="Ebola" post="van Griensven4 New England Journal of Medicine Up to"/>
   <result pre="also increased in a timeâ€�dependent manner following convalescent plasma transfusion.22" exact="Influenza" post="A/B infection Two cases of convalescent plasma were reported."/>
   <result pre="influenza B virus loads and cytokines after convalescent plasma treatment.28" exact="Ebola" post="virus infection In 1995, a small study reported that"/>
   <result pre="unknown levels of neutralizing antibodies in 84 patients with confirmed" exact="Ebola" post="virus infection was not associated with a significant improvement"/>
   <result pre="Day14 of illness onset.5 In a study of patients with" exact="Lassa fever" post="in Nigeria, all eight patients who received convalescent plasma"/>
   <result pre="COVIDâ€�19. Lancet Infect Dis2020;20:398â€�400.32113510 2GarraudO. Use of convalescent plasma in" exact="Ebola" post="virus infection. Transfus Apher Sci2017;56:31â€�4.28094110 3GuptaM, MahantyS, BrayM, et"/>
   <result pre="transfer of antibodies protects immunocompetent and immunodeficient mice against lethal" exact="Ebola" post="virus infection without complete inhibition of viral replication. J"/>
   <result pre="EdwardsT, de LamballerieX, et al. Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in Guinea. N Engl J Med2016;374:33â€�42.26735992 5ChengY,"/>
   <result pre="plasma and viral load after plasma infusion in patients with" exact="Ebola" post="virus disease. J Infect Dis2018;218:555â€�62.29659889 13FrameJD, VerbruggeGP, GillRG, et"/>
   <result pre="Infect Dis2018;218:555â€�62.29659889 13FrameJD, VerbruggeGP, GillRG, et al. The use of" exact="Lassa fever" post="convalescent plasma in Nigeria. Trans R Soc Trop Med"/>
   <result pre="convalescent whole blood or plasma collected from patients recovered from" exact="Ebola" post="virus disease for transfusion, as an empirical treatment during"/>
   <result pre="Convalescent plasma treatment reduced mortality in patients with severe pandemic" exact="Influenza" post="A (H1N1) 2009 virus infection. Clin Infect Dis2011;52:447â€�56.21248066 26BeigelJH,"/>
   <result pre="Under Review 2020. 29MupapaK, MassambaM, KibadiK, et al. Treatment of" exact="Ebola hemorrhagic fever" post="with blood transfusions from convalescent patients. International Scientific and"/>
   <result pre="syndrome after convalescent plasma use: treatment of a patient with" exact="Ebola" post="virus disease contracted in Madrid, Spain. Lancet Respir Med2015;3:554â€�62.26041403"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267562\results\search\zoonosis\results.xml">
   <result pre="emergency.file:FEB2-9999-na.pdf Abstract The World Health Organization (WHO) has declared the" exact="coronavirus disease 2019" post="(COVIDâ€�19) caused by the novel coronavirus SARSâ€�CoVâ€�2 a pandemic."/>
   <result pre="by John Briggs Abbreviations ACE2, angiotensin Iâ€�converting enzyme 2 MERS," exact="Middle East respiratory syndrome" post="RBD, receptorâ€�binding domain SARSâ€�CoV, severe acute respiratory syndrome coronavirus"/>
   <result pre="RNA virus infections, including the experiences from the SARS and" exact="Middle East respiratory syndrome" post="(MERS) epidemics, several potential target proteins and drugs have"/>
   <result pre="TongYG (2020) Repurposing of clinically approved drugs for treatment of" exact="coronavirus disease 2019" post="in a 2019â€�novel coronavirus (2019â€�nCoV) related coronavirus model. Chin"/>
   <result pre="1051â€&quot;1056.32149769 7DongL, HuS and GaoJ (2020) Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVIDâ€�19). Drug Discov Ther.14, 58â€&quot;60.32147628 8WrappD, WangN, CorbettKS, GoldsmithJA,"/>
   <result pre="The antiviral compound remdesivir potently inhibits RNAâ€�dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus. J Biol Chem295, 4773â€&quot;4779.32094225 19AshburnTT and ThorKB (2004)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267883\results\search\zoonosis\results.xml">
   <result pre="a Zika pandemic (2015), and a widespread pandemic-like extension of" exact="Ebola" post="over five African countries, with cases exported globally (2014"/>
   <result pre="million Led to additional pandemics in 1957, 1968, 2009 1976â€&quot;2020" exact="Ebola" post="15,258 First recognized in 1976; 29 regional epidemics to"/>
   <result pre="1981; ongoing pandemic 2002 SARS 813 Near pandemic 2009 H1N1" exact="swine flu" post="284,000 5th influenza pandemic of the century 2014 Chikungunya"/>
   <result pre="and affordable international air travel) had been more fully developed." exact="Influenza" post="pandemics have been noted to follow human population movement"/>
   <result pre="frightening consequences of pandemics, including reactions to the highly fatal" exact="Ebola" post="and the tragic deformities of babies during the Zika"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7269097\results\search\zoonosis\results.xml">
   <result pre="that offer opportunities for the design of novel inhibitors of" exact="SARS-CoV-2 infection." post="By discussing the current inventory of viral inhibitors, we"/>
   <result pre="drug, remdesivir, is a nucleotide analog originally developed to treat" exact="Ebola" post="infections (caused by another single-stranded RNA virus) and recently"/>
   <result pre="replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and" exact="Middle East respiratory syndrome" post="coronaviruses. Antimicrob. Agents Chemother.2014, 58 (8), 4894â€&quot;8. 10.1128/AAC.02994-14.24841268 SarafianosG."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7269098\results\search\zoonosis\results.xml">
   <result pre="light scattering. N. Engl. J. Med.382, 206110.1056/NEJMc2007800.32294341 HurleyJ. R. (1919)" exact="Influenza" post="with especial reference to the pandemic of 1918. Medical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7269525\results\search\zoonosis\results.xml">
   <result pre="anthropogenic forces that have impacted and transformed the Earth System1." exact="Smallpox" post="was restricted to the Old World for thousands of"/>
   <result pre="civilizations met on unequal terms after 12,000 years of separation." exact="Smallpox" post="emerged in January 1519 and spread rapidly to the"/>
   <result pre="Middle East and North Africa. During 2014-2015, the Western African" exact="Ebola" post="virus epidemic decimated numerous families and caused a socioeconomic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7269953\results\search\zoonosis\results.xml">
   <result pre="Immune checkpoint inhibitors: a physiology-driven approach to the treatment of" exact="coronavirus disease 2019" post="Di CosimoSerenaaMalfettoneAndreabPÃ©rez-GarcÃ­aJosÃ© M.bcLlombart-CussacAntoniobdMiceliRosalbaeCuriglianoGiuseppefgCortÃ©sJavierjacortes@vhio.netbchâˆ—[a], [b], [c], [d], [e], [f], [g],"/>
   <result pre="centre remains active. Abstract While confirmed cases of the deadly" exact="coronavirus disease 2019" post="(COVID-19) have exceeded 4.7 million globally, scientists are pushing"/>
   <result pre="their potential to restore cellular immunocompetence. Highlights â€¢Patients with severe" exact="coronavirus disease 2019" post="(COVID-19) present with lymphocytopenia and T-cell exhaustion. â€¢Persistent stimulation"/>
   <result pre="COVID-19. Keywords COVID-19 SARS-CoV-2 Cytokine storm Antiâ€&quot;PD-1 Antiâ€&quot;IL-6R Pembrolizumab Tocilizumab" exact="Coronavirus disease 2019" post="(COVID-19) is a pandemic infection caused by a positive-sense"/>
   <result pre="cancer [3]. Whether cancer per se increases the risk of" exact="SARS-CoV-2 infection" post="and its complications or rather cancer-associated comorbidities and treatment"/>
   <result pre="potential to restore immunocompetence in the context of sepsis and" exact="influenza infection." post="A recent phase Ib trial reported that in patients"/>
   <result pre="in Wuhan, ChinaJAMA Oncol202010.1001/jamaoncol.2020.0980Published online March 25 6BersanelliM.ScalaS.AffanniP.VeronesiL.ColucciM.E.BannaG.L.Immunological insights on" exact="influenza infection" post="and vaccination during immune checkpoint blockade in cancer patientsImmunotherapy122202010511010.2217/imt-2019-020032046555"/>
   <result pre="9DiaoB.WangC.TanY.ChenX.LiuY.NingL.Reduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVID-19)MedRxiv202010.1101/2020.02.18.200243642020.02.18.20024364 10ZhengY.HuangZ.YingG.ZhangX.YeW.HuZ.Study of the lymphocyte change between COVID-19 and"/>
   <result pre="Infect Dis702202019319910.1093/cid/ciz20230874791 15ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet39510223202050751310.1016/S0140-6736(20)30211-732007143 16XuX.HanM.LiT.SunW.WangD.FuB.Effective treatment of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7270404\results\search\zoonosis\results.xml">
   <result pre="Virus protein ligands (e.g., haemagglutinin or trimeric spike glycoprotein for" exact="Influenza" post="and CoV, respectively) interact with cellular receptors, such as"/>
   <result pre="alveolar type II epithelial (ATII) cells are also permissive to" exact="SARS-CoV infection" post="(35, 36). SARS-CoV-2 has also been shown to infect"/>
   <result pre="that domestic animals, including ferrets and cats, are permissive to" exact="SARS-CoV-2 infection." post="In contrast, the virus replicates poorly in pigs, ducks,"/>
   <result pre="protected from pulmonary disease and death following H1N1 and H7N9" exact="Influenza" post="infection, but not from that of the influenza H3N2"/>
   <result pre="above, distal peripheral lung alveolar epithelial cells seem to harbor" exact="SARS-CoV infection" post="in vivo, and although respiratory epithelial cells are known"/>
   <result pre="interface (ALI)] is the model of choice: in that set-up," exact="SARS-CoV infection" post="triggered an inflammatory response characterized by increased production of"/>
   <result pre="interesting tool to study SARS-CoV2-cells interactions (58), as demonstrated in" exact="Influenza" post="infections with human (59) or animal-derived material (60). As"/>
   <result pre="vitro in epithelial cells and in a murine model that" exact="Influenza" post="H3N2 is able to upregulate mucin expression and that"/>
   <result pre="addition to demonstrating the role of TLR pathways in the" exact="SARS-CoV infection," post="suggested a human genetic predisposition to SARS-CoV, and this"/>
   <result pre="have shown increased protease-mediated lung damage in mice infected with" exact="Influenza" post="(81â€&quot;83). Additionally, in a MERS-CoV murine model, it was"/>
   <result pre="from SOCS (suppressors of cytokine signaling) inhibition (85). Indeed, upon" exact="Influenza" post="infection, SOCS1 and SOCS3 were shown to reduce type"/>
   <result pre="epithelial cells (86). Also, SOCS4-deficient mice exhibited heightened sensitivity to" exact="Influenza" post="infection (87). Studies about SOCS involvement during coronavirus infections"/>
   <result pre="received grants from the FacultÃ© de MÃ©decine Sorbonne UniversitÃ© (AAP" exact="COVID19" post="and UniversitÃ© de Paris (Fonds d'urgence SARS-CoV-2 et COVID-19),"/>
   <result pre="human airway epithelium. Pathog Dis. (2013) 69:87â€&quot;100. 10.1111/2049-632X.1205323821437 20.GartenWBradenCArendtAPeitschCBaronJLuYet al.." exact="Influenza" post="virus activating host proteases: identification, localization and inhibitors as"/>
   <result pre="cytokine storm and immunopathology. Semin Immunopathol. (2017) 39:529â€&quot;39. 10.1007/s00281-017-0629-x28466096 33.SimsACBaricRSYountBBurkettSECollinsPLPicklesRJ." exact="Severe acute respiratory syndrome" post="coronavirus infection of human ciliated airway epithelia: role of"/>
   <result pre="coronavirus infection. J Virol. (2019) 93:e01815-18. 10.1128/JVI.01815-1830626688 49.LiKWohlford-LenaneCLChannappanavarRParkJEEarnestJTBairTBet al.. Mouse-adapted" exact="MERS coronavirus" post="causes lethal lung disease in human DPP4 knockin mice."/>
   <result pre="via a toll-like-receptor-related TRAF3-independent mechanism. MBio. (2016) 7:e01872â€&quot;15. 10.1128/mBio.01872-1526861016 56.YoshikawaTHillTLiKPetersCJTsengCT." exact="Severe acute respiratory syndrome" post="(SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by"/>
   <result pre="J Respir Cell Mol Biol. (2004) 30:470â€&quot;8. 10.1165/rcmb.2003-0199OC14500256 62.BarbierDGarcia-VerdugoIPothlichetJKhazenRDescampsDRousseauKet al.." exact="Influenza" post="A induces the major secreted airway mucin MUC5AC in"/>
   <result pre="and mortality. Cell Host Microbe. (2016) 20:458â€&quot;70. 10.1016/j.chom.2016.09.00527736644 83.VilleretBSolhonneBStraubeMLemaireFCazesAGarcia-VerdugoIet al.." exact="Influenza" post="a virus pre-infection exacerbates Pseudomonas aeruginosa-mediated lung damage through"/>
   <result pre="protects against severe cytokine storm and enhances viral clearance during" exact="influenza infection." post="PLoS Pathog. (2014) 10:e1004134. 10.1371/journal.ppat.100413424809749 88.CalyLDruceJDCattonMGJansDAWagstaffKMThe FDA-approved Drug Ivermectin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7270517\results\search\zoonosis\results.xml">
   <result pre="rather than the virus titer was related to death in" exact="SARS-CoV infection" post="[16, 17]. The infection is mild in most of"/>
   <result pre="syndrome, CKD chronic kidney disease, CMP cardiomyopathy, contd. continued, COVID-19" exact="coronavirus disease 2019," post="CHD coronary heart disease, cs DMARD sonventional synthetic disease"/>
   <result pre="et al. demonstrated that IgG titers against rubella increased in" exact="SARS-CoV-2 infection" post="in some cases, which might suggest a structural homology"/>
   <result pre="clinical manifestations such as Kawasaki-like disease are being related to" exact="SARS-CoV-2 infection." post="We should use the accumulating current scientific evidence and"/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the perspectives of clinical immunologists from ChinaClin Immunol202021410839310.1016/j.clim.2020.10839332222466"/>
   <result pre="children in ChinaPediatrics202010.1542/peds.2020-070232179660 24.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="disease: novel virus and novel caseHosp Pediatr202010.1542/hpeds.2020-012332265235 32.MathianAMahevasMRohmerJRoumierMCohen-AubartFAmador-BorreroBBarreletAChauvetCChazalTDelahousseMDevauxMEuvrardRFadlallahJFlorensNHarocheJHieMJuillardLLhoteRMailletTRichard-ColmantGPalluyJBPhaMPerardLRemyPRiviereESeneDSevePMorelot-PanziniCViallardJFVirotJSBenameurNZahrNYsselHGodeauBAmouraZClinical course of" exact="coronavirus disease 2019" post="(COVID-19) in a series of 17 patients with systemic"/>
   <result pre="use of hydroxychloroquine in systemic lupus erythematosus does not preclude" exact="SARS-CoV-2 infection" post="and severe COVID-19Ann Rheum Dis202010.1136/annrheumdis-2020-21769032475834 42.MoutsopoulosHMAnti-inflammatory therapy may ameliorate"/>
   <result pre="Dis202010.1136/annrheumdis-2020-21760032345617 44.GargSKimLWhitakerMO'HalloranACummingsCHolsteinRPrillMChaiSJKirleyPDAldenNBKawasakiBYousey-HindesKNiccolaiLAndersonEJOpenoKPWeigelAMonroeMLRyanPHendersonJKimSComo-SabettiKLynfieldRSosinDTorresSMuseABennettNMBillingLSuttonMWestNSchaffnerWTalbotHKAquinoCGeorgeABuddABrammerLLangleyGHallAJFryAHospitalization rates and characteristics of patients hospitalized with laboratory-confirmed" exact="coronavirus disease 2019" post="- COVID-NET, 14 States, March 1â€&quot;30, 2020MMWR Morb Mortal"/>
   <result pre="78.BartonLMDuvalEJStrobergEGhoshSMukhopadhyaySCOVID-19 autopsies, Oklahoma, USAAm J Clin Pathol.202010.1093/ajcp/aqaa06232275742 79.MenterTHaslbauerJDNienholdRSavicSHopferHDeigendeschNFrankSTurekDWilliNParggerHBassettiSLeuppiJDCathomasGTolnayMMertzKDTzankovAPost-mortem examination of" exact="COVID19" post="patients reveals diffuse alveolar damage with severe capillary congestion"/>
   <result pre="I IFNopathiesPediatr Res20208774575210.1038/s41390-019-0614-231641281 82.BasatnehRVlahovicTCAddressing the question of dermatologic manifestations of" exact="SARS-CoV-2 infection" post="in the lower extremities: a closer look at the"/>
   <result pre="Dermatol202010.1016/j.jaad.2020.04.09332417420 84.ZhangYCaoWXiaoMLiYJYangYZhaoJZhouXJiangWZhaoYQZhangSYLiTSClinical and coagulation characteristics of 7 patients with critical" exact="COVID-2019" post="pneumonia and acro-ischemiaZhonghua Xue Ye Xue Za Zhi202041E00610.3760/cma.j.issn.0253-2727.2020.000632220276 85.BatuEDKaradagOTaskiranEZKalyoncuUAksentijevichIAlikasifogluMOzenSA"/>
   <result pre="Online J201917110.1186/s12969-018-0303-430611297 90.OxleyTJMoccoJMajidiSKellnerCPShoirahHSinghIPDe LeacyRAShigematsuTLadnerTRYaegerKASkliutMWeinbergerJDangayachNSBedersonJBTuhrimSFifiJTLarge-vessel stroke as a presenting feature of" exact="Covid-19" post="in the YoungN Engl J Med202010.1056/NEJMc20097877207073 91.LachmannHJPeriodic fever syndromesBest"/>
   <result pre="HC, Lin CY, Chao WC, Sheu CC, for Taiwan Severe" exact="Influenza" post="Research Consortium IImpact of corticosteroid treatment on clinical outcomes"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern Med202010.1001/jamainternmed.2020.099432338717 124.WangYJiangWHeQWangCWangBZhouPDongNTongQA retrospective cohort"/>
   <result pre="Rheumatology Group of the Milan AAbsence of severe complications from" exact="SARS-CoV-2 infection" post="in children with rheumatic diseases treated with biologic drugsJ"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7270651\results\search\zoonosis\results.xml">
   <result pre="Article The international imperative to rapidly and inexpensively monitor community-wide" exact="Covid-19" post="infection status and trends DaughtonChristiandaughton.etox@gmail.com[], pmc-release: 2020-3-3ppub: 2020-7-7epub: 2020-3-3726138149138149received:"/>
   <result pre="continuing concerns surrounding the lack of adequate diagnostic testing for" exact="Covid-19" post="(caused by SARS-CoV-2), even less attention is being paid"/>
   <result pre="the ability to quickly determine the status and trends of" exact="Covid-19" post="within and across communities nationwide. The existing Covid-19 clinical"/>
   <result pre="trends of Covid-19 within and across communities nationwide. The existing" exact="Covid-19" post="clinical diagnostic tests will prove woefully inadequate for rapidly"/>
   <result pre="for rapidly monitoring (at comparatively low cost) the incidence of" exact="Covid-19" post="community-wide. It is simply not feasible to do repeated"/>
   <result pre="importance in quickly determining trends in whether the spread of" exact="Covid-19" post="(as well as future viral epidemics) in individual communities"/>
   <result pre="and economical WBE tool for monitoring status and trends of" exact="Covid-19" post="mass infection will encounter a number of challenges, many"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7270733\results\search\zoonosis\results.xml">
   <result pre="those with euglycemia [29], [30]. Due to the stress by" exact="SARS-CoV-2 infection" post="and to the use of glucocorticoids during hospitalization, patients"/>
   <result pre="SARS-CoV-2 in Wuhan, ChinaAllergy202010.1111/all.14238published online Feb 19 10GuanW.NiZ.HuY.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med202010.1056/NEJMoa2001282published online March 18 11European"/>
   <result pre="of diabetes in the 2009 influenza A (H1N1) and the" exact="Middle East respiratory syndrome" post="coronavirus: a systematic review and meta-analysisJ Public Health Res5201673373928083520"/>
   <result pre="Targets Inflamm Allergy3200445545815584894 22AlqahtaniF.Y.AleanizyF.S.El HadiAliMohamedR.Prevalence of comorbidities in cases of" exact="Middle East respiratory syndrome" post="coronavirus: a retrospective studyEpidemiol Infect.1472019e3510.1017/S0950268818002923Published online 2018 Nov 5"/>
   <result pre="case seriesBMJ3682020m60610.1136/bmj.m606 27ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 28WuZ.McGooganJ.Characteristics of and"/>
   <result pre="a descriptive studyLancet395202050751332007143 28WuZ.McGooganJ.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China summary of a report of"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern Med202010.1001/jamainternmed.2020.0994 30WangY.WangY.ChenY.QinQ.Unique epidemiological and"/>
   <result pre="Intern Med202010.1001/jamainternmed.2020.0994 30WangY.WangY.ChenY.QinQ.Unique epidemiological and clinical features of the emerging" exact="2019 novel coronavirus pneumonia" post="(COVID-19) implicate special control measuresJ Med Virol202010.1002/jmv.25748 31WangA.ZhaoW.XuZ.GuJ.Timely blood"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7270858\results\search\zoonosis\results.xml">
   <result pre="pilgrims and local Saudi populations against emerging Nipah, Zika and" exact="Ebola" post="viral diseases outbreaks threats TamboErnesttambo0711@gmail.comabâ�ŽEl-DessoukyAshraf G.cdKhaterEmad I.M.eXianonngZhouf[a], [b], [c],"/>
   <result pre="Abstract Summary Increasing emergence and spread of Nipah, ZIKV and" exact="Ebola" post="case and potential outbreaks threats have been reported in"/>
   <result pre="reported in several regions around the globe. Yet, emerging Nipah," exact="Ebola" post="and Zika viral diseases outbreaks have been indirectly linked"/>
   <result pre="in advancing Saudi sustainable health development goals. Keywords Emerging Nipah" exact="Ebola" post="and Zika virus Outbreaks Surveillance Hajj Saudi Arabia Abbreviations"/>
   <result pre="HeV, henipavirus R&amp;amp;D, Research and Development ZIKV, Zika virus EDV," exact="Ebola" post="virus Introduction Globalizing health challenges and health solutions are"/>
   <result pre="incidence of sporadic cases and sometimes cluster outbreaks of MERS-CoV," exact="Influenza" post="and Dengue to antimicrobial resistance been reported in most"/>
   <result pre="sporadic cases and sometimes cluster outbreaks of MERS-CoV, Influenza and" exact="Dengue" post="to antimicrobial resistance been reported in most endemics countries"/>
   <result pre="paper provides an update of the trend of emerging Nipah," exact="Ebola" post="and Zika viral diseases outbreaks in affected countries in"/>
   <result pre="is related to dengue, Chikungunya, West Nile, yellow fever, and" exact="Japanese encephalitis" post="viruses. Hajj is among the global travel gatherings, drawing"/>
   <result pre="can also occur within the third-trimester infection [3], [18], [21]." exact="Ebola" post="outbreak The new and recurring Ebola virus outbreak in"/>
   <result pre="infection [3], [18], [21]. Ebola outbreak The new and recurring" exact="Ebola" post="virus outbreak in Ituri, Kivu and Bikoro communities in"/>
   <result pre="as well as hostility local community to medical teams and" exact="Ebola" post="vaccination resistance. Ebola virus infection is a highly contagious"/>
   <result pre="hostility local community to medical teams and Ebola vaccination resistance." exact="Ebola" post="virus infection is a highly contagious and severe infection"/>
   <result pre="slow and late emergency response to the 2014 West Africa" exact="Ebola" post="outbreak crisis (Guinea, Sierra Leone and Liberia) led to"/>
   <result pre="necessary measures to respond promptly and effectively to this new" exact="Ebola" post="epidemic as $1 million Emergency fund has been released"/>
   <result pre="Arabia, there has not reported case of imported and local" exact="Ebola" post="viris in the Kingdom. Yet there is a high"/>
   <result pre="there is a high risk of transmission and spread of" exact="Ebola" post="and other emerging diseases due to Hajj and Umrah"/>
   <result pre="[28], [32]. Major weaknesses and challenges of emerging and re-emerging" exact="Ebola" post="virus outbreaks in most affected countries mainly in sub"/>
   <result pre="diagnostic tools and timely safe drugs Nipah and Zika or" exact="Ebola" post="remain a major challenge for scale mass administration and"/>
   <result pre="World Health Organ96201829229429695886 2TamboE.UgwuE.C.NgogangJ.Y.Need of surveillance response systems to combat" exact="Ebola" post="outbreaks and other emerging infectious diseases in African countriesInfect"/>
   <result pre="August 2016MMWR Morb Mortal Wkly Rep65201687087827559830 27World Health Organization (WHO)New" exact="Ebola" post="outbreak declared in Democratic Republic of the Congo. 8"/>
   <result pre="Infect Dev Ctries108201682983627580328 31MemishZ.A.Al-TawfiqJ.A.The Hajj in the time of an" exact="Ebola" post="outbreak in West AfricaTravel Med Infect Dis125201441541725257580 32AhmadM.D.UsmanM.KhanA.ImranM.Optimal control"/>
   <result pre="in West AfricaTravel Med Infect Dis125201441541725257580 32AhmadM.D.UsmanM.KhanA.ImranM.Optimal control analysis of" exact="Ebola" post="disease with control strategies of quarantine and vaccinationInfect Dis"/>
   <result pre="33(a)TamboE.Xiao-NongZ.Acquired immunity and asymptomatic reservoir impact on frontline and airport" exact="Ebola" post="outbreak syndromic surveillance and responseInfect Dis Poverty320144125699182(b)ShrivastavaS.R.ShrivastavaP.S.RamasamyJ.Lessons learnt from"/>
   <result pre="syndromic surveillance and responseInfect Dis Poverty320144125699182(b)ShrivastavaS.R.ShrivastavaP.S.RamasamyJ.Lessons learnt from the 2014" exact="Ebola" post="outbreak in West-AfricaJ Res Med Sci201201510710825767533 34GetzW.M.GonzalezJ.P.SalterR.BanguraJ.CarlsonC.CoomberM.DoughertyE.KargboD.WolfeN.D.WauquierN.Tactics and strategies"/>
   <result pre="in West-AfricaJ Res Med Sci201201510710825767533 34GetzW.M.GonzalezJ.P.SalterR.BanguraJ.CarlsonC.CoomberM.DoughertyE.KargboD.WolfeN.D.WauquierN.Tactics and strategies for managing" exact="Ebola" post="outbreaks and the salience of immunizationComput Math Methods Med201573650725755674"/>
   <result pre="Methods Med201573650725755674 35KucharskiA.J.EggoR.M.WatsonC.H.CamachoA.FunkS.EdmundsW.J.Effectiveness of ring vaccination as control strategy for" exact="Ebola" post="virus diseaseEmerg Infect Dis221201610510826691346 36GlynnR.W.BolandM.HSE Port Health Groups, Ireland."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7273044\results\search\zoonosis\results.xml">
   <result pre="similar viruses such as severe acute respiratory syndromeâ€�related coronavirus (SARSâ€�CoV)," exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV), and Influenza virus. In this article, we"/>
   <result pre="syndromeâ€�related coronavirus (SARSâ€�CoV), Middle East respiratory syndrome coronavirus (MERSâ€�CoV), and" exact="Influenza" post="virus. In this article, we have tried to reach"/>
   <result pre="similar viruses such as severe acute respiratory syndromeâ€�related coronavirus (SARSâ€�CoV)," exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV), and Influenza virus. In patients with COVIDâ€�19,"/>
   <result pre="syndromeâ€�related coronavirus (SARSâ€�CoV), Middle East respiratory syndrome coronavirus (MERSâ€�CoV), and" exact="Influenza" post="virus. In patients with COVIDâ€�19, hydroxychloroquine decreases the inflammatory"/>
   <result pre="but with the severe acute respiratory syndromeâ€�related coronavirus (SARSâ€�CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV) coronaviruses, 79% and 50% were similar, respectively."/>
   <result pre="virus. It is also active in ex vivo conditions on" exact="Ebola" post="virus in mice (T. Sheahan et al.,Â 2017; Tan,"/>
   <result pre="nucleotide analog introduced by Gilead Sciences in 2017 to treat" exact="Ebola" post="virus infection and shown to have antiviral activity against"/>
   <result pre="conducted on remdesivir and clinical trials for the treatment of" exact="Ebola" post="virus with remdesivir are ongoing. One study showed that"/>
   <result pre="F., â€¦ Toovey, S. (2010). Effectiveness of antiviral treatment in" exact="human influenza" post="A (H5N1) infections: Analysis of a global patient registry."/>
   <result pre="Trial Group (2018). Corticosteroid therapy for critically ill patients with" exact="Middle East respiratory syndrome." post="American Journal of Respiratory and Critical Care Medicine, 197(6),"/>
   <result pre="â€¦ Yuen, K. Y. (2013). Broadâ€�spectrum antivirals for the emerging" exact="Middle East respiratory syndrome" post="coronavirus. Journal of Infection, 67(6), 606â€&quot;616.24096239 Chen, C., Zhang,"/>
   <result pre="Case of the index patient who caused tertiary transmission of" exact="Coronavirus disease 2019" post="in Korea: The application of lopinavir/ritonavir for the treatment"/>
   <result pre="B. R., &amp;amp; Spiropoulou, C. F. (2019). Developing therapeutics for" exact="Ebola" post="virus disease: A multifaceted approach, Neglected tropical diseases: Drug"/>
   <result pre="PALM Consortium Study Team (2019). A randomized, controlled trial of" exact="Ebola" post="virus disease therapeutics. New England Journal of Medicine, 381(24),"/>
   <result pre="S. (2016). Therapeutic efficacy of the small molecule GSâ€�5734 against" exact="Ebola" post="virus in rhesus monkeys. Nature, 531(7594), 381â€&quot;385.26934220 Weniger, H.collab:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7277397\results\search\zoonosis\results.xml">
   <result pre="CoV, coronavirus; FIP, feline infectious peritonitis; HCoV, human coronavirus; MERS," exact="Middle East respiratory syndrome;" post="NA, neuraminidase; nABs, neutralizing antibodies; mAbs, monoclonal antibodies; SARS-CoV,"/>
   <result pre="transfected into fetal rhesus kidney FRhK4 cells before or after" exact="SARS-CoV infection" post="and the inhibitory effects were verified by the decrease"/>
   <result pre="number and viral titers. Four siRNAs demonstrated potent inhibition of" exact="SARS-CoV infection" post="and replication. Prophylactic effects with up to 90% inhibition"/>
   <result pre="expression in Vero cells [122]. It was further demonstrated that" exact="SARS-CoV infection" post="was reduced in ACE2-silenced cell lines, providing an attractive"/>
   <result pre="distinct contemporary human coronavirus OC43 strainsVirology2005337859210.1016/j.virol.2005.04.01015914223 33.MeyerB.MullerM.A.CormanV.M.ReuskenC.B.RitzD.GodekeG.J.LattweinE.KalliesS.SiemensA.van BeekJ.et al.Antibodies against" exact="MERS coronavirus" post="in dromedary camels, United Arab Emirates, 2003 and 2013Emerg."/>
   <result pre="for mouse hepatitis virusesJ. Virol.1994684525453710.1128/JVI.68.7.4525-4537.19948207827 64.van DoremalenN.MiazgowiczK.L.Milne-PriceS.BushmakerT.RobertsonS.ScottD.KinneJ.McLellanJ.S.ZhuJ.MunsterV.J.Host species restriction of" exact="Middle East respiratory syndrome" post="coronavirus through its receptor dipeptidyl peptidase 4J. Virol.2014889220923210.1128/JVI.00676-1424899185 65.LiW.MooreM.J.VasilievaN.SuiJ.WongS.K.BerneM.A.SomasundaranM.SullivanJ.L.LuzuriagaK.GreenoughT.C.et"/>
   <result pre="cat infection studiesVet. Microbiol.201821922623310.1016/j.vetmic.2018.04.02629778200 92.OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.AlmakhlafiG.A.AlbarrakM.M.MemishZ.A.AlbarrakA.M.Ribavirin and interferon alpha-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: A retrospective cohort studyLancet Infect. Dis.2014141090109510.1016/S1473-3099(14)70920-X25278221 93.LoM.K.JordanR.ArveyA.SudhamsuJ.Shrivastava-RanjanP.HotardA.L.FlintM.McMullanL.K.SiegelD.ClarkeM.O.et"/>
   <result pre="95.GordonC.J.TchesnokovE.P.FengJ.Y.PorterD.P.GotteM.The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirusJ. Biol. Chem.202010.1074/jbc.AC120.01305632094225 96.WangM.CaoR.ZhangL.YangX.LiuJ.XuM.ShiZ.HuZ.ZhongW.XiaoG.Remdesivir and chloroquine effectively inhibit the"/>
   <result pre="Med.202010.1007/s11684-020-0757-x32170559 105.WangZ.ChenX.LuY.ChenF.ZhangW.Clinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci. Trends202014646810.5582/bst.2020.0103032037389 106.HoffmannM.Kleine-WeberH.SchroederS.KrÃ¼gerN.HerrlerT.ErichsenS.SchiergensT.S.HerrlerG.WuN.NitscheA.et"/>
   <result pre="Transl. Med.20191736210.1186/s12967-019-2116-831703698 137.SrivastavaS.KamthaniaM.SinghS.SaxenaA.K.SharmaN.Structural basis of development of multi-epitope vaccine against" exact="Middle East respiratory syndrome" post="using in silico approachInfect. Drug Resist.2018112377239110.2147/IDR.S17511430538505 138.WangN.RosenO.WangL.TurnerH.L.StevensL.J.CorbettK.S.BowmanC.A.PallesenJ.ShiW.ZhangY.et al.Structural Definition"/>
   <result pre="secondary to hydroxychloroquineGut19943556957010.1136/gut.35.4.5698175002 178.ChorinE.DaiM.ShulmanE.WadhwaniL.Bar-CohenR.BarbhayiaC.AizerA.HolmesD.BernsteinS.SpinelliM.et al.The QT interval in patients with" exact="SARS-CoV-2 infection" post="treated with hydroxychloroquine/azithromycinmedRxiv202010.1101/2020.04.02.20047050v1 179.LiY.XieZ.LinW.CaiW.WenC.GuanY.MoX.WangJ.WangY.PengP.et al.An exploratory randomized, controlled study"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7278221\results\search\zoonosis\results.xml">
   <result pre="country. Subject terms Viral infection Respiratory tract diseases Facts The" exact="Covid-19" post="pandemic exploded first in China and subsequently in Italy."/>
   <result pre="with uploaded sequences in the Global Initiative on Sharing All" exact="Influenza" post="Data (GISAID, www.gisaid.org) also showed a stable evolution (H.L.,"/>
   <result pre="antiviral activities to different viruses including dengue virus, chikungunya virus," exact="Ebola" post="virus, etc. Any effect found has been limited to"/>
   <result pre="the 80 SLE patients who took long-term oral HCQ showed" exact="SARS-CoV-2 infection" post="or appeared to have related symptoms. The study found"/>
   <result pre="of LPV/r beyond standard therapy in hospitalized patients with severe" exact="Covid-19" post="(ref. 51). More importantly, in another randomized control study"/>
   <result pre="experimental drug that was generated for the therapy of the" exact="Ebola" post="viral infection. Notably, remdesivir has shown antiviral efficacy in"/>
   <result pre="is therefore related first of all to risk reduction of" exact="SARS-CoV-2 infection." post="This might be achieved by combining six main actions:"/>
   <result pre="with COVID-19 in Shanghai, ChinaJ. Infect.202080e1e632171869 9.GuanWJet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN. Engl. J. Med.20203821708172032109013 10.ZhouFet al.Clinical course and"/>
   <result pre="studyLancet20203951054106232171076 11.ChenNet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751332007143 12.Wu, Z. &amp;amp;"/>
   <result pre="McGoogan, J. M. Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China. JAMA10.1001/jama.2020.2648 (2020) 13.CaiYet al.Pivotal role"/>
   <result pre="et al. Comorbidity and its impact on 1590 patients with" exact="Covid-19" post="in China: a nationwide analysis. Eur. Respir. J. 10.1183/13993003.00547-2020"/>
   <result pre="Zarebski, A. &amp;amp; Chowell, G. Estimating the asymptomatic proportion of" exact="coronavirus disease 2019" post="(COVID-19) cases on board the Diamond Princess cruise ship,"/>
   <result pre="Eveillard, M. &amp;amp; Lebri, Y. Good IgA bad IgG in" exact="SARS-CoV-2 infection?" post="Clin. Infect. Dis. 10.1093/cid/ciaa426 (2020). 34.Dahlke, C. et al."/>
   <result pre="et al. Correlation of chest CT and RT-PCR testing in" exact="coronavirus disease 2019" post="(COVID-19) in China: a report of 1014 cases. Radiology,"/>
   <result pre="Z., Shabani, M., Shokouhi, S. &amp;amp; Saffaei, A. Aminoquinolines against" exact="coronavirus disease 2019" post="(COVID-19): chloroquine or hydroxychloroquine. Int. J. Antimicrob. Agents55,105945 (2020)."/>
   <result pre="considerations with chloroquine, hydroxychloroquine and azithromycin in the management of" exact="SARS-CoV-2 infection." post="CMAJ10.1503/cmaj.200528 (2020). 43.Molina, J. M. et al. No evidence"/>
   <result pre="severitySci. Rep.201662535927146253 48.SpanakisNet al.Virological and serological analysis of a recent" exact="Middle East respiratory syndrome" post="coronavirus infection case on a triple combination antiviral regimenInt."/>
   <result pre="(2020). 53.WarrenTKet al.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature201653138138526934220 54.de WitEet al.Prophylactic and therapeutic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7278986\results\search\zoonosis\results.xml">
   <result pre="Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The current" exact="Coronavirus disease 2019" post="or COVID-19 pandemic has infected over two million people"/>
   <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 and the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012 [2,3]. Coronaviruses are a family"/>
   <result pre="Chinese Center for Disease Control and PreventionJAMA202010.1001/jama.2020.2648 9.LiuW.ZhangQ.ChenJ.XiangR.SongH.ShuS.ChenL.LiangL.ZhouJ.YouL.et al.Detection of" exact="Covid-19" post="in Children in Early January 2020 in Wuhan, ChinaN."/>
   <result pre="shots at COVID-19Science2020368141610.1126/science.368.6486.1432241928 28.MyintA.JonesT.Possible method for the production of a" exact="Covid-19" post="vaccineVet. Rec.202018638810.1136/vr.m1193 29.BagamP.SinghD.P.IndaM.E.BatraS.Unraveling the role of membrane microdomains during"/>
   <result pre="of Coronaviruses on the Cardiovascular System: A ReviewJAMA Cardiol.202010.1001/jamacardio.2020.1286 63.AllevaL.M.BuddA.C.ClarkI.A.Minimising" exact="Influenza" post="Disease with FibratesInt. J. Infect. Dis.200812e17610.1016/j.ijid.2008.05.440 64.YuanS.ChuH.ChanJ.F.YeZ.W.WenL.YanB.LaiP.M.TeeK.M.HuangJ.ChenD.et al.SREBP-dependent lipidomic"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob. Agents Chemother.2014584875488410.1128/AAC.03011-1424841269 86.BlaisingJ.LevyP.L.PolyakS.J.StaniferM.BoulantS.PecheurE.I.Arbidol inhibits"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7278987\results\search\zoonosis\results.xml">
   <result pre="there is no strong consensus on how to treat the" exact="coronavirus disease 2019" post="(COVID-19) associated viral pneumonia. Coronaviruses code for an important"/>
   <result pre="3J. Virol.2005792079208610.1128/JVI.79.4.2079-2086.200515681410 31.YangX.ChenX.BianG.TuJ.XingY.WangY.ChenZ.Proteolytic processing, deubiquitinase and interferon antagonist activities of" exact="Middle East respiratory syndrome" post="coronavirus papain-like proteaseJ. Gen. Virol.20149561462610.1099/vir.0.059014-024362959 32.ClementzM.A.ChenZ.BanachB.S.WangY.SunL.RatiaK.Baez-SantosY.M.WangJ.TakayamaJ.GhoshA.K.et al.Deubiquitinating and Interferon"/>
   <result pre="analogs and mycophenolic acid synergistically inhibit the papain-like protease of" exact="Middle East respiratory syndrome" post="coronavirusAntivir. Res.201511591610.1016/j.antiviral.2014.12.01125542975 78.LinM.-H.MosesD.C.HsiehC.-H.ChengS.-C.ChenY.-H.SunC.-Y.ChouC.-Y.Disulfiram can inhibit MERS and SARS coronavirus"/>
   <result pre="92.MonteleoneG.ArdizzoneS.Are Patients with Inflammatory Bowel Disease at Increased Risk for" exact="Covid-19" post="Infection?J. Crohns Colitis202010.1093/ecco-jcc/jjaa06132215548 93.Dâ€™AntigaL.Coronaviruses and immunosuppressed patients. The facts"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7278991\results\search\zoonosis\results.xml">
   <result pre="dimorphism, further favoring them in counteracting the progression of the" exact="SARS-CoV-2 infection." post="SARS-CoV-2 COVID-19 ACE1 ACE2 RAS-pathway TMPRSS2 sex/gender-gap lung shut-down"/>
   <result pre="severe acute respiratory syndrome (SARS), like the previous SARS-CoV and" exact="Middle East respiratory syndrome" post="(MERS-CoV), it may cause life-threatening diseases [1,2,3,4,5,6]. Data from"/>
   <result pre="or estrogen receptor antagonists caused increased mortality in females after" exact="SARS-CoV infection" post="[7]. This observation also strongly agrees with the fact"/>
   <result pre="cells, accelerating lung damage and pulmonary shut-down triggered/worsened by the" exact="SARS-CoV-2 infection." post="Most likely, it is plausible that a combination of"/>
   <result pre="males during ACE2 receptor suppression, as in the presence of" exact="SARS-CoV-2 infection" post="[35,37]. Interestingly, a quantitative variation in ACE1 levels has"/>
   <result pre="onset of inflammatory processes is a key pathological feature of" exact="SARS-CoV-2 infection." post="The massive release of inflammatory cytokines and chemokines in"/>
   <result pre="the disease [141]. The role of the cytokine storm in" exact="SARS-CoV-2 infection" post="is attracting great attention as a crucial phase to"/>
   <result pre="may account for the low risk and better prognosis of" exact="SARS-CoV-2 infection" post="in females, though a multidisciplinary approach for such complex"/>
   <result pre="and comorbidities play crucial roles in tuning the fate of" exact="SARS-CoV-2 infection," post="worsening prognosis, and mortality rate. In turn, the mechanism"/>
   <result pre="worsening prognosis, and mortality rate. In turn, the mechanism of" exact="SARS-CoV-2 infection," post="due to ACE2 receptor entry, might be altered by"/>
   <result pre="Haemost.202010.1111/jth.1482132239799 22.TangN.BaiH.ChenX.GongJ.LiD.SunZ.Anticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathyJ. Thromb. Haemost.202010.1111/jth.14817 23.KarlbergJ.ChongD.S.LaiW.Y.Do men have a"/>
   <result pre="Singapore--predictors of disease severityAnn. Acad. Med. Singap.20063532633116829999 25.AlghamdiI.G.HussainI.I.AlmalkiS.S.AlghamdiM.S.AlghamdiM.M.El-SheemyM.A.The pattern of" exact="Middle East respiratory syndrome" post="coronavirus in Saudi Arabia: A descriptive epidemiological analysis of"/>
   <result pre="TMPRSS2 as a Susceptibility Gene for Severe 2009 Pandemic A(H1N1)" exact="Influenza" post="and A(H7N9) InfluenzaJ. Infect. Dis20152121214122110.1093/infdis/jiv24625904605 47.BaenaE.ShaoZ.LinnD.E.GlassK.HamblenM.J.FujiwaraY.KimJ.NguyenM.ZhangX.GodinhoF.J.et al.ETV1 directs androgen"/>
   <result pre="Rev.20123314710.1210/er.2010-003122240244 138.ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.et al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: A descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 139.BadawiA.RyooS.G.Prevalence of comorbidities"/>
   <result pre="Wuhan, China: A descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 139.BadawiA.RyooS.G.Prevalence of comorbidities in the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV): A systematic review and meta-analysisInt. J. Infect."/>
   <result pre="165.collab: Eurosurveillance Editorial TeamUpdated rapid risk assessment from ECDC on" exact="coronavirus disease 2019" post="(COVID-19) pandemic: Increased transmission in the EU/EEA and the"/>
   <result pre="behind the evidenceEur. J. Intern. Med.202010.1016/j.ejim.2020.04.04232345527 167.ChangeuxJ.P.AmouraZ.ReyF.MiyaraM.A nicotinic hypothesis for" exact="Covid-19" post="with preventive and therapeutic implicationsQeios202010.32388/FXGQSB.2 168.ZhengY.XiongC.LiuY.QianX.TangY.LiuL.LeungE.L.WangM.Epidemiological and Clinical Characteristics"/>
   <result pre="Environ.202072913847410.1016/j.scitotenv.2020.13847432498152 175.DaughtonC.The international imperative to rapidly and inexpensively monitor community-wide" exact="Covid-19" post="infection status and trendsSci. Total Environ.202072613814910.1016/j.scitotenv.2020.13814932315842 176.YangY.WangH.ChenK.ZhouJ.DengS.WangY.Shelter hospital mode:"/>
   <result pre="homeostasis (left) characterized by a balanced ACE1/ACE2 pathway, and during" exact="SARS-CoV-2 infection" post="condition (right) in which SARS-CoV-2 mediated suppression of ACE2"/>
   <result pre="Hypothesized mechanism of a geneticâ€&quot;environmental interaction between ACE1/ACE2 genes and" exact="SARS-CoV-2 infection." post="(a) Normal-health condition with a balanced RAS, normal Ang-II"/>
   <result pre="rs1799752, rs4340, rs13447447) in combination with ACE2 downregulation due to" exact="SARS-CoV-2 infection" post="and/or in the presence of the ACE2 8790 G-allele"/>
   <result pre="rs1799752, rs4340, rs13447447) in combination with ACE2 downregulation due to" exact="SARS-CoV-2 infection" post="counteracted by the ACE2 8790 A-allele (i.e., rs2285666), resulting"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7279248\results\search\zoonosis\results.xml">
   <result pre="systems on a global scale [3,4]. Unfortunately, the symptoms of" exact="SARS-CoV-2 infection" post="can vary in an unpredictable manner; there are asymptomatic"/>
   <result pre="global health concernLancet202039547047310.1016/S0140-6736(20)30185-931986257 2.GuoY.R.CaoQ.D.HongZ.S.TanY.Y.ChenS.D.JinH.J.TanK.S.WangD.Y.YanY.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;An update on the statusMil. Med. Res.20207101110.1186/s40779-020-00240-032151283 3.RiouJ.AlthausC.L.Pattern"/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): The experience of clinical immunologists from ChinaClin. Immunol.202021410839310.1016/j.clim.2020.10839332222466"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7279901\results\search\zoonosis\results.xml">
   <result pre="was complicated by bilateral pulmonary embolism. In patients affected by" exact="SARS-CoV-2 infection," post="particular attention should therefore be paid to possible vascular"/>
   <result pre="of print] 13ZhaiZLiCChenYGerotziafasGPrevention and treatment of venous thromboembolism associated with" exact="coronavirus disease 2019" post="infection: a consensus statement before guidelinesThromb Haemost202042110.1055/s-0040-1710019[Epub ahead of"/>
   <result pre="ground-glass opacities with consolidation and a peripheral pattern, suggestive of" exact="SARS-CoV-2 infection" post="Figure 2 Pulmonary angiography CT demonstrates multiple peripheral bilateral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7280142\results\search\zoonosis\results.xml">
   <result pre="insights into the mechanisms underlying renal cell carcinoma (RCC) and" exact="coronavirus disease 2019" post="(COVID-19). Objective This study considers up-to-date information on the"/>
   <result pre="management of RCC and COVID-19 patients. Patient summary Amid the" exact="coronavirus disease 2019" post="(COVID-19) pandemic, patients diagnosed with renal cell carcinoma and"/>
   <result pre="Take Home Message This review provides novel biological insights into" exact="coronavirus disease 2019" post="(COVID-19)-infected patients with renal disease, with special emphasis on"/>
   <result pre="Organization (WHO) formally named the disease triggered by 2019-nCoV as" exact="coronavirus disease 2019" post="(COVID-19). The Internal Committee of Taxonomy of Viruses then"/>
   <result pre="related to severe acute respiratory syndrome (SARS) of 2003 and" exact="Middle East respiratory syndrome" post="(MERS) of 2012 [1], [2]. As of April 7,"/>
   <result pre="the current understanding of the impact of angiotensin-converting enzyme-2 (ACE2)-mediated" exact="SARS-CoV-2 infection" post="on kidney function and the therapeutic targeting of underlying"/>
   <result pre="had chronic renal disease. 3 Evidence synthesis 3.1 Mechanisms of" exact="SARS-CoV-2 infection" post="The novel zoonotic coronavirus (CoV) SARS-CoV-2 belongs to the"/>
   <result pre="target cell and is regulated by androgens (Fig. 2 )." exact="SARS-CoV infection" post="is dependent on the proteolytic activity of TMPRSS2 and"/>
   <result pre="thus making these organ sites easy routes for SARS-CoV and" exact="SARS-CoV-2 infection" post="[23]. In particular, ACE2 expression is higher in the"/>
   <result pre="available should be implemented to the suction system. COVID-19 =" exact="coronavirus disease 2019;" post="OR = operating room; PPE = personal protective equipment."/>
   <result pre="patient infected with the virus (Fig. 3 ). Fig. 3" exact="SARS-CoV-2 infection" post="in renal disease and therapeutic targeting of RCC. The"/>
   <result pre="with underlying renal disease. ACE2 = angiotensin-converting enzyme-2; COVID-19 =" exact="coronavirus disease 2019;" post="SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2. 3.5"/>
   <result pre="3.7.4 Convalescent plasma antibody transfer As tried during the 2014â€&quot;2015" exact="Ebola" post="outbreak, the use of the plasma of a recovered"/>
   <result pre="early identification, intervention, and improved prognosis among RCC patients harboring" exact="SARS-CoV-2 infection." post="As research efforts escalate globally toward the eradication of"/>
   <result pre="extent? The emerging impasse of angiotensin blockadeNephron24126202019 5GuanW.NiZ.HuY.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med38220201708172032109013 6ChenN.ZhouM.DongX.Epidemiological and clinical characteristics"/>
   <result pre="J Med38220201708172032109013 6ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 7PatelA.B.VermaA.COVID-19 and angiotensin-converting"/>
   <result pre="J Med38220202012202232227758 33Wang L, Li X, Chen H, et al." exact="SARS-CoV-2 infection" post="does not significantly cause acute renal injury: an analysis"/>
   <result pre="specimensJAMA323202018431844 73ArabiY.M.ArifiA.A.BalkyH.H.Clinical course and outcomes of critically Ill patients with" exact="Middle East respiratory syndrome" post="coronavirus infectionAnn Intern Med160201438939724474051 74RussellC.D.MillarJ.E.BaillieJ.K.Clinical evidence does not support"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7280701\results\search\zoonosis\results.xml">
   <result pre="Review Articles Immunosuppressive agents for dermatological indications in the ongoing" exact="COVID 19" post="pandemic: rationalizing use and clinical applicability Khurana and Saxena"/>
   <result pre="duration of the public health emergency.file:DTH-9999-na.pdf Abstract ABSTRACT The ongoing" exact="COVID 19" post="epidemic has brought to the fore many concerns related"/>
   <result pre="on ISAs for skin conditions are more prone to develop" exact="COVID 19," post="and what impact the ISA may have on the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7280997\results\search\zoonosis\results.xml">
   <result pre="for COVID-19 treatment. COVID-19 SARS-CoV-2 antiviral therapies 1. Introduction The" exact="coronavirus disease 2019" post="(COVID-19) was first identified in patients with severe respiratory"/>
   <result pre="is an adenosine nucleoside analog drug showing antiviral activity against" exact="Ebola" post="and Marburg viruses, and other RNA viruses [53]. It"/>
   <result pre="new coronavirus of probable bat originNature202057927027332015507 3.GuanW.-J.NiZ.-Y.HuY.LiangW.-H.OuC.-Q.HeJ.-X.LiuL.ShanH.LeiC.-L.HuiD.S.et al.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaNew Engl. J. Med.202010.1056/NEJMoa200203232109013 4.GuoY.-R.CaoQ.-D.HongZ.-S.TanY.-Y.ChenS.-D.JinH.TanK.-S.WangD.-Y.YanY.The origin, transmission and"/>
   <result pre="Engl. J. Med.202010.1056/NEJMoa200203232109013 4.GuoY.-R.CaoQ.-D.HongZ.-S.TanY.-Y.ChenS.-D.JinH.TanK.-S.WangD.-Y.YanY.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;An update on the statusMil. Med Res.2020711010.1186/s40779-020-00240-031928528 5.LuR.ZhaoX.LiJ.NiuP.YangB.WuH.WangW.SongH.HuangB.ZhuN.et"/>
   <result pre="43.LimJ.JeonS.ShinH.-Y.KimM.J.SeongY.M.LeeW.J.ChoeK.-W.KangY.M.LeeB.ParkS.-J.Case of the index patient who caused tertiary transmission of" exact="coronavirus disease 2019" post="in Korea: The application of lopinavir/ritonavir for the treatment"/>
   <result pre="by quantitative RT-PCRJ. Korean Med Sci.202035e7910.3346/jkms.2020.35.e7932056407 44.DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov. Ther.202014586010.5582/ddt.2020.0101232147628 45.HoffmannM.Kleine-WeberH.KrÃ¼gerN.MÃ¼llerM.DrostenC.PÃ¶hlmannS.A MullerM.The novel coronavirus 2019 (2019-nCoV)"/>
   <result pre="control studyEng.202010.1016/j.eng.2020.03.007 47.FanH.-H.WangL.-Q.LiuW.-L.AnX.-P.LiuZ.-D.HeX.-Q.SongL.-H.TongY.-G.Repurposing of clinically approved drugs for treatment of" exact="coronavirus disease 2019" post="in a 2019-novel coronavirus (2019-nCoV) related coronavirus modelChin. Med."/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov.202061410.1038/s41421-019-0132-831934347 50.ColsonP.RolainJ.-M.LagierJ.-C.BrouquiP.RaoultD.Chloroquine and hydroxychloroquine as available weapons"/>
   <result pre="Rheumatol.20201615516610.1038/s41584-020-0372-x32034323 53.WarrenT.K.JordanR.LoM.K.RayA.S.MackmanR.L.SolovevaV.SiegelD.PerronM.BannisterR.HuiH.C.et al.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature201653138138510.1038/nature1718026934220 54.AgostiniM.L.AndresE.L.SimsA.C.GrahamR.L.SheahanT.P.LuX.SmithE.C.CaseJ.B.FengJ.Y.JordanR.et al.Coronavirus Susceptibility to the"/>
   <result pre="viral polymerase and the proofreading ExoribonucleasemBio20189e00221-1810.1128/mBio.00221-1829511076 55.TchesnokovE.P.FengJ.Y.PorterD.P.GotteM.Mechanism of inhibition of" exact="Ebola" post="Virus RNA-Dependent RNA polymerase by remdesivirViruses20191132610.3390/v1104032630987343 56.WangM.CaoR.ZhangL.YangX.LiuJ.XuM.ShiZ.HuZ.ZhongW.XiaoG.Remdesivir and chloroquine"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7281209\results\search\zoonosis\results.xml">
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Influenza" post="viruses cause a significant public health burden each year"/>
   <result pre="influenza virus infections. antiviral influenza virus rhamnan sulfate 1. Introduction" exact="Influenza" post="viruses are disease-causing agents belonging to the Orthomyxoviridae family."/>
   <result pre="are three types of influenza viruses: A, B, and C." exact="Influenza" post="A and B viruses cause seasonal flu epidemics almost"/>
   <result pre="cause seasonal flu epidemics almost every year around the world." exact="Influenza" post="A viruses (IFVs) infect a broad range of hosts,"/>
   <result pre="as the causative agents of severe acute respiratory syndrome (SARS)," exact="Middle East respiratory syndrome" post="(MERS), and the new SARS-CoV-2 have also recently emerged"/>
   <result pre="Toyama Institute of Health and were grown on Vero cells." exact="Influenza" post="A virus (A/NWS/33, H1N1 subtype) (IFV) obtained from Denka"/>
   <result pre="US oral neuraminidase study groupJAMA20002831016102410.1001/jama.283.8.101610697061 31.MemoliM.J.AthotaR.ReedS.CzajkowskiL.BristolT.ProudfootK.HageyR.VoellJ.FiorentinoC.AdemposiA.et al.The natural history of" exact="influenza infection" post="in the severely immunocompromised vs nonimmunocompromised hostsClin. Infect. Dis.20145821422410.1093/cid/cit72524186906"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7281404\results\search\zoonosis\results.xml">
   <result pre="coronavirus epidemics such as the 2003 SARS-CoV and the 2012" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) prompted the identification of compounds that could"/>
   <result pre="in previous viral pandemics, including Spanish flu in 1918 and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012, and this is also the"/>
   <result pre="appeared in the market with strong claims of effectiveness against" exact="SARS-CoV-2 infection." post="Some constitute a risk on patientsâ€™ health, e.g., chlorine"/>
   <result pre="Uncontrolled pulmonary inflammation is a major cause of death in" exact="SARS-CoV-2 infection." post="More than 80% of patients with COVID-19 have lymphopenia"/>
   <result pre="Agents Several approaches have been suggested to target the current" exact="SARS-CoV-2 infection" post="in moderate-to-severe cases in an attempt to control viral"/>
   <result pre="is an inhibitor of translation elongationâ€&quot;as potential effective therapies for" exact="SARS-CoV-2 infection." post="The study is under review [14]. 3.1.1. Remdesivir (GS-5734)"/>
   <result pre="chains. The drug was first developed for the treatment of" exact="Ebola" post="infection [15,16]. It was found to be a promising"/>
   <result pre="Institute. Umifenovir is approved for the prophylaxis and treatment of" exact="human influenza" post="type A and type B infections, as well as"/>
   <result pre="leading to apoptosis [45]. Similar to a previous study on" exact="SARS-CoV infection," post="it can be speculated that viroporin 3a may activate"/>
   <result pre="protein 3 (NLRP3) and inflammasome, thus inducing cell pyroptosis in" exact="SARS-CoV-2 infection" post="[46]. Tranilast is an antagonist of NLRP3 that inhibits"/>
   <result pre="the decrease in viral load), anti-spike protein-neutralizing antibodies (anti-S-IgG) in" exact="SARS-CoV infection" post="have been found to cause severe lung injury by"/>
   <result pre="[103], dengue virus (DENV), [104], West Nile virus (WNV) infection," exact="Japanese encephalitis" post="virus (JEV), and Zika virus infection [105]. Those specific"/>
   <result pre="to inhibit other flavivirus replication, including: dengue, tick-borne encephalitis, and" exact="Japanese encephalitis" post="viruses. One of the mechanisms involved in this inhibition"/>
   <result pre="syncytial virus, and influenza virus [118,119]. In addition, Zika and" exact="Ebola" post="viruses have been shown to be inhibited by azithromycin"/>
   <result pre="and ARB via increasing the ACE2 levels and opposing the" exact="SARS-CoV-2 infection" post="consequences. Losartan is an AT1R blocker that is widely"/>
   <result pre="A small clinical trial of rhACE2 in patients with severe" exact="SARS-CoV-2 infection" post="was recently initiated (NCT04287686). Logically, low cellular membrane ACE2"/>
   <result pre="effects of ACE2 and, hence, ACEi/ARB or rhACE2, treatment in" exact="SARS-CoV-2 infection" post="need more investigation. 6.2. Camostat In-vitro studies have shown"/>
   <result pre="drugs presented in this review are possible pharmacological modalities to" exact="COVID 19," post="but most of them are proposed based on their"/>
   <result pre="target virus entry, replication, and associated complications. The management of" exact="COVID 19" post="is rapidly evolving, as all available therapies are currently"/>
   <result pre="specificity of the papain-like protease domain of nsp3 from the" exact="Middle East respiratory syndrome" post="coronavirusJ. Virol.201488125111252710.1128/JVI.01294-1425142582 10.TsengY.-T.WangS.-M.HuangK.-J.LeeA.I.-R.ChiangC.-C.WangC.-T.Self-assembly of severe acute respiratory syndrome coronavirus"/>
   <result pre="Commun.20189401310.1038/s41467-018-06215-z30275474 17.WarrenT.K.JordanR.LoM.K.RayA.S.MackmanR.L.SolovevaV.SiegelD.PerronM.BannisterR.HuiH.C.et al.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature201653138138510.1038/nature1718026934220 18.GordonC.J.TchesnokovE.P.FengJ.Y.PorterD.P.GotteM.The antiviral compound remdesivir potently"/>
   <result pre="18.GordonC.J.TchesnokovE.P.FengJ.Y.PorterD.P.GotteM.The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirusJ. Biol. Chem.20202954772477910.1074/jbc.AC120.013056 19.De WitE.FeldmannF.CroninJ.JordanR.OkumuraA.ThomasT.ScottD.CihlarT.FeldmannH.Prophylactic and therapeutic remdesivir (GS-5734)"/>
   <result pre="findingsThorax20045925225610.1136/thorax.2003.01265814985565 34.Al-TawfiqJ.A.MomattinH.DibJ.MemishZ.A.Ribavirin and interferon therapy in patients infected with the" exact="Middle East respiratory syndrome" post="coronavirus: An observational studyInt. J. Infect. Dis.201420424610.1016/j.ijid.2013.12.00324406736 35.OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.AlmakhlafiG.A.AlbarrakM.M.MemishZ.A.AlbarrakA.M.Ribavirin and"/>
   <result pre="studyInt. J. Infect. Dis.201420424610.1016/j.ijid.2013.12.00324406736 35.OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.AlmakhlafiG.A.AlbarrakM.M.MemishZ.A.AlbarrakA.M.Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: A retrospective cohort studyLancet Infect. Dis.2014141090109510.1016/S1473-3099(14)70920-X25278221 36.SpanakisN.TsiodrasS.HaagmansB.L.RajV.S.PontikisK.KoutsoukouA.KoulourisN.G.OsterhausA.D.M.E.KoopmansM.P.G.TsakrisA.Virological"/>
   <result pre="studyLancet Infect. Dis.2014141090109510.1016/S1473-3099(14)70920-X25278221 36.SpanakisN.TsiodrasS.HaagmansB.L.RajV.S.PontikisK.KoutsoukouA.KoulourisN.G.OsterhausA.D.M.E.KoopmansM.P.G.TsakrisA.Virological and serological analysis of a recent" exact="Middle East respiratory syndrome" post="coronavirus infection case on a triple combination antiviral regimenInt."/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): The perspectives of clinical immunologists from ChinaClin. Immunol.202021410839310.1016/j.clim.2020.10839332222466"/>
   <result pre="of clinical immunologists from ChinaClin. Immunol.202021410839310.1016/j.clim.2020.10839332222466 62.DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov. Ther.202014586010.5582/ddt.2020.0101232147628 63.CostantiniC.BelletM.M.ParianoM.RengaG.StincardiniC.GoldsteinA.L.GaraciE.RomaniL.A reappraisal of thymosin Alpha1 in"/>
   <result pre="infectivity by chloroquineAIDS Res. Hum. Retroviruses1990648148910.1089/aid.1990.6.4811692728 103.OoiE.E.ChewJ.S.LohJ.P.ChuaR.C.In vitro inhibition of" exact="human influenza" post="a virus replication by chloroquineVirol. J.200633910.1186/1743-422X-3-3916729896 104.FariasK.J.MachadoP.R.Da FonsecaB.A.Chloroquine inhibits"/>
   <result pre="by interfering with virus internalization processJ. Antibiot.20197275976810.1038/s41429-019-0204-x31300721 120.MadridP.B.PanchalR.G.WarrenT.K.ShurtleffA.C.EndsleyA.N.GreenC.E.KolokoltsovA.DaveyR.MangerI.D.GilfillanL.et al.Evaluation of" exact="Ebola" post="virus inhibitors for drug repurposingACS Infect. Dis.2015131732610.1021/acsinfecdis.5b0003027622822 121.IannettaM.IppolitoG.NicastriE.Azithromycin shows"/>
   <result pre="in the upper right. Figure 2 Inflammatory responses triggered by" exact="SARS-CoV-2 infection." post="Two inflammatory pathways may be distinguished. The primary pathway"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7283245\results\search\zoonosis\results.xml">
   <result pre="today, there is no antiviral for the treatment of the" exact="SARS-CoV-2 infection," post="and the development of a vaccine might take several"/>
   <result pre="the drug11. Recently, this drug proved to be effective blocking" exact="SARS-CoV-2 infection" post="in vitro12. Figure 1 Three-dimensional structure of the SARS-CoV"/>
   <result pre="Methods Coronavirus nsp12 multiple alignment From the orf1ab polyprotein (Wuhan" exact="seafood market pneumonia" post="virus isolate Wuhan-Hu-1) deposited in the NCBI (NC_045512.2), we"/>
   <result pre="historical, epidemiological and clinical featuresInfect. Dis. Clin. N. Am.20193386988910.1016/j.idc.2019.07.001 2.AsharEIHuiDSCMemishZAZumlaAThe" exact="Middle East respiratory syndrome" post="(MERS)Infect. Dis. Clin. N. Am.20193389190510.1016/j.idc.2019.08.001 3.WHO. Coronavirus disease (COVID-19)"/>
   <result pre="B.20179344946310.2183/pjab.93.02728769016 10.WarrenTKet al.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in Rhesus monkeysNature.201653138138510.1038/nature1718026934220 11.AgostiniMLet al.Coronavirus susceptibility to the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7284144\results\search\zoonosis\results.xml">
   <result pre="surface package. Journal of Molecular Graphics, 11(2), 139â€&quot;141. 10.1016/0263-7855(93)87010-3 collab:" exact="Coronavirus disease 2019" post="(COVID-19) Situation Report-35 (n.d.). Retrieved February 26, 2020, from"/>
   <result pre="Rg radius of gyration RMSF root mean square fluctuation SARS-CoV-2" exact="Severe acute respiratory syndrome" post="coronavirus-2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7284148\results\search\zoonosis\results.xml">
   <result pre="a novel therapeutic agent to combat this deadly pandemic disease," exact="SARS-CoV-2 infection," post="but needs further experimental research. Highlights NSP10/NSP16 methyltransferase and"/>
   <result pre="that Ribavirin, vitamin B12, and nicotinamide may be helpful against" exact="COVID 19" post="infections [12]. Moreover, it has also been shown that"/>
   <result pre="The present study provided a comprehensive target of the resolved" exact="COVID19" post="structure of Mpro and NSP10/NSP16 Methyltransferase and found a"/>
   <result pre="against target proteins and may play a highly influencing against" exact="SARS-CoV-2 infection" post="3.3. Estimation of binding-free energy MM/GBSA calculation was performed"/>
   <result pre="discovery has become an important area in the field of" exact="COVID 19" post="spreading worldwide. So, the identification of drug targets is"/>
   <result pre="Many scientists are involved in searching for a cure for" exact="COVID 19." post="Most of the researchers are targeting protease complex and"/>
   <result pre="crucial role in inhibits the infection of the virus of" exact="COVID 19" post="[10,11]. It has been seen that various anti-viral, anti-malarial"/>
   <result pre="in silico study may be an excellent agent to combat" exact="SARS-CoV-2 infection" post="either alone or in combination. However, it warrants further"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="inÂ vitro. Cell Discov. 2020;6(1):1â€&quot;4.31934347 20PushpendraS, KushwahaPP, ShashankKNovel potent"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7284455\results\search\zoonosis\results.xml">
   <result pre="review, we sought to present the neurological manifestations associated with" exact="coronavirus disease 2019" post="(COVID-19). Case reports, case series, editorials, reviews, case-control and"/>
   <result pre="more than 215 countries, infecting 3,181,642 patients and causing the" exact="coronavirus disease 2019" post="(COVID-19) pandemic, as this outbreak was declared on 11th"/>
   <result pre="review, we sought to present the neurological manifestations associated with" exact="SARS-CoV-2 infection" post="and COVID-19. Caution is recommended so that clinicians can"/>
   <result pre="of these zoonotic viruses: severe acute respiratory syndrome coronavirus (SARS-CoV)," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), which both have caused epidemics in the"/>
   <result pre="old.34 More importantly, all of those patients (n=5) had confirmed" exact="SARS-CoV-2 infection" post="but were not critically ill until the stroke occurrence."/>
   <result pre="other sites, a feature observed in other viral infections like" exact="Ebola" post="and human immunodeficiency virus. A case of acute haemorrhagic"/>
   <result pre="at that time with chest examinations of patients with possible" exact="SARS-CoV-2 infection." post="There was no availability for mechanical thrombectomy in this"/>
   <result pre="was ordered and came back positive for SARS-CoV-2 RNA. Despite" exact="SARS-CoV-2 infection," post="the patient never experienced any symptoms of dyspnoea, cough,"/>
   <result pre="we present the case report of a patient with confirmed" exact="SARS-CoV-2 infection" post="who developed facial nerve palsy during hospitalization (Figure 3)."/>
   <result pre="asked from an infectious disease specialist in cases of suspected" exact="SARS-CoV-2 infection" post="or from an intensive care unit physician, if the"/>
   <result pre="requires high fractions of inspired oxygen. Stroke patients with confirmed" exact="SARS-CoV-2 infection" post="should be transferred to dedicated COVID-19 wards.54 The need"/>
   <result pre="therapies. Whether those therapies can impair the immune response to" exact="SARS-CoV-2 infection" post="is a matter of great concern, but few data"/>
   <result pre="completed through tele-neurology programs. Once a patient is confirmed with" exact="SARS-CoV-2 infection," post="the physician might consider postponing any second-line immunomodulating (fingolimod,"/>
   <result pre="26GuoTFanYChenM, et al.Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19). JAMA Cardiol. Epub ahead of print 2732020 DOI:10.1001/jamacardio.2020.1017"/>
   <result pre="print 2732020 DOI:10.1001/jamacardio.2020.1017 27BangaloreSSharmaASlotwinerAYatskarLHarariRShahB, et al.ST-Segment Elevation in Patients with" exact="Covid-19" post="â€&quot; A Case Series. [Published online ahead of print,"/>
   <result pre="doi: 10.1056/NEJMc2009020. 28MaoLJinHWangM, et al.Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, China. JAMA Neurol. Epub ahead of print"/>
   <result pre="2020). 34OxleyTJMoccoJMajidiSKellnerCPShoirahHSinghIP, et al.Large-Vessel Stroke as a Presenting Feature of" exact="Covid-19" post="in the Young. [Published online ahead of print, 2020"/>
   <result pre="Neurology. 2020. doi: 10.1212/WNL.0000000000009619. 42HelmsJKremerSMerdjiH, et al.Neurologic features in severe" exact="SARS-CoV-2 infection." post="N Engl J Med. Epub ahead of print 1542020"/>
   <result pre="1542020 DOI: 10.1056/NEJMc2008597. 43collab: Centers for Disease Control and Prevention." exact="Coronavirus disease 2019" post="(COVID-19) - people who are at higher risk, https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions"/>
   <result pre="manuscript. 46ZhaoJRuddALiuRChallenges and potential solutions of stroke care during the" exact="coronavirus disease 2019" post="(COVID-19) outbreak. Stroke. Epub ahead of print 3132020 DOI:"/>
   <result pre="April 2020). 54JinHHongCChenS, et al.Consensus for prevention and management of" exact="coronavirus disease 2019" post="(COVID-19) for neurologists. Stroke Vasc Neurol2020: svn-2020-000382. DOI: 10.1136/svn-2020-000382."/>
   <result pre="2]. Neurology. 2020. doi: 10.1212/WNL.0000000000009507. 57collab: Multiple Sclerosis Trust. Coronavirus," exact="Covid-19" post="and multiple sclerosis, https://www.mstrust.org.uk/a-z/coronavirus-covid-19-and-multiple-sclerosis#covid-19-and-steroids-for-ms-relapses. (2020, accessed 9 April 2020)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7286219\results\search\zoonosis\results.xml">
   <result pre="pathogenic in humans, including severe acute respiratory syndrome coronavirus (SARS-CoV)," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) and this novel virus, SARS-CoV-2, which has"/>
   <result pre="have been licensed to be used inÂ the treatment of" exact="SARS-CoV-2 infection" post="or other coronavirus infections in humans, and no vaccines"/>
   <result pre="such as mRNA vaccines against influenza viruses, rabies virus, HIV," exact="Ebola" post="virus, and Zika virus (Demoulins et al. 2016; Maruggi"/>
   <result pre="because the industry is highly regulated. For mRNA vaccines against" exact="SARS-CoV-2 infection," post="developers should speed up the process to make them"/>
   <result pre="an inactivated vaccine candidate for SARS-CoV-2Science202010.1126/science.abc193232616673 KatzelnickLCGreshLHalloranMEMercadoJCKuanGGordonABalmasedaAHarrisEAntibody-dependent enhancement of severe" exact="dengue disease" post="in humansScience201735892993210.1126/science.aan683629097492 LiuLWeiQLinQFangJWangHKwokHTangHNishiuraKPengJTanZWuTCheungKWChanKHAlvarezXQinCLacknerAPerlmanSYuenKYChenZAnti-spike IgG causes severe acute lung injury"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7286259\results\search\zoonosis\results.xml">
   <result pre="global epidemics such as the severe respiratory syndrome (SARS), the" exact="Middle East respiratory syndrome" post="(MERS) and recently the coronavirus disease 2019 (COVID-19). There"/>
   <result pre="(SARS), the Middle East respiratory syndrome (MERS) and recently the" exact="coronavirus disease 2019" post="(COVID-19). There has been no vaccines or drugs available"/>
   <result pre="was via dromedary camels. The virus was designated as the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) which infected 2494 people and caused 858"/>
   <result pre="coronavirus 2 (SARS-CoV-2) which has caused a pandemic known as" exact="coronavirus disease 2019" post="(COVID-19). The outbreak was first reported in Wuhan, Hubei"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7287466\results\search\zoonosis\results.xml">
   <result pre="linked to thrombotic complexities. â€¢Methylprednisolone is associated with myopathy. â€¢The" exact="COVID 19" post="ageusia/anosmia, myalgia and central nervous pathologies warrants future exploration."/>
   <result pre="exhibiting &amp;gt;50% mortality in central nervous (CNS) presenting pathologies. The" exact="COVID 19" post="neurological consequences occur more frequently even in mild cases,"/>
   <result pre="for CNS exploration and further explore the pathogenesis of the" exact="COVID 19" post="myalgia, anosmia/ageusia reported in the majority of the initial"/>
   <result pre="52Â years, concurrently, nearly 17% of the HCW reported with" exact="SARS-CoV infection" post="[31], [32]. In the most contemporary ECoV pandemic, the"/>
   <result pre="for MERS-CoV confirmation and ruling out differentials like H1N1 and" exact="Influenza" post="A and B [36], [45]. On the contrary, regarding"/>
   <result pre="moderate leukocytosis yet negative CSF RT-PCR stated [70], [71]. The" exact="COVID 19" post="Miller Fisher syndrome (MFS) symptoms preceded by infection and"/>
   <result pre="neurological complications were uncommon, yet presented with critical outcomes, in" exact="COVID 19" post="pandemic, the neurological symptoms reported frequently even in mild"/>
   <result pre="likely to present with fatal outcomes. Comparatively, 25% of the" exact="COVID 19" post="neurological quandaries befall in CNS complications. The neuroinvasive features"/>
   <result pre="Wang M, et al. Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, China. JAMA Neurol. Published online April 10,"/>
   <result pre="East respiratory syndromeJ Clin Neurol133201722728748673 22ArabiY.M.HarthiA.HusseinJ.Severe neurologic syndrome associated with" exact="Middle East respiratory syndrome" post="corona virus (MERS-CoV)Infection434201549550125600929 23ChafekarAasiyahFieldingBurtramMERS-CoV: understanding the latest human coronavirus"/>
   <result pre="Clin Neurol13201722723328748673 25ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet39510223202050751332007143 26CarterJohn B.SaundersVenetia A.Virology:"/>
   <result pre="agents in healthcare settings. 28MackayI.ArdenK.An opportunistic pathogen afforded ample opportunities:" exact="Middle East respiratory syndrome" post="coronavirusViruses9122017369 29HuiD.S.AzharE.I.KimY.-J.MemishZ.A.OhM.-d.ZumlaA.Middle East respiratory syndrome coronavirus: risk factors and"/>
   <result pre="factors: a systematic reviewBMC Public Health181201857429716568 31SengaM.ArabiY.M.FowlerR.A.Clinical spectrum of the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV)J Infect Public Health102201719119427140697 32Weekly epidemiological record RelevÃ©"/>
   <result pre="Jan 25, 2020). 41Wong SF, Chow KM, de Swiet M." exact="Severe acute respiratory syndrome" post="and pregnancy. Br J Obstetrics Gynaecol, 2003, 110:641â€&quot;642. WHO"/>
   <result pre="2004. 42AssiriA.Al-TawfifiqJ.A.Al-RabeeahA.A.Epidemiological, demographic, and clinical characteristics of 47 cases of" exact="Middle East respiratory syndrome" post="coronavirus disease from Saudi Arabia: a descriptive studyLancet Infect"/>
   <result pre="MERS-CoV Research Group. State of knowledge and data gaps of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in humans. PLoS Curr 2013; 5. 44WHO"/>
   <result pre="28]Brain Behav Immun2020S0889-1591(20)30685-1 60Al-HameedF.Spontaneous intracranial hemorrhage in a patient with" exact="Middle East respiratory syndrome" post="corona virusSMJ3822017196200 61Bashar Katirj. Disorders of peripheral nerves. In:"/>
   <result pre="71El Otmani H, El Moutawakil B, Rafai MA, et al." exact="Covid-19" post="and Guillain-BarrÃ© syndrome: More than a coincidence! [published online"/>
   <result pre="report from a World Health Organization consultationNat Med227201670170527387881 77ArabiY.M.AsiriA.Y.AssiriA.M.Treatment of" exact="Middle East respiratory syndrome" post="with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE trial):"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7287479\results\search\zoonosis\results.xml">
   <result pre="Centers for Disease Control. (2020). Interim guidance on management of" exact="coronavirus disease 2019" post="(COVID-19) in correctional and detention facilities. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/community/correction-detention/guidance-correctional-detention.html."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7288766\results\search\zoonosis\results.xml">
   <result pre="infectious disease outbreaks research in India: A case for novel" exact="coronavirus disease 2019" post="MathurRoli[], mathurr.hq@icmr.gov.inppub: 20201512-3124131(C) , 2020This is an open access"/>
   <result pre="the world for diagnosis of novel coronavirus infection recently labelled" exact="coronavirus disease 2019" post="(COVID-19) by the WHO Director-General at the media briefing"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7289747\results\search\zoonosis\results.xml">
   <result pre="urgently required. SARS-CoV-2 which is genetically similar to SARS-CoV and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) is an enveloped, single and positive-stranded RNA"/>
   <result pre="persisting T cell and B cell memory. In case of" exact="SARS-CoV infection" post="both humoral and cellular immune responses are crucial for"/>
   <result pre="domain that induces neutralizing antibody and T-cell immune responses against" exact="SARS-CoV infection" post="[19,20] making it an important target for vaccine development."/>
   <result pre="with S protein encoding DNA vaccine elicited protective immunity against" exact="SARS-CoV infection" post="in a mouse model by inducing T cell and"/>
   <result pre="neutralizing antibody thus causing protection of the vaccinated mice to" exact="SARS-CoV infection" post="[64]. Besides this, S protein associated with SARS-CoV is"/>
   <result pre="administration of the vaccine in a population currently naÃ¯ve to" exact="SARS-CoV-2 infection." post="So there is a need of tight coordination and"/>
   <result pre="Chinese horseshoe batsProc. Natl. Acad. Sci.1033920051404014045 29BaizeS.PannetierD.OestereichL.RiegerT.KoivoguiL.MagassoubaN.F.SoropoguiB.SowM.S.KeÃ¯taS.De ClerckH.TiffanyA.Emergence of Zaire" exact="Ebola" post="virus disease in GuineaN. Engl. J. Med.3711520141418142524738640 30RiskiH.HoviT.Coronavirus infections"/>
   <result pre="96VolzAKupkeA.SongF.JanyS.FuxR.Shams-EldinH. â€¦SutterG.Protective efficacy of recombinant modified vaccinia virus Ankara delivering" exact="Middle East respiratory syndrome" post="coronavirus spike glycoproteinJournal of virology891620158651865626018172 97AlharbiNKPadron-RegaladoE.ThompsonC.P.KupkeA.WellsD.SloanM.A. â€¦BeckerS.ChAdOx1 and MVA"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7290442\results\search\zoonosis\results.xml">
   <result pre="to disease spread [23,24]. Box 1 SARS CoV-2-related Definitions. SARS-CoV-2:" exact="Severe acute respiratory syndrome" post="coronavirus 2 COVID-19 or Covid-19: Corona virus disease, 2019."/>
   <result pre="Angiotensin-Converting Enzyme 2 (ACE2) ACE2 is the host receptor for" exact="SARS-CoV-2 infection" post="that interacts with the viral spike protein to gain"/>
   <result pre="a new window of opportunity to use hrsACE2 to prevent" exact="SARS-CoV-2 infection" post="at a very early stage by blocking its entry"/>
   <result pre="replication by increasing endosomal pH as many viruses such as" exact="Ebola" post="and Marburg that require the acidic environment of the"/>
   <result pre="Wuhan, China: A single-centered, retrospective, observational studyLancet Respir. Med.2020847548110.1016/S2213-2600(20)30079-532105632 7.collab:" exact="Covid-19" post="National Emergency Response Center, E.collab: Case Management Team, K.C.F.D.C.Prevention."/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob. Agents Chemother.2014584875488410.1128/AAC.03011-1424841269 70.ChanJ.F.YaoY.YeungM.L.DengW.BaoL.JiaL.LiF.XiaoC.GaoH.YuP.et al.Treatment"/>
   <result pre="an acidic pH for infectivityCell Biochem. Funct.20163419119610.1002/cbf.318227001679 80.DowallS.D.BosworthA.WatsonR.BewleyK.TaylorI.RaynerE.HunterL.PearsonG.EasterbrookL.PitmanJ.et al.Chloroquine inhibited" exact="Ebola" post="virus replication in vitro but failed to protect against"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7290740\results\search\zoonosis\results.xml">
   <result pre="doi: 10.3390/v12050557viruses-12-00557 : Article Ethanol Extract of Caesalpinia decapetala Inhibits" exact="Influenza" post="Virus Infection In Vitro and In Vivo https://orcid.org/0000-0003-0639-2431ZhangLi12ChenJungang1KeChang1ZhangHaiwei1ZhangShoujun3TangWei1LiuChunlan1LiuGe12ChenSi12HuAo12SunWenyu12XiaoYu12LiuMinli12https://orcid.org/0000-0002-4479-1145ChenXulin124*[1], zhanglicas000@outlook.comchenjg@wh.iov.cnxiaobinkechang@hotmail.comhwzhang@wh.iov.cntangwei@wh.iov.cnliuchunlan@wh.iov.cnbiohazard_1220@hotmail.comchensi880530@outlook.comhuaocn@foxmail.comwenyu.sun@hotmail.comxiaoyu.cas@foxmail.comminli.liu.work@outlook.com[2],"/>
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Influenza" post="virus infections can lead to viral pneumonia and acute"/>
   <result pre="were maintained at 37 Â°C in a 5% CO2 incubator." exact="Influenza" post="virus strains A/Puerto Rico/8/1934 (H1N1), A/Puerto Rico/8/1934 (H1N1, H274Y"/>
   <result pre="0.05 were considered statistically significant. 3. Results 3.1. EEC Inhibits" exact="Influenza" post="Virus Replication on A549 Cells To screen for natural"/>
   <result pre="a Broad Spectrum of Antiviral Activity against a Panel of" exact="Influenza" post="Viruses in A549, U937, and MDCK Cells Human influenza"/>
   <result pre="3.3. Determination of the Stage Affected by EEC in the" exact="Influenza" post="Virus Life Cycle To determine the stage of the"/>
   <result pre="release of influenza viruses. 3.4. EEC Protects Mice from Lethal" exact="Influenza" post="Virus Infection To further study the therapeutic effect of"/>
   <result pre="Virus Titer and Pathogenic Damage in the Lung Mediated by" exact="Influenza" post="Virus Infection Even though the selective indexes of EEC"/>
   <result pre="infection caused by influenza viruses that circulate the world [27]." exact="Influenza" post="A and B viruses cause seasonal epidemics of disease."/>
   <result pre="in humans are subtype A(H1N1) and A(H3N2) influenza viruses [28]." exact="Influenza" post="viruses circulating in animals, e.g., birds, pose threats to"/>
   <result pre="comparable to that of ribavirin (Figure S1). In addition to" exact="human influenza" post="A viruses H1N1 and H3N2, human influenza B virus"/>
   <result pre="In addition to human influenza A viruses H1N1 and H3N2," exact="human influenza" post="B virus strains, the 2009 (H1N1) pandemic strain, oseltamivir-resistant"/>
   <result pre="2009 (H1N1) pandemic strain, oseltamivir-resistant strain H1N1 (H274Y), and a" exact="bird flu" post="H7N8 were also tested. We did not measure the"/>
   <result pre="model. Our results demonstrated that EEC protected mice from lethal" exact="influenza infection" post="by increasing the survival rate that is associated with"/>
   <result pre="inhibitor Baloxavir MarboxilSci. Rep.20188963329941893 11.HaydenF.G.SugayaN.HirotsuN.LeeN.de JongM.D.HurtA.C.IshidaT.SekinoH.YamadaK.PortsmouthS.et al.Baloxavir marboxil for Uncomplicated" exact="Influenza" post="in Adults and AdolescentsN. Engl. J. Med.201837991392310.1056/NEJMoa171619730184455 12.HurtA.C.The epidemiology"/>
   <result pre="Engl. J. Med.201837991392310.1056/NEJMoa171619730184455 12.HurtA.C.The epidemiology and spread of drug resistant" exact="human influenza" post="virusesCurr. Opin. Virol.20148222910.1016/j.coviro.2014.04.00924866471 13.HanX.ZhangD.-K.GuoY.-M.FengW.-W.DongQ.ZhangC.-E.ZhouY.-F.LiuY.WangJ.-B.ZhaoY.-L.et al.Screening and evaluation of commonly-used"/>
   <result pre="Model to Screen Immunomodulatory Agents Regulating Cytokine Release Induced by" exact="Influenza" post="Virus InfectionVirol. Sin.20193464866110.1007/s12250-019-00145-w31286365 17.KamikawaS.OshimoS.OhtaE.NehiraT.Ã&quot;muraH.OhtaS.Cassane diterpenoids from the roots of"/>
   <result pre="influenza: past and presentAnn. Rev. Med.20005140742110.1146/annurev.med.51.1.40710774473 24.KapoorS.DhamaK.Pathogenesis and Pathogenicity of" exact="Influenza" post="VirusesInsight into Influenza Viruses of Animals and HumansSpringerCham, Switzerland2014"/>
   <result pre="presentAnn. Rev. Med.20005140742110.1146/annurev.med.51.1.40710774473 24.KapoorS.DhamaK.Pathogenesis and Pathogenicity of Influenza VirusesInsight into" exact="Influenza" post="Viruses of Animals and HumansSpringerCham, Switzerland2014 25.IwasakiA.PillaiP.Innate immunity to"/>
   <result pre="syndromeLancet Infect. Dis.201314576910.1016/S1473-3099(13)70286-X24239327 27.KrammerF.SmithG.FouchierR.PeirisJ.S.KedzierskaK.DohertyP.C.PaleseP.ShawM.L.TreanorJ.WebsterR.G.et al.InfluenzaNat. Rev. Dis. Primers20184310.1038/s41572-018-0002-y29955068 28.HanA.GiurgeaL.Cervantes-MedinaA.EdwardsK.RosasL.CzajkowskiL.BuasH.A.AthotaR.ReedS.TaubenbergerJ.et al.Sequential" exact="Influenza" post="A H1N1 and Influenza A H3N2 Challenge Infections in"/>
   <result pre="al.InfluenzaNat. Rev. Dis. Primers20184310.1038/s41572-018-0002-y29955068 28.HanA.GiurgeaL.Cervantes-MedinaA.EdwardsK.RosasL.CzajkowskiL.BuasH.A.AthotaR.ReedS.TaubenbergerJ.et al.Sequential Influenza A H1N1 and" exact="Influenza" post="A H3N2 Challenge Infections in Healthy VolunteersOpen Forum Infect."/>
   <result pre="Morbidity and Mortality of Mice Infected With Lethal Doses of" exact="Influenza" post="VirusAntimicrob Agents Chemother19974155155610.1128/AAC.41.3.5519055991 Figure 1 Caesalpinia decapetala (Roth) Alston"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7291183\results\search\zoonosis\results.xml">
   <result pre="of drug clearance. TableÂ 1 (A) Repurposing drugs to treat" exact="COVID 19." post="(B) Combinations of drugs used in the SOLIDARITY project"/>
   <result pre="Darunavir Aspartyl protease inhibitor Interface with viral replication Hepatitis C," exact="Ebola" post="virus, Marburg virus Â 36791-04-5 Ribavirin Inosine monophosphate dehydrogenase"/>
   <result pre="host cells and prevent viral entry to the target cell" exact="Influenza" post="anti viral Â 55981-09-4 Nitazoxanide Oxidative phosphorylation in mitochondria"/>
   <result pre="that may block viral nucleotide synthesis to stop viral replication" exact="Ebola" post="virus infection Â 145258-61-3 Interferon beta-1a (used in combination"/>
   <result pre="SARS-CoV-2. Various drugs that were used to viral infections like" exact="Ebola" post="and HIV or antimalarial drugs like chloroquine/hydroxychloroquine can also"/>
   <result pre="symptoms in rhesus macaques matches with the milder symptoms of" exact="SARS-CoV-2 infection" post="in humans. Further, serum analysis demonstrate an increase in"/>
   <result pre="results from China have shown that hACE2 mice do support" exact="SARS-CoV-2 infection" post="where they reduce weight by 20% and virus replication"/>
   <result pre="binding region of ACE2, making them a testable model for" exact="SARS-CoV-2 infection." post="Upon infection of SARS-CoV-2, Syrian hamsters demonstrate weight loss"/>
   <result pre="and is common for vaccine candidates of HIV/AIDS virus and" exact="Dengue" post="virus. Once the subject is immunized with the antigen,"/>
   <result pre="of success, effective and targeted drugs and vaccines for the" exact="SARS-CoV-2 infection" post="are still awaited. Moreover, agencies like WHO and FDA"/>
   <result pre="failure of the drug/vaccine could have devastating consequences. Abbreviations COVID-19" exact="coronavirus disease 2019" post="SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 MERS Middle"/>
   <result pre="disease 2019 SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 MERS" exact="Middle East respiratory syndrome" post="ACE2 angiotensin-converting enzyme 2 HA hemagglutinin WHO World Health"/>
   <result pre="severe acute lung injury by skewing macrophage responses during acute" exact="SARS-CoV infection." post="JCI Insight. 410.1172/jci.insight.123158 LuRZhaoXLiJNiuPYangBWuHWangWSongHet al.Genomic characterisation and epidemiology of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7291249\results\search\zoonosis\results.xml">
   <result pre="VirusesVirusesvirusesViruses1999-4915MDPI doi: 10.3390/v12050504viruses-12-00504 : Review Host Protective Immune Responses against" exact="Influenza" post="A Virus Infection https://orcid.org/0000-0001-6501-6810JungHi Eun1*https://orcid.org/0000-0002-3977-1510LeeHeung Kyu12*[1], [2], *Correspondence: euphoric@kaist.ac.kr"/>
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Influenza" post="viruses cause infectious respiratory disease characterized by fever, myalgia,"/>
   <result pre="produce a protective response against infection. 2. Virological Features of" exact="Influenza" post="A Virus The influenza virus is a respiratory pathogen"/>
   <result pre="the potential to elicit an immune response in humans [10,12]." exact="Influenza" post="A and B viruses are the most common causes"/>
   <result pre="most common causes of seasonal flu epidemics in humans [13]." exact="Influenza" post="B virus (IBV), which generally circulates later in the"/>
   <result pre="and enter the host cell via receptor-mediated endocytosis. However, SIA-independent" exact="influenza infection" post="has also been reported [27,28]. C-type lectin receptors are"/>
   <result pre="macrophageâ€™s galactose-type lectin and mannose receptors play important roles in" exact="influenza infection" post="[29,30,31]. DC-SIGN (DC209) and L-SIGN (CD209L) have been identified"/>
   <result pre="reduce therapeutic efficacy (Figure 2). 3. Innate Sensors Recognizing the" exact="Influenza" post="Virus After entering the host, the influenza virus infects"/>
   <result pre="respiratory tract and replicates to spread throughout the airways [62]." exact="Influenza" post="can also spread to immune cells such as macrophages"/>
   <result pre="produce dsRNA during replication [63,64], TLR3 activation can occur during" exact="influenza infection" post="[65]. However, the specific TLR3 ligand that is produced"/>
   <result pre="unclear whether TLR7-MyD88 signaling is necessary for the protection against" exact="influenza infection." post="However, TLR7 deficiency results in attenuated production of type"/>
   <result pre="infection. 4. Innate Effector Cell Types in the Response to" exact="Influenza" post="Infection During influenza virus infections, innate signaling and adaptive"/>
   <result pre="[101,102]. Defects in NK cells lead to increased susceptibility to" exact="influenza infection" post="and uncontrolled viral growth in the lungs [103,104]. However,"/>
   <result pre="These studies indicate that neutrophils play a protective role in" exact="influenza infection," post="but that excessive recruitment of neutrophils can also contribute"/>
   <result pre="lines of evidence supporting the protective role of AMs during" exact="influenza infection." post="Clodronate-induced depletion of AMs increases the mortality of mice"/>
   <result pre="increases the mortality of mice and enhances pulmonary inflammation during" exact="influenza infection" post="[116]. Csf2âˆ’/âˆ’ mice, which are deficient in AM development,"/>
   <result pre="in AM development, experience respiratory failure and reduced resistance to" exact="influenza infection" post="despite having normal adaptive immune responses against influenza virus"/>
   <result pre="led to aggressive inflammatory responses and severe lung pathology after" exact="influenza infection" post="[118]. AMs control lung dysfunction by increasing the antiviral"/>
   <result pre="AMs play a crucial role in maintaining pulmonary homeostasis during" exact="influenza infection." post="4.2. Dendritic Cells DCs, which belong to the innate"/>
   <result pre="to influenza virus infection than cDC2 and pDCs [126], but" exact="influenza infection" post="of cDC1 does not lead to productive viral replication"/>
   <result pre="cDC1 does not lead to productive viral replication [127]. Following" exact="influenza infection," post="lung-migratory cDCs take up viral antigen and migrate to"/>
   <result pre="following primary influenza challenge, and lack of MoDCs during primary" exact="influenza infection" post="reduced host resistance to secondary virus infection, suggesting that"/>
   <result pre="targets of influenza vaccine. 5. Protective Adaptive Immune Responses against" exact="Influenza" post="Infections Although innate immunity contributes to early viral control,"/>
   <result pre="responses. CD4+ T cell responses peak at 10 days after" exact="influenza infection" post="in the mouse lung [145]. Adaptive transfer of effector"/>
   <result pre="neutralizing activity and mediates early immune responses [173]. 6. Conclusions" exact="Influenza" post="remains a major annual public health burden. Further, the"/>
   <result pre="burden of influenza. Vaccination remains the best way to prevent" exact="influenza infection." post="Flu vaccines contain virus strains that are expected to"/>
   <result pre="drugs are effective at reducing the risk and severity of" exact="influenza infection." post="However, there is still room for improvement. Advancing our"/>
   <result pre="Natl. Acad. Sci. USA202011761962810.1073/pnas.191658511631843889 14.DummR.E.HeatonN.S.The Development and Use of Reporter" exact="Influenza" post="B VirusesViruses20191173610.3390/v1108073631404985 15.Gutierrez-PizarrayaA.Perez-RomeroP.AlvarezR.AydilloT.A.Osorio-GomezG.Milara-IbanezC.SanchezM.PachonJ.CorderoE.Unexpected severity of cases of influenza B"/>
   <result pre="WerfS.LinaB.et al.Clinical Characteristics Are Similar across Type A and B" exact="Influenza" post="Virus InfectionsPLoS ONE201510e013618610.1371/journal.pone.013618626325069 18.PingJ.LopesT.J.NeumannG.KawaokaY.Development of high-yield influenza B virus"/>
   <result pre="mRNA nuclear exportNat. Microbiol.201941671167910.1038/s41564-019-0482-x31263181 53.MoriyamaM.ChenI.Y.KawaguchiA.KoshibaT.NagataK.TakeyamaH.HasegawaH.IchinoheT.The RNA- and TRIM25-Binding Domains of" exact="Influenza" post="Virus NS1 Protein Are Essential for Suppression of NLRP3"/>
   <result pre="and diseasePLoS Pathog.20139e100339210.1371/journal.ppat.100339223737748 62.JungH.E.OhJ.E.LeeH.K.Cell-Penetrating Mx1 Enhances Anti-Viral Resistance against Mucosal" exact="Influenza" post="Viral InfectionViruses20191110910.3390/v1102010930696001 63.WisskirchenC.LudersdorferT.H.MullerD.A.MoritzE.PavlovicJ.The cellular RNA helicase UAP56 is required"/>
   <result pre="antiviral responses to single-stranded RNA bearing 5â€™-phosphatesScience2006314997100110.1126/science.113299817038589 65.Le GofficR.PothlichetJ.VitourD.FujitaT.MeursE.ChignardM.Si-TaharM.Cutting Edge:" exact="Influenza" post="A Virus Activates TLR3-Dependent Inflammatory and RIG-I-Dependent Antiviral Responses"/>
   <result pre="activates inflammasomes via its intracellular M2 ion channelNat. Immunol.20101140441010.1038/ni.186120383149 72.Stegemann-KoniszewskiS.BehrensS.BoehmeJ.D.HochnadelI.RieseP.GuzmanC.A.KrogerA.SchreiberJ.GunzerM.BruderD.Respiratory" exact="Influenza" post="A Virus Infection Triggers Local and Systemic Natural Killer"/>
   <result pre="Role of TLR- and RLR-Signaling in the Immune Responses to" exact="Influenza" post="A Virus Infection and VaccinationJ. Immunol.20071794711472010.4049/jimmunol.179.7.471117878370 75.Jeisy-ScottV.KimJ.H.DavisW.G.CaoW.KatzJ.M.SambharaS.TLR7 recognition is"/>
   <result pre="cellsVirology20063459610410.1016/j.virol.2005.09.04316253303 95.WareingM.D.LyonA.InglisC.GiannoniF.CharoI.SarawarS.R.Chemokine regulation of the inflammatory response to a low-dose" exact="influenza infection" post="in CCR2-/- miceJ. Leukoc. Biol.20078179380110.1189/jlb.050629917179466 96.WareingM.D.LyonA.B.LuB.GerardC.SarawarS.R.Chemokine expression during the"/>
   <result pre="102.CooperG.E.OstridgeK.KhakooS.I.WilkinsonT.M.A.StaplesK.J.Human CD49a(+) Lung Natural Killer Cell Cytotoxicity in Response to" exact="Influenza" post="A VirusFront. Immunol.20189167110.3389/fimmu.2018.0167130079068 103.NogusaS.RitzB.W.KassimS.H.JenningsS.R.GardnerE.M.Characterization of age-related changes in natural"/>
   <result pre="103.NogusaS.RitzB.W.KassimS.H.JenningsS.R.GardnerE.M.Characterization of age-related changes in natural killer cells during primary" exact="influenza infection" post="in miceMech. Ageing Dev.200812922323010.1016/j.mad.2008.01.00318304606 104.LiuB.MoriI.HossainM.J.DongL.TakedaK.KimuraY.Interleukin-18 improves the early defence"/>
   <result pre="al.Critical role of natural killer cells in lung immunopathology during" exact="influenza infection" post="in miceJ. Infect. Dis.201220616717710.1093/infdis/jis34022561366 107.HashimotoY.MokiT.TakizawaT.ShiratsuchiA.NakanishiY.Evidence for phagocytosis of influenza"/>
   <result pre="118.PurnamaC.NgS.L.TetlakP.SetiaganiY.A.KandasamyM.BaalasubramanianS.KarjalainenK.RuedlC.Transient ablation of alveolar macrophages leads to massive pathology of" exact="influenza infection" post="without affecting cellular adaptive immunityEur. J. Immunol.2014442003201210.1002/eji.20134435924687623 119.CardaniA.BoultonA.KimT.S.BracialeT.J.Alveolar Macrophages"/>
   <result pre="affecting cellular adaptive immunityEur. J. Immunol.2014442003201210.1002/eji.20134435924687623 119.CardaniA.BoultonA.KimT.S.BracialeT.J.Alveolar Macrophages Prevent Lethal" exact="Influenza" post="Pneumonia by Inhibiting Infection Of Type-1 Alveolar Epithelial CellsPLoS"/>
   <result pre="Effector CD8(+) T Cell Migration, Survival, and Memory Responses During" exact="Influenza" post="InfectionFront. Immunol.20189304310.3389/fimmu.2018.0304330622538 130.PangI.K.IchinoheT.IwasakiA.IL-1R signaling in dendritic cells replaces pattern-recognition"/>
   <result pre="141.HemannE.A.SjaastadL.E.LangloisR.A.LeggeK.L.Plasmacytoid Dendritic Cells Require Direct Infection to Sustain the Pulmonary" exact="Influenza" post="A Virus-Specific CD8 T Cell ResponseJ. Virol.2015902830283710.1128/JVI.02546-1526719269 142.CruzJ.L.Perez-GironJ.V.LudtkeA.Gomez-MedinaS.RuibalP.IdoyagaJ.Munoz-FontelaC.Monocyte-derived dendritic"/>
   <result pre="Contributes to Protective Immunity via Cytotoxic T-Cell Priming against Mucosal" exact="Influenza" post="Viral InfectionViruses20191184010.3390/v11090840 159.KrammerF.SmithG.J.D.FouchierR.A.M.PeirisM.KedzierskaK.DohertyP.C.PaleseP.ShawM.L.TreanorJ.WebsterR.G.et al.InfluenzaNat. Rev. Dis. Primers20184310.1038/s41572-018-0002-y29955068 160.SchmidtM.E.VargaS.M.The CD8"/>
   <result pre="Med.19971862063206810.1084/jem.186.12.20639396777 163.LeeB.O.Rangel-MorenoJ.Moyron-QuirozJ.E.HartsonL.MakrisM.SpragueF.LundF.E.RandallT.D.CD4 T cell-independent antibody response promotes resolution of primary" exact="influenza infection" post="and helps to prevent reinfectionJ. Immunol.20051755827583810.4049/jimmunol.175.9.582716237075 164.WaffarnE.E.BaumgarthN.Protective B cell"/>
   <result pre="Glob. Health2019902042110.7189/jogh.09.02042131673337 176.ZhangY.XuC.ZhangH.LiuG.D.XueC.CaoY.Targeting Hemagglutinin: Approaches for Broad Protection against the" exact="Influenza" post="A VirusViruses20191140510.3390/v11050405 177.GrodelandG.Baranowska-HustadM.AbadejosJ.BlaneT.R.TeijaroJ.NemazeeD.BogenB.Induction of Cross-Reactive and Protective Antibody Responses"/>
   <result pre="Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From" exact="Influenza" post="HemagglutininFront. Immunol.20201143110.3389/fimmu.2020.0043132269566 178.HoftD.F.BabusisE.WorkuS.SpencerC.T.LottenbachK.TruscottS.M.AbateG.SakalaI.G.EdwardsK.M.CreechC.B.et al.Live and inactivated influenza vaccines induce"/>
   <result pre="virus DNA vaccineJ. Virol.2011851370138310.1128/JVI.01250-1021106745 183.SheuT.G.DeydeV.M.Okomo-AdhiamboM.GartenR.J.XuX.BrightR.A.ButlerE.N.WallisT.R.KlimovA.I.GubarevaL.V.Surveillance for neuraminidase inhibitor resistance among" exact="human influenza" post="A and B viruses circulating worldwide from 2004 to"/>
   <result pre="to neuraminidase inhibitors conferred by an R292K mutation in a" exact="human influenza" post="virus H7N9 isolate can be masked by a mixed"/>
   <result pre="contains the transmembrane proteins HA, NA, and M2. Figure 2" exact="Influenza" post="A replication cycle. The virus recognizes specific receptors expressed"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7291320\results\search\zoonosis\results.xml">
   <result pre="Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The recent outbreak of" exact="coronavirus disease 2019" post="(COVID-19) caused by severe acute respiratory syndrome coronavirus 2"/>
   <result pre="COVID-19 cardiovascular disease myocardial injury 1. Introduction In December 2019," exact="coronavirus disease 2019" post="(COVID-19) infected pneumonia caused by severe acute respiratory syndrome"/>
   <result pre="in humans, such as severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS) [3]. The majority of patients have mild symptoms,"/>
   <result pre="other strains include severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), which are zoonotic in origin and have"/>
   <result pre="Altogether, these findings suggest that an acute myocardial injury in" exact="SARS-CoV-2 infection" post="may occur as the disease severity advance by cytokine"/>
   <result pre="Remdesivir is an agent that was originally developed to treat" exact="Ebola" post="and has been effective in inhibiting SARS-CoV-2 in vitro"/>
   <result pre="Dis.20202053353410.1016/S1473-3099(20)30120-132087114 3.ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.et al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: A descriptive studyLancet (Lond. Engl.)202039550751310.1016/S0140-6736(20)30211-7 4.WangD.HuB.HuC.ZhuF.LiuX.ZhangJ.WangB.XiangH.ChengZ.XiongY.et"/>
   <result pre="21.CoburnB.J.WagnerB.G.BlowerS.Modeling influenza epidemics and pandemics: Insights into the future of" exact="swine flu" post="(H1N1)BMC Med.200973010.1186/1741-7015-7-3019545404 22.ZumlaA.HuiD.S.PerlmanS.Middle East respiratory syndromeLancet (Lond. Engl.)2015386995100710.1016/S0140-6736(15)60454-8 23.PerlmanS.Another"/>
   <result pre="Another CoronavirusN. Engl. J. Med.202038276076210.1056/NEJMe200112631978944 24.MizumotoK.KagayaK.ZarebskiA.ChowellG.Estimating the asymptomatic proportion of" exact="coronavirus disease 2019" post="(COVID-19) cases on board the Diamond Princess cruise ship,"/>
   <result pre="in Relation to COVID-19 in ItalyJAMA202010.1001/jama.2020.468332203977 34.GoyalP.ChoiJ.J.PinheiroL.C.SchenckE.J.ChenR.JabriA.SatlinM.J.CampionT.R.NahidM.RingelJ.B.et al.Clinical Characteristics of" exact="Covid-19" post="in New York CityN. Engl. J. Med.202010.1056/NEJMc201041932302078 35.PetrilliC.M.JonesS.A.YangJ.RajagopalanH.Oâ€™DonnellL.F.ChernyakY.TobinK.CerfolioR.J.FrancoisF.HorwitzL.I.Factors associated"/>
   <result pre="in the greater Toronto areaJAMA20032892801280910.1001/jama.289.21.JOC3088512734147 41.BadawiA.RyooS.G.Prevalence of comorbidities in the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV): A systematic review and meta-analysisInt. J. Infect."/>
   <result pre="meta-analysis of observational studiesHeart (Br. Card. Soc.)202010635035710.1136/heartjnl-2019-31519331444266 48.CaldeiraD.RodriguesB.DavidC.CostaJ.PintoF.J.FerreiraJ.J.The association of" exact="influenza infection" post="and vaccine with myocardial infarction: Systematic review and meta-analysis"/>
   <result pre="Case Report and InsightsPreprints202010.20944/preprints202003.0180.v1 61.KwongJ.C.SchwartzK.L.CampitelliM.A.ChungH.CrowcroftN.S.KarnauchowT.KatzK.KoD.T.McGeerA.J.McNallyD.et al.Acute Myocardial Infarction after Laboratory-Confirmed" exact="Influenza" post="InfectionN. Engl. J. Med.201837834535310.1056/NEJMoa170209029365305 62.ThygesenK.AlpertJ.S.JaffeA.S.ChaitmanB.R.BaxJ.J.MorrowD.A.WhiteH.D.Fourth Universal Definition of Myocardial"/>
   <result pre="25 April 2020) 67.AlshahraniM.S.SindiA.AlshamsiF.Al-OmariA.El TahanM.AlahmadiB.ZeinA.KhataniN.Al-HameedF.AlamriS.et al.Extracorporeal membrane oxygenation for severe" exact="Middle East respiratory syndrome" post="coronavirusAnn. Intensiv. Care20188310.1186/s13613-017-0350-x 68.MadjidM.ConnollyA.T.NabutovskyY.Safavi-NaeiniP.RazaviM.MillerC.C.Effect of High Influenza Activity on"/>
   <result pre="Middle East respiratory syndrome coronavirusAnn. Intensiv. Care20188310.1186/s13613-017-0350-x 68.MadjidM.ConnollyA.T.NabutovskyY.Safavi-NaeiniP.RazaviM.MillerC.C.Effect of High" exact="Influenza" post="Activity on Risk of Ventricular Arrhythmias Requiring Therapy in"/>
   <result pre="Complication Caused by COVID-19. ARDS, acute respiratory distress syndrome; COVID-19," exact="coronavirus disease 2019;" post="CV, cardiovascular. Images were adapted from smart.servier.com by Kensuke"/>
   <result pre="n (%), mean Â± SD, or median (interquartile range); COVID-19," exact="coronavirus disease 2019;" post="ICU: intensive care unit; SD, standard deviation. * Composite"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7291595\results\search\zoonosis\results.xml">
   <result pre="229E, HKU1, OC43, NL63, severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS)-CoV [9â€&quot;12]. Of these, 229E, HKU1, OC43 and NL63"/>
   <result pre="Johns Hopkins resource center). Currently, specific vaccines and medicine for" exact="SARS-CoV-2 infection" post="are being developed [16]. This paper summarizes the epidemiological,"/>
   <result pre="posted in GenBank and the Global Initiative on Sharing All" exact="Influenza" post="Data by Chinese health authorities and the Centers for"/>
   <result pre="respiratory syndrome coronavirus 2, severe acute respiratory syndrome coronavirus and" exact="Middle East respiratory syndrome" post="coronavirus. Virus SARS-CoV-2 SARS-CoV MERS-CoV Ref. Outbreak year 2019"/>
   <result pre="IL-15: Interleukin 15;Â IL-17: Interleukin 17;Â IVIG: Intravenous immunoglobulin;Â MERS-CoV:" exact="Middle East respiratory syndrome" post="coronavirus;Â TNF-Î±: tumor necrosis factor-alpha; VEGF: Vascularendothelial growth factor;Â"/>
   <result pre="coronavirus;Â TNF-Î±: tumor necrosis factor-alpha; VEGF: Vascularendothelial growth factor;Â SARS-CoV-2:" exact="Severe acute respiratory syndrome" post="coronavirus 2. The virus can be transmitted not only"/>
   <result pre="with the virus. Clinical characteristics of patients infected with SARS-CoV-2" exact="SARS-CoV-2 infection" post="has caused clusters of severe respiratory illness similar to"/>
   <result pre="[6]. The symptoms are observed approximately 5.2Â days after the" exact="SARS-CoV-2 infection" post="[5]. In a study published in The Lancet, 41"/>
   <result pre="41 of 41 patients who were identified as positive for" exact="SARS-CoV-2 infection" post="presented with pneumonia and abnormal chest computed tomography (CT)"/>
   <result pre="In view of the large amounts of cytokines produced during" exact="SARS-CoV infection," post="infection with SARS-CoV-2 similarly induces the production of proinflammatory"/>
   <result pre="by T-helper type 2 [Th2] cells was also increased during" exact="SARS-CoV-2 infection" post="[6]) (TableÂ 1). The mortality rate of SARS-CoV-2-infected patients"/>
   <result pre="and mustached tamarins) have all been evaluated as models of" exact="SARS-CoV infection" post="[62]. All non-human primates had pneumonia, cough and respiratory"/>
   <result pre="AC70 and AC63 transgene-positive mice also showed clinical manifestation after" exact="SARS-CoV infection," post="demonstrating their usefulness to study the pathogenesis and evaluation"/>
   <result pre="specific therapeutic medicine has been approved for the treatment of" exact="SARS-CoV-2 infection." post="All patients are given empirical antibiotic or antiviral drugs."/>
   <result pre="and has demonstrated effective pan-CoV therapy. The first case of" exact="SARS-CoV-2 infection" post="in the USA was successfully treated with RDA. Moreover,"/>
   <result pre="The ability to rapidly test patients suspected of having a" exact="SARS-CoV-2 infection" post="is the cornerstone of case isolation. The experience gained"/>
   <result pre="in advance to prevent epidemics in the world. Executive summary" exact="Coronavirus disease 2019" post="(COVID-19) was first reported in China and currently poses"/>
   <result pre="glucocorticoids, monoclonal anti-inflammatory antibody (tocilizumab), have been used to treat" exact="SARS-CoV-2 infection." post="Traditional Chinese medicines are also used for therapy during"/>
   <result pre="SongQ , ChenDClinical and epidemiological features of 36 children with" exact="coronavirus disease 2019" post="(COVID-19) in Zhejiang, China: an observational cohort study. Lancet"/>
   <result pre="SubbaraoKDevelopment of animal models against emerging coronaviruses: from SARS to" exact="MERS coronavirus." post="Virology479â€&quot;480, 247â€&quot;258 (2015). 16.JiangS , DuL , ShiZAn emerging"/>
   <result pre=", DongXet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet395(10223), 507â€&quot;513 (2020).32007143"/>
   <result pre="ZuoZet al.Diagnostic value and dynamic variance of serum antibody in" exact="coronavirus disease 2019." post="Int. J. Infect. Dis.94, 49â€&quot;52 (2020).32251798 62.GongSR , BaoLLThe"/>
   <result pre="systematic review of therapeutic agents for the treatment of the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). Travel Med. Infect. Dis.30, 9â€&quot;18 (2019).31252170 67.StockmanLJ"/>
   <result pre="al.Clinical management of respiratory syndrome in patients hospitalized for suspected" exact="Middle East respiratory syndrome" post="coronavirus infection in the Paris area from 2013 to"/>
   <result pre="85.BleibtreuA , BertineM , BertinC , Houhou-FidouhN , VisseauxBFocus on" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). Med. Mal. Infect.50(3), 243â€&quot;251 (2020).31727466"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7291979\results\search\zoonosis\results.xml">
   <result pre="EpidemiolJournal of Clinical Epidemiology0895-43561878-5921Elsevier Inc. pmcid: 7291979S0895-4356(20)30645-4 doi: 10.1016/j.jclinepi.2020.06.008 :" exact="Covid-19" post="Article Pandemics and methodological developments in epidemiology history MorabiaAlfredoâˆ—[],"/>
   <result pre="tuberculosis and the formalization of cohort studies, the 1918 Great" exact="Influenza" post="and the creation of an academic epidemiologic counterpart to"/>
   <result pre="thinking beyond academic and professional circles. Keywords Epidemiology History Pandemics" exact="Covid-19" post="Plague Cholera Tuberculosis Influenza HIV/AIDS What is new? Key"/>
   <result pre="professional circles. Keywords Epidemiology History Pandemics Covid-19 Plague Cholera Tuberculosis" exact="Influenza" post="HIV/AIDS What is new? Key findings â€¢This brief retrospective"/>
   <result pre="the achievements of the subsequent chronic disease epidemiologic research. 4" exact="Influenza" post="1918 Until 1918, public health was overseen by health"/>
   <result pre="when Surgeon General Rupert Blue made him responsible for his" exact="Influenza" post="Task Force. Frost conducted a massive epidemiological house-to-house survey"/>
   <result pre="act together to affect the progression of the epidemic. Similarly," exact="Covid-19" post="may have accelerated the understanding that health inequities can"/>
   <result pre="and public health 1916-19391987Johns Hopkins University PressBaltimore, MD 31BoylstonA.W.Defying providence." exact="Smallpox" post="and the forgotten 18th century medical revolution2012CreateSpace Independent Publishing"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7293492\results\search\zoonosis\results.xml">
   <result pre="rarely reach the public until after an outbreak abates; an" exact="Ebola" post="vaccine was approved 5 years after peak outbreak and"/>
   <result pre="1 month faster than the first candidate for the H1N1" exact="swine flu" post="epidemic in 2009 (93 days) and 3 months faster"/>
   <result pre="2009 (93 days) and 3 months faster than the first" exact="Ebola" post="vaccine candidate in 2014 (167 days) (Table S1 in"/>
   <result pre="responsible for the 2003 severe acute respiratory syndrome (SARS), 2012" exact="Middle East respiratory syndrome" post="(MERS), and 2015 Zika virus outbreaks are still in"/>
   <result pre="(WHO) declared the outbreaks over. While there is now an" exact="Ebola" post="vaccine, it took 5 years to complete 12 supporting"/>
   <result pre="Slanted lines indicate overlap in development milestones; the genomes of" exact="Middle East respiratory syndrome" post="(MERS) and severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2; COVID-19)"/>
   <result pre="Slanted lines indicate overlap in development milestones; the genomes of" exact="Middle East respiratory syndrome" post="(MERS) and severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2; COVID-19)"/>
   <result pre="syndrome (SARS): World Health Organization (WHO)i; H1N1: WHOii, FluNet/WHO Global" exact="Influenza" post="Surveillance and Response System (GISRS)iii (H1N1 data comes from"/>
   <result pre="viruses; number of specimens positive for H1N1 reported to GISRS);" exact="Middle East respiratory syndrome" post="(MERS): European Centre for Disease Prevention and Control (ECDC)iv;"/>
   <result pre="syndrome (SARS): World Health Organization (WHO)i; H1N1: WHOii, FluNet/WHO Global" exact="Influenza" post="Surveillance and Response System (GISRS)iii (H1N1 data comes from"/>
   <result pre="viruses; number of specimens positive for H1N1 reported to GISRS);" exact="Middle East respiratory syndrome" post="(MERS): European Centre for Disease Prevention and Control (ECDC)iv;"/>
   <result pre="thousands of new drug development programs [8,9]. To achieve the" exact="Ebola" post="vaccinesâ€™ 5-year clinical program, global regulators from developed countries"/>
   <result pre="example, while Merck submitted the same evidence dossier for the" exact="Ebola" post="vaccine to both the EMA and FDA at the"/>
   <result pre="emergencyWHO Drug Info.292015127132 11.Henao-RestrepoA.M.On a path to accelerate access to" exact="Ebola" post="vaccines: the WHO's research and development efforts during the"/>
   <result pre="vaccines: the WHO's research and development efforts during the 2014â€&quot;2016" exact="Ebola" post="epidemic in West AfricaCurr. Opin. Virol.17201613814427180074 12.VanniceK.S.Demonstrating vaccine effectiveness"/>
   <result pre="pipelineNat. Biotechnol.38202052353232203293 14.DavisJ.S.FerreiraD.DenholmJ.T.TongS.Y.C.Clinical trials for the prevention and treatment of" exact="coronavirus disease 2019" post="(COVID-19): The current state of playMed. J. Aust.2020Published online:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7293728\results\search\zoonosis\results.xml">
   <result pre="Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against" exact="Influenza" post="B Virus Infection in the Mouse Model YangChunguang1WangYutao1HeJiayang1YanWen12JiangHaiming1ChenQiaolian1LiLi3https://orcid.org/0000-0002-2681-4171YangZifengjeffyah@163.com1[], 1[],"/>
   <result pre="any medium, provided the original work is properly cited. Abstract" exact="Influenza" post="B virus (IBV) is one of the main pathogens"/>
   <result pre="UniversitiesGCZX-A1408 Natural Science Basic Research Program of Shaanxi2019JM-513 1. Introduction" exact="Influenza" post="B virus (IBV), one of the main pathogens of"/>
   <result pre="[14]. LQ was approved for clinical trials as treatment for" exact="influenza infection" post="by the FDA in 2016. In addition, our previous"/>
   <result pre="Bioscience Co., Ltd. (Zhaoqing city, China). 2.2. Viruses and Cells" exact="Influenza" post="B virus (B/Lee/40) was purchased from American Type Culture"/>
   <result pre="B/Guangzhou/GIRD01/2016 (Victoria-like), and B/Guangzhou/0215/2012 (Victoria-like) were isolated from clinical samples." exact="Influenza" post="B virus B/Guangzhou/19/2016 (Yamagata-like) was gifted by Dr. Feng"/>
   <result pre="Feng Ye (the First Affiliated Hospital of Guangzhou Medical University)." exact="Influenza" post="A virus A/California/04/2009 was gifted by professor Malik J."/>
   <result pre="were considered significant. 3. Results 3.1. LQ Displays Efficacy against" exact="Influenza" post="B Viruses In Vitro First, a cell proliferation and"/>
   <result pre="isolated in 2016. 3.2. LQ Inhibits the Early Phase of" exact="Influenza" post="B Virus Replication According to three treatment models representing"/>
   <result pre="viral cycle of IBV. 3.3. LQ Inhibits NP Replication of" exact="Influenza" post="B Virus To identify the effect of LQ on"/>
   <result pre="decreased the synthesis of nucleoprotein (Figure 1(c)). 3.4. LQ Inhibits" exact="Influenza" post="B Virus Binding to Cell Surface To study the"/>
   <result pre="3.5. LQ Displays Inhibition of Inflammatory Cytokines and Chemokines after" exact="Influenza" post="B Virus Infection in mRNA Levels Inflammatory cytokine and"/>
   <result pre="addition to antiviral activity, it may also have anti-inflammatory activity." exact="Influenza" post="virus infection causes cell necrosis/apoptosis, which induces an immune"/>
   <result pre="after influenza A virus infection in vitroAntiviral Research201398231932410.1016/j.antiviral.2013.03.00623523553 Figure 1" exact="Influenza" post="B virus yield after treatment with LQ. (a) The"/>
   <result pre="target viral binding activity of influenza B virus B0215. (a)" exact="Influenza" post="virus hemagglutination inhibition assay after treatment with LQ. (b)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7294848\results\search\zoonosis\results.xml">
   <result pre="In this perspective, we predominantly focus on the impact of" exact="SARS-CoV-2 infection" post="on ACE2 and dysregulation of the protective effect of"/>
   <result pre="alveolar angiotensin coagulopathy fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction" exact="Severe acute respiratory syndrome" post="virus 2 (SARS-CoV-2) causes a respiratory disease that led"/>
   <result pre="(SARS-CoV-2) causes a respiratory disease that led to the fatal" exact="Coronavirus disease 2019" post="(COVID-19) pandemic. In late 2019, the SARS-CoV-2 outbreak was"/>
   <result pre="ACE2 receptor. How the known epidemiological and clinical manifestation of" exact="SARS-CoV-2 infection" post="may be explained by perturbations of physiological functions of"/>
   <result pre="critical for the understanding of the pathophysiological changes due to" exact="SARS-CoV-2 infection." post="Understanding of the molecular downstream effects of angiotensin (Ang)"/>
   <result pre="distress, myocardial injury, renal failure, and increased mortality due to" exact="SARS-CoV-2 infection" post="among the aging population and subjects with cardiovascular and"/>
   <result pre="is very important to note, especially in the context of" exact="SARS-CoV-2 infection," post="that besides the classical RAS/ACE mediated Ang II formation,"/>
   <result pre="assess the effect of ACE/ARB inhibitors (ClinicalTrials.gov Identifier: NCT04330300) on" exact="SARS-CoV-2 infection." post="If the alternative pathways in the formation of Ang"/>
   <result pre="ACE/ARB inhibitors play a role on the clinical course of" exact="SARS-CoV-2 infection." post="ACE2 acts as a ligand through its recently identified"/>
   <result pre="2020). However, pathological examination on autopsies have not investigated if" exact="SARS-CoV-2 infection" post="leads to total destruction of ACE2 receptors on the"/>
   <result pre="a randomized-controlled, open-label trial involving hospitalized adult patients with confirmed" exact="SARS-CoV-2 infection" post="showed no benefit of lopanavir (Cao et al., 2020)."/>
   <result pre="(GS5734) an inhibitor of RNA polymerase, originally developed to treat" exact="Ebola" post="infections, has in vitro activity against multiple RNA viruses,"/>
   <result pre="of remdesivir treatment alone or in conjunction with chloroquine in" exact="SARS-CoV-2 infection." post="Because hydroxychloroquine and chloroquine are considered inhibitors of endosomal"/>
   <result pre="are no randomized clinical trials to support their efficacy against" exact="SARS-CoV-2 infection." post="However, it is conceivable that their efficacy may vary"/>
   <result pre="of significant efficacy of antimalarial drugs in the treatment of" exact="SARS-CoV-2 infection" post="(Magagnoli et al., 2020). Corticosteroids are the most conventional"/>
   <result pre="lung epithelial cells and lung injury? (2) What effect(s) does" exact="SARS-CoV-2 infection" post="of lung epithelial cells/endothelial cells have on ACE2 expression"/>
   <result pre="(2013). Epidemiological, demographic, and clinical characteristics of 47 cases of" exact="Middle East respiratory syndrome" post="coronavirus disease from Saudi Arabia: a descriptive study. Lancet"/>
   <result pre="GuoY.-R.CaoQ.-D.HongZ.-S.TanY.-Y.ChenS.-D.JinH.-J.et al.. (2020). The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;an update on the status. Military Med. Res.7,"/>
   <result pre="Science325, 1680â€&quot;1682. 10.1126/science.117566719779197 MenterT.HaslbauerJ. D.NienholdR.SavicS.HopferH.DeigendeschN.et al.. (2020). Post-mortem examination of" exact="COVID19" post="patients reveals diffuse alveolar damage with severe capillary congestion"/>
   <result pre="E.DaveyR. T.JrTshiani MbayaO.ProschanM.MukadiD.et al.. (2019). A randomized, controlled trial of" exact="Ebola" post="virus disease therapeutics. N. Engl. J. Med.381, 2293â€&quot;2303. 10.1056/NEJMoa191099331774950"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7294857\results\search\zoonosis\results.xml">
   <result pre="PubMed articles. COVID-19 and management gave 167 published research papers." exact="COVID19" post="and antivirals gave thirty-five PubMed articles. Lastly, COVID-19 and"/>
   <result pre="that no competing interests exist. References References 1World Health Organization." exact="Coronavirus disease 2019" post="(â€ŽCOVID- 19)â€Ž: situation report, 872020. World Health Organizationhttps://apps.who.int/iris/handle/10665/331785 2Features,"/>
   <result pre="ResJinYHCaiLChengZSet al.47202032029004 7Correlation of chest CT and RT-PCR testing in" exact="coronavirus disease 2019" post="(COVID-19) in China: a report of 1014 casesRadiologyAiTYangZHouHet al.200642262020"/>
   <result pre="al.919594202032173574 24Clinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci TrendsWangZChenXLuYChenFZhangW646814202032037389 25Anti-HCV,"/>
   <result pre="and laboratory effects of convalescent plasma therapy for patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a study protocolSpringerplusArabiYBalkhyHHajeerAHet al.70942015https://doi.org/10.1186/s4006426618098 28Treatment of 5"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7295489\results\search\zoonosis\results.xml">
   <result pre="highly pathogenic coronavirus emerged in Middle Eastern countries caused the" exact="Middle East respiratory syndrome" post="(MERS) epidemic (Zaki et al., 2012). The ongoing SARS-CoV-2"/>
   <result pre="OC43 strain Human CoV-OC43 Human Mild respiratory tract infections AY345986" exact="Severe acute respiratory syndrome" post="SARS-CoV Human Severe acute respiratory syndrome,10% mortality rate NC_045512.2"/>
   <result pre="syndrome SARS-CoV Human Severe acute respiratory syndrome,10% mortality rate NC_045512.2" exact="Severe acute respiratory syndrome" post="coronavirus 2 SARS-CoV-2 Human Fever, Cough, Shortness of breath"/>
   <result pre="Fever, Cough, Shortness of breath or difficulty breathing MN988668.1 Wuhan" exact="seafood market pneumonia" post="virus isolate 2019-nCoV WHU01 2019-nCoV WHU0 Human Severe acute"/>
   <result pre="seafood market pneumonia virus isolate 2019-nCoV WHU01 2019-nCoV WHU0 Human" exact="Severe acute respiratory syndrome" post="MH734115.1 Middle East respiratory syndrome coronavirus MERS-CoV Human Severe"/>
   <result pre="2019-nCoV WHU01 2019-nCoV WHU0 Human Severe acute respiratory syndrome MH734115.1" exact="Middle East respiratory syndrome" post="coronavirus MERS-CoV Human Severe acute respiratory syndrome,37% mortality rate"/>
   <result pre="effusions EF424623 Bovine CoV/ENT Bovine CoV/ENT Cow Diarrhea AY394989 Equine" exact="Severe acute respiratory syndrome" post="EquineCoV/Obihiro12-1 Horse Fever, anorexia, leucopenia NC_001846.1 Mouse hepatitis virus"/>
   <result pre="Fig. 3 is a hypothetical explanation of the pathogenesis of" exact="SARS-CoV-2 infection." post="Fig. 3 Pathogenesis of SARS-CoV-2 infection. 5 Clinical manifestations"/>
   <result pre="of the pathogenesis of SARS-CoV-2 infection. Fig. 3 Pathogenesis of" exact="SARS-CoV-2 infection." post="5 Clinical manifestations The clinical features of COVID-19 range"/>
   <result pre="is proposed as a responsible for the inflammation because of" exact="SARS-CoV-2 infection" post="(Fu et al., 2020). ADE can interact with virusâ€&quot;antibody"/>
   <result pre="GuJ.HanB.WangJ.COVID-19: gastrointestinal manifestations and potential fecal-oral transmissionGastroenterology38220201708172010.1056/NEJMoa2002032 GuanWei-jieZheng-yiN.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN. Engl. J. Med.202010.1056/NEJMoa2002032 GuanG.GaoL.WangJ.WenX.MaoT.PengS.ZhangT.ChenX.LuF.Exploring the mechanism of"/>
   <result pre="HosaniF.KeatingM.K.GerberS.I.JonesT.L.MetcalfeM.G.TongS.TaoY.AlamiN.N.HaynesL.M.Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of" exact="Middle East respiratory syndrome" post="coronavirus infection in the United Arab Emirates, April 2014Am."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7295552\results\search\zoonosis\results.xml">
   <result pre="any medium, provided the original work is properly cited. Abstract" exact="Coronavirus disease 2019" post="is caused by severe acute respiratory syndrome coronavirus 2"/>
   <result pre="as part of supportive care in complicated cases of COVID-19." exact="Coronavirus disease 2019" post="SARS-CoV-2 Pharmacological treatment Medical management HIV Transplant ESKD Introduction"/>
   <result pre="2019 SARS-CoV-2 Pharmacological treatment Medical management HIV Transplant ESKD Introduction" exact="Coronavirus disease 2019" post="is caused by severe acute respiratory syndrome coronavirus 2"/>
   <result pre="patients with influenza and delayed viral clearance in patients with" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) infection. Although they were widely used in"/>
   <result pre="[22]. Azithromycin was shown to inhibit replication in Zika and" exact="Ebola" post="viruses [23, 24]. Pros and cons Chloroquine and hydroxychloroquine"/>
   <result pre="with activity against RNA viruses. Initially, it was used for" exact="Ebola" post="treatment. It has shown promising results in animalsâ€™ studies"/>
   <result pre="pandemic (H1N1) in 2009 - 2010, avian influenza A (H5N1)," exact="Ebola" post="and MERS-CoV epidemic in 2012 [47-52]. MOA The antibodies"/>
   <result pre="Abbreviations WHO World Health Organization 2019-nCoV 2019 novel coronavirus COVID-19" exact="coronavirus disease 2019" post="SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 FDA Food"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern Med202010.1001/jamainternmed.2020.0994 7TangNLiDWangXSunZAbnormal coagulation parameters"/>
   <result pre="12The American Academy of Dermatology. https://assets.ctfassets.net/1ny4yoiyrqia/PicgNuD0IpYd9MSOwab47/023ce3cf6eb82cb304b4ad4a8ef50d56/Biologics_and_COVID-19.pdf 13GuanWJNiZYHuYLiangWHOuCQHeJXLiuLet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med2020382181708172010.1056/NEJMoa200203232109013 14Centers for Disease Control"/>
   <result pre="membrane oxygenation in acute respiratory distress syndrome (ARDS) due to" exact="coronavirus disease 2019" post="(COVID-19): Pooled analysis of early reportsJ Crit Care202058272810.1016/j.jcrc.2020.03.01132279018 22AsadaMYoshidaMSuzukiTHatachiYSasakiTYasudaHNakayamaKet"/>
   <result pre="azithromycinProc Natl Acad Sci U S A201611350144081441310.1073/pnas.161802911327911847 24MadridPBPanchalRGWarrenTKShurtleffACEndsleyANGreenCEKolokoltsovAet al.Evaluation of" exact="Ebola" post="virus inhibitors for drug repurposingACS Infect Dis20151731732610.1021/acsinfecdis.5b0003027622822 25GautretPLagierJCParolaPHoangVTMeddebLMailheMDoudierBet al.Hydroxychloroquine"/>
   <result pre="with Covid-19medRxiv202010.1101/2020.04.16.20065920 28Food and Drug Administration. https://www.fda.gov/media/137564/download 29SandersJMMonogueMLJodlowskiTZCutrellJBPharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): A ReviewJAMA202010.1001/jama.2020.6019 30TanakaTNarazakiMKishimotoTImmunotherapeutic implications of IL-6 blockade for"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother20145884875488410.1128/AAC.03011-1424841269 33CaoBWangYWenDLiuWWangJFanGRuanLet al.A"/>
   <result pre="Med200639e34310.1371/journal.pmed.003034316968120 46ChannappanavarRFehrARZhengJWohlford-LenaneCAbrahanteJEMackMSompallaeRet al.IFN-I response timing relative to virus replication determines" exact="MERS coronavirus" post="infection outcomesJ Clin Invest20191303625363910.1172/JCI12636331355779 47LukeTCKilbaneEMJacksonJLHoffmanSLMeta-analysis: convalescent blood products for"/>
   <result pre="of Gynecology and Obstetrics). https://www.figo.org/news/figo-covid-19-resource-s 77PoonLCYangHKapurAMelamedNDaoBDivakarHMcIntyreHDet al.Global interim guidance on" exact="coronavirus disease 2019" post="(COVID-19) during pregnancy and puerperium from FIGO and allied"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7296089\results\search\zoonosis\results.xml">
   <result pre="children and in adults in all parts of the world." exact="Influenza" post="A and B viruses and respiratory syncytial virus (RSV)"/>
   <result pre="nine papers including six original research articles and three reviews." exact="Influenza" post="viruses are well-presented in the Topic by five papers."/>
   <result pre="articles focus on RSV and one each on rhinovirus and" exact="MERS coronavirus." post="Seasonal influenza A and B virus epidemics globally cause"/>
   <result pre="virus epidemics globally cause up to 600,000 deaths per year." exact="Influenza" post="A viruses have an animal reservoir in avian species,"/>
   <result pre="inhibitors are widely used for treatment (and sometimes prevention) of" exact="influenza infection," post="and they have demonstrated efficacy. However, new drugs are"/>
   <result pre="et al. reviewed the pathogenesis, animal models and therapeutics for" exact="MERS coronavirus" post="infections. This review is timely not only for the"/>
   <result pre="not only for the continuing identifications of human infections by" exact="MERS coronavirus" post="in the Middle East but also because of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7296288\results\search\zoonosis\results.xml">
   <result pre="national Stockpile. Unknown efficacy in humans Endonuclease inhibitor Baloxavir marboxil" exact="Influenza" post="up to 48Â h in duration in patients 12Â"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7296524\results\search\zoonosis\results.xml">
   <result pre="Asthma Immunologic disease Introduction A novel coronavirus, SARS-COV-2, lead to" exact="coronavirus disease 2019" post="(COVID-19). COVID-19 burst in China and rapidly spread worldwide."/>
   <result pre="performed. Nose and eyes scratching is a relevant source of" exact="SARS-CoV-2 infection." post="Second-generation antihistamines should be, therefore, used to control nasal"/>
   <result pre="to prevention and sterility rules to avoid the spread of" exact="COVID 19" post="[2, 6â€&quot;9]. It is recommended to avoid smoking for"/>
   <result pre="has not been associated with a higher risk of contracting" exact="SARS-CoV-2 infection." post="AD is a syndrome characterized by immune dysregulation, but"/>
   <result pre="It is not currently known whether the transmission of the" exact="SARS-CoV-2 infection" post="is more likely to occur in subjects with active"/>
   <result pre="no data that Dupilumab can somehow increase the risk of" exact="SARS-CoV-2 infection," post="and it can also be done subcutaneously at home."/>
   <result pre="years, and 553 were aged 10 to 19â€‰years) with confirmed" exact="SARS-CoV-2 infection" post="were included in the final analysis. All articles reflected"/>
   <result pre="extensive debate and appropriate measures should be considered. Abbreviations SARS-COV-2" exact="Severe acute respiratory syndrome" post="â€&quot; coronavirus COVID-19 Coronavirus disease 2019 SIAIP SocietÃ Italiana"/>
   <result pre="considered. Abbreviations SARS-COV-2 Severe acute respiratory syndrome â€&quot; coronavirus COVID-19" exact="Coronavirus disease 2019" post="SIAIP SocietÃ Italiana di Allergologia ed. Immunologia Pediatrica ICS"/>
   <result pre="Kunaviktikul W, Omura M, Petrini M. Editorial: facemasks and the" exact="COVID 19" post="pandemic: what advice should health professionals be giving the"/>
   <result pre="Y, Lai W. Dermatology staff participate in the fight against" exact="Covid-19" post="in China. J Eur Acad Dermatol Venereol. 2020; (in"/>
   <result pre="Pediatrics. 2019;144:e20192478. 53.Lu X, Zhang L, Du H, et al." exact="SARS-CoV-2 infection" post="in children. N Engl J Med. 2020. 54.https://ipopi.org/wp-content/uploads/2020/04/COVID19_Joint_StatementUpdate2_ 20200408_"/>
   <result pre="56.Chang L, Zhao L, Gong H, Wang L, Wang L." exact="Severe acute respiratory syndrome" post="coronavirus 2 RNA detected in blood donations. Emerg Infect"/>
   <result pre="(in press). 85.Castagnoli R, Votto M, Licari A, et al." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7297930\results\search\zoonosis\results.xml">
   <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. Abstract" exact="Coronavirus disease 2019" post="(COVID-19) is a pandemic infection caused by Severe Acute"/>
   <result pre="Solidarity is an international clinical trial searching for an effective" exact="Coronavirus disease 2019" post="(COVID-19) treatment launched by the World Health Organization and"/>
   <result pre="the treatment of Ebola, respiratory syncytial virus (RSV), Junin virus," exact="Lassa fever" post="virus, Nipah virus, Hendra virus, and the coronaviruses (including"/>
   <result pre="yet been reported, prior evaluations of this drug during the" exact="Ebola" post="outbreak noted that one patient developed hypotension and subsequent"/>
   <result pre="RSV, Junin virus, Nipah virus, Hendra virus, and research on" exact="Ebola" post="virus NCT04302766 NCT04280705 â€¢ NCT04292730; NCT04292899* A substrate of"/>
   <result pre="polymerase Suppressing viral RNA-dependent RNA polymerase of SARS-CoV-2; in vitro?" exact="Influenza" post="viruses, West Nile virus, yellow fever virus, foot-and-mouth disease"/>
   <result pre="for patients, health care workers, and health systems during the" exact="coronavirus disease 2019" post="(COVID-19) pandemic. J Am Coll Cardiol. 2020;75:2352â€&quot;71. 7.ChenC-YWangF-LLinC-CChronic hydroxychloroquine"/>
   <result pre="The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus. J Biol Chem. 2020;295(15):4773â€&quot;9. 10.Tchesnokov EP, Feng JY,"/>
   <result pre="N Engl J Med. 2020;382:2327â€&quot;36. 13.Lucey DR. New treatments for" exact="Ebola" post="virus disease. BMJ. 2019;366:l5371. 14.Beck BR, Shin B, Choi"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitro. Cell Discov. 2020;6:16. 53.Sahraei Z, Shabani M,"/>
   <result pre="53.Sahraei Z, Shabani M, Shokouhi S, Saffaei A. Aminoquinolines against" exact="coronavirus disease 2019" post="(COVID-19): chloroquine or hydroxychloroquine. Int J Antimicrob Agents. 2020;105945:105945."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7297931\results\search\zoonosis\results.xml">
   <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. The" exact="coronavirus disease 2019" post="(COVID-19) pandemic spares no nations or cities causing escalating"/>
   <result pre="Mortality 0 0 0 0 3 0 16 2Â§ COVID-19" exact="coronavirus disease 2019," post="IQR interquartile range. aPatients up to 19Â years old"/>
   <result pre="23 May 2020. 2.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7298161\results\search\zoonosis\results.xml">
   <result pre="Flu RdRp inhibitor Favipiravir Flu RdRp inhibitor Baloxavir Marboxil Flu" exact="Influenza" post="virus cap-dependent endonuclease inhibitor Arbidol Flu Virion entry inhibitor"/>
   <result pre="homologous to SARS-CoV, IFN-Î± is recommended for the treatment of" exact="SARS-CoV-2 infection." post="According to the latest new â€œDiagnosis and Treatment Protocol"/>
   <result pre="C [30]. Ribavirin was widely used in 2003 to treat" exact="SARS-CoV infection," post="but when used alone, it seemed to have no"/>
   <result pre="the virus envelope binds to the ACE2 receptor to mediate" exact="SARS-CoV-2 infection" post="[9, 40]. Chloroquine phosphate has been reported to interfere"/>
   <result pre="of influenza A and B [52] and can effectively inhibit" exact="Ebola" post="virus, yellow fever virus [53], etc. In vitro experiments"/>
   <result pre="arbidol group [27]. Remdesivir(GS-5734) RemdesivirÂ was first used to treat" exact="Ebola" post="virus, and it has completed phase 2 clinical trials"/>
   <result pre="are still urgently needed for the management of patients with" exact="SARS-CoV-2 infection," post="and experiences in TCM are certainly worth examining. Many"/>
   <result pre="and combination therapies with nucleoside analogs as effective inhibitors of" exact="Ebola" post="virusPLoS Negl Trop Dis201610e000436426752302 18.MoriguchiHSatoCTreatment of SARS with human"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrobial agents Chemother201458487584 26.CaoBWangYWenDLiuWWangJFanGet al.A"/>
   <result pre="Biophys Res Commun2005326905815607755 36.OmraniASSaadMMBaigKBahloulAAbdul-MatinMAlaidaroosAYet al.Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: a retrospective cohort studyLancet Infect Dis2014141090525278221 37.SavarinoAUse"/>
   <result pre="GuanQDJiangHaimingZhaoJincunYangZifengComparison of inhibitory effects of arbidol and Lianhuaqingwen Capsules on" exact="Middle East respiratory syndrome" post="coronavirus in vitro and in vivo[in Chinese]Guangdong Med J20183934548"/>
   <result pre="48.https://www.chinanews.com/gn/2020/02-04/9078596.shtml. 49.WangZChenXLuYChenFZhangWClinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci Trends20201464832037389 50.De"/>
   <result pre="virus infectionsChem-Asian J.2019143962831389664 54.MulanguSDoddLEDaveyRTTshiani MbayaOProschanMMukadiDet al.A randomized, controlled trial of" exact="Ebola" post="virus disease therapeuticsN Engl J Med2019381229330331774950 55.CihlarTRayASNucleoside and nucleotide"/>
   <result pre="polymerase; mode of action and resistanceViruses2015752062426426038 57.TchesnokovEPFengJYPorterDPGotteMMechanism of inhibition of" exact="Ebola" post="virus RNA-dependent RNA polymerase by remdesivirViruses201911326 58.AgostiniMLAndresELSimsACGrahamRLSheahanTPLuXet al.Coronavirus susceptibility"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7299651\results\search\zoonosis\results.xml">
   <result pre="the source or the spreaders of the disease. Outbreaks of" exact="Ebola" post="in various parts of Western Africa from 2014 onwards"/>
   <result pre="So, for example, recent survey evidence taken from the 2014â€&quot;2015" exact="Ebola" post="outbreak in Liberia showed that respondents who expressed low"/>
   <result pre="the virus.8 Other work using similar survey methods during an" exact="Ebola" post="outbreak found that trust was more likely to be"/>
   <result pre="several misguided anxieties over how people can be infected with" exact="Ebola" post="and how the disease spreads,10 and this same issue"/>
   <result pre="6. Anon (2019a), â€œBuilding Trust Is Essential to Combat the" exact="Ebola" post="Outbreak,â€� Nature 567, no. 7749: 433. 7. Samuel Cohn"/>
   <result pre="433. 7. Samuel Cohn and Ruth Kutalek (2016), â€œHistorical Parallels," exact="Ebola" post="Virus Disease and Cholera: Understanding Community Distrust and Social"/>
   <result pre="(2017), â€œPublic Health and Public Trust: Survey Evidence from the" exact="Ebola" post="Virus Disease Epidemic in Liberia,â€� Social Science &amp;amp; Medicine"/>
   <result pre="Wilkinson and James Fairhead (2017), â€œComparison of Social Resistance to" exact="Ebola" post="Response in Sierra Leone and Guinea Suggests Explanations Lie"/>
   <result pre="in Epidemic Response: Openness, Reflexivity and Accountability during the 2014-2016" exact="Ebola" post="Outbreak in West Africa,â€� BMJ Global Health 4, no."/>
   <result pre="â€˜Fearbolaâ€™: Examining the Psychological Predictors of Anxious Responding to the" exact="Ebola" post="Virus,â€� Cognitive Therapy Research 39: 816â€&quot;25. 11. Michael S."/>
   <result pre="Use of Pop Culture and Communication in the Face of" exact="Ebola" post="Virus,â€� PLoS Neglected Tropical Diseases 9, no. 8: e0003890;"/>
   <result pre="Franciscoâ€™s Chinatown (Baltimore: John Hopkins University Press); Nayan Shah (2001)," exact="Contagious" post="Divides: Epidemics and Race in San Franciscoâ€™s Chinatown (Berkeley,"/>
   <result pre="Bibliography collab: Anon â€œBuilding Trust Is Essential to Combat the" exact="Ebola" post="Outbreak.â€� Nature567, no. 7749 (2019a), 433.10.1038/d41586-019-00892-630914813 collab: Anon â€œEbola:"/>
   <result pre="L. â€œPublic Health and Public Trust: Survey Evidence from the" exact="Ebola" post="Virus Disease Epidemic in Liberia.â€� Social Science &amp;amp; Medicine172"/>
   <result pre="â€˜Fearbolaâ€™: Examining the Psychological Predictors of Anxious Responding to the" exact="Ebola" post="Virus.â€� Cognitive Therapy Research39 (2015): 816â€&quot;25.32214559 collab: Blindness (2008)"/>
   <result pre="Use of Pop Culture and Communication in the Face of" exact="Ebola" post="Virus.â€� PLoS Neglected Tropical Diseases9, no. 8 (2015), e0003890.10.1371/journal.pntd.000389026248052"/>
   <result pre="Diseases6, no. 4 (2000): 337â€&quot;47.10.3201/eid0604.00040310905966 CohnSamuel, and KutalekRuth â€œHistorical Parallels," exact="Ebola" post="Virus Disease and Cholera: Understanding Community Distrust and Social"/>
   <result pre="in Epidemic Response: Openness, Reflexivity and Accountability during the 2014-2016" exact="Ebola" post="Outbreak in West Africa.â€� BMJ Global Health4, no. 1"/>
   <result pre="(2020): 846â€&quot;8.10.1016/S0140-6736(20)30526-232151325 WilkinsonAnnie, and FairheadJames â€œComparison of Social Resistance to" exact="Ebola" post="Response in Sierra Leone and Guinea Suggests Explanations Lie"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7300441\results\search\zoonosis\results.xml">
   <result pre="the duration of the public health emergency.file:AJP-9999-e23158.pdf Abstract Abstract The" exact="coronavirus disease 2019" post="pandemic has radically changed the human activities worldwide. Although"/>
   <result pre="be concerned about COVIDâ€�19 with nonhuman primates?Am J Primatol. 2020;e2315810.1002/ajp.2315832495390" exact="Coronavirus disease 2019" post="(COVIDâ€�19), also informally called the new coronavirus, is a"/>
   <result pre="for research on previous related epidemics, such as SARS and" exact="Middle East respiratory syndrome" post="(MERS; Haagmans, Kuiken, &amp;amp; Martina,Â 2004; Wang, Zheng, &amp;amp;"/>
   <result pre="Doremalen, N., &amp;amp; Munster, V. J. (2015). Animal models of" exact="Middle East respiratory syndrome" post="coronavirus infection. Antiviral Research, 122, 28â€&quot;38. 10.1016/j.antiviral.2015.07.00526192750 Gao, W.,"/>
   <result pre="Yan, Y. (2020). The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVIDâ€�19) outbreakâ€&quot;an update on the status. Military Medical Research,"/>
   <result pre="A., &amp;amp; Chowell, G. (2020). Estimating the asymptomatic proportion of" exact="coronavirus disease 2019" post="(COVIDâ€�19) cases on board the Diamond Princess cruise ship,"/>
   <result pre="in rhesus macaques. Oncotarget, 8(8), 12686â€&quot;12694. 10.18632/oncotarget.847527050368 collab: WHO ." exact="Coronavirus disease 2019" post="(COVIDâ€�19). Situation Report â€&quot; 71. 2020a Accessed April 9,"/>
   <result pre="10.1038/s41586-020-2012-732015507 Zumla, A., Hui, D. S., &amp;amp; Perlman, S. (2015)." exact="Middle East respiratory syndrome." post="Lancet, 386(9997), 995â€&quot;1007. 10.1016/S0140-6736(15)60454-826049252"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7300636\results\search\zoonosis\results.xml">
   <result pre="MehrotraA, ClemensenJ, et al. Telehealth for global emergencies: Implications for" exact="coronavirus disease 2019" post="(COVIDâ€�19). J Telemed Telecare. 2020;26(5):309â€&quot;13.32196391 24PriestKC, GorfinkelL, KlimasJ, JonesAA,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7300956\results\search\zoonosis\results.xml">
   <result pre="diseases like AIDS and TB and, in recent years, the" exact="Ebola" post="Virus Disease (EVD). The majority of countriesâ€™ health systems,"/>
   <result pre="This article is protected by copyright. All rights reserved. Africa" exact="Coronavirus disease 2019" post="health system capacity response fig-count: table-count: page-count: word-count: This"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7301781\results\search\zoonosis\results.xml">
   <result pre=": Article Lockdown of 1.3 billion people in India during" exact="Covid-19" post="pandemic: A survey of its impact on mental health"/>
   <result pre="11 4 39 (3.9) Just another kind of flu like" exact="swine flu" post="2 9 5 4 20 (2.1) Seasonal flu 1"/>
   <result pre="between age groups and the multivariate variables of knowledge about" exact="COVID 19," post="effects of COVID 19 on mankind and how the"/>
   <result pre="the multivariate variables of knowledge about COVID 19, effects of" exact="COVID 19" post="on mankind and how the participants felt about the"/>
   <result pre="during COVID-19 outbreakAsian J. Psychiatry202010207610.1016/j.ajp.2020.102076 PellecchiaU.CrestaniR.DecrooT.Van den BerghR.Al-KourdiY.Social consequences of" exact="Ebola" post="containment measures in LiberiaPLoS One10122015e014303610.1371/journal.pone.0143036 RajkumarR.P.COVID-19 and mental health:"/>
   <result pre="of households actively monitored or quarantined to prevent transmission of" exact="Ebola" post="virus disease â€&quot; Margibi County, Liberia: February-March 2015Prehosp. Disaster"/>
   <result pre="quality in individuals who self-isolated for 14 days during the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in January 2020 in ChinaMed. Sci. Monit.26202010.12659/msm.923921"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7301795\results\search\zoonosis\results.xml">
   <result pre=": Article Acute respiratory distress syndrome due to SARS-CoV-2 and" exact="Influenza" post="A co-infection in an Italian patient: Mini-review of the"/>
   <result pre="active. Highlights â€¢Acute respiratory distress syndrome due to SARS-CoV-2 and" exact="Influenza" post="A co-infection. â€¢Challenging in co-infection cases identification. â€¢Improvement of"/>
   <result pre="case of acute respiratory distress syndrome due to SARS-CoV-2 and" exact="Influenza" post="A co-infection and a mini-review of the literature is"/>
   <result pre="clinical management and outcome. Keywords Acute respiratory distress syndrome SARS-CoV-2" exact="Influenza" post="A COVID-19 epidemic Introduction In December 2019, a novel"/>
   <result pre="al., 2020). Here, we report a case of SARS-CoV-2 and" exact="Influenza" post="A co-infection and a mini-review of the literature. Case"/>
   <result pre="swab was positive for SARS-CoV-2 (genes E and S) and" exact="Influenza" post="A. On March 6, a chest computed tomography (CT)"/>
   <result pre="IMV Outcome Azekawa et al. (2020) F 78 Dyslipidemia, hypothyroidism" exact="Influenza" post="A Yes No No No No No No Survived"/>
   <result pre="No No Survived Blasco et al. (2020) NA NA NA" exact="Influenza" post="A and RSV NA NA NA NA NA NA"/>
   <result pre="NA NA NA Cuadrado-PayÃ¡n et al. (2020) M 53 ERSD" exact="Influenza" post="A Yes Yes NA Yes Yes No Yes Survived"/>
   <result pre="Yes NA Yes Yes No Yes Survived M 78 T2DM" exact="Influenza" post="A Yes Yes NA Yes Yes No Yes Survived"/>
   <result pre="Yes NA Yes Yes No Yes Survived M 56 T2DM" exact="Influenza" post="A and B No No NA No No No"/>
   <result pre="No NA No No No No Survived F 81 ERSD" exact="Influenza" post="B Yes Yes NA Yes Yes No Yes Survived"/>
   <result pre="Survived de Souza Luna et al. (2020) NA 36 NA" exact="Influenza" post="B NA NA NA NA NA NA NA NA"/>
   <result pre="NA NA NA Ding et al. (2020) F 47 None" exact="Influenza" post="A Yes Yes Yes No No No No Survived"/>
   <result pre="Yes No No No No Survived M 50 Hypertension, cancer" exact="Influenza" post="A Yes Yes Yes Yes No Yes No Survived"/>
   <result pre="Yes No Yes No Survived F 66 Hypertension, CVD, HBV" exact="Influenza" post="B Yes Yes No No No No No Survived"/>
   <result pre="Yes No No No No No Survived M 39 HBV" exact="Influenza" post="B Yes Yes Yes No No No No Survived"/>
   <result pre="Yes Yes No No No No Survived F 49 None" exact="Influenza" post="A Yes Yes No No No No No Survived"/>
   <result pre="No No Survived Garazzino et al. (2020) NA &amp;lt;17 NA" exact="Influenza" post="A NA NA NA NA NA NA NA NA"/>
   <result pre="NA NA NA Hashemi et al. (2020) F 78 NA" exact="Influenza" post="A Yes Yes NA Yes NA NA NA Dead"/>
   <result pre="Yes NA Yes NA NA NA Dead M 75 NA" exact="Influenza" post="A Yes Yes NA Yes NA NA NA Dead"/>
   <result pre="NA Dead Khodamoradi et al. (2020) F 74 Hypertension, CVD" exact="Influenza" post="A Yes Yes No No No No No Survived"/>
   <result pre="Yes No No No No No Survived M 40 None" exact="Influenza" post="A Yes Yes No No No No No Survived"/>
   <result pre="Yes No No No No No Survived M 64 None" exact="Influenza" post="A Yes Yes No No No No No Survived"/>
   <result pre="Yes No No No No No Survived M 50 None" exact="Influenza" post="A Yes Yes No No No No No Survived"/>
   <result pre="No No Survived Kim et al. (2020) NA NA NA" exact="Influenza" post="A NA NA NA NA NA NA NA NA"/>
   <result pre="Konala et al. (2020b) M 57 Hypertension, T2DM, CVD, AICD" exact="Influenza" post="A Yes Yes No No No No No Survived"/>
   <result pre="No No No No Survived F 35 Sickle cell trait" exact="Influenza" post="A Yes Yes No No No No No Survived"/>
   <result pre="No No No No Survived F 68 T2DM, hypertension, GERD" exact="Influenza" post="B Yes Yes NA Yes Yes No Yes Dead"/>
   <result pre="Konala et al. (2020a) F 66 T2DM, CVD, hypertension, CKD" exact="Influenza" post="A Yes Yes NA Yes Yes No Yes Survived"/>
   <result pre="No Yes Survived Nowak et al. (2020) NA NA NA" exact="Influenza" post="A NA NA NA NA NA NA NA NA"/>
   <result pre="NA NA NA Pongpirul et al. (2020) M 61 None" exact="Influenza" post="A Yes No No No No No No Survived"/>
   <result pre="No No Survived Richardson et al. (2020) NA NA NA" exact="Influenza" post="A NA NA NA NA NA NA NA NA"/>
   <result pre="NA NA Wehl et al. (2020) NA 4 months None" exact="Influenza" post="A Yes No No No No No No Survived"/>
   <result pre="No Survived Wu et al. (2020b) NA &amp;lt;17 NA MP," exact="Influenza" post="A&amp;amp;B, RSV NA NA NA NA NA NA NA"/>
   <result pre="NA NA NA Wu et al. (2020c) M 69 None" exact="Influenza" post="A Yes NA NA Yes Yes No Yes Survived"/>
   <result pre="Survived Zhu et al. (2020) NA NA NA 2 pts" exact="Influenza" post="A NA NA NA NA NA NA NA NA"/>
   <result pre="NA NA NA NA NA NA NA NA 5 pts" exact="Influenza" post="B SARS-CoV-2: severe acute respiratory syndrome coronavirus-2, COVID-19: coronavirus"/>
   <result pre="in treatments and prognosis. Antiviral therapy is currently available for" exact="influenza infection" post="(i.e. oseltamivir, zanamivir, and peramivir) while experimental off-label drugs"/>
   <result pre="virological and clinical findingsThorax593200425225614985565 ColavitaF.BiavaM.CastillettiC.LaniniS.MiccioR.PortellaG.Inflammatory and humoral immune response during" exact="Ebola" post="virus infection in survivor and fatal cases occurred in"/>
   <result pre="in Wuhan, ChinaJ Med VirolMarch202010.1002/jmv.25781 GarazzinoS.MontagnaniC.DonÃ D.MeiniA.FeliciE.VergineG.Multicentre Italian study of" exact="SARS-CoV-2 infection" post="in children and adolescents, preliminary data as at 10"/>
   <result pre="with acute respiratory syndrome, Bojnurd, IranJ Med VirolMay202010.1002/jmv.26014 KhodamoradiZ.MoghadamiM.LotfiM.Co-infection of" exact="coronavirus disease 2019" post="and influenza A: a report from IranArch Iran Med23April"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern MedMarch202010.1001/jamainternmed.2020.0994 WuQ.XingY.ShiL.LiW.GaoY.PanS.Coinfection and other"/>
   <result pre="pneumonia, ChinaEmerg Infect Dis26June (6)20201324132610.3201/eid2606.20029932160148 ZhuX.GeY.WuT.ZhaoK.ChenY.WuB.Co-infection with respiratory pathogens among" exact="COVID-2019" post="casesVirus Res285May202019800510.1016/j.virusres.2020.198005"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7301903\results\search\zoonosis\results.xml">
   <result pre="microbial infection. LF was reported to have antiviral activity against" exact="SARS-CoV infection." post="The significant antiviral activity of LF makes it a"/>
   <result pre="two major epidemics: severe acute respiratory syndrome coronaviruses (SARS-CoVs)1 and" exact="Middle East respiratory syndrome" post="(MERS).1 Animals are the natural reservoir hosts that play"/>
   <result pre="indicates that bats are most likely the hosts that transmitted" exact="COVID 19" post="to humans.5 Furthermore, there were some reports mentioning snakes,"/>
   <result pre="Lang et al.,23 reported the antiviral activity of LF against" exact="SARS-CoV infection" post="through an increased host immune response. LF interfered at"/>
   <result pre="McGooganJ. M. (2020) Characteristics of and important lessons from the" exact="Coronavirus disease 2019" post="(COVID-19) outbreak in China: Summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7302922\results\search\zoonosis\results.xml">
   <result pre="studies have shown that lopinavir/ritonavir can inhibit the replication of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV)"/>
   <result pre="such as West Nile virus, yellow fever virus, enterovirus, and" exact="Ebola" post="virus [69â€&quot;72]. On February 15, 2020, favipiravir tablets were"/>
   <result pre="has been confirmed that hydroxychloroquine also has therapeutic effect against" exact="Ebola" post="virus and dengue virus in in vitro studies [95]."/>
   <result pre="J Antimicrob Agents202055310592432081636 8.GuoYRCaoQDHongZSTanYYChenSDJinHJTanKSWangDYYanYThe origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak - an update on the statusMil Med"/>
   <result pre="Jama 2020. 12.ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYXiaJYuTZhangXZhangLEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet20203951022350751332007143 13.Henry BM; Vikse"/>
   <result pre="a descriptive studyLancet20203951022350751332007143 13.Henry BM; Vikse J Clinical characteristics of" exact="Covid-19" post="in China. N Engl J Med 2020, 382. 14.XuZShiLWangYZhangJHuangLZhangCLiuSZhaoPLiuHZhuLTaiYBaiCGaoTSongJXiaPDongJZhaoJWangFSPathological"/>
   <result pre="2020. 35.WangZChenXLuYChenFZhangWClinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci Trends2020141646832037389 36.Runfeng"/>
   <result pre="virus infectionsAntivir Chem Chemother201826204020661876448329562753 52.RabaanAAAlahmedSHBazziAMAlhaniHMA review of candidate therapies for" exact="Middle East respiratory syndrome" post="from a molecular perspectiveJ Med Microbiol20176691261127428855003 53.Al-TawfiqJAMemishZAUpdate on therapeutic"/>
   <result pre="a molecular perspectiveJ Med Microbiol20176691261127428855003 53.Al-TawfiqJAMemishZAUpdate on therapeutic options for" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV)Expert Rev Anti-Infect Ther201715326927527937060 54.Zhang C, Huang S,"/>
   <result pre="The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus. J Biol Chem 2020. 61.Tchesnokov EP; Feng JY;"/>
   <result pre="Feng JY; Porter DP; GÃ¶tte M, Mechanism of inhibition of" exact="Ebola" post="virus RNA-dependent RNA polymerase by remdesivir. Viruses 2019, 11,"/>
   <result pre="Raoul, H.; de Lamballerie, X., Antiviral efficacy of favipiravir against" exact="Ebola" post="virus: a translational study in cynomolgus macaques. PLoS Med"/>
   <result pre="neglected and emerging RNA virusesAntivir Res2018153859429524445 73.DongLHuSGaoJDiscovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov Ther2020141586032147628 74.PotardVCanestriAGallienSCostagliolaDUse of darunavir in HIV-1-infected individuals"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov202061632194981 99.Sahraei Z; Shabani M; Shokouhi S;"/>
   <result pre="99.Sahraei Z; Shabani M; Shokouhi S; Saffaei A, Aminoquinolines against" exact="coronavirus disease 2019" post="(COVID-19): chloroquine or hydroxychloroquine. Int J Antimicrob Agents 2020,"/>
   <result pre="interferon alpha and cyclosporine treatment separately and in combination on" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo"/>
   <result pre="Lu Z, Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19). JAMA Cardiol 2020. 114.Hu H; Ma F; Wei"/>
   <result pre="S, Treatment with convalescent plasma for critically ill patients with" exact="SARS-CoV-2 infection." post="Chest 2020."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7303642\results\search\zoonosis\results.xml">
   <result pre="low, direct data evaluating the safety of such agents in" exact="coronavirus disease 2019" post="(COVID-19) are scarce. This article reviews and offers guidance"/>
   <result pre="therapy medical dermatology SARS-CoV-2 Abbreviations used CI, confidence interval COVID-19," exact="coronavirus disease 2019" post="IL, interleukin MERS, Middle East respiratory syndrome OR, odds"/>
   <result pre="CI, confidence interval COVID-19, coronavirus disease 2019 IL, interleukin MERS," exact="Middle East respiratory syndrome" post="OR, odds ratio RR, relative risk SARS, severe acute"/>
   <result pre="Capsule Summary â€¢This article adds to the limited literature on" exact="coronavirus disease 2019" post="(COVID-19) and immunosuppression. It provides expert opinion based on"/>
   <result pre="shared decision-making process concerning immunosuppressive and immunomodulatory therapy during the" exact="coronavirus disease 2019" post="pandemic 1.The severity of the underlying disease, with special"/>
   <result pre="disease course similar to previous highly pathogenic coronavirus infections (ie," exact="Middle East respiratory syndrome" post="[MERS] and severe acute respiratory syndrome [SARS]), with up"/>
   <result pre="data are needed to understand the impact of methotrexate on" exact="SARS-CoV-2 infection." post="Antimalarial drugs When used for their immunomodulatory properties, antimalarials"/>
   <result pre="small case series suggesting potential efficacy in the treatment of" exact="SARS-CoV-2 infection." post="Although inÂ vitro data suggest chloroquine and hydroxychloroquine both"/>
   <result pre="to fully characterize the risk of harm or benefit in" exact="SARS-CoV-2 infection." post="Anticytokine biologic therapy Data from BIOBADADERM (Spanish Registry ofÂ"/>
   <result pre="in psoriasis and found no significant increase in URI or" exact="influenza infection" post="rates compared with placebo.57 In contrast, Wan etÂ al58"/>
   <result pre="(5) 16 (3) AS, Ankylosing spondylitis; CD, Crohn's disease; COVID-19," exact="coronavirus disease 2019;" post="csDMARD, conventional synthetic disease-modifying antirheumatic drug; IBD, inflammatory bowel"/>
   <result pre="Table III Guidance statements for management of immunosuppression during the" exact="coronavirus disease 2019" post="(COVID-19) pandemicâˆ— Patients well-controlled on maintenance therapy We suggest"/>
   <result pre="FigÂ 1 Drug safety recommendations in the context of the" exact="coronavirus disease 2019" post="(COVID-19) pandemic. CMV, Cytomegalovirus; DVT, deep venous thrombosis; HZV,"/>
   <result pre="16HuiD.S.Systemic corticosteroid therapy may delay viral clearance in patients with" exact="Middle East respiratory syndrome" post="coronavirus infectionAm J Respir Crit Care Med19762017700701 17ArabiY.M.MandourahY.Al-HameedF.Corticosteroid therapy"/>
   <result pre="29MagagnoliJ.NarendranS.PereiraF.Outcomes of hydroxychloroquine usage in United States veterans hospitalized with" exact="Covid-19" post="[preprint]medRxiv202010.1101/2020.04.16.20065920 30TangW.CaoZ.HanM.Hydroxychloroquine in patients mainly with mild to moderate"/>
   <result pre="registry [e-pub ahead of print]Gastroenterology202010.1053/j.gastro.2020.05.032 74DamianiG.PacificoA.BragazziN.L.MalagoliP.Biologics increase the risk of" exact="SARS-CoV-2 infection" post="and hospitalization, but not ICU admission and death: real-life"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7303804\results\search\zoonosis\results.xml">
   <result pre="to kill humans [2]. Ten years later, in 2012, the" exact="MERS coronavirus" post="appeared in Saudi Arabia. It was passed on to"/>
   <result pre="number of deaths that are indirectly caused by the flu." exact="Influenza" post="is often not cited as a direct cause in"/>
   <result pre="13InsiderBAvailable: https://www.businessinsider.com/south-korea-coronavirus-testing-death-rate-2020-3?r=US&amp;amp;IR=T. Accessed: 7 March 2020. 14GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China.N Engl J Med. 2020;382:1708-20. 10.1056/NEJMoa200203232109013 15World Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7305479\results\search\zoonosis\results.xml">
   <result pre="RSV). SIâ€&quot;chemotherapy index (selectivity index), equal to CC50/EC50 ratio Compounds" exact="Influenza" post="A virus (IVA) Human parainfluenza virus type 3 (PIV-3)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7305759\results\search\zoonosis\results.xml">
   <result pre="and also by viral infectious agents such as influenza viruses," exact="Ebola" post="viruses, SARS-CoV-1, MERS-CoV, the Zika virus, and lately, SARS-CoV-2,"/>
   <result pre="and blocks the release of viral particles from host cells" exact="Influenza" post="Remdesivir â€&quot; Nucleotide analog inhibitor of RNA-dependent RNA polymerase"/>
   <result pre="Remdesivir â€&quot; Nucleotide analog inhibitor of RNA-dependent RNA polymerase (RdRp)" exact="Ebola" post="virus Umifenovir Arbidol Viral fusion inhibition with the targeted"/>
   <result pre="analog, was developed between 2014 and 2016 in response to" exact="Ebola" post="(Tchesnokov etÂ al., 2019). Similar to its promising effect"/>
   <result pre="2020). Notably, yet there is no FDA-approved therapy for neither" exact="Ebola" post="nor Zika virus, but promising clinical research is ongoing."/>
   <result pre="2018). However, lack of data of the pathophysiology of the" exact="SARS-CoV-2 infection" post="restrains the development of small molecule candidates based on"/>
   <result pre="rhesus macaques infected with SARS-CoV-2BioRxiv202010.1101/2020.03.13.990226 BeigelJ.H.TomashekK.M.DoddL.E.MehtaA.K.ZingmanB.S.KalilA.C.HohmannE.ChuH.Y.LuetkemeyerA.KlineS.Remdesivir for the treatment of" exact="Covid-19" post="â€&quot; preliminary reportN.Â Engl. J. Med.202010.1056/NEJMoa2007764 BoldescuV.BehnamM.A.M.VasilakisN.KleinC.D.Broad-spectrum agents for"/>
   <result pre="family clusterLancet395202051452331986261 ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 ChenW.LanY.YuanX.DengX.LiY.CaiX.LiL.HeR.TanY.DengX.Detectable 2019-nCoV viral"/>
   <result pre="indicator for the further clinical severityEmerging Microbes Infect.92020469473 CohnS.KutalekR.Historical parallels," exact="Ebola" post="virus disease and cholera: understanding community distrust and social"/>
   <result pre="genetic discoveries into effective therapiesHum. Mol. Genet.252016R94R9827340225 GuanW.-j.NiZ.-y.HuY.LiangW.-H.OuC.-Q.HeJ.-X.LiuL.ShanH.LeiC.-l.HuiD.S.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaNew Engl. J. Med.38220201708172032109013 HayM.ThomasD.W.CraigheadJ.L.EconomidesC.RosenthalJ.Clinical development success rates"/>
   <result pre="molecular targets for known drugsNature462200917518119881490 KilianskiA.MielechA.M.DengX.BakerS.C.Assessing activity and inhibition of" exact="Middle East respiratory syndrome" post="coronavirus papain-like and 3C-like proteases using luciferase-based biosensorsJ.Â Virol.872013119551196223986593"/>
   <result pre="asymptomatic contact in GermanyNew Engl. J. Med.382202097097132003551 SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a reviewJAMA323202018241836 SanseauP.AgarwalP.BarnesM.R.PastinenT.RichardsJ.B.CardonL.R.MooserV.Use of genome-wide association studies for"/>
   <result pre="continuing evolution of SARS-CoV-2Natl. Sci. Rev.7202010121023 TchesnokovE.P.FengJ.Y.PorterD.P.GÃ¶tteM.Mechanism of inhibition of" exact="Ebola" post="virus RNA-dependent RNA polymerase by remdesivirViruses112019326 TuranliB.AltayO.BorÃ©nJ.TurkezH.NielsenJ.UhlenM.ArgaK.Y.MardinogluA.Systems biology based"/>
   <result pre="vitroCell Res.30202026927132020029 WangY.WangY.ChenY.QinQ.Unique epidemiological and clinical features of the emerging" exact="2019 novel coronavirus pneumonia" post="(COVID-19) implicate special control measuresJ.Â Med. Virol.92202056857632134116 WangY.ZhangD.DuG.DuR.ZhaoJ.JinY.FuS.GaoL.ChengZ.LuQ.Remdesivir in"/>
   <result pre="of anti-inflammatoryÂ drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the experience of clinical immunologists from ChinaClin. Immunol.214202010839332222466"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7305919\results\search\zoonosis\results.xml">
   <result pre="million people and directly causing more than 340 000 deaths.1" exact="Coronavirus disease 2019" post="(COVID-19), the disease caused by SARS-CoV-2, was initially viewed"/>
   <result pre="requiring ICU management to support life. COVID-19 and the lungs" exact="SARS-CoV-2 infection" post="is associated with three main types of lung damage."/>
   <result pre="PMID 32354800 23GuoT.FanY.ChenM.Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol202010.1001/jamacardio.2020.1017Advance Access published on March 27, 2020. PMID"/>
   <result pre="27, 2020. PMID 32219356 24ChorinE.DaiM.ShulmanE.The QT interval in patients with" exact="SARS-CoV-2 infection" post="treated with hydroxychloroquine/azithromycinNature Med202010.1101/2020.04.02.20047050v1Preprint posted on April 3, 2020."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7306310\results\search\zoonosis\results.xml">
   <result pre="currently under evaluation as potential treatments in the fight against" exact="coronavirus disease 2019" post="(COVID-19). Plasma from patients that have overcome COVID-19 infection,"/>
   <result pre="of significant deterioration can prove valuable in this direction. Introduction" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) pneumonia was first noted in Wuhan"/>
   <result pre="where the former is not available.16 In the context of" exact="Ebola" post="virus, a meta-analysis of clinical studies was conducted during"/>
   <result pre="meta-analysis of clinical studies was conducted during the West Africa" exact="Ebola" post="virus disease outbreak, gathering a pool of 1147 individuals."/>
   <result pre="plasma or whole blood collected from patients that recovered from" exact="Ebola" post="virus has been recommended by the World Health Organization"/>
   <result pre="the World Health Organization as an empirical treatment for the" exact="Ebola" post="outbreaks, with provision of guidance also about the selection"/>
   <result pre="and laboratory effects of convalescent plasma therapy for patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a study protocol. Springerplus.2015;4:709.26618098 16.KoJHSeokHChoSYet al.Challenges of"/>
   <result pre="al.A meta-analysis of clinical studies conducted during the West Africa" exact="Ebola" post="virus disease outbreak confirms the need for randomized control"/>
   <result pre="convalescent whole blood or plasma collected from patients recovered from" exact="Ebola" post="virus disease. 2014; https://www.who.int/csr/resources/publications/ebola/convalescenttreatment/en/. Accessed April 08, 2020. 20.Shen"/>
   <result pre="al. Treatment with convalescent plasma for critically ill patients with" exact="SARS-CoV-2 infection." post="Chest. 2020 March 31. [Epub ahead of print]. 22.DuanKLiuBLiCet"/>
   <result pre="al. Clinical presentation and virological assessment of hospitalized cases of" exact="coronavirus disease 2019" post="in a travel-associated transmission cluster. 2020; 10.1101/2020.03.05.20030502. Accessed April"/>
   <result pre="12, 2020. 36.Okba NMA, Muller MA, Li W, et al." exact="Severe acute respiratory syndrome" post="coronavirus 2-specific antibody responses in coronavirus disease 2019 patients."/>
   <result pre="al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in" exact="coronavirus disease 2019" post="patients. Emerg Infect Dis. 2020 April 8. [Epub ahead"/>
   <result pre="et al. Antibody responses to SARS-CoV-2 in patients of novel" exact="coronavirus disease 2019." post="Clin Infect Dis. 2020 March 28. [Epub ahead of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7306646\results\search\zoonosis\results.xml">
   <result pre="pmcid: 73066461412 doi: 10.1186/s12931-020-01412-1 : Research Predictive factors of severe" exact="coronavirus disease 2019" post="in previously healthy young adults: a single-center, retrospective study"/>
   <result pre="factors Retrospective study Background From December 2019 to March 2020," exact="coronavirus disease 2019" post="(COVID-19) has been considered an epidemic in China, specifically"/>
   <result pre="(SARS-CoV-2) which caused COVID-19, shows stronger infectivity than SARS-CoV and" exact="Middle East respiratory syndrome" post="(MERS)-CoV, although, the mortality rate of COVID-19 is lower"/>
   <result pre="IQR Interquartile ranges L Lymphocyte count LMWH Low-molecular-weight heparin MERS-COV" exact="Middle East respiratory syndrome" post="coronavirus N Neutrophil count N% Neutrophil% NPPV Noninvasive positive-pressure"/>
   <result pre="time RBC Red blood cell ROC Receiver operating characteristic SARS-CoV" exact="Severe acute respiratory syndrome" post="coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 SPSS"/>
   <result pre="Receiver operating characteristic SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2" exact="Severe acute respiratory syndrome" post="coronavirus 2 SPSS Statistical Package for the Social Sciences"/>
   <result pre="32020 5.ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 6.World Health Organization."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7306893\results\search\zoonosis\results.xml">
   <result pre="agent was a novel coronavirus and officially named it the" exact="coronavirus disease 2019" post="COVID-19, and the virus was scientifically named SARS-CoV-2, which"/>
   <result pre="usage of PI in epidemics was carried out during the" exact="Ebola" post="virus (EBO) outbreak in 1995 in Kikwit, the Democratic"/>
   <result pre="safety and efficacy of CP for the treatment of the" exact="Ebola" post="virus disease (EVD) was carried out in Guinea. Results"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7306998\results\search\zoonosis\results.xml">
   <result pre="suggest that hemostatic imbalances may contribute to the pathophysiology of" exact="SARS-CoV-2 infection." post="We review the laboratory and clinical findings of patients"/>
   <result pre="in many severe infections.29â€&quot;31 Patients with influenza, SARS, HIV, hantavirus," exact="Ebola" post="virus, and dengue have elevations in D-dimer, prothrombin fragments,"/>
   <result pre="found in patients with other viral infections.48,49 Pathologic findings in" exact="SARS-CoV-2 infection" post="Although there are only a few published pathologic reports"/>
   <result pre="of small vessel occlusion.50,51 There are several mechanisms by which" exact="SARS-CoV-2 infection" post="may result in microvascular and macrovascular thrombosis, including cytokine"/>
   <result pre="an active area of investigation whether these are specific to" exact="SARS-CoV-2 infection" post="or a final common pathway in the thromboinflammatory response"/>
   <result pre="1. Immune activation and mechanisms of coagulopathy in patients with" exact="coronavirus disease 2019" post="(COVID-19). Multiple processes may contribute to COVID-19-associated coagulopathy including"/>
   <result pre="suggests that elevated plasminogen may be a risk factor for" exact="SARS-CoV-2 infection" post="because plasmin may cleave the S protein of the"/>
   <result pre="or late physiologic anti-viral responses. The heterogenous response to the" exact="SARS-CoV-2 infection" post="and the various time-dependent pathways driving pathology make universal"/>
   <result pre="The temporal and mechanistic role each pathway plays in severe" exact="SARS-CoV-2 infection" post="remains uncertain and requires further exploration for treatment opportunities"/>
   <result pre="Wuhan, China. Lancet2020; 395: 497â€&quot;506.31986264 6GuanWJNiZYHuY, et al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med2020; 382: 1708â€&quot;1720.32109013 7PetrilliCMJonesSAYangJ,"/>
   <result pre="https://www.who.int/csr/sars/country/table2004_04_21/en/ (2003, accessed 28 March 2020). 15collab: World Health Organization." exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). MERS Monthly Summary, 112019, http://www.who.int/emergencies/mers-cov/en/ (2019, accessed"/>
   <result pre="Microbiol Infect2020; 26:729â€&quot;734.32234451 19WuZMcGooganJM.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: Summary of a report of"/>
   <result pre="bat origin. Nature2020; 579: 270â€&quot;273.32015507 21LippiGPlebaniMHenryBM.Thrombocytopenia is associated with severe" exact="coronavirus disease 2019" post="(COVID-19) infections: A meta-analysis. Clin Chim Acta2020; 506: 145â€&quot;148.32178975"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, China. JAMA Intern Med. Epub ahead"/>
   <result pre="24ChenNZhouMDongX, et al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: A descriptive study. Lancet2020; 395: 507â€&quot;513.32007143"/>
   <result pre="Eur J Intern Med2015; 26: 596â€&quot;598.26365372 38BuncePEHighSMNadjafiM, et al.Pandemic H1N1" exact="influenza infection" post="and vascular thrombosis. Clin Infect Dis2011; 52: e14â€&quot;17.21288835 39ObiATTignanelliCJJacobsBN,"/>
   <result pre="9â€&quot;14.32353746 43OxleyTJMoccoJMajidiS, et al.Large-vessel stroke as a presenting feature of" exact="Covid-19" post="in the young. N Engl J Med2020; 382: e60.32343504"/>
   <result pre="44GuoTFanYChenM, et al.Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19). JAMA Cardiol. Epub ahead of print 27 Mar"/>
   <result pre="J2004; 31: 4â€&quot;13.15061620 49KwongJCSchwartzKLCampitelliMA, et al.Acute myocardial infarction after laboratory-confirmed" exact="influenza infection." post="N Engl J Med2018; 378: 345â€&quot;353.29365305 50TianSHuWNiuL, et al.Pulmonary"/>
   <result pre="et al.Anticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathy. J Thromb Haemost2020; 18: 1094â€&quot;1099.32220112 102ThachilJTangNGandoS,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7307799\results\search\zoonosis\results.xml">
   <result pre="Dis. 2020;ciaa229. 10.1093/cid/ciaa22932147715 2Rukmini S. The curious case of Indiaâ€™s" exact="Covid-19" post="death rates. 2020. Available: https://www.indiatoday.in/news-analysis/story/the-curious-case-of-india-s-covid-19-death-rates-1676505-2020-05-10. Accessed: 20 May 2020."/>
   <result pre="Availabl: https://www.reuters.com/article/us-health-coronavirus-india-casualties/mortality-rates-drop-sharply-in-parts-of-india-bucking-coronavirus-trend-idUSKCN2260WM. Accessed: 19 May 2020. 7Sepkowitz K. Why is" exact="Covid-19" post="death rate so low in Germany? 2020 Mar 24."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7307801\results\search\zoonosis\results.xml">
   <result pre="inflammatory response of monocytes-macrophages [16]. Studies in animal models of" exact="SARS-CoV infection" post="have shown that intense virus replication associated with reduced"/>
   <result pre="Virol. 2020 Apr 16. 10.1002/jmv.25894 2MizumotoKKagayaKZarebskiAChowellGEstimating the asymptomatic proportion of" exact="coronavirus disease 2019" post="(COVID-19) cases on board the Diamond Princess cruise ship,"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitro.Cell Discov. 2020;6:16. 10.1038/s41421-020-0156-032194981 29ChoyKTWongAYKaewpreedeePSiaSFChenDHuiKPYet al.Remdesivir, lopinavir, emetine,"/>
   <result pre="Res. 2020;178:104786. 10.1016/j.antiviral.2020.10478632251767 30GaoJHuSUpdate on use of chloroquine/hydroxychloroquine to treat" exact="coronavirus disease 2019" post="(COVID-19).Biosci Trends. 2020;14:156-8. 10.5582/bst.2020.0307232281583 31GautretPLagierJCParolaPHoangVTMeddebLSevestreJet al.Clinical and microbiological effect"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7307812\results\search\zoonosis\results.xml">
   <result pre="cleavage site) occur in the hemagglutinin proteins of avian and" exact="human influenza" post="viruses, their virulence is greatly increased (43). Functionally the"/>
   <result pre="other pathologies, GR 127935, a known potent entry inhibitor of" exact="Ebola" post="and Marburg viruses, binds the SARS-CoV-2 receptor ACE2 and"/>
   <result pre="Abelson (Abl) kinase inhibitor GNF5, known to inhibit replication of" exact="Dengue" post="virus, which deserves further attention. It was shown that"/>
   <result pre="mice lacking STAT1 signaling pathway (STAT1 knockouts), which after the" exact="SARS-CoV infection," post="had an increased number of M2 macrophages in their"/>
   <result pre="of complex lipids (inositol phosphate, nicotinate, nicotinamide), intermediates needed in" exact="SARS-CoV infection" post="and probably linked to prenylation. The strongest proviral activation"/>
   <result pre="the hepatitis C virus protein NS3-4A, the capsid of the" exact="Dengue" post="and West Nile virus, and the vMIA protein of"/>
   <result pre="study (n=168) evaluated the influence of ACE I/D polymorphism on" exact="SARS-CoV infection" post="susceptibility and development of ARDS in a Chinese population"/>
   <result pre="hypertension and pulmonary fibrosis; ACE2 expression increases after IFN-I administration." exact="SARS-CoV infection" post="produces a rapid downregulation of ACE2 expression at cell"/>
   <result pre="activity in mice resulted in reduced lung fibrotic lesions in" exact="SARS-CoV infection," post="suggesting the virus produces a shift to M2 activities,"/>
   <result pre="to be elevated in elderly patients, and further elevated by" exact="SARS-CoV infection" post="and in more severe forms of COVID-19 (73); however"/>
   <result pre="interests. References References 1WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: Summary of a report of"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern Med31320202020 (Epub ahead of"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother5848754884201410.1128/AAC.03011-1424841269 18CascellaMRajnikMCuomoADulebohnSCDi NapoliRFeatures,"/>
   <result pre="are potent inhibitors of severe acute respiratory syndrome coronavirus and" exact="Middle East respiratory syndrome" post="coronavirus fusionJ Virol9089248933201610.1128/JVI.01429-1627466418 67SiskJMFriemanMBMachamerCECoronavirus S protein-induced fusion is blocked"/>
   <result pre="inhibitorsJ Biol Chem2753674136749200010.1074/jbc.M00384820010958789 76ChannappanavarRLuLXiaSDuLMeyerholzDKPerlmanSJiangSProtective effect of intranasal regimens containing peptidic" exact="Middle East respiratory syndrome" post="coronavirus fusion inhibitor against MERS-CoV infection. - Abstract -"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7307834\results\search\zoonosis\results.xml">
   <result pre="are made. coronavirus COVID-19 ARS-CoV-2 severe acute respiratory syndrome SARS-CoV" exact="Middle East respiratory syndrome" post="MERS-CoV pandemic lockdown immune system COVID-19 Since March, 2020,"/>
   <result pre="coronavirus-based infectious disease outbreaks/epidemics/pandemics: severe acute respiratory syndrome (SARS), 2002-2003;" exact="Middle East respiratory syndrome" post="(MERS), starting in 2012; COVID-19, starting in December 2019."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7308898\results\search\zoonosis\results.xml">
   <result pre="the lessons that should have been learned from the 2014â€&quot;2015" exact="Ebola" post="epidemic in West Africa, the largest and longest Ebola"/>
   <result pre="2014â€&quot;2015 Ebola epidemic in West Africa, the largest and longest" exact="Ebola" post="outbreak in history, was â€œthe need to be better"/>
   <result pre="of the R&amp;amp;D blueprint in the aftermath of the 2014â€&quot;2015" exact="Ebola" post="epidemic in West Africa was a recognition of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7309195\results\search\zoonosis\results.xml">
   <result pre="antiviral activity against a number of RNA viruses including the" exact="Ebola" post="virus by interfering with the viral polymerase enzyme. Remdesivir"/>
   <result pre="epidermal growth factor receptor 2 IRB Institutional review board MERS" exact="Middle East respiratory syndrome" post="RNA Ribonucleic acid SFDA State Food and Drug Administration"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7309305\results\search\zoonosis\results.xml">
   <result pre="HaydenF. G., &amp;amp; YuenK.-Y. (2013). Broad-spectrum antivirals for the emerging" exact="Middle East respiratory syndrome" post="coronavirus. The Journal of Infection, 67(6), 606â€&quot;616. 10.1016/j.jinf.2013.09.02924096239 ChenF.,"/>
   <result pre="ChengV. C., LauS. K., WooP. C., &amp;amp; YuenK. Y. (2007)." exact="Severe acute respiratory syndrome" post="coronavirus as an agent of emerging and reemerging infection."/>
   <result pre="WooP. C. Y., ZakiA. M., ZambonM., &amp;amp; ZiebuhrJ. (2013). Commentary:" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. Journal"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell culture. Antimicrobial Agents and Chemotherapy,"/>
   <result pre="B. (2014). Repurposing of clinically developed drugs for treatment of" exact="Middle East respiratory syndrome" post="coronavirus infection. Antimicrobial Agents and Chemotherapy, 58(8), 4885â€&quot;4893. 10.1128/AAC.03036-1424841273"/>
   <result pre="H. L., WongS. S. Y., LeungS.-Y., ChanK.-H., &amp;amp; YuenK.-Y. (2005)." exact="Severe acute respiratory syndrome" post="coronavirus-like virus in Chinese horseshoe bats. Proceedings of the"/>
   <result pre="&amp;amp; AlbarrakA. M. (2014). Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: A retrospective cohort study. The Lancet. Infectious"/>
   <result pre="BeekJ., NowotnyN., van MaanenK., Hidalgo-HermosoE., BoschB.-J., â€¦ KoopmansM. P. (2013)." exact="Middle East respiratory syndrome" post="coronavirus neutralising serum antibodies in dromedary camels: A comparative"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7309518\results\search\zoonosis\results.xml">
   <result pre="been also associated with viral epidemics or pandemics, including H1N1," exact="swine flu" post="A/New Jersey influenza strain, arthropod-borne flaviviruses, such as the"/>
   <result pre="Nile virus, chikungunya, or Zika, and with coronaviruses, including the" exact="Middle East respiratory syndrome" post="(MERS)-CoV and SARS-CoV.1â€&quot;3 We are now more than 4"/>
   <result pre="Guillain-BarrÃ© syndrome ICU intensive care unit IVIg intravenous immunoglobulin MERS" exact="Middle East respiratory syndrome" post="MFS Miller Fisher syndrome NAM necrotizing autoimmune myositis References"/>
   <result pre="Engl J Med2020;382:727â€&quot;733.31978945 5.GuanWJ, NiZY, HuY, et al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med2020;382:1708â€&quot;1720.32109013 6.MaoL, JinH,WangM, et"/>
   <result pre="Med2020;382:1708â€&quot;1720.32109013 6.MaoL, JinH,WangM, et al.Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, China. JAMA Neurol202010.1001/jamaneurol.2020.1127. 7.ZhaoH, ShenD, ZhouH, LiuJ,"/>
   <result pre="doi: 10.1212/WNL.0000000000009619. 11.BigautK, MallaretM, BalogluS, et al.Guillain-BarrÃ© syndrome related to" exact="SARS-CoV-2 infection." post="Neurol Neuroimmunol Neuroinflamm2020;7:e785. doi: 10.1212/NXI.0000000000000785.32461235 12.YanCH, FarajiF, PtajapatiD, DeCondeASAssociation"/>
   <result pre="a new mechanism of action of chloroquine and hydroxychloroquine against" exact="SARS-CoV-2 infection." post="Int J Antimicrob Agents202010.1016/j.ijantimicag.2020.105960. 16.VaduganathanM, VardenyO, MichelT, et al.Reninâ€&quot;angiotensinâ€&quot;aldosterone"/>
   <result pre="a target in COVID-19?Nat Rev Immunol202010.1038/s41577-020-0320-7. 42.collab: Eculizumab (Soliris) in" exact="Covid-19" post="Infected Patients (SOLID-C19). Available at: https://clinicaltrials.gov/ct2/show/NCT04288713. NLM identifier: NCT04288713."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7309685\results\search\zoonosis\results.xml">
   <result pre="the 1970s and 1980sâ€&quot;periods marked by the Legionnairesâ€™ Disease and" exact="swine flu" post="outbreaks, and the advent of HIV/AIDsâ€&quot;much less why the"/>
   <result pre="2018, the WHO listed eight priority pathogens: Crimean-Congo Haemorrhagic Fever;" exact="Ebola" post="and Marburg; MERS Co-V and SARS; Lassa Fever; Nipah;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7310596\results\search\zoonosis\results.xml">
   <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. Abstract" exact="Coronavirus disease 2019" post="(COVID-19), caused by severe acute respiratory syndrome coronavirus 2"/>
   <result pre="key cardiac manifestations, their management, and future implications. Key Points" exact="Coronavirus disease 2019" post="(COVID-19) has a significant impact on the cardiovascular (CV)"/>
   <result pre="the CV effects of drugs used for COVID-19 treatment. Introduction" exact="Coronavirus disease 2019" post="(COVID-19) is a rapidly spreading novel infectious disease of"/>
   <result pre="1965: Tyrrell and Bynoe1 identified a virus named B814 2002â€&quot;2003:" exact="Severe acute respiratory syndrome" post="(SARS) 2012: Middle East Respiratory Syndrome 2019â€&quot;2020: Covid-19 (the"/>
   <result pre="acute respiratory syndrome (SARS) 2012: Middle East Respiratory Syndrome 2019â€&quot;2020:" exact="Covid-19" post="(the illness caused by SARS-CoV-2 infection) First reported case"/>
   <result pre="cohort studyLancet2020395102291054106232171076 18.GuoTFanYChenMWuXZhangLHeTWangHWanJWangXLuZCardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol201910.1001/jamacardio.2020.101730673084 19.ChenLLiXChenMFengYXiongCThe ACE2 expression in human heart indicates"/>
   <result pre="with SARSEur J Clin Invest200939761862519453650 21.LauerSAGrantzKHBiQJonesFKZhengQMeredithHRet al.The incubation period of" exact="coronavirus disease 2019" post="(COVID-19) from publicly reported confirmed cases: estimation and applicationAnn"/>
   <result pre="Cardiol2020109553153832161990 30.ChenNZhouMDongXQuJGongFHanYet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet20203951022350751332007143 31.ZhangJJDongXCaoYYYuanYDYangYBYanYQet al.Clinical characteristics"/>
   <result pre="a Nationwide Analysis of ChinaEur Respir J2020556200056232269086 36.McMichaelTMCurrieDWClarkSPogosjansSKayMSchwartzNGet al.Epidemiology of" exact="Covid-19" post="in a long-term care facility in King County, WashingtonN"/>
   <result pre="in the New York City areaJAMA20203232020522059 40.GoyalPChoiJJPinheiroLCSchenckEJChenRJabriAet al.Clinical characteristics of" exact="Covid-19" post="in New York CityN Engl J Med.202010.1056/NEJMc201041932383831 41.GrasselliGZangrilloAZanellaAAntonelliMCabriniLCastelliAet al.Baseline"/>
   <result pre="and meta-analysisProg Cardiovasc Dis.202010.1016/j.pcad.2020.04.00832305557 52.LippiGLavieCJSanchis-GomarFCardiac troponin I in patients with" exact="coronavirus disease 2019" post="(COVID-19): evidence from a meta-analysisProg Cardiovasc Dis.202010.1016/j.pcad.2020.03.00132224113 53.ZengJHLiuYXYuanJWangFXWuWBLiJXet al.First"/>
   <result pre="on COVID-19 and heart failureIndian Heart J.202010.1016/j.ihj.2020.04.01232405088 59.TamCFCheungKSLamSWongAYungASzeMet al.Impact of" exact="coronavirus disease 2019" post="(COVID-19) outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong"/>
   <result pre="Virol202012710436232305883 69.TangNBaiHChenXGongJLiDSunZAnticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathyJ Thromb Haemost20201851094109932220112 70.PanigadaMBottinoNTagliabuePGrasselliGNovembrinoCChantarangkulVet al.Hypercoagulability of COVID-19"/>
   <result pre="or risk of death in patients with hypertension hospitalized for" exact="coronavirus disease 2019" post="(COVID-19) infection in Wuhan, ChinaJAMA Cardiol202010.1001/jamacardio.2020.162432324209 89.GuoJHuangZLinLLvJCoronavirus disease 2019"/>
   <result pre="91.HajraABandyopadhyayDCOVID-19 and ACEI/ARB: not associated?Am J Hypertens.202010.1093/ajh/hpaa07632415832 92.SandersJMMonogueMLJodlowskiTZCutrellJBpharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a reviewJAMA20203231818241836 93.US FDA. Kaletra prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021251s046_021906s039lbl.pdf."/>
   <result pre="108.De FilippoODâ€™AscenzoFAngeliniFBocchinoPPConrottoFSagliettoAet al.Reduced rate of hospital admissions for ACS during" exact="Covid-19" post="outbreak in Northern ItalyN Engl J Med.202010.1056/NEJMc200916632343497 109.BaldiESechiGMMareCCanevariFBrancaglioneAPrimiRet al.Out-of-hospital"/>
   <result pre="ItalyN Engl J Med.202010.1056/NEJMc200916632343497 109.BaldiESechiGMMareCCanevariFBrancaglioneAPrimiRet al.Out-of-hospital cardiac arrest during the" exact="Covid-19" post="outbreak in ItalyN Engl J Med.202010.1056/NEJMc201041832348640"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7310912\results\search\zoonosis\results.xml">
   <result pre="respiratory syndrome (SARS- 2002; 8000 infected cases and 774 deaths)," exact="Middle East respiratory syndrome" post="(MERS-2012; 858 casualties and 2494 infected cases) and ongoing"/>
   <result pre="in both CoV strains for host entry [11]. Likewise, recent" exact="COVID-2019" post="outbreak reported to be traced from seafood market located"/>
   <result pre="Med2020946210.3390/jcm9020462 17.ChenNZhouMDongXQuJGongFHanYet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, ChinaLancet202039550751310.1016/S0140-673632007143 18.WangDHuBHuCZhuFLiuXZhangJet al.Clinical characteristics of 138 hospitalized"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7313527\results\search\zoonosis\results.xml">
   <result pre="of CoVs namely severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) have caused epidemics with high mortality (Hui"/>
   <result pre="Infect. Dis.20202039840010.1016/S1473-3099(20)30141-932113510 ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.XiaJ.YuT.ZhangX.ZhangL.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet (London, England)395202050751310.1016/S0140-6736(20)30211-7 ColsonP.RolainJ.-M.LagierJ.-C.BrouquiP.RaoultD.Chloroquine"/>
   <result pre="GordonC.J.TchesnokovE.P.FengJ.Y.PorterD.P.GotteM.The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirusJ. Biol. Chem.202010.1074/jbc.AC120.013056 HammingI.TimensW.BulthuisM.L.C.LelyA.T.NavisG.J.van GoorH.Tissue distribution of ACE2 protein,"/>
   <result pre="(2019-nCoV) in vitroCell Res.202010.1038/s41422-020-0282-0 WangZ.YangB.LiQ.WenL.ZhangR.Clinical features of 69 cases with" exact="coronavirus disease 2019" post="in Wuhan, ChinaClin. Infect. Dis. Off. Publ. Infect. Dis."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7313828\results\search\zoonosis\results.xml">
   <result pre="cited. For commercial re-use, please contact journals.permissions@oup.comofaa232.pdf Abstract Abstract As" exact="coronavirus disease 2019" post="cases and deaths continue to expand globally, there is"/>
   <result pre="The global community is enduring the horrific first wave of" exact="coronavirus disease 2019" post="(COVID-19). In many cities, emergency departments are inundated, and"/>
   <result pre="of viruses leads to better outcomes. In a trial of" exact="Ebola" post="treatment, shorter symptom duration at presentation correlated with lower"/>
   <result pre="Disease Control and Prevention. Analysis on 54 mortality cases of" exact="coronavirus disease 2019" post="in the Republic of Korea from January 19 to"/>
   <result pre="Writing Group; PALM Consortium Study TeamA randomized, controlled trial of" exact="Ebola" post="virus disease therapeutics. N Engl J Med2019; 381:2293â€&quot;303.31774950 13.HaydenFG,"/>
   <result pre="San Francisco. PLoS One2010; 5:e11068.20548786 16.Severe outcomes among patients with" exact="coronavirus disease 2019" post="(COVID-19) â€&quot; United States, February 12â€&quot;March 16, 2020. MMWR"/>
   <result pre="9(1):20160001. 33.NacotiM, CioccaA, GiupponiA, et al.At the epicenter of the" exact="Covid-19" post="pandemic and humanitarian crises in Italy: changing perspectives on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7314063\results\search\zoonosis\results.xml">
   <result pre="relies on a solid theoretical understanding of the mechanisms of" exact="SARS-CoV-2 infection" post="and host responses, which is coupled to the practical"/>
   <result pre="appear to be the ideal candidate for the treatment of" exact="SARS-CoV-2 infection." post="AT1R antagonists counterbalance the negative consequences of angiotesnin II"/>
   <result pre="past epidemics such as severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS), as well as the current emerging SARS-CoV-2 pandemic."/>
   <result pre="seem to be the ideal candidate for the treatment of" exact="SARS-CoV-2 infection." post="AT1R antagonists counterbalance the negative consequences of AngII and"/>
   <result pre="discussion about the role of the reninâ€&quot;angiotensin system (RAS) in" exact="SARS-CoV-2 infection." post="Some authors claim that the use of ACE inhibitors"/>
   <result pre="to the observation that among the more severe cases of" exact="SARS-CoV-2 infection," post="a larger number of individuals had hypertension and diabetes.2â€&quot;5"/>
   <result pre="the inflammatory response. Therefore, it is suggested that, during active" exact="SARS-CoV-2 infection," post="AT1R-mediated ACE2 destruction plays a deleterious role, promoting both"/>
   <result pre="disruptions of these organs. It has been shown that the" exact="SARS-CoV-2 infection" post="was related to active myocardial injury, myocardial stress, and"/>
   <result pre="higher AngII levels, due to the disrupted ACE2 by the" exact="SARS-CoV-2 infection," post="it was recently shown that this was associated with"/>
   <result pre="observed higher values of D-dimer and cardiovascular thrombotic events.35 Treating" exact="SARS-CoV-2 infection" post="with AT1R antagonists Following the above, SARS-CoV-2 infection by"/>
   <result pre="events.35 Treating SARS-CoV-2 infection with AT1R antagonists Following the above," exact="SARS-CoV-2 infection" post="by binding to ACE2 disrupts the normal AngII:ACE2 balance,"/>
   <result pre="side effects, which make them the ideal treatment option for" exact="SARS-CoV-2 infection." post="We are not the only ones suggesting this hypothesis;"/>
   <result pre="antagonist may completely prevent the excessive inflammation related to the" exact="SARS-CoV-2 infection," post="by restoring ACE2 function and thereby preventing viral load"/>
   <result pre="chloroquine appears to be unsuitable for the treatment of a" exact="SARS-CoV-2 infection," post="whereas it could play a modest role in its"/>
   <result pre="with regard to their relationship with the severity of the" exact="SARS-CoV-2 infection." post="A recent article by Zhang et al. showed that"/>
   <result pre="that among 1128 hypertensive individuals admitted to hospital because of" exact="SARS-CoV-2 infection," post="individuals using either ACEIs or an AT1R antagonist were"/>
   <result pre="double-blind, placebo-controlled randomized Losartan 25 mg o.d. Placebo Non-hospitalized Proven" exact="SARS-CoV-2 infection" post="Cough, rhinorrhea, or fever Admission to hospital 580 Yes"/>
   <result pre="double-blind, placebo-controlled randomized Losartan 50 mg o.d. Placebo Hospitalized Proven" exact="SARS-CoV-2 infection" post="Respiratory failure Difference in estimated (PEEP adjusted) P/F ratio"/>
   <result pre="to 50 mg o.d. day 3 Standard care Hospitalized Proven" exact="SARS-CoV-2 infection" post="Respiratory failure Adverse event due to losartan 50 Yes"/>
   <result pre="100 mg/asprin 150 mg/simvastatin 80 mg o.d. Comparison Hospitalized Suspected" exact="SARS-CoV-2 infection" post="Fever, cough, hypoxia 28 day death 10 000 No"/>
   <result pre="placebo-controlled, randomized comparison Losartan 25 mg o.d. Placebo Hospitalized Proven" exact="SARS-CoV-2 infection" post="NCOSS scores 4000 Yes NCT04340557 Sharp HealthCare Multicentre open"/>
   <result pre="label, randomized Losartan 12.5 mg t.i.d Standard care Hospitalized Proven" exact="SARS-CoV-2 infection" post="Requiring oxygen ICU admission for mechanical ventilation 200 Yes"/>
   <result pre="Clinical trial, factorial, randomized Losartan 25 mg o.d. Comparison Proven" exact="SARS-CoV-2 infection" post="Improvement in FMTVDM measurement with nuclear imaging. 500 Enrolling"/>
   <result pre="label, randomized Candesartan 4 mg o.d. Standard care Hospitalized Proven" exact="SARS-CoV-2 infection" post="Sustained improvement (&amp;gt;48 h) of one point on the"/>
   <result pre="label, randomized Telmisartan 80 mg t.d. Standard care Hospitalized Proven" exact="SARS-CoV-2 infection" post="Need for supplementary oxygen 400 Yes NCT04335786 Radboud University"/>
   <result pre="mg titrated up to 160 mg o.d. Placebo Hospitalized Proven" exact="SARS-CoV-2 infection" post="Admission to the ICU for mechanical ventilation or death"/>
   <result pre="label, randomized Telmisartan 20 mg o.d. Vitamin complex Non-hospitalized Proven" exact="SARS-CoV-2 infection" post="Age â‰¥ 65 years Proportion of participants with an"/>
   <result pre="China Medical Treatment Expert Group for Covid-19. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med2020;382:1708â€&quot;1720.32109013 3HuangC, WangY, LiX,"/>
   <result pre="LiD, SunZ.Anticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathy. J Thromb Haemost2020;18:1094â€&quot;1099.32220112 36WangF, XiaZF, ChenXL,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7314230\results\search\zoonosis\results.xml">
   <result pre="1 The main physiopathological pathways of cardiorenal syndrome associated with" exact="SARS-CoV-2 infection." post="CARDIAC INVOLVEMENT IN COVID-19 It has been documented that"/>
   <result pre="epidemics of severe acute respiratory syndrome (SARS) [8, 9] and" exact="Middle East respiratory syndrome" post="(MERS) coronavirus [10]. Interestingly, in COVID, the pulmonary risk"/>
   <result pre="is greater in those with pre-existing cardiac disease [4]. The" exact="SARS-CoV-2 infection" post="causes acute myocardial injury, shock and arrhythmia in 7.2,"/>
   <result pre="[11]. Myocardial injury in patients with COVID-19 In patients with" exact="SARS-CoV-2 infection," post="the most important features that suggest myocardial injury are"/>
   <result pre="for patients, health care workers, and health systems during the" exact="coronavirus disease 2019" post="(COVID-19) pandemic. J Am Coll Cardiol2020; doi: 10.1016/j.jacc.2020.03.031 5TamCF,"/>
   <result pre="Coll Cardiol2020; doi: 10.1016/j.jacc.2020.03.031 5TamCF, CheungKS, LamSet al. Impact of" exact="coronavirus disease 2019" post="(COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong"/>
   <result pre="follow-up study. Circulation2003; 108: 1798â€&quot;180314504188 10AlhogbaniT.Acute myocarditis associated with novel" exact="Middle East respiratory syndrome" post="coronavirus. Ann Saudi Med2016; 36: 78â€&quot;8026922692 11WangD, HuB, HuCet"/>
   <result pre="1054â€&quot;1062 14LippiG, LavieCJ, Sanchis-GomarF. Cardiac troponin I in patients with" exact="coronavirus disease 2019" post="(COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis2020; doi:"/>
   <result pre="DongXet al. Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet 2020; 395:"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, China. JAMA Intern Med 2020; doi:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7315394\results\search\zoonosis\results.xml">
   <result pre="caused more than 185,000 fatalities as of April 23, 2020." exact="Coronavirus disease 2019" post="(COVID-19) causes a respiratory illness with symptoms such as"/>
   <result pre="health emergency of international concern, following H1N1 (2009), Polio (2014)," exact="Ebola" post="in West Africa (2014), Zika (2016), and Ebola (2019)"/>
   <result pre="Polio (2014), Ebola in West Africa (2014), Zika (2016), and" exact="Ebola" post="(2019) [2]. The rapid global expansion and rising fatalities"/>
   <result pre="that camostat mesylate displays an inhibitory effect in mice for" exact="SARS-CoV infection" post="[152]. Recent research by Hoffmann et al. showed a"/>
   <result pre="was synthesized and developed by Gilead Science in 2017 for" exact="Ebola" post="virus infection [186]. Remdesivir needs to be metabolized into"/>
   <result pre="immunoinformatics approach2020BioRxiv10.1101/2020.02.04.934232 23collab: WHOReport of the WHO-China joint mission on" exact="coronavirus disease 2019" post="(COVID-19)2020https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf 24SurveillancesV.The epidemiological characteristics of an outbreak of 2019"/>
   <result pre="T.WeidmannM.Reverse transcription recombinase polymerase amplification assay for the detection of" exact="Middle East respiratory syndrome" post="coronavirusPLoS Currents2013510.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364 52YanT.LiX. N.WangL.et al.Development of a reverse transcription"/>
   <result pre="clinical application of a rapid IgM-IgG combined antibody test for" exact="SARS-CoV-2 infection" post="diagnosisJournal of Medical Virology202010.1002/jmv.25727 85HosseinyM.KoorakiS.GholamrezanezhadA.ReddyS.MyersL.Radiology perspective of coronavirus disease"/>
   <result pre="for SARS-CoV-2 infection diagnosisJournal of Medical Virology202010.1002/jmv.25727 85HosseinyM.KoorakiS.GholamrezanezhadA.ReddyS.MyersL.Radiology perspective of" exact="coronavirus disease 2019" post="(COVID-19): lessons from severe acute respiratory syndrome and Middle"/>
   <result pre="B2010114258544855410.1021/jp102619w20527735 127WangZ.ChenX.LuY.ChenF.ZhangW.Clinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatmentBioScience Trends2020141646810.5582/bst.2020.0103032037389 128DongL.HuS.GaoJ.Discovering"/>
   <result pre="Chinese and Western medicine treatmentBioScience Trends2020141646810.5582/bst.2020.0103032037389 128DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discoveries &amp;amp; Therapeutics2020141586010.5582/ddt.2020.0101232147628 129SavarinoA.BoelaertJ. R.CassoneA.MajoriG.CaudaR.Effects of chloroquine on"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discovery202061p. 1610.1038/s41421-020-0156-0 136VincentM. J.BergeronE.BenjannetS.et al.Chloroquine is a"/>
   <result pre="A.MomattinH.DibJ.MemishZ. A.Ribavirin and interferon therapy in patients infected with the" exact="Middle East respiratory syndrome" post="coronavirus: an observational studyInternational Journal of Infectious Diseases201420424610.1016/j.ijid.2013.12.00324406736 177MomattinH.MohammedK.ZumlaA.MemishZ."/>
   <result pre="motif of the viral polymeraseJournal of Virology2017911210.1128/jvi.00487-17 180PettiniF.TrezzaA.SpigaO.A Focus on" exact="Ebola" post="Virus PolymeraseViral Polymerases201918121010.1016/b978-0-12-815422-9.00007-3 181FurutaY.GowenB. B.TakahashiK.ShirakiK.SmeeD. F.BarnardD. L.Favipiravir (T-705), a"/>
   <result pre="K.JordanR.LoM. K.et al.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature2016531759438138510.1038/nature1718026934220 186Al-TawfiqJ. A.Al-HomoudA. H.MemishZ. A.Remdesivir as"/>
   <result pre="Respiratory Medicine20208547548110.1016/S2213-2600(20)30079-532105632 225WuZ.McGooganJ. M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in ChinaJAMA2020323131239124210.1001/jama.2020.2648 226KimH.-Y.ShinH. S.ParkH.et al.In vitro inhibition"/>
   <result pre="approves 29-minute testing kit for new coronavirus2020https://www.chinadaily.com.cn/a/202003/07/WS5e63521aa31012821727d239.html 247S'pore researchers invent" exact="Covid-19" post="test that can tell if someone's infected in 5"/>
   <result pre="Remdesivir Genome replication The new antiviral drug initially developed for" exact="Ebola" post="In vitro antiviral activities toward 2019-nCoV on primate cells"/>
   <result pre="indication Mechanism of action Clinical status References Chemical drugs â€ƒUmifenovir" exact="Influenza" post="A &amp;amp; B Inhibition of binding of the virus"/>
   <result pre="viral entry into host cells Preclinical [113, 151, 152] â€ƒRemdesivir" exact="Ebola" post="(proposed) Inhibits viral RNA polymerase Phase 3 trials for"/>
   <result pre="3 trials for the treatment of COVID-19 [186, 188] â€ƒFavipiravir" exact="Influenza" post="Inhibits RdRp Phase 3 and randomized trials for the"/>
   <result pre="â€ƒHuman monoclonal antibodies Nil Binding to the receptor-binding domain of" exact="COVID-2019" post="Preclinical [214] â€ƒmRNA-1273, Ad5-nCoV Nil Eliciting immune response via"/>
   <result pre="COVID-19 [235, 236] TCM/herbal remedies â€ƒLian Hua Qing Wen Capsule" exact="Influenza" post="Downregulates MCP-1 which decreases monocytes chemotaxis to infection foci"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7315698\results\search\zoonosis\results.xml">
   <result pre="76 were included. Most presented data relating to the 2014â€&quot;2016" exact="Ebola" post="virus outbreak or the H1N1 outbreak in 2009. The"/>
   <result pre="2). Most articles presented challenges and solutions identified during the" exact="Ebola" post="virus epidemic in 2014 to 2016 and/or during the"/>
   <result pre="perspective covered more than one type of outbreak Outbreak setting" exact="Ebola" post="and other VHFs, n Arboviruses, n CNS infections, n"/>
   <result pre="H1N1 pandemic in HICs [15, 37] and again during the" exact="Ebola" post="outbreak in LMICs [36]. Table 4 Solutions to PEARLES"/>
   <result pre="al., where the implementation of a vaccine RCT during an" exact="Ebola" post="outbreak was attributed to decisive action by the national"/>
   <result pre="effective responses [1, 2, 13, 29, 36]. Researchers delivering an" exact="Ebola" post="vaccine RCT in Sierra Leone illustrated reactive solutions implemented"/>
   <result pre="found that double ethical review improved the quality of an" exact="Ebola" post="protocol and led to better protection of patients due"/>
   <result pre="ethical review process, a sub-committee established specifically for review of" exact="Ebola" post="studies reviewed protocols in 6Â days (max. 15â€‰days) on"/>
   <result pre="2014â€&quot;2016 outbreak. Barriers causing delays were mainly protocol related [18]." exact="Ebola" post="2014â€&quot;2016 West Africa 6â€‰days on average An H1N1 pandemic"/>
   <result pre="children and pregnant women was an ethical concern during the" exact="Ebola" post="outbreak in LMICs [18, 69], compounded by challenges of"/>
   <result pre="or verbal consent models for pandemics [70, 74]. An interventional" exact="Ebola" post="study set in Guinea reported patient preference for verbal"/>
   <result pre="implemented, and the same issues were documented again during the" exact="Ebola" post="response in 2014 to 2016. Most challenges experienced were"/>
   <result pre="into outbreak response facilitated the further assessment of a candidate" exact="Ebola" post="vaccine during the current outbreak in the Democratic Republic"/>
   <result pre="research for outbreak control [92]. A recent RCT of four" exact="Ebola" post="treatments in DRC shows that well-planned scientifically and ethically"/>
   <result pre="LMICs. Most studies were set in West Africa during the" exact="Ebola" post="outbreak or in Europe and Northern America during the"/>
   <result pre="Central nervous system DRC Democratic Republic of the Congo EVD" exact="Ebola" post="virus disease GHS Global health security HIC High-income country"/>
   <result pre="board REC Research ethics committee R&amp;amp;D Research and development SARS" exact="Severe acute respiratory syndrome" post="S.E Southeast UK United Kingdom VHF Viral haemorrhagic fever"/>
   <result pre="a pandemic proposalCrit Care Med2010384 Supple138e14220029349 3.BauschDGSprecherAGJeffsBBoumandoukiPTreatment of Marburg and" exact="Ebola" post="hemorrhagic fevers: a strategy for testing new drugs and"/>
   <result pre="operational complexities of conducting a clinical treatment trial during an" exact="Ebola" post="virus disease epidemicClin Infect Dis20186691454145729206908 5.EzeomeERSimonCEthical problems in conducting"/>
   <result pre="II/III clinical research trial in resource-poor Liberia during the largest-ever" exact="Ebola" post="outbreakContemp Clin Trials Commun20164687328042619 17.FolayanMOBrownBHaireBYakubuAPetersonKTegliJStakeholdersâ€™ engagement with Ebola therapy"/>
   <result pre="the largest-ever Ebola outbreakContemp Clin Trials Commun20164687328042619 17.FolayanMOBrownBHaireBYakubuAPetersonKTegliJStakeholdersâ€™ engagement with" exact="Ebola" post="therapy research in resource limited settingsBMC Infect Dis20151524226113124 18.AlirolEKueselACGuraiibMMde"/>
   <result pre="the experience of the WHO ethics review committee during the" exact="Ebola" post="virus disease epidemic. [Erratum appears in BMC Med Ethics."/>
   <result pre="Ethics. 2017 Jul 12;18(1):45; PMID: 28701168]BMC Med Ethics20171814328651650 19.Henao-RestrepoAMPreziosiMPWoodDMoorthyVKienyMPcollab: WHO" exact="Ebola" post="Research DTOn a path to accelerate access to Ebola"/>
   <result pre="WHO Ebola Research DTOn a path to accelerate access to" exact="Ebola" post="vaccines: the WHOâ€™s research and development efforts during the"/>
   <result pre="vaccines: the WHOâ€™s research and development efforts during the 2014-2016" exact="Ebola" post="epidemic in West AfricaCurr Opin Virol20161713814427180074 20.Wilder-SmithAPreetRRenhornKEXimenesRARodriguesLCSolomonTet al.ZikaPLAN: Zika"/>
   <result pre="in crisis settings, 2012 military coup in Mali and the" exact="Ebola" post="virus outbreak in 2014 in West AfricaAm J Trop"/>
   <result pre="public health emergenciesLancet2016387100342197219827302027 25.SchieffelinJMosesLMShafferJGobaAGrantDSClinical validation trial of a diagnostic for" exact="Ebola" post="Zaire antigen detection: design rationale and challenges to implementationClin.20161316672"/>
   <result pre="and challenges to implementationClin.20161316672 26.KeuschGTMcAdamKPWJClinical trials during epidemicsLancet2017389100882455245728656892 27.MoonSSridharDPateMAJhaAKClintonCDelaunaySet al.Will" exact="Ebola" post="change the game? Ten essential reforms before the next"/>
   <result pre="al.Implementing a multisite clinical trial in the midst of an" exact="Ebola" post="outbreak: lessons learned from the Sierra Leone Trial to"/>
   <result pre="a vaccine against EbolaJ Infect Dis2018217Supplement 1S16S2329788343 30.HiggsESHaydenFGChotpitayasunondhTWhitworthJFarrarJThe Southeast Asian" exact="Influenza" post="Clinical Research Network: development and challenges for a new"/>
   <result pre="Ishola D, et al. EBOVAC-Salone: lessons learned from implementing an" exact="Ebola" post="vaccine trial in an Ebola-affected country. Clin. 2018;15(5):436â€&quot;43. 41.WalleyTDavidsonPResearch"/>
   <result pre="Clin. 2018;15(5):436â€&quot;43. 41.WalleyTDavidsonPResearch funding in a pandemicLancet.201037597201063106520096451 42.WiddowsonMASchragSJCarterRJCarrWLegardy-WilliamsJGibsonLet al.Implementing an" exact="Ebola" post="vaccine study - Sierra LeoneMMWR Suppl20166539810627387395 43.IdrissAWertheimRCKargboBSierra Leone Trial"/>
   <result pre="LeoneMMWR Suppl20166539810627387395 43.IdrissAWertheimRCKargboBSierra Leone Trial to Introduce a Vaccine Against" exact="Ebola" post="(strive): implementation challenges, successes and lessons learnedAm J Trop"/>
   <result pre="trial â€˜in hibernationâ€™, ready for rapid activationHealth Technol Assess201519161viii25716702 47.collab:" exact="Ebola" post="ca Suffit Ring Vaccination Trial CThe ring vaccination trial:"/>
   <result pre="al.A response adaptive randomization platform trial for efficient evaluation of" exact="Ebola" post="virus treatments: a model for pandemic responseClin.20161312230 51.CalainPFioreNPoncinMHurstSAResearch ethics"/>
   <result pre="responseClin.20161312230 51.CalainPFioreNPoncinMHurstSAResearch ethics and international epidemic response: the case of" exact="Ebola" post="and Marburg hemorrhagic feversPublic Health Ethics200921729 52.ChretienJPRiversCMJohanssonMAMake data sharing"/>
   <result pre="Med2010384 Supple120e13220101176 56.Lie RK, Wendler D. The Guinea Phase III" exact="Ebola" post="Vaccine Trial: lessons for research ethics review in public"/>
   <result pre="J, Ciglenecki I, Carson G, et al. Experimental treatment of" exact="Ebola" post="virus disease with brincidofovir. PLoS One. 2016;11(9). 58.CrowcroftNSRosellaLCPakesBNThe ethics"/>
   <result pre="horns: ethical considerations in the design and implementation of an" exact="Ebola" post="virus therapy trialSoc Sci Med201614816317026653137 60.Richardson T, Johnston AM,"/>
   <result pre="60.Richardson T, Johnston AM, Draper H. A systematic review of" exact="Ebola" post="treatment trials to assess the extent to which they"/>
   <result pre="trial in GuineaIndian J Med Ethics201612768226826351 66.RidAMillerFGEthical rationale for the" exact="Ebola" post="â€œring vaccinationâ€� trial designAm J Public Health2016106343243526794172 67.RavinettoRDe CropMDelamouAVan"/>
   <result pre="and implementing a clinical trial at field level in an" exact="Ebola" post="emergency: a case study in Guinea, West AfricaPLoS Negl"/>
   <result pre="community engagement system during a clinical trial of a candidate" exact="Ebola" post="vaccine within an outbreak settingInt J Infect Dis20161191 72.EnriaLLeesSSmoutEMooneyTTengbehAFLeighBet"/>
   <result pre="four European countriesHealth Expect201821138739528960624 75.BellanSEPulliamJRPearsonCAChampredonDFoxSJSkripLet al.Statistical power and validity of" exact="Ebola" post="vaccine trials in Sierra Leone: a simulation study of"/>
   <result pre="phase 3 trial design to evaluate vaccine effectiveness to prevent" exact="Ebola" post="virus disease infection: statistical considerations, design rationale, and challengesClin.20161315765"/>
   <result pre="trials or non-randomised studies the best way to address the" exact="Ebola" post="outbreak in West Africa?Lancet Infect Dis201515673874525881871 78.SchopperDRavinettoRSchwartzLKamaaraESunitaSSegelidMJet al.Research ethics"/>
   <result pre="PE, Schulz WS, Smout E, Fernandez-Luque L, Larson HJ. Controversial" exact="Ebola" post="vaccine trials in Ghana: a thematic analysis of critiques"/>
   <result pre="for this countryâ€�: participantsâ€™ decision-making and grounded ethics in an" exact="Ebola" post="vaccine clinical trialSoc Sci Med2018203354229544144 81.Nuffield Council on Bioethics."/>
   <result pre="vaccine developmentAnnu Rev Microbiol201872142344630200851 85.AbdullahIRashidIODcollab: African Leadership CUnderstanding West Africaâ€™s" exact="Ebola" post="epidemic: towards a political economy2017 86.Simpson CR, Beever D,"/>
   <result pre="2019 Dec.]. 92.WHO. Preliminary results on the efficacy of rVSV-ZEBOV-GP" exact="Ebola" post="vaccine using the ring vaccination strategy in the control"/>
   <result pre="using the ring vaccination strategy in the control of an" exact="Ebola" post="outbreak in the Democratic Republic of the Congo: an"/>
   <result pre="[cited 2019 Dec.]. 93.MulanguSDoddLEDaveyRTTshiani MbayaOProschanMMukadiDet al.A randomized, controlled trial of" exact="Ebola" post="virus disease therapeuticsN Engl J Med2019381242293230331774950"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7315836\results\search\zoonosis\results.xml">
   <result pre="Î²-CoVs, the severe acute respiratory syndrome coronavirus (SARS-CoV), and the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) have caused severe epidemics in the past.4,5"/>
   <result pre="confirms that TMPRSS2 expressing VeroE6 cells are highly susceptible to" exact="SARS-CoV-2 infection," post="highlighting the importance of TMPRSS2 in the replication cycle.19"/>
   <result pre="observed in hemagglutinin (HA) proteins of highly virulent avian and" exact="human influenza" post="viruses, and similar furin-like processing events are also observed"/>
   <result pre="events are also observed for other RNA viruses such as" exact="Ebola" post="virus and Marburg virus, human immune deficiency virus (HIV),"/>
   <result pre="received 40 mg/kg of mAb 201 or mAb 68 before" exact="SARS-CoV infection" post="showed complete protection from reinfection of lung tissues.43,44 Cross-reactivity"/>
   <result pre="Table 2) could target ACE2, and showed antiviral activity against" exact="SARS-CoV infection" post="in vitro, with an EC50 value of 41.6 Î¼M,"/>
   <result pre="was shown to block the entry of SARS, MERS, and" exact="Ebola" post="virus by specifically inhibiting the cathepsin L activity.111 More"/>
   <result pre="(EC50 value of 273 nM) showed some inhibition activity for" exact="Ebola" post="virus infection (EC50 value of 193 nM) of human"/>
   <result pre="a new promising point for the treatment of SARS and" exact="Ebola" post="virus infections.114 Recently, in a cell-based assay screen of"/>
   <result pre="Simon Cocklin and is currently working in infectious disease-related (HIV-1," exact="Ebola" post="virus, SARS-CoV-2) computationally aided drug design supported by biochemical,"/>
   <result pre="His interests have since expanded to include inhibitor discovery against" exact="Ebola" post="and SARS-CoV-2 viruses. His research spans multiple disciplines, including"/>
   <result pre="ADAM A disintegrin and metalloproteinase bnAbs broadly neutralizing antibodies COVID-19" exact="coronavirus disease 2019" post="CPE cytopathic effect ELISA enzyme-linked immunosorbent assay FP fusion"/>
   <result pre="hepatic C virus IFA immunofluorescence assay KM immunized Kunming MERS-CoV" exact="Middle East respiratory syndrome" post="coronavirus MHV mouse hepatitis coronavirus NTD N-terminal domain PD"/>
   <result pre="181, 271â€&quot;280. 10.1016/j.cell.2020.02.052.32142651 MilletJ. K.; WhittakerG. R.Host cell entry of" exact="Middle East respiratory syndrome" post="coronavirus after two-step, furin-mediated activation of the spike protein."/>
   <result pre="M.; HaagmansB. L.; GrosveldF.; BoschB. J.A human monoclonal antibody blocking" exact="SARS-CoV-2 infection." post="Nat. Commun.2020, 11, 225110.1038/s41467-020-16256-y.32366817 BrouwerP. J. M.; CanielsT. G.;"/>
   <result pre="RNA synthesis reveals potent inhibition of diverse coronaviruses including the" exact="Middle East respiratory syndrome" post="virus. PLoS Pathog.2014, 10, e100416610.1371/journal.ppat.1004166.24874215 TurnerA. J.Angiotensin-converting enzyme 2:"/>
   <result pre="DuL.; YuF.; MaC.; YeS.; YuenK. Y.; ZhangR.; JiangS.Structure-based discovery of" exact="Middle East respiratory syndrome" post="coronavirus fusion inhibitor. Nat. Commun.2014, 5, 306710.1038/ncomms4067.24473083 ChannappanavarR.; LuL.;"/>
   <result pre="W.; QinC.; SunF.; ShiZ. L.; ZhuY.; JiangS. B.; LuL.Inhibition of" exact="SARS-CoV-2 infection" post="(previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor"/>
   <result pre="SunY.; ZhangH.; ShiJ.; ZhangZ.; GongR.Identification of a novel inhibitor against" exact="Middle East respiratory syndrome" post="coronavirus. Viruses2017, 9, 25510.3390/v9090255. XiaS.; XuW.; WangQ.; WangC.; HuaC.;"/>
   <result pre="WangZ.; YangB.; LiQ.; WenL.; ZhangR.Clinical features of 69 cases with" exact="coronavirus disease 2019" post="in Wuhan, China. Clin. Infect. Dis.2020, ciaa27210.1093/cid/ciaa272.32176772 BoschB. J.;"/>
   <result pre="L in the late endosome/lysosome and block the entry of" exact="Ebola" post="virus, Middle East respiratory syndrome coronavirus (MERS-CoV), and severe"/>
   <result pre="the late endosome/lysosome and block the entry of Ebola virus," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV)."/>
   <result pre="BasuA.; AbrahamP.; GangakhedkarR. R.; BhargavaB.Perspectives for repurposing drugs for the" exact="coronavirus disease 2019." post="Indian J. Med. Res.2020, 151, 160â€&quot;171. 10.4103/ijmr.IJMR_585_20.32317408 BlanchardE.; BelouzardS.;"/>
   <result pre="6, e2892310.1371/journal.pone.0028923.22205980 LiuQ.; XiaS.; SunZ.; WangQ.; DuL.; LuL.; JiangS.Testing of" exact="Middle East respiratory syndrome" post="coronavirus replication inhibitors for the ability to block viral"/>
   <result pre="are potent inhibitors of severe acute respiratory syndrome coronavirus and" exact="Middle East respiratory syndrome" post="coronavirus fusion. J. Virol.2016, 90, 8924â€&quot;8933. 10.1128/JVI.01429-16.27466418 DyallJ.; ColemanC."/>
   <result pre="and laboratory effects of convalescent plasma therapy for patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a study protocol. SpringerPlus2015, 4, 70910.1186/s40064-015-1490-9.26618098"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7315944\results\search\zoonosis\results.xml">
   <result pre=": Article Applications of machine learning and artificial intelligence for" exact="Covid-19" post="(SARS-CoV-2) pandemic: A review LalmuanawmaSamuelsamuellalmuanawma@mzu.edu.inaâ�ŽHussainJamalaChhakchhuakLalrinfelab[a], [b], â�ŽCorresponding author. samuellalmuanawma@mzu.edu.in"/>
   <result pre="to application of Machine Learning and Artificial Intelligent for tackling" exact="Covid-19" post="pandemic. â€¢Challenges on computational system with real world problem"/>
   <result pre="on model design, medical experts, and policymakers for tackling the" exact="Covid-19" post="pandemic and ahead. â€¢Targeting on treatment, medication, screening, prediction,"/>
   <result pre="screening, prediction, forecasting, contact tracing, and drug/vaccination process for the" exact="Covid-19" post="pandemic. Abstract Background and objective During the recent global"/>
   <result pre="searching for a new technology to support in tackling the" exact="Covid-19" post="pandemic. The evidence of Machine Learning (ML) and Artificial"/>
   <result pre="experts, and policymakers in the current situation while tackling the" exact="Covid-19" post="pandemic and ahead. Conclusion The ongoing development in AI"/>
   <result pre="prediction, forecasting, contact tracing, and drug/vaccine development process for the" exact="Covid-19" post="pandemic and reduce the human intervention in medical practice."/>
   <result pre="up to the mark to tackle the SARS-CoV-2 epidemic. Keywords" exact="Covid-19" post="Machine learning Artificial intelligence Pandemic 1 Introduction There are"/>
   <result pre="globe fight against these pandemics to date. Since the first" exact="Covid-19" post="(Coronavirus) disease case confirmed in China December 2019 Wuhan"/>
   <result pre="worldwide employed various ML and AI technology to tackle the" exact="Covid-19" post="pandemic to address the challenges during the outbreak. In"/>
   <result pre="are modeled for [5]. This paper focuses on the novel" exact="Covid-19" post="epidemic and how the modern AI and ML technology"/>
   <result pre="on the model and technology applied to tackle the novel" exact="Covid-19" post="pandemic. The studies further discuss types of AI and"/>
   <result pre="employing AI and ML on 1020 CT images of 108" exact="Covid-19" post="infected patients along with viral pneumonia of 86 patients,"/>
   <result pre="Cross-validataion Total of 253 samples from 169 patients suspected with" exact="Covid-19" post="collected from multiple sources. Clinical blood test of 49"/>
   <result pre="derived from commercial clinic center. 24 samples infected patient with" exact="Covid-19" post="Accuracy: 95.95% Specificity: 96.95% Recent studies design an auxiliary"/>
   <result pre="studies design an auxiliary tool to increase the accuracy of" exact="Covid-19" post="diagnosis with new model Automatic COVID-19 detection based on"/>
   <result pre="relevant indices which can assist as a discrimination tool of" exact="Covid-19" post="for healthcare expert toward rapid diagnosis [31]. The studies"/>
   <result pre="and manage people who are recently exposed to an infected" exact="Covid-19" post="patient to avoid further spread. Generally, the process identifies"/>
   <result pre="12 Germany CoronaApp Bluetooth, Google/Apple May, 2020 13 Ghana GH" exact="Covid-19" post="Tracker App GPS April 12, 2020 14 Hungary VÃ­rusRadar"/>
   <result pre="2020 17 Iran Mask.ir GSM May, 2020 18 Ireland HSE" exact="Covid-19" post="App Bluetooth, Google/Apple May, 2020 19 Israel HaMagen Standard"/>
   <result pre="2020 35 UAE TraceCovid Bluetooth May, 2020 36 UK NHS" exact="Covid-19" post="App Bluetooth May, 2020 Concerning contact tracing, studies have"/>
   <result pre="it becomes a global health emergency. To fight against the" exact="Covid-19" post="as one, one should provide a standard de-facto centralized"/>
   <result pre="forecast and predicting 1-3 to 6 days ahead of total" exact="Covid-19" post="patient of 10 Brazilian states, using stacking-ensemble with support"/>
   <result pre="stacking-ensemble with support vector regression algorithm on the cumulative positive" exact="Covid-19" post="cases of Brazilian data was proposed, thus augmenting the"/>
   <result pre="the highest rank of 90% accuracy in predicting and assessing" exact="Covid-19" post="patient into general, severe and mortality rate [39]. Furthermore,"/>
   <result pre="Neural Network on the eighty old drugs with potential for" exact="Covid-19" post="treatment, the study suggested eight drugs, i.e., vismodegib, gemcitabine,"/>
   <result pre="the need for an antiviral drug that can treat the" exact="Covid-19" post="virus [43]. The study compares the accessible virtual screening"/>
   <result pre="model employing a deep learning algorithm on 3C-like proteinase of" exact="Covid-19" post="and FDA approved 3,410 existing drugs available in the"/>
   <result pre="Antazanavir (Kd of 94.94 nM) is the best drug for" exact="Covid-19" post="medication, followed by Remdisivir (Kd of 113.13 nM). Furthermore,"/>
   <result pre="compounds like Kaletra might be utilized for the medicine of" exact="Covid-19" post="human patients. A group of researchers from the USA"/>
   <result pre="from the USA discovered an antiviral drug for treating the" exact="Ebola" post="virus. The discovery was first active in the year"/>
   <result pre="a limited size of in vitro infected carriers of the" exact="Ebola" post="virus. The study proposed an amodiaquine and chloroquine compound"/>
   <result pre="was proposed [45]. Researchers refer to the successful discovery of" exact="Ebola" post="[44], and the Zika virus [46] experience gain belief"/>
   <result pre="same model could be repeatedly utilized for drug discovery on" exact="Covid-19" post="and future virus pandemic ahead. The selected review paper"/>
   <result pre="in predicting the reusability of an existing old drug on" exact="Covid-19" post="medication and dramatically minimize the level of a risk"/>
   <result pre="&amp;amp; prediction, forecasting, contact tracing, and drug/vaccine development for the" exact="Covid-19" post="pandemic and reduce the human intervention in medical practice."/>
   <result pre="proposal and saliency analysisNeurocomputing267201722023110.1016/j.neucom.2017.06.004 13ColubriA.HartleyM.-A.SiakorM.WolfmanV.FelixA.SesayT.ShafferJ.G.GarryR.F.GrantD.S.LevineA.C.SabetiP.C.Machine-learning prognostic models from the 2014â€&quot;16" exact="Ebola" post="Outbreak: data-harmonization challenges, validation strategies, and mHealth applicationsEClinicalMedicine.201910.1016/j.eclinm.2019.06.003 14ChoiS.LeeJ.KangM.-G.MinH.ChangY.-S.YoonS.Large-scale"/>
   <result pre="Metab Syndr144202033733910.1016/j.dsx.2020.04.01232305024 27AiT.YangZ.HouH.ZhanC.ChenC.LvW.TaoQ.SunZ.XiaL.Correlation of chest CT and RT-PCR testing in" exact="coronavirus disease 2019" post="(COVID-19) in China: a report of 1014 cases.Radiology202010.1148/radiol.2020200642 28ArdakaniA.A.KanafiA.R.AcharyaU.R.KhademN.MohammadiA.Application"/>
   <result pre="the context of COVID-19. https://www.who.int/publications-detail/contact-tracing-in-the-context-of-covid-19 (accessed 29 May 2020). 34Wikipedia:" exact="Covid-19" post="apps, 2020. https://en.wikipedia.org/wiki/COVID-19_apps#Centralized_contact_tracing (Accessed 2 June 2020). 35MIT: Covid"/>
   <result pre="J18202078479010.1016/j.csbj.2020.03.02532280433 44EkinsS.FreundlichJ.CoffeeM.A common feature pharmacophore for FDA-approved drugs inhibiting the" exact="Ebola" post="virusF1000Research3201427725653841 45EkinsS.MottinM.RamosP.R.P.S.SousaB.K.P.NevesB.J.FoilD.H.ZornK.M.BragaR.C.CoffeeM.SouthanC.PuhlC.A.AndradeC.H.DÃ©jÃ vu: stimulating open drug discovery for SARS-CoV-2Drug"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7317260\results\search\zoonosis\results.xml">
   <result pre="more than 8000 individuals mainly in Asia [4], and the" exact="Middle East respiratory syndrome" post="(MERS), which in 2012 affected over 2000 people mainly"/>
   <result pre="Emerg Med202010.1007/s11739-020-02355-732385628 2.DengSQPengHJCharacteristics of and public health responses to the" exact="coronavirus disease 2019" post="outbreak in ChinaJ Clin Med202010.3390/jcm902057532093211 3.VioliFPastoriDPignatelliPCangemiRSARS-CoV-2 and myocardial injury:"/>
   <result pre="studyLancet Respir Med2020847548110.1016/S2213-2600(20)30079-532105632 7.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="Med Assoc202010.1001/jama.2020.2648 8.Istituto Superiore della SanitÃ (ISS) (2020) Characteristics of" exact="Covid-19" post="patients dying in Italy. 15 May 2020. https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019 9.MeshkaniRVakiliSTissue"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7318922\results\search\zoonosis\results.xml">
   <result pre="of diseases from the common cold to severe acute and" exact="Middle East respiratory syndrome" post="CoV epidemics. In 2019, a novel virus emerged from"/>
   <result pre="presented with severe atypical pneumonia, and experts named the illness" exact="coronavirus disease 2019" post="(COVID-19; European Centre for Disease Prevention and Control, 2020)."/>
   <result pre="between this SARS CoV-2 and the previous SARS CoV-1 and" exact="Middle East respiratory syndrome" post="(MERS) CoV epidemics. All three diseases originate from the"/>
   <result pre="a petechial rash who was given an original diagnosis of" exact="Dengue fever" post="that was later confirmed to be COVID-19 (Joob and"/>
   <result pre="Case report of petechial rash that can be mistaken for" exact="Dengue" post="Joob and Wiwanitkit, 2020 Drug reaction Drugs used to"/>
   <result pre="an investigational drug that was considered as a treatment for" exact="Ebola" post="but never approved by the U.S. Food and Drug"/>
   <result pre="Med197201875776729161116 AssiriA.Al-TawfiqJ.A.Al-RabeeahA.A.Al-RabiahF.A.Al-HajjarS.Al-BarrakA.Epidemiological, demographic, and clinical characteristics of 47 cases of" exact="Middle East respiratory syndrome" post="coronavirus disease from Saudi Arabia: a descriptive studyLancet Infect"/>
   <result pre="1]. Available from: https://www.genemedi.net/i/comparison-between-covid-19-and-sars-ncov-in-pathology-pathogenesis Centers for Disease Control and Prevention." exact="Coronavirus disease 2019" post="situation summary [Internet]. 2020a [cited 2020 March 1]. Available"/>
   <result pre="Control and Prevention. Interim guidance for ships on managing suspected" exact="coronavirus disease 2019" post="[Internet]. 2020b [cited 2020 March 13]. Available from: https://www.cdc.gov/quarantine/maritime/recommendations-for-ships.html"/>
   <result pre="13]. Available from: https://www.cdc.gov/quarantine/maritime/recommendations-for-ships.html Centers for Disease Control and Prevention." exact="Coronavirus disease 2019" post="(COVID-19) guidance for ships [Internet]. 2020c [cited 2020 March"/>
   <result pre="17]. Available from: https://www.cdc.gov/plague/symptoms/index.html Centers for Disease Control and Prevention." exact="Coronavirus disease 2019" post="(COVID19): Travel [Internet]. 2020f [cited 2020 April 11]. Available"/>
   <result pre="Engl J Med3822420202327233632275812 GrennanD.What is a pandemic?JAMA3219201991030835310 GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med3821820201708172032109013 GuanY.ZhengB.J.HeY.Q.LiuX.L.ZhuangZ.X.CheungC.L.Isolation and characterization of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7319607\results\search\zoonosis\results.xml">
   <result pre="beta CoVs and the apparent resistance of asthma patients to" exact="SARS-CoV-2 infection" post="due to inhaling medications containing EDTA excipients. Strategy for"/>
   <result pre="YG C Fl2 HCoV-229E/CoV-2 923 KRYGFC 928 GenBank: CAA71056.1 Fl2-CoV2/HA" exact="Influenza" post="No significant similarity found GenBank: AD177360.1 The results demonstrated"/>
   <result pre="but significant homology with the FL2 domain. In contrast, the" exact="Influenza" post="H1N1 hemagglutinin (HA) protein has no significant similarity to"/>
   <result pre="can be used to directly demonstrate that EDTA can inhibit" exact="SARS-CoV-2 infection" post="with relative safety based on prior studies of asthmatics"/>
   <result pre="chronic respiratory diseases or their treatment affect the risk of" exact="SARS-CoV-2 infection?" post="Lancet Respir Med.Â 2020 Apr 3. pii: S2213-2600(20)30167-3. 34Bhatraju"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7319644\results\search\zoonosis\results.xml">
   <result pre="[9], [10]]. In contrast to other viral infections, such as" exact="Ebola" post="and Influenza, SARS-CoV-2 has high infectious power and easy"/>
   <result pre="and respiratory failure caused by the virus [15]. Since 2012," exact="MERS-Cov" post="has spread to many countries in a wide geographic"/>
   <result pre="and 8b [8,44,45]. 5 Immune response to MERS-CoV, SARS-CoV and" exact="SARS-CoV-2 infection" post="One of the characteristics among SARS-CoV, MERS-CoV, and SARS-CoV-2"/>
   <result pre="T cells were found in a patient who recovered from" exact="SARS-CoV infection" post="within four years after the acute phase of the"/>
   <result pre="date are too preliminary to draw definitive conclusions regarding to" exact="SARS-CoV-2 infection." post="Recent studies have shown inconclusive pathways promoted by the"/>
   <result pre="both children died, while the remaining cases did not have" exact="SARS-CoV infection" post="[2,93]. In the United States, in 2003, a study"/>
   <result pre="healthy baby by emergency cesarean section [95]. Another case of" exact="MERS coronavirus" post="infection in a pregnant woman described in South Korea"/>
   <result pre="infected pregnant women to their fetuses. A case of neonatal" exact="SARS-CoV-2 infection" post="in China with pharyngeal swabs was reported with a"/>
   <result pre="mother to the baby the treatment strategy for children with" exact="Covid-19" post="is based on the adult experience. It is also"/>
   <result pre="with Vero E6 cells, CQ was effective to inhibit the" exact="SARS-CoV-2 infection" post="[123,124]. In addition 70 % of a patient group"/>
   <result pre="syndrome: a pathophysiological evaluationPathology383201621021810.1080/00313020600696280 4OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: a retrospective cohort studyLancet Infect Dis141120141090109510.1016/S1473-3099(14)70920-X25278221 5LaiC.C.ShihT.P.KoW.C.TangH.J.HsuehP.R.Severe"/>
   <result pre="and the challengesInt J Antimicrob Agents55202010592410.1016/j.ijantimicag.2020.105924 6PayneD.C.IblanI.AlqasrawiS.NsourM.A.RhaB.TohmeR.A.Stillbirth during infection with" exact="Middle East respiratory syndrome" post="coronavirusJ Infect Dis20920141870187210.1093/infdis/jiu068524474813 7MalikA.El MasryK.M.RaviM.SayedF.Middle east respiratory syndrome coronavirus"/>
   <result pre="respiratory syndrome)Available from:2003https://www.who.int/ith/diseases/sars/en/ 14WHOSARS outbreak contained worldwideAvailable from:2003https://www.who.int/mediacentre/news/releases/2003/pr56/en/ 15MullerM.A.MeyerB.CormanV.M.MasriM.A.TurkestaniA.RitzD.Presence of" exact="Middle East respiratory syndrome" post="coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological"/>
   <result pre="to the virus-encoded spike proteinMol Enzymol Drug Targets11201411010.21767/2572-5475.10001 18ChoiJ.KimMgOhYkKimYb.Progress of" exact="Middle East respiratory syndrome" post="coronavirus vaccines: a patent reviewExpert opinion on therapeutic patentes276201772173110.1080/13543776.2017.1281248"/>
   <result pre="the virus and development of rational therapyCurr Mol Med57200567769710.2174/15665240577464112416305493 39LiK.Wohlford-LenaneC.L.ChannappanavarR.ParkvvJ.E.EarnestJ.T.BairT.B.Mouse-adapted" exact="MERS coronavirus" post="causes lethal lung disease in human DPP4 knockin miceProc"/>
   <result pre="chest CT findingsAm J Roentgenol2034201478278710.2214/AJR.14.1302124918624 50ArabiY.M.HarthiA.HusseinJ.BouchamaA.JohaniS.HajeerA.H.Severe neurologic syndrome associated with" exact="Middle East respiratory syndrome" post="corona virus (MERS-CoV)Infection434201549550110.1007/s15010-015-0720-y25600929 51KoJ.H.ParkG.E.LeeJ.Y.LeeJ.Y.ChoS.Y.HaY.E.Predictive factors for pneumonia development and"/>
   <result pre="antivirals and important differences with SARS coronavirusMBio432013e001651310.1128/mBio.00165-1323631916 57ChuH.ZhouJ.WongB.H.Y.LiC.ChengZ.S.LinX.Productive repliC.aTion of" exact="Middle East respiratory syndrome" post="coronavirus in monocyte-derived dendritic cells modulates innate immune responseVirology454201419720510.1016/j.virol.2014.02.01824725946"/>
   <result pre="innate immune responseVirology454201419720510.1016/j.virol.2014.02.01824725946 58YingT.LiW.DimitrovD.S.Discovery of T-cell infection and apoptosis by" exact="Middle East respiratory syndrome" post="coronavirusJ Infect Dis2136201687787910.1093/infdis/jiv38126203059 59IshiiT.OhnumaK.MurakamiA.TakasawaN.KobayashiS.DanN.H.CD26-mediated signaling for T cell activation"/>
   <result pre="immunity and inflammationEmerg Microbes Infect2120131510.1038/emi.2013.58 63ParkW.B.RAPMPereraChoeP.G.LauE.H.Y.ChoiS.J.ChunJ.Y.Kinetics of serologic responses to" exact="MERS coronavirus" post="infection in humans, South KoreaEmerging Infect Dis21122015218610.3201/eid2112.15142126583829 64CormanV.M.AlbarrakA.M.OmraniA.S.AlbarrakA.M.FarahM.E.AlmasriM.Viral shedding"/>
   <result pre="Dis21122015218610.3201/eid2112.15142126583829 64CormanV.M.AlbarrakA.M.OmraniA.S.AlbarrakA.M.FarahM.E.AlmasriM.Viral shedding and antibody response in 37 patients with" exact="Middle East respiratory syndrome" post="coronavirus infectionClin Infect Dis624201647748310.1093/cid/civ95126565003 65AlshukairiA.N.KhalidI.K.AhmedW.A.DadaA.M.BayumiD.T.MÃ¡licaL.S.Antibody response and disease severity"/>
   <result pre="and Control (ECDC)Rapid risk assessment: severe respiratory disease associated with" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV)22nd update2018 80KongW.AgarwalP.P.Chest imaging apperance of COVID-19 infectionRadiol"/>
   <result pre="MERS-CoV infectionProc Natl Acad Sci1171220206771677610.1073/pnas.192208311732054787 112MulanguS.DaveyR.T.MbayaO.T.ProschanM.MukadiD.ManzoM.L.A randomized, controlled trial of" exact="Ebola" post="virus disease therapeuticsN Engl J Med3812420192293230310.1056/NEJMoa191099331774950 113KimS.H.ChangS.Y.SungM.ParkJ.H.BinK.H.LeeH.Extensive viable Middle"/>
   <result pre="of Ebola virus disease therapeuticsN Engl J Med3812420192293230310.1056/NEJMoa191099331774950 113KimS.H.ChangS.Y.SungM.ParkJ.H.BinK.H.LeeH.Extensive viable" exact="Middle East respiratory syndrome" post="(MERS) coronavirus contamination in air and surrounding environment in"/>
   <result pre="surrounding environment in MERS isolation wardsRev Infect Dis633201636336910.1093/cid/ciw239 114ArabiY.M.AsiriA.Y.AssiriA.M.JokhdarH.A.A.AlothmanA.BalkhyH.H.Treatment of" exact="Middle East respiratory syndrome" post="with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE trial):"/>
   <result pre="recursive two-stage group sequential randomized controlled trialTrials21120201810.1186/s13063-019-3846-x31898511 115MomattinH.ZumlaA.MemoshZ.A.Al-TawfiqJ.A.Therapeutic options for" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV)â€&quot;possible lessons from a systematic review of SARS-CoV"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother5820144875488410.1128/AAC.03011-1424841269 124CongY.HartB.J.GrossR.ZhouH.FriemanM.BollingerL.MERS-CoV pathogenesis"/>
   <result pre="autoimmune diseasesPediatr Rheumatol Online J72009910.1186/1546-0096-7-919439078 133Al-TawfiqJ.A.MemishZ.A.Update on therapeutic options for" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV)Expert Rev Anti Infect Ther153201726927510.1080/14787210.2017.127171227937060 134ChannappanavarR.FehrA.R.ZhengJ.Wohljord-LenaneC.AbrahanteJ.E.MackM.IFN-I response timing"/>
   <result pre="Infect Ther153201726927510.1080/14787210.2017.127171227937060 134ChannappanavarR.FehrA.R.ZhengJ.Wohljord-LenaneC.AbrahanteJ.E.MackM.IFN-I response timing relative to virus replication determines" exact="MERS coronavirus" post="infection outcomesJ Clin Invest1299201910.1172/JCI126363 135HabibA.M.G.AliM.A.E.ZouaouiB.R.TahaM.A.H.MohammedB.S.SaquibN.Clinical outcomes among hospital patients"/>
   <result pre="infection outcomesJ Clin Invest1299201910.1172/JCI126363 135HabibA.M.G.AliM.A.E.ZouaouiB.R.TahaM.A.H.MohammedB.S.SaquibN.Clinical outcomes among hospital patients with" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) infectionBMC Infect Dis19120191610.1186/s12879-019-4555-530606108 136LokugamageK.G.HageA.SchindewolfC.RajsbaumR.MenacheryV.SARS-CoV-2 sensitive to type"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7319650\results\search\zoonosis\results.xml">
   <result pre="and of high mortality in adults and old people. Since" exact="Covid-19" post="binds to ACE2 which is expressed in different cell"/>
   <result pre="It also inhibits the replication of other viruses, such as" exact="Ebola" post="and HIV-1 [69,80,81]. Azithromycin has been linked to an"/>
   <result pre="is confusing. Contrary, some authors indicate overexpression of ACE2 in" exact="SARS-CoV-2 infection" post="[86,87], which we could explain as a rebound effect"/>
   <result pre="using anti-RAAS or ACE inhibitors have a higher risk of" exact="SARS-CoV-2 infection" post="or that they have a higher cardiovascular risk. Furthermore,"/>
   <result pre="Some authors suggest the protective role of ace inhibitors against" exact="SARS-CoV-2 infection" post="as opposed to others. However, we still have doubts"/>
   <result pre="patients infected with SARS-CoV-2Cardiovasc. Res.30202010.1093/cvr/cvaa078March pii: cvaa078 4GuanW.J.ZhongN.S.Clinical characteristics of" exact="Covid-19" post="in ChinaReply. N Engl J Med.27202038210.1056/NEJMc2005203March pii: 10.1056/NEJMc2005203#sa5 5JinY.YangH.JiW.WuW.ChenS.ZhangW.DuanG.Virology,"/>
   <result pre="(10)20141493150210.1111/cmi.1234025131438 90RothwellC.LebretonA.Young NgC.LimJ.Y.LiuW.VasudevanS.LabowM.GuF.GaitherL.A.Cholesterol biosynthesis modulation regulates dengue viral replicationVirology389200981910.1016/j.virol.2009.03.02519419745 91FedsonD.S.RordamO.M.Treating" exact="Ebola" post="patients: aâ€™ bottom upâ€™ approach using generic statins and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7320698\results\search\zoonosis\results.xml">
   <result pre="treatment of Covid-19. Methods CP treatment was applied to 26" exact="Covid-19" post="patients in intensive care unit who had quantitative reverse"/>
   <result pre="Sars-Cov-2 infection. The collected CP (200cc) were applied to severe" exact="Covid-19" post="patients. Laboratory values of patients just before CP and"/>
   <result pre="before specific vaccines and treatments are developed. In early stage" exact="Covid-19" post="patients who do not need mechanical ventilation, CP treatment"/>
   <result pre="be a curative treatment option. Keywords Convalescent plasma Sars-Cov-2 infection" exact="Covid-19" post="Coronavirus Immun plasma 1 Introduction A pneumonia associated with"/>
   <result pre="syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China [1]. The" exact="SARS-CoV-2 infection" post="spread rapidly all over the world. As of June"/>
   <result pre="423.349 deaths [2]. There are currently no proven treatment for" exact="Coronavirus disease 2019" post="(Covid-19). There is no effective antiviral drug in the"/>
   <result pre="There is no effective antiviral drug in the treatment of" exact="Covid-19" post="disease. It is an urgent need to seek an"/>
   <result pre="the administration of antibodies collected from recently infected and recovered" exact="Covid-19" post="patients to Covid-19 patients for therapeutic purposes. CP was"/>
   <result pre="antibodies collected from recently infected and recovered Covid-19 patients to" exact="Covid-19" post="patients for therapeutic purposes. CP was used during the"/>
   <result pre="[4]. However, the benefit of CP treatment to mortality in" exact="Ebola" post="virus disease has not been showed [5]. Recently, CP"/>
   <result pre="as a effective and reliable treatment option in SARS-CoV-1 and" exact="Middle East respiratory syndrome" post="(MERS) epidemics [6]. Therefore, it suggested that the use"/>
   <result pre="and lopinavirâ€‰+â€‰ritonavirâ€‰+â€‰interferon-beta. There is widespread interest to CP from recovered" exact="Covid-19" post="patients as treatment. The United States Food and Drug"/>
   <result pre="time in the world after China in the treatment of" exact="Covid-19" post="disease. The purpose of this study was to share"/>
   <result pre="share our clinical experience with CP transfusion administered to severe" exact="Covid-19" post="patients. 2 Materials and methods 2.1 Study design CP"/>
   <result pre="methods 2.1 Study design CP treatment was applied to 26" exact="Covid-19" post="patients in intensive care unit who had quantitative reverse"/>
   <result pre="starting the procedure, PCR was confirmed to be negative for" exact="Covid-19" post="in both the swab and serum of the donor."/>
   <result pre="sterile combining set. The collected CPs were applied to severe" exact="Covid-19" post="patients. Laboratory values of patients just before CP and"/>
   <result pre="2020 under the number 2020/77. 2.2 Study population PCR positive" exact="Covid-19" post="patients who received CP treatment were included in the"/>
   <result pre="the study. Patients with no PCR positivity and strongly suspected" exact="Covid-19" post="disease were excluded from the study. In addition to"/>
   <result pre="and dead patients. pâ€‰ 3 Results A total of twenty-six" exact="Covid-19" post="patients (8 females and 18 males) with a mean"/>
   <result pre="who did not need mechanical ventilation died. Of the 26" exact="Covid-19" post="patients included in the study, 20 were alive and"/>
   <result pre="0,018 4 Discussion There is no specific therapeutic agent for" exact="Covid-19" post="disease. Treatment of the disease and prevention of its"/>
   <result pre="of the treatment options used in the current treatment of" exact="Covid-19" post="are hydroxychloroquine, lopinavir / ritonavir, azithromycin, favipiravir and Interleukin-6"/>
   <result pre="the use of passive antibody transfer is considered for treating" exact="Covid-19" post="patients. The FDA has approved the use of experimental"/>
   <result pre="use of experimental CP therapy in clinical trials and critical" exact="Covid-19" post="patients without other treatment options, and has published a"/>
   <result pre="Ahn et al. applied 200â€‰mL CP therapy to two serious" exact="Covid-19" post="patients aged 67 and 71, whose anti-SARS-CoV-2 IgG antibody"/>
   <result pre="1: 640) to the treatment of 10 critical patients with" exact="Covid-19" post="(age range 34â€&quot;78) after an average of 16.5 days"/>
   <result pre="a meta-analysis to investigate the effect of CP therapy on" exact="Covid-19" post="disease [7]. They identified the reliability of CP treatment."/>
   <result pre="al., added CP in addition to standard therapy in 103" exact="Covid-19" post="patients. The trial was conducted in open, multicentric randomized"/>
   <result pre="two groups [17]. Zhang et al. reported that 4 critical" exact="Covid-19" post="patients who received supportive therapy were cured with CP"/>
   <result pre="be confirmed by randomized studies [18]. In our trial, twenty-six" exact="Covid-19" post="patients had no severe adverse reactions after CP transfusion."/>
   <result pre="CP looks to be effective for a better follow of" exact="Covid-19" post="when administered in severe and critically ill patients and"/>
   <result pre="care unit hospitalization. We observed that all patients with early-stage" exact="Covid-19" post="who did not need mechanical ventilation improved with CP"/>
   <result pre="%) patients who needed mechanical ventilation died. In early stage" exact="Covid-19" post="patients who do not need mechanical ventilation, CP treatment"/>
   <result pre="References References 1ChenN.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet39510223202050751332007143 2WHOWHO coronavirus disease"/>
   <result pre="for COVID-19Lancet Infect Dis204202039840032113510 5Van GriensvenJ.Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in GuineaN Engl J Med37412016334226735992 6KoJ.-H.Challenges of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7320718\results\search\zoonosis\results.xml">
   <result pre="the health system already induced by the COVID-19 epidemic. Prevention" exact="Covid-19" post="Lockdown Emerging hazards Health system Prevention failure Â It"/>
   <result pre="May 2020)10.1016/S0140-6736(20)31035-7 10DraulansDâ€œFinally, a virus got meâ€�. Scientist who fought" exact="Ebola" post="and HIV reflects on facing death from COVID-19. Science202010.1126/science.abc7042"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7320840\results\search\zoonosis\results.xml">
   <result pre="Comprehensive Clinical Medicine2523-8973Springer International PublishingCham pmcid: 7320840373 doi: 10.1007/s42399-020-00373-2 :" exact="Covid-19" post="Novel Coronavirus (nCoV): a Bitter Old Enemy in a"/>
   <result pre="declaration of COVID-19 as a global pandemic. Abstract Currently, pandemic" exact="coronavirus disease 2019" post="(COVID-19) is the biggest threat to all human beings"/>
   <result pre="coronavirus Pandemic nCoV Pneumonia ACE2 Plasma therapy Introduction The novel" exact="coronavirus disease 2019" post="(COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)"/>
   <result pre="Organization named disease caused by a novel coronavirus (2019-nCoV) as" exact="coronavirus disease 2019" post="(COVID-19) [1, 2]. Initially, this was identified in three"/>
   <result pre="changes were seen in the blood coagulation of patients with" exact="SARS-CoV-2 infection." post="The coagulation function in patients with SARS-CoV-2 is significantly"/>
   <result pre="several clinical trials of hydroxychloroquine for prophylaxis or treatment of" exact="SARS-CoV-2 infection" post="are going on. Although its temporary use on patients"/>
   <result pre="outbreaks. Several clinical, genetic, and epidemiological features of nCoV resemble" exact="SARS-CoV infection." post="Hence, the research advancements on SARS-CoV treatment might help"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014;58:4875â€&quot;84."/>
   <result pre="Falzarano D, Bushmaker T, Feldmann F, Brining DL, et al." exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) causes transient lower respiratory tract infection in"/>
   <result pre="et al. Prominent changes in blood coagulation of patients with" exact="SARS-CoV-2 infection." post="Clin Chem Lab Med. 2020. 10.1515/cclm-2020-0188. 22.Li B, Yang"/>
   <result pre="Clin Res Cardiol. 2020a. 10.1007/s00392-020-01626-9. 23.WHO Situation Report â€&quot;51 (2020)" exact="Coronavirus disease 2019" post="(COVID-19). Available at:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 24.CucinottaDVanelliMWHO declares COVID-19 a pandemicActa Biomed20209115716032191675"/>
   <result pre="declares COVID-19 a pandemicActa Biomed20209115716032191675 25.WHO Situation Report âˆ’140 (2020)" exact="Coronavirus disease 2019" post="(COVID-19). Available https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200608-covid-19-sitrep-140.pdf?sfvrsn=2f310900_2 26.LukHKHLiXFungJLauSKPWooPCYMolecular epidemiology, evolution and phylogeny of"/>
   <result pre="J200623515816575522 45.ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751332007143 46.MackayIMArdenKEMERS coronavirus: diagnostics,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7321236\results\search\zoonosis\results.xml">
   <result pre="are ribavirin, a nucleoside analogue used for the treatment of" exact="Lassa fever" post="virus, influenza A and B and HCV [12]; telbivudine,"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov.20206162010.1038/s41421-020-0156-032194981 8.UBC, Apeiron Biologics to Trial Coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7323073\results\search\zoonosis\results.xml">
   <result pre="pregnant women.21 More recently, pregnant women were excluded from all" exact="Ebola" post="drug treatment and vaccine trials during the 2013 to"/>
   <result pre="print]): doi:10.1016/j.jinf.2020.02.028; Hantoushzadeh, S., et al., â€œMaternal Death Due to" exact="Covid-19" post="Disease,â€� American Journal of Obstetrics and Gynecology (2020 [epub"/>
   <result pre="of print]): doi:10.1016/j.ajog.2020.04.030. 5Hantoushzadeh et al., â€œMaternal Death Due to" exact="Covid-19" post="Disease.â€� 6Ibid. 7Ibid.; Liu et al., â€œClinical Manifestations and"/>
   <result pre="H., et al., â€œAntibodies in Infants Born to Mothers with" exact="Covid-19" post="Pneumonia,â€� Journal of the American Medical Association 323, no."/>
   <result pre="et al., â€œClinical Characteristics and Intrauterine Vertical Transmission Potential of" exact="Covid-19" post="Infection in Nine Pregnant Women: A Retrospective Review of"/>
   <result pre="Registration, https://clinicaltrials.gov/ct2/results?cond=COVID-19. 15collab: World Health Organization , â€œDraft Landscape of" exact="Covid-19" post="Candidate Vaccines,â€� June 6, 2020, https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines; The PREVENT Working"/>
   <result pre="al., â€œProtected to Death: Systematic Exclusion of Pregnant Women from" exact="Ebola" post="Virus Disease Trials,â€� Reproductive Health14 (2017): article 172. 23Healy,"/>
   <result pre="(That Should Have Been) Learned from Excluding Immunization with the" exact="Ebola" post="Vaccine during Pregnancy and Lactation,â€� Vaccines 6 (2008): article"/>
   <result pre="in the Emergency Department: A Single ED's Experience during the" exact="Covid-19" post="Pandemic,â€� Academic Emergency Medicine27 (2020): 375â€&quot;78.32320506 31Sanghavi, M., and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7323156\results\search\zoonosis\results.xml">
   <result pre="humoral response and provided greater protective effect against live H1N1" exact="influenza infection" post="in mice, thus demonstrating a biological link between proâ€�resolution"/>
   <result pre="a potential vaccine adjuvant (Kim et al.,Â 2018). A previous" exact="influenza infection" post="is known to increase the risk to a subsequent"/>
   <result pre="acid, acetate, appeared to account for the facilitating effects of" exact="influenza infection." post="Indeed, treatment with acetate reduced bacterial loads, lung pathology,"/>
   <result pre="funded by the National Institute of Science and Technology in" exact="Dengue" post="and hostâ€�microbial interactions, a programme grant (465425/2014â€�3) from FundaÃ§Ã£o"/>
   <result pre="H. M., Li, F., â€¦ Lim, L. H. K. (2016)." exact="Influenza" post="A virus enhances its propagation through the modulation of"/>
   <result pre="&amp;amp; Garcia, C. C. (2017). The inflammatory response triggered by" exact="Influenza" post="virus: A two edged sword. Inflammation Research, 66, 283â€&quot;302."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7323229\results\search\zoonosis\results.xml">
   <result pre="coronavirus, SARSâ€�CoVâ€�2, which results in a disease syndrome known as" exact="Coronavirus disease 2019" post="(COVIDâ€�19). This disease started as an outbreak in Wuhan,"/>
   <result pre="7.3% and 6.0% for diabetes and hypertension patients, respectively.6 2" exact="COVID 19" post="AND THE HEART: EPIDEMIOLOGY 2.1 Sex Men are at"/>
   <result pre="of COVIDâ€�19 and cardiac involvement Laboratory results for patients with" exact="COVID 19" post="exhibit elevated cardiac biomarkers. Mild elevation of cardiac troponin"/>
   <result pre="Several mechanisms may trigger or aggravate arrhythmias in subjects with" exact="COVID 19." post="Potential causes include electrolyte disturbance (mainly hypokalemia), adverse effects"/>
   <result pre="from intracoronary plaque rupture or obstruction in the setting of" exact="COVID 19" post="disease and it is likely low. Acute coronary events"/>
   <result pre="long term cardiovascular outcome for patients who have recovered from" exact="COVID 19" post="infection, However, the potential outcome may be similar to"/>
   <result pre="RNA polymerases and which was initially developed to treat the" exact="Ebola" post="virus has also shown good inâ€�vitro activity against the"/>
   <result pre="and heart muscle (which might explain the cardiac manifestations of" exact="COVID19" post="disease). The involvement of the RAAS system in viral"/>
   <result pre="Lancet. 2020;395:1054â€�1062.32171076 3GuanWâ€�J, NiZâ€�Y, HuY, et al. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. 2020;382:1708â€�1720.32109013 4NguyenJL, YangW,"/>
   <result pre="ShahPJ, KorimilliV, WinH. Frequency of troponin elevations in patients with" exact="influenza infection" post="during the 2017â€&quot;2018 influenza season. Int J Cardiol Hear"/>
   <result pre="9BialekS, BoundyE, BowenV, et al. Severe outcomes among patients with" exact="coronavirus disease 2019" post="(COVIDâ€�19) â€� United States. Morb Mortal Wkly Rep. 2020;69(12):343â€�346."/>
   <result pre="heart. Circ Res. 2020;126(10):1443â€�1455.32252591 14TanW, AboulhosnJ. The cardiovascular burden of" exact="coronavirus disease 2019" post="(COVIDâ€�19) with a focus on congenital heart disease. Int"/>
   <result pre="coronavirus (SARSâ€�CoV2). Science (80â€�). 2020;368:489â€�493. 24ClerkinKJ, FriedJA, RaikhelkarJ, et al." exact="Coronavirus disease 2019" post="(COVIDâ€�19) and cardiovascular disease. Circulation. 2020;141(20):1648â€�1655.32200663 25TamCâ€�CF, CheungKâ€�S, LamS,"/>
   <result pre="et al. Review of emerging pharmacotherapy for the treatment of" exact="coronavirus disease 2019." post="Pharmacotherapy. 2020;40(5):416â€�437.32259313 27AggarwalG, LippiG, MichaelHB. Cerebrovascular disease is associated"/>
   <result pre="is associated with an increased disease severity in patients with" exact="coronavirus disease 2019" post="(COVIDâ€�19): a pooled analysis of published literature. Int J"/>
   <result pre="cardiac angiotensinâ€�converting enzyme 2. Circulation. 2005;111(20):2605â€�2610.15897343 36JunyiG, ZhengH, LiL, JiagaoL." exact="Coronavirus disease 2019" post="(COVIDâ€�19) and cardiovascular disease: a viewpoint on the potential"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7323662\results\search\zoonosis\results.xml">
   <result pre="such a global situation could be prolonged or repeated. Keywords" exact="Covid-19" post="Pandemic Mental disorder Adolescent Post-traumatic stress disorder Depression 1"/>
   <result pre="M. (n.d.). An increasing risk of family violence during the" exact="Covid-19" post="pandemic: Strengthening community collaborations to save lives. Forensic Science"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7325419\results\search\zoonosis\results.xml">
   <result pre="main pathogens transmitted in the Americas. Vector Pathogen References Aedes" exact="Dengue" post="vÃ­rus (6) Yellow fever vÃ­rus* (7) Chikungunya vÃ­rus (8)"/>
   <result pre="in Figure 1. Figure 1 Origin of arboviral genotype of" exact="Dengue" post="(DENV), Chikungunya (CHIKV), Zika (ZIKV), Yellow Fever (YFV), Mayaro"/>
   <result pre="rationale. One example is the use of subunit vaccines against" exact="Dengue" post="in which nanocarrier platforms are added to recombinant immunogenic"/>
   <result pre="and challenged with a virulent DENV3 strain. Briefly, the recombinant" exact="Dengue" post="serotype 3 Envelope protein was produced in E. coli,"/>
   <result pre="strategies currently under development. Viruses. (2011) 3:800â€&quot;14. 10.3390/v310180022069516 71.del AngelRMReyes-DelJ." exact="Dengue" post="vaccines: strongly sought but not a reality just yet."/>
   <result pre="a reality just yet. PLoS Pathog. (2013) 9:e1003551. 10.1371/journal.ppat.100355124098108 72.McArthurMASzteinMBEdelmanR." exact="Dengue" post="vaccines: recent developments, ongoing challenges and current candidates. Expert"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7326413\results\search\zoonosis\results.xml">
   <result pre="low socioeconomic status and its relationship to immune response in" exact="Covid-19" post="pandemic context Mattos dos SantosRodrigo1[], 1UNIPEX - LaboratÃ³rio de"/>
   <result pre="long as the COVID-19 resource centre remains active. Abstract The" exact="coronavirus disease 2019" post="(COVID-19) outbreak was first reported December 2019, in Wuhan,"/>
   <result pre="be biologically observed. This condition tends to remain during the" exact="Covid-19" post="pandemic. Social disruption stress (SDR) raises important questions regarding"/>
   <result pre="studies for a better understanding of these characteristics. Highlights â€¢The" exact="coronavirus disease 2019" post="(COVID-19) outbreak has spread worldwide. â€¢Community mitigation guidelines, such"/>
   <result pre="be activated due to social isolation and socioeconomic status. Keywords" exact="Covid-19" post="Conserved transcriptional response to adversity (CTRA) Sociogenomics Social disruption"/>
   <result pre="(CTRA) Sociogenomics Social disruption stress Stress hormones Immune response 1" exact="Covid-19" post="pandemic and mitigation guidelines The coronavirus disease 2019 (Covid-19)"/>
   <result pre="hormones Immune response 1 Covid-19 pandemic and mitigation guidelines The" exact="coronavirus disease 2019" post="(Covid-19) outbreak caused by the novel coronavirus SARS-CoV-2 was"/>
   <result pre="is to point out questions about the effects of the" exact="Covid-19" post="pandemic in conditions such as isolation and low socioeconomic"/>
   <result pre="Abelson etÂ al., 2010). Thus, in this context of a" exact="Covid-19" post="pandemic, social disruption stress (SDR) raises important questions regarding"/>
   <result pre="and social distancing are necessary and a recommendation during the" exact="Covid-19" post="pandemic, but may increase the loneliness levels, what may"/>
   <result pre="with disease and mortality, what tends to remain during the" exact="Covid-19" post="pandemic (Khalatbari-Soltani etÂ al., 2020). Taken together, this data"/>
   <result pre="non-pharmaceutical interventions, including social distancing have substantially reduced transmissibility of" exact="Covid-19" post="across the country. However, a second wave of Covid-19"/>
   <result pre="of Covid-19 across the country. However, a second wave of" exact="Covid-19" post="transmission is possible because of viral reintroduction, which has"/>
   <result pre="labour, resources, and facilities to minimise the mortality risk of" exact="Covid-19" post="(Xu and Li, 2020). Particularly, in this pandemic period,"/>
   <result pre="etÂ al., 2019; MaÃ±as etÂ al., 2010). 4 Conclusion The" exact="Covid-19" post="pandemic and interventions to mitigate the transmission of the"/>
   <result pre="these conditions in patients infected or susceptible to contamination by" exact="Covid-19" post="to provide support to government officials, health agents and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7326430\results\search\zoonosis\results.xml">
   <result pre="for years, decades or even indefinitely. Keywords Coronavirus COVID SARS2" exact="Severe acute respiratory syndrome" post="coronavirus 2 SARS-CoV-2 Model Epidemiology Outbreak Zoonosis Emerging infection"/>
   <result pre="al., 2019). It is also encouraging that viral outbreaks of" exact="Ebola" post="in 2014 and 2018, Severe Acute Respiratory Syndrome in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7326458\results\search\zoonosis\results.xml">
   <result pre="five patients, because of ALT elevation and/or renal failure. Abstract" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) has been identified as the virus"/>
   <result pre="(SARS-CoV-2) has been identified as the virus responsible for the" exact="coronavirus disease 2019" post="(COVID-19) outbreak worldwide. Data on treatment are scare and"/>
   <result pre="syndrome coronavirus 2 (SARS-CoV-2) was identified as responsible for the" exact="coronavirus disease 2019" post="(COVID-19) outbreak that started in China (Zhu et al.,"/>
   <result pre="options investigated during previous severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS) epidemics, both caused by other viruses of the"/>
   <result pre="could have been related either to remdesivir or to the" exact="SARS-CoV-2 infection." post="None of these patients received immunomodulatory drugs. Grein et"/>
   <result pre="they have no competing interests. References References ArabiY.M.AsiriA.Y.AssiriA.M.Aziz JokhdarH.A.AlothmanA.BalkhyH.H.Treatment of" exact="Middle East respiratory syndrome" post="with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE trial):"/>
   <result pre="the United StatesN Engl J Med38210202092993632004427 KujawskiS.A.WongK.K.CollinsJ.P.EpsteinL.KillerbyM.E.MidgleyC.M.First 12 patients with" exact="coronavirus disease 2019" post="(COVID-19) in the United StatesmedRxivJanuary20202020.03.09.20032896 LescureF.-X.BouadmaL.NguyenD.PariseyM.WickyP.-H.BehillilS.Clinical and virological data"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7328712\results\search\zoonosis\results.xml">
   <result pre="in Context1745-19811740-4398BioExcel Publishing Ltd pmcid: 7328712 doi: 10.7573/dic.2020-4-15dic-2020-4-15 : Review" exact="Coronavirus disease 2019" post="(COVID-19): latest developments in potential treatments HonKam LunMBBS, MD1LeungKaren"/>
   <result pre="by SARS-CoV spread globally. In the summer of 2012, the" exact="Middle East respiratory syndrome" post="(MERS) outbreak caused by MERS-CoV occurred in Saudi Arabia."/>
   <result pre="occurred in Saudi Arabia. In the winter of 2019, the" exact="coronavirus disease 2019" post="(COVID-19) outbreak caused by a novel coronavirus SARS-CoV-2 occurred"/>
   <result pre="by a new coronavirus. The WHO named this respiratory disease" exact="Middle East respiratory syndrome" post="also known by the acronym MERS and called the"/>
   <result pre="due to similarities to SARS-CoV, and the disease was called" exact="coronavirus disease 2019" post="(COVID-19). SARS-CoV-2 is a newly emergent coronavirus closely related"/>
   <result pre="it is unknown if newborns and patients already recovered from" exact="Covid-19" post="will need to be vaccinated. It is also uncertain"/>
   <result pre="of the history of treatments for coronavirus outbreaks SARS 2003" exact="Severe acute respiratory syndrome" post="is a viral respiratory disease of zoonotic origin caused"/>
   <result pre="epidemic, but no effective vaccine has since emerged. MERS 2012" exact="Middle East respiratory syndrome" post="caused by MERS-CoV may have been transmitted to humans"/>
   <result pre="and was developed by Gilead Science in response to the" exact="Ebola" post="outbreak in 2017.42â€&quot;44 It is considered to be one"/>
   <result pre="lopinavirâ€&quot;ritonavir treatment has little benefit as a standalone therapy against" exact="SARS-CoV-2 infection." post="In a clinical trial involving 199 patients with laboratory-confirmed"/>
   <result pre="infection. In a clinical trial involving 199 patients with laboratory-confirmed" exact="SARS-CoV-2 infection," post="lopinavirâ€&quot;ritonavir treatment was not associated with any clinical improvements"/>
   <result pre="A trial in China involving more than 100 patients with" exact="Covid-19" post="showed that chloroquine was better able to inhibit exacerbation"/>
   <result pre="often overlooked and therefore go undiagnosed. Comparing the immunopathology of" exact="SARS-CoV-2 infection" post="between children and adults could reveal the pathology of"/>
   <result pre="Respiratory Syndrome Coronavirus (MERS-CoV)Travel Med Infect Dis20193091810.1016/j.tmaid.2019.06.01231252170 16ArabiYMAsiriAYAssiriAMet al.Treatment of" exact="Middle East respiratory syndrome" post="with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE trial):"/>
   <result pre="pneumonia (standard version)Mil Med Res20207110.1186/s40779-020-0233-6 41PhuaJWengLLingLet al.Intensive care management of" exact="coronavirus disease 2019" post="(COVID-19 ): challenges and recommendationsLancet Respir202020192011210.1016/S2213-2600(20)30161-2 42GreinJOhmagariNShinDet al.Compassionate use"/>
   <result pre="with SARS in the Greater Toronto areaJAMA200328921280110.1001/jama.289.21.JOC3088512734147 64SandersJMMonogueMLJodlowskiTZCutrellJBPharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a reviewJama2020323181824183610.1001/jama.2020.6019 65FalzaranoDde WitEMartellaroCCallisonJMunsterVJFeldmannHInhibition of novel Î² coronavirus"/>
   <result pre="al.Reduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVID-19)medRxiv2202010.1101/2020.02.18.20024364 92XuXHanMLiTet al.Effective treatment of severe COVID-19 patients with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7331074\results\search\zoonosis\results.xml">
   <result pre="LinE.; LinY.-L.Blocking of the alpha interferon-induced Jak-Stat signaling pathway by" exact="Japanese encephalitis" post="virus infection. J. Virol.2004, 78, 9285â€&quot;9294. 10.1128/jvi.78.17.9285-9294.2004.15308723 PalmaJ. P.;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7331567\results\search\zoonosis\results.xml">
   <result pre="2020 novel coronavirus epidemic in ChinaJ Autoimmun109202010243410.1016/j.jaut.2020.102434 7GuanW.NiZ.HuY.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med3821820201708172010.1056/NEJMoa200203232109013 8LauH.KhosrawipourV.KocbachP.The positive impact of"/>
   <result pre="SARS coronavirus infection among healthcare workers, SingaporeEmerg Infect Dis11720051142114510.3201/eid1107.04116516022801 18Al-TawfiqJ.A.GautretP.Asymptomatic" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) infection: extent and implications for infection control:"/>
   <result pre="the important residues involved in the dimerization and catalysis of" exact="MERS coronavirus" post="main proteasePLoS ONE10122015e014486510.1371/journal.pone.0144865 72PillaiyarT.ManickamM.NamasivayamV.HayashiY.JungS.-H.An overview of severe acute respiratory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7332457\results\search\zoonosis\results.xml">
   <result pre="several human diseases, including severe acute respiratory syndrome. The global" exact="coronavirus disease 2019" post="(COVID-19) pandemic has become a huge threat to humans."/>
   <result pre="the zoonotic severe acute respiratory syndrome coronavirus (SARS-CoV) and the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) cause severe respiratory diseases and are associated"/>
   <result pre="In late 2019, a new infectious respiratory disease (now termed" exact="coronavirus disease 2019" post="[COVID-19]) emerged in Wuhan, China (Wang etÂ al., 2020a;"/>
   <result pre="substantial mortality rate (Chen etÂ al., 2020). ARDS during a" exact="SARS-CoV-2 infection" post="is also associated with dysregulation of cytokine production, barrier"/>
   <result pre="al., 2020; Mao etÂ al., 2020; Sultan etÂ al., 2020)." exact="SARS-CoV-2 infection" post="triggers an inflammatory response in the gut, as evidenced"/>
   <result pre="reduced expression and impaired function of this protein during a" exact="SARS-CoV infection" post="might substantially contribute to local disorders and pathogenesis. It"/>
   <result pre="modulate gastrointestinal disorders, including gut dysbiosis, in the context of" exact="SARS-CoV-2 infection." post="Along with inflammation and dysfunction of ACE2, other mechanisms"/>
   <result pre="that this may play a role in gastrointestinal disorders during" exact="SARS-CoV-2 infection." post="It is possible that the enteric nervous system could"/>
   <result pre="gut microbiota. Recent pilot studies suggest gut microbiota alterations during" exact="SARS-CoV-2 infection" post="(Yu etÂ al., 2020; Gu etÂ al., 2020b; Zuo"/>
   <result pre="that resiliency is long lasting (Zuo etÂ al., 2020). Hence," exact="SARS-CoV-2 infection" post="modifies the composition of the gut microbiota in humans."/>
   <result pre="after discovery to delineate the role of microbiome changes in" exact="SARS-CoV-2 infection" post="and post-infection recovery. It will be critical to consider"/>
   <result pre="and the comorbidity status of those patients. The consequences of" exact="SARS-CoV-2 infection" post="on the gut microbiota should also be investigated in"/>
   <result pre="of SCFA-promoting high-fiber diets and/or probiotics on the outcome of" exact="SARS-CoV-2 infection." post="Patients with respiratory infections generally have gut-dysfunction-related complications that"/>
   <result pre="in COVID-19 is still an open question. Evidence suggests that" exact="SARS-CoV-2 infection" post="alters the gut-blood barrier and thus leads to systemic"/>
   <result pre="al., 2020). This might affect the hostâ€™s initial response to" exact="SARS-CoV-2 infection" post="and might then contribute to multisystem dysfunction, septic shock,"/>
   <result pre="the systemic inflammation storm seen in the second phase of" exact="SARS-CoV-2 infection," post="which typically result in death (Guan etÂ al., 2020;"/>
   <result pre="changes in microbial profiles, and intestinal inflammation and leakiness during" exact="SARS-CoV infection" post="strongly amplify systemic pathways in comorbid individuals and exacerbate"/>
   <result pre="comorbid individuals and exacerbate underlying pathologies (e.g., diabetes and hypertension)." exact="SARS-CoV-2 infection" post="may also deteriorate the course of human inflammatory bowel"/>
   <result pre="diseases (Effenberger etÂ al., 2020). The mortality rate associated with" exact="SARS-CoV-2 infection" post="is higher in older adults, who also tend to"/>
   <result pre="be a therapeutic option. Concluding Remarks The complex pathogenesis of" exact="SARS-CoV-2 infection" post="is only starting to be deciphered. Along with the"/>
   <result pre="actively explored. In particular, several lines of evidence suggest that" exact="SARS-CoV-2 infection" post="is associated with alteration of the gut microbiota. It"/>
   <result pre="and moderate coronavirus disease 2019J.Â Clin. Invest.13020202620262932217835 CheungK.S.HungI.F.N.ChanP.P.Y.LungK.C.TsoE.LiuR.NgY.Y.ChuM.Y.ChungT.W.H.TamA.R.Gastrointestinal manifestations of" exact="SARS-CoV-2 infection" post="and virus load in fecal samples from a Hong"/>
   <result pre="by a clinically proven protease inhibitorCell1812020271280.e832142651 HonceR.Schultz-CherryS.Impact of obesity on" exact="Influenza" post="A Virus pathogenesis, immune response, and evolutionFront. Immunol.1020191071108431134099 HuangC.WangY.LiX.RenL.ZhaoJ.HuY.ZhangL.FanG.XuJ.GuX.Clinical"/>
   <result pre="Physiol.23420192277229530191985 ReddW.D.ZhouJ.C.HathornK.E.McCartyT.R.BazarbashiA.N.ThompsonC.C.ShenL.ChanW.W.Prevalence and characteristics of gastrointestinal symptoms in patients with" exact="SARS-CoV-2 infection" post="in the United States: A multicenter cohort studyGastroenterology202010.1053/j.gastro.2020.04.045Published online"/>
   <result pre="with COVID-19Gastroenterology202010.1053/j.gastro.2020.05.001Published online May 11, 2020 SunS.-H.ChenQ.GuH.-J.YangG.WangY.-X.HuangX.-Y.LiuS.-S.ZhangN.-N.LiX.-F.XiongR.A mouse model of" exact="SARS-CoV-2 infection" post="and pathogenesisCell Host Microbe202010.1016/j.chom.2020.05.020Published online May 27, 2020 SungnakW.HuangN.BÃ©cavinC.BergM.QueenR.LitvinukovaM.Talavera-LÃ³pezC.MaatzH.ReichartD.SampaziotisF.collab:"/>
   <result pre="in Wuhan, ChinaJAMA323202010611069 WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="Coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="subtype of coronavirus disease 2019medRxiv202010.1101/2020.03.03.20030650 ZangR.Gomez CastroM.F.McCuneB.T.ZengQ.RothlaufP.W.SonnekN.M.LiuZ.BruloisK.F.WangX.GreenbergH.B.TMPRSS2 and TMPRSS4 promote" exact="SARS-CoV-2 infection" post="of human small intestinal enterocytesSci. Immunol.52020eabc358232404436 ZhangW.DuR.H.LiB.ZhengX.S.YangX.L.HuB.WangY.Y.XiaoG.F.YanB.ShiZ.L.ZhouP.Molecular and serological"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7332875\results\search\zoonosis\results.xml">
   <result pre="T cell epitopes elevated humoral and cellular immune responses against" exact="SARS-CoV infection." post="Vaccine, 26(13), 1644â€&quot;1651. 10.1016/j.vaccine.2008.01.02518289745 ElfikyA. A. (2020a). Natural products"/>
   <result pre="Journal of Medicine, 382(8), 727â€&quot;733. 10.1056/NEJMoa200101731978945 Abbreviations CoV coronavirus COVID-19" exact="coronavirus disease 2019" post="FDA food and drug administration HB hydrogen bond HTVS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7332877\results\search\zoonosis\results.xml">
   <result pre="were similar to influenza, and both viruses cause respiratory issues." exact="Influenza" post="is a communicable disease caused by the influenza virus."/>
   <result pre="can be considered as a standard treatment to combat the" exact="SARS-CoV-2 infection" post="(Cai etÂ al., 2020). Further, a randomized controlled trial"/>
   <result pre="2019-nCoV. According to WHO, the recommended administration of Remdesivir for" exact="Ebola" post="virus (EBOV) in single or multiple-dose phase intravenous between"/>
   <result pre="GregoryV., DouglasA. R., &amp;amp; LinY. P. (2001). The evolution of" exact="human influenza" post="viruses. Philosophical Transactions of the Royal Society of London."/>
   <result pre="of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of" exact="Ebola" post="and emerging viruses. Journal of Medicinal Chemistry, 60(5), 1648â€&quot;1661."/>
   <result pre="Y., PorterD. P., &amp;amp; GotteM. (2019). Mechanism of inhibition of" exact="Ebola" post="virus RNA-dependent RNA polymerase by remdesivir. Viruses, 11(4), 32610.3390/v11040326"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7332961\results\search\zoonosis\results.xml">
   <result pre="an agent of public health burden. In South America, where" exact="Dengue" post="virus is endemic and Zika virus was recently introduced,"/>
   <result pre="an already well-established mechanism for other enveloped viruses, such as" exact="Ebola" post="virus (EBOV), and non-enveloped viruses, such as adenoviruses; the"/>
   <result pre="the epidemic of Zika virus, and the ongoing outbreaks of" exact="Dengue" post="virus. Co-infections may promote the onset of serious illness,"/>
   <result pre="of antiviral responses.J. Mol. Biol.4261148â€&quot;1160. 10.1016/j.jmb.2013.11.02324316047 HalsteadS. B.UdomsakdiS.ScanlonJ. E.RohitayodhinS. (1969)." exact="Dengue" post="and chikungunya virus infection in man in Thailand, 1962-1964."/>
   <result pre="A.Silva-CasoW.WeilgP.VÃ¡squez-AchayaF.et al. (2018). Identification of infection by Chikungunya, Zika, and" exact="Dengue" post="in an area of the Peruvian coast. Molecular diagnosis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7333627\results\search\zoonosis\results.xml">
   <result pre="long as the COVID-19 resource centre remains active. Dear Editor," exact="Coronavirus disease 2019" post="(COVID-19) pandemic is causing huge impacts on health and"/>
   <result pre="24 2020]. 5TsangK.ZhongN.S.SARS: pharmacotherapyRespirology82003S25S3015018130 6RabaanA.A.AlahmedS.H.BazziA.M.AlhaniH.MA review of candidate therapies for" exact="Middle East respiratory syndrome" post="from a molecular perspectiveJ Med Microbiol6620171261127428855003 7ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical"/>
   <result pre="Med Microbiol6620171261127428855003 7ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 8ZhouF.YuT.DuR.FanG.LiuY.LiuZ.Clinical course and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7334131\results\search\zoonosis\results.xml">
   <result pre="Comprehensive Clinical Medicine2523-8973Springer International PublishingCham pmcid: 7334131388 doi: 10.1007/s42399-020-00388-9 :" exact="Covid-19" post="Multiple Acute Ischemic Strokes in a COVID-19 Patient: a"/>
   <result pre="anti-inflammatory drugs with supportive care. Seven days after admission to" exact="Covid-19" post="Unit, the patient rapidly developed worsening respiratory failure and"/>
   <result pre="from COVID-19, developed multiple strokes, and died 1Â day later." exact="SARS-CoV-2 infection" post="seems to predispose pluripathological subjects to cerebrovascular complications. Keywords"/>
   <result pre="care from March 20, 2020. Seven days after admission to" exact="Covid-19" post="Unit, the patient rapidly developed worsening respiratory failure and"/>
   <result pre="patients were older and had multiple risk factors, more severe" exact="SARS-CoV-2 infection," post="and inflammatory response in the state of blood hypercoagulable."/>
   <result pre="at higher risk as in our case. The association between" exact="Covid-19" post="and stroke might be coincidental, but large artery stroke"/>
   <result pre="patients with SARS in Singapore [8]. Nevertheless, several critically ill" exact="Covid-19" post="patients treated at our hospital also had venous thromboembolism"/>
   <result pre="strokes suggests that a pro-coagulant state could be present in" exact="Covid-19" post="patients. Other viral infections, such as varicella zoster [9],"/>
   <result pre="strokes. Although we cannot be certain of the contribution of" exact="Covid-19" post="to the development of stroke, we believe our experience"/>
   <result pre="stroke. This article is part of the Topical Collection on" exact="Covid-19" post="We dedicate this case report to our colleagues who"/>
   <result pre="IP, et al. Large-vessel stroke as a presenting feature of" exact="Covid-19" post="in the young. N Engl J Med This case"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7334951\results\search\zoonosis\results.xml">
   <result pre="paid to IFN-I treatment in patients with severe COVID-19. Abstract" exact="Coronavirus disease 2019" post="(COVID-19) first emerged in late 2019 in China. At"/>
   <result pre="Beta Interferon 1 Introduction The rapid and devastating outbreak of" exact="Coronavirus disease 2019" post="(COVID-19) pandemic and the lack of approved treatments for"/>
   <result pre="of the IFN-I system and the dysregulated IFN-I response in" exact="SARS-CoV-2 infection" post="point to the need of a fine-tuning of route,"/>
   <result pre="pathogenic mechanisms intervening in early stage versus late stage of" exact="SARS-CoV-2 infection" post="(reviewed in [17]) and to the role of comorbidities"/>
   <result pre="of disease and fatal outcomes in MERS patients [26]. Likewise," exact="SARS-CoV-2 infection" post="(either in cell lines, primary cell cultures, ferrets, and"/>
   <result pre="results are in line with data on mouse model of" exact="SARS-CoV infection," post="where a robust viral replication associated with delayed IFN-I"/>
   <result pre="disease [32]. In conclusion, in comparison to other respiratory viruses," exact="SARS-CoV-2 infection" post="drives a lower antiviral transcriptional response that is marked"/>
   <result pre="systemic effects potentially protective in the very early phases of" exact="SARS-CoV-2 infection." post="Several clinical trials using inhaled IFN-Î± either as monotherapy"/>
   <result pre="intranasal administration of IFN-Î± to medical staff at risk of" exact="SARS-CoV-2 infection" post="results in complete protection [61]. Since the beneficial effects"/>
   <result pre="stimulus, further studies are needed to confirm IFN-I efficacy against" exact="SARS-CoV-2 infection" post="and to better characterize the biological activities, the mechanisms"/>
   <result pre="urgent need to identify antiviral agents immediately available to combat" exact="SARS-CoV-2 infection." post="As shown in Table 1 , among the many"/>
   <result pre="at least in part, responsible for the spontaneous resolution of" exact="SARS-CoV-2 infection" post="in the majority of infected patients (estimated around 80"/>
   <result pre="role of the endogenous IFN-I signaling in the susceptibility to" exact="SARS-CoV-2 infection" post="and in the progression to the severe forms of"/>
   <result pre="type I interferon activity and exacerbated inflammatory responses in severe" exact="Covid-19" post="patientsMedRxiv.202010.1101/2020.04.19.20068015 28Trouillet-AssantS.VielS.GaymardA.PonsS.RichardJ.-C.PerretM.VillardM.Brengel-PesceK.LinaB.MezidiM.BitkerL.BelotA.MoutonW.OriolG.CompagnonC.GenerenazL.CheynetV.AderF.BeckerA.BenechN.ChauvelotP.ChidiacC.ConradA.FerryT.MiailhesP.PerpointT.PerryM.PouderouxC.RouxS.Triffault-FillitC.ValourF.HodaneY.ChauvelotL.ChabertP.ProvoostJ.DavidG.FollietL.LecamP.BillaudG.BouscambertM.EscuretV.FrobertE.BalA.DestrasG.JossetL.MorfinF.MunierC.ValetteM.VenetF.GarnierL.PescarmonaR.LombardC.WalzerT.Type I IFN immunoprofiling in COVID-19 patientsJ. Allergy"/>
   <result pre="Host Microbe19201618119310.1016/j.chom.2016.01.00726867177 32ChannappanavarR.FehrA.R.ZhengJ.Wohlford-LenaneC.AbrahanteJ.E.MackM.SompallaeR.McCrayP.B.MeyerholzD.K.PerlmanS.IFN-I response timing relative to virus replication determines" exact="MERS coronavirus" post="infection outcomesJ. Clin. Invest.12920193625363910.1172/JCI12636331355779 33Blanco-MeloD.Nilsson-PayantB.E.LiuW.C.UhlS.HoaglandD.MÃ¸llerR.JordanT.X.OishiK.PanisM.SachsD.WangT.T.SchwartzR.E.LimJ.K.AlbrechtR.A.B.R. tenOever, imbalanced host response"/>
   <result pre="49ArabiY.M.AsiriA.Y.AssiriA.M.Aziz JokhdarH.A.AlothmanA.BalkhyH.H.AlJohaniS.Al HarbiS.KojanS.Al JeraisyM.DeebA.M.MemishZ.A.GhazalS.Al FarajS.Al-HameedF.AlSaediA.MandourahY.Al MekhlafiG.A.SherbeeniN.M.ElzeinF.E.AlmotairiA.Al BshabsheA.KharabaA.JoseJ.Al HarthyA.Al SulaimanM.MadyA.FowlerR.A.HaydenF.G.Al-DawoodA.AbdelzaherM.BajhmomW.HusseinM.A.Treatment of" exact="Middle East respiratory syndrome" post="with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE trial):"/>
   <result pre="sequential randomized controlled trialTrials.212020810.1186/s13063-019-3846-x31900204 50OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.AlmakhlafiG.A.AlbarrakM.M.MemishZ.A.AlbarrakA.M.Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: a retrospective cohort studyLancet Infect. Dis.1420141090109510.1016/S1473-3099(14)70920-X25278221 51ZumlaA.ChanJ.F.W.AzharE.I.HuiD.S.C.YuenK.Y.Coronaviruses-drug"/>
   <result pre="a double-blind, parallel controlled trial during an influenza pandemic year," exact="Influenza" post="Other RespiViruses.7201385486210.1111/irv.12094 60BocciV.Absorption of Cytokines via Oropharyngeal-Associated Lymphoid Tissues:"/>
   <result pre="trial of recombinant human interferon alpha nasal drops to prevent" exact="coronavirus disease 2019" post="in medical staff in an epidemic areaMedRxiv.202010.1101/2020.04.11.200614732020.04.11.20061473 62SallardE.LescureF.-X.YazdanpanahY.MentreF.Peiffer-SmadjaN.Type 1"/>
   <result pre="activities of systemic and mucosal type I Interferons in both" exact="influenza infection" post="as well as tumor models. The research activity is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7335243\results\search\zoonosis\results.xml">
   <result pre="[5]. In the past 17 years, three neoteric Î²-CoVs, SARS-CoV," exact="Middle East respiratory syndrome" post="CoV (MERS-CoV), along with SARS-CoV-2 have emerged, engendering severe"/>
   <result pre="RT-PCR system. The E gene PCR was adequate for diagnosing" exact="SARS-CoV-2 infection," post="but the RdRp protocol was endorsed to verify positive"/>
   <result pre="et al. recently identified the host cell pathways modulated by" exact="SARS-CoV-2 infection" post="and revealed that suppression of these pathways may prevent"/>
   <result pre="may prevent viral replication in human cells [65]. Of note," exact="SARS-CoV-2 infection" post="profile was determined by translatome3 and proteome proteomics at"/>
   <result pre="investigation in clinical trials for pre-exposure or post-exposure prophylaxis of" exact="SARS-CoV-2 infection" post="Antibodies CR3022 [82] A SARS Cov-specific human monoclonal antibody"/>
   <result pre="ritonavir [90]. In the United States, the first case of" exact="SARS-CoV-2 infection" post="was reported, and remdesivir was administered. The patient's clinical"/>
   <result pre="found that it is an ideal candidate antiviral drug against" exact="SARS-CoV-2 infection" post="in Vero E6 cells with EC50 value of around"/>
   <result pre="that cytokines IL-6 and IL-10 are elevated in response to" exact="SARS-CoV-2 infection," post="which may induce the cytokine storm (Fig. 5), which"/>
   <result pre="SARS-CoV2-specifc neutralization activity in vitro against SARS-CoV-2. Moreover, CB6â€…could suppress" exact="SARS-CoV-2 infection" post="in rhesus monkeys at both prophylactic and treatmentâ€…settings. The"/>
   <result pre="patients with miscellaneous viral infections (i.e., SARS, H5N1, H1N1, and" exact="Ebola" post="virus infection) [117]. The theoretical basis for the therapeutic"/>
   <result pre="syndromes [120]. Previous studies also indicated that the patients with" exact="SARS-CoV infection" post="have benefited from TCM treatment [121], involving amelioration of"/>
   <result pre="clusterLancet395202051452331986261 2AndersenK.G.RambautA.LipkinW.I.HolmesE.C.GarryR.F.The proximal origin of SARS-CoV-2Nat Med20201331932805 3ChanJ.F.W.LauS.K.P.WooP.C.Y.The emerging novel" exact="Middle East respiratory syndrome" post="coronavirus: the â€œknownsâ€� and â€œunknowns.â€�J Formos Med Assoc112201337238123883791 4ZumlaA.ChanJ.F.W.AzharE.I.HuiD.S.C.YuenK.Y.Coronavirusesâ€&quot;drug"/>
   <result pre="16AhnD.G.ShinH.J.KimM.H.LeeS.KimH.S.MyoungJ.Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel" exact="coronavirus disease 2019" post="(COVID-19)J Microbiol Biotechnol30202031332238757 17HoehlS.RabenauH.BergerA.KortenbuschM.CinatlJ.BojkovaD.Evidence of SARS-CoV-2 infection in returning"/>
   <result pre="for novel coronavirus disease 2019 (COVID-19)J Microbiol Biotechnol30202031332238757 17HoehlS.RabenauH.BergerA.KortenbuschM.CinatlJ.BojkovaD.Evidence of" exact="SARS-CoV-2 infection" post="in returning travelers from Wuhan, ChinaN Engl J Med38220201278128032069388"/>
   <result pre="Microbiol5320152722272626019210 40BhadraS.JiangY.S.KumarM.R.JohnsonR.F.HensleyL.E.EllingtonA.D.Real-time sequence-validated loop-mediated isothermal amplification assays for detection of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV)PLoS One42015e0123126 41SheridanC.Fast, portable tests come online to"/>
   <result pre="human interferonsLancet362200329329412892961 70DyallJ.ColemanC.M.HartB.J.VenkataramanT.HolbrookM.R.KindrachukJ.Repurposing of clinically developed drugs for treatment of" exact="Middle East respiratory syndrome" post="coronavirus infectionAntimicrob Agents Chemother5820144885489324841273 71KindrachukJ.OrkB.HartB.J.MazurS.HolbrookM.R.FriemanM.B.Antiviral potential of ERK/MAPK and"/>
   <result pre="Chemother5820144885489324841273 71KindrachukJ.OrkB.HartB.J.MazurS.HolbrookM.R.FriemanM.B.Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for" exact="Middle East respiratory syndrome" post="coronavirus infection as identified by temporal kinome analysisAntimicrob Agents"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother5820144875488424841269 74QueT.L.WongV.C.W.YuenK.Y.Treatment of"/>
   <result pre="Commun318200471972515144898 77Al-TawfiqJ.A.MomattinH.DibJ.MemishZ.A.Ribavirin and interferon therapy in patients infected with the" exact="Middle East respiratory syndrome" post="coronavirus: an observational studyInt J Infect Dis202014424624406736 78De ClercqE.New"/>
   <result pre="novel coronavirus (2019-nCoV) in vitroCell Res30202026927132020029 89TchesnokovE.P.FengJ.Y.PorterD.P.GÃ¶tteM.Mechanism of inhibition of" exact="Ebola" post="virus RNA-dependent RNA polymerase by remdesivirViruses112019326 90SheahanT.P.SimsA.C.LeistS.R.SchÃ¤ferA.WonJ.BrownA.J.Comparative therapeutic efficacy"/>
   <result pre="I and type II interferonsAntivir Ther920041003101115651759 96DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov Ther142020586032147628 97WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.E.Small molecules targeting severe acute respiratory"/>
   <result pre="with convalescent plasmaJAMA32316202015821589 120DuH.Z.HouX.Y.MiaoY.H.HuangB.S.LiuD.H.Traditional chinese medicine: an effective treatment for" exact="2019 novel coronavirus pneumonia" post="(NCP)Chin J Nat Med18202020621032245590 121LiuX.ZhangM.HeL.LiY.Chinese herbs combined with Western"/>
   <result pre="clinical trial for coronavirus vaccine. https://health.economictimes.indiatimes.com/news/diagnostics/chinese-research-firm-attached-to-pla-first-to-start-2nd-clinical-trial-for-coronavirus-vaccine/75152489. 145UK researchers to trial" exact="Covid-19" post="vaccine and plasma therapy. https://www.clinicaltrialsarena.com/news/uk-covid-vaccine-plasma-therapy/. 146Chinese clinical trial registry2020."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7335248\results\search\zoonosis\results.xml">
   <result pre="by a new deadly (&amp;gt;30% mortality) MERS-CoV in 2012. The" exact="Ebola" post="outbreak in West Africa (2014â€&quot;2016) became the deadliest occurrence"/>
   <result pre="antiviral agent studied [24,28]. 3 Antiviral activity of stilbenoids 3.1" exact="Influenza" post="viruses Influenza viruses are responsible for acute respiratory infections"/>
   <result pre="studied [24,28]. 3 Antiviral activity of stilbenoids 3.1 Influenza viruses" exact="Influenza" post="viruses are responsible for acute respiratory infections in two"/>
   <result pre="of deaths every year worldwide, according to WHO estimations [29]." exact="Influenza" post="viruses belong to the Orthomyxoviridae family. There are four"/>
   <result pre="main responsible for human infections and may cause seasonal epidemics." exact="Influenza" post="A virus is a single-stranded, segmented RNA virus that"/>
   <result pre="stilbenoid compounds isolated from some species of Dipterocarpaceaeous plants, against" exact="Influenza" post="A virus (IAV) (A/NWS/33 strain, H1N1 subtype). Hopeaphenol and"/>
   <result pre="lianas of Gnetum pendulum and tested as anti-influenza compounds [34]." exact="Influenza" post="A may induce the inflammation of infected airway epithelial"/>
   <result pre="intestinal epithelium and to intestinal first pass effects [58]. 3.4" exact="Dengue" post="virus (DENV) Dengue virus (DENV) is a mosquito-borne virus,"/>
   <result pre="to intestinal first pass effects [58]. 3.4 Dengue virus (DENV)" exact="Dengue" post="virus (DENV) is a mosquito-borne virus, causing a wide"/>
   <result pre="(DENV-1-4). 100â€&quot;400 million dengue virus infections are estimated each year." exact="Dengue" post="affects in particular South-East Asia (about 70% of the"/>
   <result pre="virus. The exact mechanism of action is not known. Interestingly," exact="Dengue" post="virus belong to the same family of HCV, sharing"/>
   <result pre="B and Ïµ-viniferin were found to inhibit HCV NS3 [57,58]," exact="Dengue" post="virus NS3 could be likely one of the possible"/>
   <result pre="Compound Virus Target Activity (Î¼M) and cell lines Ref. Hopeaphenol" exact="Influenza" post="A (A/NWS/33, H1N1) NI IC50Â =Â 6.4Â Î¼M on"/>
   <result pre="Î¼g/mL (6.4Â Î¼M)Â (H3N2) on MDCK Liu [34] (+)-Vitisin A" exact="Influenza" post="A (A/PR/8/34, H1N1)- â†&quot; RANTES EC50Â =Â 0.27Â Î¼M"/>
   <result pre="0.27Â Î¼M on Human alveolar epithelial A549 Huang [38] 2b" exact="Influenza" post="A (A/PR/8/34, H1N1) Neuraminidase EC50Â =Â 7.28Â Î¼g/mL (28Â"/>
   <result pre="and the Microbiology Laboratoryeighth ed.2014Elsevier Inc.10.1016/B978-1-4557-4801-3.00016-3 29collab: World Health OrganisationGlobal" exact="Influenza" post="Strategy Summary 2019-2030 Influenza201912 30LampejoT.Influenza and antiviral resistance: an"/>
   <result pre="Med.7620101874187610.1055/s-0030-125003020539973 35MatsukuraS.KokubuF.KuboH.TomitaT.TokunagaH.KadokuraM.YamamotoT.KuroiwaY.OhnoT.SuzakiH.AdachiM.Expression of RANTES by normal airway epithelial cells after" exact="Influenza" post="virus A infectionAm. J. Respir. Cell Mol. Biol.18199825526410.1165/ajrcmb.18.2.28229476913 36BianZ.M.ElnerS.G.YoshidaA.ElnerV.M.Differential"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7335730\results\search\zoonosis\results.xml">
   <result pre="have not been vaccinated and have cardiovascular diseases. Keywords Obesity" exact="Influenza" post="Cardiovascular disease Cardioprotective effects of vaccination Influenza vaccine Introduction"/>
   <result pre="diseases. Keywords Obesity Influenza Cardiovascular disease Cardioprotective effects of vaccination" exact="Influenza" post="vaccine Introduction This review focuses on how obesity and"/>
   <result pre="pneumonia, and prolonged viral shedding [1]. Therefore, management of the" exact="influenza infection" post="in this at-risk population has to have special consideration"/>
   <result pre="respond optimally to vaccination [2]. Obesity and Its Impact on" exact="Influenza" post="Infection Excessive fat accumulation that results in obesity impairs"/>
   <result pre="to develop better treatments for this increasing population. Importance of" exact="Influenza" post="Vaccination Obesity causes a chronic state of inflammation in"/>
   <result pre="decrease in efficacy than that observed in non-obese populations [11]." exact="Influenza" post="vaccine as a method of prevention is formulated each"/>
   <result pre="used in the obese population [9, 10]. Cardiovascular Risk and" exact="Influenza" post="Infection In the twentieth century during influenza epidemics, there"/>
   <result pre="after the onset of infection [17]. Cardiovascular complications associated with" exact="influenza infection" post="include myocarditis, pericardial effusion, myopericarditis, right and left ventricle"/>
   <result pre="myocardial infarction based on clinical, electrocardiographic, and laboratory evaluation [23]." exact="Influenza" post="infection can trigger type 1 and type 2 myocardial"/>
   <result pre="can activate inflammatory cells in atherosclerotic plaques [16] [24]. Acute" exact="influenza infection" post="is associated to a procoagulant state that increases the"/>
   <result pre="myocardial oxygen supply and demand unrelated to coronary thrombosis. [23]." exact="Influenza" post="infection produces a systemic inflammatory response with a resulting"/>
   <result pre="increasing the risk of myocardial infarction [16, 18]. Heart Failure" exact="Influenza" post="infection is also associated with increased mortality in patients"/>
   <result pre="to volume overload [28]. In a healthy heart, severe acute" exact="influenza infection" post="produces pro-inflammatory cytokine level elevations that can cause acute"/>
   <result pre="15% of the patients admitted to a military hospital with" exact="influenza infection" post="had wall motion abnormalities on echocardiogram [18]. This becomes"/>
   <result pre="increase in incidence of ischemic stroke within 2Â weeks after" exact="influenza infection" post="has been suggested [34, 35]. Protein C pathway and"/>
   <result pre="and endogenous fibrinolysis are mechanisms associated with cerebrovascular ischemia and" exact="influenza infection" post="[19]. Influenza infection develops a prothrombotic state by increasing"/>
   <result pre="are mechanisms associated with cerebrovascular ischemia and influenza infection [19]." exact="Influenza" post="infection develops a prothrombotic state by increasing tissue factor"/>
   <result pre="to atherosclerosis, obesity, or infection [37]. Possible Cardioprotective Effects of" exact="Influenza" post="Vaccination The Sixth Joint Task Force of the European"/>
   <result pre="[13]. The unspecific mechanism is based on the fact that" exact="influenza infection" post="causes a systemic inflammatory response, endothelial dysfunction, and a"/>
   <result pre="leading to myocardial infarction or sudden cardiac death [13] [15]." exact="Influenza" post="vaccination reduces the risk of infection and inflammation by"/>
   <result pre="overall mortality in a hospitalized setting. Cardiovascular complications associated with" exact="influenza infection" post="include myocarditis, pericardial effusion, myopericarditis, right and left ventricle"/>
   <result pre="outcomes among adult patients with obesity in Detroit, Michigan, 2011." exact="Influenza" post="Other Respi Viruses [Internet]. 2013;7(6):1004â€&quot;7 [cited 2019 Oct 22];"/>
   <result pre="14.Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K." exact="Influenza" post="vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev"/>
   <result pre="NS, Karnauchow T, et al. Acute myocardial infarction after laboratory-confirmed" exact="influenza infection." post="N Engl J Med. 2018;378(4):345â€&quot;53. 18.FagnoulDPasquierPBodsonLOrtizJAVincentJLDe BackerDMyocardial dysfunction during"/>
   <result pre="Prev Cardiol201724181958196610.1177/204748731772400928764553 22.Madjid M, Naghavi M, Litovsky S, Casscells SW." exact="Influenza" post="and cardiovascular disease: a new opportunity for prevention and"/>
   <result pre="strokeAnn Clin Transl Neurol20185445646310.1002/acn3.54529687022 36.Urbanek C, Palm F, Grau A." exact="Influenza" post="and stroke risk: a key target not to be"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7336121\results\search\zoonosis\results.xml">
   <result pre="Keywords Monoclonal antibody Antibody fragments Viral infections Viral targets Biopharmaceuticals" exact="Covid-19" post="1 Introduction Viruses are a large, attractive, and diverse"/>
   <result pre="larcaviximab, porgaviximab) developed by Mapp Biopharmaceutical, Inc., designed against the" exact="Ebola" post="virus glycoprotein in phase II/III clinical trials [11]. Because"/>
   <result pre="cervical cancer. Detection of HPV in cervical exfoliated cells [27]" exact="Dengue" post="Virus NS1 Nonstructural protein 1 is secreted from infected"/>
   <result pre="library. They recognized binders to viral antigens that contained both" exact="Middle East respiratory syndrome" post="(MERS) and severe acute respiratory syndrome (SARS) spike proteins."/>
   <result pre="JL et al. made a single domain fragment antibody for" exact="Ebola" post="virus envelope glycoprotein (GP) and enhanced its solidity to"/>
   <result pre="use in austere locals. A llama was immunized with killed" exact="Ebola" post="virus and GP recombinant protein and an immune phage"/>
   <result pre="domain antibodies as candidates for diagnostic or therapeutic purposes for" exact="Ebola" post="[51]. Zhu M. et al. have been proposed a"/>
   <result pre="probably illustrate a useful, actual and low cost choice in" exact="Ebola" post="diagnostics applications than full-length antibodies. Rodriguez-Martinez LM et al."/>
   <result pre="usage of samples containing proper EBOV particles and samples from" exact="Ebola" post="disease patients have to be studied to entirely validate"/>
   <result pre="herpes simplex virus (HSV), cytomegalovirus (CMV), hepatitis C virus (HCV)," exact="Ebola" post="virus, Marburg virus, SARS virus, dengue virus, rabies virus,"/>
   <result pre="HIV Phase II/III [65] Diridavumab (CR6261) Whole antibody A Hemagglutinin" exact="Influenza" post="A Unknown [66] Human viruses generate potent, neutralizing antibody"/>
   <result pre="characterization, and thermal stabilization of llama single domain antibodies towards" exact="Ebola" post="virus glycoproteinMicrob. Cell Fact.161201722329233140 52ZhuM.HuY.LiG.OuW.MaoP.XinS.Combining magnetic nanoparticle with biotinylated"/>
   <result pre="virus CJ Antivir Antiretrovir.7220155259 54Rodriguez-MartinezL.M.Marquez-IpinaA.R.Lopez-PachecoF.Perez-ChavarriaR.Gonzalez-VazquezJ.C.Gonzalez-GonzalezE.Antibody derived peptides for detection of" exact="Ebola" post="virus glycoproteinPLoS ONE10102015 55MwaleP.F.LeeC.H.LinL.T.LeuS.J.HuangY.J.ChiangL.C.Expression, purification, and characterization of anti-Zika"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7337839\results\search\zoonosis\results.xml">
   <result pre="properly cited. For commercial re-use, please contact journals.permissions@oup.combvaa082.pdf Abstract Abstract" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) virus has spread across the globe"/>
   <result pre="clear. To compile a mini-review describing possible endocrine consequences of" exact="SARS-CoV-2 infection," post="we performed a literature survey using the key words"/>
   <result pre="appears to be associated with increased susceptibility or severity to" exact="SARS-CoV-2 infection," post="and replacement may improve outcomes. Robust strategies required for"/>
   <result pre="are discussed extensively in this mini-review. SARS-CoV2 COVID-19 Endocrine page-count:" exact="Coronavirus disease 2019" post="(COVID-19), which was first reported in Wuhan, Hubei province,"/>
   <result pre="expressed in the hypothalamus and could be disrupted by the" exact="SARS-CoV-2 infection," post="it may play a role in postviral fatigue and"/>
   <result pre="it is possible that the thyroiditis is etiologically related to" exact="SARS-CoV-2 infection." post="A. Management Considerations of Preexisting Thyroid Conditions If infected"/>
   <result pre="than islet cells [93]. It is not known whether the" exact="SARS-CoV infection" post="alters the patterns of pancreatic cell ACE2 expression, dependent"/>
   <result pre="reduces serum levels of pro-inflammatory cytokines TNF-Î± and IFN-Î³ [121]." exact="SARS-CoV-2 infection" post="also results in an increase in the levels of"/>
   <result pre="vitamin D may play a role in reducing inflammation in" exact="COVID 19" post="by increasing the anti-inflammatory cytokines and reducing the pro-inflammatory"/>
   <result pre="to examine whether vitamin D status contributes to the higher" exact="COVID 19" post="mortality seen in these ethnicities in the United Kingdom"/>
   <result pre="suggests that the testis is a high-risk organ vulnerable to" exact="SARS-CoV-2 infection." post="However, there are no similar studies on ACE2 expression"/>
   <result pre="distribution or pathological effects of virus on human gonads from" exact="SARS-CoV-2 infection." post="A study conducted to define the organ distribution of"/>
   <result pre="DongX, et al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. doi:10.1016/S0140-6736(20)30211-732007143"/>
   <result pre="CaoQD, HongZS, et al.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak - an update on the status. Mil"/>
   <result pre="QifaS, HuC, SuF, DaiJHypokalemia and clinical implications in patients with" exact="coronavirus disease 2019" post="(COVID-19). medRxiv. January 2020:2020.02.27.20028530. doi:10.1101/2020.02.27.20028530 55.Cycloset, Parlodel (bromocriptine) dosing,"/>
   <result pre="J Pathol.2004;203(2):622-630.15141376 88.BrancatellaA, RicciD, ViolaN, SgrÃ²D, SantiniF, LatrofaF.Subacute thyroiditis after" exact="SARS-CoV-2 infection." post="J Clin Endocrinol Metab. 105(7):dgaa276. doi:10.1210/clinem/dgaa276 89.COVID-19 resources for"/>
   <result pre="al.Highly ACE2 expression in pancreas may cause pancreas damage after" exact="SARS-CoV-2 infection." post="medRxiv. January 2020:2020.02.28.20029181. doi:10.1101/2020.02.28.20029181 94.Roca-HoH, RieraM, PalauV, PascualJ, SolerMJCharacterization"/>
   <result pre="reveals the presence of the ACE2 receptor, a target for" exact="SARS-CoV-2 infection" post="in spermatogonia, Leydig and Sertoli cells. Cells. 2020;9(4). doi:10.3390/cells9040920"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7338124\results\search\zoonosis\results.xml">
   <result pre="Korea Centers for Disease Control and Prevention operates the Korea" exact="Influenza" post="and Respiratory Viruses Surveillance System (KINRESS) to monitor epidemics"/>
   <result pre="future epidemics and pandemics caused by drug-resistant influenza viruses. Keywords" exact="Influenza" post="virus Drug resistance H275Y Immunocompromised patients Funding http://dx.doi.org/10.13039/501100003669Korea Centers"/>
   <result pre="for Diseases Control and Prevention (KCDC) has operated the Korea" exact="Influenza" post="and Respiratory Viruses Surveillance System (KINRESS) to monitor epidemic"/>
   <result pre="A fluorescence-based neuraminidase inhibition assay was conducted using the NA-Fluorâ&quot;¢" exact="Influenza" post="Neuraminidase Assay Kit (Applied Biosystems), according to the manufacturerâ€™s"/>
   <result pre="Tokyo, Japan). Results A(H1N1)pdm09 detection and isolation in immunocompromised patients" exact="Influenza" post="A virus was detected in oropharyngeal swab samples collected"/>
   <result pre="facilitate the risk assessment of NAI viruses. Abbreviations KINRESS Korea" exact="Influenza" post="and Respiratory Viruses Surveillance System SARI Severe Acute Respiratory"/>
   <result pre="MDCK Madin-Darby canine kidney GISAID Global Initiative on Sharing All" exact="Influenza" post="Data IC50 Half maximal inhibitory concentration Publisherâ€™s Note Springer"/>
   <result pre="first global approvalDrugs.20187869369710.1007/s40265-018-0899-129623652 4.MoasserEMoasserAZaraketHIncidence of antiviral drug resistance markers among" exact="human influenza" post="a viruses in the eastern Mediterranean region, 2005-2016Infect Genet"/>
   <result pre="Europe, May 20192019 14.LackenbyABesselaarTGDanielsRSFryAGregoryVGubarevaLVet al.Global update on the susceptibility of" exact="human influenza" post="viruses to neuraminidase inhibitors and status of novel antivirals,"/>
   <result pre="virological surveillance of influenza2011 17.Okomo-AdhiamboMSleemanKBallengerKNguyenHTMishinVPSheuTGet al.Neuraminidase inhibitor susceptibility testing in" exact="human influenza" post="viruses: a laboratory surveillance perspectiveViruses.201022269228910.3390/v210226921994620 18.MemoliMJAthotaRReedSCzajkowskiLBristolTProudfootKet al.The natural history"/>
   <result pre="viruses: a laboratory surveillance perspectiveViruses.201022269228910.3390/v210226921994620 18.MemoliMJAthotaRReedSCzajkowskiLBristolTProudfootKet al.The natural history of" exact="influenza infection" post="in the severely immunocompromised vs nonimmunocompromised hostsClin Infect Dis20135821422410.1093/cid/cit72524186906"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7338534\results\search\zoonosis\results.xml">
   <result pre="on the concept of passive immunity. Individuals who recover from" exact="SARS-CoV-2 infection" post="have, in principle, developed neutralizing antibodies against the virus2."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7338588\results\search\zoonosis\results.xml">
   <result pre="on host immune response pathways leading to increased susceptibility to" exact="SARS-CoV-2 infection." post="Understanding these pathways may help not only in unraveling"/>
   <result pre="host genetics may provide some explanation for failure to control" exact="SARS-CoV-2 infection." post="Primary immunodeficiencies (PIDs) are a group of genetically determined"/>
   <result pre="which may predispose otherwise healthy individuals without comorbidities to severe" exact="SARS-CoV-2 infection." post="Clinical Presentations of COVID-19 The severity of COVID-19 is"/>
   <result pre="of developing aneurisms. This inflammatory condition associated with a previous" exact="SARS-CoV-2 infection" post="has been named Pediatric Multisystem Inflammatory Syndrome temporally associated"/>
   <result pre="Furthermore, overexpression of ACE2 enhances disease severity in mice upon" exact="SARS-CoV infection," post="indicating the importance of this receptor in facilitating viral"/>
   <result pre="are known to be activated during viral infection and replication." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) infects human cells through the angiotensin-converting"/>
   <result pre="the downstream adaptors TRIF and MyD88 (77, 78). Interestingly, following" exact="SARS-CoV infection" post="of Trifâˆ’/âˆ’ mice, the aberrant proinflammatory cytokine and chemokine"/>
   <result pre="those seen in human patients with poor disease outcome during" exact="SARS-CoV infection" post="(80) or MERS-CoV infection (81). This may suggest that"/>
   <result pre="limited reports indicating that the other RLRs are important in" exact="SARS-CoV infection." post="This is, however, not due to the virus failing"/>
   <result pre="had been deleted by CASP1/11 knock-out displayed less mortality upon" exact="influenza infection" post="compared to wild-type mice (88). Furthermore, inflammation was shown"/>
   <result pre="might predict that inhibiting this response may improve outcomes in" exact="SARS-CoV-2 infection." post="These studies are supported by other data demonstrating that"/>
   <result pre="most prominent antiviral effectors of the innate immune system, and" exact="SARS-CoV infection" post="is highly susceptible to this potent antiviral substance, as"/>
   <result pre="viral replication and a reduced type I IFN response in" exact="SARS-CoV-2 infection" post="of ex-vivo human lung cultures compared to SARS-CoV (104)."/>
   <result pre="CD4+ T cell responses correlates well with positive outcomes during" exact="SARS-CoV infection" post="(108, 109). Clinical investigations of severe COVID-19 patients consistently"/>
   <result pre="115). Histological examination of a patient who died from severe" exact="SARS-CoV-2 infection" post="identified that whilst the overall peripheral CD4+ and CD8+"/>
   <result pre="CD8+ T cell response is known to be important in" exact="SARS-CoV infection," post="and mild cases of COVID-19 have increased clonal expansion"/>
   <result pre="infections (131), but in the case of disease progression in" exact="SARS-CoV-2 infection," post="little is known regarding the influence of the host"/>
   <result pre="IFN production may undermine the innate immune response during early" exact="SARS-CoV infection," post="resulting in a more severe disease course (80, 132,"/>
   <result pre="the IFN-inducible genes OAS1 and MX1, associated with susceptibility to" exact="SARS-CoV infection" post="and disease progression (134, 135). Moreover, exogenous administration of"/>
   <result pre="SARS patients in Taiwan identified an association between HLA-B*4601 and" exact="SARS-CoV infection" post="(155); however, this was not confirmed in a study"/>
   <result pre="polymorphisms in the IL28B gene could also predispose to severe" exact="SARS-CoV-2 infection." post="Perhaps the most compelling reason to believe that genetic"/>
   <result pre="highlight how genetic differences may explain the great variability in" exact="SARS-CoV-2 infection" post="outcome. As we start to gain further insight into"/>
   <result pre="potential protective role of ACE2 defects, rendering cells restistant to" exact="SARS-CoV-2 infection," post="in analogy to protection from HIV infection by Delta32"/>
   <result pre="homozygosity (166). Given the important role of host ACE2 in" exact="SARS-CoV-2 infection," post="we might speculate that ACE2 genetic polymorphisms may be"/>
   <result pre="rare, genetic variants in TMPRSS2 as possible disease modulators of" exact="SARS-CoV-2 infection" post="in Italy (168). Although these findings necessitate functional validation,"/>
   <result pre="patients receiving remdesivir (180), preliminary results from the larger Adaptive" exact="Covid-19" post="Treatment Trial (ACTT) showed that remdesivir significantly shortened the"/>
   <result pre="otherwise healthy, will identify rare, deleterious mutations that lead to" exact="SARS-CoV-2 infection" post="and severe clinical outcome. This will offer unique insights"/>
   <result pre="80:e1â€&quot;13. 10.1016/j.jinf.2020.03.006 36.WuZMcGooganJM. Characteristics of and important lessons from the" exact="coronavirus disease 2019." post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="Wuhan, China. JAMA. (2020) 323:1061â€&quot;9. 10.1001/jama.2020.158532031570 38.GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. (2020) 382:1708â€&quot;20. 10.1056/NEJMoa200203232109013"/>
   <result pre="Neurol Sci. (2020) 414:116884. 10.1016/j.jns.2020.11688432464367 42.CheungKSHungIFChanPPLungKCTsoELiuRet al.. Gastrointestinal manifestations of" exact="SARS-CoV-2 infection" post="and virus load in fecal samples from the hong"/>
   <result pre="and lethal influenza disease. Science. (2016) 352:463â€&quot;6. 10.1126/science.aaf392627102485 89.Nieto-TorresJLVerdia-BaguenaCJimenez-GuardenoJMRegla-NavaJACastano-RodriguezCFernandez-DelgadoRet al.." exact="Severe acute respiratory syndrome" post="coronavirus E protein transports calcium ions and activates the"/>
   <result pre="activates NLRP3 inflammasomes. Cell Death Discov. (2019) 5:101. 10.1038/s41420-019-0181-731231549 91.ChenIYMoriyamaMChangMFIchinoheT." exact="Severe acute respiratory syndrome" post="coronavirus viroporin 3a activates the NLRP3 inflammasome. Front Microbiol."/>
   <result pre="Reduction and functional exhaustion of t cells in patients with" exact="coronavirus disease 2019." post="(COVID-19). Front Immunol. (2020) 11:827. 10.3389/fimmu.2020.0082732425950 113.ZhengHYZhangMYangCXZhangNWangXCYangXPet al.. Elevated"/>
   <result pre="349:508â€&quot;9. 10.1056/NEJM20030731349052012890855 123.KellamPBarclayW. The dynamics of humoral immune responses following" exact="SARS-CoV-2 infection" post="and the potential for reinfection. J Gen Virol. (2020)."/>
   <result pre="10.1038/s41591-020-0897-132350462 125.ZhaoJYuanQWangHLiuWLiaoXSuYet al.Antibody responses to SARS-CoV-2 in patients of novel" exact="coronavirus disease 2019." post="Clin Infect Dis. (2020). [Epub ahead of print]. 10.1093/cid/ciaa344."/>
   <result pre="immunity. J Allergy Clin Immunol. (2019) 143:507â€&quot;27. 10.1016/j.jaci.2018.07.01330075154 132.ZieglerTMatikainenSRonkkoEOsterlundPSillanpaaMSirenJet al.." exact="Severe acute respiratory syndrome" post="coronavirus fails to activate cytokine-mediated innate immune responses in"/>
   <result pre="al.. Clinical course and outcomes of critically ill patients with" exact="Middle East respiratory syndrome" post="coronavirus infection. Ann Intern Med. (2014) 160:389â€&quot;97. 10.7326/M13-248624474051 147.DaubyN."/>
   <result pre="effort to define the human genetics of protective immunity to" exact="SARS-CoV-2 infection." post="Cell. (2020) 181:1194â€&quot;9. 10.1016/j.cell.2020.05.01632405102 149.MatzarakiVKumarVWijmengaCZhernakovaA. The MHC locus and"/>
   <result pre="autoimmune and infectious diseases. Genome Biol. (2017) 18:76. 10.1186/s13059-017-1207-128449694 150.DimarcoAD." exact="Covid-19" post="and ethnicity: it's too early to point to healthcare"/>
   <result pre="The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus. J Biol Chem. (2020) 295: 4773â€&quot;9. 10.1074/jbc.AC120.01305632094225 175.WangMCaoRZhangLYangXLiuJXuMet"/>
   <result pre="(2020) 395:1569â€&quot;78. 10.1016/S0140-6736(20)31022-932423584 181.BeigelJHTomashekKMDoddLEMehtaAKZingmanBSKalilACet al.. Remdesivir for the treatment of" exact="Covid-19" post="- preliminary report. N Engl J Med. (2020). [Epub"/>
   <result pre="Med. (2020). 10.1056/NEJMoa2015301 183.AntinoriSCossuMVRidolfoALRechRBonazzettiCPaganiGet al.. Compassionate remdesivir treatment of severe" exact="Covid-19" post="pneumonia in intensive care unit (ICU) and Non-ICU patients:"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitro. Cell Discov. (2020) 6:16. 10.1038/s41421-020-0156-032194981 188.CaoBWangYWenDLiuWWangJFanGet al.."/>
   <result pre="2:e393â€&quot;400. 10.1016/S2665-9913(20)30164-8 207.DimopoulosGde MastQMarkouNTheodorakopoulouMKomnosAMouktaroudiMet al.. Favorable anakinra responses in severe" exact="Covid-19" post="patients with secondary hemophagocytic lymphohistiocytosis. Cell Host Microbe. (2020)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7339094\results\search\zoonosis\results.xml">
   <result pre="those that commonly cause community-based respiratory diseases: respiratory syncytial virus," exact="Influenza" post="virus and rhinovirus. However, in some cases the clinical"/>
   <result pre="hematological patient in terms of both clinical severity and mortality." exact="Influenza" post="(IFV) and parainfluenza viruses (PIV), respiratory syncytial virus (RSV),"/>
   <result pre="within the epithelial cells of the upper airways [5]. The" exact="human influenza" post="virus belongs to the Orthomyxoviridae family, and its genome"/>
   <result pre="syncitial virus 1â€&quot;50 11â€&quot;47 S, C, D Pavilizumab Ribavirin aerosol" exact="Influenza" post="1.3â€&quot;40 8â€&quot;28 S, D Seasonal influenza immunization Post-exposure prophylaxis"/>
   <result pre="[33] Leukemia 33.9% [12] â€&quot; Other tumors 31.8% [12] â€&quot;" exact="Influenza" post="HM â€&quot; â€&quot; ALL 36â€&quot;38% [5, 22] â€&quot; Parainfluenza"/>
   <result pre="ALL, 11% of AML and 1% of lymphoma, respectively [1]." exact="Influenza" post="Virus (FLU) The influenza virus is probably the most"/>
   <result pre="incidence in HSCT patients ranges between 1 and 3% [27]." exact="Influenza" post="is the most common virus in ALL pediatric patients,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7339606\results\search\zoonosis\results.xml">
   <result pre="SARS-CoV-2 Phylogenetic tree Homology modeling Molecular Docking Active site Background" exact="Severe acute respiratory syndrome" post="coronavirus (SARS-CoV) is a positive-sense single-stranded RNA virus from"/>
   <result pre="ranging from the common cold to severe diseases such as" exact="Middle East respiratory syndrome" post="(MERS) and severe acute respiratory syndrome (SARS). SARS-CoV-2 is"/>
   <result pre="epidemic was previously predicted by the WHO soon after the" exact="Ebola" post="virus outbreak in 2016 [16, 17]; and this prediction"/>
   <result pre="clinical trials for different viruses (e.g. Hepatitis C, Zika virus," exact="Dengue" post="and SARS-CoV-2) on the basis of anti-RdRp activity [44â€&quot;51]."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7340244\results\search\zoonosis\results.xml">
   <result pre="treatment.50 The first case of KD associated with a concomitant" exact="SARS-CoV-2 infection" post="was a 6-month infant hospitalized in Palo Alto (California,"/>
   <result pre="with severe acute respiratory distress and shock syndrome, referred to" exact="SARS-CoV-2 infection" post="detected via RT-PCR from his nasopharyngeal swab.52 In April"/>
   <result pre="2002 Shingadia RT-PCR Varicella-zoster virus 36 2004 Lee Clinical assessment" exact="Influenza" post="virus 37,38,46 2011, 2015, 2019 Joshi, Huang, Wang RT-PCR"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7341697\results\search\zoonosis\results.xml">
   <result pre="to Covid-19â€&quot;A once-in-a-century pandemic?N Engl J Med2020382181677167910.1056/NEJMp200376232109012 3.Rosenbaum L. Facing" exact="Covid-19" post="in Italyâ€&quot;ethics, logistics, and therapeutics on the epidemicâ€™s front"/>
   <result pre="in infectious disease outbreaks2016GenevaWorld Health Organization 5.RomeBNAvornJDrug evaluation during the" exact="Covid-19" post="pandemicN Engl J Med202010.1056/NEJMp200945732289216 6.ShimizuK2019-nCoV, fake news, and racismLancet20203951022568568610.1016/S0140-6736(20)30357-3"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7342332\results\search\zoonosis\results.xml">
   <result pre="evidence of efficacy and safety.[2] Selection of investigational interventions for" exact="Ebola" post="was based on the World Health Organization's (WHO) ethical"/>
   <result pre="is justified based on the laboratory and animal studies. In" exact="Ebola" post="proof-of-concept trial, the investigators used in vivo and in"/>
   <result pre="in vivo and in vitro data on favipiravir activity against" exact="Ebola" post="and pharmacokinetics in uninfected mice and humans to calculate"/>
   <result pre="adult patients 18 years of age or older, with confirmed" exact="SARS-CoV-2 infection," post="suffering from pneumonia and SARS.[1] In contrast, French clinical"/>
   <result pre="which safety data were available. Although pregnant women suffering from" exact="Ebola" post="had a higher case-fatality rate compared to nonpregnant women,"/>
   <result pre="of therapy.[247] Carazo Perez et al. who conducted the clinical" exact="Ebola" post="trial recommend that individual patient's interests must prevail over"/>
   <result pre="of 31 patients (8.6%) did not give consent.[1] In the" exact="Ebola" post="trial, the investigators decided to conduct single-arm open-label nonrandomized"/>
   <result pre="of potential adverse effects of IP complex and difficult. In" exact="Ebola" post="studies, the investigators monitored the patients for adverse events"/>
   <result pre="patients for adverse events (AEs) not corresponding to symptoms of" exact="Ebola" post="virus disease and focused on AEs of favipiravir described"/>
   <result pre="J Med2020Last accessed on 2020 Mar 18Available from: https://wwwnejmorg/doi/full/101056/NEJMoa2001282 2CalainPThe" exact="Ebola" post="clinical trials: a precedent for research ethics in disastersJ"/>
   <result pre="23Available from: https://appswhoint/iris/bitstream/handle/10665/250580/9789241549837-engpdf; jsessionid=419B1547EE0CA67098BCC0C03E795D3Dsequence=1 4SissokoDLaouenanCFolkessonEMâ€™LebingABBeavoguiAHBaizeSet al.Experimental treatment with Favipiravir for" exact="Ebola" post="virus disease (the JIKI trial): A historically controlled, single-arm"/>
   <result pre="and implementing a clinical trial at field level in an" exact="Ebola" post="emergency: A case study in Guinea, West AfricaPLoS Negl"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7343578\results\search\zoonosis\results.xml">
   <result pre="and warrant a full study in the next future. Keywords" exact="Covid-19" post="Diabetes mellitus Obesity Malnourishment Pituitary Thyroid Calcium Vitamin D"/>
   <result pre="mellitus Obesity Malnourishment Pituitary Thyroid Calcium Vitamin D Hypoadrenalism Introduction" exact="Coronavirus disease 2019" post="(COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"/>
   <result pre="range in the US. Thus, confirming what was found with" exact="Influenza" post="A (H1N1) pandemic, Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)"/>
   <result pre="disease modality and excessive mortality while the occurrence of the" exact="Influenza" post="A (H1N1) pandemic, SARS-CoV and MERSCoV outbreaks [4]. Influenza"/>
   <result pre="the Influenza A (H1N1) pandemic, SARS-CoV and MERSCoV outbreaks [4]." exact="Influenza" post="A (H1N1) pandemic, tripled the risk of hospitalization and"/>
   <result pre="How can obesity impact COVID-19 infection? The high impact of" exact="H1N1 Influenza" post="and now COVID-19 in patients with obesity and severe"/>
   <result pre="can obesity impact COVID-19 infection? The high impact of H1N1" exact="Influenza" post="and now COVID-19 in patients with obesity and severe"/>
   <result pre="communities in which obesity is prevalent [44]. In addition, in" exact="influenza infection" post="obesity not only increases the severity but also enhances"/>
   <result pre="hospital admission), although generally mild [85], and in patients with" exact="Ebola" post="virus disease (62%) [86]. A case of COVID-19 infection"/>
   <result pre="this may be in part responsible for organ injury in" exact="Covid-19" post="[102]. At present, we cannot rule out that long-term"/>
   <result pre="a prospective therapeutic agent for Covid-19. Use of melatonin in" exact="COVID 19" post="Viruses induce an explosion of inflammatory cytokines and reactive"/>
   <result pre="exist. References References 1.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="and PreventionJAMA.20203231239 2.DengS-QPengH-JCharacteristics of and public health responses to the" exact="coronavirus disease 2019" post="outbreak in ChinaJ Clin Med20209575 3.AlvesCCasqueiroJCasqueiroJInfections in patients with"/>
   <result pre="Cummings. Urgent Safety Notice: Use of SGLT2 inhibitors during the" exact="Covid-19" post="Crisis. R United Hosp Bath NHS Found Trust. 2020"/>
   <result pre="genes in the thymi of NOD miceMol Cell Endocrinol201642610111226911933 31.LiKWohlford-LenaneCLChannappanavarRParkJ-EEarnestJTBairTBBatesAMBrogdenKAFlahertyHAGallagherTMeyerholzDKPerlmanSMcCrayPBJrMouse-adapted" exact="MERS coronavirus" post="causes lethal lung disease in human DPP4 knockin miceProc"/>
   <result pre="Yao J, et al. Obesity-Related Microenvironment Promotes Emergence of Virulent" exact="Influenza" post="Virus Strains. Moscona A, editor. mBio. 2020;11:e03341â€&quot;19, /mbio/11/2/mBio.03341â€&quot;19.atom. 46.MuscogiuriGPuglieseGBarreaLSavastanoSColaoAComentary:"/>
   <result pre="cellsVirology.20185173829275820 83.Straus MR, et al. Ca2+ ions promote fusion of" exact="Middle East respiratory syndrome" post="coronavirus with host cells and increase infectivity. J Virol."/>
   <result pre="J Virol. 2020 Apr;15. 84.NathanLLaiALMilletJKStrausMRFreedJHWhittakerGRDanielSCalcium ions directly interact with the" exact="Ebola" post="virus fusion peptide to promote structure-function changes that enhance"/>
   <result pre="SARS in the greater Toronto areaJAMA.20032892801280912734147 86.UyekiTMMehtaAKDaveyRTLiddellAMWolfTVetterPet al.Clinical Management of" exact="Ebola" post="Virus Disease in the United States and EuropeN Engl"/>
   <result pre="L, Giustina A. Severe hypocalcemia in a thyroidectomized woman with" exact="Covid-19" post="infection. Endocrine [Internet]. 2020 [cited 2020 May 21]; Available"/>
   <result pre="with hypoparathyroidismEndocrine.20196669970031655979 91.ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYXiaJ'YuTZhangXZhangLEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet Lond Engl2020395507513 92.Channappanavar"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7343716\results\search\zoonosis\results.xml">
   <result pre="of Kerala (8, 9). Various forms of encephalitis, such as" exact="Japanese encephalitis" post="(JEV), Acute Encephalitis Syndrome (AES), and West Nile encephalitis"/>
   <result pre="rate were reported (4). With these previous outbreaks, India's first" exact="SARS-CoV-2 infection" post="was identified in Kerala on January 30, 2020, and"/>
   <result pre="decades in Kerala (2000â€&quot;2020). Outbreaks Cases Death Chikungunya 2,720 NA" exact="Japanese encephalitis" post="59 11 Acute encephalitis syndrome (AES) 286 54 West"/>
   <result pre="encephalitis syndrome (AES) 286 54 West nile encephalitis 300 4" exact="Dengue" post="58,919 217 Viral hepatitis 69,284 119 Nipah 19 18"/>
   <result pre="established â€œwalk-in facilityâ€� centers for people to safely test for" exact="SARS-CoV-2 infection" post="(https://dashboard.kerala.gov.in/). In line with this, the state also established"/>
   <result pre="India, 2018. J Infect Dis. (2019) 219:1867â€&quot;78. 10.1093/infdis/jiy61230364984 5.ThomasBChandranPLilabiMPGeorgeBSivakumarCPJayadevVKet al.." exact="Nipah virus infection" post="in Kozhikode, Kerala, South India, in 2018: epidemiology of"/>
   <result pre="India. J Gen Virol. (2008) 89:1945â€&quot;8. 10.1099/vir.0.83628-018632966 10.BalakrishnanAThekkekareRJSapkalGTandaleBV. Seroprevalence of" exact="Japanese encephalitis" post="virus &amp;amp; West Nile virus in Alappuzha district, Kerala."/>
   <result pre="Kerala. Available online at: https://dhs.kerala.gov.in/wp-content/uploads/2020/05/6.Daily-Bulletin-HFWD-English-May-02.pdf (accessed May 2, 2020). 14.collab:" exact="Covid-19" post="Jagratha (2020). Available online at: https://covid19jagratha.kerala.nic.in/ (accessed May 27,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344048\results\search\zoonosis\results.xml">
   <result pre="stated in a credit line to the data. Abstract Background" exact="Severe acute respiratory syndrome" post="(SARS) has been initiating pandemics since the beginning of"/>
   <result pre="genomes were collected from The Global Initiative on Sharing All" exact="Influenza" post="Data (GISAID) database containing 9 genomes from pangolin-CoV origin"/>
   <result pre="achieved a global pandemic status and was recognised as novel" exact="Covid-19" post="disease (nCovid-19) [1]. The present coronavirus outbreak is associated"/>
   <result pre="have been deposited at The Global Initiative on Sharing Avian" exact="Influenza" post="Data (GISAID) [19] database and more sequences continue to"/>
   <result pre="of people [21]. In 2012, another novel coronavirus outbreak, termed" exact="Middle East respiratory syndrome" post="(MERS), caused over 400 fatalities and spread to over"/>
   <result pre="Collection of SARS-Cov-2 genome The Global Initiative on Sharing Avian" exact="Influenza" post="Data (GISAID) is headquartered in Munich, Germany and is"/>
   <result pre="out for data deposited up to 31 May 2020 (https://www.gisaid.org/)." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) Wuhan genome was collected from NCBI,"/>
   <result pre="and Africa regions [43]. Drug discovery and vaccine development against" exact="SARS-CoV-2 infection" post="require time and lengthy processes, however drug repurposing represents"/>
   <result pre="lopinavir/ritonavir, a 3CLpro and RdRp inhibitors, showed no benefit in" exact="Covid-19" post="adult patients [48]. The double point mutation in RdRp"/>
   <result pre="the development of mechanism-based and targeted therapeutic strategies to treat" exact="SARS-CoV-2 infection" post="and reduce its virulence. Supplementary information LINK Additional file"/>
   <result pre="sequence alignment of 3CLPro shares around 95% similarity. Abbreviations SARS-CoV-2" exact="Severe acute respiratory syndrome" post="coronavirus (nCovid-19) 3 CLPro 3-Chymotrypsin-like cysteine protease WHO World"/>
   <result pre="Protein Data Bank GISAID The Global Initiative on Sharing Avian" exact="Influenza" post="Data MERS Middle East respiratory syndrome RBD Receptor binding"/>
   <result pre="GISAID The Global Initiative on Sharing Avian Influenza Data MERS" exact="Middle East respiratory syndrome" post="RBD Receptor binding domain RdRP RNA-dependent RNA polymerase nt"/>
   <result pre="inhibitors: peptidomimetics and small molecule chemotherapyJ Med Chem2016596595662826878082 5.SeahIAgrawalRCan the" exact="coronavirus disease 2019" post="(COVID-19) affect the eyes? A review of coronaviruses and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344049\results\search\zoonosis\results.xml">
   <result pre="229E causes common cold symptoms while two other strain including" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) reported in the Middle East in 2012"/>
   <result pre="30) Preclinical â€&quot; [108] Influenza; SARS- CoV-2 RdRp Favipiravir Approved" exact="Influenza" post="[99, 109] Randomized trial SARS-CoV-2 SARS-CoV; SARS-CoV-2; RSV; HCV"/>
   <result pre="Remdesivir (GS-5734) Phase 3 SARS-CoV-2 [99, 109, 110] Phase 1" exact="Ebola" post="SARS-CoV-2; MERS-CoV; SARS-CoV; HCoV-229E; HIV; HPV 3CLpro Lopinavir Approved"/>
   <result pre="significantly increased in severe or critical patients with COVID-19, while" exact="SARS-CoV-2 infection" post="also increases secretion of anti-inflammatory cytokines (IL4 and IL10)"/>
   <result pre="rotavirus, reovirus, norovirus, enterovirus, parvovirus, and coronavirus [45]. IFN-Î» restricts" exact="Influenza" post="A virus (IAV) replication andÂ alleviates infectionâ€�induced morbidity, while"/>
   <result pre="O, Phelan A, et al. Baricitinib as potential treatment for" exact="2019-nCoV acute respiratory disease." post="Lancet 2020. 66.XieJZhangSHuYLiDCuiJXueJet al.Regulatory roles of c-jun in H5N1"/>
   <result pre="for COVID-19Front Immunol202011106132574262 95.MulanguSDoddLEDaveyRTJrTshiani MbayaOProschanMMukadiDet al.A randomized, controlled trial of" exact="Ebola" post="virus disease therapeuticsN Engl J Med2019381242293230331774950 96.ShenCWangZZhaoFYangYLiJYuanJet al.Treatment of"/>
   <result pre="MERS-CoVâ€&quot;infected rhesus macaquesNat Med201319101313131724013700 102.ChanJFChanK-HKaoRYToKKZhengB-JLiCPet al.Broad-spectrum antivirals for the emerging" exact="Middle East respiratory syndrome" post="coronavirusJ Infect201367660661624096239 103.KimUJWonE-JKeeS-JJungS-IJangH-CCase report combination therapy with lopinavir/ritonavir, ribavirin"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother20145884875488424841269 105.MadridPBChopraSMangerIDGilfillanLKeepersTRShurtleffACet al.A"/>
   <result pre="epidemic and zoonotic coronavirusesSci Transl Med20179396 111.ArabiYMAlothmanABalkhyHHAl-DawoodAAlJohaniSAl HarbiSet al.Treatment of" exact="Middle East respiratory syndrome" post="with a combination of lopinavir-ritonavir and interferon-Î²1b (MIRACLE trial):"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344768\results\search\zoonosis\results.xml">
   <result pre="Institute, China reported that cats and ferrets were susceptible to" exact="SARS-CoV-2 infection" post="whereas dogs, pigs, chickens and ducks were not permissive"/>
   <result pre="infection [36]. The World Organization for Animal Health has reported" exact="SARS-CoV-2 infection" post="in farmed minks, dogs, golden Syrian hamsters, cynomolgus and"/>
   <result pre="death [42,43]. Acute liver damage in patients with SARS or" exact="Influenza" post="has been reported in the past [24]. Severe cases"/>
   <result pre="in the development of a non-human primate model to study" exact="SARS-CoV-2 infection" post="for testing potential vaccines and antivirals. In addition to"/>
   <result pre="shown a positive effect in containing previous epidemics of SARS," exact="Ebola" post="and plague. Hence, immediate travel restrictions should have been"/>
   <result pre="and IgM antibodies produced in the body in response to" exact="SARS-CoV-2 infection." post="The registered serological kits claim to provide a result"/>
   <result pre="meta-analysisJ. Med. Virol.20209257758310.1002/jmv.2575732162702 10.WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in ChinaJ. Am. Med. Assoc.20203231239124210.1001/jama.2020.2648 11.WHO Coronavirus"/>
   <result pre="the COVID-19 outbreak in ChinaJ. Travel Med.202027taaa03710.1093/jtm/taaa03732181488 33.XieZ.Pay attention to" exact="SARS-CoV-2 infection" post="in childrenPediatr. Investig.202041410.1002/ped4.12178 34.YuanB.ChenY.ZhangK.WangC.Recurrence of positive SARS-CoV-2 Viral RNA"/>
   <result pre="Pipeline: An OverviewCurr. Trop. Med. Rep.20201410.1007/s40475-020-00201-6 52.WHO Draft Landscape of" exact="Covid-19" post="Candidate Vaccinesâ€&quot;27WHOGeneva, Switzerland52020 53.RauchS.JasnyE.SchmidtK.E.PetschB.New vaccine technologies to combat outbreak"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344800\results\search\zoonosis\results.xml">
   <result pre="difficult to distinguish from diseases caused by other arboviruses including" exact="Dengue" post="virus (DENV), Chikungunya, and West Nile virus [9]. Complications"/>
   <result pre="Island, Federated States of MicronesiaN. Engl. J. Med.20093602536254310.1056/NEJMoa080571519516034 11.LadhanimS.N.Oâ€™ConnorC.KirkbrideH.BrooksT.MorganD.Outbreak of" exact="Zika virus disease" post="in the Americas and the association with microcephaly, congenital"/>
   <result pre="virus 20 20 0 Yellow fever virus 15 15 0" exact="Japanese encephalitis" post="virus 3 3 0 Antinuclear antibodies 12 12 0"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344926\results\search\zoonosis\results.xml">
   <result pre="the transmission. Another member of the family Coronaviridae is the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), which was first reported by Saudi Arabia"/>
   <result pre="recently shown to be effective against other viral diseases, including" exact="Ebola" post="and the novel coronavirus (SARS-CoV-2) [21]. Clinical trials in"/>
   <result pre="used to better understand the proteins that are involved in" exact="SARS-CoV-2 infection" post="to help the search for potential targets for treatment."/>
   <result pre="has shown to be useful in the case of the" exact="Ebola" post="virus, uncovering a previously unknown structure of the viral"/>
   <result pre="used in the past to slow down epidemics such as" exact="Ebola" post="and HIV. While manual contact tracing is tedious and"/>
   <result pre="emerging RNA virusesAntivir. Res.2018153859410.1016/j.antiviral.2018.03.00329524445 21.GuedjJ.PiorkowskiG.JacquotF.MadelainV.NguyenT.H.T.RodallecA.GÃ¼ntherS.CarbonnelleC.MentrÃ©F.RaoulH.et al.Antiviral efficacy of favipiravir against" exact="Ebola" post="virus: A translational study in cynomolgus macaquesPLoS Med.201815e100253510.1371/journal.pmed.100253529584730 22.Chinese"/>
   <result pre="2020) 69.MIT Initiates Mass Manufacture of Disposable Face Shields for" exact="Covid-19" post="ResponseAvailable online: http://news.mit.edu/2020/face-shield-ppe-manufacture-covid-19-0331(accessed on 12 May 2020) 70.HappyShieldAvailable online:"/>
   <result pre="May 2020) 86.YanL.ZhangH.-T.XiaoY.WangM.SunC.LiangJ.LiS.ZhangM.GuoY.XiaoY.et al.Prediction of criticality in patients with severe" exact="Covid-19" post="infection using three clinical features: A machine learning-based prognostic"/>
   <result pre="using Weak LabelmedRxiv202010.1101/2020.03.12.20027185 88.DandekarR.BarbastathisG.Quantifying the effect of quarantine control in" exact="Covid-19" post="infectious spread using machine learningmedRxiv202010.1101/2020.04.03.20052084 89.HuZ.GeQ.LiS.JinL.XiongM.Artificial Intelligence Forecasting of"/>
   <result pre="Covid-19 infectious spread using machine learningmedRxiv202010.1101/2020.04.03.20052084 89.HuZ.GeQ.LiS.JinL.XiongM.Artificial Intelligence Forecasting of" exact="Covid-19" post="in ChinaarXiv2020[q-bio] 90.BershteynA.GerardinJ.BridenbeckerD.LortonC.W.BloedowJ.BakerR.S.Chabot-CoutureG.ChenY.FischleT.FreyK.et al.Implementation and applications of EMOD, an"/>
   <result pre="in an EpidemicarXiv2020[cs] 103.MaghdidH.S.GhafoorK.Z.SadiqA.S.CurranK.RabieK.A Novel AI-enabled Framework to Diagnose Coronavirus" exact="COVID 19" post="using Smartphone Embedded Sensors: Design StudyarXiv2020[cs, q-bio] 104.RaoA.S.R.S.VazquezJ.A.Identification of"/>
   <result pre="Available by SeptemberAvailable online: https://www.cbsnews.com/news/coronavirus-vaccine-september-oxford-university/(accessed on 12 May 2020) 120.LurieN.SavilleM.HatchettR.HaltonJ.Developing" exact="Covid-19" post="Vaccines at Pandemic SpeedN. Engl. J. Med.20203821969197310.1056/NEJMp200563032227757 121.AdministratorJ.Website Global"/>
   <result pre="of coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV), SARS-CoV-2, and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). Even though the fatality rate is not"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7345039\results\search\zoonosis\results.xml">
   <result pre="coronavirus (HCoV) causing severe acute respiratory syndrome (SARS-CoV) in 2003," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012, and the recent outbreak of"/>
   <result pre="combined with an immune response or cytokine storm induced by" exact="SARS-CoV-2 infection" post="could enhance the infection severity [32]. Since human-to-human transmission"/>
   <result pre="are no specific antiviral drugs or vaccine recommended specifically for" exact="SARS-CoV-2 infection" post="for potential therapy of humans till date, scientists are"/>
   <result pre="have not been addressed. Previous pandemics such as the H1N1," exact="Influenza" post="A caused high mortality rates in rural Turkey, and"/>
   <result pre="receptorProc. Natl. Acad. Sci. USA2009106199701997410.1073/pnas.090883710619901337 18.van DoremalenN.MiazgowiczK.L.Milne-PriceS.BushmakerT.RobertsonS.ScottD.KinneJ.McLellanJ.S.ZhuJ.MunsterV.J.Host species restriction of" exact="Middle East respiratory syndrome" post="coronavirus through its receptor, dipeptidyl peptidase 4J. Virol.2014889220923210.1128/JVI.00676-1424899185 19.HuangX.DongW.MilewskaA.GoldaA.QiY.ZhuQ.K.MarascoW.A.BaricR.S.SimsA.C.PyrcK.et"/>
   <result pre="Island, FL, USA2020 42.GuoY.R.CaoQ.D.HongZ.S.TanY.Y.ChenS.D.JinH.J.TanK.S.WangD.Y.YanY.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak-an update on the statusMil. Med. Res.202071110.1186/s40779-020-00240-032169119 43.ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.et"/>
   <result pre="Res.202071110.1186/s40779-020-00240-032169119 43.ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.et al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: A descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 44.MeoS.A.AlhowikanA.M.Al-KhlaiwiT.MeoI.M.HalepotoD.M.IqbalM.UsmaniA.M.HajjarW.AhmedN.Novel coronavirus 2019-nCoV:"/>
   <result pre="Wuhan, ChinaLancet202039549750610.1016/S0140-6736(20)30183-531986264 48.WangY.WangY.ChenY.QinQ.Unique epidemiological and clinical features of the emerging" exact="2019 novel coronavirus pneumonia" post="(COVID-19) implicate special control measuresJ. Med. Virol.20209210.1002/jmv.25748 49.GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.LiuL.ShanH.LeiC.L.HuiD.S.C.et al.China"/>
   <result pre="Med.2017910.1126/scitranslmed.aal3653 61.MulanguS.DoddL.E.DaveyR.T.Jr.Tshiani MbayaO.ProschanM.MukadiD.Lusakibanza ManzoM.NzoloD.Tshomba OlomaA.IbandaA.et al.A Randomized, Controlled Trial of" exact="Ebola" post="Virus Disease TherapeuticsN. Engl. J. Med.20193812293230310.1056/NEJMoa191099331774950 62.VincentM.J.BergeronE.BenjannetS.EricksonB.R.RollinP.E.KsiazekT.G.SeidahN.G.NicholS.T.Chloroquine is a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7345211\results\search\zoonosis\results.xml">
   <result pre="(Table 5). Negative results from serological tests do not exclude" exact="SARS-CoV-2 infection," post="as the â€˜window periodâ€™ (delay in the production of"/>
   <result pre="a significant role in identifying healthcare workers who recovered from" exact="SARS-CoV-2 infection," post="to assess their suitability to provide frontline health services."/>
   <result pre="clinical application of a rapid IgM-IgG combined antibody test for" exact="SARS-CoV-2 infection" post="diagnosisJ. Med. Virol.202010.1002/jmv.2572732104917 31.Independent Evaluations of COVID-19 Serological TestsAvailable"/>
   <result pre="S gene Real Time PCR Kit CE-IVD Co-diagnostics Logix Smart" exact="Coronavirus disease 2019" post="CE-IVD CTK Biotech, Inc. Aridia COVID-19 Real Time PCR"/>
   <result pre="nd - nd nd - - - - - -" exact="Influenza" post="A virus - - nd - - - -"/>
   <result pre="- - - - - - - - - -" exact="Influenza" post="B Virus nd - - - - - -"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7345743\results\search\zoonosis\results.xml">
   <result pre="replicationVet. Microbiol.201518125226010.1016/j.vetmic.2015.10.02126525739 66.BoruahB.M.LiuD.YeD.GuT.-j.JiangC.-l.QuM.WrightE.WangW.HeW.LiuC.et al.Single Domain Antibody Multimers Confer Protection against" exact="Rabies" post="InfectionPLoS ONE20138e7138310.1371/journal.pone.007138323977032 67.MolinkovÃ¡D.SklÃ¡dalP.CelerV.In vitro neutralization of equid herpesvirus 1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7346995\results\search\zoonosis\results.xml">
   <result pre="asthma is suggested to be not a predisposing condition for" exact="coronavirus disease 2019" post="(COVID-19) infection. However, patients with severe asthma/allergic disease requiring"/>
   <result pre="immunotherapy Funding Korea Health Industry Development Institutehttps://doi.org/10.13039/501100003710 HI16C0992 INTRODUCTION The" exact="coronavirus disease 2019" post="(COVID-19) outbreak has started from Wuhan in China in"/>
   <result pre="for Disease Control and PreventionReport on the epidemiological feature of" exact="coronavirus disease 2019" post="(COVID-19) Outbreak in the Republic of Korea from January"/>
   <result pre="Korean Med Sci202035e11232174069 4WuZMcGooganJMCharacteristics of and important lesson from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="inpatients in WuhanJ Allergy Clin Immunol2020S0091-6749(20)30495-4 13GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med20203821708172032109013 14ZhengXYXuYJGuanWJLinLFRegional, age and respiratory-secretion-specific"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7347348\results\search\zoonosis\results.xml">
   <result pre="emergency of international concern. The most common clinical manifestations of" exact="SARS-CoV-2 infection" post="are fever, cough, and dyspnea, however also muscle pain,"/>
   <result pre="in SARS-CoV and MERS-CoV infections (Mahallawi et al., 2018). Specifically," exact="SARS-CoV-2 infection" post="is characterized by persistent antigenic T cellsâ€™ activation leading"/>
   <result pre="patients treated with immunotherapy. For this latter group of patients," exact="SARS-CoV-2 infection" post="may represent a serious threat. In fact, the immune"/>
   <result pre="virus-specific CD4â€¯+â€¯T cells, showing features of exhausted lymphocytes. Patients with" exact="SARS-CoV-2 infection" post="have a markedly decreased number of NK and CD8â€¯+â€¯T"/>
   <result pre="interplay between immune system of oncologic patients receiving immunotherapy and" exact="SARS-CoV-2 infection" post="is extremely complex. What happens when a reinforced immune"/>
   <result pre="coronavirus infectionsJ. Pathol.235201518519525270030 GrivennikovS.I.GretenF.R.KarinM.Immunity, inflammation, and cancerCell140201088388920303878 GuanW.NiZ.LiangW.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN. Engl. J. Med.202010.1056/NEJMoa2002032 GuoF.F.CuiJ.W.The role of tumor-infiltrating"/>
   <result pre="a risk assessment score for patients with cancer during the" exact="coronavirus disease 2019" post="pandemicEur. J. Cancer1352020475010.1016/j.ejca.2020.05.01732534244 JaziehA.R.AlenaziT.H.AlhejaziA.Outcome of oncology patients infected with"/>
   <result pre="of COVID-19Ann. Intern. Med.202010.7326/M20-1133 LambertiniM.TossA.PassaroA.Cancer care during the spread of" exact="coronavirus disease 2019" post="(COVID-19) in Italy: young oncologistsâ€™ perspectiveESMO Open202010.1136/esmoopen-2020-000759 LennonH.SperrinM.BadrickE.RenehanA.G.The obesity"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7348116\results\search\zoonosis\results.xml">
   <result pre="May 28, 2020) 5.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7349555\results\search\zoonosis\results.xml">
   <result pre="while others only manifest mild or no symptoms. So far," exact="Covid-19" post="management remains mainly supportive. However, many researches are underway"/>
   <result pre="system and discusses recent findings on proposed pharmacologic treatments. coronavirus" exact="Covid-19" post="SARS-CoV-2 immune response T cell repertoire cytokine storm antiviral"/>
   <result pre="posing critical challenges for the medical community [1]. So far" exact="Covid-19" post="seems to be more contagious and more deadly than"/>
   <result pre="this number is reportedly around 1.3 [2,3]. Fatality rates for" exact="Covid-19" post="differ significantly in magnitude across countries. Discrepancies most likely"/>
   <result pre="under-ascertainment bias suggest that the overall case fatality rate of" exact="Covid-19" post="could be close to 1.38% [4]. However, taking into"/>
   <result pre="hovering 0.4â€&quot;0.7% [5]. These figures are lower than that of" exact="Severe acute respiratory syndrome" post="(SARS) and Middle East respiratory syndrome (MERS), which had"/>
   <result pre="lower than that of Severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS), which had case fatality rates around 10% and"/>
   <result pre="disease severity and mortality. As clinical and epidemiologic information on" exact="SARS-CoV-2 infection" post="have increased, a better knowledge on the burden of"/>
   <result pre="describes how distinct immune mechanisms may affect the fate of" exact="SARS-CoV-2 infection." post="2.1. A Possible Scenario of Covid-19 Immune Response with"/>
   <result pre="the fate of SARS-CoV-2 infection. 2.1. A Possible Scenario of" exact="Covid-19" post="Immune Response with Effective Recovery 2.1.1. Viral Entry via"/>
   <result pre="explain the involvement of these cells in severe cases of" exact="Covid-19" post="[19,30,31]. The ability of SARS-CoV-2 to infect enterocytes has"/>
   <result pre="primary role of endothelial cell infection and resulting endotheliitis in" exact="Covid-19" post="pathogenesis, which may lead to vasculopathy, coagulopathy, and multiple"/>
   <result pre="the suggestion to introduce prophylactic heparin in hospitalized patients with" exact="Covid-19" post="[35,36]. Overall, the occurrence of pulmonary vascular (micro)thrombosis and"/>
   <result pre="note, a trial with third party NK cells to treat" exact="Covid-19" post="is ongoing in China. 2.1.5. Activation of Dendritic Cells,"/>
   <result pre="CD8 T cells [64]. Interestingly, in a mouse model of" exact="SARS-CoV infection," post="removal of inflammatory macrophages protected the animals from lethal"/>
   <result pre="recovered patients has been proposed to treat patients with severe" exact="Covid-19" post="[70]. However, the development of protective antibodies is not"/>
   <result pre="disease, since two subjects with congenital agammaglobulinemia spontaneously recovered from" exact="Covid-19" post="pneumonia [71]. In contrast, subjects with common variable immunodeficiency,"/>
   <result pre="suggest that B cells may also be implied in severe" exact="Covid-19" post="pathogenesis. Non-protective antiviral antibodies may also be produced, which"/>
   <result pre="For example, subjects who recovered from a first infection with" exact="Dengue" post="virus may get infected again with worse course because"/>
   <result pre="presence of enhancing antibodies [75]. Similarly, subjects who recovered from" exact="Dengue" post="may undergo a severe course from Zika virus infection"/>
   <result pre="has been hypothesized also in subjects with severe course of" exact="Covid-19" post="in China, in areas that were previously hit by"/>
   <result pre="kinds of antibodies may be involved in the modulation of" exact="Covid-19" post="immunopathology. Liu et al. showed in an animal model"/>
   <result pre="immunopathology. Liu et al. showed in an animal model of" exact="SARS-CoV infection" post="that the presence of anti-spike IgG actually promoted proinflammatory"/>
   <result pre="[84]. 2.2. A Possible Scenario of Immune Response in Severe" exact="Covid-19" post="Hereafter, for explanatory purposes, we will consider the scenario"/>
   <result pre="Inflammation Induced Tissue Damage (Figure 1b VII) Tissue damage in" exact="Covid-19" post="is associated both with direct cytopathic action of the"/>
   <result pre="serum IFN-Î± and lymphocyte depletion was described in pigs with" exact="swine flu" post="[90] and confirmed in experimental models of viral infection"/>
   <result pre="cytokine mediated immune paralysis. Notably, lymphocytes from patients with severe" exact="Covid-19" post="often present an exhausted phenotype [92] and this may"/>
   <result pre="the immune response in a group of patients with severe" exact="Covid-19" post="with respiratory failure highlighted features supportive of either lymphocyte"/>
   <result pre="Age Gradient The risk of severe disease and death in" exact="Covid-19" post="increase directly with age. This increase is particularly significant"/>
   <result pre="were used to speculate on a possible increased susceptibility to" exact="SARS-CoV-2 infection" post="in patients under those treatments, or vice versa, if"/>
   <result pre="advice not to discontinue such therapies on the base of" exact="Covid-19" post="fear or actual disease. 3.1.2. T Cell Repertoire and"/>
   <result pre="that these changes are related to the higher severity of" exact="Covid-19" post="in the elderly. 3.1.4. Innate Immune System and Ageing"/>
   <result pre="elderly dysregulation of IFN pathways could contribute to lethality from" exact="SARS-CoV-2 infection" post="by determining the inability to control viral replication at"/>
   <result pre="In an in vitro model to examine the effects of" exact="influenza infection" post="on DC function, T-cell proliferation occurred at low multiplicities"/>
   <result pre="(HSV), including HSV encephalitis [50]. Whether patients who develop lethal" exact="Covid-19" post="infections harbor genetic variants predisposing to disease progression is"/>
   <result pre="Accordingly, primary immunodeficiencies might explain a proportion of the rare" exact="Covid-19" post="pediatric cases requiring intensive care. However, only a few"/>
   <result pre="severe varicella [120] or subjects with Cartilage Hair Hypoplasia [121]." exact="Covid-19" post="could also have a worse course in subjects with"/>
   <result pre="therapy [122]. 3.2.4. Immunodeficiencies Affecting Cytotoxic Functions Severe cases of" exact="Covid-19" post="have been associated with the development of secondary hemophagocytic"/>
   <result pre="and MERS coronaviruses, Nipah and Hendra paramyxoviruses, and Marburg and" exact="Ebola" post="filoviruses [128,129,130,131]. Understanding how can bats coexist with so"/>
   <result pre="A possible list of critical mechanisms affecting the fate of" exact="Covid-19" post="is proposed in Table 1. 6. Therapies under Evaluation"/>
   <result pre="bacterial superinfection are the mainstay of management in patients with" exact="SARS-CoV-2 infection." post="Many off-label and compassionate-use pharmacologic therapies are being used"/>
   <result pre="to prevail. Antivirals that have been used or proposed in" exact="Covid-19" post="include lopinavir/ritonavir, remdesivir, ribavirin, and favipiravir. So far, lopinavir/ritonavir"/>
   <result pre="received this treatment [142]. The first published randomized trial in" exact="Covid-19" post="was open-label and included 199 hospitalized adult patients with"/>
   <result pre="was open-label and included 199 hospitalized adult patients with confirmed" exact="SARS-CoV-2 infection." post="No adjunctive benefit in the time to clinical improvement,"/>
   <result pre="[144]. A small cohort of 53 patients hospitalized for severe" exact="Covid-19" post="were treated with remdesivir on compassionate-use bases [145]. Clinical"/>
   <result pre="randomized, double-blind, placebo-controlled, multicenter trial that included 237 patients with" exact="Covid-19" post="from China admitted to hospital with an interval from"/>
   <result pre="a small open-label non-randomized control study conducted in China in" exact="Covid-19" post="have been published recently [147]. In the study patients"/>
   <result pre="Ribavirin has been empirically included into various treatment protocols for" exact="Covid-19" post="even though there is little evidence for its efficacy"/>
   <result pre="possibly due to attenuation of IL6), for the treatment of" exact="Covid-19" post="has widely spread despite very limited efficacy data and"/>
   <result pre="A retrospective analysis of data from 368 hospitalized patients with" exact="Covid-19" post="across the United States investigated the risk of death"/>
   <result pre="April, the National Institute of Health expert panel that issued" exact="Covid-19" post="treatment guidelines recommended against the use, outside clinical trials,"/>
   <result pre="several proinflammatory cytokines driving the uncontrolled immune inflammatory response of" exact="Covid-19" post="have been measured in serum of patients who develop"/>
   <result pre="series, the repeated administration of tocilizumab to patients with severe" exact="Covid-19" post="was associated with rapid cessation of fever, improvement of"/>
   <result pre="prospective, case series on 100 patients admitted to hospital for" exact="Covid-19" post="pneumonia showed an improved or stable respiratory status in"/>
   <result pre="drugs seem to have a rationale for the treatment of" exact="Covid-19" post="associated inflammation. This is the case of anakinra, an"/>
   <result pre="[166]. Similarly, given the major role of inflammatory macrophages in" exact="Covid-19" post="immunopathogenesis, emapalumab, an anti-IFN-Î³ monoclonal antibody used for the"/>
   <result pre="potential treatment to prevent progression to needing intensive care in" exact="Covid-19" post="[168]. Elements supporting a role of anti-TNF-Î± are the"/>
   <result pre="the evidence of elevated TNF-Î± levels in patients with severe" exact="Covid-19" post="[158], and the biologic effects of anti-TNF-Î± therapy, which"/>
   <result pre="respiratory syncytial virus. Plasma from individuals who have recovered from" exact="Covid-19" post="containing antibodies to SARS-CoV-2 or specific antibody preparations derived"/>
   <result pre="safety concerns [175,176]. No experience with hyperimmune globulin products in" exact="Covid-19" post="has been published so far. Small clinical experiences have"/>
   <result pre="[65]. IFNs have been proposed as a potential treatment of" exact="Covid-19" post="for their in vitro and in vivo antiviral properties."/>
   <result pre="study reported a cohort of 12 patients hospitalized for moderate" exact="Covid-19" post="pneumonia who were treated with baricitinib in addition to"/>
   <result pre="lopinavir/ritonavir. Compared to the previous 12 consecutive patients with moderate" exact="Covid-19" post="admitted before study start, who were treated with lopinavir/ritonavir"/>
   <result pre="trials are ongoing. 6.7. Corticosteroids Corticosteroids have a rationale in" exact="Covid-19" post="for their potent anti-inflammatory effect and their potential role"/>
   <result pre="these experiences, further studies assessing the role of corticosteroids in" exact="Covid-19" post="would be of extreme importance, and several clinical trials"/>
   <result pre="clinical trials are ongoing. The U.S. National Institute of Health" exact="Covid-19" post="expert panel considered their use in severely ill patients"/>
   <result pre="significant proportion of patients (up to 30%) who recovered from" exact="Covid-19" post="develop low or absent neutralizing antibodies [9]. The reasons"/>
   <result pre="[207,208]. Recent observation in agammaglobulinemic patients of spontaneous recovery from" exact="SARS-CoV-2 infection" post="supports the hypothesis that T-cell immunity might be more"/>
   <result pre="thousands of research articles published each month, most knowledge on" exact="Covid-19" post="is derived from descriptive works. To date a possible"/>
   <result pre="Microbiol.20161452353410.1038/nrmicro.2016.8127344959 7.ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.et al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: A descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 8.ZhouF.YuT.DuR.FanG.LiuY.LiuZ.XiangJ.WangY.SongB.GuX.et al.Clinical course"/>
   <result pre="SchayckJ.MykytynA.Z.DuimelH.Q.et al.SARS-CoV-2 productively infects human gut enterocytesScience202010.1126/science.abc1669 33.WangX.ZhouY.JiangN.ZhouQ.MaW.L.Persistence of intestinal" exact="SARS-CoV-2 infection" post="in patients with COVID-19 leads to re-admission after pneumonia"/>
   <result pre="signalingJ. Virol.202010.1128/JVI.00099-20 49.ChannappanavarR.FehrA.R.ZhengJ.Wohlford-LenaneC.AbrahanteJ.E.MackM.SompallaeR.McCrayP.B.Jr.MeyerholzD.K.PerlmanS.IFN-I response timing relative to virus replication determines" exact="MERS coronavirus" post="infection outcomesJ. Clin. Investig.20191303625363910.1172/JCI126363 50.JingH.SuH.C.New immunodeficiency syndromes that help"/>
   <result pre="proximal origin of SARS-CoV-2Nat. Med.202010.1038/s41591-020-0820-9 128.LeroyE.M.KumulunguiB.PourrutX.RouquetP.HassaninA.YabaP.DelicatA.PaweskaJ.T.GonzalezJ.P.SwanepoelR.Fruit bats as reservoirs of" exact="Ebola" post="virusNature200543857557610.1038/438575a16319873 129.ClaytonB.A.WangL.F.MarshG.A.Henipaviruses: An updated review focusing on the pteropid"/>
   <result pre="the NOD-Like Receptor Protein 3 Inflammasome Is Protective in Juvenile" exact="Influenza" post="A Virus InfectionFront. Immunol.2017878210.3389/fimmu.2017.0078228740490 139.TateM.D.OngJ.D.H.DowlingJ.K.McAuleyJ.L.RobertsonA.B.LatzE.DrummondG.R.CooperM.A.HertzogP.J.MansellA.Reassessing the role of the"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov.2020610.1038/s41421-020-0156-0 152.GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraV.E.et al.Hydroxychloroquine and azithromycin as a"/>
   <result pre="Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Intern. Med.202010.1001/jamainternmed.2020.0994 189.NIH" exact="Covid-19" post="Treatment GuidelinesAvailable online: https://www.covid19treatmentguidelines.nih.gov(accessed on 5 May 2020) 190.AbbadiA.LoftisJ.WangA.YuM.WangY.ShakyaS.LiX.MaytinE.HascallV.Heparin"/>
   <result pre="For explanation, see paragraph 2.1. (b) Immune response in severe" exact="SARS-CoV-2 infection." post="T memory n.v. = non virus-specific. For explanation, see"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7350360\results\search\zoonosis\results.xml">
   <result pre="damage have already been raised, e.g., with a case of" exact="SARS-CoV-2 infection" post="concurrent with liver failure, without other apparent cause, recently"/>
   <result pre="members and others in the local population. In accordance with" exact="Influenza" post="A/HINI guidance, calcineurin inhibitors were stopped in seven patients"/>
   <result pre="Business Media LLCBerlin, Germany2015Volume 1282123 5.OtrompkeJ.Investigating treatment strategies for the" exact="Middle East respiratory syndrome" post="coronavirusPharm. J.201429310.1211/pj.2014.20066890 6.World Health Organization2004Available online: https://www.who.int/ith/diseases/sars/en/(accessed on 12"/>
   <result pre="study of a family clusterLancet202039551452310.1016/S0140-6736(20)30154-931986261 10.MizumotoK.KagayaK.ZarebskiA.ChowellG.Estimating the asymptomatic proportion of" exact="coronavirus disease 2019" post="(COVID-19) cases on board the Diamond Princess cruise ship,"/>
   <result pre="2019 novel coronavirus in Wuhan, ChinaLancet202039549750610.1016/S0140-6736(20)30183-531986264 16.GoyalP.ChoiJ.J.PinheiroL.C.SchenckE.J.ChenR.JabriA.SatlinM.J.CampionT.R.NahidM.RingelJ.B.et al.Clinical Characteristics of" exact="Covid-19" post="in New York CityN. Engl. J. Med.202010.1056/NEJMc201041932302078 17.GiacomelliA.PezzatiL.ContiF.BernacchiaD.SianoM.OreniL.RusconiS.GervasoniC.RidolfoA.L.RizzardiniG.et al.Self-reported"/>
   <result pre="challengesLancet Gastroenterol. Hepatol.2020542843010.1016/S2468-1253(20)30057-132145190 24.XieH.ZhaoJ.LianN.LinS.XieQ.ZhuoH.Clinical characteristics of non-ICU hospitalized patients with" exact="coronavirus disease 2019" post="and liver injury: A retrospective studyLiver Int.202010.1111/liv.14449 25.ChaiX.HuL.ZhangY.HanW.LuZ.KeA.ZhouJ.ShiG.FangN.FanJ.et al.Specific"/>
   <result pre="10 confirmed cases in Wuhan, ChinaEur. Urol.20207774875410.1016/j.eururo.2020.03.03932317180 52.KumarD.MorrisM.I.KottonC.FischerS.A.MichaelsM.G.AllenU.BlumbergE.A.GreenM.HumarA.IsonM.G.Guidance on Novel" exact="Influenza" post="A/H1N1 in Solid Organ Transplant Recipientsâ€ Arab. Archaeol. Epigr.200910182510.1111/j.1600-6143.2009.02960.x19958321"/>
   <result pre="the US epicenterArab. Archaeol. Epigr.202010.1111/ajt.15941 54.LippiG.PlebaniM.Procalcitonin in patients with severe" exact="coronavirus disease 2019" post="(COVID-19): A meta-analysisClin. Chim. Acta202050519019110.1016/j.cca.2020.03.00432145275 55.LurieN.SavilleM.HatchettR.HaltonJ.Developing Covid-19 Vaccines at"/>
   <result pre="severe coronavirus disease 2019 (COVID-19): A meta-analysisClin. Chim. Acta202050519019110.1016/j.cca.2020.03.00432145275 55.LurieN.SavilleM.HatchettR.HaltonJ.Developing" exact="Covid-19" post="Vaccines at Pandemic SpeedN. Engl. J. Med.20203821969197310.1056/NEJMp200563032227757 56.LiuM.A.A Comparison"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7351052\results\search\zoonosis\results.xml">
   <result pre="treatment compared to placebo group (Stockman et al., 2006). Similarly," exact="Middle East respiratory syndrome" post="(MERS)-CoV patients treated with steroids appeared to experience worse"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7352498\results\search\zoonosis\results.xml">
   <result pre="8000 confirmed cases [10]. In 2012, after ten years, the" exact="Middle East respiratory syndrome" post="â€œ(MERS)-CoVâ€� emerged in a universal outbreak, which was transmitted"/>
   <result pre="viruses (HCVs), influenza virus (e.g., H5N1, H1N1, etc.), cytomegaloviruses (CMV)," exact="Ebola" post="viruses, RSV, and SARS-CoVs [64]. Figure 5 and Figure"/>
   <result pre="49.LayqahL.A.EissaS.An electrochemical immunosensor for the corona virus associated with the" exact="Middle East respiratory syndrome" post="using an array of gold nanoparticle-modified carbon electrodesMikrochim. Acta201918622410.1007/s00604-019-3345-530847572"/>
   <result pre="agonist-loaded hollow polymeric nanoparticles for safe and effective vaccination against" exact="Middle East respiratory syndrome" post="coronavirusAdv. Funct. Mater.201929180761610.1002/adfm.20180761632313544 87.JungS.Y.KangK.W.LeeE.Y.SeoD.W.KimH.L.KimH.KwonT.ParkH.L.KimH.LeeS.M.et al.Heterologous primeâ€&quot;boost vaccination with adenoviral"/>
   <result pre="of virus-like particle mimetic nanovesicles displaying the S protein of" exact="Middle East respiratory syndrome" post="coronavirus using insect cellsJ. Biotechnol.201930617718410.1016/j.jbiotec.2019.10.00731614169 127.Sanchez-GuzmanD.Le GuenP.VilleretB.SolaN.Le BorgneR.GuyardA.KemmelA.CrestaniB.SallenaveJ.M.Garcia-VerdugoI.Silver nanoparticle-adjuvanted"/>
   <result pre="cellsJ. Biotechnol.201930617718410.1016/j.jbiotec.2019.10.00731614169 127.Sanchez-GuzmanD.Le GuenP.VilleretB.SolaN.Le BorgneR.GuyardA.KemmelA.CrestaniB.SallenaveJ.M.Garcia-VerdugoI.Silver nanoparticle-adjuvanted vaccine protects against lethal" exact="influenza infection" post="through inducing BALT and IgA-mediated mucosal immunityBiomaterials201921711930810.1016/j.biomaterials.2019.11930831279103 128.YeS.ShaoK.LiZ.GuoN.ZuoY.LiQ.LuZ.ChenL.HeQ.HanH.Antiviral Activity"/>
   <result pre="Intradermal [90] Gold NPs H1N1 Membrane matrix protein 2 (M2e)/CpG" exact="Influenza" post="Intranasal [91] Gold NPs FMDV a Viral protein Foot"/>
   <result pre="mouth disease Intradermal [92] Gold NPs H1N1, H3N2, H5N1 M2e/CpG" exact="Influenza" post="Intranasal [93] Chitosan NPs HBV b HBsAg Hepatitis B"/>
   <result pre="HBsAg Hepatitis B Intranasal [97] Î³-PGA NPs H1N1 Hemagglutinin (HA)" exact="Influenza" post="Intranasal [98] VLPs NV Capsid protein Norwalk virus infection"/>
   <result pre="H3N2 Structural proteins, e.g., HA, neuraminidase, NA, and matrix (M1)" exact="Influenza" post="Intramuscular [99] VLPs RV e 8-2/6/7-VLP Multiple proteins, e.g.,"/>
   <result pre="liposomes H1N1 M2, HA, NP/MPL j and trehalose 6,6â€² dimycolate" exact="Influenza" post="Intramuscular, intratracheal, intranasal [109] Cationic nanomicelles based on PSA"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7353929\results\search\zoonosis\results.xml">
   <result pre="syndrome coronavirus 2 (SARS-CoV-2) and is called as the novel" exact="coronavirus disease 2019" post="(COVID-19). The disease spreads across China and subsequently the"/>
   <result pre="epidemics so far: SARS-CoV-1 leading to SARS pandemic in 2003," exact="Middle East respiratory syndrome" post="(MERS) in 2013, and the novel coronavirus outbreak in"/>
   <result pre="coronavirus-infected pneumoniaN Eng J Med2020doi: 101056/NEJMoa2001316 10GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Eng J Med2020Last assessed on 2020 Apr"/>
   <result pre="therapeutic measuresZhonghua Shao Shang Za Zhi202036E00632174095 16collab: ICMRRevised Strategy of" exact="COVID19" post="Testing in India Version 3Last accessed on 2020 Mar"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7354589\results\search\zoonosis\results.xml">
   <result pre="animals in a Wuhan market (Hubei Province, China) [1,2], the" exact="coronavirus disease 2019" post="(COVID-19) quickly reached a planetary dimension forcing billions of"/>
   <result pre="full genome characterization of two beta CoV viruses related to" exact="Middle East respiratory syndrome" post="from bats in ItalyVirol. J.20171423910.1186/s12985-017-0907-129258555 14.AlhammadY.M.O.FehrA.R.The Viral Macrodomain Counters"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7354743\results\search\zoonosis\results.xml">
   <result pre="century, following severe acute respiratory syndrome (SARS) in 2002â€&quot;2003 and" exact="Middle East respiratory syndrome" post="(MERS) in 2012, which have not stopped yet. Since"/>
   <result pre="strains, as follows. The most well-known example is influenza vaccines." exact="Influenza" post="virusesÂ belong to the Orthomyxoviridae family and are characterized"/>
   <result pre="cell-mediated immunity [20]. Based on data gathered by the Global" exact="Influenza" post="Surveillance and Response System (GISRS), a partnership of 141"/>
   <result pre="virus-specific memory T cells in broad and long-term protection against" exact="SARS-CoV infection." post="This is important as the response of neutralizing Abs"/>
   <result pre="Infect Dis20122061636163823048169 19.SridharSBrokstadKACoxRJInfluenza Vaccination Strategies: Comparing Inactivated and Live Attenuated" exact="Influenza" post="VaccinesVaccines (Basel)20153237338926343192 20.Isakova-SivakIRudenkoLSafety, immunogenicity and infectivity of new live"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7354768\results\search\zoonosis\results.xml">
   <result pre="was the case in SARS (severe acute respiratory syndrome) or" exact="Ebola" post="(Ebola haemorrhagic fever) and the new Covid-19 infection. These"/>
   <result pre="respiratory syndrome) or Ebola (Ebola haemorrhagic fever) and the new" exact="Covid-19" post="infection. These dilemmas, whilst applicable to the population at"/>
   <result pre="causing pandemics such as SARS, pandemic influenza and the recent" exact="Covid-19" post="corona virus infection are transmitted through droplets. Vertical transmission"/>
   <result pre="maternal survival - even where maternal infection is life-threatening e.g." exact="swine flu" post="in late gestation. Other infections can be more detrimental"/>
   <result pre="of outbreaks, epidemics or pandemics. Moral dimensions relevant to the" exact="Covid-19" post="As Covid-19 became a major pandemic at the time"/>
   <result pre="epidemics or pandemics. Moral dimensions relevant to the Covid-19 As" exact="Covid-19" post="became a major pandemic at the time of writing"/>
   <result pre="public health considerations are matters for debate. The risk of" exact="Covid-19" post="to health care workers is well recognised and entails"/>
   <result pre="vary between individuals and communities. This is particularly relevant as" exact="Covid-19" post="is a notifiable disease. Numerical risk estimates, whilst relevant"/>
   <result pre="tests done outside the direct therapeutic framework. Testing positive for" exact="Covid-19" post="usually entails the requirement for isolation of the index"/>
   <result pre="close proximity. Members of staff can be the source of" exact="Covid-19" post="transmission to patients under their care. The need to"/>
   <result pre="women, who perhaps are not at higher risk from the" exact="Covid-19" post="exposing a generational divide. Rather than being seen as"/>
   <result pre="the potential implications of these disruptions. The clinical manifestations of" exact="Covid-19" post="vary from the asymptomatic or mild to severe and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7356537\results\search\zoonosis\results.xml">
   <result pre="epidemiological data related to ACS at the time of the" exact="Covid-19" post="pandemic; and learnings that have emerged so far from"/>
   <result pre="for optimal management of ACS patients with confirmed or suspected" exact="SARS-CoV-2 infection." post="acute coronary syndromes myocardial infarction STEMI Covid-19 infectious disease"/>
   <result pre="or suspected SARS-CoV-2 infection. acute coronary syndromes myocardial infarction STEMI" exact="Covid-19" post="infectious disease respiratory infections pathophysiology percutaneous coronary intervention thrombolysis"/>
   <result pre="30 January 2020, the World Health Organization (WHO) declared the" exact="Covid-19" post="outbreak a public health emergency of international concern, and"/>
   <result pre="might have an increased risk of death [5,6,7]. Moreover, the" exact="Covid-19" post="outbreak has put a lot of pressure on overloaded"/>
   <result pre="in Lombardy (Italy) and more generally in Northern Italy, where" exact="Covid-19" post="has spread very rapidly, causing concern regarding the capacity"/>
   <result pre="and a common guidance on how to handle ACS in" exact="Covid-19" post="and non-Covid-19 patients is needed. The aim of this"/>
   <result pre="some light on those issues, analyzing possible physiopathological links between" exact="Covid-19" post="and ACS and evaluating the best strategy to balance"/>
   <result pre="to balance optimal ACS management and infectious risks related to" exact="Covid-19" post="outbreak. 2. Acute Coronary Syndromes and COVID-19 2.1. Pathophysiology"/>
   <result pre="a two-fold increased risk of AMI in patients with recent" exact="influenza infection" post="or respiratory tract infection; a recent influenza infection, influenza-like"/>
   <result pre="with recent influenza infection or respiratory tract infection; a recent" exact="influenza infection," post="influenza-like illness, or other respiratory tract infection was significantly"/>
   <result pre="Vejpongsa et al. also showed that AMI patients with concomitant" exact="influenza infection" post="or other viral respiratory infections were less likely to"/>
   <result pre="highlighted and related to what is currently happening during this" exact="Covid-19" post="pandemic, given that patients infected with SARS-CoV-2 virus seem"/>
   <result pre="between severe acute respiratory syndromes, thrombophilia, and subsequently ACS. Additionally," exact="Middle East respiratory syndrome" post="(MERS), which was first reported in 2012 in Saudi"/>
   <result pre="lacking. Alhogbani reported a case of a 60-year-old patient with" exact="MERS coronavirus" post="(MERS-CoV) infection who presented with respiratory symptoms, chest pain,"/>
   <result pre="with Covid-19: What We Know Although the clinical manifestations of" exact="Covid-19" post="are dominated by respiratory symptoms, evidence of myocardial injury"/>
   <result pre="may have a relevant role in worsening clinical outcomes in" exact="Covid-19" post="patients, even without clear evidence of myocardial ischemia. Indeed,"/>
   <result pre="Shi et al., conducted on a cohort of 416 consecutive" exact="Covid-19" post="patients in Wuhan, China, cardiac injury was found in"/>
   <result pre="that cTnI values were significantly increased in patients with severe" exact="SARS-CoV-2 infection" post="compared to those with milder forms of disease [68]."/>
   <result pre="onset of acute myocardial injury related to myocardial ischemia in" exact="SARS-CoV-2 infection" post="have been proposed. Some of them may resemble the"/>
   <result pre="differential diagnosis in many cases. Furthermore, specific damage caused by" exact="SARS-CoV-2 infection" post="might be related to angiotensin-converting enzyme 2 (ACE2) receptors,"/>
   <result pre="Where did All the STEMIs Go? The relevant impact of" exact="Covid-19" post="pandemic is related to the diagnosis and management of"/>
   <result pre="catheterizations). The EMS is now focused on dealing with the" exact="Covid-19" post="outbreak, so less resources are available to cope with"/>
   <result pre="staff, who are either sick or committed to handling the" exact="Covid-19" post="emergency. In order to avoid SARS-CoV-2 spreading, on 8"/>
   <result pre="1 of those should be dedicated to suspected or diagnosed" exact="Covid-19" post="patients, so that the most appropriate protocol can be"/>
   <result pre="between risks related to untimely treatment of ACS patients and" exact="SARS-CoV-2 infection" post="control has become a global challenge. Commonly, regional reperfusion"/>
   <result pre="[81]. Despite this clinical evidence, to cope with the abrupt" exact="Covid-19" post="outbreak, case decisions were individualized at the beginning of"/>
   <result pre="STEMI patients, thrombolytic therapy was recommended over primary PCI if" exact="Covid-19" post="was confirmed or could not be excluded within a"/>
   <result pre="short time, while for NSTEMIâ€&quot;UA, the priority was to exclude" exact="SARS-CoV-2 infection" post="first, since door-to-balloon time is less crucial in those"/>
   <result pre="are undoubtedly useful for minimizing and controlling the spread of" exact="SARS-CoV-2 infection," post="but data on the outcomes of ACS patients are"/>
   <result pre="a first therapy to treat STEMI in confirmed or suspected" exact="Covid-19" post="patients are not associated with worse outcomes. Indeed, despite"/>
   <result pre="thrombolysis. Stefanini et al. performed a retrospective analysis on 28" exact="Covid-19" post="patients who were admitted for STEMI: they found that"/>
   <result pre="PCI were reported among more than 900 patients admitted for" exact="SARS-CoV-2 infection," post="as of May 5, 2020, suggesting a possible link"/>
   <result pre="first case series from New York City (USA) described 18" exact="Covid-19" post="patients with ST-segment elevation indicating potential AMI; among those"/>
   <result pre="(AHA) published guidance on the management of AMI during the" exact="Covid-19" post="pandemic in the US [89,90]. These guidelines state that"/>
   <result pre="although door-to-balloon times are expected to be longer during the" exact="Covid-19" post="pandemic, a primary PCI strategy should remain the first"/>
   <result pre="feasibility of performing PCI in facilities approved for treatment of" exact="Covid-19" post="patients, avoiding potentially harmful thrombolysis, in compliance with adequate"/>
   <result pre="in American guidelines on the management of AMI during the" exact="Covid-19" post="pandemic [89]. An efficacious strategy could be to organize"/>
   <result pre="Interventional Cardiology (CAIC) announced the formation of the North American" exact="Covid-19" post="ST-Segment Elevation Myocardial Infarction Registry (NACMI) [92], which hopefully"/>
   <result pre="are needed to detect and characterize patients with STEMI and" exact="Covid-19" post="and to optimize treatment. 3.3. Organization Issues for Workers"/>
   <result pre="that device times in catheterization labs were higher during the" exact="Covid-19" post="outbreak when compared to 2018â€&quot;2019 times during office and"/>
   <result pre="conducted by Cao et al., hospitalized adult patients with severe" exact="Covid-19" post="showed no benefit with lopinavirâ€&quot;ritonavir treatment beyond standard care,"/>
   <result pre="health care utilization, or quality of life in patients with" exact="Covid-19" post="using aspirin and other non-steroidal anti-inflammatory drugs (NSAIDS) has"/>
   <result pre="low-dose aspirin can be safely used as antiplatelet drug in" exact="Covid-19" post="patients. Additionally, atorvastatin and rosuvastatin should be started at"/>
   <result pre="eventually be related to myocardial injury. Antivirals drugs used for" exact="SARS-CoV-2 infection" post="treatment may have potential interactions with oral anticoagulants (OACs)."/>
   <result pre="moreover, the first evidence showed decreased mortality in most severe" exact="Covid-19" post="patients with coagulopathy [111]. Drugs that are potentially useful"/>
   <result pre="summarized in Table 4. 4. Conclusions Despite being eclipsed by" exact="Covid-19" post="outbreak, acute coronary syndromes are still a major cause"/>
   <result pre="especially because of the possible physiopathological links (currently unexplored) with" exact="SARS-CoV-2 infection." post="Given the limited heterogeneity of data published in recent"/>
   <result pre="in recent months, the potential overlapping symptomatology between ACS and" exact="SARS-CoV-2 infection," post="and the underestimation of ACS cases during Covid-19 outbreak,"/>
   <result pre="and SARS-CoV-2 infection, and the underestimation of ACS cases during" exact="Covid-19" post="outbreak, more reliable data are needed to estimate the"/>
   <result pre="pandemic. Although reports to date suggest that cTn elevation in" exact="Covid-19" post="may be related more to myocardial injury or type"/>
   <result pre="to properly understand all mechanisms that may induce ACS in" exact="SARS-CoV-2 infection." post="All efforts made during the last decades to develop"/>
   <result pre="be forgotten. Specific protocols to balance infective risks related to" exact="Covid-19" post="and optimal ACS management should be implemented (especially STEMI),"/>
   <result pre="expert commentary on how to manage ischemic patients during the" exact="Covid-19" post="pandemic due to their expertise in treating coronary artery"/>
   <result pre="myocardial involvement, and on infectious risk in ischemic patients during" exact="Covid-19" post="pandemic due to his expertise in infectious disease. G.B.-Z.,"/>
   <result pre="ChinaJAMA Cardiol.202010.1001/jamacardio.2020.095032211816 7.GuoT.FanY.ChenM.WuX.ZhangL.HeT.WangH.WanJ.WangX.LuZ.Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.101732219356 8.RemuzziA.RemuzziG.COVID-19 and Italy: What next?Lancet20203951225122810.1016/S0140-6736(20)30627-932178769 9.EisenA.GiuglianoR.P.BraunwaldE.Updates on"/>
   <result pre="http://www.emro.who.int/health-topics/mers-cov/mers-outbreaks.html(accessed on 16 April 2020) 56.BadawiA.RyooS.G.Prevalence of comorbidities in the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV): A systematic review and meta-analysisInt. J. Infect."/>
   <result pre="meta-analysisInt. J. Infect. Dis.20164912913310.1016/j.ijid.2016.06.01527352628 57.MatsuyamaR.NishiuraH.KutsunaS.HayakawaK.OhmagariN.Clinical determinants of the severity of" exact="Middle East respiratory syndrome" post="(MERS): A systematic review and meta-analysisBMC Public Health20161610.1186/s12889-016-3881-4 58.ParkJ.E.JungS.KimA.MERS"/>
   <result pre="cardiovascular systemNat. Rev. Cardiol.20201725926010.1038/s41569-020-0360-532139904 68.LippiG.LavieC.J.Sanchis-GomarF.Cardiac troponin I in patients with" exact="coronavirus disease 2019" post="(COVID-19): Evidence from a meta-analysisProg. Cardiovasc. Dis.202010.1016/j.pcad.2020.03.00132169400 69.ClerkinK.J.FriedJ.A.RaikhelkarJ.SayerG.GriffinJ.M.MasoumiA.JainS.S.BurkhoffD.KumaraiahD.RabbaniL.R.et al.Coronavirus"/>
   <result pre="76.De FilippoO.Dâ€™AscenzoF.AngeliniF.BocchinoP.P.ConrottoF.SagliettoA.SeccoG.G.CampoG.GalloneG.VerardiR.et al.Reduced rate of hospital admissions for ACS during" exact="Covid-19" post="outbreak in northern ItalyN. Engl. J. Med.202010.1056/NEJMc200916632343497 77.TamC.C.F.CheungK.S.LamS.WongA.YungA.SzeM.LamY.M.ChanC.TsangT.C.TsuiM.et al.Impact"/>
   <result pre="outbreak in northern ItalyN. Engl. J. Med.202010.1056/NEJMc200916632343497 77.TamC.C.F.CheungK.S.LamS.WongA.YungA.SzeM.LamY.M.ChanC.TsangT.C.TsuiM.et al.Impact of" exact="coronavirus disease 2019" post="(COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong"/>
   <result pre="immunoglobulinEur. Heart J.202010.1093/eurheartj/ehaa190 87.InciardiR.M.LupiL.ZacconeG.ItaliaL.RaffoM.TomasoniD.CaniD.S.CeriniM.FarinaD.GavazziE.et al.Cardiac involvement in a patient with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.109632219357 88.BangaloreS.SharmaA.SlotwinerA.YatskarL.HarariR.ShahB.IbrahimH.FriedmanG.H.ThompsonC.AlviarC.L.et al.ST-segment elevation in patients with covid-19â€&quot;A"/>
   <result pre="Are we taking care of healthcare workers in the Italian" exact="Covid-19" post="outbreak?J. Hosp. Infect.202010.1016/j.jhin.2020.04.04532387745 97.ChuC.M.ChengV.C.C.HungI.F.N.WongM.M.L.ChanK.H.ChanK.S.KaoR.Y.T.PoonL.L.M.WongC.L.P.GuanY.et al.Role of lopinavir/ritonavir in the"/>
   <result pre="for patients, health care workers, and health systems during the" exact="coronavirus disease 2019" post="(COVID-19) pandemicJ. Am. Coll. Cardiol.202010.1016/j.jacc.2020.03.031 102.LittleP.Non-steroidal anti-inflammatory drugs and"/>
   <result pre="in patients with covid-19N. Engl. J. Med.20203821653165910.1056/NEJMsr200576032227760 108.SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): A reviewJAMA202010.1001/jama.2020.6019 109.PetersonD.Van ErmenA.Increased warfarin requirements in a"/>
   <result pre="Pharmacol.20174211511810.1111/jcpt.12475 111.TangN.BaiH.ChenX.GongJ.LiD.SunZ.Anticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathyJ. Thromb. Haemost.202010.1111/jth.1481732220112 112.ValgimigliM.BuenoH.ByrneR.A.ColletJ.P.CostaF.JeppssonA.JÃ¼niP.KastratiA.KolhP.MauriL.et al.2017 ESC focused"/>
   <result pre="Kwong et al., 2018, New England Journal of Medicine [43]" exact="Influenza" post="A/B, RSV, adenovirus, CoV, enterovirus (including rhinovirus), HPIV, and"/>
   <result pre="= 19,045 Warren-Gash et al., 2013, British Medical Journal [44]" exact="Influenza" post="A H1N1 Respiratory tract infection developed within one month"/>
   <result pre="= 123 Ruane et al., 2017, Internal Medicine Journal, [50]" exact="Influenza" post="Association between STEMI and influenza epidemic Angiographically confirmed STEMI"/>
   <result pre="HPIV: human parainfluenza virus; ICD: international classification of diseases; MERS:" exact="Middle East respiratory syndrome;" post="MI: myocardial infarction; NA: not available, NSTEMI: myocardial infarction"/>
   <result pre="artery diseaseâ€&quot;evidence and potential interactions with drugs used to treat" exact="SARS-CoV-2 infection." post="Therapy Potential Interactions Evidence Notes P2Y12 inhibitor: -Clopidogrel -Ticagrelor"/>
   <result pre="Aspirin - Lack of evidence on discontinuation of aspirin in" exact="Covid-19" post="patients. Low-dose aspirin can be assumed to be safe"/>
   <result pre="can be assumed to be safe as antiplatelet drug in" exact="Covid-19" post="patients [103]. Statins: -Atorvastatin -Rosuvastatin -Lovastatin -Simvastatin Lopinavirâ€&quot;Ritonavir When"/>
   <result pre="the use of these medications with an increased risk of" exact="Covid-19" post="acquisition or illness severity [108]. Abrupt withdrawal in high-risk"/>
   <result pre="[107,108]. Heparin - First evidences showed decreased mortality in severe" exact="Covid-19" post="patients with coagulopathy [111]. Given the interactions between some"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7356583\results\search\zoonosis\results.xml">
   <result pre="intubation have been reported in studies investigating statin therapy in" exact="influenza infection," post="and statin therapy was shown to increase viral clearance"/>
   <result pre="atherosclerosis cholesterol coronavirus COVID-19 lipid-lowering therapy SARS-CoV-2 statins 1. Introduction" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), responsible for the current pandemic of"/>
   <result pre="further supported by examining the effect of depleting cholesterol on" exact="SARS-CoV infection," post="which resulted in a significant reduction in viral mRNA"/>
   <result pre="been reported in previous viral epidemics such as SARS-CoV and" exact="Middle East respiratory syndrome" post="(MERS), which have been characterised by cytokine storms resulting"/>
   <result pre="the course of COVID-19. While myalgias are easily attributable to" exact="SARS-CoV-2 infection" post="in statin untreated patients, their differential diagnosis may be"/>
   <result pre="in Wuhan, ChinaJAMA20203231061106910.1001/jama.2020.158532031570 5.WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in china: Summary of a report of"/>
   <result pre="and preventionJAMA20203231239124210.1001/jama.2020.264832091533 6.GuoT.FanY.ChenM.WuX.ZhangL.HeT.WangH.WanJ.WangX.LuZ.Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.1017 7.SahebkarA.KotaniK.SerbanC.UrsoniuS.MikhailidisD.P.JonesS.R.RayK.K.BlahaM.J.RyszJ.TothP.P.et al.Statin therapy reduces plasma endothelin-1 concentrations:"/>
   <result pre="COVID-19â€&quot;Can we end this viral series?Arch. Med. Sci.202010.5114/aoms.2020.96497 25.BonowR.O.FonarowG.C.Oâ€™GaraP.T.YancyC.W.Association of" exact="coronavirus disease 2019" post="(COVID-19) with myocardial injury and mortalityJAMA Cardiol.202010.1001/jamacardio.2020.1105 26.ChannappanavarR.PerlmanS.Pathogenic human"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7356825\results\search\zoonosis\results.xml">
   <result pre="that is heavily affected by arboviral diseases caused by dengue," exact="Japanese encephalitis," post="West Nile, Zika, and chikungunya viruses. Major gaps in"/>
   <result pre="groups: flaviviruses and alphaviruses. These include the dengue virus (DENV)," exact="Japanese encephalitis" post="virus (JEV), West Nile virus (WNV), and Zika virus"/>
   <result pre="as yellow fever virus and hepatitis C virus (HCV). 2.1." exact="Dengue" post="Virus (DENV) Transmitted by the Aedes aegypti and Aedes"/>
   <result pre="agent exists for dengue and treatment is mainly supportive. 2.2." exact="Japanese Encephalitis" post="Virus (JEV) JEV is the leading cause of viral"/>
   <result pre="mosquitoes, pigs and/or wading water birds; humans are incidental hosts." exact="Japanese encephalitis" post="is primarily a disease of children, with ~75% of"/>
   <result pre="symptoms [40]. The majority of people with symptoms will develop" exact="West Nile fever," post="and only a small number will progress to severe"/>
   <result pre="and future arboviral threatsAntivir. Res.20108532834510.1016/j.antiviral.2009.10.00819857523 9.collab: World Health OrganizationFact Sheet:" exact="Dengue" post="and Severe DengueAvailable online: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue(accessed on 1 April 2020)"/>
   <result pre="A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 15.collab: Sanofi PasteurPress Release: DengvaxiaÂ®, Worldâ€™s First" exact="Dengue" post="Vaccine, Approved in MexicoAvailable online: https://www.sanofi.com/en/media-room/press-releases/2015/2015-12-09-16-30-00(accessed on 9 April"/>
   <result pre="of Flavonoids: An OverviewSci. World J.2013201316275010.1155/2013/16275024470791 21.SuroowanS.MahomoodallyF.RagooL.Management and Treatment of" exact="Dengue" post="and Chikungunya-Natural Products to the RescueComb. Chem. High Throughput"/>
   <result pre="reviewEXCLI J.201918988100610.17179/excli2019-182531762724 23.OliveiraA.F.TeixeiraR.R.OliveiraA.S.SouzaA.P.SilvaM.L.PaulaS.O.Potential Antivirals: Natural Products Targeting Replication Enzymes of" exact="Dengue" post="and Chikungunya VirusesMolecules20172250510.3390/molecules22030505 24.BradyO.J.GethingP.W.BhattS.MessinaJ.P.BrownsteinJ.S.HoenA.G.MoyesC.L.FarlowA.W.ScottT.W.HayS.I.Refining the global spatial limits of"/>
   <result pre="in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and" exact="Dengue" post="VirusClin. Infect. Dis.2016631584159010.1093/cid/ciw58927578819 27.SridharS.LuedtkeA.LangevinE.ZhuM.BonaparteM.MachabertT.SavarinoS.ZambranoB.MoureauA.KhromavaA.et al.Effect of Dengue Serostatus on"/>
   <result pre="Chikungunya Virus, and Dengue VirusClin. Infect. Dis.2016631584159010.1093/cid/ciw58927578819 27.SridharS.LuedtkeA.LangevinE.ZhuM.BonaparteM.MachabertT.SavarinoS.ZambranoB.MoureauA.KhromavaA.et al.Effect of" exact="Dengue" post="Serostatus on Dengue Vaccine Safety and EfficacyN. Engl. J."/>
   <result pre="Dengue VirusClin. Infect. Dis.2016631584159010.1093/cid/ciw58927578819 27.SridharS.LuedtkeA.LangevinE.ZhuM.BonaparteM.MachabertT.SavarinoS.ZambranoB.MoureauA.KhromavaA.et al.Effect of Dengue Serostatus on" exact="Dengue" post="Vaccine Safety and EfficacyN. Engl. J. Med.201837932734010.1056/NEJMoa180082029897841 28.collab: Sanofi"/>
   <result pre="J. Med.201837932734010.1056/NEJMoa180082029897841 28.collab: Sanofi PasteurPress Release: Sanofi Updates Information on" exact="Dengue" post="VaccineAvailable online: https://www.sanofi.com/en/media-room/press-releases/2017/2017-11-29-17-36-30(accessed on 9 April 2020) 29.HadinegoroS.R.Arredondo-GarcÃ­aJ.L.CapedingM.R.DesedaC.ChotpitayasunondhT.DietzeR.Hj Muhammad"/>
   <result pre="2020) 29.HadinegoroS.R.Arredondo-GarcÃ­aJ.L.CapedingM.R.DesedaC.ChotpitayasunondhT.DietzeR.Hj Muhammad IsmailH.I.ReynalesH.LimkittikulK.Rivera-MedinaD.M.et al.Efficacy and Long-Term Safety of a" exact="Dengue" post="Vaccine in Regions of Endemic DiseaseN. Engl. J. Med.20153731195120610.1056/NEJMoa150622326214039"/>
   <result pre="33.SolomonT.Japanese encephalitisJ. Neurol. Neurosurg. Psychiatry20006840541510.1136/jnnp.68.4.40510727474 34.Van GesselY.KladeC.S.PutnakR.FormicaA.KrasaesubS.SpruthM.CenaB.TungtaengA.GettayacaminM.DewasthalyS.Correlation of protection against" exact="Japanese encephalitis" post="virus and JE vaccine (IXIAROÂ®) induced neutralizing antibody titersVaccine2011295925593110.1016/j.vaccine.2011.06.06221723353"/>
   <result pre="Polynesia, South Pacific, 2013Emerg. Infect. Dis.2014201084108610.3201/eid2006.14013824856001 49.Dupont-RouzeyrolM.Oâ€™ConnorO.CalvezE.DaurÃ¨sM.JohnM.GrangeonJ.-P.GourinatA.-C.Co-infection with Zika and" exact="Dengue" post="Viruses in 2 Patients, New Caledonia, 2014Emerg. Infect. Dis.20152138138210.3201/eid2102.14155325625687"/>
   <result pre="activityParasites Vectors2014713010.1186/1756-3305-7-13024678592 83.JohariJ.KianmehrA.MustafaM.AbubakarS.ZandiK.Antiviral Activity of Baicalein and Quercetin against the" exact="Japanese Encephalitis" post="VirusInt. J. Mol. Sci.201213167851679510.3390/ijms13121678523222683 84.PancheA.N.DiwanA.D.ChandraS.R.Flavonoids: An overviewJ. Nutr. Sci.2016510.1017/jns.2016.41"/>
   <result pre="Gallate against the Flaviviruses West Nile Virus, Zika Virus, and" exact="Dengue" post="VirusFront. Microbiol.2017810.3389/fmicb.2017.01314 93.ColpittsC.C.SchangL.M.A Small Molecule Inhibits Virion Attachment to"/>
   <result pre="103.FangC.-Y.ChenS.-J.WuH.-N.PingY.-H.LinC.-Y.ShiuanD.ChenC.-L.LeeY.-R.HuangK.-J.Honokiol, a Lignan Biphenol Derived from the Magnolia Tree, Inhibits" exact="Dengue" post="Virus Type 2 InfectionViruses201574894491010.3390/v709285226378567 104.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DesprÃ¨sP.El-KalamouniC.The Flavonoid Isoquercitrin Precludes Initiation"/>
   <result pre="Medicinal Plant from Reunion Island, Inhibits the Early Stages of" exact="Dengue" post="and Zika Virus InfectionInt. J. Mol. Sci.201920186010.3390/ijms20081860 114.LaniR.HassandarvishP.ChiamC.W.MoghaddamE.ChuJ.J.H.RausaluK.MeritsA.HiggsS.VanlandinghamD.Abu BakarS.et"/>
   <result pre="Analysis of the molecular mechanisms involvedJ. Dermatol. Sci.20074725325510.1016/j.jdermsci.2007.05.00917600687 132.MaroisI.CloutierA.MeunierI.WeingartlH.M.CantinA.M.RichterM.V.Inhibition of" exact="Influenza" post="Virus Replication by Targeting Broad Host Cell PathwaysPLoS ONE20149e11063110.1371/journal.pone.011063125333287"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7356962\results\search\zoonosis\results.xml">
   <result pre="encouraging the use of herbal and medicinal plants in fighting" exact="SARS-CoV-2 infection" post="[15,16,17,21,22,24,25,26,29,30]. After the outbreak of SARS-CoV, first described in"/>
   <result pre="2020Infect. Dis. Model.2020525626332110742 10.GuoY.R.CaoQ.D.HongZ.S.TanY.Y.ChenS.D.JinH.J.YanY.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;an update on the statusMilit. Med. Res.2020711010.1186/s40779-020-00240-0 11.HuB.GeX.WangL.F.ShiZ.Bat"/>
   <result pre="PandemicAvailable online: www.worldometers.info/coronavirus/(accessed on 23 May 2020) 37.GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.DuB.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN. Engl. J. Med.20203821708172010.1056/NEJMoa200203232109013 38.ZhengY.Y.MaY.T.ZhangJ.Y.XieX.COVID-19 and the cardiovascular"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7357070\results\search\zoonosis\results.xml">
   <result pre="viruses, such as West Nile virus, human papillomaviruses, Zika, Dengue," exact="Ebola" post="viruses, and HIV. The dangerous spreading of SARS-CoV-2 has"/>
   <result pre="to that of SARS-CoV-2, we also evaluated texts associated with" exact="Dengue" post="virus and determined an overlap between the proteins relevant"/>
   <result pre="a similar profile of molecular pathways for proteins shared by" exact="Dengue" post="virus and SARS-CoV-2 to that for proteins shared by"/>
   <result pre="the replication of certain viruses, including HIV-1, Sindbis virus, and" exact="Ebola" post="virus [57]. Some proteins, such as interferon gamma, interferon"/>
   <result pre="a role of some signaling pathways in both HIV-1 ad" exact="SARS-CoV-2 infection." post="To perform the pathway enrichment analysis, first we manually"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7358098\results\search\zoonosis\results.xml">
   <result pre="a safe and effective approach for PML and PML-associated cancers." exact="Influenza" post="Influenza, a highly contagious respiratory disease, is responsible for"/>
   <result pre="syndrome was not addressed in these studies.54 In rare cases," exact="influenza infection" post="and vaccination are associated with the occurrence of organ-specific"/>
   <result pre="influenza cases. In this context, Yu et al66 reported that" exact="influenza infection" post="substantially increases the number of highly PD-1 positive innate"/>
   <result pre="in response to infectious agents.71 Similar to SARS-COV and the" exact="Middle East respiratory syndrome" post="(MERS-COV), SARS-COV-2 is associated with increased amounts of proinflammatory"/>
   <result pre="ICI could safely be employed in cancer patients with a" exact="SARS-CoV-2 infection" post="and even COVID-19. As long as there is no"/>
   <result pre="al.Reduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVID-19). Front Immunol2020;11:827. 10.3389/fimmu.2020.0082732425950 72HuangC, WangY, LiX, et al.Clinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7358456\results\search\zoonosis\results.xml">
   <result pre="is now clear that no country is immune to the" exact="SARS-CoV-2 infection." post="Resource-poor countries with weaker health systems are struggling with"/>
   <result pre="Here, we propose trehalose as a potential preventative treatment for" exact="SARS-CoV-2 infection" post="and transmission. trehalose SARS-CoV-2 COVID-19 prophylaxis autophagy fig-count: table-count:"/>
   <result pre="autophagy fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction The pandemic" exact="coronavirus disease 2019" post="(COVID-19), caused by severe acute respiratory syndrome coronavirus 2"/>
   <result pre="Food and Drug Administration (FDA)-approved treatment that can effectively control" exact="SARS-CoV-2 infection" post="and transmission. This review aims to propose trehalose as"/>
   <result pre="feasibility and safety of trehalose treatment for the prevention of" exact="SARS-CoV-2 infection" post="and transmission. Since 1925, several studies aimed to understand"/>
   <result pre="biogenesis. The beta-coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), encode viral proteins that impair autophagosome-lysosome fusion,"/>
   <result pre="phase leading to a cytokine storm (67). For instance, during" exact="influenza infection," post="the viral shedding phase peaks 2â€&quot;3 days after infection"/>
   <result pre="reopen their education system, and the long term effects of" exact="SARS-CoV-2 infection" post="are still unknown in children. Clinical studies on the"/>
   <result pre="benefit as an anti-inflammatory in the initial phase of the" exact="SARS-CoV-2 infection." post="Treating severe COVID-19 patients in the late stage of"/>
   <result pre="(98). In vitro studies on the effects of trehalose on" exact="SARS-CoV-2 infection" post="still need to be investigated since some type of"/>
   <result pre="or without concomitant azithromycin among hospitalized patients testing positive for" exact="coronavirus disease 2019" post="(COVID-19). JAMA Cardiol. (2020). [Epub ahead of print]. 10.1001/jamacardio.2020.1834"/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the perspectives of clinical immunologists from China. Clin"/>
   <result pre="Vaccin Immunother. (2020). [Epub ahead of print]. 10.1080/21645515.2020.173522732186952 74.LurieNSavilleMHatchettRHaltonJ. Developing" exact="Covid-19" post="vaccines at pandemic speed. N Engl J Med. (2020)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7358648\results\search\zoonosis\results.xml">
   <result pre="(2000). Phage therapy-advantages over antibiotics?Lancet356:141810.1016/s0140-6736(05)74059-9 PittetL. A.Hall-StoodleyL.RutkowskiM. R.HarmsenA. G. (2010)." exact="Influenza" post="virus infection decreases tracheal mucociliary velocity and clearance of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7359800\results\search\zoonosis\results.xml">
   <result pre="2002â€&quot;2003 through severe acute respiratory syndrome (SARS), and in 2011," exact="Middle East respiratory syndrome" post="(MERS) for the first time. The causative agents for"/>
   <result pre="immune system are positioned throughout the body [12]. Impacts of" exact="Covid-19" post="on the human body COVID-19 is an RNA virus"/>
   <result pre="hypertension, are at risk for severe disease and death from" exact="SARS-CoV-2 infection" post="[[21], [22], [23]]. Mechanism of immune systems in the"/>
   <result pre="China SARS-CoV None [58] South Korea MERS-CoV None [59] Guinea" exact="Ebola" post="Nausea, skin erythema, fever. No major adverse events. [60]"/>
   <result pre="Nausea, skin erythema, fever. No major adverse events. [60] China" exact="Influenza" post="A (H1N1) None [61] China Influenza A (H1N1) None"/>
   <result pre="adverse events. [60] China Influenza A (H1N1) None [61] China" exact="Influenza" post="A (H1N1) None [62] China Influenza A (H1N1) None"/>
   <result pre="(H1N1) None [61] China Influenza A (H1N1) None [62] China" exact="Influenza" post="A (H1N1) None [63] China Influenza A (H1N1) None"/>
   <result pre="(H1N1) None [62] China Influenza A (H1N1) None [63] China" exact="Influenza" post="A (H1N1) None [64] Because there is no definite"/>
   <result pre="the treatment of patients with COVID-19. For the treatment of" exact="Ebola" post="virus infection in 2017, Gilead Sciences synthesized and developed"/>
   <result pre="existence of antibodies against it may suggest the neutralization of" exact="SARS-CoV-2 infection." post="To assess that phenomenon, they performed a pseudovirus particle-based"/>
   <result pre="J Allergy Immunol2020 2Yan-RongGuoQing-DongCaoZhong-SiHongYuan-YangTanShou-DengChenHong-JunJinThe origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak â€&quot; an update on the statusMil Med"/>
   <result pre="novel coronavirus infected pneumoniaN Engl J Med192020 4GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med2020 5KwokK.O.LaiF.WeiW.I.WongS.Y.S.TangJ.W.T.Herd immunity â€&quot; estimating"/>
   <result pre="February 2020] 21ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet2020(January) 22HuangC.WangY.LiX.RenL.ZhaoJ.HuY.Clinical features of"/>
   <result pre="(7)2020102554 47BinZhangShuyiLiuTanTan.WenhuiHuangYuhaoDongLuyanChenTreatment with convalescent plasma for critically ill patients with" exact="SARS-CoV-2 infection" post="chest2020 48ShenC.WangZ.ZhaoF.YangY.LiJ.YuanJ.Treatment of 5 critically ill patients with Covid-19"/>
   <result pre="SARS-CoV-2 infection chest2020 48ShenC.WangZ.ZhaoF.YangY.LiJ.YuanJ.Treatment of 5 critically ill patients with" exact="Covid-19" post="with convalescent plasmaJAMA3231620201582158932219428 49DuanK.LiuB.LiC.ZhangH.YuT.QuJ.Effectiveness of convalescent plasma therapy in"/>
   <result pre="centre experienceAntivir Ther23201861762229923831 60van GriensvenJ.EdwardsT.de LamballerieX.SempleM.G.GallianP.BaizeS.Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in GuineaN Engl J Med3742016334226735992 61HungI.F.ToK.K.LeeC.-K.-K.LeeC.-K.-L.ChanK.YanW.-W.-W.Convalescent plasma"/>
   <result pre="of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of" exact="Ebola" post="and emerging virusesJ Med Chem60520171648166128124907 66RynesR.Antimalarial drugs in the"/>
   <result pre="and zoonotic coro-navirusesSci Transl Med93962017eaal3653 82MulanguS.DoddL.E.DaveyR.T.Thsihani MbayaO.ProschanM.MukadiD.A.Randomized controlled trial of" exact="Ebola" post="virus disease therapeuticsN Engl J Med3812420192293230331774950 83GreinJ.OhmagariN.ShinD.DiazG.AspergesE.CastagnaA.Compassion-ate use of"/>
   <result pre="Covid-19N Engl J Med2020(March) 87WangZ.YangB.LiQ.WenL.ZhangR.Clinical features of 69 cases with" exact="coronavirus disease 2019" post="in Wuhan, ChinaClin Infect Dis2020(March) 88DengL.LiC.ZengQ.LiuX.LiX.ZhangH.Arbidol combined with LPV/r"/>
   <result pre="a retrospective cohort studyJ Infect2020(March) 89SissokoD.LaouenanC.FolkessonE.MLebingÂ´A.B.BeavoguiA.H.BaizeS.Exper-imental treatment with favipiravir for" exact="Ebola" post="virus disease (the JIKI Trial): a historically controlled, single-arm"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7360125\results\search\zoonosis\results.xml">
   <result pre="Review Autoimmune and rheumatic musculoskeletal diseases as a consequence of" exact="SARS-CoV-2 infection" post="and its treatment http://orcid.org/0000-0003-3224-1151ShahSanketsanketimmunology@gmail.com1http://orcid.org/0000-0002-2121-0942DandaDebashishdebashish.danda@cmcvellore.ac.in2http://orcid.org/0000-0002-3643-3989KavadichandaChengappadoc.chengappa@gmail.com1http://orcid.org/0000-0002-3153-4166DasSaibalsaibaldas123@gmail.com3http://orcid.org/0000-0001-8091-1952AdarshM. B.adarshmb@gmail.com1http://orcid.org/0000-0003-1518-6031NegiVir Singhvsnegi22@yahoo.co.in1[1], grid.414953.e0000000417678301Department of Clinical"/>
   <result pre="the general population [20]. Spectrum of rheumatic musculoskeletal manifestations of" exact="SARS-CoV-2 infection" post="and antiviral drugs With scientific literature pouring in from"/>
   <result pre="long-term immune dysregulation. Table 1 Rheumatic musculoskeletal manifestations associated with" exact="SARS-CoV-2 infection" post="Reported with SARS-CoV-2 Clinical characteristics Refs. Musculoskeletal manifestations Â"/>
   <result pre="Â Cytokine storm/Secondary Hemophagocytic lymphohistiocytosis (sHLH) Represents critical patients with" exact="SARS-CoV-2 infection" post="After 8â€&quot;9Â days of the symptom onset Unremitting fever,"/>
   <result pre="immunosuppressants in addition to anticoagulants in severe COVID-19 cases [44]." exact="SARS-CoV-2 infection" post="and autoimmunity The interplay of various genetic, hormonal, immunological,"/>
   <result pre="and arthritis were reported following Zika [48], Chikungunya [49] and" exact="Ebola" post="infections [50]. Besides overt clinical manifestations, long-term persistence of"/>
   <result pre="et al. [52]. Similar mechanisms may lead to autoimmunity following" exact="SARS-CoV-2 infection." post="We herein describe some of the possible mechanism of"/>
   <result pre="herein describe some of the possible mechanism of autoimmunity following" exact="SARS-CoV-2 infection" post="as follows: Table 3 Mechanisms of autoimmune manifestation following"/>
   <result pre="virus Human herpes encephalitis Human T-lymphotropic virus-1 Myelopathy/tropical spastic paraparesis" exact="Influenza" post="Acute disseminated encephalomyelitis Measles virus Multiple sclerosis Theilerâ€™s virus"/>
   <result pre="Human Herpesvirus 6A Thyroiditis Human immunodeficiency virus Autoantibodies in AIDS" exact="Influenza" post="Acute disseminated encephalomyelitis Persistent infection and polyclonal activation Epstein-Barr"/>
   <result pre="to be due to a similar autoreactive adaptive response with" exact="SARS-CoV-2 infection" post="[3]. The role of genetic susceptibility should also be"/>
   <result pre="Smith (Sm), and ribonuclear protein (RNP) antigens [64]. Although with" exact="SARS-CoV-2 infection," post="epitope diversification is not reported, it would be worthwhile"/>
   <result pre="cells via proinflammatory cytokine and reactive oxygen species [72]. With" exact="SARS-CoV-2 infection," post="the multisystem inflammatory syndrome appears after the peak of"/>
   <result pre="the manifestations like ARDS, myocarditis, and neurological involvement reported with" exact="SARS-CoV-2 infection." post="Autopsy reports of COVID-19 patients show diffuse infiltration of"/>
   <result pre="by cytotoxic CD8+ T cells [74]. Besides, in patients surviving" exact="SARS-CoV-2 infection," post="bystander activation may lead to sequestered autoantigen presentation leading"/>
   <result pre="[84]. This may reduce the occurrence of subsequent effects of" exact="influenza infection" post="on RMDs. Diseases like acute rheumatic fever, where overcrowding"/>
   <result pre="autoimmunity Currently, a multitude of vaccines for the prevention of" exact="SARS-CoV-2 infection" post="is under investigation [90]. Except for the nucleocapsid, all"/>
   <result pre="to the risk of pathogenic priming. Targeted immunosuppressive therapy for" exact="SARS-CoV-2 infection" post="The clinical outcome of the patients relies on the"/>
   <result pre="play a significant role in cytokine release syndrome associated with" exact="SARS-CoV-2 infection." post="The cells get activated directly by viruses as well"/>
   <result pre="help in the effective management of the rheumatic manifestations of" exact="SARS-CoV-2 infection" post="in the post-COVID-19 era. Publisher's Note Springer Nature remains"/>
   <result pre="disease 2019 (COVID-19) with gastrointestinal symptomsGut20206961002100910.1136/gutjnl-2020-32092632213556 17.GoyalPChoiJJPinheiroLCet al.Clinical characteristics of" exact="Covid-19" post="in New York CityN Engl J Med2020382242372237410.1056/NEJMc201041932302078 18.WuPDuanFLuoCet al.Characteristics"/>
   <result pre="J Med2020382242372237410.1056/NEJMc201041932302078 18.WuPDuanFLuoCet al.Characteristics of ocular findings of patients with" exact="coronavirus disease 2019" post="(COVID-19) in Hubei ProvinceChina JAMA Ophthalmol2020138557557810.1001/jamaophthalmol.2020.1291 19.CDC Coronavirus Disease"/>
   <result pre="Dermatol. 10.1111/bjd.19163 24.OxleyTJMoccoJMajidiSet al.Large-vessel stroke as a presenting feature of" exact="Covid-19" post="in the youngN Engl J Med202038220e6010.1056/NEJMc200978732343504 25.InciardiRMLupiLZacconeGet al.Cardiac involvement"/>
   <result pre="Engl J Med202038220e6010.1056/NEJMc200978732343504 25.InciardiRMLupiLZacconeGet al.Cardiac involvement in a patient with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol202010.1001/jamacardio.2020.109632219357 26.KimI-CKimJYKimHAHanSCOVID-19-related myocarditis in a 21-year-old female patientEur"/>
   <result pre="COVID-19MedRxiv202010.1101/2020.04.30.2008673632587992 44.TangNBaiHChenXGongJLiDSunZAnticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathyJ Thromb Haemost20201851094109910.1111/jth.1481732220112 45.ShoenfeldYIsenbergDAThe mosaic of autoimmunityImmunol"/>
   <result pre="coronavirus in WuhanChina The Lancet20203951022349750610.1016/S0140-6736(20)30183-5 73.KimJYKoJHKimYet al.Viral load kinetics of" exact="SARS-CoV-2 infection" post="in first two patients in KoreaJ Korean Med Sci2020357e8610.3346/jkms.2020.35.e8632080991"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7360901\results\search\zoonosis\results.xml">
   <result pre="health emergency and an unprecedented socioeconomic crisis. The severity of" exact="coronavirus disease 2019" post="(COVID-19), the illness caused by SARS-CoVâ€‘2, is highly variable."/>
   <result pre="contains supplementary material, which is available to authorized users. Keywords" exact="Coronavirus disease 2019" post="Severe acute respiratory syndrome coronavirus 2 Pandemic Acute respiratory"/>
   <result pre="which is available to authorized users. Keywords Coronavirus disease 2019" exact="Severe acute respiratory syndrome" post="coronavirus 2 Pandemic Acute respiratory distress syndrome Vaccine Antiviral"/>
   <result pre="case for infections with severe acute respiratory syndrome (SARS)-CoV and" exact="Middle East respiratory syndrome" post="(MERS)-CoV, for which case-fatality rates of ~10 and ~35%,"/>
   <result pre="syndrome coronavirusÂ 2 [7], and the accompanying disease was designated" exact="coronavirus disease 2019" post="(COVID-19). Like SARS-CoV and MERS-CoV, SARS-CoVâ€‘2 is assumed to"/>
   <result pre="of Ernest ShackletonThorax202010.1136/thoraxjnl-2020-21509132461231 30.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of aÂ report of"/>
   <result pre="RoldanEBiasiottoGet al.The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against" exact="SARS-CoV-2 infection" post="(COVID-19): aÂ role for iron homeostasis?Pharmacol Res202015810490432430286 69.BlochEMShohamSCasadevallAet al.Deployment"/>
   <result pre="82.TangNBaiHChenXet al.Anticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathyJ Thromb Haemost2020181094109932220112 83.BikdeliBMadhavanMVJimenezDet al.COVID-19 and thrombotic"/>
   <result pre="ChinaJAMA202010.1001/jamacardio.2020.0950 89.GuoTFanYChenMet al.Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19)JAMA202010.1001/jamacardio.2020.101732492084 90.DrigginEMadhavanMVBikdeliBet al.Cardiovascular considerations for patients, health care workers,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361075\results\search\zoonosis\results.xml">
   <result pre="for the duration of the public health emergency.file:TID-9999-e13404.pdf Abstract Abstract" exact="Severe acute respiratory syndrome" post="Coronavirus 2 (SARSâ€�Cov2) outbreak has caused a pandemic rapidly"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361119\results\search\zoonosis\results.xml">
   <result pre="prior epidemics studied [bird flu, severe acute respiratory syndrome (SARS)," exact="swine flu," post="Middle East Respiratory Syndrome (MERS), Ebola, and Zika] were"/>
   <result pre="treatments have emerged to treat the previous six epidemics of" exact="bird flu," post="SARS, swine flu, MERS, Ebola, and Zika as well"/>
   <result pre="to treat the previous six epidemics of bird flu, SARS," exact="swine flu," post="MERS, Ebola, and Zika as well as, thus far,"/>
   <result pre="for seven major disease outbreaks of the past two decades:" exact="bird flu" post="(H5N1), SARS, swine flu (H1N1), MERS, Ebola fever, Zika"/>
   <result pre="outbreaks of the past two decades: bird flu (H5N1), SARS," exact="swine flu" post="(H1N1), MERS, Ebola fever, Zika fever, and COVID-19. We"/>
   <result pre="two decades: bird flu (H5N1), SARS, swine flu (H1N1), MERS," exact="Ebola" post="fever, Zika fever, and COVID-19. We assessed the response"/>
   <result pre="bird flu (H5N1), SARS, swine flu (H1N1), MERS, Ebola fever," exact="Zika fever," post="and COVID-19. We assessed the response of the scientific"/>
   <result pre="to the seven major outbreaks of the past two decades:" exact="bird flu," post="SARS, swine flu, MERS, Ebola, Zika, and COVID-19. These"/>
   <result pre="major outbreaks of the past two decades: bird flu, SARS," exact="swine flu," post="MERS, Ebola, Zika, and COVID-19. These metrics indicate the"/>
   <result pre="can also see that, for more recent epidemics, such as" exact="Ebola" post="and Zika, more clinical trials were launched during the"/>
   <result pre="than had been the case for previous epidemics, such as" exact="bird flu" post="and MERS (Fig. 1). The only exception to this"/>
   <result pre="(Fig. 1). The only exception to this general observation was" exact="swine flu," post="which is an anomaly because H1N1 flu strains had"/>
   <result pre="H1N1 epidemics 20, 21. This is in stark contrast to" exact="Ebola" post="virus and Zika virus, which had caused smaller-scale outbreaks"/>
   <result pre="trials as recorded in ClinicalTrials.gov. Abbreviations: COVID-19, coronavirus 2019; MERS," exact="Middle East respiratory syndrome;" post="SARS, severe acute respiratory syndrome. Figure 2 The evolution"/>
   <result pre="BioRxiv, MedRxiv, ArXiv, and ChemRxiv. Abbreviations: COVID-19, coronavirus 2019; MERS," exact="Middle East respiratory syndrome;" post="SARS, severe acute respiratory syndrome. Rate of response Equally"/>
   <result pre="as a vertical dashed line. Abbreviations: COVID-19, coronavirus 2019; MERS," exact="Middle East respiratory syndrome;" post="NIH, National Institutes of Health; SARS, severe acute respiratory"/>
   <result pre="data are available before January 2004; thus, some timepoints for" exact="bird flu" post="and SARS were not available). When observing the first"/>
   <result pre="). For diseases that had been previously studied, such as" exact="swine flu" post="and Ebola hemorrhagic fever, there was already some search"/>
   <result pre="that had been previously studied, such as swine flu and" exact="Ebola hemorrhagic fever," post="there was already some search interest before the start"/>
   <result pre="scale from 0 to 100. Abbreviations: COVID-19, coronavirus 2019; MERS," exact="Middle East respiratory syndrome;" post="SARS, severe acute respiratory syndrome. COVID-19 is interesting in"/>
   <result pre="and Drug Administration (FDA)-approved anti-HIV treatments is highlighted. Abbreviations: COVID-19," exact="coronavirus disease 2019;" post="MERS, Middle East respiratory syndrome; NIH, National Institutes of"/>
   <result pre="anti-HIV treatments is highlighted. Abbreviations: COVID-19, coronavirus disease 2019; MERS," exact="Middle East respiratory syndrome;" post="NIH, National Institutes of Health; SARS, severe acute respiratory"/>
   <result pre="the scientific community to outbreaks. We have observed that the" exact="Ebola" post="(2014â€&quot;2016) and Zika (2015â€&quot;2016) outbreaks had more publications and"/>
   <result pre="time than those that were understudied previously. Zika virus and" exact="Ebola" post="virus had both been discovered long before they caused"/>
   <result pre="1918PLoS Pathog.42008e100001210.1371/journal.ppat.100001218463694 21RelmanD.A.The Domestic and International Impacts of the 2009-H1N1" exact="Influenza" post="A Pandemic: Global ChallengesGlobal Solutions: Workshop Summary2010National Academies Press"/>
   <result pre="for controlAntiviral Res.1302016698026996139 23KeuschG.Integrating Clinical Research into Epidemic Response: The" exact="Ebola" post="Experience2017National Academies Press 24FernerR.E.AronsonJ.K.Chloroquine and hydroxychloroquine in COVID-19BMJ3692020m143232269046 25DuanY.Advance"/>
   <result pre="agents against COVID-19 in ChinaDrug Discov. Today25202081081232198066 26ChenX.Comparative epidemiology of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in Saudi Arabia and South KoreaEmerg. Microbes"/>
   <result pre="outbreakWashington Post2018(accessed March 26, 2020)https://www.washingtonpost.com/news/to-your-health/wp/2018/02/01/cdc-to-cut-by-80-percent-efforts-to-prevent-global-disease-outbreak/ 45FDATecovirimat for the Treatment of" exact="Smallpox" post="Disease Antimicrobial Division Advisory Committee Meeting2018FDA 46AnonREADDI: Rapidly Emerging"/>
   <result pre="Meeting2018FDA 46AnonREADDI: Rapidly Emerging Antiviral Drug Discovery Initiative2020READDI 47GatesB.Responding to" exact="Covid-19" post="- a once-in-a-century pandemic?N. Engl. J. Med.38220201677167932109012 48ThanhLe T.The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361333\results\search\zoonosis\results.xml">
   <result pre="caused recent important epidemics: SARS caused by SARSâ€�CoV and the" exact="Middle East respiratory syndrome" post="(MERS) caused by MERSâ€�CoV. SARSâ€�CoV and MERSâ€�CoV have caused"/>
   <result pre="initial period of the epidemic, many patients were diagnosed with" exact="coronavirus disease 2019" post="(COVIDâ€�19) only after developing critical illness or even at"/>
   <result pre="Engl J Med. 2003;348(20):1967â€�1976.12690091 4de GrootRJ, BakerSC, BaricRS, et al." exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV): announcement of the Coronavirus Study Group. J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361338\results\search\zoonosis\results.xml">
   <result pre="of illness.10 CP was also used in the West African" exact="Ebola" post="epidemic in 2013. Eightyâ€�four patients received 500â€‰mL of CP."/>
   <result pre="of action of CP in other viral infections such as" exact="Ebola" post="virus and Respiratory Syncytial Virus is mainly viral neutralization."/>
   <result pre="EdwardsT, de LamballerieX, et al. Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in Guinea. N Engl J Med. 2016;374:33â€�42.26735992"/>
   <result pre="role for fc function in therapeutic monoclonal antibodyâ€�mediated protection against" exact="Ebola" post="virus. Cell Host Microbe. 2018;24:221â€�233.30092199 20OzmaMA, MaroufiP, KhodadadiE, et"/>
   <result pre="et al. Antibody responses to SARSâ€�CoVâ€�2 in patients of novel" exact="coronavirus disease 2019." post="Clin Infect Dis. 202010.1093/cid/ciaa344. 27CasadevallA, ScharffMD. Return to the"/>
   <result pre="10.3201/eid2607.200839.32243255 39KatzelnickLC, GreshL, HalloranME, et al. Antibodyâ€�dependent enhancement of severe" exact="dengue disease" post="in humans. Science. 2017;358:929â€�932.29097492 40TetroJA. Is COVIDâ€�19 receiving ADE"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361534\results\search\zoonosis\results.xml">
   <result pre="Î² 17 Man Human coronavirus HKU1 HCoVâ€�HKU1 Î² 18 Man" exact="Middle East respiratory syndrome" post="coronavirus MERSâ€�CoV Î² 19 Mouse Murine hepatisis virus MHV"/>
   <result pre="24 Â Bat Rousettus bat coronavirus HKU9 Î² 25 Man" exact="Severe acute respiratory syndrome" post="coronavirus SARSâ€�CoV Î² 26 Chinese bulbul, Redâ€�whiskered bulbul, Sootyâ€�headed"/>
   <result pre="eukaryotic microorganisms.103 Mycalamide is used for treatment of polio, HSVâ€�1" exact="Influenza" post="and CoVâˆ’A59 (Mice survival 14â€…days after A59 CoV infection"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361641\results\search\zoonosis\results.xml">
   <result pre="caution to avoid mistakes that occurred during the West African" exact="Ebola" post="epidemic, in which haphazard experiments flourished and randomized clinical"/>
   <result pre="and developed by Gilead Sciences (Foster City, CA) against the" exact="Ebola" post="virus, incorporates into nascent viral RNA chains resulting in"/>
   <result pre="wide range of DNA and RNA viruses such as paramyxovirus," exact="Influenza" post="A and B, Hepatitis C, respiratory syncytial virus, parainfluenza,"/>
   <result pre="replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and" exact="Middle East respiratory syndrome" post="coronaviruses. Antimicrobial Agents and Chemotherapy, 58(8), 4894â€&quot;4898. 10.1128/aac.02994-1424841268 Amanat,"/>
   <result pre="of an FDAâ€�approved compound library identifies four smallâ€�molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell culture. Antimicrobial Agents and Chemotherapy,"/>
   <result pre="Reduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVIDâ€�19). medRxiv 2020.2002.2018.20024364. doi:10.1101/2020.02.18.20024364%J Dong, X., Dong, X., &amp;amp;"/>
   <result pre="R. E., Mesecar, A. D., &amp;amp; Baric, R. S. (2009)." exact="Severe acute respiratory syndrome" post="coronavirus papainâ€�like protease ubiquitinâ€�like domain and catalytic domain regulate"/>
   <result pre="Guo, J., Huang, Z., Lin, L., &amp;amp; Lv, J. (2020)." exact="Coronavirus disease 2019" post="(COVIDâ€�19) and cardiovascular disease: A viewpoint on the potential"/>
   <result pre="E. A., &amp;amp; Gambotto, A. (2014). Immunogenicity of an adenoviralâ€�based" exact="Middle East respiratory syndrome" post="coronavirus vaccine in BALB/c mice. Vaccine, 32(45), 5975â€&quot;5982. 10.1016/j.vaccine.2014.08.05825192975"/>
   <result pre="C. (2016). Combination therapy with lopinavir/ritonavir, ribavirin and interferonâ€�Î± for" exact="Middle East respiratory syndrome." post="Antiviral Therapy, 21(5), 455â€&quot;459. 10.3851/imp300226492219 Kirchdoerfer, R. N., &amp;amp;"/>
   <result pre="Hilgenfeld, R. (2014). Crystal structure of the papainâ€�like protease of" exact="MERS coronavirus" post="reveals unusual, potentially druggable activeâ€�site features. Antiviral Research, 109,"/>
   <result pre="S. C., Stevens, R. C., &amp;amp; Mesecar, A. D. (2006)." exact="Severe acute respiratory syndrome" post="coronavirus papainâ€�like protease: Structure of a viral deubiquitinating enzyme."/>
   <result pre="of a Pyrrolo[2,1â€�f][triazinâ€�4â€�amino] adenine Câ€�nucleoside (GSâ€�5734) for the treatment of" exact="Ebola" post="and emerging viruses. Journal of Medicinal Chemistry, 60(5), 1648â€&quot;1661."/>
   <result pre="D. P., &amp;amp; GÃ¶tte, M. (2019). Mechanism of inhibition of" exact="Ebola" post="virus RNAâ€�dependent RNA polymerase by Remdesivir. Viruses, 11(4), 32610.3390/v11040326"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362761\results\search\zoonosis\results.xml">
   <result pre="3. Figure 3 Some important diagnostic and therapeutic targets for" exact="SARS-CoV-2 infection." post="ACE2, angiotensin-converting enzyme 2; R, receptor; IL, interleukin; GCSF,"/>
   <result pre="of camostat in protecting mice from death from a lethal" exact="SARS-CoV infection" post="with a 60% survival rate (34). It is considered"/>
   <result pre="mg, three times) of camostat daily are expected to reduce" exact="SARS-CoV-2 infection;" post="but human clinical trials are needed (35). Mesylate camostat,"/>
   <result pre="of inflammation of the pancreas in Japan. Remdesivir Antiviral for" exact="Ebola" post="Inhibits RNA-dependent RNA polymerase, prematurely blocking RNA transcription. Broad"/>
   <result pre="in vivo studies; The safety profile has been demonstrated in" exact="Ebola" post="studies; Superior efficacy of the Lopinavir/Ritonavir/IFNbeta combination in animal"/>
   <result pre="longer (39). Reduced side effects Favipiravir Antiviral for flu and" exact="Ebola" post="RNA polymerase inhibitor Used in China in patients of"/>
   <result pre="cells by abrogating the infection, resulting in the inhibition of" exact="SARS-CoV-2 infection" post="and spread (44). Emergence of the HCoV strains such"/>
   <result pre="vitro and in vivo studies; a safety profile demonstrated in" exact="Ebola" post="studies; and a higher efficacy than the combination lopinavir/ritonavir/IFN"/>
   <result pre="RNA polymerase inhibitor that has been used for influenza and" exact="Ebola" post="infection. It was originally produced in Japan and used"/>
   <result pre="The convalescent plasma was also used during the 2013 African" exact="Ebola" post="epidemic (62). Experience from previous coronavirus situations, such as"/>
   <result pre="this year (72). The efficacy of nafamostat in patients with" exact="Covid-19" post="(RACONA study), is the subject of another ongoing clinical"/>
   <result pre="toxic (77). Recently, hydroxychloroquine was found to efficiently inhibit the" exact="SARS-CoV-2 infection" post="in vitro through an anti-inflammatory mechanism (48). In a"/>
   <result pre="several phase I and II studies, carried out within the" exact="SARS-CoV-2 infection." post="The therapeutic hypothesis is that the immunomodulatory and regenerative"/>
   <result pre="addressing public health emergencies, having been active during the 2014" exact="Ebola" post="outbreak (93, 94). China has already announced that it"/>
   <result pre="adenoviruses. It is the same platform where a vaccine for" exact="Ebola" post="was successful in 2017 (95). Ad5-nCoV is a novel"/>
   <result pre="several potential molecules; from remdesivir, an antiviral previously tested for" exact="Ebola" post="already approved by the FDA, to antiretrovirals used against"/>
   <result pre="remedies along with personal precautions are urgently needed to avoid" exact="SARS-CoV-2 infection." post="Author Contributions MT, MN, IK, SM, MK-E-Z, TA, and"/>
   <result pre="Wuhan, China. Int J Infect Dis. (2020) 91:264â€&quot;66. 10.1016/j.ijid.2020.01.00931953166 3.ChanJFLauSKToKKChengVCWooPCYuenKY." exact="Middle East respiratory syndrome" post="coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol"/>
   <result pre="10.1016/j.toxrep.2020.04.01232355638 13.GuoYRCaoQDHongZSTanYYChenSDJinHJet al.. The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak - an update on the status. Mil"/>
   <result pre="and epidemic predictions. medRxiv. (2020). 10.1101/2020.01.23.20018549 20.GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. (2020) 382:1708â€&quot;20. 10.1056/NEJMoa200203232109013"/>
   <result pre="of clinical diagnosis and treatment of a case infected with" exact="coronavirus disease 2019." post="J Med Virol. (2020) 92:461â€&quot;3. 10.1002/jmv.2571132073161 24.DoceaAOGofitÄƒECalinaDZaharieSValceaDIMitru?PAutoimmune disorders due"/>
   <result pre="al.Case of the index patient who caused tertiary transmission of" exact="coronavirus disease 2019" post="in Korea: the application of lopinavir/ritonavir for the treatment"/>
   <result pre="The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus. J Biol Chem. (2020) 295:4773â€&quot;9. 10.1074/jbc.AC120.01305632094225 46.KeyaertsELiSVijgenLRysmanEVerbeeckJVan RanstMet"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitro. Cell Discov. (2020) 6:16. 10.1038/s41421-020-0156-032194981 49.YamamotoMMatsuyamaSLiXTakedaMKawaguchiYInoueJIet al.."/>
   <result pre="fusion assay. Antimicrob Agents Chemother. (2016) 60:6532â€&quot;9. 10.1128/AAC.01043-1627550352 50.BurkiTOutbreak of" exact="coronavirus disease 2019." post="Lancet Infect Dis. (2020) 20:292â€&quot;3. 10.1016/S1473-3099(20)30076-132078809 51.ZhouYHouYShenJHuangYMartinWChengF. Network-based drug"/>
   <result pre="69.collab: Oslo University HospitalThe Efficacy of Different Anti-viral Drugs in" exact="COVID 19" post="Infected Patients. NCT04321616 (2020). Available online at: https://clinicaltrials.gov/ (accessed"/>
   <result pre="April 10, 2020). 73.collab: University Hospital PadovaEfficacy of Nafamostat in" exact="Covid-19" post="Patients (RACONA Study) (RACONA). NCT04352400 (2020). Available online at:"/>
   <result pre="Mol Med Rep. (2017) 16:8771â€&quot;80. 10.3892/mmr.2017.774629039613 80.SandersJMMonogueMLJodlowskiTZCutrellJB. Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a review. JAMA. (2020) 323:1824â€&quot;36. 10.1001/jama.2020.601932282022 81.ChenLXiongJBaoLShiY. Convalescent"/>
   <result pre="(2009) 7:226â€&quot;36. 10.1038/nrmicro209019198616 94.AgnandjiSTHuttnerAZinserMENjugunaPDahlkeCFernandesJFet al.. Phase 1 trials of rVSV" exact="Ebola" post="vaccine in Africa and Europe. N Engl J Med."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362831\results\search\zoonosis\results.xml">
   <result pre="eIF4A Prohibitin COVID-19 SARS-CoV-2 Coronavirus Zika virus Chikungunya virus Picornaviruses" exact="Ebola" post="virus Natural products 1 Introduction 1.1 Overview of the"/>
   <result pre="on eIF4A or PHBs. TableÂ 1 Virus Flavagline Target Reference" exact="Ebola" post="virus Silvestrol (2) eIF4A [6] MERS-CoV Silvestrol (2) eIF4A"/>
   <result pre="Silvestrol (2)a eIF4A [9,10] Zika virus Silvestrol (2) eIF4A [11]" exact="Influenza" post="A virus Silvestrol (2) eIF4A [12] HCoV-229E, MERS-CoV, Zika"/>
   <result pre="those that are responsible for Ebola, chikungunya, hepatitis E, poliomyelitis," exact="Zika fever," post="â€œhand, foot and mouthâ€� disease, SARS, MERS and COVID-19"/>
   <result pre="the activity of eIF4A holds great interest as antiviral agents." exact="Ebola" post="is a deadly disease manifested by a hemorrhagic fever."/>
   <result pre="fever. It is caused by a negative-stranded RNA virus, and" exact="Ebola" post="is currently raging in the Democratic Republic of the"/>
   <result pre="in developing countries, but also in Europe and America [28]." exact="Influenza" post="A viruses (IAV) are negative-sense single-stranded RNA viruses that"/>
   <result pre="severe acute respiratory syndrome (SARS) caused by SARS-CoV in 2002," exact="Middle East respiratory syndrome" post="(MERS) caused by MERS-CoV, and COVID-19 caused by SARS-CoV-2."/>
   <result pre="to cells, blocks viral mRNA translation and viral replication of" exact="Ebola" post="virus and MERS-CoV in cells [6,7]. Silvestrol also blocked"/>
   <result pre="and 72Â hÂ at non-toxic concentrations in primary human hepatocytes." exact="Influenza" post="A virus (IAV) hijacks the host protein synthesis machinery"/>
   <result pre="Dis.2220165567 6BiedenkopfN.Lange-GruenwellerK.SchulteF.W.WeisserA.MuellerC.BeckerD.BeckerS.HartmannR.K.GruenwellerA.The natural compound silvestrol is a potent inhibitor of" exact="Ebola" post="virus replicationAntivir. Res.13720177681 7MuellerC.SchulteF.W.Lange-GruenwellerK.ObermannW.MadhugiriR.PleschkaS.ZiebuhrJ.HartmannR.K.GruenwellerA.Broad-spectrum antiviral activity of the eIF4A"/>
   <result pre="21MonteroH.PÃ©rez-GilG.SampieriC.L.Eukaryotic initiation factor 4A (eIF4A) during viral infectionsVirus Gene.552019267273 22RohanH.McKayG.The" exact="Ebola" post="outbreak in the Democratic Republic of the Congo: why"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362842\results\search\zoonosis\results.xml">
   <result pre="in the severe acute respiratory syndrome (SARS) outbreak in 2002," exact="Middle East respiratory syndrome" post="(MERS) outbreak in 2012, and in the current coronavirus"/>
   <result pre="respiratory syndrome (MERS) outbreak in 2012, and in the current" exact="coronavirus disease 2019" post="(COVID-19) pandemic [2,3]. Up to the submission date, Johns"/>
   <result pre="coronaviruses SARS severe acute respiratory syndrome NO nitric oxide MERS" exact="Middle East respiratory syndrome," post="MERS COVID-19 coronavirus disease 2019 ARDS acute respiratory distress"/>
   <result pre="NO nitric oxide MERS Middle East respiratory syndrome, MERS COVID-19" exact="coronavirus disease 2019" post="ARDS acute respiratory distress syndrome ALI acute lung injury"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362851\results\search\zoonosis\results.xml">
   <result pre="ACE2 protein. The acute lung injury (ALI) resulting from the" exact="SARS-CoV infection" post="was shown to be mediated through the down-regulation of"/>
   <result pre="inflammation in the lungs leading to ALI. ACE2 down-regulation by" exact="SARS-CoV infection" post="was found in severe lung failure and was associated"/>
   <result pre="and was associated with mortality in SARS infection.9 Similarly, in" exact="SARS-CoV-2 infection," post="the ACE2 deficiency after the viral spike binding and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362854\results\search\zoonosis\results.xml">
   <result pre="similar to severe acute respiratory syndrome coronavirus (SARS-CoV) [3] and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) [4]. The common symptoms of a person"/>
   <result pre="[35], [36], [37]]. However, due to the critical situation of" exact="coronavirus disease 2019," post="the WHO launched a megatrial to test selected repurposed"/>
   <result pre="Sciences (Foster City, CA, USA) to combat the West African" exact="Ebola" post="virus disease epidemic in the mid-2010s. This nucleotide prodrug"/>
   <result pre="found clinically effective against influenza, herpesvirus infections, hemorrhagic fever and" exact="Lassa fever" post="but ineffective against Ebola and Marburg viruses [[64], [65],"/>
   <result pre="herpesvirus infections, hemorrhagic fever and Lassa fever but ineffective against" exact="Ebola" post="and Marburg viruses [[64], [65], [66], [67]]. Ruxolitinib (AkaviÂ®)"/>
   <result pre="and compassionate use in treatment of patients hospitalized for severe" exact="Covid-19" post="showed clinical improvement [101]. The best absorption (% ABS)"/>
   <result pre="inhibition activity. According to recent work on control of the" exact="SARS-CoV-2 infection" post="inÂ vitro, hydroxychloroquine was less toxic and more efficient"/>
   <result pre="and anti-COVID-19 drug discovery from medicinal plantsJ.Â Pharm. Anal.20202610.1016/j.jpha.2020.03.009March 34ZhavoronkovA.AladinskiyV.ZhebrakA.ZagribelnyyB.TerentievV.BezrukovD.S.Potential" exact="COVID-2019" post="3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches2020ChemRxiv10.26434/chemrxiv.11829102.v2"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="inÂ vitroCell Discov6120201610.1038/s41421-020-0156-032194981 107MarmorM.F.KellnerU.LaiT.Y.MellesR.B.MielerW.F.Recommendations on screening for chloroquine and"/>
   <result pre="pyrrolo [2, 1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of" exact="Ebola" post="and emerging virusesJ.Â Med. Chem.60520171648166128124907 144collab: Oxford University News"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7364167\results\search\zoonosis\results.xml">
   <result pre="coronavirus outbreaks worldwide, namely, severe acute respiratory syndrome (SARS-CoV) and" exact="Middle East respiratory syndrome" post="(MERS-CoV). Because the genetic diversity of coronaviruses renders the"/>
   <result pre="a therapeutic target for the treatment of coronavirus infection, especially" exact="coronavirus disease 2019" post="(COVID-19), and non-immunosuppressive cyclosporine analogues. Keywords cyclophilin A cyclosporine"/>
   <result pre="the HIV-1 virus through interaction with the virus-associated CyPA. During" exact="SARS-CoV infection" post="of host cells, the CD147 molecule works via a"/>
   <result pre="CyPA may play a pivotal role in with CD147 in" exact="SARS-CoV-2 infection," post="and CyPA inhibitors may inhibit the infection of SARS-CoV-2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7366108\results\search\zoonosis\results.xml">
   <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Coronavirus disease 2019" post="(COVID-19) is an unprecedented disease caused by highly pathogenic"/>
   <result pre="changes, and trans-signaling in endothelial cells [[17], [18], [19], [20]]." exact="SARS-CoV-2 infection" post="cause final release and increase in pro-inflammatory cytokines, including"/>
   <result pre="or cells expressing ACE2 are possibly at extreme risk for" exact="SARS-CoV-2 infection." post="In COVID-19 patients with pre-existing CVD, the demise of"/>
   <result pre="patient, a moderate level of microvascular steatosis indicates that either" exact="SARS-CoV-2 infection" post="or drug used during treatment was the possible cause"/>
   <result pre="COVID-19 patients, but the predisposition of the diabetic population to" exact="SARS-CoV-2 infection" post="may not be higher as compared to healthy people."/>
   <result pre="a paucity of data to confirm that pregnant women with" exact="COVID 19" post="are more susceptible to severe pneumonia and vertical transmission"/>
   <result pre="as pneumonia and some proof of vertical maternal-fetal transmission of" exact="SARS-CoV-2 infection" post="[81]. A recent study on pediatric patients with COVID-19"/>
   <result pre="viruses, including coronaviruses Umifenovir is an antiviral treatment used for" exact="influenza infection" post="used in Russia and China. National Clinical Trial Identifier:(NCT04252885),"/>
   <result pre="Investigating the Safety and Effects of Four BNT162 Vaccines Against" exact="COVID-2019" post="in Healthy Adults Biontech RNA Pharmaceuticals GmbH Phase1 &amp;amp;II(200)"/>
   <result pre="Phase I(100) On-going NCT04299724 7. Lentiviral Minigene Vaccine (LV-SMENP) of" exact="Covid-19" post="Coronavirus; Subcutaneously Shenzhen Geno-Immune Medical Institute, Guangdong, China Phase"/>
   <result pre="Wuhan, ChinaJama32320201061106910.1001/jama.2020.1585 9WangY.WangY.ChenY.QinQ.Unique epidemiological and clinical features of the emerging" exact="2019 novel coronavirus pneumonia" post="(COVID-19) implicate special control measuresJ. Med. Virol.92202056857610.1002/jmv.2574832134116 10Di Gennaro,"/>
   <result pre="Am. Heart Assoc.92020e01621910.1161/JAHA.120.016219 46GuoY.R.CaoQ.D.HongZ.S.TanY.Y.ChenS.D.JinH.J.TanK.S.WangD.Y.YanY.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;an update on the statusMilitary Medical Research7202011010.1186/s40779-020-00240-031928528 47WuY.XuX.ChenZ.DuanJ.HashimotoK.YangL.YangC.Nervous"/>
   <result pre="treating COVID-19Current Pharmacology Reports62020567010.1007/s40495-020-00216-7 49MaoL.JinH.WangM.HuY.ChenS.HeQ.MiaoX.Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, ChinaJAMA neurology202010.1001/jamaneurol.2020.1127 50XiangP.XuX.M.GaoL.L.WangH.Z.XiongH.F.LiR.H.First case of 2019 novel"/>
   <result pre="Reznikov, L. R., ... &amp;amp; McCray Jr, P. B. (2016)." exact="Middle East respiratory syndrome" post="coronavirus causes multiple organ damage and lethal disease in"/>
   <result pre="with acute respiratory distress syndromeLancet Respir. Med.8202042042210.1016/S2213-2600(20)30076-X32085846 70CheungK.S.HungI.F.ChanP.P.LungK.C.TsoE.LiuR.NgY.Y.ChuM.Y.ChungT.W.TamA.R.YipC.C.Gastrointestinal manifestations of" exact="SARS-CoV-2 infection" post="and virus load in fecal samples from the Hong"/>
   <result pre="individuals without underlying diseases in pandemic epicentersmedRxiv202010.1101/2020.04.05.20054361 85SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a reviewJama202010.1001/jama.2020.6019 86https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment. 87https://www.europeanpharmaceuticalreview.com/news/121787/glenmark-approved-to-supply-favipiravir-as-covid-19-treatment-in-india/. 88https://www.ashp.org/-/media/assets/pharmacy-practice/resourcecenters/Coronavirus/docs/ASHP-COVID-19-Evidence-Table.ashx?. 89KeithP.DayM.PerkinsL.MoyerL.HewittK.WellsA.A novel treatment"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7366994\results\search\zoonosis\results.xml">
   <result pre="provided herbal medicines, which I truly appreciated.â€� Unlike the past" exact="swine flu," post="SARS, and Middle-East Respiratory Syndrome (MERS) pandemics, this teleconsultation"/>
   <result pre="role of KM teleconsultation in pandemic era.4 The notorious SARS," exact="swine flu," post="and MERS pandemics in 2003, 2009, and 2013 have"/>
   <result pre="have emphasized the use of Korean medical approaches during the" exact="swine flu" post="and MERS epidemics, they were not able to participate"/>
   <result pre="solutions to address it. 3 Summary Unlike in the past" exact="swine flu," post="SARS, or MERS outbreaks, KM experts from various fields"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7367788\results\search\zoonosis\results.xml">
   <result pre="RepCurrent Pharmacology Reports2198-641XSpringer International PublishingCham pmcid: 7367788226 doi: 10.1007/s40495-020-00226-5 :" exact="Covid-19" post="(ATY Lau and A Kong, Section Editors) Pipeline Pharmacological"/>
   <result pre="the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for causing" exact="coronavirus disease 2019" post="(COVID-19), marked the third time in the twenty-first century"/>
   <result pre="to other parts of the world. This quick spread of" exact="SARS-CoV-2 infection" post="to many states across the globe affecting many people"/>
   <result pre="FDA-approved drugs or vaccines are available to treat or prevent" exact="SARS-CoV-2 infection." post="The current therapeutic options for COVID-19 are limited only"/>
   <result pre="severe acute respiratory syndrome (SARS) in 2002 and 2003 and" exact="Middle East respiratory syndrome" post="(MERS) in 2012 when a highly pathogenic coronavirus of"/>
   <result pre="of immunologically directed strategies and anti-cytokine therapy is indispensable in" exact="SARS-CoV-2 infection" post="as a notable proportion of COVID-19 patients have reported"/>
   <result pre="of ACEI, ARBs, and rbACE2 will increase or alleviate the" exact="SARS-CoV-2 infection." post="Another approach for reducing the impact of COVID-19 pandemic"/>
   <result pre="inhibiting viral replication and viral RNA synthesis Investigational drug for" exact="Ebola" post="virus and variety of RNA viruses; FDA Emergency Use"/>
   <result pre="other patients Investigational approach tried for emerging Infectious Diseases like" exact="Ebola" post="virus Anakinra (recombinant interleukin, immunotherapy) Phase 2/3 Target Interleukin-1"/>
   <result pre="combination with antiviral) Phase 3 Inhibit cyclo-oxygenase 2 (COX-2) and" exact="Influenza" post="A virus nucleoprotein (NP), reduces inflammation Osteoarthritis, rheumatoid arthritis,"/>
   <result pre="has shown anti-viral activity for various RNA viruses including the" exact="Ebola" post="virus and oseltamivir-resistant influenza virus [26]. It is a"/>
   <result pre="In India, HCQ is used as a prophylactic drug for" exact="SARS-CoV-2 infection" post="in healthcare professionals. Recently, the results of a most"/>
   <result pre="cytokines has been reported to correlate with disease severity in" exact="SARS-CoV-2 infection," post="and it might lead to acute lung injury, acute"/>
   <result pre="to COVID-19 patients to increase the ability to fight to" exact="SARS-CoV-2 infection." post="Another cell-based therapy that has shown promising results in"/>
   <result pre="the ACE2 receptor and exerting an antiviral effect to prevent" exact="SARS-CoV-2 infection" post="[70]. Medical institutions in China have published many TCM"/>
   <result pre="pandemics. This article is part of the Topical Collection on" exact="Covid-19" post="Publisherâ€™s Note Springer Nature remains neutral with regard to"/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the experience of clinical immunologists from ChinaClin Immunol202021415"/>
   <result pre="infectionProc Natl Acad Sci20201176771677632054787 17.ProschanMPhDMukadiDManzoMLPhDNzoloDet al.A randomized, controlled trial of" exact="Ebola" post="virus disease therapeutics SabueN Engl J Med20193812293230331774950 18.BrownAJWonJJGrahamRLDinnonKHSimsACFengJYet al.Broad"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother2014584875488424841269 34.CaoBWangYWenDLiuWWangJFanGRuanLSongBCaiYWeiMLiXXiaJChenNXiangJYuTBaiTXieXZhangLLiCYuanYChenHLiHHuangHTuSGongFLiuYWeiYDongCZhouFGuXXuJLiuZZhangYLiHShangLWangKLiKZhouXDongXQuZLuSHuXRuanSLuoSWuJPengLChengFPanLZouJJiaCWangJLiuXWangSWuXGeQHeJZhanHQiuFGuoLHuangCJakiTHaydenFGHorbyPWZhangDWangCA trial"/>
   <result pre="J Med20073571450145117914053 48.Van GriensvenJEdwardsTDe LamballerieXSempleMGGallianPBaizeSet al.Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in GuineaN Engl J Med2016374334226735992 49.RinaldoCRPassive immunization"/>
   <result pre="10.1007/s00134-020-05991-x. 56.RamanathanKAntogniniDCombesAPadenMZakharyBOginoMet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet.202039550751332007143 57.Wu C, Chen"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, China. JAMA Intern Med. 2020:1â€&quot;24. 58.Liu"/>
   <result pre="Z, et al. The potential role of IL-6 in monitoring" exact="coronavirus disease 2019." post="medRxiv. 2020;10.1101/2020.03.01.20029769. 59.Xu X, Han M, Li T, Sun"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7368942\results\search\zoonosis\results.xml">
   <result pre="tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1" exact="influenza infection" post="in miceCritical Care2013176p. R30110.1186/cc13171 Table 1 Clinical and demographic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7369569\results\search\zoonosis\results.xml">
   <result pre="credit line to the data. Abstract Background The outbreak of" exact="coronavirus disease 2019" post="(COVID-19) has caused a public catastrophe and global concern."/>
   <result pre="and previous outbreaks of severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS) and to provide guidance regarding new methods of"/>
   <result pre="Keywords COVID-19 Coronavirus SARS MERS Autodock Background The outbreak of" exact="coronavirus disease 2019" post="(COVID-19) caused by a novel coronavirus has become a"/>
   <result pre="Center for Disease Control and Prevention (China CDC) determined that" exact="SARS-CoV-2 infection" post="is the cause of the outbreak that started in"/>
   <result pre="the autopsy reports of patients with COVID-19 that show that" exact="SARS-CoV-2 infection" post="mainly causes deep airway inflammatory reactions and alveolar damage."/>
   <result pre="Transl Med2020812832175421 29.ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYXiaJYuTZhangXZhangLEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751332007143 30.JiWWangWZhaoXZaiJLiXHomologous recombination within"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7369591\results\search\zoonosis\results.xml">
   <result pre="severe acute respiratory syndrome coronavirus 2, the causal agent of" exact="coronavirus disease 2019" post="(COVID-19), quickly spread around the world, resulting in the"/>
   <result pre="landscape for promising therapies is described. Abbreviations and Acronyms COVID-19," exact="coronavirus disease 2019" post="CPT, convalescent plasma therapy CQ, chloroquine EC50, half-maximal effective"/>
   <result pre="unit IL-6, interleukin 6 JAK, Janus kinase LPV/RTV, lopinavir/ritonavir MERS," exact="Middle East respiratory syndrome" post="RCT, randomized controlled trial SARS, severe acute respiratory syndrome"/>
   <result pre="WHO, World Health Organization Article Highlights â€¢Most emerging therapies for" exact="coronavirus disease 2019" post="have antiviral activity for addressing infection directly or counteract"/>
   <result pre="severe disease. â€¢The currently available clinical evidence for promising emerging" exact="coronavirus disease 2019" post="therapies provides rationale for continued investigation but is inconclusive"/>
   <result pre="respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), the causal agent of" exact="coronavirus disease 2019" post="(COVID-19), appeared in December 2019 in Wuhan, China, and"/>
   <result pre="and drugs that were used for similar diseases including SARS," exact="Middle East respiratory syndrome" post="(MERS), and Ebola have emerged as treatment options because"/>
   <result pre="similar diseases including SARS, Middle East respiratory syndrome (MERS), and" exact="Ebola" post="have emerged as treatment options because of their known"/>
   <result pre="112 Transfer of humoral immunity Antiâ€&quot;SARS-CoV-2 humoral immunity aCOVID-19Â =" exact="coronavirus disease 2019;" post="SARS-CoV-2Â = severe acute respiratory distress syndrome coronavirusÂ 2."/>
   <result pre="of viral replication and RNA synthesis.8,9 Data supporting treatment of" exact="SARS-CoV-2 infection" post="with remdesivir include established potency against coronaviruses inÂ vitro8"/>
   <result pre="Single 0 (0) Multi 1 (8) Other 838 aCOVID-19 =" exact="coronavirus disease 2019;" post="SARS-CoV-2 = severe acute respiratory distress syndrome coronavirus 2;"/>
   <result pre="a WHO-sponsored, adaptive RCT open to any patient with confirmed" exact="SARS-CoV-2 infection" post="worldwide. On the basis of institutional drug availability, patients"/>
   <result pre="21, 28, and 60-d mortality Convalescent Plasma as Therapy for" exact="Covid-19" post="Severe SARS-CoV-2 Disease (CONCOVID Study) (ClinicalTrials.gov identifier: NCT04342182) The"/>
   <result pre="until hospital discharge or 60-dHospital length of stay COVID-19Â =" exact="coronavirus disease 2019;" post="CQ/HCQÂ = chloroquine or hydroxychloroquine; FiO2Â = fraction of"/>
   <result pre="29, 2020 3DengY.LiuW.LiuK.Clinical characteristics of fatal and recovered cases of" exact="coronavirus disease 2019" post="(COVID-19) in Wuhan, China: a retrospective studyChin Med J"/>
   <result pre="TeamClinical and virologic characteristics of the first 12 patients with" exact="coronavirus disease 2019" post="(COVID-19) in the United StatesNat Med266202086186832327757 18AntinoriS.CossuM.V.RidolfoA.L.Compassionate remdesivir treatment"/>
   <result pre="in the United StatesNat Med266202086186832327757 18AntinoriS.CossuM.V.RidolfoA.L.Compassionate remdesivir treatment of severe" exact="Covid-19" post="pneumonia in intensive care unit (ICU) and non-ICU patients:"/>
   <result pre="InvestigatorsRemdesivir for 5 or 10 days in patients with severe" exact="Covid-19" post="[published online ahead of print May 27, 2020]N Engl"/>
   <result pre="respiratory syndromeAntivir Ther215201645545926492219 28SpanakisN.TsiodrasS.HaagmansB.L.Virological and serological analysis of a recent" exact="Middle East respiratory syndrome" post="coronavirus infection case on a triple combination antiviral regimenInt"/>
   <result pre="trialTrials19120188129382391 30WangZ.ChenX.LuY.ChenF.ZhangW.Clinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci Trends1412020646832037389 31YoungB.E.OngS.W.X.KalimuddinS.collab:"/>
   <result pre="Biol124202032232532236562 41SchoergenhoferC.JilmaB.StimpflT.KarolyiM.ZoufalyA.Pharmacokinetics of lopinavir and ritonavir in patients hospitalized with" exact="coronavirus disease 2019" post="(COVID-19) [published online ahead of print May 12, 2020]Ann"/>
   <result pre="Wuhan, ChinaLancet39510223202049750631986264 44ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet39510233202050751332007143 45WanS.YiQ.FanS.Characteristics of lymphocyte"/>
   <result pre="and cytokines in peripheral blood of 123 hospitalized patients with" exact="2019 novel coronavirus pneumonia" post="(NCP) [published online ahead of print February 12, 2020]medRxivhttps://doi.org/10.1101/2020.02.10.20021832"/>
   <result pre="with COVID-19 in Wuhan, ChinaClin Infect Dis7115202076276832161940 48ShiY.TanM.ChenX.Immunopathological characteristics of" exact="coronavirus disease 2019" post="cases in Guangzhou, China [published online ahead of print"/>
   <result pre="REgistry (SMACORE)Microorganisms852020695 61MarfellaR.PaolissoP.SarduC.Negative impact of hyperglycaemia on tocilizumab therapy in" exact="Covid-19" post="patients [published online ahead of print May 21, 2020]Diabetes"/>
   <result pre="print June 24, 2020]J Infecthttps://doi.org/10.1016/j.jinf.2020.06.052 65CaoY.WeiJ.ZouL.Ruxolitinib in treatment of severe" exact="coronavirus disease 2019" post="(COVID-19): a multicenter, single-blind, randomized controlled trialJÂ Allergy Clin"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="inÂ vitroCell Discov620201632194981 78YaoX.YeF.ZhangM.InÂ vitro antiviral activity and projection"/>
   <result pre="pharmacokinetically guided dosing for investigational treatments of pediatric patients with" exact="coronavirus disease 2019" post="[published online ahead of print June 5, 2020]JAMA Pediatrhttps://doi.org/10.1001/jamapediatrics.2020.2422"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7369612\results\search\zoonosis\results.xml">
   <result pre="other domesticated animals to SARSâ€&quot;coronavirus 2Science368649420201016102032269068 6DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov The14120205860 7StebbingJ.PhelanA.GriffinI.TuckerC.OechsleO.SmithD.COVID-19: combining antiviral and anti-inflammatory treatmentsLancet"/>
   <result pre="COVID-19 epidemic?Lancet39510228202093193432164834 17COVIDCDC and Team, ResponseSevere outcomes among patients with" exact="coronavirus disease 2019" post="(COVID-19) United States, February 12â€&quot;March 16, 2020MMWR Morb Mortal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7370876\results\search\zoonosis\results.xml">
   <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. Abstract" exact="Coronavirus disease 2019" post="(COVID-19), caused by a strain of coronavirus known as"/>
   <result pre="cardiovascular comorbidities is linked with worse outcomes in patients with" exact="coronavirus disease 2019" post="(COVID-19), and COVID-19 can induce cardiovascular damage. In this"/>
   <result pre="to our current understanding of COVID-19-related cardiovascular disease. Key points" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease"/>
   <result pre="acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes" exact="coronavirus disease 2019" post="(COVID-19), shares many biological features with SARS-CoV, the virus"/>
   <result pre="efficacy profiles. Subject terms Cardiovascular diseases SARS-CoV-2 Molecular biology Introduction" exact="Coronavirus disease 2019" post="(COVID-19) was first reported in Wuhan, China, in late"/>
   <result pre="caused pandemic diseases (severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV))1â€&quot;4. As with SARS-CoV and MERS-CoV, SARS-CoV-2 causes"/>
   <result pre="in some patients1. However, in addition to respiratory symptoms, uncontrolled" exact="SARS-CoV-2 infection" post="can trigger a cytokine storm, whereby pro-inflammatory cytokines and"/>
   <result pre="SARS-CoV, which introduces a novel furin cleavage site. c |" exact="SARS-CoV-2 infection" post="is triggered by the binding of the S protein"/>
   <result pre="disease specifically. bPrevalence of comorbidity among patients who died. COVID-19," exact="coronavirus disease 2019;" post="ICU, intensive care unit; NR, not reported. A similar"/>
   <result pre="artery disease are associated with high mortality in patients with" exact="coronavirus disease 2019" post="(COVID-19). Drugs used to reduce cardiovascular risk such as"/>
   <result pre="the plaque ruptures67. Direct endothelial or vascular injury caused by" exact="SARS-CoV-2 infection" post="might also increase the risk of thrombus formation and"/>
   <result pre="clinical findings are suggestive of a new phenomenon caused by" exact="SARS-CoV-2 infection" post="in children that can lead to a hyperinflammatory syndrome"/>
   <result pre="the need to screen for COVID-19. Given that individuals with" exact="SARS-CoV-2 infection" post="might be asymptomatic, routine screening of donor tissues is"/>
   <result pre="patients during the pandemic is to balance the risk of" exact="SARS-CoV-2 infection" post="with the need to provide timely cancer treatment. Clinicians"/>
   <result pre="in the biological mechanism underlying tissue-specific infection. As with SARS-CoV," exact="SARS-CoV-2 infection" post="is triggered by binding of viral SÂ protein to"/>
   <result pre="cardiomyocytes has not been found. Given that myocarditis related to" exact="SARS-CoV-2 infection" post="is rare23,53, the interaction between SARS-CoV-2 and ACE2 might"/>
   <result pre="treatment with recombinant ACE2 rescued lung damage106. Therefore, like SARS-CoV," exact="SARS-CoV-2 infection" post="might result in the downregulation of ACE2, which can"/>
   <result pre="that exogenous administration of recombinant human ACE2 (rhACE2) can prevent" exact="SARS-CoV-2 infection" post="by acting as a decoy114. The investigators demonstrated that"/>
   <result pre="a decoy114. The investigators demonstrated that clinical-grade rhACE2 can reduce" exact="SARS-CoV-2 infection" post="in cell culture and in engineered human blood vessel"/>
   <result pre="test, suggesting that these agents do not affect susceptibility to" exact="SARS-CoV-2 infection." post="Furthermore, the use of these agents was not associated"/>
   <result pre="against cardiovascular disease and lung injury. In the setting of" exact="coronavirus disease 2019," post="downregulation of ACE2 by severe acute respiratory syndrome coronavirus"/>
   <result pre="prolongation Tocilizumab IL-6 inhibition Hypertension ACE2, angiotensin-converting enzyme 2; COVID-19," exact="coronavirus disease 2019;" post="RdRP, RNA-dependent RNA polymerase; S protein, spike protein. Hydroxychloroquine"/>
   <result pre="targeting RdRP27,154,155. Remdesivir was originally developed for the treatment of" exact="Ebola" post="virus disease. Prophylactic and therapeutic administration of remdesivir has"/>
   <result pre="human ACE2, other animal species that are naturally susceptible to" exact="SARS-CoV-2 infection" post="(such as ferrets, hamsters and non-human primates)164,165,167â€&quot;170 or in"/>
   <result pre="ACC COVID-19 hub: https://www.acc.org/latest-in-cardiology/features/accs-coronavirus-disease-2019-covid-19-hub ESC COVID-19 and cardiology: https://www.escardio.org/Education/COVID-19-and-Cardiology COVID-19," exact="coronavirus disease 2019." post="Competing interests The authors declare no competing interests. Peer"/>
   <result pre="Wuhan, China: a retrospective cohort studyLancet20203951054106232171076 20.GuanWJet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN. Engl. J. Med.20203821708172032109013 21.WuZMcGooganJMCharacteristics of and important"/>
   <result pre="Engl. J. Med.20203821708172032109013 21.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="Cardiol.202010.1001/jamacardio.2020.095032639516 24.GuoTet al.Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.101732667620 25.ShiSet al.Characteristics and clinical significance of myocardial"/>
   <result pre="M.) 410â€&quot;448 (Lippincott Williams &amp;amp; Wilkins, 2020). 41.SandersJMMonogueMLJodlowskiTZCutrellJBPharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a reviewJAMA202010.1001/jama.2020.601932282022 42.LiGDe ClercqETherapeutic options for the 2019"/>
   <result pre="China Life Sci.20196218720230519877 55.InciardiRMet al.Cardiac involvement in a patient with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.109632219357 56.HuHMaFWeiXFangYCoronavirus fulminant myocarditis saved with glucocorticoid and"/>
   <result pre="90.TangNet al.Anticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathyJ. Thromb. Haemost.2020181094109932220112 91.QiuHet al.Clinical and epidemiological"/>
   <result pre="Haemost.2020181094109932220112 91.QiuHet al.Clinical and epidemiological features of 36 children with" exact="coronavirus disease 2019" post="(COVID-19) in Zhejiang, China: an observational cohort studyLancet Infect."/>
   <result pre="inhibitors and angiotensin II receptor blockers with testing positive for" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.185532432651 129.IshiyamaYet al.Upregulation of angiotensin-converting enzyme 2 after"/>
   <result pre="or without concomitant azithromycin among hospitalized patients testing positive for" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.183432356863 152.HancoxJCHasnainMViewegWVCrouseELBaranchukAAzithromycin, cardiovascular risks, QTc interval prolongation, Torsade"/>
   <result pre="laboratory biosafety guidelines for handling and processing specimens associated with" exact="coronavirus disease 2019" post="(COVID-19).https://www.cdc.gov/coronavirus/2019-ncov/lab/lab-biosafety-guidelines.html (CDC, 2020). 162.World Health Organization. Laboratory biosafety guidance"/>
   <result pre="(CDC, 2020). 162.World Health Organization. Laboratory biosafety guidance related to" exact="coronavirus disease 2019" post="(COVID-19). https://www.who.int/publications-detail/laboratory-biosafety-guidance-related-to-coronavirus-disease-2019-(covid-19) (2020). 163.BaoLet al.The pathogenicity of SARS-CoV-2 in"/>
   <result pre="Microbiol.2019443844630531978 169.ChanJFet al.Simulation of the clinical and pathological manifestations of" exact="coronavirus disease 2019" post="(COVID-19) in golden Syrian hamster model: implications for disease"/>
   <result pre="173.Sharma, A. et al. Human iPSC-derived cardiomyocytes are susceptible to" exact="SARS-CoV-2 infection." post="Cell Rep. Med.10.1016/j.xcrm.2020.100052 (2020). 174.McCauleyKBHawkinsFKottonDNDerivation of epithelial-only airway organoids"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7371486\results\search\zoonosis\results.xml">
   <result pre="disproportionately affected by crisis.1 For example, reports from the 2014â€&quot;2015" exact="Ebola" post="epidemic suggest that the shutdown of routine services resulted"/>
   <result pre="2ElstonJWT, CartwrightC, NdumbiP, et al.The health impact of the 2014-15" exact="Ebola" post="outbreak. Public Health2017;143:60â€&quot;70. 10.1016/j.puhe.2016.10.02028159028 3McQuilkinPA, UdhayashankarK, NiescierenkoM, et al.Health-care"/>
   <result pre="Health2017;143:60â€&quot;70. 10.1016/j.puhe.2016.10.02028159028 3McQuilkinPA, UdhayashankarK, NiescierenkoM, et al.Health-care access during the" exact="Ebola" post="virus epidemic in Liberia. Am J Trop Med Hyg2017;97:931â€&quot;6."/>
   <result pre="pandemic. Lancet Glob Health2020;8:e760â€&quot;1. 10.1016/S2214-109X(20)30190-X32330429 8BayefskyMJ, BartzD, WatsonKLAbortion during the" exact="Covid-19" post="pandemic - ensuring access to an essential health service."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7371569\results\search\zoonosis\results.xml">
   <result pre="critical care 17 April 2020, 2020. 4collab: Department of HealthDaily" exact="Covid-19" post="figures - 28 April 2020, 2020 Available: https://www.health-ni.gov.uk/news/daily-covid-19-figures-28-april-2020 [Accessed"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7372203\results\search\zoonosis\results.xml">
   <result pre="pandemic. Abstract The severe acute respiratory syndrome coronavirus 2 associated" exact="coronavirus disease 2019" post="(COVID-19) illness is a syndrome of viral replication in"/>
   <result pre="against the use of JAK inhibitors for the treatment of" exact="COVID19" post="except in the context of a clinical trial, in"/>
   <result pre="NIH COVID-19 Treatment Guidelines Panel and the Surviving Sepsis Campaign" exact="COVID19" post="subcommittee do not recommend the use of commercially available"/>
   <result pre="as avascular necrosis, psychosis, diabetes, and delayed viral clearance [78]." exact="Influenza" post="patients manifest a higher risk of mortality and secondary"/>
   <result pre="treatment (e.g. NCT04354259, NCT04388709) and postexposure prophylaxis (e.g. NCT04344600) of" exact="SARS-CoV-2 infection" post="are also underway. A multicenter, randomized, prospective study on"/>
   <result pre="in inflammation and lung pathology and increased mouse survival after" exact="SARS-CoV infection" post="[113]. OverexpressionÂ orÂ underexpression of the MyD888 gene can"/>
   <result pre="that colchicine may not have a protective role against a" exact="SARS-CoV-2 infection." post="It has also been hypothesized that colchicine may be"/>
   <result pre="aminotransferase, bid twice daily, COPD chronic obstructive pulmonary disease, COVID-19" exact="coronavirus disease 2019," post="CrCl creatinine clearance, CYP cytochrome P450, ESRD end-stage renal"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in WuhanChina JAMA Intern Med2020180711110.1001/jamainternmed.2020.0994 7.MahallawiWHKhabourOFZhangQMakhdoumHMSulimanBAMERS-CoV infection in"/>
   <result pre="cohort studyLancet Rheumatol202010.1016/S2665-9913(20)30164-8 22.DimopoulosGde MastQMarkouNet al.Favorable anakinra responses in severe" exact="Covid-19" post="patients with secondary hemophagocytic lymphohistiocytosisCell Host Microbe2020281117123.e110.1016/j.chom.2020.05.00732411313 23.CaoXCOVID-19: immunopathology"/>
   <result pre="Lilly. https://investor.lilly.com/news-releases/news-release-details/lilly-begins-clinicaltesting-therapies-covid-19. Accessed 10 Apr 2020. 42.National Institutes of Health." exact="Coronavirus disease 2019" post="(COVID-19) treatment guidelines. https://www.covid19treatmentguidelines.nih.gov/). Accessed 11 May 2020. 43.NIH"/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the perspectives of clinical immunologists from ChinaClin Immunol202021410839310.1016/j.clim.2020.10839332222466"/>
   <result pre="of clinical immunologists from ChinaClin Immunol202021410839310.1016/j.clim.2020.10839332222466 61.I-Mab seeks approval for" exact="Covid-19" post="trial in South Korea. https://www.clinicaltrialsarena.com/news/i-mab-covid-19-drug-trial/. Accessed 14 May 2020."/>
   <result pre="and laboratory effects of convalescent plasma therapy for patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a study protocolSpringerplus2015470910.1186/s40064-015-1490-926618098 71.HungIFToKKLeeCKet al.Convalescent plasma treatment"/>
   <result pre="campaign: guidelines on the management of critically ill adults with" exact="coronavirus disease 2019" post="(COVID-19)Crit Care Med2020486e440e46910.1097/CCM.000000000000436332224769 86.RussellCDMillarJEBaillieJKClinical evidence does not support corticosteroid"/>
   <result pre="a preliminary studyJAMA2003290243222322810.1001/jama.290.24.322214693875 104.OmraniASSaadMMBaigKet al.Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: a retrospective cohort study [published correction appears"/>
   <result pre="systematic reviewJ Infect20136729310110.1016/j.jinf.2013.04.01523665030 112.YuanSStatins may decrease the fatality rate of" exact="Middle East respiratory syndrome" post="infectionmBio201564e01120-1510.1128/mBio.01120-1526265720 113.DeDiegoMLNieto-TorresJLRegla-NavaJAJimenez-GuardeÃ±oJMFernandez-DelgadoRFettCet al.Inhibition of NF-ÎºB-mediated inflammation in severe acute"/>
   <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2)Clin Infect Dis202010.1093/cid/ciaa23732613227 139.SahraeiZShabaniMShokouhiSet al.Aminoquinolines against" exact="coronavirus disease 2019" post="(COVID-19): chloroquine or hydroxychloroquineInt J Antimicrob Agents202055410594510.1016/j.ijantimicag.2020.10594532194152 140.ZhouDDaiSMTongQCOVID-19: a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7374000\results\search\zoonosis\results.xml">
   <result pre="provided the original work is properly cited. Abstract The novel" exact="coronavirus disease 2019" post="(COVID-19) is spreading globally. Although its etiologic agent is"/>
   <result pre="COVID-19 Pathogenesis Protein-homeostasis-system hypothesis Corticosteroids Intravenous immunoglobulin Introduction The novel" exact="coronavirus disease 2019" post="(COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2),"/>
   <result pre="discusses unresolved issues in our understanding of infectious diseases and" exact="SARS-CoV-2 infection" post="and possible mechanisms of acute organ cell injury in"/>
   <result pre="cold, with rare cases manifesting as severe pneumonia. SARS-CoV and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) can cause serious respiratory tract infections, although"/>
   <result pre="reservoirs during epidemics of MP pneumonia, seasonal influenza, and possibly" exact="SARS-CoV-2 infection" post="[50,51]. It is unknown when this pandemic will fade."/>
   <result pre="Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200313-sitrep-53-covid-19 2DengSQPengHJCharacteristics of public health responses to the" exact="coronavirus disease 2019" post="outbreak in ChinaJ Clin Med20209E57532093211 3ParkPGKimCHYoonHKimTSParkCWKimCHOut-of-hospital cohort treatment of"/>
   <result pre="2019 outbreak in ChinaJ Clin Med20209E57532093211 3ParkPGKimCHYoonHKimTSParkCWKimCHOut-of-hospital cohort treatment of" exact="coronavirus disease 2019" post="patients with mild symptoms in Korea: an experience from"/>
   <result pre="6 [Epub]. 10.1007/s00405-020-05965-1 22MaoLJinHWangMHuYChenSHeQet al.Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, ChinaJAMA Neurol2020 Apr 10 [Epub]. 10.1001/jamaneurol.2020.1127 23ChengYLuoRWangKZhangMWangZDongLet"/>
   <result pre="Health Wkly Rep200927445 46DudarevaSSchweigerBThammMHÃ¶hleMStarkKKrauseGet al.Prevalence of antibodies to 2009 pandemic" exact="Influenza" post="A (H1N1) virus in German adult population in pre-"/>
   <result pre="as human reservoirsJ Infect Dis2001183675811170998 51ChoiSHKimHWKangJMKimDHChoEYEpidemiology and clinical features of" exact="coronavirus disease 2019" post="in childrenClin Exp Pediatr2020631253232252139 52MuthamilarasanMPrasadMPlant innate immunity: an updated"/>
   <result pre="A review of guidelinesComplement Ther Clin Pract20203910117432379639 96SandersJMMonogueMLJodlowskiTZCutrellJBPharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a reviewJAMA2020 Apr 13 [Epub]. 10.1001/jama.2020.6019 97BarlowALandolfKMBarlowBYeungSYAHeavnerJJClaassenCWHeavnerMSReview of"/>
   <result pre="use in the clinical setting?Ecancermedicalscience202014102332256706 113VeroneseNDemurtasJYangLTonelliRBarbagalloMLopalcoPet al.Use of corticosteroids in" exact="coronavirus disease 2019" post="pneumonia: a systematic review of the literatureFront Med (Lausanne)2020717032391369"/>
   <result pre="A presumed pathogenesis of acute lung injury in the novel" exact="coronavirus disease 2019" post="(COVID-19). During the incubation period, the severe acute respiratory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7375387\results\search\zoonosis\results.xml">
   <result pre="Health Organization (WHO) declaration of COVID-19 as a global pandemic.JVI.00957-20.pdf" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) emerged by the end of 2019"/>
   <result pre="(SARS-CoV) emerged and rapidly disappeared in May 2003. In 2012," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) was identified as a possible threat to"/>
   <result pre="virus replicated in ciliated cells and was released apically. IMPORTANCE" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) emerged by the end of 2019"/>
   <result pre="(SARS-CoV) disappeared after one season, never to come back, and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) never fully crossed the species border, as"/>
   <result pre="to verify whether HAE cultures may be used to study" exact="SARS-CoV-2 infection" post="and identified cellular targets in the tissue. First, HAE"/>
   <result pre="Similarly as for other human coronaviruses, the apical-apical polarity of" exact="SARS-CoV-2 infection" post="release restricts the virus to the airway lumen (16)."/>
   <result pre="China Medical Treatment Expert Group for COVID-19. 2020Clinical Characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med382:1708â€&quot;1720. doi:10.1056/NEJMoa2002032.32109013 10.MorensDM, DaszakP,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7376323\results\search\zoonosis\results.xml">
   <result pre="doi: 10.1186/s12981-020-00301-3 : Case Report Case report: one case of" exact="coronavirus disease 2019" post="(COVID-19) in a patient co-infected by HIV with a"/>
   <result pre="Dis J2020397e95e9932379191 6.AiTYangZHouHZhanCChenCLvWTaoQSunZXiaLCorrelation of chest CT and RT-PCR testing in" exact="coronavirus disease 2019" post="(COVID-19) in China: a report of 1014 casesRadiology202010.1148/radiol.20202006427233399 7.JinYHCaiLChengZSChengHDengTFanYPA"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7376532\results\search\zoonosis\results.xml">
   <result pre="and safety of integrated traditional Chinese and Western medicine for" exact="coronavirus disease 2019" post="(COVID-19): a systematic review and meta-analysisPharmacol Res202015810489610.1016/j.phrs.2020.10489632438037 5.NiLZhouLZhouMZhaoJWangDCombination of"/>
   <result pre="Guideline-based Chinese herbal medicine treatment plus standard care for severe" exact="coronavirus disease 2019" post="(G-CHAMPS): evidence from China. Medrxiv 2020; doi: 10.1101/2020.03.27.20044974 7.WangCCaoBLiuQQZouZQLiangZAGuLDongJPLiangLRLiXWHuKHeXSSunYHAnYYangTCaoZXGuoYMWenXMWangYGLiuYLJiangLDOseltamivir"/>
   <result pre="trialAnn Intern Med2011155421722510.7326/0003-4819-155-4-201108160-0000521844547 8.DuHZHouXYMiaoYHHuangBSLiuDHTraditional Chinese medicine: an effective treatment for" exact="2019 novel coronavirus pneumonia" post="(NCP)Chin J Nat Med202018320621032245590 9.Jin Z, Du X, Xu"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7376974\results\search\zoonosis\results.xml">
   <result pre="H2N2 and H3N3 flu, HIV, and SARS, while MERS and" exact="Ebola" post="viruses are considered still in a prepandemic phase. Hard"/>
   <result pre="and 2012), SARS (2009), while MERS (2012 to now) and" exact="Ebola" post="(1975 to now) viruses are in a prepandemic phase."/>
   <result pre="into host cells. Glycofullerenes The emerging of mortal viruses, like" exact="Ebola" post="or Zika, and the lack of suitable treatments led"/>
   <result pre="the inhibition capacity of the glycofullerenes on viral infection of" exact="Ebola" post="(Figure 6, route A). The study revealed an IC50"/>
   <result pre="between fullerene and mannose IC50 ref glycofullerene monosaccharide malonate 12" exact="Ebola" post="8 2Â Î¼M (66) glycofullerene monosaccharide trialkynyl pentaerythritol 36"/>
   <result pre="Ebola 8 2Â Î¼M (66) glycofullerene monosaccharide trialkynyl pentaerythritol 36" exact="Ebola" post="22 68Â Î¼M glycofullerene monosaccharide trialkynyl pentaerythritol 36 Ebola"/>
   <result pre="36 Ebola 22 68Â Î¼M glycofullerene monosaccharide trialkynyl pentaerythritol 36" exact="Ebola" post="28 0.3Â Î¼M trideca-fullerenesa monosaccharide malonate 120 Ebola 8"/>
   <result pre="pentaerythritol 36 Ebola 28 0.3Â Î¼M trideca-fullerenesa monosaccharide malonate 120" exact="Ebola" post="8 20.375Â nM (69) trideca-fullerenesb monosaccharide malonate 120 Ebola"/>
   <result pre="120 Ebola 8 20.375Â nM (69) trideca-fullerenesb monosaccharide malonate 120" exact="Ebola" post="8 0.667Â nM glycofullerene disaccharide trialkynyl pentaerythritol 36 Zika"/>
   <result pre="glycofullerene disaccharide trialkynyl pentaerythritol 36 Zika 29 8.35Â nM (70)" exact="Dengue" post="7.71Â nM trideca-fullerenes disaccharide trialkynyl pentaerythritol 120 Zika 29"/>
   <result pre="nM trideca-fullerenes disaccharide trialkynyl pentaerythritol 120 Zika 29 0.52Â nM" exact="Dengue" post="0.098Â nM trideca-fullerenes disaccharide trialkynyl pentaerythritol 360 Zika 48"/>
   <result pre="nM trideca-fullerenes disaccharide trialkynyl pentaerythritol 360 Zika 48 0.067Â nM" exact="Dengue" post="0.035Â nM micellar glycofullerenes monosaccharide trialkynyl pentaerythritol 6 Ebola"/>
   <result pre="nM Dengue 0.035Â nM micellar glycofullerenes monosaccharide trialkynyl pentaerythritol 6" exact="Ebola" post="23 424Â nM (72) micellar glycofullerenes monosaccharide trialkynyl pentaerythritol"/>
   <result pre="23 424Â nM (72) micellar glycofullerenes monosaccharide trialkynyl pentaerythritol 12" exact="Ebola" post="25 196Â nM aSmall spacer between core C60 and"/>
   <result pre="orders of magnitude lower was measured on the inhibition of" exact="Ebola" post="virus (Table 3).66,68 In order to present more carbohydrates"/>
   <result pre="this molecule was studied in vitro with viral pseudoparticles of" exact="Dengue" post="and Zika. The comparison was made between 360 and"/>
   <result pre="results highlighted a picomolar IC50 inhibition on both Zika and" exact="Dengue" post="models for the 360 disaccharide glycofullerene (Table 3). The"/>
   <result pre="of carbohydrate at the surface, leading to an inhibition of" exact="Ebola" post="virus in the nanomolar range (IC50 of 424 nM"/>
   <result pre="broad spectrum viral blocking capacity in vitro for enveloped (e.g.," exact="Japanese encephalitis" post="virus, Dengue virus, and Zika virus) and non-enveloped viruses"/>
   <result pre="blocking capacity in vitro for enveloped (e.g., Japanese encephalitis virus," exact="Dengue" post="virus, and Zika virus) and non-enveloped viruses (e.g., porcine"/>
   <result pre="in various types of viruses (e.g., herpes viruses, human papillomavirus," exact="Dengue" post="virus).83 The use of organic sulfate-functionalized graphene sheets mimicking"/>
   <result pre="graphene nanosheets in the proximity of the surface of the" exact="Ebola" post="viral matrix protein VP40 showing that the nanosheets can"/>
   <result pre="VP40, a key protein for the replication and stability of" exact="Ebola" post="virus (Figure 8).93 These findings suggest that graphene nanosheets"/>
   <result pre="biosynthesized from Actinobacteria showing good stability and capacity to inhibit" exact="Dengue" post="virus in vitro.120 Moreover, SeNPs were used to carry"/>
   <result pre="as chronic inflammation may contribute to the aggravation of the" exact="Covid-19" post="symptoms and to the general spread of the infection.124"/>
   <result pre="10.2147/IJN.S50070. XiangD.; ChenQ.; PangL.; ZhengC.Inhibitory Effects of Silver Nanoparticles on" exact="H1N1 Influenza" post="A Virus In Vitro. J. Virol. Methods2011, 178, 137â€&quot;142."/>
   <result pre="XiangD.; ChenQ.; PangL.; ZhengC.Inhibitory Effects of Silver Nanoparticles on H1N1" exact="Influenza" post="A Virus In Vitro. J. Virol. Methods2011, 178, 137â€&quot;142."/>
   <result pre="L.; HussainS. M.A Preliminary Assessment of Silver Nanoparticle Inhibition of" exact="Monkeypox" post="Virus Plaque Formation. Nanoscale Res. Lett.2008, 3, 129â€&quot;133. 10.1007/s11671-008-9128-2."/>
   <result pre="Based Codelivery of Oseltamivir to Inhibit the Activity of the" exact="H1N1 Influenza" post="Virus through ROS-Mediated Signaling Pathways. ACS Appl. Mater. Interfaces2016,"/>
   <result pre="Codelivery of Oseltamivir to Inhibit the Activity of the H1N1" exact="Influenza" post="Virus through ROS-Mediated Signaling Pathways. ACS Appl. Mater. Interfaces2016,"/>
   <result pre="10.1021/acsami.6b06613.27588566 LiY.; LinZ.; ZhaoM.; GuoM.; XuT.; WangC.; XiaH.; ZhuB.Reversal of" exact="H1N1 Influenza" post="Virus-Induced Apoptosis by Silver Nanoparticles Functionalized with Amantadine. RSC"/>
   <result pre="LiY.; LinZ.; ZhaoM.; GuoM.; XuT.; WangC.; XiaH.; ZhuB.Reversal of H1N1" exact="Influenza" post="Virus-Induced Apoptosis by Silver Nanoparticles Functionalized with Amantadine. RSC"/>
   <result pre="LiY.; GuoM.; XuT.; WangC.; ZhaoM.; WangH.; ChenT.; ZhuB.The Inhibition of" exact="H1N1 Influenza" post="Virus-Induced Apoptosis by Silver Nanoparticles Functionalized with Zanamivir. RSC"/>
   <result pre="GuoM.; XuT.; WangC.; ZhaoM.; WangH.; ChenT.; ZhuB.The Inhibition of H1N1" exact="Influenza" post="Virus-Induced Apoptosis by Silver Nanoparticles Functionalized with Zanamivir. RSC"/>
   <result pre="I.; BarclayW. S.; ZambonM. C.Changes in In Vitro Susceptibility of" exact="Influenza" post="A H3N2 Viruses to a Neuraminidase Inhibitor Drug During"/>
   <result pre="ParkG.; ParkC.; SongD.; HaamS.Porous Gold Nanoparticles for Attenuating Infectivity of" exact="Influenza" post="A Virus. J. Nanobiotechnol.2020, 18, 5410.1186/s12951-020-00611-8. HalderA.; DasS.; OjhaD.;"/>
   <result pre="WileyD. C.Receptor Binding and Membrane Fusion in Virus Entry: The" exact="Influenza" post="Hemagglutinin. Annu. Rev. Biochem.2000, 69, 531â€&quot;569. 10.1146/annurev.biochem.69.1.531.10966468 SametbandM.; ShuklaS.;"/>
   <result pre="ShuklaS.; MeningherT.; HirshS.; MendelsonE.; SaridR.; GedankenA.; MandelboimM.Effective Multi-Strain Inhibition of" exact="Influenza" post="Virus by Anionic Gold Nanoparticles. MedChemComm2011, 2, 421â€&quot;423. 10.1039/c0md00229a."/>
   <result pre="10.1002/chem.201504262.26875938 PappI.; SiebenC.; LudwigK.; RoskampM.; BÃ¶ttcherC.; SchlechtS.; HerrmannA.; HaagR.Inhibition of" exact="Influenza" post="Virus Infection by Multivalent Sialic-Acid- Functionalized Gold Nanoparticles. Small2010,"/>
   <result pre="Interfaces2019, 11, 19799â€&quot;19807. 10.1021/acsami.9b04240.31099550 NoyceJ. O.; MichelsH.; KeevilC. W.Inactivation of" exact="Influenza" post="A Virus on Copper Versus Stainless Steel Surfaces. Appl."/>
   <result pre="TaniM.; YamamotoY.; YamadaM.; NakamuraK.; ImaiK.Inactivation and Morphological Changes of Avian" exact="Influenza" post="Virus by Copper Ions. Arch. Virol.2008, 153, 1467â€&quot;1472. 10.1007/s00705-008-0154-2.18592130"/>
   <result pre="Nanosized Copper(i) Iodide Particles Showing Inactivation Activity against 2009 Pandemic" exact="H1N1 Influenza" post="Virus. Appl. Environ. Microbiol.2012, 78 (78), 951â€&quot;955. 10.1128/AEM.06284-11.22156433 HangX.;"/>
   <result pre="Copper(i) Iodide Particles Showing Inactivation Activity against 2009 Pandemic H1N1" exact="Influenza" post="Virus. Appl. Environ. Microbiol.2012, 78 (78), 951â€&quot;955. 10.1128/AEM.06284-11.22156433 HangX.;"/>
   <result pre="Globular Multivalent Glycofullerenes as Potent Inhibitors in a Model of" exact="Ebola" post="Virus Infection. Nat. Chem.2016, 8, 50â€&quot;57. 10.1038/nchem.2387.27055288 Ramos-SorianoJ.; ReinaJ."/>
   <result pre="StahelinR. V.; ChapagainP. P.Graphene-VP40 Interactions and Potential Disruption of the" exact="Ebola" post="Virus Matrix Filaments. Biochem. Biophys. Res. Commun.2017, 493, 176â€&quot;181."/>
   <result pre="Absence of Reactive Oxygen Species Improves the Resolution of Lung" exact="Influenza" post="Infection. Eur. J. Immunol.2006, 36, 1364â€&quot;1373. 10.1002/eji.200635977.16703568 TavakoliA.; Ataei-PirkoohA.;"/>
   <result pre="FarahmandM.; JavanmardD.; KianiS. J.; EsghaeiM.; Pirhajati-MahabadiV.; Ataei-PirkoohA.; MonavariS. H.Inhibition of" exact="H1N1 Influenza" post="Virus Infection by Zinc Oxide Nanoparticles: Another Emerging Application"/>
   <result pre="JavanmardD.; KianiS. J.; EsghaeiM.; Pirhajati-MahabadiV.; Ataei-PirkoohA.; MonavariS. H.Inhibition of H1N1" exact="Influenza" post="Virus Infection by Zinc Oxide Nanoparticles: Another Emerging Application"/>
   <result pre="GongG.; XiaY.; WangC.; ChenY.; HuaL.; ZhongJ.; TangY.; LiuX.; ZhuB.Restriction of" exact="H1N1 Influenza" post="Virus Infection by Selenium Nanoparticles Loaded with Ribavirin via"/>
   <result pre="XiaY.; WangC.; ChenY.; HuaL.; ZhongJ.; TangY.; LiuX.; ZhuB.Restriction of H1N1" exact="Influenza" post="Virus Infection by Selenium Nanoparticles Loaded with Ribavirin via"/>
   <result pre="LinZ.; LiY.; GuoM.; XiaoM.; WangC.; ZhaoM.; XuT.; XiaY.; ZhuB.Inhibition of" exact="H1N1 Influenza" post="Virus by Selenium Nanoparticles Loaded with Zanamivir through P38"/>
   <result pre="LiY.; GuoM.; XiaoM.; WangC.; ZhaoM.; XuT.; XiaY.; ZhuB.Inhibition of H1N1" exact="Influenza" post="Virus by Selenium Nanoparticles Loaded with Zanamivir through P38"/>
   <result pre="ChenT.; ZhuB.Inhibitory Activity of Selenium Nanoparticles Functionalized with Oseltamivir on" exact="H1N1 Influenza" post="Virus. Int. J. Nanomed.2017, 12, 5733â€&quot;5743. 10.2147/IJN.S140939. LiY.; LinZ.;"/>
   <result pre="ZhuB.Inhibitory Activity of Selenium Nanoparticles Functionalized with Oseltamivir on H1N1" exact="Influenza" post="Virus. Int. J. Nanomed.2017, 12, 5733â€&quot;5743. 10.2147/IJN.S140939. LiY.; LinZ.;"/>
   <result pre="10.2147/IJN.S140939. LiY.; LinZ.; GuoM.; ZhaoM.; XiaY.; WangC.; XuT.; ZhuB.Inhibition of" exact="H1N1 Influenza" post="Virus-Induced Apoptosis by Functionalized Selenium Nanoparticles with Amantadine through"/>
   <result pre="LiY.; LinZ.; GuoM.; ZhaoM.; XiaY.; WangC.; XuT.; ZhuB.Inhibition of H1N1" exact="Influenza" post="Virus-Induced Apoptosis by Functionalized Selenium Nanoparticles with Amantadine through"/>
   <result pre="to Gold Nanoparticles Confers Protection against H1N1, H3N2 and H5N1" exact="Influenza" post="A Viruses. Antiviral Res.2017, 141, 62â€&quot;72. 10.1016/j.antiviral.2017.01.021.28161578 SekimukaiH.; Iwata-YoshikawaN.;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7377207\results\search\zoonosis\results.xml">
   <result pre="and 229E cause mild symptoms [16]. The first time that" exact="Severe acute respiratory syndrome" post="(SARS) coronavirus (SARS-CoV) appeared, it was in Guangdong, southern"/>
   <result pre="China, in November 2002 and the first time when the" exact="Middle East respiratory syndrome" post="(MERS) coronavirus (MERS-CoV) emerged, it was in 2012 in"/>
   <result pre="highly effective in decreasing viral replication and it can block" exact="SARS-CoV-2 infection" post="at low concentration (half-maximal effective concentration (EC50) of 1.13â€‰Î¼M"/>
   <result pre="cell cultures [50, 51] and also can be effective against" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in-vitro [52]. Hydroxychloroquine (HCQ) with a very"/>
   <result pre="ritonavir, lopinavir, and darunavir, might have a therapeutic impact on" exact="coronavirus disease 2019" post="(COVID-19). It is implied that the therapeutic effect of"/>
   <result pre="(Evidence that Vitamin D Supplementation Could Reduce the Risk of" exact="Influenza" post="and COVID-19 Infections and deaths). Vitamin D also deregulates"/>
   <result pre="2014, WHO suggested the use of convalescent plasma acquired from" exact="Ebola" post="virus-infected cases who had recovered as an empirical treatment"/>
   <result pre="for the use of convalescent plasma in the remedy of" exact="Middle East respiratory syndrome" post="coronavirus was appointed [93]. In a study, Hung and"/>
   <result pre="Donors of plasma were 5 patients who were recovered from" exact="SARS-CoV-2 infection" post="and they were the ages of 18 and 60â€‰years"/>
   <result pre="is similar to their platform which was used for the" exact="Ebola" post="vaccine; they are using Janssenâ€™s AdVacÂ® adenoviral vector and"/>
   <result pre="syndromeNat Med20041012S88S9715577937 18.Chan-YeungMXuRHSARS: epidemiologyRespirology20038S91415018127 19.LeeJChowellGJungEA dynamic compartmental model for the" exact="Middle East respiratory syndrome" post="outbreak in the Republic of Korea: a retrospective analysis"/>
   <result pre="24.PiepenburgOWilliamsCHStempleDLArmesNADNA detection using recombination proteinsPLoS Biol200647e20416756388 25.[cited 2020 march 27];" exact="Coronavirus disease 2019" post="(COVID-19)Situation Report âˆ’67.Available from: https://www.who.int/#. 26.Xiang YT, Yang Y,"/>
   <result pre="2020 march 28]; Available from: https://www.cdc.gov/features/rhinoviruses/index.html. 31.DavisJMMurphyEAMcClellanJLCarmichaelMDGangemiJDQuercetin reduces susceptibility to" exact="influenza infection" post="following stressful exerciseAm J Physiol Regul Integ Comp Physiol20082952R505R509"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother20145884875488410.1128/AAC.03011-1424841269 53.Ruiz-Irastorza G,"/>
   <result pre="bioRxiv. 2020 Jan 1. 10.1101/2020.01.31.929695. 74.BhatnagarTMurhekarMVSonejaMGuptaNGiriSWigNGangakhedkarRLopinavir/ritonavir combination therapy amongst symptomatic" exact="coronavirus disease 2019" post="patients in India: protocol for restricted public health emergency"/>
   <result pre="convalescent whole blood or plasma collected from patients recovered from" exact="Ebola" post="virus disease for transfusion, as an empirical treatment during"/>
   <result pre="and laboratory effects of convalescent plasma therapy for patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a study protocolSpringerplus2015411825674489 94.HungIFcollab: To KKLeeCKLeeKLChanKYanWWLiuRWattCLChanWMLaiKYKooCKConvalescent plasma"/>
   <result pre="with convalescent plasmaJAMA.2020323161582158910.1001/jama.2020.4783 103.Iran starts testing plasma treatment plan for" exact="COVID19" post="patients. 2020; Available from: https://en.irna.ir/news/83728876/Iran-starts-testing-plasma-treatment-plan-for-COVID19-patients. 104.The first US coronavirus"/>
   <result pre="H, Lei CL, Hui DS, Du B. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. New Engl J Med. 2020;382(18):1708â€&quot;1720.doi: DOI: 10.1056/NEJMoa2002032."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7380217\results\search\zoonosis\results.xml">
   <result pre="coronavirus (SARS-CoV-1), influenza A virus subtype H1N1, Zika virus, and" exact="Ebola" post="virus. The issues arising from these epidemics were relatively"/>
   <result pre="procedure also puts the pulmonologist at risk of acquiring the" exact="SARS-CoV-2 infection." post="Specific symptoms/findings ascribed to SARS-CoV-2 infection including fever, chills,"/>
   <result pre="risk of acquiring the SARS-CoV-2 infection. Specific symptoms/findings ascribed to" exact="SARS-CoV-2 infection" post="including fever, chills, cough, shortness of breath or difficulty"/>
   <result pre="include diarrhea and nausea. BOS indicates bronchiolitis obliterans syndrome; MERS," exact="Middle East respiratory syndrome;" post="ACE: angiotensin-converting enzyme; MAS, macrophage activation syndrome; TTP, thrombotic"/>
   <result pre="deal with the real-world scenarios. References REFERENCES 1World Health Organization." exact="Coronavirus disease 2019" post="(COVID-2019) situation report 181: 19 July 2020. Available at:"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern Med1802020111 7American Society for"/>
   <result pre="the severe COVIDâ€�19J Med Virol92202079179632181911 16LippiGPlebaniM.Laboratory abnormalities in patients with" exact="COVID-2019" post="infectionClin Chem Lab Med5820201131113432119647 17Principi N, Esposito S.Chloroquine or"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7380759\results\search\zoonosis\results.xml">
   <result pre="doi: 10.4103/jfmpc.jfmpc_384_20 : Invited Article Are we prepared? Lessons from" exact="Covid-19" post="and OMAG position paper on epidemic preparedness RainaSunil Kumar1KumarRaman2GalwankarSagar3GargSuneela4BhattRamesh5DhariwalAkshay"/>
   <result pre="PMC and Europe PMC, consistent with existing copyright protections.jfmpc-9-2161.pdf Abstract" exact="Covid-19" post="has once again brought into focus our limited preparedness"/>
   <result pre="have shown great commitment to protecting its people from Covid-19." exact="Covid-19" post="has also taught us a few things for the"/>
   <result pre="epidemic preparedness to limit the influence of epidemics like Covid-19." exact="Covid-19" post="epidemic lessons OMAG position paper Background Organised Medicine Academic"/>
   <result pre="medical professionals in India.[3] ICMR leading our fight against the" exact="Covid-19" post="through the establishment of laboratories across the country (using"/>
   <result pre="services This is equally important as happened during the 2014-2016" exact="Ebola" post="epidemics in West Africa; more people died because of"/>
   <result pre="on 2020 Mar 13From wwwwhoint ' Emergencies ' Diseases '" exact="Coronavirus disease 2019" post="6collab: Home: Integrated Disease Surveillance Programme (IDSP)Ministry of Health"/>
   <result pre="health â€º coronavirus-pandemic-frieden 10BhatnagarTMurhekar ManojVSonejaMGuptaNGiriSWigNet al.Lopinavir/ritonavir combination therapy amongst symptomatic" exact="coronavirus disease 2019" post="patients in India: Protocol for restricted public health emergency"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7381894\results\search\zoonosis\results.xml">
   <result pre="decade of the 21st century (2020) started with a deadly" exact="coronavirus disease 2019" post="(COVID-19) pandemic caused by a novel coronavirus (SARS-CoV-2) in"/>
   <result pre="Only a decade later (during 2012), the world witnessed the" exact="Middle East respiratory syndrome" post="(MERS) outbreak caused by MERS-CoV in the Middle East"/>
   <result pre="camels in Saudi ArabiaMBio52014e008841424570370 12PadenC.R.YusofM.Al HammadiZ.M.QueenK.TaoY.Zoonotic origin and transmission of" exact="Middle East respiratory syndrome" post="coronavirus in the UAEZoonoses Public Health65201832233329239118 13ChuD.K.W.HuiK.P.Y.PereraR.A.P.M.MiguelE.NiemeyerD.ZhaoJ.MERS coronaviruses from"/>
   <result pre="Hospitalized with Severe Covid-19N Engl J Med38220201787179910.1056/NEJMoa200128232187464 46ArabiY.M.AsiriA.Y.AssiriA.M.Aziz JokhdarH.A.AlothmanA.Treatment of" exact="Middle East respiratory syndrome" post="with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE trial):"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7383122\results\search\zoonosis\results.xml">
   <result pre="the virus. Keywords Heart failure COVID-19 Cardiac biomarkers Hemodynamics Introduction" exact="Coronavirus disease 2019" post="(COVID-19) is an infectious disease caused by severe acute"/>
   <result pre="associated with QTc prolongation at high doses used to treat" exact="Ebola" post="virus and not the current doses used for treatment"/>
   <result pre="Jessup M (2020) Considerations for heart failure care during the" exact="coronavirus disease 2019" post="(COVID-19) pandemic. JACC Heart Fail S2213-1779(20)30273â€&quot;0. 10.1016/j.jchf.2020.05.006 17.Zhou F,"/>
   <result pre="2019 novel coronavirusâ€&quot;infected pneumonia in Wuhan, ChinaJAMA20203231110611069 24.GuanWJNiZYHuYLiangWHOuCQHeJXLiuLShanHLeiCLHuiDSDuBClinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med2020382181708172032109013 25.HuangCWangYLiXRenLZhaoJHuYZhangLFanGXuJGuXChengZClinical features of patients"/>
   <result pre="Wuhan, ChinaLancet20203951022349750631986264 26.ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYYuTEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet20203951022350751332007143 27.Fang Z, Yi"/>
   <result pre="or risk of death in patients with hypertension hospitalized for" exact="coronavirus disease 2019" post="(COVID-19) infection in Wuhan, China. JAMA Cardiol 5(7):1â€&quot;6. 10.1001/jamacardio.2020.1624"/>
   <result pre="N, Pittalis S, Biava G, Ippolito G, Nicastri E, INMI" exact="Ebola" post="Team. QTc interval prolongation during favipiravir therapy in an"/>
   <result pre="(2020) Characteristics and outcomes of recipients of heart transplant with" exact="coronavirus disease 2019." post="JAMA Cardiol e202159. 10.1001/jamacardio.2020.2159 69.Guidance for cardiothoracic transplant and"/>
   <result pre="Prenner S, Wald J, Atluri P, Birati EY (2020) Novel" exact="coronavirus disease 2019" post="in a patient on durable left ventricular assist device"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7384729\results\search\zoonosis\results.xml">
   <result pre="Publishing Group UKLondon pmcid: 7384729387 doi: 10.1038/s41371-020-0387-4 : Review Article" exact="Covid-19" post="and the cardiovascular system: a comprehensive review http://orcid.org/0000-0001-6864-8805AzevedoRafael Bellottihttp://orcid.org/0000-0002-4130-5148BotelhoBruna"/>
   <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 and the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012 [1]. SARS-CoV-2 presents a transmissibility"/>
   <result pre="respiratory or intestinal infections in humans and animals [2]. The" exact="SARS-CoV-2 infection" post="occurs through the coupling of S-protein located on the"/>
   <result pre="diverging or not related to the cardiovascular complications associated with" exact="SARS-CoV-2 infection" post="were excluded from the revision. Articles that were not"/>
   <result pre="to a higher risk of developing severe disease due to" exact="SARS-CoV-2 infection" post="[7]. A retrospective cohort study included 126 patients with"/>
   <result pre="with COVID-19 without hypertension. Among hypertensives, 21.3% had more severe" exact="SARS-CoV-2 infection" post="and higher death rate, 10.3% vs. 6.4%, when compared"/>
   <result pre="when compared to controls, indicating that hypertension enhances inflammation in" exact="SARS-CoV-2 infection." post="Interestingly, hypertensive patients undergoing anti-hypertensive therapy with RAAS blockers"/>
   <result pre="Hypertension seems to enhance the inflammatory profile in patients with" exact="SARS-CoV-2 infection," post="inferring that resistant hypertension possiblyÂ increases even more the"/>
   <result pre="of patients with resistant hypertension and COVID-19 [9]. Myocarditis The" exact="SARS-CoV-2 infection," post="mainly in its severe forms, apparently induce an aggression"/>
   <result pre="controlled, open-label trial with 199 patients, investigating lopinavir/ritonavir efficacy for" exact="SARS-CoV-2 infection," post="only 1.1% of the patients in the lopinavir/ritonavir group"/>
   <result pre="severity was assessed in 6,272 patients who tested positive for" exact="SARS-CoV-2 infection;" post="the use of ACEi/ARBs was not associated with an"/>
   <result pre="association between the use of these drugs and more severe" exact="SARS-CoV-2 infection" post="was demonstrated [33]. Therefore, ACEi/ARBs are possibly potential drugs"/>
   <result pre="with more favorable outcomes. Conclusion Hypertension is strongly associated with" exact="SARS-CoV-2 infection" post="possibly due to the proinflammatory state of this chronic"/>
   <result pre="proven protease inhibitorCell20201812718010.1016/j.cell.2020.02.05232142651 3.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in ChinaJAMA202032312394210.1001/jama.2020.2648 4.YeQWangBMaoJThe pathogenesis and treatment of"/>
   <result pre="Cardiol20207529507310.1016/j.jacc.2020.04.03132311448 21.TangNBaiHChenXGongJLiDSunZAnticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathyJ Thromb Haemost2020181094910.1111/jth.1481732220112 22.Lakkireddy DR, Chung MK,"/>
   <result pre="or without concomitant azithromycin among hospitalized patients testing positive for" exact="coronavirus disease 2019" post="(COVID-19). JAMA Cardiol. 2020;e201834. 10.1001/jamacardio.2020.1834 26.HancoxJCHasnainMViewegWVCrouseELBaranchukAAzithromycin, cardiovascular risks, QTc"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7385132\results\search\zoonosis\results.xml">
   <result pre="which does not comply with these terms. Abstract The new" exact="coronavirus disease 2019" post="(COVID-19) has become a world health emergency. The disease"/>
   <result pre="COVID-19 dialysis transplant fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), first described in humans in December"/>
   <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 and the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012 have been toppled in case"/>
   <result pre="receptor regulator Ongoing trials Naproxen Inhibitor of both COX-2 of" exact="Influenza" post="A virus NP Ongoing trials Pirfenidone Inhibits IL-1Î² and"/>
   <result pre="promising results, a Chinese clinical trial (ChiC-TR2000029308) in patients with" exact="SARS-CoV-2 infection" post="showed that treatment with lopinavirâ€&quot;ritonavir added to standard supportive"/>
   <result pre="(108, 112). It is currently being tested for treatment of" exact="Ebola" post="virus infection and, in the future, might be useful"/>
   <result pre="plasma was recommended as an empirical treatment during outbreaks of" exact="Ebola" post="virus in 2014 and as a protocol for treatment"/>
   <result pre="of the MSC treatment in patients with ARDS secondary to" exact="Influenza" post="A (H7N9) infection (124). Several ongoing clinical trials are"/>
   <result pre="animal models of acute lung injury, including a model of" exact="SARS-CoV infection," post="showed that ARBs reduce Ang II-mediated lung damage and"/>
   <result pre="PC to the handling editor. References References 1.McMichaelTMCurrieDWClarkSPogosjansSKayMSchwartzNGet al.Epidemiology of" exact="Covid-19" post="in a long-term care facility in King County, Washington."/>
   <result pre="Reduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVID-19). Front Immunol. (2020) 11:827. 10.3389/fimmu.2020.0082732425950 19.CravediPHeegerPS. Complement as"/>
   <result pre="10.2214/AJR.09.359919933638 27.TangNBaiHChenXGongJLiDSunZAnticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathy. J Thromb Haemost. (2020) 18:1094â€&quot;9. 10.1111/jth.1481732220112"/>
   <result pre="N Engl J Med. (2020) 382:e38. 10.1056/NEJMc200757532268022 29.GatesB. Responding to" exact="Covid-19" post="â€&quot; A once-in-a-century pandemic?N Engl J Med. (2020) 382:1677â€&quot;9."/>
   <result pre="Engl J Med. (2020) 382:1677â€&quot;9. 10.1056/NEJMp200376232109012 30.HoehlSRabenauHBergerAKortenbuschMCinatlJBojkovaDet al.. Evidence of" exact="SARS-CoV-2 infection" post="in returning travelers from Wuhan, China. N Engl J"/>
   <result pre="Med. (2020) 382:1564â€&quot;7. 10.1056/NEJMc200497332182409 33.PhuaJWengLLingLEgiMLimCMDivatiaJVet al.. Intensive care management of" exact="coronavirus disease 2019" post="(COVID-19): challenges and recommendations. Lancet Respir Med. (2020) 8:506â€&quot;17."/>
   <result pre="105949. 10.1016/j.ijantimicag.2020.105949. [Epub ahead of print].32205204 35.GuanWNiZHuYLiangWOuCHeJet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. (2020) 382:1708â€&quot;20. 10.1056/NEJMoa200203232109013"/>
   <result pre="37.DengYLiuWLiuKFangYYShangJZhouLet al.. Clinical characteristics of fatal and recovered cases of" exact="coronavirus disease 2019" post="in Wuhan, China: a retrospective study. Chin Med J."/>
   <result pre="clinical characteristics of severe acute respiratory syndrome coronavirus 2 and" exact="coronavirus disease 2019." post="Gastroenterology. (2020) 158:2298â€&quot;301.e7. S0016508520303991.32234303 55.WangWXuYGaoRLuRHanKWuGet al.. Detection of SARS-CoV-2"/>
   <result pre="98:228â€&quot;31. 10.1016/j.kint.2020.04.00632471639 64.HenryBMLippiG. Chronic kidney disease is associated with severe" exact="coronavirus disease 2019" post="(COVID-19) infection. Int Urol Nephrol. (2020) 52:1193â€&quot;4. 10.1007/s11255-020-02451-932222883 65.PereiraMRMohanSCohenDJHusainSADubeGKRatnerLEet"/>
   <result pre="US epicenter. Am J Transplant. (2020) 20:1800â€&quot;8. 10.1111/ajt.1594132330343 66.AkalinEAzziYBartashRSeethamrajuHParidesMHemmigeVet al.." exact="Covid-19" post="and kidney transplantation. N Engl J Med. (2020) 382:2475â€&quot;7."/>
   <result pre="and COVID-19. J Am Soc Nephrol. (2020) 31:1409â€&quot;15. 10.1681/ASN.202004047032467113 83.KwanBCH." exact="Severe acute respiratory syndrome" post="in dialysis patients. J Am Soc Nephrol. (2004) 15:1883â€&quot;8."/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, China. JAMA Intern Med. (2020) 13:e200994."/>
   <result pre="Lung Transplant. (2020) 39:405â€&quot;7. 10.1016/j.healun.2020.03.01232362390 108.DongLHuSGaoJ. Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19). Drug Discov Ther. (2020) 14:58â€&quot;60. 10.5582/ddt.2020.0101232147628 109.de WildeAHJochmansDPosthumaCCZevenhoven-DobbeJCvan"/>
   <result pre="cell treatment for acute respiratory distress syndrome induced by epidemic" exact="Influenza" post="A (H7N9) infection: a hint for COVID-19 treatment. Engineering."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7385229\results\search\zoonosis\results.xml">
   <result pre="is permitted which does not comply with these terms. Abstract" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) is the third coronavirus leading to"/>
   <result pre="interest of the scientific community, the underlying physiopathology of the" exact="SARS-CoV-2 infection," post="remains partially unclear. SARS-CoV-2 shares similar features with SARS-CoV-1,"/>
   <result pre="on immune deregulation and that its low expression during the" exact="SARS-CoV-2 infection" post="could explain the severity of infection. This introduces angiotensin"/>
   <result pre="insufficient sampling. A second CoV epidemic occurred in 2012 with" exact="Middle East respiratory syndrome" post="(MERS)-CoV, which has mostly led to small-size outbreaks in"/>
   <result pre="associated with SARS-CoV-1 and MERS-CoV infections. Patients suffering from severe" exact="SARS-CoV-2 infection" post="could be healthy or only have mild comorbidities such"/>
   <result pre="in COVID-19 on the other. Physiopathology of Respiratory Failure in" exact="Covid-19" post="Most of the time, the need for intensive care"/>
   <result pre="be strongly involved in the development of ARDS. Implications of" exact="Covid-19" post="in Obese Patients Obesity is a common condition, affecting"/>
   <result pre="not the only subjects at a higher risk of severe" exact="SARS-CoV-2 infection." post="When considering metabolic disorders separately, diabetes, non-alcoholic liver disease,"/>
   <result pre="supplementation of Ang1-7 in these patients might improve fitness upon" exact="SARS-CoV infection." post="Figure 2 Impact of severe acute respiratory syndrome coronavirus"/>
   <result pre="underlying metabolic disorders. Understanding the multiple and interrelated factors linking" exact="SARS-CoV-2 infection," post="angiotensin metabolism, global inflammation, and metabolic disorders such as"/>
   <result pre="Foundation of Grenoble Alpes University, Grenoble, France. References References 1.ChengVCCLauSKPWooPCYYuenKY." exact="Severe acute respiratory syndrome" post="coronavirus as an agent of emerging and reemerging infection."/>
   <result pre="Lancet. (2020) 395:497â€&quot;506. 10.1016/S0140-6736(20)30183-531986264 9.PhuaJWengLLingLEgiMLimC-MDivatiaJVet al.. Intensive care management of" exact="coronavirus disease 2019" post="(COVID-19): challenges and recommendations. Lancet Respir Med. (2020) 8:506â€&quot;17."/>
   <result pre="10.ChenNZhouMDongXQuJGongFHanYet al.. Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet. (2020) 395:507â€&quot;13."/>
   <result pre="mRNAs of cytoplasmic origin. J Virol. (2015) 89:10970â€&quot;81. 10.1128/JVI.01352-1526311885 44.FriemanMYountBHeiseMKopecky-BrombergSAPalesePBaricRS." exact="Severe acute respiratory syndrome" post="coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import"/>
   <result pre="J Gastroenterol Hepatol. (2020). 10.1111/jgh.15112. [Epub ahead of print]. 76.PazarliACEkizTIlikF." exact="Coronavirus disease 2019" post="and obstructive sleep apnea syndrome. Sleep Breath. (2020) 1."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7388682\results\search\zoonosis\results.xml">
   <result pre="previous emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), it was expected that the globe would"/>
   <result pre="Envelope; HE: Hemagglutinin; N: Nucleocapsid; M: Membrane; S: Spike; SARS-CoV-2:" exact="Severe acute respiratory syndrome" post="coronavirus-2. (B) Reproduced with permission from [13]. Types of"/>
   <result pre="to a connection between gut functionality and microbiome responses to" exact="SARS-CoV-2 infection" post="[38]. Alterations of fecal microbiota are considered to be"/>
   <result pre="release antibodiesAdjuvants needed to increase immunogenicity [80â€&quot;83,85,87] CoV: Coronavirus; SARS-CoV:" exact="Severe acute respiratory syndrome" post="coronavirus. Multiple antigenic components using the whole virus either"/>
   <result pre="2) [50]. Figure 2. Clinical phase vaccine candidates for the" exact="coronavirus disease 2019." post="aAPC: Artificial antigen-presenting cells; Ad5-nCoV: Adenovirus Type 5 vectored"/>
   <result pre="cell; LNP: Lipid nanoparticles; LV: Lentiviral vector; S: Spike; SARS-CoV-2:" exact="Severe acute respiratory syndrome" post="coronavirus-2. DNA vaccines DNA vaccine platforms, which are developed"/>
   <result pre="Induced strong IgG responsesLung eosinophilic immunopathology [6] CoV: Coronavirus; MERS-CoV:" exact="Middle East respiratory syndrome" post="coronavirus; NP: Nanoparticle; RBD: Receptor-binding domains; S-AuNP: Spike proteins-functionalized"/>
   <result pre="Nanoparticle; RBD: Receptor-binding domains; S-AuNP: Spike proteins-functionalized gold NP; SARS-CoV:" exact="Severe acute respiratory syndrome" post="coronavirus; VLP: Virus-like particle. Structure-based assembly is the most"/>
   <result pre="Chiroplasmonic AuNP; CoV: Coronavirus; E: Envelope; FITC: Fluorescein isothiocyanate; MERS-CoV:" exact="Middle East respiratory syndrome" post="coronavirus; MNP: Magnetic NP; N: Nucleocapsid; NP: Nanoparticle; ORF:"/>
   <result pre="ORF: Open-reading frame; pcMNP: Polycarboxyl-functionalized MNP; QD: Quantum dot; SARS-CoV:" exact="Severe acute respiratory syndrome" post="coronavirus; SFNP: Silica-coated fluorescence NP; SMNP: Superparamagnetic NP. Accurate"/>
   <result pre="therapy for coronaviruses via preventing viral entry. NP: Nanoparticle; SARS-CoV-2:" exact="Severe acute respiratory syndrome" post="coronavirus-2; RBD: Receptor-binding domain. Compared with PIH alone, PIH-gold"/>
   <result pre="EissaSAn electrochemical immunosensor for the corona virus associated with the" exact="Middle East respiratory syndrome" post="using an array of gold nanoparticle-modified carbon electrodes. Microchimica"/>
   <result pre="al.Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel" exact="coronavirus disease 2019" post="(COVID-19). J. Microbiol. Biotechnol.30(3), 313â€&quot;324 (2020).32238757 12.Å�oczechinA , SÃ©ronK"/>
   <result pre="CaoQD , HongZSet al.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak â€&quot; an update on the status. Mil."/>
   <result pre="30.CormanVM , ItheteNL , RichardsLRet al.Rooting the phylogenetic tree of" exact="Middle East respiratory syndrome" post="coronavirus by characterization of a conspecific virus from an"/>
   <result pre="CaoQ-D , HongZ-Set al.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak â€&quot; an update on the status. Mil."/>
   <result pre=", HouHet al.Correlation of chest CT and RT-PCR testing in" exact="coronavirus disease 2019" post="(COVID-19) in China: a report of 1014 cases. Radiology"/>
   <result pre="from a stool specimen of a laboratory-confirmed case of the" exact="coronavirus disease 2019" post="(COVID-19). CCDC Weekly2(8), 123â€&quot;124 (2020). 44.XiaoF , TangM ,"/>
   <result pre="72.AdneyDR , WangL , van DoremalenNet al.Efficacy of an adjuvanted" exact="Middle East respiratory syndrome" post="coronavirus spike protein vaccine in dromedary camels and alpacas."/>
   <result pre="domain protein induces partial protective immunity in Rhesus macaques against" exact="Middle East respiratory syndrome" post="coronavirus challenge. EBioMedicine2(10), 1438â€&quot;1446 (2015).26629538 76.ChenY , LuS ,"/>
   <result pre="N-terminal domain of spike proteins is a potential vaccine against" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) infection. Vaccine35(1), 10â€&quot;18 (2017).27899228 78.DuL , HeY"/>
   <result pre=", MemishZARibavirin and interferon therapy in patients infected with the" exact="Middle East respiratory syndrome" post="coronavirus: an observational study. Int. J. Infect. Dis20, 42â€&quot;46"/>
   <result pre="of virus-like particle mimetic nanovesicles displaying the S protein of" exact="Middle East respiratory syndrome" post="coronavirus using insect cells. J. Biotechnol.306, 177â€&quot;184 (2019).31614169 127.WangC"/>
   <result pre="LiM , XuYet al.Novel gold nanorod-based HR1 peptide inhibitor for" exact="Middle East respiratory syndrome" post="coronavirus. ACS Appl. Mater. Interfaces11(22), 19799â€&quot;19807 (2019).31099550 149.HanY ,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7391015\results\search\zoonosis\results.xml">
   <result pre="emerged as causative agent of a multifaceted syndrome, known as" exact="coronavirus disease 2019" post="(COVID-19) [1]. The outbreak rapidly spread from the Wuhan"/>
   <result pre="Wuhan City, Hubei Province, China, where the first cases of" exact="SARS-CoV-2 infection" post="occurred in early December 2019, toward western countries, resulting"/>
   <result pre="lavage, is the gold standard for a confirmed diagnosis of" exact="SARS-CoV-2 infection." post="However, physicians soon learned that in some cases, a"/>
   <result pre="on seven consecutive sputum sample, before achieving the diagnosis of" exact="SARS-CoV-2 infection" post="on the eighth sample [13]. Typical and atypical clinical"/>
   <result pre="accidents and Guillainâ€&quot;BarrÃ© syndrome have occurred in many patients with" exact="Covid-19" post="[16, 17]. Morjaria et al. described two cases of"/>
   <result pre="the real impact of these compounds on the outcome on" exact="Covid-19" post="patients are still lacking, albeit a constant flow of"/>
   <result pre="to its TMPRSS2 inhibitor activity [29]. However, overall management of" exact="Covid-19" post="patients exceeds the administration of antiviral drugs. Immune-modulant drugs"/>
   <result pre="Moreover, the infusion of hyperimmune plasma from donors recovered from" exact="SARS-CoV-2 infection" post="emerged as an attractive option. Perotti et al. presented"/>
   <result pre="explored the potential implication of ACE-Is and ARBs use in" exact="Covid-19" post="patients [36, 37]. Finally, Testa et al. addressed the"/>
   <result pre="[36, 37]. Finally, Testa et al. addressed the management of" exact="Covid-19" post="patients on oral anticoagulant drugs, and the high risk"/>
   <result pre="department and out-of-hospital emergency system (112â€&quot;AREU 118) integrated response to" exact="coronavirus disease 2019" post="in a Northern Italy centreIntern Emerg Med202010.1007/s11739-020-02390-432507926 11.CogliatiCCerianiEBrambillaAMWhen internal"/>
   <result pre="Engl J Med2020382262574257610.1056/NEJMc200919132302082 17.MaoLJinHWangMet al.Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan ChinaJAMA Neurol20207761910.1001/jamaneurol.2020.1127 18.MorjariaJBOmarFPolosaRet al.Bilateral lower limb weakness:"/>
   <result pre="Emerg Med202010.1007/s11739-020-02418-932617903 19.HenryBMde OliveiraMHSBenoitJet al.Gastrointestinal symptoms associated with severity of" exact="coronavirus disease 2019" post="(COVID-19): a pooled analysisIntern Emerg Med202010.1007/s11739-020-02329-932303970 20.VioliFPastoriDPignatelliPet al.SARS-CoV-2 and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7391235\results\search\zoonosis\results.xml">
   <result pre="al.Human intestinal tract serves as an alternative infection route for" exact="Middle East respiratory syndrome" post="coronavirusSci. Adv.20173eaao496629152574 20.GowrisankarYVClarkMAAngiotensin II regulation of angiotensin-converting enzymes in"/>
   <result pre="ill ICU patients with COVID-19Thromb. Res202019114514732291094 50.LippiGWongJHenryBMHypertension in patients with" exact="coronavirus disease 2019" post="(COVID-19): a pooled analysisPol. Arch. Intern Med202013030430932231171 51.SchwartzMKipnisJRivestSPratAHow do"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7392152\results\search\zoonosis\results.xml">
   <result pre="channelFront. Pharmacol.1201013721833176 39DyallJ.ColemanC.M.HartB.J.VenkataramanT.HolbrookM.R.KindrachukJ.JohnsonR.F.OlingerG.G.Jr.JahrlingP.B.LaidlawM.JohansenL.M.Lear-RooneyC.M.GlassP.J.HensleyL.E.FriemanM.B.Repurposing of clinically developed drugs for treatment of" exact="Middle East respiratory syndrome" post="coronavirus infectionAntimicrob. Agents Chemother.5820144885489324841273 40SiskJ.M.FriemanM.B.MachamerC.E.Coronavirus S protein-induced fusion is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7392210\results\search\zoonosis\results.xml">
   <result pre="R0 of SARS was 2 and 1.3 for the 2009" exact="H1N1 Influenza" post="[26].The mortality rate for COVID-19 ranges between 2 and"/>
   <result pre="of SARS was 2 and 1.3 for the 2009 H1N1" exact="Influenza" post="[26].The mortality rate for COVID-19 ranges between 2 and"/>
   <result pre="RNA-chain terminator by binding to RNA dependent RNA polymerase (RdRP)." exact="Ebola" post="200Â mg intravenously (IV) on day 1 followed by"/>
   <result pre="[45], [46], [47] Oseltamivir(1999) Antiviral; Neuraminidase inhibitor Inhibits viral replication." exact="Influenza" post="75Â mg orally twice a day for 5Â days"/>
   <result pre="vitro. Also showed antiviral activity in an animal model for" exact="SARS-CoV infection" post="Limited data available. [57], [58] Hydroxychloroquine / chloroquine (HCQ/CQ)"/>
   <result pre="of an adenosine analog, was originally developed to combat the" exact="Ebola" post="outbreak in 2014. It has been highly touted as"/>
   <result pre="inhibitor. It is used in China for the treatment of" exact="Influenza" post="and is capable of blocking the replication of other"/>
   <result pre="In mice, camostat mesylate showed a 60% survival rate following" exact="SARS-CoV infection," post="at dose concentrations similar to that in humans [58]."/>
   <result pre="completion date of March 30, 2021. 11 Non-Pharmacological therapies for" exact="Covid-19" post="11.1 Immunoglobulin therapy 11.1.1 Convalescent plasma therapy (CP) Inducing"/>
   <result pre="] NCT04343092 Efficacy of Ivermectin as Add on Therapy in" exact="COVID19" post="Patients Experimental: Ivermectin (IVM) 12Â mg /weeklyÂ +Â Hydroxychloroquin"/>
   <result pre="] NCT04342650 Chloroquine Diphosphate in the Prevention of SARS in" exact="Covid-19" post="Infection (CloroCOVID19II) Active Comparator: InterventionCQ 450Â mg twice daily"/>
   <result pre="Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition" exact="Covid-19" post="Brasil II) Experimental: HydroxychloroquineÂ +Â azithromycinHydroxychloroquine [400Â mg 2Ã—/day,"/>
   <result pre="Comparator: Placebo Phase 3 Randomized; Quadruple blind 1309(â‰¥18) Incidence of" exact="COVID19" post="Disease among those who are asymptomatic at baseline [Â"/>
   <result pre="52L. Dong, S. Hu, J. Gao, Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19), 3 (2020). 53FurutaY.KomenoT.NakamuraT.Favipiravir (T-705), a broad spectrum inhibitor"/>
   <result pre="against SARS-CoV-2 infectionViruses122020642 81Coronavirus India: Rush for plasma therapy as" exact="Covid-19" post="cases rise, https://www.bbc.com/news/world-asia-india-53387607. Accessed 21 July 2020. 82CaoW.-C.LiuW.ZhangP.-H.ZhangF.RichardusJ.H.Disappearance of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7393415\results\search\zoonosis\results.xml">
   <result pre="and fury in the microbiology labScience33520121033103522383821 2French researcher posts successful" exact="Covid-19" post="drug trial. The ConnexionAvailable at:https://www.connexionfrance.com/French-news/French-researcher-in-Marseille-posts-successful-Covid-19-coronavirus-drug-trial-results 3â€˜What do you have"/>
   <result pre="COVID-19 vaccine to be available beginning in OctoberAvailable at:https://www.hhs.gov/about/news/2020/05/21/trump-administration-accelerates-astrazeneca-covid-19-vaccine-to-be-available-beginning-in-october.html 12LurieN.SavilleM.HatchettR.HaltonJ.Developing" exact="Covid-19" post="vaccines at pandemic speedN Eng J Med382202019691973 13ThompsonS.A.How long"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7396637\results\search\zoonosis\results.xml">
   <result pre="Cellular and Infection Microbiology: Review Role of Extracellular Vesicles in" exact="Influenza" post="Virus Infection JiangYuan12CaiXiaowen1YaoJiwen1GuoHuanhuan1YinLiangjun3LeungWingnang4*XuChuanshan1*[], 1Key Laboratory of Molecular Target and"/>
   <result pre="is permitted which does not comply with these terms. Abstract" exact="Influenza" post="virus infection is a major health care concern associated"/>
   <result pre="immune response vaccine fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction" exact="Influenza" post="virus, a single-stranded negative-sense RNA virus, belongs to Orthomyxoviridae"/>
   <result pre="the upper and lower respiratory tract (Tumpey and Belser, 2009)." exact="Influenza" post="virus infection usually causes various syndromes such as fever,"/>
   <result pre="combat influenza virus. Similarity in EVs Biogenesis and Release of" exact="Influenza" post="Virus Particles Exosomes are the smallest one of EVs"/>
   <result pre="from infected cells via ESCRT machinery (Schorey et al., 2015)." exact="Influenza" post="viruses bud from the plasma membrane of host cells"/>
   <result pre="EVs secretion. Role of EVs in Host Immune Responese for" exact="Influenza" post="Virus Infection During the viral infection, host innate and"/>
   <result pre="immune responses to promote their virulence and evade immune surveillance." exact="Influenza" post="viruses evolved multiple ways to escape from the host"/>
   <result pre="yet undefined factors. EVs as an Emerging Vaccine Carriers for" exact="Influenza" post="Virus Infection The occurrence of new influenza viral strains"/>
   <result pre="A virus infection. Epigenomics10, 829â€&quot;844. 10.2217/epi-2017-017029888954 KeshavarzM.MirzaeiH.SalemiM.MomeniF.MousaviM. J.SadeghalvadM.et al.. (2019)." exact="Influenza" post="vaccine: where are we and where do we go?Rev."/>
   <result pre="Curr. Clin. Microbiol. Rep. 6, 10â€&quot;17. 10.1007/s40588-019-0111-831592409 MossadS. B. (2018)." exact="Influenza" post="update 2018-2019: 100 years after the great pandemic. Cleve."/>
   <result pre="as a vaccine platform. Nat. Commun.9:1379. 10.1038/s41467-018-03847-z29643357 Warren-GashC.SmeethL.HaywardA. C. (2009)." exact="Influenza" post="as a trigger for acute myocardial infarction or death"/>
   <result pre="systematic review. Lancet. Infect. Dis.9, 601â€&quot;610. 10.1016/S1473-3099(09)70233-619778762 WatanabeR.LambR. A. (2010)." exact="Influenza" post="virus budding does not require a functional AAA+ ATPase,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7396720\results\search\zoonosis\results.xml">
   <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. Abstract" exact="Coronavirus disease 2019" post="is a newly emerging infectious disease currently spreading across"/>
   <result pre="fusion inhibitors; host proteases inhibitors Introduction The epidemic of novel" exact="coronavirus disease 2019" post="(COVID-19) was caused by a new coronavirus occurred in"/>
   <result pre="a promising target for the development of fusion inhibitors against" exact="SARS-CoV-2 infection." post="Functions of the S protein The S protein on"/>
   <result pre="Env), influenza virus (influenza hemagglutinin, HA), paramyxovirus (paramyxovirus F), and" exact="Ebola" post="(Ebola virus glycoprotein) [30]. Similar to other coronaviruses, the"/>
   <result pre="combination with other nAbs, for the prevention and treatment of" exact="SARS-CoV-2 infection" post="[57]. A mAb targeting S1 prepared from immunized transgenic"/>
   <result pre="be further studied to contribute elucidation of the mechanism of" exact="SARS-CoV-2 infection." post="Similarly, focusing on high expression of the S protein"/>
   <result pre="or prophylactic has been used clinically to treat or prevent" exact="SARS-CoV-2 infection." post="Nonspecific antiviral drugs, such as IFN-Î± (recombinant human IFN-Î±1b,"/>
   <result pre="and related human coronavirus diseasesACS Cent Sci202063153132226821 4.SandersJMMonogueMLJodlowskiTZCutrellJBPharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a reviewJAMA2020323182436 5.LuRZhaoXLiJNiuPYangBWuHet al.Genomic characterisation and epidemiology of"/>
   <result pre="Shan S, et al. Potent human neutralizing antibodies elicited by" exact="SARS-CoV-2 infection." post="bioRxiv.Â 2020; 10.1101/2020.03.21.990770. 63.Chi X, Yan R, Zhang J,"/>
   <result pre="L in the late endosome/lysosome and block the entry of" exact="Ebola" post="virus, Middle East respiratory syndrome coronavirus (MERS-CoV), and severe"/>
   <result pre="the late endosome/lysosome and block the entry of Ebola virus," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV)J"/>
   <result pre="via the induction of autophagyOncol Rep2019411971930569119 73.SakuraiYKolokoltsovAAChenCCTidwellMWBautaWEKlugbauerNet al.Two-pore channels control" exact="Ebola" post="virus host cell entry and are drug targets for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7397939\results\search\zoonosis\results.xml">
   <result pre="pmcid: 7397939S0165-1781(20)31375-5 doi: 10.1016/j.psychres.2020.113366113366 : Article Psychological effects of the" exact="COVID-2019" post="pandemic: Perceived stress and coping strategies among healthcare professionals"/>
   <result pre="a short period. The World Health Organization (2020) renamed it" exact="Coronavirus disease 2019" post="(COVID-19) and declared a state of pandemic on 11th"/>
   <result pre="hunan between january and march 2020 during the outbreak of" exact="coronavirus disease 2019" post="(COVID-19) in Hubei, ChinaMed. Sci. Monit.262020e924171110.12659/2FMSM.924171 CarverC.S.ScheierM.F.WeintraubJ.K.Assessing coping strategies:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7399136\results\search\zoonosis\results.xml">
   <result pre="32713366 doi: 10.1017/S0950268820001636S0950268820001636 : Commentary Prevention and control mechanism for" exact="coronavirus disease 2019" post="epidemic at the primary level: perspective from China https://orcid.org/0000-0002-1815-5188ZhangXiaoyan1https://orcid.org/0000-0002-1613-5140WangYuxuan2[1],"/>
   <result pre="capabilities towards public health emergencies have greatly improved. During the" exact="coronavirus disease 2019" post="epidemic, primary-level administrative and medical personnel, social organisations, volunteers,"/>
   <result pre="for mobilisation of resources. Regarding operational mechanisms, China launched the" exact="Contagious" post="Disease National Direct Reporting System in early 2004 [5]"/>
   <result pre="early warning and detection mechanism is not sound, and the" exact="Contagious" post="Disease National Direct Reporting System for public health emergencies"/>
   <result pre="the Ministry of Health on Strengthening Medical Treatment Work for" exact="Influenza" post="A (H1N1). Available at http://www.nhc.gov.cn/yzygj/s3585u/200911/7084a4b9d9c04e3cb2dbfd25384ffc76.shtml (Accessed 5 May 2020)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7400054\results\search\zoonosis\results.xml">
   <result pre="for its progenitor. Women and children are less susceptible to" exact="SARS-CoV-2 infection," post="while the elderly and people with comorbidities are more"/>
   <result pre="(84,507; 4645) [5]. Notably, all age groups show susceptibility to" exact="SARS-CoV-2 infection," post="from newborns to the elderly [6]. The average age"/>
   <result pre="newborns to the elderly [6]. The average age noted for" exact="SARS-CoV-2 infection" post="susceptibility is 55.5 years, while that for the case"/>
   <result pre="mutations in civet CoVs prior to its spillover. Similarly, the" exact="Middle East respiratory syndrome" post="(MERS)-CoV also circulated and acquired mutations in camels for"/>
   <result pre="syndrome (SARS) and MERS. 2.1. SARS-CoV The first incidence of" exact="SARS-CoV infection" post="was reported on 16 November 2002, in the coastal"/>
   <result pre="of virus transmission [19,23]. 2.3. SARS-CoV-2 The first case of" exact="SARS-CoV-2 infection" post="was reported in the first week of December 2019"/>
   <result pre="pregnancy stage [55]. 7.2. Incubation Period The incubation period for" exact="SARS-CoV-2 infection" post="ranged from 2 to 14 days in human-to-human transmission,"/>
   <result pre="Population Susceptibility There is no age limit for vulnerability to" exact="SARS-CoV-2 infection." post="However, cases with higher morbidity and chances of mortality"/>
   <result pre="susceptible to the infection [25]. Women are less susceptible to" exact="SARS-CoV-2 infection" post="than men and this is possibly due to different"/>
   <result pre="less virus load and inflammation. Recently, studies have shown that" exact="SARS-CoV-2 infection" post="in children (though less severely affected), may develop the"/>
   <result pre="not clear whether Kawasaki disease-like forms are a result of" exact="SARS-CoV-2 infection" post="alone or just SARS-CoV-2 induced aggravations in Kawasaki disease"/>
   <result pre="9.2. Immunopathobiology Existing literature documents that patients suffering from severe" exact="SARS-CoV-2 infection" post="might suffer from the cytokine storm syndrome that could"/>
   <result pre="occur at a similar point or slightly earlier than in" exact="SARS-CoV infection" post="[86,87]. A recently released antibody profile against SARS-CoV-2 has"/>
   <result pre="responses against SARS-CoV-2. Increasing evidence suggests that fatalities resulting from" exact="SARS-CoV-2 infection" post="could be primarily attributed to the ARDS [90,91], which"/>
   <result pre="IP10, MCP1, MIP1Î±, and TNF) from immune effector cells during" exact="SARS-CoV-2 infection" post="[91,93,94,95,96,97,98]. In this context, the increased levels of IL-6"/>
   <result pre="different animals has recently been evaluated through an experiment on" exact="SARS-CoV-2 infection," post="where SARS-CoV-2 was found to replicate efficiently in cats"/>
   <result pre="an ongoing search for a suitable animal model to study" exact="SARS-CoV-2 infection" post="[104]. After the SARS outbreak, numerous inbred mouse strains"/>
   <result pre="being made globally to develop safe and effective vaccines against" exact="SARS-CoV-2 infection" post="[120]. Approximately 200 vaccine candidates have already been developed"/>
   <result pre="of China in February 2020, is commonly used to treat" exact="influenza infection" post="in China and Japan and has shown promising results"/>
   <result pre="and has shown promising results in shortening the course of" exact="SARS-CoV-2 infection" post="[12,124,125]. This drug acts by inhibiting the RNA-dependent RNA"/>
   <result pre="repurposed drug that was initially developed for the treatment of" exact="Ebola" post="virus infection. Remdisivir is reported to prevent viral replication"/>
   <result pre="readily available therapies may prove beneficial in patients with severe" exact="SARS-CoV-2 infection." post="A humanized monoclonal antibody, viz. tocilizumab, competitively binds to"/>
   <result pre="Assoc.20203231313131410.1001/jama.2020.2131 7.ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.et al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: A descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 8.WangD.HuB.HuC.ZhuF.LiuX.ZhangJ.WangB.XiangH.ChengZ.XiongY.et al.Clinical characteristics"/>
   <result pre="Engl. J. Med.20203821199120710.1056/NEJMoa200131631995857 12.GuoY.R.CaoQ.D.HongZ.S.TanY.Y.ChenS.D.JinH.J.TanK.S.WangD.Y.YanY.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;An update on the statusMil. Med. Res.202071110.1186/s40779-020-00240-032169119 13.HodgsonJ.The"/>
   <result pre="20.CormanV.M.AlbarrakA.M.OmraniA.S.AlbarrakM.M.FarahM.E.AlmasriM.MuthD.SiebergA.MeyerB.AssiriA.M.et al.Viral shedding and antibody response in 37 patients with" exact="Middle East respiratory syndrome" post="coronavirus infectionClin. Infect. Dis.20166247748310.1093/cid/civ95126565003 21.SuS.WongG.ShiW.LiuJ.LaiA.C.ZhouJ.LiuW.BiY.GaoG.F.Epidemiology, genetic recombination, and pathogenesis"/>
   <result pre="as compared with SARS-CoV-1N. Engl. J. Med.20203821564156710.1056/NEJMc200497332182409 47.Van DoremalenN.BushmakerT.MunsterV.Stability of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) under different environmental conditionsEurosurveillance2013182059010.2807/1560-7917.ES2013.18.38.2059024084338 48.SizunJ.YuM.TalbotP.Survival of human"/>
   <result pre="Assoc.20203231406140710.1001/jama.2020.2565 58.HindsonJ.COVID-19: Faecalâ€&quot;oral transmission?Nat. Rev. Gastroenterol. Hepatol.20201725910.1038/s41575-020-0295-732214231 59.XuY.LiX.ZhuB.LiangH.FangC.GongY.GuoQ.SunX.ZhaoD.ShenJ.Characteristics of pediatric" exact="SARS-CoV-2 infection" post="and potential evidence for persistent fecal viral sheddingNat. Med.20202650250510.1038/s41591-020-0817-432284613"/>
   <result pre="clinical application of a rapid IGM-IGG combined antibody test for" exact="SARS-CoV-2 infection" post="diagnosisJ. Med. Virol.202010.1002/jmv.2572732104917 114.ZhengJ.SARS-CoV-2: An emerging coronavirus that causes"/>
   <result pre="in designing and developing vaccines, drugs, and therapies to counter" exact="Ebola" post="virusFront. Immunol.20189180310.3389/fimmu.2018.0180330147687 153.ChatterjeeP.NagiN.AgarwalA.DasB.BanerjeeS.SarkarS.GuptaN.GangakhedkarR.R.The 2019 novel coronavirus disease (COVID-19) pandemic:"/>
   <result pre="USA Clinical trials are under progress Developed for treatment of" exact="Ebola" post="virus infection Lopinavir + Ritonavir AbbVie, USA Further research"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402078\results\search\zoonosis\results.xml">
   <result pre="its self-reliance. Keywords COVID-19 Spanish flu Pandemics HIV/AIDS Social distancing" exact="Severe acute respiratory syndrome" post="Introduction Since the birth of civilisation, humans have experienced"/>
   <result pre="acccessed on 15 June 2020), SARS (2002â€&quot;2003), HIV/AIDS pandemic (2005â€&quot;2012)," exact="swine flu" post="(2009â€&quot;2010), Ebola (2014â€&quot;2016), MERS-CoV (2015), and COVID-19, an RNA"/>
   <result pre="June 2020), SARS (2002â€&quot;2003), HIV/AIDS pandemic (2005â€&quot;2012), swine flu (2009â€&quot;2010)," exact="Ebola" post="(2014â€&quot;2016), MERS-CoV (2015), and COVID-19, an RNA virus disease."/>
   <result pre="of water/daily monitoring of water quality parameters Flu pandemic 1889â€&quot;1890" exact="Influenza" post="A virus/H2N2/H3N3/1 million Central Asia, Canada, Greenland Bed rest;"/>
   <result pre="Morens 2006; Martin et al. 2019; Tsoucalas et al. 2015)." exact="COVID 19" post="has shown initial signs of recurrence in Wuhan, China,"/>
   <result pre="Ramesh KV (2020) Binding site analysis of potential inhibitors of" exact="COVID 19" post="using AutoDock. VirusDisease 31:194â€&quot;199. 10.1007/s13337-020-00585-z MouryaDTYadavPDUlhasPTBharwajSDEmerging/re-emerging viral diseases and"/>
   <result pre="History of the diseaseBull World Health Organ195410342113160764 SandersJMMonogueMLJodlowskiTZCutrellJBPharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a reviewJAMA2020323181824183610.1001/jama.2020.6019 SarkarPKDHLDhumalCPanigrahiSSChoudharyRTraditional and ayurvedic foods of Indian"/>
   <result pre="online 1 April 2020 Velavan TP, Mayer CG (2020) The" exact="COVID 19" post="Epidemic. Trop Med Int Health. 25:278â€&quot;280. 10.1111/tmi.13383 WeverPCVan BergenLDeath"/>
   <result pre="convalescent whole blood or plasma collected from patients recovered from" exact="Ebola" post="virus disease for transfusion, as an empirical treatment during"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402116\results\search\zoonosis\results.xml">
   <result pre="reservoirs and include severe acute respiratory distress syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS) and other inconsequential coronaviruses from human reservoirs like"/>
   <result pre="the common cold and are generally inconsequential. Both SARS and" exact="Middle East respiratory syndrome" post="(MERS) came from animal reservoirs and caused global epidemics."/>
   <result pre="a CYP3A4 substrate, is an anti-viral agent developed to treat" exact="Ebola" post="but proved ineffective [119]. It also showed promise in"/>
   <result pre="HanoudA.SlimJ.Weakness and elevated creatinine kinase as the initial presentation of" exact="coronavirus disease 2019" post="(COVID-19)Am. J. Emerg. Med.2020381548.e11548.e310.1016/j.ajem.2020.05.01532414522 33.SamiesN.L.PinnintiS.JamesS.H.Rhabdomyolysis and Acute Renal Failure"/>
   <result pre="Use with COVID-19 Diagnosis and MortalityJAMA202010.1001/jama.2020.11301 100.GoyalP.ChoiJ.J.PinheiroL.C.SchenckE.J.ChenR.JabriA.SatlinM.J.CampionT.R.Jr.NahidM.RingelJ.B.et al.Clinical Characteristics of" exact="Covid-19" post="in New York CityN. Engl. J. Med.202010.1056/NEJMc201041932302078 101.GrasselliG.ZangrilloA.ZanellaA.AntonelliM.CabriniL.CastelliA.CeredaD.ColuccelloA.FotiG.FumagalliR.et al.Baseline"/>
   <result pre="Natl. Acad. Sci. USA1991881756175910.1073/pnas.88.5.17562000384 148.Hill-BatorskiL.HalfmannP.NeumannG.KawaokaY.The cytoprotective enzyme heme oxygenase-1 suppresses" exact="Ebola" post="virus replicationJ. Virol.201387137951380210.1128/JVI.02422-1324109237 149.ToledoS.L.O.GuedesJ.V.M.AlpoimP.N.RiosD.R.A.PinheiroM.B.Sickle cell disease: Hemostatic and inflammatory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402212\results\search\zoonosis\results.xml">
   <result pre="of viruses (ICTV) and the diseaseâ€™s name is COVID-19 for" exact="coronavirus disease 2019." post="SARS-CoV-2 is very contagious and is capable of spreading"/>
   <result pre="incubation time in humans (days) 2â€&quot;7 2â€&quot;14 2â€&quot;14 Caused disease" exact="Severe acute respiratory syndrome" post="(SARS) Middle East respiratory syndrome (MERS) Coronavirus disease 2019"/>
   <result pre="2â€&quot;7 2â€&quot;14 2â€&quot;14 Caused disease Severe acute respiratory syndrome (SARS)" exact="Middle East respiratory syndrome" post="(MERS) Coronavirus disease 2019 (COVID-19) Clinical symptoms Malaise, diarrhea,"/>
   <result pre="Severe acute respiratory syndrome (SARS) Middle East respiratory syndrome (MERS)" exact="Coronavirus disease 2019" post="(COVID-19) Clinical symptoms Malaise, diarrhea, cough, fever and shortness"/>
   <result pre="cells becoming unable to exchange carbon dioxide and oxygen after" exact="SARS-CoV-2 infection" post="[42]. A recent study showed that that SARS-CoV-2 could"/>
   <result pre="(endotracheal aspirate, expectorated sputum, or bronchoalveolar lavage) of patients suspected" exact="SARS-CoV-2 infection" post="[71]. At the initial stage of the outbreak, identification"/>
   <result pre="inhibitor that may compete for RdRp, was designed for the" exact="Ebola" post="virus and was with efficient against MERS and SARS"/>
   <result pre="Med Assoc1195202098298932307322 5HuangY.TuM.WangS.ChenS.ZhouW.ChenD.Clinical characteristics of laboratory confirmed positive cases of" exact="SARS-CoV-2 infection" post="in Wuhan, China: a retrospective single center analysisTravel Med"/>
   <result pre="coronavirusJ Virol202094 21WangY.WangY.ChenY.QinQ.Unique epidemiological and clinical features of the emerging" exact="2019 novel coronavirus pneumonia" post="(COVID-19) implicate special control measuresJ Med Virol926202056857632134116 22LiP.FuJ.B.LiK.F.ChenY.WangH.L.LiuL.J.Transmission of"/>
   <result pre="from Wuhan, China, 20-28 January 2020Euro Surveill202025 24GuanW.J.ZhongN.S.Clinical characteristics of" exact="Covid-19" post="in ChinaReplyN Engl J Med3821920201861186232220206 25YangW.CaoQ.QinL.WangX.ChengZ.PanA.Clinical characteristics and imaging"/>
   <result pre="ocular surface of COVID-19 patientsEye Vis (Lond)720202332355863 30ZhangX.ChenX.ChenL.DengC.ZouX.LiuW.The evidence of" exact="SARS-CoV-2 infection" post="on ocular surfaceOcul Surf183202036036232289466 31MaoL.JinH.WangM.HuY.ChenS.HeQ.Neurologic manifestations of hospitalized patients"/>
   <result pre="on ocular surfaceOcul Surf183202036036232289466 31MaoL.JinH.WangM.HuY.ChenS.HeQ.Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, ChinaJAMA Neurol776202019 32WolfelR.CormanV.M.GuggemosW.SeilmaierM.ZangeS.MullerM.A.Virological assessment of hospitalized patients"/>
   <result pre="diseases?Lancet Infect Dis3200372272714592603 85GaoJ.HuS.Update on use of chloroquine/hydroxychloroquine to treat" exact="coronavirus disease 2019" post="(COVID-19)Biosci Trends142202015615832281583 86RussellC.D.MillarJ.E.BaillieJ.K.Clinical evidence does not support corticosteroid treatment"/>
   <result pre="for Disease Control and PreventionReport on the epidemiological features of" exact="coronavirus disease 2019" post="(COVID-19) outbreak in the Republic of Korea from January"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402395\results\search\zoonosis\results.xml">
   <result pre="studies have shown that both drugs could be effective against" exact="SARS-CoV infection" post="and prevent from the virus spread [88], but several"/>
   <result pre="interacting with the infected environment. Abbreviations COVID-19 Coronavirus disease-19 SARS-CoV-2" exact="Severe acute respiratory syndrome" post="coronavirus 2 2019-nCoV Novel coronavirus ACE Angiotensin-converting enzyme MERS-CoV"/>
   <result pre="A, de Filippis C, Marioni G. Upper airway symptoms in" exact="coronavirus disease 2019" post="(COVID-19). Am J Otolaryngol. 2020:102474. 4.Paranjpe I, Russak A,"/>
   <result pre="Miotto R, Vaid A, et al. Clinical Characteristics of Hospitalized" exact="Covid-19" post="Patients in New York City. medRxiv. 2020. 5.ZhuJZhongZJiPLiHLiBPangJet al.Clinicopathological"/>
   <result pre="the COVID-19 outbreak. Curr Biol. 2020. 51.SpiteriGFieldingJDierckeMCampeseCEnoufVGaymardAet al.First cases of" exact="coronavirus disease 2019" post="(COVID-19) in the WHO European Region, 24 January to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402641\results\search\zoonosis\results.xml">
   <result pre="against various RNA viruses, including influenza A virus, Zika virus," exact="Ebola" post="virus, and particularly against SARS-CoV-2. Notably, S416 is reported"/>
   <result pre="Introduction Acute viral infections, such as influenza virus, SARS-CoV, MERS-CoV," exact="Ebola" post="virus, Zika virus, and the very recent SARS-CoV-2 are"/>
   <result pre="(Âµmol/L)/CC50 (Âµmol/L)/SI Viruses A/WSN/33 (H1N1) A/DongHu/06 (H3N2) A/GuangZhou/99 (H9N2) Zika" exact="Ebola" post="SARS-CoV-2 (MOI = 0.03) SARS-CoV-2 (MOI = 0.05) S312"/>
   <result pre="than Osel. The broad-spectrum antiviral activities of DHODHi to Zika," exact="Ebola" post="and newly-emerged SARS-CoV-2 viruses in infected cells As all"/>
   <result pre="Teriflunomide, Brequinar, S312, and S416 showed inhibitory effects against the" exact="Ebola" post="virus (EBOV) mini-replicon, with EC50 of 3.41, 0.102, 11.39"/>
   <result pre="H1N1 in 2009, MERS-CoV in 2012, AIV H7N9 in 2013," exact="Ebola" post="virus in 2013, Zika virus in 2016, to SARS-CoV-2"/>
   <result pre="low toxicity and high potency. Moreover, S312 can rescue severe" exact="influenza infection" post="by limiting inflammatory cytokine storm in vivo. DHODH is"/>
   <result pre="SI value of S416 against Zika (SI = 2 880.53)," exact="Ebola" post="(SI = 4 746.11), and the latest SARS-CoV-2 (SI"/>
   <result pre="antiviral; DHO, dihydroorotate; DHODH, dihydroorotate dehydrogenase; DHODHi, DHODH inhibitors; EBOV," exact="Ebola" post="virus; EC50, the half maximal effective concentration; G, guanosine;"/>
   <result pre="a future H5N1 Treatment?Ann Intern Med200614559960916940336 LuthraPNaidooJPietzschCADeSKhadkaSAnantpadmaMWilliamsCGEdwardsMRDaveyRABukreyevAInhibiting pyrimidine biosynthesis impairs" exact="Ebola" post="virus replication through depletion of nucleoside pools and activation"/>
   <result pre="and cytokines in peripheral blood of 123 hospitalized patients with" exact="2019 novel coronavirus pneumonia" post="(NCP). medRxiv WangCHLiuC-YWanY-LChouC-LHuangK-HLinH-CLinS-MLinT-YChungKFKuoH-PPersistence of lung inflammation and lung cytokines"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402643\results\search\zoonosis\results.xml">
   <result pre="COVID-19 epidemic. Domain Keywords Awareness of COVID-19a coronavirus (å† çŠ¶ç—…æ¯’)," exact="Wuhan pneumonia" post="(æ­¦æ±‰è‚ºç‚Ž) Behavioral response to protection measures mask (å�£ç½©), hand"/>
   <result pre="Wuhan, ChinaLancet202023951022349750610.1016/s0140-6736(20)30183-531986264 2ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYXiaJYuTZhangXZhangLEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet202023951022350751310.1016/s0140-6736(20)30211-732007143 3National Health Commission"/>
   <result pre="a Public Health Emergency: A Case Study of 2009â€&quot;2010 Pandemic" exact="Influenza" post="a Virus Subtype H1N1Public Health Rep2014111296_suppl4496010.1177/00333549141296s40825355975 8HsuYChenYWeiHYangYChenYRisk and Outbreak"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7403001\results\search\zoonosis\results.xml">
   <result pre="infection control response to the rapidly evolving epidemiology of the" exact="coronavirus disease 2019" post="(COVID-19) due to SARS-CoV-2 in Hong KongInfect. Control Hosp."/>
   <result pre="diversity in SARS-CoV-2Clin. Infect. Dis.42020ciaa213 20ShenZ.J.XiaoY.KangL.MaW.T.ShiL.S.LiZ.Genomic diversity of SARS-CoV-2 in" exact="coronavirus disease 2019" post="patientsClin. Infect. Dis.2020ciaa20310.1093/cid/ciaa203 21YiH.2019 novel coronavirus is undergoing active"/>
   <result pre="issues that require attention and actionJAMA20202010.1001/jama.2020.2467 71Bernard StoecklinS.RollandP.SilueY.MaillesA.CampeseC.SimondonA.MechainM.MeuriceL.NguyenM.BassiC.First cases of" exact="coronavirus disease 2019" post="(COVID-19) in France: surveillance, investigations and control measures, January"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7403098\results\search\zoonosis\results.xml">
   <result pre="where the blood group is linked with the susceptibility of" exact="SARS-CoV-2 infection." post="A recent study in COVID-19 patients (nÂ =Â 1775)"/>
   <result pre="manifestations Pneumonia appears to be the most frequent manifestation of" exact="SARS-CoV-2 infection," post="characterized primarily by fever, cough, dyspnea, and bilateral infiltrates"/>
   <result pre="the infection. Currently, no promising treatment options are available against" exact="COVID19" post="that can be recommended globally. However, Remdesivir, baricitinib, chloroquine,"/>
   <result pre="4 (dpp 4): implications for the origin and emergence of" exact="Middle East respiratory syndrome" post="coronavirusVirol. J.10201330410.1186/1743-422X-10-30424107353 Di PierroF.BertuccioliA.CavecchiaI.Possible therapeutic role of a highly"/>
   <result pre="a Statement of the Coronavirus Study GroupBioRxiv202010.1101/02.07.9378622020 GuanW.-j.NiZ.-y.HuY.LiangW.-h.OuC.-q.HeJ.-x.LiuL.ShanH.LeiC.-l.HuiD.S.C.DuB.LiL.-j.ZengG.YuenK.-Y.ChenR.-c.TangC.-l.WangT.ChenP.-y.XiangJ.LiS.-y.WangJ.-l.LiangZ.-j.PengY.-x.WeiL.LiuY.HuY.-h.PengP.WangJ.-m.LiuJ.-y.ChenZ.LiG.ZhengZ.-j.QiuS.-q.LuoJ.YeC.-j.ZhuS.-y.ZhongN.-s.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN. Engl. J. Med.3821820201708172010.1056/NEJMoa200203232109013 HanJ.-H.LeeD.ChewC.H.C.KimT.PakJ.J.A multi-virus detectable microfluidic"/>
   <result pre="LayqahL.A.EissaS.An electrochemical immunosensor for the corona virus associated with the" exact="Middle East respiratory syndrome" post="using an array of gold nanoparticle-modified carbon electrodesMicrochimica Acta186201922430847572"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404079\results\search\zoonosis\results.xml">
   <result pre="acute respiratory tract illnesses: severe acute respiratory syndrome coronavirus (SARS-CoV)," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), and the highly morbific SARS-CoV-2. Coronavirus disease"/>
   <result pre="East respiratory syndrome coronavirus (MERS-CoV), and the highly morbific SARS-CoV-2." exact="Coronavirus disease 2019" post="(COVID-19), an emerging disease with a quick rise in"/>
   <result pre="cardiomyocytes, and cholangiocytes. Such cellular outspreading elucidates the consequences of" exact="SARS-CoV-2 infection" post="that is not only limited to respiratory disorders but"/>
   <result pre="T-lymphotropic virus (HTLV), human adenovirus (HAdV), influenza A virus and" exact="Dengue" post="virus (DENV) [38]. The interaction between Nsp7 and P-TEFb"/>
   <result pre="as it could anticipate novel-targeted strategies for the management of" exact="SARS-CoV-2 infection" post="[52]. Antiviral therapies targeting the pathogen itself act by"/>
   <result pre="of histone marks at the promoters of ISG genes. During" exact="SARS-CoV infection," post="the promoter regions of ISG genes had more histones"/>
   <result pre="CCL5, CXCL8, CXCL9, CXCL10) are upregulated by effector cells in" exact="SARS-CoV infection" post="linked with respiratory distress [14, 77â€&quot;79]. Unlike the proinflammatory"/>
   <result pre="the lung of COVID-19 patients can also be shaped by" exact="SARS-CoV-2 infection" post="of the airway epithelial cells. Thus, prominent epigenetic regulators"/>
   <result pre="decrease the cytokine storm syndrome with reduced mortality rates in" exact="COVID19" post="patients [84, 85]. IL-1 inhibitor anakinra and the IL-6"/>
   <result pre="COVID-19 as it operated at entry and post-entry phases of" exact="SARS-CoV-2 infection" post="[16, 96â€&quot;98]. Generally, CQ blocks viral infection by elevating"/>
   <result pre="CQ Chloroquine DCs Dendritic cells DDR DNA damage response DENV" exact="Dengue" post="virus DNMT DNA methyltransferase DPP4 Dipeptidyl peptidase 4 DZNep"/>
   <result pre="receptor MCP1 Monocyte chemoattractant protein MEPCE Methyl-phosphate capping enzyme MERS-CoV" exact="Middle East respiratory syndrome" post="coronavirus MIP1A Macrophage inflammatory protein 1-Î± MNA Microneedle array"/>
   <result pre="RNA dependent RNA polymerase S Spike SAHA Suberanilohydroxamic acid SARS-CoV" exact="Severe acute respiratory syndrome" post="coronavirus sHLH Secondary haemophagocytic lymphohistiocytosis SIRT1 Silent information regulator"/>
   <result pre="10.MizutaniTFukushiSSaijoMKuraneIMorikawaSJNK and PI3k/Akt signaling pathways are required for establishing persistent" exact="SARS-CoV infection" post="in Vero E6 cellsBiochim Biophys Acta - Mol Basis"/>
   <result pre="human coronavirus 229E-infected cellsPLoS Pathog.201713e100628628355270 77.Chiusano ML. The modelling of" exact="COVID19" post="pathways sheds light on mechanisms, opportunities and on controversial"/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): The Perspectives of clinical immunologists from ChinaClin Immunol.202021410839332222466"/>
   <result pre="and inflammation by DNA methylation in obesityJCI Insight.20161e8774827882346 94.Thomas G." exact="Middle East respiratory syndrome" post="coronavirus Joint Kingdom of Saudi Arabia/WHO mission. WHO. 2013;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404132\results\search\zoonosis\results.xml">
   <result pre="[46]. Remdesivir is an experimental drug for the treatment of" exact="Ebola" post="virus infection that was effective for the treatment of"/>
   <result pre="infections, including those caused by influenza, hepatitis C, Ebola, and" exact="Dengue" post="viruses [47]. The future use of mAbs could overcome"/>
   <result pre="Preparedness Innovations cGAMP Cyclic guanosine monophosphateâ€&quot;adenosine monophosphate CoV Coronavirus COVID-19" exact="Coronavirus disease 2019" post="CP Convalescent plasma CQ Chloroquine CRP C reactive protein"/>
   <result pre="Detect COVID-19J. Appl. Lab. Med.20207910.1093/jalm/jfaa079 26.LippiG.PlebaniM.Laboratory abnormalities in patients with" exact="COVID-2019" post="infectionClin. Chem. Lab. Med.2020581131113410.1515/cclm-2020-019832119647 27.LippiG.PlebaniM.The critical role of laboratory"/>
   <result pre="Chem. Lab. Med.2020581131113410.1515/cclm-2020-019832119647 27.LippiG.PlebaniM.The critical role of laboratory medicine during" exact="coronavirus disease 2019" post="(COVID-19) and other viral outbreaksClin. Chem. Lab. Med.2020581063106910.1515/cclm-2020-024032191623 28.HanH.YangL.LiuR.LiuF.WuK.-L.LiJ.LiuX.-H.ZhuC.Prominent"/>
   <result pre="galvanizes scientistsScience202036749249310.1126/science.367.6477.49232001631 47.SeesuayW.JittavisutthikulS.Sae-LimN.SookrungN.SakolvareeY.ChaicumpaW.Human transbodies that interfere with the functions of" exact="Ebola" post="virus VP35 protein in genome replication and transcription and"/>
   <result pre="L in the Late Endosome/Lysosome and Block the Entry of" exact="Ebola" post="Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404531\results\search\zoonosis\results.xml">
   <result pre="doi: 10.1111/dewb.12275DEWB12275 : Special Issue: Special Issues Lessons from the" exact="Ebola" post="epidemics and their applications for COVIDâ€�19 pandemic response in"/>
   <result pre="of 03 June 2020. The lessons learned during the recent" exact="Ebola" post="virus disease (EVD) outbreaks in some subâ€�Saharan African countries"/>
   <result pre="strengthen the COVIDâ€�19 response in subâ€�Saharan Africa are provided. COVIDâ€�19" exact="Ebola" post="lessons subâ€�Saharan Africa fig-count: table-count: page-count: word-count: AfolabiMO, FolayanMO,"/>
   <result pre="page-count: word-count: AfolabiMO, FolayanMO, MunungNS, et al. Lessons from the" exact="Ebola" post="epidemics and their applications for COVIDâ€�19 pandemic response in"/>
   <result pre="Disease. 12(1): 15â€�22. Africa is no stranger to epidemics. The" exact="Ebola" post="virus disease (EVD) outbreaks in West Africa 3Oleribe, O.O.,"/>
   <result pre="Africa 3Oleribe, O.O., Salako, B.L., Ka, M.M., et al. (2015)." exact="Ebola" post="virus disease epidemic in West Africa: lessons learned and"/>
   <result pre="infections and 11,325 deaths as of 30 March 2016; 10WHO" exact="Ebola" post="Situation Report. (2020). Retrieved May 2, 2020 from https://apps.who.int/iris/bitstream/handle/10665/204714/ebolasitrep_30mar2016_eng.pdf."/>
   <result pre="In this article, we discuss the lessons learned from the" exact="Ebola" post="epidemics in SSA and highlight relevant strategies to strengthen"/>
   <result pre="Wesseh, C.S., et al. (2018). Contact tracing performance during the" exact="Ebola" post="epidemic in Liberia, 2014â€�2015. PLOS Neglected Tropical Diseases. 12(9):"/>
   <result pre="Haire, B. (2016). History, culture and social norms: implications for" exact="Ebola" post="drug and vaccine clinical trials in affected region. In:"/>
   <result pre="et al. (2018). The Response to and Impact of the" exact="Ebola" post="Epidemic: Towards an Agenda for Interdisciplinary Research. International Journal"/>
   <result pre="al. (2016). Social Mobilization and Community Engagement Central to the" exact="Ebola" post="Response in West Africa: Lessons for Future Public Health"/>
   <result pre="for this countryâ€�: Participants' decisionâ€�making and grounded ethics in an" exact="Ebola" post="vaccine clinical trial. Social Science &amp;amp; Medicine. 203: 35â€�42."/>
   <result pre="K., Niescierenko, M., et al. (2017). Healthâ€�Care Access during the" exact="Ebola" post="Virus Epidemic in Liberia. American Journal of Tropical Medicine"/>
   <result pre="E., Rawaf, S. (2017). The link between the West African" exact="Ebola" post="outbreak and health systems in Guinea, Liberia and Sierra"/>
   <result pre="45Keshtkarâ€�Jahromi, M., Martins, K.A.O., Cardile, A.P., et al. (2018). Treatmentâ€�focused" exact="Ebola" post="trials, supportive care and future of filovirus care. Expert"/>
   <result pre="trials were conducted to test candidate vaccines. 46Overview of candidate" exact="Ebola" post="vaccines as of August 19, 2019. (2019). Retrieved May"/>
   <result pre="48Rid, A., &amp;amp; Miller, F.G. (2016). Ethical Rationale for the" exact="Ebola" post="&quot;Ring Vaccination&quot; Trial Design. American Journal of Public Health."/>
   <result pre="to measure an effect. 49Haire, B.G., &amp;amp; Folayan, M.O. (2016)." exact="Ebola" post="&quot;Ring&quot; Vaccine Trial Was Ethically Innovative.Â American Journal of"/>
   <result pre="Emanuel, E.J. (2014). Ethical considerations of experimental interventions in the" exact="Ebola" post="outbreak. Lancet. 384(9957): 1896â€�9. The high fatality associated with"/>
   <result pre="et al. (2017). Integrating clinical research into epidemic response: the" exact="Ebola" post="experience: National Academies Press Washington, DC. â€�52Joffe, S. (2014)."/>
   <result pre="Washington, DC. â€�52Joffe, S. (2014). Evaluating Novel Therapies During the" exact="Ebola" post="Epidemic. JAMA. 312(13): 1299â€�300. In COVIDâ€�19 pandemic, compassionate access"/>
   <result pre="Anthropological and Historical Perspectives on Data Sharing during the 2014â€�2016" exact="Ebola" post="Epidemic and the 2016 Yellow Fever Epidemic. (2019). Retrieved"/>
   <result pre="M. (2016). Slow response contributed to scale of West African" exact="Ebola" post="epidemic, CDC concludes. BMJ. 354: i3814. Improved competency for"/>
   <result pre="infrastructure development agenda in the wake of the West African" exact="Ebola" post="outbreak. Pan African Medicine Journal. 24: 270â€�270. The limited"/>
   <result pre="et al. (2016). A practical communityâ€�based response strategy to interrupt" exact="Ebola" post="transmission in Sierra Leone, 2014â€&quot;2015. Infectious Diseases of Poverty."/>
   <result pre="Will Africaâ€™s future epidemic ride on forgotten lessons from the" exact="Ebola" post="epidemic? BMC Medicine. 13(1): 116. As with Ebola, 67Leeâ€�Kwan,"/>
   <result pre="Global health security: the wider lessons from the west African" exact="Ebola" post="virus disease epidemic. The Lancet. 385(9980): 1884â€�901. Lessons learned"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404868\results\search\zoonosis\results.xml">
   <result pre="new epidemics of viral infections â€&quot; SARS, MERS, EBOLA, ZIKA," exact="Influenza" post="A (H1N1) pandemic,Covidâ€�2019 â€� over the past 3 decades"/>
   <result pre="Sci. 2017;113(8):1501â€�1502. 7QuJ, GaoZ, ZhangY, WainwrightM, WickramasingheC, OmairiT. Sunspot Activity," exact="Influenza" post="and Ebola Outbreak Connection. Astrobiol Outreach. 2016;4:154. 8WickramasingheNC, SteeleEJ,"/>
   <result pre="7QuJ, GaoZ, ZhangY, WainwrightM, WickramasingheC, OmairiT. Sunspot Activity, Influenza and" exact="Ebola" post="Outbreak Connection. Astrobiol Outreach. 2016;4:154. 8WickramasingheNC, SteeleEJ, WainwrightM, GensukeT,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405164\results\search\zoonosis\results.xml">
   <result pre="support a link between the essential element zinc and the" exact="coronavirus disease 2019" post="(COVIDâ€�19). An important fact is that zinc is present"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405170\results\search\zoonosis\results.xml">
   <result pre="DENTAL PROCEDURES (AGMP AND AGDP) The SARSâ€�1, 2009 H1N1 MERS," exact="Ebola" post="and Zika outbreaks were instrumental in drawing attention to"/>
   <result pre="protection. Ann ICRP1994;66:1â€�3. 3Institute of Medicine. Preventing Transmission of Pandemic" exact="Influenza" post="and Other Viral Respiratory Diseases: Personal Protective Equipment for"/>
   <result pre="in room compartments. Indoor Air. 2012;22:77â€�87.21906177 14LeffelEK, ReedDS. Marburg and" exact="Ebola" post="viruses as aerosol threats. Biosecur Bioterror. 2004;2:186â€�191.15588056 15UrbanowskiME, IhmsEA,"/>
   <result pre="Infect Dis. 2018;18:707.30594124 25VetterP, FischerWA, 2nd, SchiblerM, JacobsM, BauschDG, KaiserL." exact="Ebola" post="virus shedding and transmission: review of current evidence. J"/>
   <result pre="Hong Kong. PLoS One. 2014;9:e107338.25208000 54MiltonDK, FabianMP, CowlingBJ, GranthamML, McDevittJJ." exact="Influenza" post="virus aerosols in human exhaled breath: particle size, culturability,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405322\results\search\zoonosis\results.xml">
   <result pre="Pulmonology. 2020;1â€&quot;3. 10.1002/ppul.24927 1 INTRODUCTION The rapid global spread of" exact="coronavirus disease 2019" post="(COVIDâ€�19) is now wellâ€�known with the first case in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405402\results\search\zoonosis\results.xml">
   <result pre="various types of RNA viruses such as SARSâ€�CoV, MERSâ€�CoV and" exact="Ebola" post="virus (EBOV) (GarcÃ­aâ€�Serradilla, Risco, &amp;amp; Pacheco,Â 2019). The investigated"/>
   <result pre="for the purpose of viral infection control caused by the" exact="Ebola" post="virus. The remdesivir is entered to the phase III"/>
   <result pre="ACE2 binding expose the RGD containing region. Different viruses like" exact="Ebola" post="virus (Schornberg etÂ al.,Â 2009), human papillomavirus (Yoon, Kim,"/>
   <result pre="by targeting viral neuraminidase to block the release of the" exact="Influenza" post="virus (De Clercq &amp;amp; Li,Â 2016). Bone marrow matrix"/>
   <result pre="mainly causing the severe acute respiratory syndrome coronavirus (SARSâ€�CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV) responsible for the epidemics in 2002 and"/>
   <result pre="L., Enjuanes, L., Weiss, S., &amp;amp; Sarafianos, S. G. (2012)." exact="Severe acute respiratory syndrome" post="coronavirus replication inhibitor that interferes with the nucleic acid"/>
   <result pre="S. M., Tavakoliâ€�Ardakani, M., &amp;amp; Saffaei, A. (2020). Thalidomide against" exact="coronavirus disease 2019" post="(COVIDâ€�19): A medicine with a thousand faces. Iranian Journal"/>
   <result pre="The antiviral compound remdesivir potently inhibits RNAâ€�dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus. Journal of Biological Chemistry, 295, 4773â€&quot;4779. 10.1074/jbc.AC120.01305632094225 Harrison,"/>
   <result pre="&amp;amp; Baker, S. C. (2013). Assessing activity and inhibition of" exact="Middle East respiratory syndrome" post="coronavirus papainâ€�like and 3Câ€�like proteases using luciferaseâ€�based biosensors. Journal"/>
   <result pre="Bernbaum, J. G., Venkataraman, T., â€¦ Frieman, M. B. (2015)." exact="Severe acute respiratory syndrome" post="coronavirus ORF7a inhibits bone marrow stromal antigen 2 virion"/>
   <result pre="D. P., &amp;amp; GÃ¶tte, M. (2019). Mechanism of inhibition of" exact="Ebola" post="Virus RNAâ€�dependent RNA polymerase by remdesivir. Viruses, 11, 326â€&quot;342."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405496\results\search\zoonosis\results.xml">
   <result pre="Ang II angiotensin II CARâ€�T chimeric antigen receptor Tâ€�cells COVIDâ€�19" exact="coronavirus disease 2019" post="CRS cytokine release syndrome CVD cardiovascular disease DEGs differentially"/>
   <result pre="transmembrane protease, serine 2 1 INTRODUCTION The outbreak of novel" exact="coronavirus disease 2019" post="(COVIDâ€�19) is likely to have started in China (Zhou,"/>
   <result pre="is, therefore, recommended that sexâ€�disaggregated data are provided for all" exact="COVID19" post="studies. 6.1 Nomenclature of targets and ligands Key protein"/>
   <result pre="M. M., &amp;amp; Elâ€�Sheemy, M. A. (2014). The pattern of" exact="Middle East respiratory syndrome" post="coronavirus in Saudi Arabia: A descriptive epidemiological analysis of"/>
   <result pre="Cingolani, O., &amp;amp; Lakatta, E. G. (2020). The dilemma of" exact="coronavirus disease 2019," post="aging, and cardiovascular disease: Insights from cardiovascular aging science."/>
   <result pre="Y. (2020). Simulation of the clinical and pathological manifestations of" exact="coronavirus disease 2019" post="(COVIDâ€�19) in golden Syrian hamster model: Implications for disease"/>
   <result pre="L. (2020). Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: A descriptive study. Lancet, 395(10223), 507â€&quot;513."/>
   <result pre="Treatment Expert Group for Covidâ€�19 . (2020). Clinical characteristics of" exact="coronavirus disease 2019" post="in China. The New England Journal of Medicine, 382,"/>
   <result pre="(2020). Anticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathy. Journal of Thrombosis and Haemostasis, 18(5),"/>
   <result pre="of antiâ€�inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVIDâ€�19): The perspectives of clinical immunologists from China. Clinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405836\results\search\zoonosis\results.xml">
   <result pre="diseases have emerged in different geographical areas, with pathogens including" exact="Ebola" post="virus, Zika virus, Nipah virus, and coronaviruses (CoVs). Recently,"/>
   <result pre="now been termed severe acute respiratory syndrome CoV-2 (SARS-CoV-2). Although" exact="coronavirus disease 2019" post="(COVID-19) is suspected to originate from an animal host"/>
   <result pre="diseases have emerged in different geographical areas, with pathogens including" exact="Ebola" post="virus, Zika virus, Nipah virus, and coronaviruses (CoVs). Recently,"/>
   <result pre="now been termed severe acute respiratory syndrome CoV-2 (SARS-CoV-2). Although" exact="coronavirus disease 2019" post="(COVID-19) is suspected to originate from an animal host"/>
   <result pre="confirmed cases globally. Compared to other emerging viruses, such as" exact="Ebola" post="virus, avian H7N9, SARS-CoV, and Middle East respiratory syndrome"/>
   <result pre="emerging viruses, such as Ebola virus, avian H7N9, SARS-CoV, and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), SARS-CoV-2 has shown relatively low pathogenicity and"/>
   <result pre="Middle East. The severe acute respiratory syndrome (SARS) and the" exact="Middle East respiratory syndrome" post="(MERS) began to emerge in 2002 and 2012, respectively."/>
   <result pre="novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing" exact="coronavirus disease 2019" post="(COVID-19), emerged in late 2019, and it has posed"/>
   <result pre="often associated with lower transmissibility. Compared to emerging viruses like" exact="Ebola" post="virus, avian H7N9, SARS-CoV, and MERS-CoV, SARS-CoV-2 has relatively"/>
   <result pre="that there is a potential risk for the reemergence of" exact="SARS-CoV infection" post="from the viruses that are currently circulating in the"/>
   <result pre="by SARS-CoV-2 is also named severe specific contagious pneumonia (SSCP)," exact="Wuhan pneumonia," post="and, recently, COVID-19 (110). Compared to SARS-CoV, SARS-CoV-2 has"/>
   <result pre="the possible role played by farm and wild animals in" exact="SARS-CoV-2 infection," post="the WHO, in their novel coronavirus (COVID-19) situation report,"/>
   <result pre="infected cats efficiently transmitted the disease to naive cats (329)." exact="SARS-CoV-2 infection" post="and subsequent transmission in ferrets were found to recapitulate"/>
   <result pre="feces. In a recent survey from 17 confirmed cases of" exact="SARS-CoV-2 infection" post="with available data (representing days 0 to 13 after"/>
   <result pre="of resources and logistical limitations associated with an outbreak (155)." exact="SARS-CoV-2 infection" post="can also be confirmed by isolation and culturing. The"/>
   <result pre="cross-infection. Hence, the use of CT for early diagnosis of" exact="SARS-CoV-2 infection" post="in high-risk groups should be done with great caution"/>
   <result pre="However, this was brought down to 5 years during the" exact="Ebola" post="emergency for viral vector vaccines. In the urgency associated"/>
   <result pre="lopinavir-ritonavir treatment over standard care (273). The efforts to control" exact="SARS-CoV-2 infection" post="utilize defined strategies as followed against MERS and SARS,"/>
   <result pre="the cytokine storm that is observed in severe cases of" exact="SARS-CoV-2 infection," post="thereby reducing mortality. Among the different types of MSCs,"/>
   <result pre="drugs) revealed remdesivir and chloroquine to be highly effective against" exact="SARS-CoV-2 infection" post="in vitro (194). Ribavirin, penciclovir, and favipiravir might not"/>
   <result pre="Remdesivir, a novel nucleotide analog prodrug, was developed for treating" exact="Ebola" post="virus disease (EVD), and it was also found to"/>
   <result pre="it does not have any sort of inhibitory action against" exact="SARS-CoV-2 infection" post="(194). Recently, several newly synthesized halogenated triazole compounds were"/>
   <result pre="examples include transbodies to the influenza virus, hepatitis C virus," exact="Ebola" post="virus, and dengue virus (206). Producing similar transbodies against"/>
   <result pre="its efficacy (311). Potential Therapeutic Agents Potent therapeutics to combat" exact="SARS-CoV-2 infection" post="include virus binding molecules, molecules or inhibitors targeting particular"/>
   <result pre="COVID-19. Even though airborne spread has not been reported in" exact="SARS-CoV-2 infection," post="transmission can occur through droplets and fomites, especially when"/>
   <result pre="the risk of infection (299). The human-to-human transmission reported in" exact="SARS-CoV-2 infection" post="occurs mainly through droplet or direct contact. Due to"/>
   <result pre="coronavirus case in Nepal. Lancet Infect Dis20:279â€&quot;280. doi:10.1016/S1473-3099(20)30067-0.32057299 65.VelavanTP, MeyerCG2020The" exact="Covid-19" post="epidemic. Trop Med Int Health25:278â€&quot;280. doi:10.1111/tmi.13383.32052514 66.AyitteyFK, AyitteyMK, ChiweroNB,"/>
   <result pre="and nsp3 in its pathogenesis. J Med Virol92:584â€&quot;588. doi:10.1002/jmv.25719.32083328 101.MahaseE2020Coronavirus" exact="Covid-19" post="has killed more people than SARS and MERS combined,"/>
   <result pre="SchipperD, SolanesD, CordÃ³nI, BensaidA, HaagmansBL, SegalÃ©sJ2017Livestock susceptibility to infection with" exact="Middle East respiratory syndrome" post="coronavirus. Emerg Infect Dis23:232â€&quot;240. doi:10.3201/eid2302.161239.27901465 110.WuYC, ChenCS, ChanYJ2020Overview of"/>
   <result pre="ZumlaAI, MemishZA2013Epidemiological, demographic, and clinical characteristics of 47 cases of" exact="Middle East respiratory syndrome" post="coronavirus disease from Saudi Arabia: a descriptive study. Lancet"/>
   <result pre="in designing and developing vaccines, drugs, and therapies to counter" exact="Ebola" post="virus. Front Immunol9:1803. doi:10.3389/fimmu.2018.01803.30147687 163.SinghRK, DhamaK, ChakrabortyS, TiwariR, NatesanS,"/>
   <result pre="immunization with recombinant adenovirus-based vaccine expressing full-length spike protein of" exact="Middle East respiratory syndrome" post="coronavirus. PLoS One14:e0220196. doi:10.1371/journal.pone.0220196.31329652 178.ShiJ, ZhangJ, LiS, SunJ, TengY,"/>
   <result pre="ShalhoubS, JoseJ, FowlerRA, HaydenFG, HusseinMA, collab: MIRACLE Trial Group2018Treatment of" exact="Middle East respiratory syndrome" post="with a combination of lopinavir-ritonavir and interferon-Î²1b (MIRACLE trial):"/>
   <result pre="ChenF, ZhangW2020Clinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatment. Biosci Trends14:64â€&quot;68."/>
   <result pre="with dromedary immune serum in an experimental animal model for" exact="Middle East respiratory syndrome" post="coronavirus infection. J Virol89:6117â€&quot;6120. doi:10.1128/JVI.00446-15.25787284 205.ZhangL, LiuY2020Potential interventions for"/>
   <result pre="SookrungN, SakolvareeY, ChaicumpaW2018Human transbodies that interfere with the functions of" exact="Ebola" post="virus VP35 protein in genome replication and transcription and"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell culture. Antimicrob Agents Chemother58:4875â€&quot;4884. doi:10.1128/AAC.03011-14.24841269"/>
   <result pre="PaddockCD, GuarnerJ, ZakiSR, SheahanT, BaricR, SubbaraoK2008Animal models and vaccines for" exact="SARS-CoV infection." post="Virus Res133:20â€&quot;32. doi:10.1016/j.virusres.2007.03.025.17499378 216.FalzaranoD, de WitE, FeldmannF, RasmussenAL, OkumuraA,"/>
   <result pre="Microbiol2:16226. doi:10.1038/nmicrobiol.2016.226.27892925 223.EckerleI, CormanVM, MÃ¼llerMA, LenkM, UlrichRG, DrostenC2014Replicative capacity of" exact="MERS coronavirus" post="in livestock cell lines. Emerg Infect Dis20:276â€&quot;279. doi:10.3201/eid2002.131182.24457147 224.MilewskaA,"/>
   <result pre="Hosp Infect104:252â€&quot;253. doi:10.1016/j.jhin.2020.01.019.32032614 227.SunK, ChenJ, ViboudC2020Early epidemiological analysis of the" exact="coronavirus disease 2019" post="outbreak based on crowdsourced data: a population-level observational study."/>
   <result pre="MakTM, MaiwaldM, LiJ, ChongCY, NaduaK, TanNWH, ThoonKC2822020A well infant with" exact="coronavirus disease 2019" post="with high viral load. Clin Infect Dis doi:10.1093/cid/ciaa201. 248.WoelfelR,"/>
   <result pre="DrostenC, WendtnerC2020Clinical presentation and virological assessment of hospitalized cases of" exact="coronavirus disease 2019" post="in a travel-associated transmission cluster. medRxiv10.1101/2020.03.05.20030502. 249.HeY, WangZ, LiF,"/>
   <result pre="KimYJ, KimJM, ChungYS, KimHM, HanMG, KimSY, ChinBS2020Viral load kinetics of" exact="SARS-CoV-2 infection" post="in first two patients in Korea. J Korean Med"/>
   <result pre="COVID-19?Int J Antimicrob Agents55:105938. doi:10.1016/j.ijantimicag.2020.105938.32171740 264.SahraeiZ, ShabaniM, ShokouhiS, SaffaeiA2020Aminoquinolines against" exact="coronavirus disease 2019" post="(COVID-19): chloroquine or hydroxychloroquine. Int J Antimicrob Agents55:105945. doi:10.1016/j.ijantimicag.2020.105945.32194152"/>
   <result pre="pathology, pathogenesis, immunopathology and mitigation strategiesâ€&quot;a review. Preprintshttps://www.preprints.org/manuscript/202003.0348/v1. 283.KimberlinDW, StagnoS2632020Can" exact="SARS-CoV-2 infection" post="be acquired in utero? More definitive evidence is needed."/>
   <result pre="292.HuangY, ChengW, ZhaoN, QuH, TianJ2632020CT screening for early diagnosis of" exact="SARS-CoV-2 infection." post="Lancet Infect Dis doi:10.1016/S1473-3099(20)30241-3. 293.OuX, LiuY, LeiX, LiP, MiD,"/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the experience of clinical immunologists from China. Clin"/>
   <result pre="campaign: guidelines on the management of critically ill adults with" exact="coronavirus disease 2019" post="(COVID-19). Intensive Care Med46:854â€&quot;887. doi:10.1007/s00134-020-06022-5.32222812 304.AtluriS, ManchikantiL, HirschJA2020Expanded umbilical"/>
   <result pre="Gastrointest Endosc doi:10.1016/j.gie.2020.03.019. 313.LiuX, ZhangS2932020COVID-19: face masks and human-to-human transmission." exact="Influenza" post="Other Respir Viruses doi:10.1111/irv.12740. 314.YangC2020Does hand hygiene reduce SARS-CoV-2"/>
   <result pre="Dis20:393â€&quot;405. doi:10.1089/vbz.2020.2650.32374208 331.ShanthikumarSR2020We should err on side of caution with" exact="Covid-19" post="advice. Vet Rec186:458. doi:10.1136/vr.m1488. 332.LiX2020Can cats become infected with"/>
   <result pre="SteyerbergEW, WallischC, van SmedenM2020Prediction models for diagnosis and prognosis of" exact="Covid-19" post="infection: systematic review and critical appraisal. BMJ369:m1328. doi:10.1136/bmj.m1328.32265220 361.WhiteheadCL,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405927\results\search\zoonosis\results.xml">
   <result pre="Rights. TognottiEugeniaLessons from the History of Quarantine, from Plague to" exact="Influenza" post="AEmerging Infectious Diseases201319225425910.3201/eid1902.12031223343512 UpshurRossPrinciples for the Justification of Public"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7409030\results\search\zoonosis\results.xml">
   <result pre="management of this crisis. Considerable scientific progress was recorded regarding" exact="SARS-CoV-2 infection" post="in terms of genomic structure, diagnostic tools, viral transmission,"/>
   <result pre="therapeutics was also included. In addition, a comprehensible overview of" exact="SARS-CoV-2 infection" post="in terms of general description and structure, mechanism of"/>
   <result pre="perspective. This review plans to offer a comprehensible overview of" exact="SARS-CoV-2 infection" post="in terms of general description and structure, mechanism of"/>
   <result pre="even death [31]. Lungs were considered the main target for" exact="SARS-CoV-2 infection," post="but other injured organs were also described after encounter"/>
   <result pre="the present review, anosmia was considered an uncommon symptom of" exact="SARS-CoV-2 infection," post="but according to the latest studies, this symptom became"/>
   <result pre="factor (TNF-Î±), and vascular endothelial growth factor (VEGF) [28,43]. Additionally," exact="SARS-CoV-2 infection" post="may cause cell pyroptosis within macrophages and lymphocytes, which"/>
   <result pre="caused severe acute lung injury in the early stages of" exact="SARS-CoV infection." post="It is believed that the antibody-dependent injuries are owing"/>
   <result pre="still remains unclear, is the decreased susceptibility of children to" exact="SARS-CoV-2 infection" post="as compared with the adult population. Even though an"/>
   <result pre="with the adult population. Even though an age-dependent susceptibility to" exact="SARS-CoV-2 infection" post="was established, a valid explanation for these disparities is"/>
   <result pre="is considered at this point the most promising treatment for" exact="SARS-CoV-2 infection" post="on the basis of the latest outcomes acquired within"/>
   <result pre="by Gilead Sciences, Inc. as an antiviral candidate against the" exact="Ebola" post="virus, but it also proved to be highly efficient"/>
   <result pre="form, interfering with the action of the viral RdRp of" exact="Ebola" post="virus via insertion into the newly nascent viral RNA"/>
   <result pre="understanding of the antiviral mechanism of action of RDV in" exact="SARS-CoV-2 infection" post="[67,68,69]. In order to investigate whether this mechanism of"/>
   <result pre="phase III clinical trials on healthy volunteers and patients with" exact="Ebola" post="virus infection asserted the pharmacokinetic properties and a safety"/>
   <result pre="COVID-19 patients [78]. These latest data regarding RDV efficacy against" exact="SARS-CoV-2 infection" post="are stimulating, although the gaps concerning its safety profile"/>
   <result pre="RDV administration or are in fact consequences/complications determined by the" exact="SARS-CoV-2 infection" post="[71]. One of the randomized, double-blind, placebo-controlled, multicentre clinical"/>
   <result pre="it is unclear what causes itâ€&quot;the medication administered or the" exact="SARS-CoV-2 infection," post="thus liver protection would do no harm); As RDV"/>
   <result pre="CQ [95,96]; and (v) HCQ apparently offered no protection against" exact="SARS-CoV-2 infection" post="(results of a large healthcare Israelian database analysis) [97]."/>
   <result pre="based on several premises: azithromycin proved in vitro activity against" exact="Ebola" post="and Zika viruses, as well as a preventive effect"/>
   <result pre="by WHO that evaluates these compounds as possible therapy against" exact="SARS-CoV-2 infection;" post="the HERO-HCQ, a study sponsored by the National Institutes"/>
   <result pre="clinical data regarding the use of CQ and HCQ in" exact="SARS-CoV-2 infection" post="are not considered robust [102], and EMA did not"/>
   <result pre="oral lopinavir (400 mg) associated with ritonavir (200 mg) in" exact="SARS-CoV-2 infection." post="At the end of their study, there was no"/>
   <result pre="patients with severe viral infections such as EBV, H1N1, and" exact="Ebola" post="[143]. A recent cohort study evaluated the effect of"/>
   <result pre="Considering the imperative need to find an effective treatment against" exact="SARS-CoV-2 infection" post="(which is lacking at present), administration of immune â€œconvalescentâ€�"/>
   <result pre="assessed the following directions: (i) treatment for mild forms of" exact="SARS-CoV-2 infection;" post="(ii) treatment for moderately ill patients; (iii) as rescue"/>
   <result pre="still unknown if the hemostatic disorders are a cause of" exact="SARS-CoV-2 infection" post="or a repercussion of the cytokine storm that triggers"/>
   <result pre="the infection spread repression); and (v) the clinical impact of" exact="SARS-CoV-2 infection" post="(characteristic symptomatology, onset, clinical stages, complications) is mostly described,"/>
   <result pre="constantly being updated. The urge to find a therapy for" exact="SARS-CoV-2 infection" post="determined the occurrence of multiple therapeutic alternatives, such as"/>
   <result pre="At present, remdesivir is considered the most promising therapy for" exact="SARS-CoV-2 infection" post="being already included in the interim guidelines for COVID-19"/>
   <result pre="is debatable at this point. The use of lopinavir/ritonavir against" exact="SARS-CoV-2 infection" post="determined controversial results; that is, according to some clinical"/>
   <result pre="ruloxitinib, and so on) should be recommended as therapy for" exact="SARS-CoV-2 infection" post="only when the laboratory results indicate a potential â€œcytokine"/>
   <result pre="Hepatol.20208131710.14218/JCTH.2020.0001932274341 43.HongE.H.SongJ.H.KangK.B.SungS.H.KoH.J.YangH.Anti-Influenza Activity of Betulinic Acid From Zizyphus Jujuba on" exact="Influenza" post="A/PR/8 VirusBiomol. Ther.20152334534910.4062/biomolther.2015.019 44.KulkarniR.Antibody-Dependent Enhancement of Viral InfectionsDyn. Immune"/>
   <result pre="Transmission and Control of COVID-19 EpidemicsNat. Med.202010.1038/s41591-020-0962-9 46.XieZ.Pay attention to" exact="SARS-CoV-2 infection" post="in childrenPediatric Investig.202041410.1002/ped4.12178 47.LiguoroI.PilottoC.BonanniM.FerrariM.E.PusiolA.NocerinoA.VidalE.CogoP.SARS-COV-2 infection in children and newborns:"/>
   <result pre="Novel Coronavirus (2019-nCoV) in VitroCell Res.20203026927110.1038/s41422-020-0282-032020029 62.TchesnokovE.P.FengJ.Y.PorterD.P.GÃ¶tteM.Mechanism of Inhibition of" exact="Ebola" post="Virus RNA-Dependent RNA Polymerase by RemdesivirViruses20191132610.3390/v1104032630987343 63.DainaA.MichielinO.ZoeteV.wissADME: A Free"/>
   <result pre="https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/(accessed on 25 April 2020) 117.GoriT.LelieveldJ.MÃ¼nzelT.Perspective: Cardiovascular Disease and the" exact="Covid-19" post="PandemicBasic Res. Cardiol.20201153210.1007/s00395-020-0792-432277299 118.BassettiM.GiacobbeD.R.AlibertiS.BarisioneE.CentanniS.De RosaF.G.Di MarcoF.GoriA.GranataG.MikulskaM.et al.Balancing Evidence and"/>
   <result pre="121.LewW.ChenX.KimC.U.Discovery and Development of GS 4104 (Oseltamivir): An Orally Active" exact="Influenza" post="Neuraminidase InhibitorCurr. Med. Chem.2000766367210.2174/092986700337488610702632 122.DaviesB.E.Pharmacokinetics of Oseltamivir: An Oral"/>
   <result pre="Oseltamivir: An Oral Antiviral for the Treatment and Prophylaxis of" exact="Influenza" post="in Diverse PopulationsJ. Antimicrob. Chemother.20106510.1093/jac/dkq015 123.ThomasE.GhanyM.G.LiangT.J.Review the application and"/>
   <result pre="roles in pathogenesisJ. Microbiol. Immunol. Infect.202010.1016/j.jmii.2020.03.022 128.DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov. Ther.202014586010.5582/ddt.2020.0101232147628 129.DuY.X.ChenX.P.Favipiravir: Pharmacokinetics and Concerns about Clinical"/>
   <result pre="more than 5000 cases at that date) [8]. Figure 2" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) structure. This image contains Servier Medical"/>
   <result pre="https://smart.servier.com. Figure 4 Schematic overview of the steps involved in" exact="SARS-CoV-2 infection" post="from the first contact with the virus until the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7409380\results\search\zoonosis\results.xml">
   <result pre="with SARS-CoV-1.11 Figure 1 SARS-CoV-2 genomic organization and virus structure." exact="SARS-CoV-2 infection" post="is initiated with viral entry, in which the S"/>
   <result pre="staining.8 A TMPRSS2-expressing VeroE6 cell line is highly susceptible to" exact="SARS-CoV-2 infection," post="making it ideal for virus isolation and cytopathic testing.18"/>
   <result pre="integrated CRISPR/Cas13a with microfluidics and custom-designed a mini-fluorometer to detect" exact="Ebola" post="virus at 20 plaque forming units (pfu)/mL.90 The assay"/>
   <result pre="acid test kits, but they cannot be used to confirm" exact="SARS-CoV-2 infection." post="COVID-19 Diagnosis by Chest Computed Tomography (CT) COVID-19 is"/>
   <result pre="authors thank Wenrong He for the schematic design. Abbreviations COVID-19" exact="coronavirus disease 2019" post="SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 FNR false-negative"/>
   <result pre="K.; LiaoQ.; et al. (2014) Comparison of Patients Hospitalized with" exact="Influenza" post="A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1. Clin."/>
   <result pre="OhS.; LeeM. K.; ChiS. W. (2019) Single-Molecule-Based Detection of Conserved" exact="Influenza" post="A Virus RNA Promoter Using a Protein Nanopore. ACS"/>
   <result pre="Enzymatic Cascade Amplification for Optomagnetic Detection of a Highly Conserved" exact="Dengue" post="Virus Sequence. Biosens. Bioelectron.160, 11221910.1016/j.bios.2020.112219.32339155 YeX.; LiL.; LiJ.; WuX.;"/>
   <result pre="Screen Identifies N-Acetylglucosamine-1-Phosphate Transferase as a Potential Antiviral Target for" exact="Ebola" post="Virus. Nat. Commun.10, 1â€&quot;13. 10.1038/s41467-018-08135-4.30602773 HeQ.; YuD.; BaoM.; KorenskyG.;"/>
   <result pre="HeQ.; YildizA.; MathiesR.; et al. (2019) Rapid and Fully Microfluidic" exact="Ebola" post="Virus Detection with CRISPR-Cas13a. ACS sens.4, 1048â€&quot;1054. 10.1021/acssensors.9b00239.30860365 KellnerM."/>
   <result pre="MudanyaliO.; UlrichR. G. (2019) A Smartphone-Based Rapid Telemonitoring System for" exact="Ebola" post="and Marburg Disease Surveillance. ACS Sens4, 61â€&quot;68. 10.1021/acssensors.8b00842.30525467 NandhakumarP.;"/>
   <result pre="YonezawaY.; ImaiK.; OgawaH.; TokeshiM. (2020) Rapid Detection of Anti-H5 Avian" exact="Influenza" post="Virus Antibody by Fluorescence Polarization Immunoassay Using a Portable"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7409838\results\search\zoonosis\results.xml">
   <result pre="Human immunodeficiency virus HCoV human coronavirus M Membrane protein MERS-CoV" exact="Middle East respiratory syndrome" post="coronavirus MLPCN Molecular Libraries Probe Production Centers Network Mpro"/>
   <result pre="RNA-dependent RNA polymerase S Spike protein SAR Structure-activity relationship SARS-CoV" exact="Severe acute respiratory syndrome" post="coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 SFC"/>
   <result pre="SAR Structure-activity relationship SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2" exact="Severe acute respiratory syndrome" post="coronavirus 2 SFC Supercritical fluid chromatography SPR Surface plasmon"/>
   <result pre="chromatography SPR Surface plasmon resonance 1 Introduction 1.1 COVID-19 pandemic" exact="Coronavirus disease 2019" post="(COVID-19) is a highly infectious disease caused by severe"/>
   <result pre="East in 2012. According to the World Health Organization records," exact="MERS coronavirus" post="has thus far resulted in 2494 cases of infection"/>
   <result pre="the pathogenesis mechanism, animal models and novel therapeutic interventions for" exact="Middle East respiratory syndrome" post="coronavirus infectionsFront. Microbiol.10201956930984127 17MustafaS.BalkhyH.GabereM.N.Current treatment options and the role"/>
   <result pre="Chem. Lett2820183472347630286952 70KankanamalageA.C.G.KimY.DamalankaV.C.RathnayakeA.D.FehrA.R.MehzabeenN.BattaileK.P.LovellS.LushingtonG.H.PerlmanS.ChangK.O.GroutasW.C.Structure-guided design of potent and permeable inhibitors of" exact="MERS coronavirus" post="3CL protease that utilize a piperidine moiety as a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7409942\results\search\zoonosis\results.xml">
   <result pre="7409942S0025-5564(20)30105-X doi: 10.1016/j.mbs.2020.108438108438 : Article Modeling the viral dynamics of" exact="SARS-CoV-2 infection" post="WangSunpengaPanYangbcdWangQuanyibcMiaoHongyueBrownAshley N.fRongLibingâ�Ž[a], [b], [c], [d], [e], [f], [g], â�ŽCorresponding"/>
   <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Coronavirus disease 2019" post="(COVID-19), an infectious disease caused by the infection of"/>
   <result pre="and causing the global coronavirus pandemic. The viral dynamics of" exact="SARS-CoV-2 infection" post="have not been quantitatively investigated. In this paper, we"/>
   <result pre="we use mathematical models to study the pathogenic features of" exact="SARS-CoV-2 infection" post="by examining the interaction between the virus, cells and"/>
   <result pre="and immune responses. Models are fit to the data of" exact="SARS-CoV-2 infection" post="in patients and non-human primates. Data fitting and numerical"/>
   <result pre="Data fitting and numerical simulation show that viral dynamics of" exact="SARS-CoV-2 infection" post="have a few distinct stages. In the initial stage,"/>
   <result pre="also evaluate the effect of several potential therapeutic interventions for" exact="SARS-CoV-2 infection." post="Model simulation shows that anti-inflammatory treatments or antiviral drugs"/>
   <result pre="strategies against COVID-19. Highlights â€¢Mathematical models are developed to study" exact="SARS-CoV-2 infection." post="â€¢Models are fit to viral load data of patients"/>
   <result pre="load data of patients and non-human primates. â€¢Viral dynamics of" exact="SARS-CoV-2 infection" post="has a few distinct stages. â€¢Model explains viral rebound"/>
   <result pre="2 (SARS-CoV-2) by the World Health OrganizationÂ [10]. Since then," exact="SARS-CoV-2 infection" post="has been detected in about 190 countries and caused"/>
   <result pre="highly resembles the severe acute respiratory syndrome (SARS-CoV) and the" exact="Middle East respiratory syndrome" post="(MERS-CoV), both classified as beta coronaviruses identified in batsÂ"/>
   <result pre="and transmissibility. Currently, there are no approved antiviral drugs for" exact="SARS-CoV-2 infection." post="Many patients were given symptomatic management such as empirical"/>
   <result pre="[46], [47], [48], [49]. However, the within-host viral dynamics of" exact="SARS-CoV-2 infection" post="have not been quantitatively investigated. Here we use mathematical"/>
   <result pre="we use mathematical models to study the pathogenic characteristics of" exact="SARS-CoV-2 infection" post="by examining the interaction between viral replication and the"/>
   <result pre="These findings may provide new insights into the pathogenesis of" exact="SARS-CoV-2 infection" post="and development of new treatment strategies. 2 Methods 2.1"/>
   <result pre="models, with increasing complexity, to study the viral dynamics of" exact="SARS-CoV-2 infection." post="The first is a very basic model, which only"/>
   <result pre="the third one includes a secondary target cell population of" exact="SARS-CoV-2 infection." post="The basic model is given by the following equations."/>
   <result pre="= p I âˆ’ c V The exact target of" exact="SARS-CoV-2 infection" post="is not fully clear. Based on the findings from"/>
   <result pre="cell. The virus is cleared at a constant rate c." exact="SARS-CoV-2 infection" post="can lead to the diffuse alveolar damage (DAD)Â [60]."/>
   <result pre="the R programming language. 3 Results 3.1 Viral dynamics of" exact="SARS-CoV-2 infection" post="We fit each of the three models Eqs. ((1)â€&quot;(3))"/>
   <result pre="three models Eqs. ((1)â€&quot;(3)) to the viral load data of" exact="SARS-CoV-2 infection" post="in patients from Germany and ChinaÂ [14], [51]. The"/>
   <result pre="simulations of model (3) show that the viral dynamics of" exact="SARS-CoV-2 infection" post="can exhibit a few distinct phases (Fig.Â 5A). During"/>
   <result pre="treat HIV-1 infectionÂ [87], while remdesivir was developed to treat" exact="Ebola" post="and Marburg virus infection, acting as an analog of"/>
   <result pre="novel coronavirus infection. The severe acute respiratory syndrome induced by" exact="SARS-CoV-2 infection" post="is characterized by over-exuberant inflammatory response. Baricitinib, fedratinib and"/>
   <result pre="the secondary target of infection. 4 Discussion Within-host dynamics of" exact="SARS-CoV-2 infection" post="have not been quantitatively investigated. We developed mathematical models"/>
   <result pre="countries. Our study provides explanations to several pathogenic features of" exact="SARS-CoV-2 infection." post="Firstly, SARS-CoV-2â€™s very high transmission capacity is likely to"/>
   <result pre="the model shows that the current best possible control of" exact="SARS-CoV-2 infection" post="might be the adaptive immune response of the infected"/>
   <result pre="results may improve our understanding of the pathogenic features of" exact="SARS-CoV-2 infection." post="Comparison of the prediction by the three models and"/>
   <result pre="the three models and the viral load data suggests that" exact="SARS-CoV-2 infection" post="might have a secondary target. Without the second target"/>
   <result pre="with the data in many patients. The secondary target of" exact="SARS-CoV-2 infection" post="might be lymphocytes. Lymphocytopenia is a predominant feature of"/>
   <result pre="acid truncation in its ORF6Â [53]. These alterations might make" exact="SARS-CoV-2 infection" post="more sensitive to IFN. IFN was also administrated with"/>
   <result pre="using IFN with and without other antiviral drugs to treat" exact="SARS-CoV-2 infection" post="in humans. Table 2 Best fits of model (3)"/>
   <result pre="with 2019 novel coronavirus in Wuhan, ChinaLancet39510223202049750610.1016/S0140-6736(20)30183-531986264 4GuanW.-J.NiZ.-Y.HuY.LiangW.-H.OuC.-Q.HeJ.-X.Clinical characteristics of" exact="Coronavirus disease 2019" post="in ChinaNew Engl. J. Med.202010.1056/NEJMoa2002032 5ZhuN.ZhangD.WangW.LiX.YangB.SongJ.A Novel Coronavirus from"/>
   <result pre="coronavirus-EMCNature4957440201325125410.1038/nature1200523486063 27ScobeyT.YountB.L.SimsA.C.DonaldsonE.F.AgnihothramS.S.MenacheryV.D.Reverse genetics with a full-length infectious cDNA of the" exact="Middle East respiratory syndrome" post="coronavirusProc. Natl. Acad. Sci. USA110402013161571616210.1073/pnas.131154211024043791 28RuanQ.YangK.WangW.JiangL.SongJ.Clinical predictors of mortality"/>
   <result pre="perspectives on immune responsesCell Death Differ.202010.1038/s41418-020-0530-3 38PhuaJ.WengL.LingL.EgiM.LimC.M.DivatiaJ.V.Intensive care management of" exact="coronavirus disease 2019" post="(COVID-19): challenges and recommendationsLancet Respir. Med.202010.1016/s2213-2600(20)30161-2 39ThevarajanI.NguyenT.H.O.KoutsakosM.DruceJ.CalyL.SandtC.E.van.de.Breadth of concomitant"/>
   <result pre="of a novel coronavirusInfect. Dis. Poverty9120202410.1186/s40249-020-00640-332111262 50KimJ.Y.KoJ.H.KimY.KimY.J.KimJ.M.ChungY.S.Viral load kinetics of" exact="SARS-CoV-2 infection" post="in first two patients in KoreaJ. Korean Med. Sci.357202010.3346/jkms.2020.35.e86"/>
   <result pre="cell biology perspectiveEur. Respir. J.5542020200060710.1183/13993003.00607-2020 64MizumotoK.KagayaK.ZarebskiA.ChowellG.Estimating the asymptomatic proportion of" exact="coronavirus disease 2019" post="(COVID-19) cases on board the Diamond Princess cruise ship,"/>
   <result pre="gut enterocytesScience202010.1126/science.abc1669eabc1669 92ChannappanavarR.FehrA.R.ZhengJ.Wohlford-LenaneC.AbrahanteJ.E.MackM.IFN-I Response timing relative to virus replication determines" exact="MERS coronavirus" post="infection outcomesJ. Clin. Invest.130920193625363910.1172/jci126363 93ToturaA.L.BaricR.S.SARS Coronavirus pathogenesis: host innate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7410019\results\search\zoonosis\results.xml">
   <result pre="based on incoming data from publications and the clinics in" exact="SARS-CoV-2 infection" post="and related infectious conditions including other oncological diseases. Table"/>
   <result pre="considerations We consider patients with CLL at increased risk of" exact="SARS-CoV-2 infection" post="and COVID-19 morbidity and mortality due to their immune"/>
   <result pre="risk of infection.19 We limit patientsâ€™ exposure to potential nosocomial" exact="SARS-CoV-2 infection" post="by minimizing the number of visits, postponing in-hospital routine"/>
   <result pre="the absence of a vaccine, the sole effective prevention of" exact="SARS-CoV-2 infection" post="and COVID-19 is public health, non-pharmaceutical interventions aimed at"/>
   <result pre="not iwCLL guideline recommended must be avoided to prevent nosocomial" exact="SARS-CoV-2 infection." post="Marrow aspirate and biopsy generally are not required for"/>
   <result pre="been established, making it difficult to balance the risks of" exact="SARS-CoV-2 infection" post="and those of starting, deferring, or halting treatment on"/>
   <result pre="pattern of decreasing risk of death was reported for the" exact="Middle East respiratory syndrome" post="as the infection reproduction number declined toward a more"/>
   <result pre="It is not known whether corticosteroids increases the risk of" exact="SARS-CoV-2 infection" post="or mitigates its severity.29,64â€&quot;70 Clinical trials with novel agents"/>
   <result pre="of the recommendation is to reduce the risk of nosocomial" exact="SARS-CoV-2 infection" post="by reducing hospital visits and to avoid chemo(immuno)therapy, idelalisib"/>
   <result pre="what extent, neutropenia is predictive of a negative outcome in" exact="SARS-CoV-2 infection." post="Idelalisib and other approved PI3K inhibitors cause hyper-activation of"/>
   <result pre="anti-leukemic therapy during the pandemic We test asymptomatic patients for" exact="SARS-CoV-2 infection" post="by nasopharyngeal swab RT-PCR 72-24â€Šhours before starting CLL therapy."/>
   <result pre="Rev.2018;32:499â€&quot;507.29709246 12.ChenGWuDGuoWet al.Clinical and immunological features of severe and moderate" exact="coronavirus disease 2019." post="J Clin Invest.2020;130:2620â€&quot;2629.32217835 13.RussellCDMillarJEBaillieJKClinical evidence does not support corticosteroid"/>
   <result pre="Z, McGoogan JM. Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) Outbreak in China: summary of a report of"/>
   <result pre="16.ChenRLiangWJiangMet al.Risk factors of fatal outcome in hospitalized subjects with" exact="coronavirus disease 2019" post="from a nationwide analysis in China. Chest.2020;158:97â€&quot;105.32304772 17.StauderREichhorstBHamakerMEet al.Management"/>
   <result pre="Lymphocytic Leukemia Study Group trials. Haematologica.2014;99:1095â€&quot;1100.24584349 19.PfefferbaumBNorthCSMental Health and the" exact="Covid-19" post="Pandemic. N Engl J Med.2020;April 13. [Epub ahead of"/>
   <result pre="ahead of print]. 20.CowlingBJAliSTNgTWYet al.Impact assessment of non-pharmaceutical interventions against" exact="coronavirus disease 2019" post="and influenza in Hong Kong: an observational study. Lancet"/>
   <result pre="a global pandemic. Nat Rev Clin Oncol.2020;17:268â€&quot;270.32242095 39.DignaniMCCostantiniPSalgueiraCet al.Pandemic 2009" exact="Influenza" post="A (H1N1) virus infection in cancer and hematopoietic stem"/>
   <result pre="Care Med.2003;168:1449â€&quot;1456.12947028 67.ArabiYMMandourahYAl-HameedFet al.Corticosteroid therapy for Critically Ill patients with" exact="Middle East respiratory syndrome." post="Am J Respir Crit Care Med.2018;197:757â€&quot;767.29161116 68.WuCChenXCaiYet al.Risk factors"/>
   <result pre="al.Symptom screening at illness onset of health care personnel with" exact="SARS-CoV-2 infection" post="in King County, Washington. JAMA.2020;323:2087â€&quot;2089. 105.CheungKSHungIFChanPPet al.Gastrointestinal manifestations of"/>
   <result pre="infection in King County, Washington. JAMA.2020;323:2087â€&quot;2089. 105.CheungKSHungIFChanPPet al.Gastrointestinal manifestations of" exact="SARS-CoV-2 infection" post="and virus load in fecal samples from the Hong"/>
   <result pre="(SARS-CoV-2), Italy, February 2020. Euro Surveill.2020;25:2000170. 111.ChuHYEnglundJAStaritaLMet al.Early detection of" exact="Covid-19" post="through a citywide pandemic surveillance platform. N Engl J"/>
   <result pre="13. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed April 30th, 2020. 118.SandersJMMonogueMLJodlowskiTZet al.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a review. JAMA.2020;April 13. [Epub ahead of print]."/>
   <result pre="27. [Epub ahead of print]. 120.MorrisDEClearyDWClarkeSCSecondary Bacterial Infections Associated with" exact="Influenza" post="Pandemics. Front Microbiol.2017;8:1041.28690590 121.MikulskaMCesaroSde LavalladeHet al.Vaccination of patients with"/>
   <result pre="campaign: guidelines on the management of critically Ill adults with" exact="coronavirus disease 2019" post="(COVID-19). Crit Care Med.2020;48:e440â€&quot;e469.32224769 125.YuFYanLWangNet al.Quantitative detection and viral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7410434\results\search\zoonosis\results.xml">
   <result pre="Piece Responding to the Challenge of the Dual COVID-19 and" exact="Ebola" post="Epidemics in the Democratic Republic of Congoâ€&quot;Priorities for Achieving"/>
   <result pre="Hopkins University Bloomberg School of Public Health, Baltimore, MD, and" exact="Ebola" post="Response Team, Health, Nutrition and Population, Global Practice, World"/>
   <result pre="infectious and noninfectious diseases. The DRC recently controlled its tenth" exact="Ebola" post="virus disease (EVD) outbreak, but COVID-19 and a new"/>
   <result pre="Democratic Republic of the Congo (DRC) recently experienced its tenth" exact="Ebola" post="virus disease (EVD) outbreak, the second largest globally after"/>
   <result pre="and Operational Management Task Force comparable to that of the" exact="Ebola" post="Incident Management System, has support from the WHO, U.S."/>
   <result pre="resetting the countdown clock. This was the first time an" exact="Ebola" post="outbreak occurred in a conflict zone with an ongoing"/>
   <result pre="an important factor in the large-scale progression of the 2014â€&quot;2016" exact="Ebola" post="outbreak in West Africa. A range of novel Ebola"/>
   <result pre="2014â€&quot;2016 Ebola outbreak in West Africa. A range of novel" exact="Ebola" post="diagnostic tools were trialed and introduced, including automated PCR"/>
   <result pre="the EVD outbreaks are informing the COVID-19 response.6 First, the" exact="Ebola" post="standard operating procedures (SOPs) have been used as a"/>
   <result pre="to speed the development and updating of COVID-19 SOPs. Second," exact="Ebola" post="contact follow-up approaches have been leveraged for the follow-up"/>
   <result pre="Globally, the current gold standard test for the diagnosis of" exact="SARS-CoV-2 infection" post="is detection of viral RNA in a sample from"/>
   <result pre="Leverage infrastructure, human resources, medical management and training platform of" exact="Ebola" post="Viral Disease for COVID-19 Increase resources in affected provinces"/>
   <result pre="Leverage infrastructure, human resources, medical management, and training platform of" exact="Ebola" post="viral disease for COVID-19 Limited logistical resources to carry"/>
   <result pre="at the national level based on lessons learned from the" exact="Ebola" post="virus disease outbreak in the Democratic Republic of the"/>
   <result pre="J Trop Med Hyg103: 12â€&quot;17.32431285 7.MulanguSet al.2019A rendomized trial of" exact="Ebola" post="virus disease therapeutics. N Engl J Med381: 2293â€&quot;2303.31774950 8.RohanHMcKayG,"/>
   <result pre="virus disease therapeutics. N Engl J Med381: 2293â€&quot;2303.31774950 8.RohanHMcKayG, 2020The" exact="Ebola" post="outbreak in the Democratic Republic of the Congo: why"/>
   <result pre="15.OkbaNMAet al.2020Severe acute respiratory syndrome coronavirus 2-specific antibody responses in" exact="coronavirus disease 2019" post="patients. Emerg Infect Dis26, 10.3201/eid2607.200841. 16.collab: World Health Organization,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7410516\results\search\zoonosis\results.xml">
   <result pre="SciNeurol. SciNeurological Sciences1590-18741590-3478Springer International PublishingCham pmcid: 74105164544 doi: 10.1007/s10072-020-04544-w :" exact="Covid-19" post="Challenges and management of neurological and psychiatric manifestations in"/>
   <result pre="Finally, several authors reported cases of Guillain-BarrÃ© syndrome associated with" exact="SARS-CoV-2 infection" post="[39â€&quot;42]. The main etiopathological hypothesis involves â€œmolecular mimicryâ€�, by"/>
   <result pre="[43]. Impact of COVID-19 in patients with chronic neurological diseases" exact="SARS-CoV-2 infection" post="has impacted on the health and well-being of patients"/>
   <result pre="patients. In Italy, 1.9% of reported cases were 73]. Nonetheless," exact="SARS-CoV-2 infection" post="shows different characteristics in children compared with the adult"/>
   <result pre="the past SARS-CoV-1 epidemic and largely found in patients with" exact="SARS-CoV-2 infection" post="are a direct consequence of the central nervous system"/>
   <result pre="and disruption of personal and social healthcare and lifestyle [80]." exact="SARS-CoV-2 infection" post="has recently been implicated in the onset of psychosis,"/>
   <result pre="92(6):552â€&quot;555. 10.1002/jmv.25728 12.ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYXiaJ'YuTZhangXZhangLEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet.20203951022350751332007143 13.ToKFLoAWExploring the pathogenesis"/>
   <result pre="(2020) Concomitant neurological symptoms observed in a patient diagnosed with" exact="coronavirus disease 2019." post="J Med Virol. 10.1002/jmv.25888 21.HuangCWangYLiXRenLZhaoJHuYZhangLFanGXuJGuXChengZYuTXiaJWeiYWuWXieXYinWLiHLiuMXiaoYGaoHGuoLXieJWangGJiangRGaoZJinQWangJCaoBClinical features of patients infected"/>
   <result pre="M, et al (2020) Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, China. JAMA Neurol 77(6):1â€&quot;9. 10.1001/jamaneurol.2020.1127 23.MehtaPMcAuleyDFBrownMSanchezETattersallRSMansonJJCOVID-19: consider"/>
   <result pre="Singh IP et alLarge-vessel stroke as a presenting feature of" exact="Covid-19" post="in the young. N Engl J Med 3822020:e60 35.KlokFAKruipMvan"/>
   <result pre="ICU patients with COVID-19Thromb Res202019114514732291094 36.LippiGPlebaniMHenryBMThrombocytopenia is associated with severe" exact="coronavirus disease 2019" post="(COVID-19) infections: a meta-analysisClin Chim Acta202050614514832178975 37.IadecolaCAnratherJThe immunology of"/>
   <result pre="and epidemiological features. Clin Infect Dis. 10.1093/cid/ciaa198 75.XuYLiXZhuBLiangHFangCGongYGuoQSunXZhaoDShenJZhangHLiuHXiaHTangJZhangKGongSCharacteristics of pediatric" exact="SARS-CoV-2 infection" post="and potential evidence for persistent fecal viral sheddingNat Med202026450250532284613"/>
   <result pre="G, Plebani M (2020) Laboratory abnormalities in children with novel" exact="coronavirus disease 2019." post="Clin Chem Lab Med 58(7):1135â€&quot;1138. 10.1515/cclm-2020-0272 77.SunDLiHLuXXXiaoHRenJZhangFRLiuZSClinical features of"/>
   <result pre="Med 58(7):1135â€&quot;1138. 10.1515/cclm-2020-0272 77.SunDLiHLuXXXiaoHRenJZhangFRLiuZSClinical features of severe pediatric patients with" exact="coronavirus disease 2019" post="in Wuhan: a single centerâ€™s observational studyWorld J Pediatr20201625125932193831"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7411102\results\search\zoonosis\results.xml">
   <result pre="(http://creativecommons.org/licenses/by-nc-nd/4.0/). Keywords COVID-19 Paediatric population Congenital heart disease 1 Introduction" exact="Coronavirus disease 2019" post="(COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus-2"/>
   <result pre="on those with heart disease. 1.1 Lessons from the past" exact="Influenza" post="epidemics have been associated with surge in cardiovascular deaths"/>
   <result pre="(CHD) may be at a higher risk of complications with" exact="COVID 19" post="similar to adults. Other coronavirus infections in children are"/>
   <result pre="CHD patients is recommended as a standard of care. 2" exact="COVID 19" post="and paediatric population People of all age groups are"/>
   <result pre="paediatric population People of all age groups are susceptible to" exact="SARS-CoV-2 infection." post="However, available epidemiological data mainly from USA and China3,13"/>
   <result pre="surrounding halo sign is considered as a typical sign of" exact="COVID 19" post="in paediatric patients.14 The mean Incubation period in children"/>
   <result pre="In the past severe acute respiratory syndrome (SARS) coronavirus and" exact="Middle East respiratory syndrome" post="(MERS) coronavirus were associated with critical maternal illness, spontaneous"/>
   <result pre="in children.26 A new phenomenon affecting previously asymptomatic children with" exact="SARS-CoV-2 infection" post="manifesting as a hyperinflammatory syndrome with multiorgan involvement similar"/>
   <result pre="syntial virus29 but conflicting reports are there in case of" exact="COVID 19." post="Children may have some peculiar mechanisms which regulate the"/>
   <result pre="respiratory machinery. This may be the contributing mechanism for milder" exact="COVID 19" post="disease in children. It may be possible that lung"/>
   <result pre="that lung infiltrates may have a protective role in paediatric" exact="SARS-CoV-2 infection," post="similar to lymphocytes participating in inducible bronchus-associated lymphoid structure"/>
   <result pre="elevated D-Dimer levels in children similar to adults.18,19 Consequent to" exact="SARS-CoV-2 infection" post="there is upregulation of pro-inflammatory cytokines which causes severe"/>
   <result pre="heart disease with reduced cardiac reserve may become unstable. 2.1" exact="COVID 19" post="and congenital heart disease Children with congenital heart disease"/>
   <result pre="is difficult to outline the spectrum of cardiovascular presentations of" exact="COVID19" post="in children however with the currently available knowledge it"/>
   <result pre="likely to have decreased functional reserve and high risk of" exact="SARS-CoV-2 infection" post="related complications. 3 Issues in management Most of the"/>
   <result pre="complications. 3 Issues in management Most of the children with" exact="COVID 19" post="can be managed conservatively and do not require specific"/>
   <result pre="with caution in children.42 There is no specific cure for" exact="SARS-CoV-2 infection" post="and lots of therapies are being under investigation (Remdesivir,"/>
   <result pre="to QT prolongation. Consequent to the metabolic and pathophysiologic consequences" exact="SARS-CoV-2 infection" post="and drug interactions such patients likely to have longer"/>
   <result pre="RAAS inhibitors in certain high-risk patients with known or suspected" exact="Covid-19" post="may be harmful for the patients.31,47 The data is"/>
   <result pre="paediatric patients event with CHD with severe ARDS.48 4 Conclusions" exact="SARS-CoV-2 infection" post="in majority of children is asymptomatic or mild and"/>
   <result pre="Infect Dis41suppl 72005S481S48916237651 7WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada," exact="Influenza" post="Other RespirViruses542011247255 12YuM.WongR.S.M.WuE.B.Cardiovascular complications of severe acute respiratory syndromePostgrad"/>
   <result pre="Pathology &amp;amp; Laboratory Medicine 18LuX.ZhangL.DuH.Chinese pediatric novel coronavirus study team." exact="SARS-CoV-2 infection" post="in childrenN Engl J Med202010.1056/NEJMc2005073Epub March 18, 2020 19QiuH.WuJ.HongL.LuoY.SongQ.ChenD.Clinical"/>
   <result pre="18, 2020 19QiuH.WuJ.HongL.LuoY.SongQ.ChenD.Clinical and epidemiological features of 36 children with" exact="coronavirus disease 2019" post="(COVID-19) in Zhejiang, China: an observational cohort study LancetInf"/>
   <result pre="observational cohort study LancetInf Disp202010.1016/S1473-3099(20)30198-5 20LippiG.PlebaniM.Laboratory Abnormalities in Patients with" exact="COVID-2019" post="Infection2020Clinical Chemistry and Laboratory Medicine (CCLM)10.1515/cclm-2020-0198published online ahead of"/>
   <result pre="Clin Invest39200961862519453650 35GuoT.FanY.ChenM.Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol202010.1001/jamacardio.2020.1017 36StoutK.K.DanielsC.J.AboulhosnJ.A.AHA/ACC guideline for the management of adults"/>
   <result pre="Children with Coronavirus Disease 20192020World J Pediatr10.1007/s12519-020-00353-5 43SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a review [published online ahead of print, 2020"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7412427\results\search\zoonosis\results.xml">
   <result pre="Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in" exact="Influenza" post="A Virus Infection SchloerSebastian1GoretzkoJonas1PleschkaStephan2LudwigStephan3https://orcid.org/0000-0001-8892-319Xhttps://sciprofiles.com/profile/397952RescherUrsula1*[1], SebastianMaximilian.Schloer@ukmuenster.deJonas.Goretzko@ukmuenster.de[2], Stephan.Pleschka@viro.med.uni-giessen.de[3], ludwigs@uni-muenster.de *Correspondence: rescher@uni-muenster.de"/>
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Influenza" post="virus infections and their associated morbidity and mortality are"/>
   <result pre="oseltamivir is still the leading, most commonly used drug in" exact="influenza infection" post="treatment. The second class of approved antivirals are the"/>
   <result pre="publish the results. References References 1.MillerM.S.PaleseP.Peering into the crystal ball:" exact="Influenza" post="pandemics and vaccine efficacyCell201415729429910.1016/j.cell.2014.03.02324725400 2.LeangS.K.DengY.M.ShawR.CaldwellN.IannelloP.KomadinaN.BuchyP.ChittaganpitchM.DwyerD.E.FaganP.et al.Influenza antiviral resistance in"/>
   <result pre="The challenge of antigenic driftVaccine2007256852686210.1016/j.vaccine.2007.07.02717719149 5.FauciA.S.Emerging and re-emerging infectious diseases:" exact="Influenza" post="as a prototype of the host-pathogen balancing actCell200612466567010.1016/j.cell.2006.02.01016497575 6.VillalÃ³n-LetelierF.BrooksA.G.SaundersP.M.LondriganS.L.ReadingP.C.Host"/>
   <result pre="for the optimal treatment and management of influenza. Part I:" exact="Influenza" post="life-cycle and currently available drugsJ. Prev. Med. Hyg.201455698525902573 11.LewW.ChenX.KimC.U.Discovery"/>
   <result pre="from Eastern IndiaPLoS ONE20161110.1371/journal.pone.0168464 16.HaydenF.G.SugayaN.HirotsuN.LeeN.de JongM.D.HurtA.C.IshidaT.SekinoH.YamadaK.PortsmouthS.et al.Baloxavir Marboxil for Uncomplicated" exact="Influenza" post="in Adults and AdolescentsN. Engl. J. Med.201837991392310.1056/NEJMoa171619730184455 17.HuY.MusharrafiehR.MaC.ZhangJ.SmeeD.F.DeGradoW.F.WangJ.An M2-V27A"/>
   <result pre="28.DunningJ.BaillieJ.K.CaoB.HaydenF.G.Antiviral combinations for severe influenzaLancet Infect. Dis.2014141259127010.1016/S1473-3099(14)70821-725213733 29.PopovA.F.ShchelkanovM.Y.E.Combined Therapy of" exact="Influenza" post="with Antiviral Drugs with a Different Mechanism of Action"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7413162\results\search\zoonosis\results.xml">
   <result pre="other coronaviruses (CoV) epidemics; severe acute respiratory syndrome (SARS-CoV-1) and" exact="Middle East respiratory syndrome" post="(MERS-CoV) have been associated with neurological complications. Methods This"/>
   <result pre="other coronaviruses (CoV) epidemics; severe acute respiratory syndrome (SARS-CoV-1) and" exact="Middle East respiratory syndrome" post="(MERS-CoV) have been associated with neurological complications. CoV neurotropism,"/>
   <result pre="Flu pandemic, was believed to be in relation to the" exact="influenza infection." post="[5] Moreover, despite controversies, it was shown that Parkinson's"/>
   <result pre="and from Jan 1, 2020, to July 7, 2020, for" exact="Covid-19" post="(Part E). These Keywords were used: Fig. 1 PRISMA"/>
   <result pre="diagnosis in such patients. [25,28] 3.3 MERS-CoV outbreak MERS or" exact="Camel Flu" post="caused by the MERS-CoV, was first identified in 2012"/>
   <result pre="never been detected in the CNS of humans. [37] 3.4" exact="COVID 19" post="pandemic To date there are several reports on neurological"/>
   <result pre="(SARS-CoV-1 and MERS-CoV). During the current pandemic, 370 patients with" exact="SARS-CoV-2 infection" post="out of 37 studies (Table 3) were reported to"/>
   <result pre="these cases. Coagulation abnormalities have been shown in critically ill" exact="COVID 19" post="patients. This was characterized by rise in procoagulant factors,"/>
   <result pre="3) Zoghi et al. reported a 21-year-old-man with encephalomyelitis following" exact="SARS-CoV-2 infection." post="The patient reported having upper respiratory infection symptoms for"/>
   <result pre="reported. [175] Moreover, the accumulation of inflammatory markers associated with" exact="SARS-CoV-2 infection," post="may cause a local cortical irritation that precipitates seizures"/>
   <result pre="and SARS-CoV-2 infections. [15,16,24,33,60,98,100,150,151,151,152,153,154,155,156,157,158] ADEM was reported after HCoV-OC43 and" exact="SARS-CoV-2 infection." post="[17,120,121,122,123] Headache, ischemic stroke, encephalitis and encephalopathy, seizure and"/>
   <result pre="OrganizationJanuaryJanuary 20202020 32SaadM.OmraniA.S.BaigK.BahloulA.ElzeinF.MatinM.A.Clinical aspects and outcomes of 70 patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a single-center experience in Saudi ArabiaInt J"/>
   <result pre="ArabiaInt J Infect Dis.292014 Dec30130625303830 33ArabiY.M.HarthiA.HusseinJ.BouchamaA.JohaniS.HajeerA.H.Severe neurologic syndrome associated with" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV)Infection43201549550125600929 34AlgahtaniH.SubahiA.ShirahB.Neurological Complications of Middle East Respiratory Syndrome"/>
   <result pre="Rep Neurol Med.201620163502683 35Al-HameedF.M.Spontaneous intracranial hemorrhage in a patient with" exact="Middle East respiratory syndrome" post="coronavirusSaudi Med J.3822017 Feb19620028133694 36KimJ.E.HeoJ.H.KimH.O.SongS.H.ParkS.S.ParkT.H.Neurological Complications during Treatment of"/>
   <result pre="Apr 1019e201127 40ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 41HuangC.WangY.LiX.Clinical features of"/>
   <result pre="prospective cohort studyLancet395102392020 Jun 617631770S0140-6736(20)31189-232442528 50HuangR.ZhuL.XueL.LiuL.YanX.WangJ.Clinical findings of patients with" exact="coronavirus disease 2019" post="in Jiangsu province, China: A retrospective, multicenter studyPLoS Negl"/>
   <result pre="seriesJ Neurol.26782020 Aug2185219210.1007/s00415-020-09885-232436105 80OxleyT.MoccoJ.MajidiS.KellnerC.ShoirahH.SinghP.Large-Vessel Stroke as a Presenting Feature of" exact="Covid-19" post="in the YoungN Engl J Med.382202020 May 14e6010.1056/NEJMc2009787 81GoldbergM.F.GoldbergM.F.CerejoR.TayalA.H.Cerebrovascular"/>
   <result pre="Thrombolysis.2020 Jun 915 95FaraM.G.SteinL.K.SkliutM.MorgelloS.FifiJ.T.DhamoonM.S.Macrothrombosis and stroke in patients with mild" exact="Covid-19" post="infectionJ Thromb Haemost.2020 May 2810.1111/jth.14938 96HelmsJ.KremerS.MerdjiH.Clere-JehlR.SchenckM.KummerlenC.Neurologic Features in Severe"/>
   <result pre="J Case Rep Intern Med.752020 Apr 29001691 117HemasianH.AnsariB.First case of" exact="Covid-19" post="presented with cerebral venous thrombosis: A rare and dreaded"/>
   <result pre="acute disseminated encephalomyelitis (ADEM)-like pathologyActa Neuropathol.14012020 Jul1610.1007/s00401-020-02166-232449057 123AbdiS.GhorbaniA.FatehiF.The association of" exact="SARS-CoV-2 infection" post="and acute disseminated encephalomyelitis without prominent clinical pulmonary symptomsJ"/>
   <result pre="meningoencephalitis: Case seriesBrain Behav Immun.872020 Jul15515810.1016/j.bbi.2020.05.02232389697 152PilottoA.OdoliniS.Stefano MasciocchiS.ComelliA.VolonghiI.Steroid-responsive encephalitis in" exact="Covid-19" post="diseaseAnn Neurol.2020 May 1710.1002/ana.25783 153Al-OlamaM.RashidA.GarozzoD.COVID-19-associated meningoencephalitis complicated with intracranial"/>
   <result pre="EEG changes indicating critical illness associated cerebral microbleeds in a" exact="Covid-19" post="patient. Version 2Clin Neurophysiol Pract.52020 Jun 1012512932607454 173KarimiN.Sharifi RazaviA.RouhaniN.Frequent"/>
   <result pre="183MÃ©ndez-GuerreroA.Laespada-GarcÃ­aM.GÃ³mez-GrandeA.Ruiz-OrtizM.Blanco-PalmeroV.A.Azcarate-DiazV.J.Acute Hypokinetic-Rigid Syndrome Following SARS-CoV-2 InfectionNeurology.2020 Jul 810 184BalestrinoR.RizzoneM.ZibettiM.RomagnoloA.ArtusiC.A.MontanaroE.Onset of" exact="Covid-19" post="with impaired consciousness and ataxia: a case reportJ Neurol.272020"/>
   <result pre="in neuro-COVID-19 PatientsJ Neurol.2020 Jun 61430536109 196Demirci OtluogluG.YenerU.DemirM.K.YilmazB.Encephalomyelitis associated with" exact="Covid-19" post="infection: case reportr J Neurosurg.2020 Jul 713 197RadmaneshA.RazE.ZanE.DermanA.KaminetzkyM.Brain Imaging"/>
   <result pre="and Oy-sters: Facial nerve palsy as a neurological manifestation of" exact="Covid-19" post="infectionNeurology.2020 May 2110.1212/WNL.0000000000009863 218SedaghatZ.KarimiN.Guillain Barre syndrome associated with COVID-19"/>
   <result pre="A case reportJ Clin Neurosci.152020 AprS0967-5868(20)30882-1 219OttavianiD.BosoF.TranquilliniE.GapeniI.PedrottiG.CozzioS.Early Guillain-BarrÃ© syndrome in" exact="coronavirus disease 2019" post="(COVID-19): a case report from an Italian COVID-hospitalNeurol Sci.2020"/>
   <result pre="unitNeurology.2020 Jun 2910 251TankisiH.TankisiA.HarboT.MarkvardsenL.K.AndersenH.PedersenT.H.Critical illness myopathy as a consequence of" exact="Covid-19" post="infectionClin Neurophysiol.13182020 Jun 121931193232619798 252ZhangH.CharmchiZ.SeidmanR.J.AnziskaY.VelayudhanV.PerkJ.COVID-19Â associated myositis with severe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7413836\results\search\zoonosis\results.xml">
   <result pre="These ten well-characterized drugs, previously used to treat malaria and" exact="Ebola" post="infections, were screened based on their interactions with the"/>
   <result pre="the outbreak of many life-threatening pathogens including Ebola, Zika, the" exact="Middle East respiratory syndrome" post="(MERS) coronavirus, severe acute respiratory syndrome (SARS) coronavirus and,"/>
   <result pre="were previously considered vital targets to combat the SARS and" exact="MERS coronavirus" post="epidemics (Wu et al. 2020). These two proteases were"/>
   <result pre="hits, previously used in the treatment of malarial, fungal/bacterial and" exact="Ebola" post="infections and FDA-approved/fast-tracked for human treatment, were selected. For"/>
   <result pre="Table 1 Docking score and energy of the malaria and" exact="Ebola" post="drugs and 1Q2W of COVID-19 with site 1 of"/>
   <result pre="COVID-19 protease (PDB codeâ€‰=â€‰1Q2W) TableÂ 2 Interaction between malaria and" exact="Ebola" post="drugs and 1Q2W of COVID-19 with site 1 of"/>
   <result pre="Table 3 Docking score and energy of the malaria and" exact="Ebola" post="drugs with ACE-2 receptor (PDB codeâ€‰=â€‰6M0J) TableÂ 4 Interaction"/>
   <result pre="ACE-2 receptor (PDB codeâ€‰=â€‰6M0J) TableÂ 4 Interaction between malaria and" exact="Ebola" post="drugs with ACE-2 receptor (PDB codeâ€‰=â€‰6M0J) Drug Ligand Receptor"/>
   <result pre="receptor (PDB codeâ€‰=â€‰6M0J) Fig.Â 1 3d Docking of malaria and" exact="Ebola" post="drugs and 1Q2W of COVID-19 with site 1 of"/>
   <result pre="protease (PDB codeâ€‰=â€‰1Q2W) Fig.Â 2 2d Docking of malaria and" exact="Ebola" post="drugs and 1Q2W of COVID-19 with fixing the active"/>
   <result pre="protease (PDB codeâ€‰=â€‰1Q2W) Fig.Â 3 3d Docking of malaria and" exact="Ebola" post="drugs with ACE-2 receptor (PDB codeâ€‰=â€‰6M0J) Fig.Â 4 2d"/>
   <result pre="receptor (PDB codeâ€‰=â€‰6M0J) Fig.Â 4 2d Docking of malaria and" exact="Ebola" post="drugs with ACE-2 RECEPTOR (PDB CODEâ€‰=â€‰6M0J) Fig.Â 5 Chemical"/>
   <result pre="have also shown the drug potential for the treatment ofÂ" exact="Ebola" post="virus disease, despite that Ebola is an RNA virus,"/>
   <result pre="potential for the treatment ofÂ Ebola virus disease, despite that" exact="Ebola" post="is an RNA virus, albeit trials were eventually discontinued"/>
   <result pre="eventually discontinued (Dunning et al. 2016). Being acted on the" exact="Ebola" post="RNA virus so, it is encouraging to act as"/>
   <result pre="the approval process. Webpage. Updated: May DunningJet al.Experimental treatment of" exact="Ebola" post="virus disease with brincidofovirPLOS ONE201611e016219910.1371/journal.pone.016219927611077 FlorescuDFKeckMADevelopment of CMX001 (Brincidofovir)"/>
   <result pre="by using a reaction-diffusion equationJ Bioinf Comput Biol202018205001310.1142/s0219720020500134 Organization WH" exact="Ebola" post="virus disease. Fact sheet N 103. Updated September 2014."/>
   <result pre="drug applications for brincidofovir authorized by FDA for patients with" exact="Ebola" post="virus disease SikkaVet al.The emergence of Zika virus as"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7414935\results\search\zoonosis\results.xml">
   <result pre="respiratory tract, digestive tract, and nervous system. For example, the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) caused Middle East respiratory syndrome after infecting"/>
   <result pre="For example, the Middle East respiratory syndrome coronavirus (MERS-CoV) caused" exact="Middle East respiratory syndrome" post="after infecting dromedary camels. Currently, there are seven known"/>
   <result pre="HCoV-HKU1, SARS-CoV, MERS-CoV, and the newly discovered SARS-CoV-2 that causes" exact="coronavirus disease 2019" post="(COVID-19).3 CoVs usually cause self-limiting and mild respiratory tract"/>
   <result pre="areas or territories and more than 13876441 confirmed cases of" exact="coronavirus disease 2019" post="(COVID-19) caused by SARS-CoV-2, where the virus infects all"/>
   <result pre="is the most common incubation period. The main symptoms of" exact="SARS-CoV-2 infection" post="include fever, fatigue, and dry cough along with ground-glass"/>
   <result pre="human diet, has climbed during these decades. For example, SARS," exact="Marburg hemorrhagic fever," post="and Ebola hemorrhagic fever are associated with human consumption"/>
   <result pre="during these decades. For example, SARS, Marburg hemorrhagic fever, and" exact="Ebola hemorrhagic fever" post="are associated with human consumption of wildlife. And Public"/>
   <result pre="and other consumption methods. However, most bacteria and viruses (eg" exact="Ebola" post="virus, SARS-CoV) have strong infectivity under room temperature and"/>
   <result pre="disease for deadly pathogens like the ones behind COVID-19, SARS," exact="bird flu," post="and more (PHE).49 Due to the risk of virus"/>
   <result pre="J Biotech. 2001;88:183â€&quot;204. doi:10.1016/S0168-1656(01)00281-4 23.KhanRM, Al-DorziHM, Al JohaniS, et al." exact="Middle East respiratory syndrome" post="coronavirus on inanimate surfaces: a risk for health care"/>
   <result pre="doi:10.1016/j.jhin.2015.08.02726597631 26.LeclercqI, BatejatC, BurguiereAM, et al. Heat inactivation of the" exact="Middle East respiratory syndrome" post="coronavirus. Influenza Other Respir. 2014;8:585â€&quot;586. doi:10.1111/irv.12261 27.ZhangC, WangG, YaoY."/>
   <result pre="al. Heat inactivation of the Middle East respiratory syndrome coronavirus." exact="Influenza" post="Other Respir. 2014;8:585â€&quot;586. doi:10.1111/irv.12261 27.ZhangC, WangG, YaoY. Resistance and"/>
   <result pre="de BrandJMA, WidagdoW, et al. Livestock susceptibility to infection with" exact="Middle East respiratory syndrome" post="coronavirus. Emerg Infect Dis. 2017;23:232â€&quot;240. doi:10.3201/eid2302.16123927901465 59.SabirJSM, LamTT, AhmedMM,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7416109\results\search\zoonosis\results.xml">
   <result pre="the search of therapeutic interventions has been intense for the" exact="coronavirus disease 2019" post="(COVID-19). The absence of an effective vaccine, treatment regimen,"/>
   <result pre="due to lethal pneumonia caused by rampant inflammation [2]. The" exact="SARS-CoV-2 infection" post="is characterized by an increase in pro-inflammatory and decrease"/>
   <result pre="effectiveness of the dexamethasone (a corticosteroid) for the management of" exact="SARS-CoV-2 infection" post="(https://clinicaltrials.gov/ct2/results?cond=covid-19&amp;amp;term=dexamethasone&amp;amp;cntry=&amp;amp;state=&amp;amp;city=&amp;amp;dist=). Recently, dexamethasone was declared as the world's first"/>
   <result pre="is suggested to probably counter the cytokine storm caused by" exact="SARS-CoV-2 infection" post="safeguarding the lungs and subsequently lives, for which detailed"/>
   <result pre="systematic review of therapeutic agents for the treatment of the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV)Trav Med Infect Dis302019918 2HuangC.WangY.LiX.RenL.ZhaoJ.HuY.ZhangL.FanG.XuJ.GuX.ChengZ.YuT.XiaJ.WeiY.WuW.XieX.YinW.LiH.LiuM.XiaoY.GaoH.GuoL.XieJ.WangG.JiangR.GaoZ.JinQ.WangJ.CaoB.Clinical features of patients"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7416802\results\search\zoonosis\results.xml">
   <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. Abstract" exact="Coronavirus disease 2019," post="also known as COVID-19, is caused by a novel"/>
   <result pre="four thousand viruses, including CoVs and deadlier viruses such as" exact="Ebola" post="virus [3]. The CoVs transmitted by bats are genetically"/>
   <result pre="mass movements of infected people [6]. Channels of COVID-19 spread" exact="SARS-CoV-2 infection" post="occurs through the mucosal membrane of the upper respiratory"/>
   <result pre="analog drug that was produced for the treatment of the" exact="Ebola" post="virus in Africa by Gilead Science and is currently"/>
   <result pre="days. The antiviral potential of remdesivir was first demonstrated against" exact="Ebola" post="virus in monkeys, in which it successfully inhibited the"/>
   <result pre="clinical trial demonstrated the fatality rate of patients infected with" exact="Ebola" post="virus to be more than 50% in patients treated"/>
   <result pre="patients treated with remdesivir and three additional therapies during the" exact="Ebola" post="outbreak in 2018, which led to the discontinuation of"/>
   <result pre="the formation of membrane attack complex USA Favipiravir Antiviral/used against" exact="Ebola" post="RNA-dependent RNA polymerase inhibitor USA Galidesivir (BCX4430) Antiviral/used against"/>
   <result pre="Ebola RNA-dependent RNA polymerase inhibitor USA Galidesivir (BCX4430) Antiviral/used against" exact="Ebola" post="Nucleoside RNA polymerase inhibitor USA Griffithsin Anti-HIV microbicide Potent"/>
   <result pre="patients [144]. Convalescent serum was also experimented with during the" exact="Ebola" post="pandemic in 2013. Its use reduced mortality in infected"/>
   <result pre="as observed in a study conducted in Africa during the" exact="Ebola" post="outbreak [145]. Furthermore, evidence from studies conducted during various"/>
   <result pre="with recent use of monoclonal antibodies in the treatment of" exact="Ebola" post="[85]. Deployment and proposed use For administering convalescent serum"/>
   <result pre="is assumed that the patients who have recuperated successfully from" exact="SARS-CoV-2 infection" post="can be safely requested to donate their blood to"/>
   <result pre="for design of improved Î±-ketoamide inhibitorsScience2020368648940941232198291 77.DongLHuSGaoJDiscovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov Ther2020141586032147628 78.WangMCaoRZhangLYangXLiuJXuMShiZHuZZhongWXiaoGRemdesivir and chloroquine effectively inhibit the"/>
   <result pre="The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus. J Biol Chem AC120:013056 80.SheahanTSimsALeistSSchÃ¤ferAWonJBrownAMontgomerySHoggABabusisDClarkeMComparative therapeutic efficacy of"/>
   <result pre="Med Chem20176051648166128124907 84.WarrenTKJordanRLoMKRayASMackmanRLSolovevaVSiegelDPerronMBannisterRHuiHCTherapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature2016531759438138526934220 85.MulanguSDoddLEDaveyRTJrTshiani MbayaOProschanMMukadiDLusakibanza ManzoMNzoloDTshomba OlomaAIbandaAA randomized,"/>
   <result pre="rhesus monkeysNature2016531759438138526934220 85.MulanguSDoddLEDaveyRTJrTshiani MbayaOProschanMMukadiDLusakibanza ManzoMNzoloDTshomba OlomaAIbandaAA randomized, controlled trial of" exact="Ebola" post="virus disease therapeuticsN Engl J Med2019381242293230331774950 86.HolshueMLDeBoltCLindquistSLofyKWiesmanJBruceHet al.First case"/>
   <result pre="novel coronavirus in the United StatesN Engl J Med20203821092993632004427 87.JacobsMRodgerABellDJBhaganiSCropleyIFilipeAGiffordRJHopkinsSHughesJJabeenFLate" exact="Ebola" post="virus relapse causing meningoencephalitis: a case reportLancet20163881004349850327209148 88.DÃ¶rnemannJBurzioCRonsseASprecherADe ClerckHVan"/>
   <result pre="88.DÃ¶rnemannJBurzioCRonsseASprecherADe ClerckHVan HerpMKoliÃ©M-CYosifivaVCaluwaertsSMcElroyAKFirst newborn baby to receive experimental therapies survives" exact="Ebola" post="virus diseaseJ Infect Dis2017215217117428073857 89.First 12 patients with coronavirus"/>
   <result pre="survives Ebola virus diseaseJ Infect Dis2017215217117428073857 89.First 12 patients with" exact="coronavirus disease 2019" post="(COVID-19) in the United States. https://www.medrxiv.org/content/10.1101/2020.03.09.20032896v1.full.pdf. Retrieved 14 Mar"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother20145884875488424841269 98.AspirozELBuelgaDSFigueroaSCGaleraRMLPascuetERHurlÃ© AD-G,"/>
   <result pre="common marmoset. J Infect Dis 212(12):1904â€&quot;1913 100.ArabiYMAsiriAYAssiriAMJokhdarHAAAlothmanABalkhyHHAlJohaniSAl HarbiSKojanSAl JeraisyMTreatment of" exact="Middle East respiratory syndrome" post="with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE trial):"/>
   <result pre="Virol202092546146332073161 106.WangZChenXLuYChenFZhangWClinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci Trends2020141646832037389 107.WangDHuBHuCZhuFLiuXZhangJWangBXiangHChengZXiongYet"/>
   <result pre="Wuhan, ChinaJAMA20203231110611069 108.ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet20203951022350751332007143 109.ZhouFYuTDuRFanGLiuYLiuZet al.Clinical course"/>
   <result pre="Syndr201158438521876444 111.RossignolJ-FNitazoxanide, a new drug candidate for the treatment of" exact="Middle East respiratory syndrome" post="coronavirusJ Infect Public Health20169322723027095301 112.HaffizullaJHartmanAHoppersMResnickHSamudralaSGinocchioCBardinMRossignolJEffect of nitazoxanide in adults"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern Med20201807111 125.ShangLZhaoJHuYDuRCaoBOn the use"/>
   <result pre="infectionClin Infect Dis201152444745621248066 145.SahrFAnsumanaRMassaquoiTIdrissBSesayFLaminJBakerSNicolSContonBJohnsonWEvaluation of convalescent whole blood for treating" exact="Ebola" post="Virus Disease in Freetown, Sierra LeoneJ Infect201774330230927867062 146.KraftCSHewlettALKoepsellSWinklerAMKratochvilCJLarsonLVarkeyJBMehtaAKLyonGMIIIFriedman-MoracoRJThe use"/>
   <result pre="use of TKM-100802 and convalescent plasma in 2 patients with" exact="Ebola" post="virus disease in the United StatesClin Infect Dis201561449650225904375 147.KongLZhouBSuccessful"/>
   <result pre="role for Fc function in therapeutic monoclonal antibody-mediated protection against" exact="Ebola" post="virus. Cell Host Microbe 24(2):221â€&quot;233 (e225) 157.China puts 245"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7417167\results\search\zoonosis\results.xml">
   <result pre="and influenza are believed to cause myocarditis and arrhythmias (10)." exact="Influenza" post="has been noted to cause various tachyarrhythmias, heart block,"/>
   <result pre="Johns Hopkins Coronavirus Resource CenterAvailable at:https://coronavirus.jhu.edu/us-map 3LipsitchM.SwerdlowD.L.FinelliL.Defining the epidemiology of" exact="Covid-19" post="â€&quot; studies neededNÂ Engl J Med38220201194119632074416 4ZhouF.YuT.DuR.Clinical course and"/>
   <result pre="ChinaJAMA Cardiology5202080281032211816 6GuoT.FanY.ChenM.Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol5202018 7PuntmannV.O.CarerjM.L.WietersI.Outcomes of cardiovascular magnetic resonance imaging in"/>
   <result pre="of cardiovascular magnetic resonance imaging in patients recently recovered from" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol2020 July 27[E-pub ahead of print]. 8YuC.-M.WongR.S.-M.WuE.B.Cardiovascular complications"/>
   <result pre="Med J82200614014416461478 9SaadM.OmraniA.S.BaigK.Clinical aspects and outcomes of 70 patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a single-center experience in Saudi ArabiaInt J"/>
   <result pre="Clin Electrophysiol2020 Jun 16[E-pub ahead of print] 16GoyalP.ChoiJ.J.PinheiroL.C.Clinical characteristics of" exact="Covid-19" post="in New York CityNÂ Engl J Med38220202372237432302078 17ColonC.M.BarriosJ.G.ChilesJ.W.AtrialÂ arrhythmias"/>
   <result pre="critical COVID-19Eur Heart J412020213132285920 19KirD.MohanC.SancassaniR.HEART BRAKE-an unusual cardiac manifestation of" exact="coronavirus disease 2019" post="(COVID-19)JÂ Am Coll Cardiol Case Rep2202012521255 20HeJ.WuB.ChenY.Characteristic ECG manifestations"/>
   <result pre="Cardiovasc Care2009215221 23VidovichM.I.Transient Brugada-like ECG pattern in a patient with" exact="coronavirus disease 2019" post="(COVID-19)JÂ Am Coll Cardiol Case Rep2202012451249 24SeecheranR.NarayansinghR.GiddingsS.Atrial arrhythmias in"/>
   <result pre="Engl J Med370201484785924571757 48HuertasA.MontaniD.SavaleL.Endothelial cell dysfunction: a major player in" exact="SARS-CoV-2 infection" post="(COVID-19)?Eur Respir J562020200163432554538 49VargaZ.FlammerA.J.SteigerP.Endothelial cell infection and endotheliitis in"/>
   <result pre="or without concomitant azithromycin among hospitalized patients testing positive for" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol2020 May 1[E-pub ahead of print] 61ESC Guidance"/>
   <result pre="Coll Cardiol EP62020878880 72MitraR.L.GreensteinS.A.EpsteinL.M.An algorithm for managing QT prolongation in" exact="coronavirus disease 2019" post="(COVID-19) patients treated with either chloroquine or hydroxychloroquine in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7418792\results\search\zoonosis\results.xml">
   <result pre="primordial hosts of the virus [6,7]. In 2012, the emerging" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) caused an outbreak in Saudi Arabia, which"/>
   <result pre="mutations and intra-host diversity not only forms intra-host evolution of" exact="Influenza" post="A, but also greatly affects the pathogenesis of the"/>
   <result pre="inter- and intra-host evolution might be associated with susceptibility to" exact="SARS-CoV-2 infection" post="and the severity of COVID-19 [24]. Viruses have developed"/>
   <result pre="third 41-year-old male patient (SRR1097138/PRJNA603194), presented acute onset of common" exact="COVID19" post="symptoms. A combinatory antiviral therapy was administered to the"/>
   <result pre="MERS epidemicAsian Pac. J. Allergy Immunol.3820201910.12932/AP-200220-077232105090 10AleanizyF.S.MohmedN.AlqahtaniF.Y.El Hadi MohamedR.A.Outbreak of" exact="Middle East respiratory syndrome" post="coronavirus in Saudi Arabia: a retrospective studyBMC Infect. Dis.1720172310.1186/s12879-016-2137-328056850"/>
   <result pre="with HB eAg-negative chronic HBV infectionLiver Int.3520152506251325939635 21XueK.S.MonclaL.H.BedfordT.BloomJ.D.Within-host evolution of" exact="human influenza" post="virusTrends Microbiol.26201878179310.1016/j.tim.2018.02.00729534854 22DestrasG.PichonM.SimonB.ValetteM.EscuretV.BolzeP.-A.DubernardG.GaucherandP.LinaB.JossetL.Impact of pregnancy on intra-host genetic diversity"/>
   <result pre="(Asp268del)Clin. Microbiol. Infect.26202096096210.1016/j.cmi.2020.03.02032234449 57NohJ.Y.YoonS.-W.KimD.-J.LeeM.-S.KimJ.-H.NaW.SongD.JeongD.G.KimH.K.Simultaneous detection of severe acute respiratory syndrome," exact="Middle East respiratory syndrome," post="and related bat coronaviruses by real-time reverse transcription PCRArch."/>
   <result pre="N-terminal domain of spike proteins is a potential vaccine against" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) infectionVaccine352017101810.1016/j.vaccine.2016.11.06427899228 Appendix A Supplementary data The following"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7419580\results\search\zoonosis\results.xml">
   <result pre="of infectious agents (SARS-CoV: 2002-2004; H1N1 Influenza: 2009â€&quot;2010; MERS-CoV: 2012â€&quot;2020;" exact="Ebola" post="virus: 2013â€&quot;2016; Zika virus: 2015â€&quot;2016; SARS-CoV-2: 2019-present), infection with"/>
   <result pre="virus: 2015â€&quot;2016; SARS-CoV-2: 2019-present), infection with four of which (SARS-CoV," exact="H1N1 Influenza," post="MERS-CoV, SARS-CoV-2) result in respiratory tract infections. During the"/>
   <result pre="million deaths ascribed to bacterial co-infections and during the 2009" exact="H1N1 Influenza" post="pandemic up to 34% of all deaths were a"/>
   <result pre="deaths ascribed to bacterial co-infections and during the 2009 H1N1" exact="Influenza" post="pandemic up to 34% of all deaths were a"/>
   <result pre="with COVID-19 requiring hospitalization and critical care. Early stages of" exact="SARS-CoV-2 infection" post="typically include symptoms of mild fever and shortness of"/>
   <result pre="that may result in pneumonia. In almost all severe cases," exact="SARS-CoV-2 infection" post="results in pneumonia and the inflamed fluid-filled alveolar tissue"/>
   <result pre="Supplementary Information, where we have analyzed 15 case studies reporting" exact="SARS-CoV-2 infection" post="(Supplemental Data Sheet 1). In particular for data obtained"/>
   <result pre="Secondary Bacterial Infections and Treatment The first cases of the" exact="Middle East respiratory syndrome" post="(MERS) CoV epidemic occurred in June 2012 in Saudi"/>
   <result pre="complications due to bacterial infections in intensive care units (55)." exact="Influenza" post="Viruses and Secondary Bacterial Infections Influenza viruses are known"/>
   <result pre="intensive care units (55). Influenza Viruses and Secondary Bacterial Infections" exact="Influenza" post="viruses are known to cause seasonal flu every year"/>
   <result pre="at: https://www.frontiersin.org/articles/10.3389/fmed.2020.00420/full#supplementary-material Supplementary Figure 1 Overview of case reports of" exact="SARS-CoV-2 infection" post="data reviewed in this study, including rate of secondary"/>
   <result pre="Western, Kenya. PLoS Neglect Trop D. (2017) 11:e0005901. 10.1371/journal.pntd.000590128886013 12.PittetLAHall-StoodleyLRutkowskiMRHarmsenAG." exact="Influenza" post="virus infection decreases tracheal mucociliary velocity and clearance of"/>
   <result pre="25.ChenNZhouMDongXQuJGongFHanYet al.. Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet. (2020) 395:507â€&quot;13."/>
   <result pre="Engl J Med. (2020) 382:929â€&quot;36. 10.1056/NEJMoa200119132004427 30.GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med. (2020) 382:1708â€&quot;20. 10.1056/NEJMoa200203232109013"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, China. JAMA Intern Med. (2020) 180:1â€&quot;11."/>
   <result pre="COVID-19 infection; experience from a UK regional infectious disease unit." exact="Influenza" post="Other Respir Viruses. (2020) 14:374â€&quot;9. 10.1111/irv.1273932223012 37.ChenTWuDChenHYanWYangDChenGet al.. Clinical"/>
   <result pre="BMJ. (2020) 368:m1295. 10.1136/bmj.m129532234718 38.WangZYangBLiQWenLZhangRClinical features of 69 cases with" exact="coronavirus disease 2019" post="in Wuhan, China. Clin Infect Dis. (2020) ciaa27210.1093/cid/ciaa272. [Epub"/>
   <result pre="with 2009 pandemic influenza A (H1N1) in Santa Fe, Argentina." exact="Influenza" post="Other Respir Viruses. (2013) 7:410â€&quot;7. 10.1111/j.1750-2659.2012.00405.x22817648 67.CrottyMPMeyersSHamptonNBledsoeSRitchieDJBullerRSet al.. Impact"/>
   <result pre="opportunity for stewardship. Critical Care. (2015) 19:404. 10.1186/s13054-015-1120-526577540 68.Abelenda-AlonsoGRombautsAGudiolCMeijeYOrtegaLClementeMet al.." exact="Influenza" post="and bacterial coinfection in adults with community-acquired pneumonia admitted"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7423503\results\search\zoonosis\results.xml">
   <result pre="rapidly-spreading virusâ€&quot; Severe Acute Respiratory Syndrome Coronavirus 2, responsible for" exact="Coronavirus disease 2019" post="or COVID-19. Despite the resurgences in positive cases after"/>
   <result pre="Keywords COVID-19 Coronavirus Pandemics SARS Virus Vaccines Antiviral Drugs 1918" exact="Influenza" post="Pandemic Stem Cells Funding National Institutes of Health (US)R01NS090962,"/>
   <result pre="mitigate symptoms and prevent infection in humans. Cardiac involvement in" exact="SARS-CoV-2 infection" post="is prevalent among patients [56]. As noted above, the"/>
   <result pre="heart without direct viral infection of the tissue [57]. Direct" exact="SARS-CoV-2 infection," post="hypoxemia, and respiratory failure all also contribute to myocardial"/>
   <result pre="indirectly by systemic inflammation. Acute coronary syndromes are present with" exact="SARS-CoV-2 infection." post="The risk of this instance is significantly increased when"/>
   <result pre="[76]. Although the exact mechanism mediating the chronic manifestations of" exact="SARS-CoV-2 infection" post="is currently unknown, the interaction of SP and ACE2"/>
   <result pre="human transmission was not possible at the time of this" exact="bird flu" post="pandemic, researchers were worried that this virus could mutate"/>
   <result pre="average over 10Â years. Even the accelerated development of the" exact="Ebola" post="vaccine took 5Â years [84]. To assess the efficacy"/>
   <result pre="Antiviral Drugs In response to the influenza virus, the Global" exact="Influenza" post="Surveillance Network was established in 1947 and is responsible"/>
   <result pre="repurposing the available therapeutic drugs to treat patients with the" exact="SARS-CoV-2 infection." post="Hydroxychloroquine and chloroquine are antiviral drugs that possess similar"/>
   <result pre="cepharanthine/selamectin/mefloquine hydrochloride serves as a candidate drug combination against the" exact="SARS-CoV-2 infection" post="with access through ACE2 [90]. The ability to weaken"/>
   <result pre="(80 million cells) to patients with severe pneumonia caused by" exact="SARS-CoV-2 infection." post="Safety and efficacy will be measured through the frequency"/>
   <result pre="of SARS-CoV-2 by full-length human ACE2Science202036764851444144832132184 18.MilletJKWhittakerGRHost cell entry of" exact="Middle East respiratory syndrome" post="coronavirus after two-step, furin-mediated activation of the spike proteinProceedings"/>
   <result pre="patientsJounral of Medical Virology2020926552555 52.MaoLJinHWangMHuYChenSHeQChangJHongCZhouYWangDMiaoXLiYHuBNeurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, ChinaJAMA Neurology2020776683690 53.ChanPKToKLoAWCheungJLChuIAuFWTongJHTamJSSungJJNgHPersistent infection of SARS coronavirus"/>
   <result pre="Hepatology20201871561156632283325 65.SunJAghemoAFornerAValentiLCOVID-19 and liver diseaseLiver International20204061278128132251539 66.ZangRCastroMFMcCuneBTZengQRothlaufPWSonnekNMLiuZBruloisKFWangXGreenbergHBDiamondMSCiorbaMAWhelanSPDingSTMPRSS2 and TMPRSS4 promote" exact="SARS-CoV-2 infection" post="of human small intestinal enterocytesScience Immunology2020547eabc358232404436 67.LauerSAGrantzKHBiQJonesFKZhengQMeredithHRAzmanASReichNGLesslerJThe incubation period"/>
   <result pre="of human small intestinal enterocytesScience Immunology2020547eabc358232404436 67.LauerSAGrantzKHBiQJonesFKZhengQMeredithHRAzmanASReichNGLesslerJThe incubation period of" exact="coronavirus disease 2019" post="(COVID-19) from publicly reported confirmed cases: estimation and applicationAnnuals"/>
   <result pre="84.Thanh LeTAndreadakisZKumarARomanRGTollefsenSSavilleMMayhewSThe COVID-19 vaccine development landscapeNature Reviews Drug Discovery202019530530632273591 85.LurieNSavilleMHatchettRHaltonJDeveloping" exact="Covid-19" post="vaccines at pandemic speedNew England Journal of Medicine2020382211969197332227757 86.LiuWJBiYWangDGaoGFOn"/>
   <result pre="COVID-19 epidemicTropical Medicine &amp;amp; International Health202025327828032052514 92.DongLHuSGaoJDiscovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discoveries &amp;amp; Therapeutics2020141586032147628 93.VincentMJBergeronEBenjannetSEricksonBRRollinPEKsiazekTGSeidahNGNicholSTChloroquine is a potent inhibitor"/>
   <result pre="stem cell treating acute respiratory distress syndrome induced by epidemic" exact="Influenza" post="A (H7N9) infection, a hint for COVID-19 treatment. Engineering"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7423511\results\search\zoonosis\results.xml">
   <result pre="understanding and development of intervention approaches against these pathogens, including" exact="Ebola" post="and the novel coronavirus disease 2019 (COVID-19). Discussion Africa"/>
   <result pre="intervention approaches against these pathogens, including Ebola and the novel" exact="coronavirus disease 2019" post="(COVID-19). Discussion Africa has contributed few genomes of severe"/>
   <result pre="ACDC Genomic hubs Brief introduction of COVID-19 situation The novel" exact="coronavirus disease 2019" post="(COVID-19), a viral outbreak caused by the severe acute"/>
   <result pre="user-friendly field-based technologies were instrumental in the sequencing of the" exact="Ebola" post="virus (EBOV) during the last outbreak in West and"/>
   <result pre="from: https://africacdc.org/news-item/african-union-rolls-out-partnership-to-accelerate-covid-19-testing/ [cited 09 July 2020] AriasA.WatsonS.J.AsogunD.TobinE.A.LuJ.PhanM.V.T.Rapid outbreak sequencing of" exact="Ebola" post="virus in Sierra Leone identifies transmission chains linked to"/>
   <result pre="[cited 04 June 2020] HoenenT.GrosethA.RosenkeK.FischerR.J.HoenenA.JudsonS.D.Nanopore sequencing as a rapidly deployable" exact="Ebola" post="outbreak toolEmerg Infect Dis222201633133426812583 LuR.ZhaoX.LiJ.NiuP.YangB.WuH.Genomic characterisation and epidemiology of"/>
   <result pre="reporting in NigeriaBMJ Glob Heal32018e000659 QuickJ.LomanN.J.DuraffourS.SimpsonJ.T.SeveriE.CowleyL.Real-time, portable genome sequencing for" exact="Ebola" post="surveillanceNature [Internet]5307589201622823210.1038/nature16996 WeymannD.LaskinJ.RoscoeR.SchraderK.A.ChiaS.YipS.The cost and cost trajectory of whole-genome"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7424135\results\search\zoonosis\results.xml">
   <result pre="There have already been three zoonotic outbreaks in this century." exact="Severe acute respiratory syndrome" post="coronavirus (SARS-CoV) with about 10% case fatality rate (CFR)"/>
   <result pre="rate (CFR) was initially witnessed from China in 2002, while" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) infection with about 34.4% CFR was originally"/>
   <result pre="of SARS-CoV-2 from India illustrated high (~â€‰99.98%) identity with Wuhan" exact="seafood market pneumonia" post="virus (accession number: NC 045512) [14]. Analysing the 15"/>
   <result pre="[20]. In another study, analysis of thirty-two genomes of Indian" exact="COVID 19" post="patients revealed that ORF3a gene possesses single and double"/>
   <result pre="is an efficient investigative means to determine the prevalence for" exact="SARS-CoV-2 infection" post="among the population [53]. COVID-19 infection stimulates IgG antibodies"/>
   <result pre="the Zn-chelating characteristic of tetracyclines may be responsible to inhibit" exact="SARS-CoV-2 infection" post="in humans, and controlling their capacity to multiply within"/>
   <result pre="clinical application of a rapid IgM-IgG combined antibody test for" exact="SARS-CoV-2 infection" post="diagnosisJ Med Virol202010.1002/jmv.2572732936465 56.ZhouSWangYZhuTXiaLCT features of coronavirus disease 2019"/>
   <result pre="test for SARS-CoV-2 infection diagnosisJ Med Virol202010.1002/jmv.2572732936465 56.ZhouSWangYZhuTXiaLCT features of" exact="coronavirus disease 2019" post="(COVID-19) pneumonia in 62 patients in Wuhan, ChinaAJR Am"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov202061632194981 85.ZhouDDaiSMTongQCOVID-19: a recommendation to examine the"/>
   <result pre="89.GordonCJTchesnokovEPFengJYPorterDPGotteMThe antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirusJ Biol Chem2020295154773477932094225 90.MuralidharanNSakthivelRVelmuruganDGromihaMMComputational studies of drug repurposing and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7425093\results\search\zoonosis\results.xml">
   <result pre="COVID-19. In different clinical trials, efficacy of remdesivir (GS-5734) against" exact="Ebola" post="virus has been demonstrated. Moreover, remdesivir may be an"/>
   <result pre="analogs are available.4 In clinical trials associated with MERS-CoV and" exact="Ebola" post="virus infections, remdesivir (GS-5734) has demonstrated to be beneficial."/>
   <result pre="the unapproved drug remdesivir for management of suspected or laboratory-confirmed" exact="SARS-CoV-2 infection" post="in adults and pediatric patients hospitalized with severe disease.15"/>
   <result pre="remdesivir was an effective therapeutic against multiple variants of acute" exact="Ebola" post="virus and other filoviruses. In a rhesus monkey model"/>
   <result pre="for prophylaxis and early treatment in a mouse model with" exact="SARS-CoV infection" post="led to a decrease of the viral load in"/>
   <result pre="The authors suggested remdesivir as a highly effective agent against" exact="SARS-CoV-2 infection" post="in vitro.18 Information obtained from in vitro studies and"/>
   <result pre="from clinical trials on the safety profile of remdesivir against" exact="Ebola" post="virus9 support remdesivir as a promising agent to fight"/>
   <result pre="RNA viruses with potential to induce a global pandemic (eg" exact="Ebola" post="virus, Middle East respiratory syndrome (MERS) and severe acute"/>
   <result pre="with potential to induce a global pandemic (eg Ebola virus," exact="Middle East respiratory syndrome" post="(MERS) and severe acute respiratory syndrome (SARS) coronaviruses).20â€&quot;23 In"/>
   <result pre="In 2016, the first clinical experience of using remdesivir against" exact="Ebola" post="virus in human was reported.24 Ebola meningoencephalitis was diagnosed"/>
   <result pre="of using remdesivir against Ebola virus in human was reported.24" exact="Ebola" post="meningoencephalitis was diagnosed in a female nurse by detection"/>
   <result pre="meningoencephalitis was diagnosed in a female nurse by detection of" exact="Ebola" post="virus RNA in the plasma and cerebrospinal fluid. The"/>
   <result pre="It was concluded that remdesivir might be effective against endemic" exact="MERS coronavirus," post="circulating human coronaviruses and, in particular, emerging coronaviruses in"/>
   <result pre="compassionate-use basis to patients with severe COVID-19. Patients with confirmed" exact="SARS-CoV-2 infection" post="and breathing oxygen support or receiving ambient air were"/>
   <result pre="10-day courses of the intravenous remdesivir. In patients with severe" exact="Covid-19" post="not needing mechanical ventilation, there was not any significant"/>
   <result pre="NCT04302766 An intermediate-size patient population expanded access treatment protocol for" exact="coronavirus disease 2019" post="(COVID-19) using remdesivir (RDV; GS-5734â&quot;¢) Available â€&quot; â€&quot; NCT04252664"/>
   <result pre="in combination with intravenous remdesivir in adult patients with advanced" exact="coronavirus disease 2019" post="(COVID-19) Recruiting USA August 2020 NCT04292730 A phase 3,"/>
   <result pre="The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus. J Biol Chem. 2020;295(15):4773â€&quot;4779. doi:10.1074/jbc.AC120.01305632094225 7.SheahanTP, SimsAC, LeistSR,"/>
   <result pre="inhibitor that provides complete therapeutic protection against the development of" exact="Ebola" post="virus disease (EVD) in infected non-human primatesOpen Forum Infectious"/>
   <result pre="9.MulanguS, DoddLE, DaveyRTJr, et al. A randomized, controlled trial of" exact="Ebola" post="virus disease therapeutics. N Engl J Med. 2019;381(24):2293â€&quot;2303. doi:10.1056/NEJMoa191099331774950"/>
   <result pre="et al. Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeys. Nature. 2016;531(7594):381â€&quot;385. doi:10.1038/nature1718026934220 11.PedersenNC, PerronM,"/>
   <result pre="of a Pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of" exact="Ebola" post="and emerging viruses. J Med Chem. 2017;60(5):1648â€&quot;1661. doi:10.1021/acs.jmedchem.6b0159428124907 13.TchesnokovEP,"/>
   <result pre="2017;60(5):1648â€&quot;1661. doi:10.1021/acs.jmedchem.6b0159428124907 13.TchesnokovEP, FengJY, PorterDP, GÃ¶tteM. Mechanism of inhibition of" exact="Ebola" post="virus RNA-dependent RNA polymerase by remdesivir. Viruses. 2019;11(4):326. doi:10.3390/v11040326"/>
   <result pre="Antiviral Res. 2018;154:66â€&quot;86. doi:10.1016/j.antiviral.2018.04.00429649496 24.JacobsM, RodgerA, BellDJ, et al. Late" exact="Ebola" post="virus relapse causing meningoencephalitis: a case report. Lancet. 2016;338(10043):498â€&quot;503."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426275\results\search\zoonosis\results.xml">
   <result pre="antiviral agents against emerging flaviviruses such as dengue virus (DENV)," exact="Japanese encephalitis" post="virus (JEV), and Zika virus (ZIKV) (Lim et al.,"/>
   <result pre="mannerJ. Biol. Chem.28220078873888217276984 MillerS.SparacioS.BartenschlagerR.Subcellular localization and membrane topology of the" exact="Dengue" post="virus type 2 Non-structural protein 4BJ. Biol. Chem.28120068854886316436383 MonathT.P.VasconcelosP.F.Yellow"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426442\results\search\zoonosis\results.xml">
   <result pre="COVID-19, SARS emerged as an epidemic in 2003, followed by" exact="Middle East respiratory syndrome" post="(MERS) in 2012, both caused by a novel coronavirus"/>
   <result pre="the characteristic IgG and IgM production. At the onset of" exact="SARS-CoV infection," post="B cells elicit an early response against the N"/>
   <result pre="(69). Although there is no clear evidence regarding ADE in" exact="SARS-CoV-2 infection," post="it is still necessary to consider all of the"/>
   <result pre="whereas the HLA-DRB1*03, HLA-A*02, and HLA-Cw*15 haplotypes are protected from" exact="SARS-CoV infection" post="(74). Similarly, HLA-DRB1*11 and HLA-DQB1*02 were found to be"/>
   <result pre="77). So far, HLA association is not very well-identified for" exact="SARS-CoV-2 infection," post="and this could be crucial for the prevention and"/>
   <result pre="in SARS patients (61). In a large cohort study during" exact="SARS-CoV infection," post="S protein was the only immuno-dominant epitope for CD8+"/>
   <result pre="prospective subunit vaccine for stimulating a strong T-cell response in" exact="COVID 19" post="patients (84). In a recent study, samples from 20"/>
   <result pre="elevated chemokines (IP-10, CCL2/MCP1, CXCL1, CXCL5) were also detected in" exact="SARS-CoV-2 infection" post="(96â€&quot;99). In children, the increased inflammatory markers include IL-6,"/>
   <result pre="ISRE promoters (109â€&quot;111) (Figure 3). A new investigation revealed that" exact="SARS-CoV-2 infection" post="leads to an overall decrease in the transcription of"/>
   <result pre="COVID-19 severity (112). In addition to reduction in T cells," exact="SARS-CoV-2 infection" post="also enhances the exhaustion of effector T cells, decreasing"/>
   <result pre="producing IFN-Î³, which further contributes to conferring protective immunity against" exact="SARS-CoV-2 infection" post="(184). Recently, a monoclonal antibody (47D11) has been identified"/>
   <result pre="determine the efficacy of these antibodies in the treatment of" exact="SARS-CoV-2 infection." post="Clinical trial ChiCTR2000029765 with tocilizumab, a monoclonal humanized antibody"/>
   <result pre="(2016) 14:523â€&quot;34. 10.1038/nrmicro.2016.8127344959 5.VerityROkellLCDorigattiIWinskillPWhittakerCImaiNet al.. Estimates of the severity of" exact="coronavirus disease 2019" post=": a model-based analysis. Lancet Infect Dis. (2020) 3099:1â€&quot;9."/>
   <result pre="(2005) 79:5288â€&quot;95. 10.1128/jvi.79.9.5288-5295.200515827143 38.PerrierABonninADesmaretsLDanneelsAGoffardARouillÃ©Yet al.. The C-terminal domain of the" exact="MERS coronavirus" post="M protein contains a trans-Golgi network localization signal. J"/>
   <result pre="16:240â€&quot;6. 10.1007/s12519-020-00345-532026148 51.ShekerdemianLSMahmoodNRWolfeKKRiggsBJRossCEMcKiernanCAet al.. Characteristics and outcomes of children with" exact="coronavirus disease 2019" post="(COVID-19) infection admitted to US and canadian pediatric intensive"/>
   <result pre="responses. Vaccine. (2007) 25:6981â€&quot;91. 10.1016/j.vaccine.2007.06.04717709158 82.ZhaoJAlshukairiANBaharoonSAAhmedWABokhariAANehdiAMet al.. Recovery from the" exact="Middle East respiratory syndrome" post="is associated with antibody and T cell responses. Sci"/>
   <result pre="cytokines and suppression of innate antiviral response by the novel" exact="Middle East respiratory syndrome" post="coronavirus: implications for pathogenesis and treatment. J Gen Virol."/>
   <result pre="91.ChannappanavarRFehrARZhengJWohlford-LenaneCAbrahanteJEMackMet al.. IFN-I response timing relative to virus replication determines" exact="MERS coronavirus" post="infection outcomes. J Clin Invest. (2019) 129:3625â€&quot;39. 10.1172/JCI12636331355779 92.NgDLAl"/>
   <result pre="Reduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVID-19). Front Immunol. (2020) 2019:1â€&quot;14. 10.3389/fimmu.2020.0082732425950 95.ZheXuLeiShiYijinWangJiyuanZhangLeiHuangChaoZhanget al.. Pathological"/>
   <result pre="Rev. (2020) 7:1â€&quot;5. 10.1093/nsr/nwaa041 98.WenZhangYanZhaoFengchunZhangQianWangTaishengLiZhengyinLiuet al.. Anti-inflammation treatment of severe" exact="coronavirus disease 2019" post="(COVID-19): from the perspective of clinical immunologists from China."/>
   <result pre="proteins M, ORF 4a, ORF 4b, and ORF 5 of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell. (2013)"/>
   <result pre="reading frame 3b protein. J Virol. (2009) 83:6631â€&quot;40. 10.1128/jvi.00367-0919403678 110.Kopecky-BrombergSAMartinez-SobridoLFriemanMBaricRAPaleseP." exact="Severe acute respiratory syndrome" post="coronavirus open reading frame (ORF) 3b, ORF 6, and"/>
   <result pre="Immunity. (2016) 44:1379â€&quot;91. 10.1016/j.immuni.2016.05.00627287409 122.SunSChenQGuHYangGWangYHuangXet al.. A mouse model of" exact="SARS-CoV-2 infection" post="and pathogenesis. Cell Host Microbe. (2020) 28:124â€&quot;33.e4. 10.1016/j.chom.2020.05.02032485164 123.ZumlaAChanJFWAzharEIHuiDSCYuenKY."/>
   <result pre="(2020) 5883:1â€&quot;21. 10.1126/scitranslmed.abb588332253226 137.RichardsonPGriffinITuckerCSmithDOechsleOPhelanAet al.. Baricitinib as potential treatment for" exact="2019-nCoV acute respiratory disease." post="Lancet. (2020) 395:e30â€&quot;e31. 10.1016/S0140-6736(20)30304-432032529 138.SheahanTPSimsACLeistSRSchÃ¤ferAWonJBrownAJet al.. Comparative therapeutic efficacy"/>
   <result pre="30:269â€&quot;71. 10.1038/s41422-020-0282-032020029 142.OmraniASSaadMMBaigKBahloulAAbdul-MatinMAlaidaroosAYet al.. Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: a retrospective cohort study. Lancet Infect Dis."/>
   <result pre="Med. (2020) 382:929â€&quot;36. 10.1056/NEJMoa200119132004427 153.BeigelJHTomashekKMDoddLEMehtaAKZingmanBSKalilACet al.Remdesivir for the Treatment of" exact="Covid-19" post="- Preliminary Report. N Engl J Med. (2020) NEJMoa2007764."/>
   <result pre="the sera of convalescent cases. Virology. (2004) 324:251â€&quot;6. 10.1016/j.virol.2004.04.01715207612 174.Tsunetsugu-YokotaYOhnishiKTakemoriT." exact="Severe acute respiratory syndrome" post="(SARS) coronavirus: application of monoclonal antibodies and development of"/>
   <result pre="(2020) 52:1â€&quot;7. 10.1016/j.immuni.2020.04.02331940266 185.WangCLiWDrabekDOkbaNMAHaperenRVan OsterhausADMEet al.A human monoclonal antibody blocking" exact="SARS-CoV-2 infection." post="Nat Commun. (2020) 11:1â€&quot;6. 10.1038/s41467-020-16256-y31911652 186.WuYLiCXiaSXiaolongTKongYWangZet al.. Identification of"/>
   <result pre="LimitedMesoblast To Evaluate Anti-Inflammatory Cell Therapy Remestemcel-L for Treatment of" exact="Covid-19" post="Lung Disease. Melbourne; New York, NY: ASX announcement (2020)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426546\results\search\zoonosis\results.xml">
   <result pre="the context of our overall understanding of viral diseases. Coronavirus" exact="coronavirus disease 2019" post="human coronavirus severe acute respiratory syndrome INTRODUCTION In March"/>
   <result pre="measures against deadly virus pandemics.1 He referred to the 2014" exact="Ebola" post="virus outbreak, which killed more than 11,000 people in"/>
   <result pre="later, in 2020, when the World Health Organization declared the" exact="coronavirus disease 2019" post="(COVID-19)â€&quot;caused by the newly emerging SARS-CoV-2 virusâ€&quot;to be a"/>
   <result pre="disease emerged in China in 2002,3â€&quot;5 and later when the" exact="Middle East respiratory syndrome" post="(MERS) appeared in Saudi Arabia in 2012.6,7 These outbreaks"/>
   <result pre="also suggest potential therapeutic strategies. Development of animal models for" exact="SARS-CoV-2 infection" post="is vital in providing comprehensive understanding of the pathogenic"/>
   <result pre="unfortunately, at present there is no effective drug to treat" exact="SARS-CoV-2 infection" post="or any other CoV. The emergence of COVID-19 highlights"/>
   <result pre="of a variety of strategies to detect potential inhibitors of" exact="SARS-CoV-2 infection" post="is expected to identify a large panel of potential"/>
   <result pre="influenza virus and SARS-CoV,41 and treatment protocols were established for" exact="Ebola" post="virus42,43 and MERS-CoV44 infections. Accordingly, transfusion of convalescent plasma"/>
   <result pre="relevant to this article was reported. Abbreviations CoV coronavirus COVID-19" exact="coronavirus disease 2019" post="hCoV human coronavirus SARS severe acute respiratory syndrome. References"/>
   <result pre="in Saudi ArabiaN Engl J Med201236718142010.1056/NEJMoa121172123075143 7AssiriAMcGeerAPerlTMet al.Hospital outbreak of" exact="Middle East respiratory syndrome" post="coronavirusN Engl J Med20133694071610.1056/NEJMoa130674223782161 8DecaroNLorussoANovel human coronavirus (SARS-CoV-2): a"/>
   <result pre="Infect Dis20052444610.1007/s10096-004-1271-915616839 42van GriensvenJEdwardsTde LamballerieXet al.Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in GuineaN Engl J Med2016374334210.1056/NEJMoa151181226735992 43FlorescuDFKalilACHewlettALet al.Administration"/>
   <result pre="al.Administration of brincidofovir and convalescent plasma in a patient with" exact="Ebola" post="virus diseaseClin Infect Dis2015619697310.1093/cid/civ39525991468 44ArabiYBalkhyHHajeerAHet al.Feasibility, safety, clinical, and"/>
   <result pre="and laboratory effects of convalescent plasma therapy for patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a study protocolSpringerplus2015470910.1186/s40064-015-1490-926618098 45ShenCWangZZhaoFet al.Treatment of 5"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426550\results\search\zoonosis\results.xml">
   <result pre="its first 6 months. Eventually, the novel disease was named" exact="coronavirus disease 2019" post="(COVID-19), and the new virus was identified as severe"/>
   <result pre="paper reviews the microbiological, clinical, and epidemiological characteristics of the" exact="coronavirus disease 2019" post="(COVID-19) pandemic, as well as its socio-economic impact. In"/>
   <result pre="middle line, intermediate hosts; bottom line, infected human hosts. COVID-19," exact="coronavirus disease 2019;" post="HCoV-229E, human coronavirus 229E; HCoV-NL63, human coronavirus Netherlands 63;"/>
   <result pre="human coronavirus OC43; HCoV-HKU1, human coronavirus Hong Kong U1; MERS," exact="Middle East respiratory syndrome;" post="MERS-CoV, Middle East respiratory syndrome coronavirus; SARS, severe acute"/>
   <result pre="coronavirus Hong Kong U1; MERS, Middle East respiratory syndrome; MERS-CoV," exact="Middle East respiratory syndrome" post="coronavirus; SARS, severe acute respiratory syndrome; SARS-CoV-1, severe acute"/>
   <result pre="age distribution, quality of healthcare services, medical equipment, etc. COVID-19," exact="coronavirus disease 2019;" post="HCoV-229E, human coronavirus 229E; HCoV-HKU1, human coronavirus Hong Kong"/>
   <result pre="HCoV-NL63, human coronavirus Netherlands 63; HCoV-OC43, human coronavirus OC43; MERS-CoV," exact="Middle East respiratory syndrome" post="coronavirus; SARS-CoV-1, severe acute respiratory syndrome-coronavirus-1; SARS-CoV-2, severe acute"/>
   <result pre="the transmissibility of both severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS) is lower than that of COVID-19, the case"/>
   <result pre="Clinical Identifiers of Recognized Pandemic Diseases. Disease Salient Clinical Features" exact="Smallpox" post="Typical widespread vesiculo-pustular rash, occasionally corneal opacification Measles Morbilliform"/>
   <result pre="Sudden-onset profuse watery diarrhea, early hypovolemic shock Yellow fever Jaundice" exact="Influenza" post="H1N1 Flu-like illness*, severe disease and death in young"/>
   <result pre="H1N1 Flu-like illness*, severe disease and death in young adults" exact="Influenza" post="H3N2 Flu-like illness* Influenza H2N2 Flu-like illness* AIDS Opportunistic"/>
   <result pre="disease and death in young adults Influenza H3N2 Flu-like illness*" exact="Influenza" post="H2N2 Flu-like illness* AIDS Opportunistic infections, Kaposiâ€™s sarcoma of"/>
   <result pre="sarcoma of skin and viscera, profound emaciation SARS Severe pneumonia" exact="Ebola" post="Bleeding from multiple sites MERS Severe pneumonia COVID-19 Severe"/>
   <result pre="respiratory symptoms, extreme weakness. AIDS, acquired immune deficiency syndrome; COVID-19," exact="coronavirus disease 2019;" post="Flu, influenza; H1N1, hemagglutinin-1 neuraminidase-1; H2N2, hemagglutinin-2 neuraminidase-2; H3N2,"/>
   <result pre="H1N1, hemagglutinin-1 neuraminidase-1; H2N2, hemagglutinin-2 neuraminidase-2; H3N2, hemagglutinin-3 neuraminidase-2; MERS," exact="Middle East respiratory syndrome;" post="SARS, severe acute respiratory syndrome. DEFINITION OF PANDEMICS The"/>
   <result pre="Justinian Yersinia pestis (Gram-negative bacteria) 30â€&quot;50M 735â€&quot;737 Japanese smallpox epidemic" exact="Smallpox" post="(DNA virus) 1M 1347â€&quot;1351 Black death Yersinia pestis 200M"/>
   <result pre="&amp;gt;1M 1885 Third plague Yersinia pestis 12M 1889â€&quot;1890 Russian flu" exact="Influenza" post="H2N2? (RNA virus) 1M 1918â€&quot;1919 Spanish flu Influenza H1N1"/>
   <result pre="Russian flu Influenza H2N2? (RNA virus) 1M 1918â€&quot;1919 Spanish flu" exact="Influenza" post="H1N1 40â€&quot;50M 1957â€&quot;1958 Asian flu Influenza H2N2 1.1M 1968â€&quot;1970"/>
   <result pre="1M 1918â€&quot;1919 Spanish flu Influenza H1N1 40â€&quot;50M 1957â€&quot;1958 Asian flu" exact="Influenza" post="H2N2 1.1M 1968â€&quot;1970 Hong Kong flu Influenza H3N2 1M"/>
   <result pre="1957â€&quot;1958 Asian flu Influenza H2N2 1.1M 1968â€&quot;1970 Hong Kong flu" exact="Influenza" post="H3N2 1M 1981â€&quot;present AIDS HIV (RNA virus) 25â€&quot;35M 2002â€&quot;2003"/>
   <result pre="25â€&quot;35M 2002â€&quot;2003 SARS SARS-CoV-1 (RNA virus) 0.8K 2009â€&quot;2010 Swine flu" exact="Influenza" post="H1N1 200K 2014â€&quot;2016 Ebola Ebola virus (RNA virus) 11K"/>
   <result pre="(RNA virus) 0.8K 2009â€&quot;2010 Swine flu Influenza H1N1 200K 2014â€&quot;2016" exact="Ebola" post="Ebola virus (RNA virus) 11K 2015â€&quot;present MERS MERS-CoV (RNA"/>
   <result pre="virus) 0.8K 2009â€&quot;2010 Swine flu Influenza H1N1 200K 2014â€&quot;2016 Ebola" exact="Ebola" post="virus (RNA virus) 11K 2015â€&quot;present MERS MERS-CoV (RNA virus)"/>
   <result pre="given. AIDS, acquired immune deficiency syndrome; BC, before Christ; COVID-19," exact="coronavirus disease 2019;" post="DNA, deoxyribonucleic acid; flu, influenza; H1N1, hemagglutinin-1 neuraminidase-1; H2N2,"/>
   <result pre="HIV, human immune deficiency virus; K, thousands; M, millions; MERS," exact="Middle East respiratory syndrome;" post="MERS-CoV, Middle East respiratory syndrome coronavirus; RNA, ribonucleic acid;"/>
   <result pre="K, thousands; M, millions; MERS, Middle East respiratory syndrome; MERS-CoV," exact="Middle East respiratory syndrome" post="coronavirus; RNA, ribonucleic acid; SARS, severe acute respiratory syndrome;"/>
   <result pre="cause of most pandemics, with the only exception being the" exact="variola" post="virus, which is composed of DNA. Relatively few pandemics"/>
   <result pre="and chikungunya virus.34 For close to half a century, several" exact="Ebola" post="virus outbreaks have occurred in Western and Central Africa."/>
   <result pre="also infected. Currently, there is an effective vaccine to prevent" exact="Ebola" post="(Table 5) as well as a drug composed of"/>
   <result pre="for Pandemic Diseases.* Disease R0 Vaccine(s) Current Number of Cases/Year" exact="Smallpox" post="3.5â€&quot;6 Yesâ€ None Measles 12â€&quot;18 Yesâ€ 5M Plague â€¡"/>
   <result pre="0.5K Cholera â€¡ Yesâ€ 1.4â€&quot;4M Yellow fever â€¡ YesÂ§ 200K" exact="Influenza" post="H1N1 1.4â€&quot;2.8 Yesâ€ &amp;gt;5M; various types of influenza Influenza"/>
   <result pre="200K Influenza H1N1 1.4â€&quot;2.8 Yesâ€ &amp;gt;5M; various types of influenza" exact="Influenza" post="H3N2 1.5 Yesâ€ &amp;gt;5M; various types of influenza Influenza"/>
   <result pre="influenza Influenza H3N2 1.5 Yesâ€ &amp;gt;5M; various types of influenza" exact="Influenza" post="H2N2 1.5 Yesâ€ &amp;gt;5M; various types of influenza AIDS"/>
   <result pre="of influenza AIDS â€¡ None 1.7M SARS 0.19â€&quot;1.08 None None" exact="Ebola" post="1.5â€&quot;1.9 Yesâ€ 0â€&quot;several thousands MERS 0.3â€&quot;0.8 None 0â€&quot;0.3K COVID-19"/>
   <result pre="**During a 6-month period. AIDS, acquired immune deficiency syndrome; COVID-19," exact="coronavirus disease 2019;" post="H1N1, hemagglutinin-1 neuraminidase-1; H2N2, hemagglutinin-2 neuraminidase-2; H3N2, hemagglutinin-3 neuraminidase-2;"/>
   <result pre="hemagglutinin-2 neuraminidase-2; H3N2, hemagglutinin-3 neuraminidase-2; K, thousands; M, millions; MERS," exact="Middle East respiratory syndrome;" post="R0, basic reproduction number; SARS, severe acute respiratory syndrome."/>
   <result pre="syndrome. Table 6 Treatment Used for Pandemic Diseases.* Disease Treatment" exact="Smallpox" post="Tecovirimatâ€ Measles Vitamin A Plague Doxycyclineâ€¡ Cholera Massive rehydration;"/>
   <result pre="rehydration; doxycycline (in adults)â€¡; azithromycin (in children)â€¡ Yellow fever None" exact="Influenza" post="H1N1 OseltamivirÂ§ Influenza H3N2 OseltamivirÂ§ Influenza H2N2 OseltamivirÂ§ AIDS"/>
   <result pre="adults)â€¡; azithromycin (in children)â€¡ Yellow fever None Influenza H1N1 OseltamivirÂ§" exact="Influenza" post="H3N2 OseltamivirÂ§ Influenza H2N2 OseltamivirÂ§ AIDS &amp;gt;20 antiviral drugs"/>
   <result pre="children)â€¡ Yellow fever None Influenza H1N1 OseltamivirÂ§ Influenza H3N2 OseltamivirÂ§" exact="Influenza" post="H2N2 OseltamivirÂ§ AIDS &amp;gt;20 antiviral drugs grouped in 8"/>
   <result pre="and &amp;gt;40 combinations of two or more drugs SARS None" exact="Ebola" post="REGN-EB3** MERS None COVID-19 Remdesivirâ€ â€ *Only approved drugs"/>
   <result pre="other antivirals under investigation. AIDS, acquired immune deficiency syndrome; COVID-19," exact="coronavirus disease 2019;" post="H1N1, hemagglutinin-1 neuraminidase-1; H2N2, hemagglutinin-2 neuraminidase-2; H3N2, hemagglutinin-3 neuraminidase-2;"/>
   <result pre="H1N1, hemagglutinin-1 neuraminidase-1; H2N2, hemagglutinin-2 neuraminidase-2; H3N2, hemagglutinin-3 neuraminidase-2; MERS," exact="Middle East respiratory syndrome;" post="SARS, severe acute respiratory syndrome. Influenza Pandemics During the"/>
   <result pre="MERS, Middle East respiratory syndrome; SARS, severe acute respiratory syndrome." exact="Influenza" post="Pandemics During the twentieth century, there were four major"/>
   <result pre="by variants of the corresponding virus from the prior pandemics." exact="Influenza" post="viruses involved in seasonal flu accumulate antigenic changes in"/>
   <result pre="diseases.59 Unfortunately, to date, no human genetic markers predisposing to" exact="SARS-CoV-2 infection," post="nor the severity of COVID-19, have been foundâ€&quot;although recent"/>
   <result pre="several centuries before the discovery of viruses in general, and" exact="variola" post="and vaccinia viruses in particular. As recently summarized by"/>
   <result pre="from prior pandemics should illuminate our vision for the future." exact="Smallpox" post="went from being a totally empiric vaccine to global"/>
   <result pre="article was reported. Abbreviations AIDS acquired immune deficiency syndrome COVID-19" exact="coronavirus disease 2019" post="DNA deoxyribonucleic acid Flu influenza gRNA guide ribonucleic acid"/>
   <result pre="H1N1 hemagglutinin-1 neuraminidase-1 H2N2 hemagglutinin-2 neuraminidase-2 H3N2 hemagglutinin-3 neuraminidase-2 MERS" exact="Middle East respiratory syndrome" post="MERS-CoV Middle East respiratory syndrome coronavirus RNA ribonucleic acid"/>
   <result pre="neuraminidase-2 H3N2 hemagglutinin-3 neuraminidase-2 MERS Middle East respiratory syndrome MERS-CoV" exact="Middle East respiratory syndrome" post="coronavirus RNA ribonucleic acid SARS severe acute respiratory syndrome"/>
   <result pre="Available at: https://nextstrain.org/ncov/globalaccessed July 2, 2020 2GuanWJNiZYHuYet al.Clinical characteristics of" exact="coronavirus disease 2019" post="ChinaN Engl J Med202038217082010.1056/NEJMoa200203232109013 3TayMZPohCMRÃ©niaLMacAryPANgLFPThe trinity of COVID-19: immunity,"/>
   <result pre="at: https://www.modernatx.com/modernas-work-potential-vaccine-against-covid-19accessed July 2, 2020 5Inovio Urgently Focused On Developing" exact="Covid-19" post="Vaccine: Because the World Canâ€™t WaitInovio Website2020Inovio PharmaceuticalsAvailable at:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426727\results\search\zoonosis\results.xml">
   <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Coronavirus disease 2019" post="(COVID-19) and previous pandemics have been viewed almost exclusively"/>
   <result pre="clinical course. 3 Role of SARS-CoV-2 in emergence of COVID-19" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) is the zoonotic virus most closely"/>
   <result pre="2 (SARS-CoV-2) is the zoonotic virus most closely associated with" exact="coronavirus disease 2019" post="(COVID-19). There are strong misconceptions about the role played"/>
   <result pre="References References BhagavathulaA.S.AldhaleeiW.RovettaA.RahmaniJ.Vaccines and drug therapeutics to lock down novel" exact="coronavirus disease 2019" post="(COVID-19): a systematic review of clinical trialsCureus1252020 BormanE.D.FosterW.G.deCatanzaroD.Concurrent administration"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7427555\results\search\zoonosis\results.xml">
   <result pre="â€¢The article shed new light about the surprise effect of" exact="COVID 19." post="â€¢The surprise lies in the co-action of two different"/>
   <result pre="provoked by this strain of virus was the 2009 H1N1" exact="swine flu," post="which caused about 500,000 deaths worldwide (CDC,Â 2012). Some"/>
   <result pre="~10% for SARS). Before considering the case of our actual" exact="COVID 19," post="caused by the SARS-CoV-2, as well as some important"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7428724\results\search\zoonosis\results.xml">
   <result pre="(2014), and Zika (2015), as well as pandemic-like emergences of" exact="Ebola" post="fever over large parts of Africa (2014 to the"/>
   <result pre="disappearing in response to public health control measures. The related" exact="Middle East respiratory syndrome" post="(MERS) coronavirus (MERS-CoV) emerged into humans from dromedary camels"/>
   <result pre="million Led to additional pandemics in 1957, 1968, 2009 1976â€&quot;2020" exact="Ebola" post="15,258 First recognized in 1976; 29 regional epidemics to"/>
   <result pre="3 ) (Dowdle and Cochi, 2011; Hopkins, 2013; Tomori, 2011)." exact="Smallpox" post="and the veterinary disease rinderpest were declared eradicated in"/>
   <result pre="remains in enzootic circulation and could re-emerge from nature, as" exact="Ebola" post="viruses have been doing for the past 44 years"/>
   <result pre="al., 2016; Wang etÂ al., 2018; Zhou etÂ al., 2020a)." exact="Influenza" post="A viruses (IAVs) infect cells via binding to terminal"/>
   <result pre="virus types, exemplified, for example, by comparing the highly pathogenic" exact="Ebola" post="Zaire strain to the closely related but lowly pathogenic"/>
   <result pre="Ebola Zaire strain to the closely related but lowly pathogenic" exact="Ebola" post="Reston strain (Baseler etÂ al., 2017). Although not yet"/>
   <result pre="disease transmitted from person to person. For example, while both" exact="Ebola" post="and SARS-CoV-2 are potentially fatal diseases transmitted person to"/>
   <result pre="ONE102015e013922526431199 BaranowskiE.Ruiz-JaraboC.M.DomingoE.Evolution of cell recognition by virusesScience29220011102110511352064 BaselerL.ChertowD.S.JohnsonK.M.FeldmannH.MorensD.M.The Pathogenesis of" exact="Ebola" post="Virus DiseaseAnnu. Rev. Pathol.12201738741827959626 Blanco-MeloD.Nilsson-PayantB.E.LiuW.C.UhlS.HoaglandD.MollerR.JordanT.X.OishiK.PanisM.SachsD.Imbalanced Host Response to SARS-CoV-2"/>
   <result pre="the risk of influenza A(H5N1) infection?J.Â Infect. Dis.21120151364136625355943 MorensD.M.TaubenbergerJ.K.The 1918" exact="Influenza" post="Pandemic: A Still-Mysterious Litmus Test for Pandemic Prevention and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7428753\results\search\zoonosis\results.xml">
   <result pre=": Review Article Incidence and impact of cardiac arrhythmias in" exact="coronavirus disease 2019" post="(COVID-19): A systematic review and meta-analysis PranataRaymondraymond_pranata@hotmail.comraymond_pranata@hotmail.comaâˆ—HuangIanianhuang2108@gmail.comacRaharjoSunu Budhisunu.b.raharjo@gmail.comb[a], [b],"/>
   <result pre="may occur in up to 44% of patients with severe" exact="coronavirus disease 2019" post="(COVID-19) and has been associated with an increased risk"/>
   <result pre="outcomes. Keywords Arrhythmia Cardiovascular Coronavirus COVID-19 Rhythm SARS-CoV-2 1 Introduction" exact="Coronavirus disease 2019" post="(COVID-19) was declared pandemic, and at the time this"/>
   <result pre="that respiratory-borne infections might also be related to cardiovascular manifestations." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) has been shown to cause cardiac"/>
   <result pre="2C). Fig.Â 2 Incidence of arrhythmia in COVID-19 patients with" exact="COVID 19." post="The incidence of arrhythmia is 19% (A). Arrhythmia occurs"/>
   <result pre="to metabolic disarray, hypoxia, inflammation, or neurohormonal stress associated with" exact="SARS-CoV-2 infection" post="[16]. Furthermore, COVID-19 induced coagulopathy may cause thrombosis leading"/>
   <result pre="for patients, health care workers, and health systems during the" exact="coronavirus disease 2019" post="(COVID-19) pandemicJÂ Am Coll Cardiol202010.1016/j.jacc.2020.03.031 17HuangI.PranataR.LimM.A.OehadianA.AlisjahbanaB.C-reactive protein, procalcitonin, D-dimer,"/>
   <result pre="of renin angiotensin system inhibitor on mortality in patients with" exact="coronavirus disease 2019" post="(COVID-19): a systematic review and meta-analysisDiabetes Metab Syndr Clin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7428924\results\search\zoonosis\results.xml">
   <result pre="of appetite, abdominal pain, nausea and diarrhea. Cardiovascular complications of" exact="influenza infection," post="including myocarditis, acute myocardial infarction and exacerbation of heart"/>
   <result pre="been hypothesized that these drugs could lead to worsening of" exact="SARS-CoV-2 infection." post="For now, there is no consensus that the use"/>
   <result pre="Possible Role?Med Arch2020474213413810.5455/medarh.2020.74.134-13832577056 4.SalihefendicNZildzicMAhmetagicSAcute Respiratory Distress Syndrome (ARDS) from Endemic" exact="Influenza" post="A/H1N1: Prehospital ManagementMed Arh201526916263 5.https://avaz.ba/globus/svijet/574468/broj-mrtvih-od-koronavirusa-u-svijetu-premasio-400-000 6.JeromeRLechien-CarlosMChiesaEde SlatiDROlfactory and gustatory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7429184\results\search\zoonosis\results.xml">
   <result pre="in China, pandemic influenza (swine flu) A/H1N1 in 2009, the" exact="MERS coronavirus" post="in 2012 in the Middle East, and Ebola virus"/>
   <result pre="the MERS coronavirus in 2012 in the Middle East, and" exact="Ebola" post="virus disease in 2013â€&quot;2014 in Africa. Currently, the world"/>
   <result pre="influenza (including seasonal, pandemic H1N1, and avian influenza), MERS, and" exact="Ebola" post="virus disease, and compare them to HIV/AIDS and viral"/>
   <result pre="and raised international public health concern. Additionally, we also analyzed" exact="Ebola" post="virus disease, influenza (seasonal, avian influenza, swine flu), HIV/AIDS,"/>
   <result pre="quickly, and a similar phenomenon can be observed for the" exact="swine flu" post="pandemic. The MERS outbreak achieved a much lower NPR"/>
   <result pre="the first cluster contains avian influenza, Ebola, MERS, SARS, and" exact="swine flu" post="and the second cluster contains HIV/AIDS, hepatitis B, hepatitis"/>
   <result pre="1 (Q1) journals. We discovered that for SARS, MERS, the" exact="swine flu," post="and Ebola, Q1 publication trends were almost parallel to"/>
   <result pre="was a 2.5-paper difference between HIV and SARS authors. Furthermore," exact="swine flu," post="SARS, and MERS were the diseases on which authors"/>
   <result pre="4 Avian influenza 5 Swine flu 5 Hepatitis B 5" exact="Ebola" post="5 Influenza 6 HIV/AIDS 7 MERS Coronavirus 7 Hepatitis"/>
   <result pre="influenza 5 Swine flu 5 Hepatitis B 5 Ebola 5" exact="Influenza" post="6 HIV/AIDS 7 MERS Coronavirus 7 Hepatitis C 8"/>
   <result pre="19% of SARS and MERS studies, respectively, as opposed to" exact="Ebola" post="studies, 29% of which were conducted in Europe. Figure"/>
   <result pre="Disease Papers Swine flu 3.45 SARS 3.84 MERS Coronavirus 3.86" exact="Ebola" post="4.07 Hepatitis B 4.42 Avian influenza 4.47 Influenza 5.04"/>
   <result pre="Coronavirus 3.86 Ebola 4.07 Hepatitis B 4.42 Avian influenza 4.47" exact="Influenza" post="5.04 Hepatitis C 5.24 HIV/AIDS 6.31 Second, when looking"/>
   <result pre="While we can see some correlation to outbreaks in Ebola," exact="swine flu," post="and SARS, it is harder to interpret the curve"/>
   <result pre="diseases that are characterized by large epidemics, such as the" exact="swine flu" post="and SARS. On the other side of the scale"/>
   <result pre="high global burdens. These diseases involve more prolific authors. Regarding" exact="Ebola" post="and MERS, it is too early to predict whether"/>
   <result pre="available via the GigaScience GigaDB Database [54]. Abbreviations COVID-19: novel" exact="coronavirus disease 2019;" post="DTW: dynamic time warping; EID: emerging infectious disease; JCR:"/>
   <result pre="disease; JCR: Journal Citation Reports; MAG: Microsoft Academic Graph; MERS:" exact="Middle East respiratory syndrome;" post="MeSH: Medical Subject Heading; NCR: Normalized Citation Rate; NPR:"/>
   <result pre="GeoNames data2020https://github.com/yaph/geonamescache. Accessed April 17, 2020. 50.Saâ€™edHZGlobal research trends of" exact="Middle East respiratory syndrome" post="coronavirus: A bibliometric analysis. BMC Infect Dis. 2016;16(1):255.27267256 51.collab:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7429403\results\search\zoonosis\results.xml">
   <result pre="paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Abstract Abstract" exact="Coronavirus disease 2019" post="(COVID-19) is a type of viral pneumonia with an"/>
   <result pre="genome, clinical symptoms, diagnosis, prevention, and treatment. Keywords novel coronavirus" exact="coronavirus disease 2019" post="COVID-19 SARS-CoV-2 fig-count: table-count: ref-count: page-count: History The human"/>
   <result pre="lethal infections, such as the severe acute respiratory syndrome (SARS)," exact="Middle East respiratory syndrome" post="(MERS) and Coronavirus disease 2019 (COVID-19). The coronavirus first"/>
   <result pre="acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and" exact="Coronavirus disease 2019" post="(COVID-19). The coronavirus first appeared in the form of"/>
   <result pre="coronavirus (SARS-CoV) in Guangdong province, China, in 20027 followed by" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) isolated from the sputum of a 60-year-old"/>
   <result pre="World Health Organization (WHO) has named the new disease as" exact="Coronavirus disease 2019" post="(COVID-19), and Coronavirus Study Group (CSG) of the International"/>
   <result pre="virus, and present RNA virus vaccines (measles, polio, influenza, and" exact="Japanese encephalitis" post="virus) can offer a promising option to prevent person-to-person"/>
   <result pre="HongZ-S, et al. The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak â€&quot; an update on the status. Mil"/>
   <result pre="for attachment and cell-cell fusion. Virology. 1982;119(2):358â€&quot;371. doi:10.1016/0042-6822(82)90095-26281979 18.RamadanN, ShaibH." exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV): A review. Germs. 2019;9(1):35â€&quot;42. doi:10.18683/germs.2019.115531119115 19.de HaanCA,"/>
   <result pre="E. J Virol. 2000;74(5):2333â€&quot;2342. doi:10.1128/jvi.74.5.2333-2342.200010666264 24.Nieto-TorresJL, DeDiegoML, VerdiÃ¡-BÃ¡guenaC, et al." exact="Severe acute respiratory syndrome" post="coronavirus envelope protein ion channel activity promotes virus fitness"/>
   <result pre="Saf Health Work. 2020. doi:10.1016/j.shaw.2020.03.001 39.Lai-C-C, ShihT-P, KoW-C, TangH-J, HsuehP-R." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic"/>
   <result pre="et al. Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507â€&quot;513. doi:10.1016/S0140-6736(20)30211-732007143"/>
   <result pre="Infection in Elderly Individuals. Clin Infect Dis. 2001;33(11):1892â€&quot;1900. doi:10.1086/32450911692301 97.AbdiM." exact="Coronavirus disease 2019" post="(COVID-19) outbreak in Iran; actions and problems. Infect Control"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7429453\results\search\zoonosis\results.xml">
   <result pre="to scale and is a potential candidate therapy for pandemic" exact="coronavirus disease 2019" post="(COVID-19). Azithromycin was widely used to treat severe SARS-CoV"/>
   <result pre="is also evidence of in vitro activity against enteroviruses [15]," exact="Ebola" post="[16, 17] and SARS [18], with in vivo activity"/>
   <result pre="of response and also insight into the immune consequences of" exact="SARS-CoV-2 infection" post="on the peripheral blood and airway epithelial cell transcriptome."/>
   <result pre="file 5. Abbreviations AZM Azithromycin BTS British Thoracic Society COVID-19" exact="Coronavirus disease 2019" post="CURB-65 Confusion, urea &amp;gt;â€‰7.0 mmol/L, respiratory rate â‰¥â€‰30 breaths/min,"/>
   <result pre="acid ePR Electronic patient record IMV Invasive mechanical ventilation MERS" exact="Middle East respiratory syndrome" post="NHS National Health Service (UK) PCR Polymerase chain reaction"/>
   <result pre="PCR Polymerase chain reaction RNA Ribonucleic acid RV Rhinovirus SARS" exact="Severe acute respiratory syndrome" post="SPIRIT Standard Protocol Items: Recommendations for Interventional Trials SSRI"/>
   <result pre="vitro and in vivoInt J Antimicrob Agents201953436236930599241 16.MadridPBPanchalRGWarrenTKShurtleffACEndsleyANGreenCEet al.Evaluation of" exact="Ebola" post="virus inhibitors for drug repurposingACS Infect Dis20151731732627622822 17.KouznetsovaJSunWMartinez-RomeroCTawaGShinnPChenCZet al.Identification"/>
   <result pre="repurposingACS Infect Dis20151731732627622822 17.KouznetsovaJSunWMartinez-RomeroCTawaGShinnPChenCZet al.Identification of 53 compounds that block" exact="Ebola" post="virus-like particle entry via a repurposing screen of approved"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7429942\results\search\zoonosis\results.xml">
   <result pre="disorder (NMD) patients. The risk of a severe course of" exact="SARS-CoV-2 infection" post="is increased in all but the mildest forms of"/>
   <result pre="specific NMDs (metabolic, mitochondrial, myotonic diseases) and experimental approaches for" exact="Coronavirus disease 2019" post="may be offered â€œcompassionatelyâ€� only after consulting the patientâ€™s"/>
   <result pre="the lives of more than 400,000 individuals worldwide (https://coronavirus.jhu.edu/map.html). Symptomatic" exact="SARS-CoV-2 infection" post="causes a wide spectrum of symptoms (referred to as"/>
   <result pre="systemic manifestations in severe disease courses (Fig.Â 1). In parallel," exact="SARS-CoV-2 infection" post="poses a greater risk for old, oncologic, and immunosuppressed"/>
   <result pre="neurologic community facing common challenges. Fig. 1 Systemic involvement in" exact="SARS-CoV-2 infection." post="The figure shows the different organs and systems possibly"/>
   <result pre="to review the management of NMD patients with and without" exact="SARS-CoV-2 infection," post="focusing on COVID-19 therapies, COVID-19 drug-related complications, and ventilatory"/>
   <result pre="to neuromuscular disorders will probably encounter. The NMD patient without" exact="SARS-CoV-2 infection" post="Risk assessment and stratification Risk assessment and stratification are"/>
   <result pre="patients and families and their physicians to prevent and manage" exact="SARS-CoV-2 infection" post="in this category [6â€&quot;9]. Overall, these documents recognize that"/>
   <result pre="help to quickly identify NMD patients who suffered from severe" exact="SARS-CoV-2 infection" post="in other regions/states of the country and promptly manage"/>
   <result pre="of a neurologic examination at-distance comprises a suspected diagnosis of" exact="SARS-CoV-2 infection" post="in a young patient with Charcotâ€&quot;Marieâ€&quot;Tooth polyneuropathy undergoing post-surgical"/>
   <result pre="to which immunosuppressive drugs can contribute to severe forms of" exact="SARS-CoV-2 infection" post="is still unclear. Depending on the regional pandemic burden,"/>
   <result pre="Immunomodulant therapies currently used in NMD patients may help against" exact="SARS-CoV-2 infection." post="Some severe SARS-CoV-2 cases with acute respiratory insufficiency may"/>
   <result pre="home-delivery, and extending refill periods [42]. The NMD patient with" exact="SARS-CoV-2 infection" post="SARS-CoV-2 infection in NMD patients Clinical syndromes associated with"/>
   <result pre="extending refill periods [42]. The NMD patient with SARS-CoV-2 infection" exact="SARS-CoV-2 infection" post="in NMD patients Clinical syndromes associated with SARS-CoV-2 infection"/>
   <result pre="infection SARS-CoV-2 infection in NMD patients Clinical syndromes associated with" exact="SARS-CoV-2 infection" post="have been classified by the World Health Organization (WHO)"/>
   <result pre="and septic shock [7]. In case of symptoms suggestive for" exact="SARS-CoV-2 infection," post="NMD patients should follow local health authorities' policies, call"/>
   <result pre="on the clinical course and recovery of NMD patients with" exact="SARS-CoV-2 infection." post="A small case series of 5 immunosuppressed MG patients"/>
   <result pre="has been approved (Table 3). Table 3 Experimental treatments for" exact="SARS-CoV-2 infection" post="Drug Results so far Potential NMD-relevant side effects Chloroquine"/>
   <result pre="is a novel nucleotide analogue developed for the treatment of" exact="Ebola" post="and Marburg viruses. Remdesivir was shown to have in"/>
   <result pre="outcome was favourable. Overall, the literature on NMD patients with" exact="SARS-CoV-2 infection" post="is limited in number and general considerations are difficult."/>
   <result pre="literature regarding the management of NMD patients with and without" exact="SARS-CoV-2 infection," post="addressing the concerns and challenges on the recommendations on"/>
   <result pre="guidance. https://apps-who-int.pros.lib.unimi.it:2050/iris/handle/10665/330854. Accessed 26 Apr 2020 8.World Muscle Society (2020)" exact="Covid-19" post="and people with neuromuscular disorders: World Muscle Society position"/>
   <result pre="Allergy Clin Immunol202010.1016/j.jaip.2020.04.00332169379 16.MaoLJinHWangMHuYChenSHeQet al.Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, ChinaJAMA Neurol201910.1001/jamaneurol.2020.1127 17.Toscano G, Palmerini F, Ravaglia"/>
   <result pre="53.ArabiYMArifiAABalkhyHHNajmHAldawoodASGhabashiAet al.Clinical course and outcomes of critically ill patients with" exact="Middle East respiratory syndrome" post="coronavirus infectionAnn Intern Med201416038939724474051 54.Hui DS, Chow BK, Lo"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7430223\results\search\zoonosis\results.xml">
   <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="SARS-CoV-2 infection" post="associated respiratory disease- COVID-19 has evolved into a pandemic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7431281\results\search\zoonosis\results.xml">
   <result pre="those with preexisting health conditions. However, the potential pathogenesis of" exact="SARS-CoV-2 infection" post="in humans is still unknown. The dysregulated/exuberant immune response"/>
   <result pre="for the development of vaccines or anti-viral drug molecules against" exact="SARS-CoV-2 infection" post="in humans. Keywords Novel coronavirus disease COVID-19 SARS-CoV-2 Anti-viral"/>
   <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 [2, 3]," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012 [4], and SARS CoV-2 in"/>
   <result pre="to December 2019 [4, 7, 8]. The recent outbreak of" exact="coronavirus disease 2019" post="(COVID-19) started in December 2019 in Wuhan City of"/>
   <result pre="the patients with COVID-19 infection [18â€&quot;20]. The reproductive number of" exact="SARS-CoV-2 infection" post="is estimated to be 2â€&quot;3 [11], and the elderly"/>
   <result pre="masks, etc. are used to restrict the further transmission of" exact="SARS-CoV-2 infection" post="across the world. Several pharmacological treatment possibilities are being"/>
   <result pre="or other viral infections is now being followed to treat" exact="SARS-CoV-2 infection" post="and might have gained significant improvement in pneumonia-associated symptoms"/>
   <result pre="of repurposing various drugs as a possible therapeutic strategy against" exact="SARS-CoV-2 infection." post="Remdesivir, a nucleotide analog, is a broad-spectrum antiviral drug"/>
   <result pre="Kong Amid COVID-19 Pandemic Active, not recruiting COVID Diagnostic test:" exact="COVID 19" post="diagnostic test â€¢ Hong Kong Sanatorium &amp;amp; Hospital, Hong"/>
   <result pre="and Efficacy of Autologous Non-hematopoietic Peripheral Blood Stem Cells in" exact="Covid-19" post="Completed Coronavirus disease 2019 (COVID-19) Biological: autologous non-hematopoietic peripheral"/>
   <result pre="of Autologous Non-hematopoietic Peripheral Blood Stem Cells in Covid-19 Completed" exact="Coronavirus disease 2019" post="(COVID-19) Biological: autologous non-hematopoietic peripheral blood stem cells (NHPBSC)"/>
   <result pre="Poland 19 COVID19-Convalescent Plasma for Treating Patients with Active Symptomatic" exact="COVID 19" post="Infection (FALP-COVID) Recruiting COVID-19 infection Cancer patients General population"/>
   <result pre="Large-Scale Automated Serologic Testing for COVID-19 Recruiting COVID-19 Coronavirus infection" exact="Severe acute respiratory syndrome" post="coronavirus 2 Diagnostic test: EUROIMMUN assay â€¢ Beaumont Health"/>
   <result pre="Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic Recruiting Pregnancy Diagnostic test:" exact="COVID 19" post="diagnostic test by PCR â€¢ University Hospital of Toulouse,"/>
   <result pre="42 Clinical Characteristics and Outcomes of Pediatric COVID-19 Recruiting COVID-19" exact="SARS-CoV-2 infection" post="Pediatric ALL Pneumonia, viral Pandemic response Other: exposure (not"/>
   <result pre="Validation of COVID-19 Tests Active, not recruiting COVID-19 Diagnostic test:" exact="Covid-19" post="Rapid Test Kit (RAPG-COV-019) Diagnostic test: quantitative IgG test"/>
   <result pre="57 A Clinical Trial of Mycobacterium w in Critically Ill" exact="COVID 19" post="Patients Recruiting COVID-19 Drug: suspension of heat killed (autoclaved)"/>
   <result pre="COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection Recruiting" exact="Severe acute respiratory syndrome" post="coronavirus 2 Biological: COVID-19 convalescent plasma â€¢ Hospital ClÃ­nico"/>
   <result pre="67 Testing the Accuracy of a Digital Test to Diagnose" exact="Covid-19" post="Recruiting COVID-19 Diagnostic test: COVID-19 swab PCR test â€¢"/>
   <result pre="STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti" exact="Covid-19" post="Linked to Covid-19 Infection, Symptoms and Genetic Expression of"/>
   <result pre="for the Evaluation of Specific Antibodies Anti Covid-19 Linked to" exact="Covid-19" post="Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in"/>
   <result pre="COVID-19 IgG) in Patients Hospitalized for COVID-19 Not yet recruiting" exact="Coronavirus disease 2019" post="(COVID-19) Biological: COVID-19 convalescent plasma Biological: anti-COVID-19 human immunoglobulin"/>
   <result pre="the antiviral action of hydroxychloroquine might be effective in limiting" exact="SARS-CoV-2 infection" post="[49, 50]. Further, a combination of hydroxychloroquine and azithromycin"/>
   <result pre="in several viruses including coronaviruses showing a strong impact on" exact="SARS-CoV infection" post="[52â€&quot;55]. Moreover, chloroquine and hydroxychloroquine are known to modulate"/>
   <result pre="for therapeutic strategies to counter the severe effects of the" exact="SARS-CoV-2 infection." post="A preliminary clinical trial of chloroquine repurposing against SARS-CoV-2"/>
   <result pre="SARS-CoV-2 infection. A preliminary clinical trial of chloroquine repurposing against" exact="SARS-CoV-2 infection" post="has shown some positive results, which led to the"/>
   <result pre="shows the status of recent clinical trials of vaccines against" exact="SARS-CoV-2 infection." post="Table 2 shows the current status of the clinical"/>
   <result pre="vaccines and candidate therapy for cytokine release syndrome (CRS) against" exact="SARS-CoV-2 infection." post="Table 2 Current status of the clinical trials of"/>
   <result pre="Institute Vaccine Phase 1 Using a platform first developed for" exact="Ebola" post="Moderna Therapeutics Vaccine Phase 3 RNA vaccine (mRNA âˆ’1273)"/>
   <result pre="then it may help generate a healthy immune response against" exact="SARS-CoV-2 infection." post="(2) Also IL-6 blocks the expression of granzyme B"/>
   <result pre="be effective in controlling the cytokine storm resulting from the" exact="SARS-CoV-2 infection." post="These are small molecules known to show a host-directed"/>
   <result pre="is a panacea and has also proven effective against the" exact="Ebola" post="and Zika viruses. Another important characteristic of this drug"/>
   <result pre="antibodies, peptides, small-molecule drugs, etc. are being explored against emerging" exact="SARS-CoV-2 infection." post="However, the whole world is facing a challenge in"/>
   <result pre="coronavirusesNat Rev Microbiol201917318119230531947 9.GuoYRCaoQDHongZSTanYYChenSDJinHJTanKSWangDYYanYThe origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak - an update on the statusMilitary Med"/>
   <result pre="and MERS-CoVEur Rev Med Pharmacol Sci20202442012201932141570 14.World Health Organization (2020)" exact="Coronavirus disease 2019" post="(COVID-19): situation report, 194 (1st Aug 2020). 15.HuangCWangYLiXRenLZhaoJHuYZhangLFanGXuJGuXChengZYuTXiaJWeiYWuWXieXYinWLiHLiuMXiaoYGaoHGuoLXieJWangGJiangRGaoZJinQWangJCaoBClinical features"/>
   <result pre="with 2019 novel coronavirus in Wuhan, ChinaLancet20203951022349750631986264 16.ZavasckiAPFalciDRClinical characteristics of" exact="Covid-19" post="in ChinaN Engl J Med20203821859186232220202 17.Guan WJ, Ni ZY,"/>
   <result pre="Medical Treatment Expert Group for C (2020) Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med 10.1056/NEJMoa2002032, 382, 1708,"/>
   <result pre="C (2020) Comorbidity and its impact on 1590 patients with" exact="Covid-19" post="in China: a nationwide analysis. Eur Respir J 10.1183/13993003.00547-2020,"/>
   <result pre="J Antimicrob Agents:105932. 10.1016/j.ijantimicag.2020.105932 38.GuastalegnameMValloneACould chloroquine /hydroxychloroquine be harmful in" exact="coronavirus disease 2019" post="(COVID-19) treatment?Clin Infect Dis20207188888932211771 39.BrownAJWonJJGrahamRLDinnonKHIIISimsACFengJYCihlarTDenisonMRBaricRSSheahanTPBroad spectrum antiviral remdesivir inhibits"/>
   <result pre="MERS-CoVNat Commun202011111431911652 42.MulanguSDoddLEDaveyRTJrTshiani MbayaOProschanMMukadiDLusakibanza ManzoMNzoloDTshomba OlomaAIbandaAA randomized, controlled trial of" exact="Ebola" post="virus disease therapeuticsN Engl J Med2019381242293230331774950 43.LiGDe ClercqETherapeutic options"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov202061632194981 50.YaoXYeFZhangMCuiCHuangBNiuPLiuXZhaoLDongESongCZhanSLuRLiHTanWLiuDIn vitro antiviral activity and projection"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7431560\results\search\zoonosis\results.xml">
   <result pre="respectively) (4). Of note, although in Italy the outbreak of" exact="SARS-CoV-2 infection" post="grew progressively from end of Feb 2020 to end"/>
   <result pre="onco-hematologic diseases are exposed either to greater risk of contracting" exact="SARS-CoV-2 infection" post="or to have a worse prognosis. In fact, these"/>
   <result pre="As of now no validated vaccines or antiviral drugs against" exact="SARS-CoV-2 infection" post="exist (7), the hospital in our country have provided"/>
   <result pre="could produce telematic clinical strategies that will allow, in the" exact="Covid-19" post="post-emergency, to continue caring for cancer patients in an"/>
   <result pre="Med. (2020) 201:1372â€&quot;9. 10.1164/rccm.202003-0543OC32242738 2.WangZYangBLiQWenLZhangR.Clinical features of 69 cases with" exact="Coronavirus disease 2019" post="in Wuhan, China.Clin Infect Dis. (2020) 16:ciaa272. 10.1093/cid/ciaa27232176772 3.MoorthyVHenao"/>
   <result pre="at: https://www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_20_marzo.pdf(accessed April 27, 2020). 6.PhuaJWengLLingLEgiMLimCMDivatiaJVet al.Intensive care management of" exact="coronavirus disease 2019" post="(COVID-19): challenges and recommendations.Lancet Respir Med. (2020) 8: 506â€&quot;17.32272080"/>
   <result pre="(2020) 78:11â€&quot;5.32307215 9.MolettaLPierobonESCapovillaGCostantiniMSalvadorRMeriglianoSet al.International guidelines and recommendations for surgery during" exact="Covid-19" post="pandemic: a systematic review.Int J Surg. (2020) 79: 180â€&quot;8.32454253"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7432271\results\search\zoonosis\results.xml">
   <result pre="Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The pandemic of" exact="coronavirus disease 2019" post="(COVID-19), with rising numbers of patients worldwide, presents an"/>
   <result pre="pharmacological strategies, based on our present understanding of SARS-CoV and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) infections. Finally, we outline clinical trials currently"/>
   <result pre="three epidemics of lethal diseases: severe acute respiratory syndrome (SARS)," exact="Middle East respiratory syndrome" post="(MERS) and COVID-19. SARS-CoV-2 seems to be less virulent"/>
   <result pre="endocytosis has not been identified [23]. The initial step during" exact="SARS-CoV-2 infection" post="is the binding of S to its host receptors,"/>
   <result pre="interferon (IFN)-Î± and IFN-Î², determine the innate immune response to" exact="SARS-CoV-2 infection" post="[35]. Pathogen associated molecular patterns (PAMPs) such as viral"/>
   <result pre="TNF-Î±), which have been reported to be overexpressed significantly in" exact="SARS-CoV-2 infection" post="in association with â€œcytokine stormâ€� [37,38]. TI IFNs and"/>
   <result pre="CD8+ T cells are cytotoxic to virus-infected cells [53]. During" exact="SARS-CoV infection," post="the majority (approximately 80%) of inflammatory cells infiltrating the"/>
   <result pre="CD8+ cells to infection by MERS-CoV and SARS-CoV [56]. During" exact="SARS-CoV-2 infection," post="a reduction in the number and quality of CD4+"/>
   <result pre="role of IL-17 and related altered cytokines are highlighted in" exact="SARS-CoV-2 infection" post="[57]. One of the important methods that SARS-CoV-2 may"/>
   <result pre="and morbidity of COVID-19 [70]. CRS is not specific to" exact="SARS-CoV-2 infection" post="and has been demonstrated for MERS-CoV and SARS-CoV, as"/>
   <result pre="COVID-19 outcomes will help researchers to understand the pathophysiology of" exact="SARS-CoV-2 infection" post="and its interactions with underlying chronic diseases. Early clinical"/>
   <result pre="Remdesivir Remdesivir (RDV) was originally developed as a treatment for" exact="Ebola" post="and Marburg virus infection and is a promising candidate"/>
   <result pre="E6 cells has shown that remdesivir at low-micromolar concentrations blocks" exact="SARS-CoV-2 infection" post="with high selectivity (half-maximal effective concentration (EC50), 0.77 Î¼M;"/>
   <result pre="et al. reported a clinical trial including 199 patients with" exact="SARS-CoV-2 infection," post="which showed that LPV/r was not associated with clinical"/>
   <result pre="been used as a therapeutic agent against respiratory syncytial virus," exact="Lassa fever" post="virus, influenza A and B and in combination with"/>
   <result pre="of ribavirin and LPV/r in combination with interferon alpha-1b for" exact="SARS-CoV-2 infection" post="[132]. 8.1.5. Arbidol Hydrochloride (Umifenovir) Arbidol (ARB; ethyl-6-bromo-4-[(dimethylamino) methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-indole-3-carboxylate"/>
   <result pre="one study from Wuhan in 67 hospitalized patients with confirmed" exact="SARS-CoV-2 infection," post="36 (53.7%) received arbidol treatment for a median duration"/>
   <result pre="TMPRSS2 [142]. Additionally, the effect of camostat mesylate in blocking" exact="SARS-CoV-2 infection" post="of human lung Calu-3 cells has been demonstrated [143]."/>
   <result pre="effect of gabexate mesylate, nafamostat mesylate and camostat mesylate on" exact="SARS-CoV-2 infection" post="and demonstrated that nafamostat mesylate inhibited S-mediated entry of"/>
   <result pre="rabies virus, hepatitis A virus, poliovirus, Chikungunya virus, Lassa virus," exact="Dengue" post="virus, Hendra and Nipah viruses, Crimeanâ€&quot;Congo hemorrhagic fever virus,"/>
   <result pre="and Nipah viruses, Crimeanâ€&quot;Congo hemorrhagic fever virus, Zika virus and" exact="Ebola" post="virus, as well as HBV and herpes simplex virus"/>
   <result pre="were evaluated in Vero E6; chloroquine was effective in controlling" exact="SARS-CoV-2 infection" post="in vitro with an EC50 at 48 h of"/>
   <result pre="in the U.S. (NCT04308668) as a post-exposure prophylaxis/preemptive therapy for" exact="SARS-CoV-2 infection." post="Recently the NIH guidelines panel for COVID-19 treatment recommended"/>
   <result pre="(DENV), West Nile Virus, Venezuelan equine encephalitis virus (VEEV) and" exact="Influenza" post="virus [166]. Ivermectin inhibits the interaction between the integrase"/>
   <result pre="in humans [169]. Overall, the possible efficacy of ivermectin against" exact="SARS-CoV-2 infection" post="needs data to support it. 9. Immunotherapy Several studies"/>
   <result pre="Previous coronavirus outbreaks including SARS-CoV and MERS-CoV as well as" exact="Ebola" post="virus disease, avian influenza A (H5N1), 2009 H1N1 pandemic"/>
   <result pre="convalescent serum [173,174]. However, convalescent plasma was not successful for" exact="Ebola" post="[175]. Patients with SARS-CoV-2 infection develop a serum antibody"/>
   <result pre="convalescent plasma was not successful for Ebola [175]. Patients with" exact="SARS-CoV-2 infection" post="develop a serum antibody response (IgG) to different epitopes"/>
   <result pre="derived from memory B cells from an individual convalescing from" exact="SARS-CoV infection" post="are also capable of neutralizing SARS-CoV-2 [213]. By screening"/>
   <result pre="humanized mAb, which in cell culture was able to block" exact="SARS-CoV-2 infection" post="[214]. In another study, four mAbs were isolated from"/>
   <result pre="Previous studies have suggested an antiviral function for azithromycin in" exact="Ebola" post="virus infection, both in vitro and in mice [216]."/>
   <result pre="Interestingly, Tran et al. reported antiviral activity of azithromycin against" exact="Influenza" post="(H1N1) virus; treatment prior to infection inhibited virus replication"/>
   <result pre="storm are two important aspects of the pathogenesis in severe" exact="SARS-CoV-2 infection" post="[222]. However, a meta-analysis of previous observational studies revealed"/>
   <result pre="Interest The authors declare no conflict of interest. Abbreviations COVID-19" exact="Coronavirus disease 2019" post="SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 FDA US"/>
   <result pre="syndrome coronavirus 2 FDA US Food and Drug Administration MERS-CoV" exact="Middle East respiratory syndrome" post="coronavirus ARDS acute respiratory distress syndrome RSCU synonymous codon"/>
   <result pre="AssayAntimicrob. Agents Chemother.2016606532653910.1128/AAC.01043-1627550352 23.GuoY.-R.CaoQ.-D.HongZ.TanY.-Y.ChenS.JinH.TanK.S.WangD.Y.YanY.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;An update on the statusMil. Med. Res.202071111010.1186/s40779-020-00240-032169119 24.AstutiI.J.D.Research"/>
   <result pre="J. Allergy Immunol2020381932105090 28.BourgonjeA.R.AbdulleA.E.TimensW.HillebrandsJ.L.NavisG.J.GordijnS.J.Angiotensin-converting enzyme-2 (ACE2), SARS-CoV-2 and pathophysiology of" exact="coronavirus disease 2019" post="(COVID-19)J. Pathol.202010.1002/path.5471 29.SpiegelM.WeberF.Inhibition of cytokine gene expression and induction"/>
   <result pre="Treatment and Preventive Strategies in COVID-19Vaccines2020822410.3390/vaccines802022432423059 60.XuJ.JiaW.WangP.ZhangS.ShiX.WangX.ZhangL.-Q.WangT.GoldingH.KhuranaS.Antibodies and vaccines against" exact="Middle East respiratory syndrome" post="coronavirusEmerg. Microbes Infect.2019884185610.1080/22221751.2019.162448231169078 61.RavichandranS.CoyleE.M.KlenowL.TangJ.GrubbsG.LiuS.WangT.GoldingH.KhuranaS.Antibody signature induced by SARS-CoV-2 spike"/>
   <result pre="the Greater Toronto AreaJAMA2003289280110.1001/jama.289.21.JOC3088512734147 89.AlqahtaniF.Y.AleanizyF.MohamedR.A.E.H.AlanaziM.S.MohamedN.AlrasheedM.M.AbanmyN.AlhawassiT.Prevalence of comorbidities in cases of" exact="Middle East respiratory syndrome" post="coronavirus: A retrospective studyEpidemiol. Infect.20181471510.1017/S095026881800292330394248 90.The Centers for Disease"/>
   <result pre="al.Case of the index patient who caused tertiary transmission of" exact="coronavirus disease 2019" post="in Korea: The application of lopinavir/ritonavir for the treatment"/>
   <result pre="Sci.202035e7910.3346/jkms.2020.35.e7932056407 111.WangZ.ChenX.LuY.ChenF.ZhangW.Clinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci. Trends202014646810.5582/bst.2020.0103032037389 112.YoungB.E.OngS.W.X.KalimuddinS.LowJ.G.TanS.Y.LohJ.NgO.-T.MarimuthuK.AngL.W.MakT.M.et"/>
   <result pre="Med. Virol.20057714715010.1002/jmv.2043116121363 175.Van GriensvenJ.EdwardsT.De LamballerieX.SempleM.G.GallianP.BaizeS.HorbyP.RaoulH.MagassoubaN.AntierensA.et al.Evaluation of Convalescent Plasma for" exact="Ebola" post="Virus Disease in GuineaN. Engl. J. Med.2016374334210.1056/NEJMoa151181226735992 176.AnudeepT.JeyaramanM.ShettyD.U.RajH.AjayS.Rajeswari SomasundaramV.K.V.KumarV.JainR.ShirodkarJ.Convalescent"/>
   <result pre="binding to its receptor ACE2Science20203681274127810.1126/science.abc224132404477 216.SweitiH.EkwunifeO.JaschinskiT.LhachimiS.K.Repurposed Therapeutic Agents Targeting the" exact="Ebola" post="Virus: A Systematic ReviewCurr. Ther. Res.201784102110.1016/j.curtheres.2017.01.00728761574 217.GielenV.JohnstonS.L.EdwardsM.R.Azithromycin induces anti-viral"/>
   <result pre="systematic review and meta-analysisJ. Infect.202081e13e2010.1016/j.jinf.2020.03.06232283144 226.ZhaL.LiS.PanL.TefsenB.LiY.FrenchN.ChenL.YangG.VillanuevaE.V.Corticosteroid treatment of patients with" exact="coronavirus disease 2019" post="(COVID -19)Med. J. Aust.202021241642010.5694/mja2.5057732266987 227.FangX.MeiQ.YangT.LiL.WangY.TongF.GengS.PanA.Low-dose corticosteroid therapy does not"/>
   <result pre="the Pandemic Coronavirus Disease 2019 (COVID-19)Cureus20201210.7759/cureus.7560 238.DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov. Ther.202014586010.5582/ddt.2020.0101232147628 239.SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic Treatments for Coronavirus Disease 2019"/>
   <result pre="diameter with a 26â€&quot;32 kb single stranded RNA (ssRNA) genome." exact="Severe acute respiratory syndrome" post="coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and"/>
   <result pre="stranded RNA (ssRNA) genome. Severe acute respiratory syndrome coronavirus (SARS-CoV)," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus 2"/>
   <result pre="red cross. ijms-21-05559-t001_Table 1Table 1 List of available drugs targeting" exact="SARS-CoV-2 infection" post="and their effective dosage. Name of Medicine Target Classification"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7432648\results\search\zoonosis\results.xml">
   <result pre="syndrome coronavirus 2 (SARS-CoV-2). WHO first declared the outbreak of" exact="coronavirus disease 2019" post="(COVID-19) a six public-health emergency of international concern, before"/>
   <result pre="belongs to the beta-coronavirus (Î²) family and was termed the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). In 2019, a novel CoV caused the"/>
   <result pre="the bats were a source of the virus [9]. The" exact="Middle East respiratory syndrome" post="(MERS) coronavirus (2012) in Saudi Arabia is a beta-coronavirus"/>
   <result pre="aggravate viral transmission under given conditions. Indoor environments can proliferate" exact="SARS-CoV-2 infection" post="by raised viral loads through droplets and direct contact"/>
   <result pre="evolved on the American continent. The first confirmed case of" exact="SARS-CoV-2 infection" post="in the United States of America (USA) was reported"/>
   <result pre="SARS coronavirusVirus Res.2008133748710.1016/j.virusres.2007.03.01217451830 10.PadenC.R.YusofM.F.Al HammadiZ.M.QueenK.TaoY.EltahirY.M.ElsayedE.A.MarzougB.A.BensalahO.K.KhalafallaA.I.et al.Zoonotic origin and transmission of" exact="Middle East respiratory syndrome" post="coronavirus in the UAEZoonoses Public Health20186532233310.1111/zph.1243529239118 11.LuR.ZhaoX.LiJ.NiuP.YangB.WuH.WangW.SongH.HuangB.ZhuN.et al.Genomic characterization"/>
   <result pre="PandemicSustainability202012432110.3390/su12104321 20.GrantW.B.LahoreH.McDonnellS.L.BaggerlyC.A.FrenchC.B.AlianoJ.L.BhattoaH.P.Evidence that Vitamin D Supplementation Could Reduce Risk of" exact="Influenza" post="and COVID-19 Infections and DeathsNutrients20201298810.3390/nu12040988 21.EdisZ.Haj BloukhS.Vitamin D Deficiencyâ€&quot;Main"/>
   <result pre="Sci.202012223010.4103/jpbs.JPBS_93_19 27.IlieP.C.StefanescuS.SmithL.The role of vitamin D in the prevention of" exact="coronavirus disease 2019" post="infection and mortalityAging Clin. Exp. Res.2020114 28.LuoL.LiuD.LiaoX.L.WuX.B.JingQ.L.ZhengJ.Z.LiuF.H.YangS.G.BiB.LiZ.H.et al.Modes of"/>
   <result pre="role of community-wide wearing of face mask for control of" exact="coronavirus disease 2019" post="(COVID-19) epidemic due to SARS-CoV-2J. Infect.2020in press10.1016/j.jinf.2020.04.024 30.CowlingB.J.AliS.T.NgT.W.TsangT.K.LiJ.C.FongM.W.LiaoQ.KwanM.Y.LeeS.L.ChiuS.S.et al.Impact"/>
   <result pre="SARS-CoV-2J. Infect.2020in press10.1016/j.jinf.2020.04.024 30.CowlingB.J.AliS.T.NgT.W.TsangT.K.LiJ.C.FongM.W.LiaoQ.KwanM.Y.LeeS.L.ChiuS.S.et al.Impact assessment of non-pharmaceutical interventions against" exact="coronavirus disease 2019" post="and influenza in Hong Kong: An observational studyLancet20205E279E28810.1016/S2468-2667(20)30090-632311320 31.DengY.LiuW.LiuK.FangY.-Y.ShangJ.ZhouL.WangK.LengF.WeiS.ChenL.et"/>
   <result pre="studyLancet20205E279E28810.1016/S2468-2667(20)30090-632311320 31.DengY.LiuW.LiuK.FangY.-Y.ShangJ.ZhouL.WangK.LengF.WeiS.ChenL.et al.Clinical characteristics of fatal and recovered cases of" exact="coronavirus disease 2019" post="(COVID-19) in Wuhan, China-a retrospective studyJ. Clin. Med.202010.1097/CM9.0000000000000824 32.Thanh-Long"/>
   <result pre="future directionsAm. J. Emerg. Med.2020in press10.1016/j.ajem.2020.04.072 47.LinJ.OuyangJ.PengX.-R.IsnardS.FombuenaB.RoutyJ.-P.ChenY.-K.Potential therapeutic options for" exact="coronavirus disease 2019" post="using knowledge of past outbreaks to guide future treatmentChin."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7434367\results\search\zoonosis\results.xml">
   <result pre="disinfection Hypothiocyanite Lactoperoxidase Lactoferrin 1 Background 1.1 Rationale The current" exact="coronavirus disease 2019" post="(COVID-19), caused by the novel beta coronavirus SARS-CoV-2, has"/>
   <result pre="further investigation. Fig. 3 Protective role of Lactoferrin (LF) in" exact="SARS-CoV infection." post="(A) LF blocks the infection of SARS-CoV by binding"/>
   <result pre="(LFÂ +Â LPO) in alleviating symptoms of common cold and/or" exact="influenza infection." post="Treatment and non-treatment groups (overall 407 subjects) were further"/>
   <result pre="et al., 2018). The incidence and duration of common cold," exact="influenza infection" post="and gastrointestinal symptoms was not statistically different between treatment"/>
   <result pre="of LLF on 256 household contacts was effective to prevent" exact="SARS-CoV-2 infection" post="(Serrano et al., 2020). Last but not least, out"/>
   <result pre="simplex virus type 1; Herpes simplex virus type 2; Adenovirus;" exact="Influenza" post="virus A and HIV-1). NCT can be applied to"/>
   <result pre="GaoH.ZhangL.L.WeiQ.Preventive and therapeutic effects of recombinant IFN-alpha2b nasal spray for" exact="SARS-CoV infection" post="in Macaca mulataZhonghua Shi Yan He Lin Chuang Bing"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov620201632194981 MarcozziG.LiberatiV.MadiaF.PizzingaA.de FeoG.Effect of hormone replacement therapy"/>
   <result pre="trial of recombinantX human interferon alpha nasal drops to prevent" exact="coronavirus disease 2019" post="in medical staff in an epidemic areaMedRxiv2020Available from:https://www.medrxiv.org/content/10.1101/2020.04.11.20061473v2(last accessed"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7435473\results\search\zoonosis\results.xml">
   <result pre="found to be the same for both aerosolised viruses of" exact="human influenza" post="A virus (H1N1) and avian influenza virus (H9N2) under"/>
   <result pre="cotton and surgical masks [118] found that when patients with" exact="Covid-19" post="were instructed to cough five times on a petri"/>
   <result pre="(COVID-19)Int. J. Surg.202076717610.1016/j.ijsu.2020.02.03432112977 3.GuoY.-R.CaoQ.-D.HongZ.TanY.-Y.ChenS.JinH.TanK.S.WangD.Y.YanY.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak - an update on the statusMil. Med."/>
   <result pre="respiratory face mask for capturing air pollutants and pathogens including" exact="human influenza" post="and rhinovirusesJ. Thorac. Dis.2018102059206910.21037/jtd.2018.03.10329707364 60.TuiteA.R.FismanD.N.GreerA.L.Mathematical modelling of COVID-19 transmission"/>
   <result pre="a SIR model on Euclidean networkarXiv2020 64.BastosS.B.CajueiroD.O.Modeling and forecasting the" exact="Covid-19" post="pandemic in BrazilarXiv2020 65.ChangS.L.HardingN.ZachresonC.CliffO.M.ProkopenkoM.Modelling transmission and control of the"/>
   <result pre="70.BrienenN.C.J.TimenA.WallingaJ.Van SteenbergenJ.E.TeunisP.F.M.The Effect of Mask Use on the Spread of" exact="Influenza" post="During a PandemicRisk Anal.2010301210121810.1111/j.1539-6924.2010.01428.x20497389 71.SchimitP.MonteiroL.Who should wear mask against"/>
   <result pre="the Effectiveness of Facemasks in Reducing the Spread of Novel" exact="Influenza" post="A (H1N1)PLoS ONE20105e901810.1371/journal.pone.000901820161764 73.MacIntyreC.R.CauchemezS.DwyerD.E.SealeH.CheungP.BrowneG.FasherM.WoodJ.GaoZ.BooyR.et al.Face mask use and control"/>
   <result pre="111.A FischerW.WeberD.J.WohlD.A.Personal Protective Equipment: Protecting Health Care Providers in an" exact="Ebola" post="OutbreakClin. Ther.2015372402241010.1016/j.clinthera.2015.07.00726452427 112.ViscusiD.J.BergmanM.S.EimerB.C.ShafferR.E.Evaluation of Five Decontamination Methods for Filtering"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7435512\results\search\zoonosis\results.xml">
   <result pre="interferon IL interleukin M membrane protein mAbs monoclonal Abs MERS" exact="Middle East respiratory syndrome" post="MoA mode of action N nucleoprotein nsp nonstructural protein"/>
   <result pre="pathologies. On the other hand, the emergence of SARSâ€�CoV and" exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV) has led to a growing number of"/>
   <result pre="also an option.24 This approach was used in the latest" exact="Ebola" post="outbreak and led to the development of ZMapp.25 Neutralizing"/>
   <result pre="the other hand, molecules such as remdesivir, initially developed against" exact="Ebola" post="virus,45 appear to have an inhibitory effect against SARSâ€�CoV"/>
   <result pre="activity, with antiviral effects against flaviviruses,74, 75 alphaviruses,76 noroviruses,77 and" exact="Ebola" post="virus.78, 79, 80 Favipiravir was approved for influenza treatment"/>
   <result pre="J. 2005;170(2):193â€�211.16129340 25HoenenT, GrosethA, FeldmannH. Therapeutic strategies to target the" exact="Ebola" post="virus life cycle. Nat Rev Microbiol. 2019;17(10):593â€�606.31341272 26WangL, ShiW,"/>
   <result pre="of neutralizing monoclonal antibodies targeting multiple antigenic sites on the" exact="Middle East respiratory syndrome" post="coronavirus spike glycoprotein to avoid neutralization escape. J Virol."/>
   <result pre="et al. Therapeutic efficacy of the small molecule GSâ€�5734 against" exact="Ebola" post="virus in rhesus monkeys. Nature. 2016;531(7594):381â€�385.26934220 46AgostiniML, AndresEL, SimsAC,"/>
   <result pre="57BhatnagarT, MurhekarMV, SonejaM, et al. Lopinavir/ritonavir combination therapy amongst symptomatic" exact="coronavirus disease 2019" post="patients in India: protocol for restricted public health emergency"/>
   <result pre="of an FDAâ€�approved compound library identifies four smallâ€�molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014;58(8):4875â€�4884.24841269"/>
   <result pre="78GuedjJ, PiorkowskiG, JacquotF, et al. Antiviral efficacy of favipiravir against" exact="Ebola" post="virus: a translational study in cynomolgus macaques. PLoS Med.2018;15(3):e1002535.29584730"/>
   <result pre="79OestereichL, LÃ¼dtkeA, WurrS, RiegerT, MuÃ±ozâ€�FontelaC, GÃ¼ntherS. Successful treatment of advanced" exact="Ebola" post="virus infection with Tâ€�705 (favipiravir) in a small animal"/>
   <result pre="LenkRP, LeverMS. Postâ€�exposure efficacy of oral Tâ€�705 (favipiravir) against inhalational" exact="Ebola" post="virus infection in a mouse model. Antiviral Res. 2014;104:153â€�155.24462697"/>
   <result pre="dosing regimens. Biotechnol Biotechnol Equip. 2020;34(1):469â€&quot;474. 10.1101/2020.04.11.20061804. 123GubarevaLV, KaiserL, HaydenFG." exact="Influenza" post="virus neuraminidase inhibitors. Lancet. 2000;355(9206):827â€�835.10711940"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7436557\results\search\zoonosis\results.xml">
   <result pre="the duration of the public health emergency.file:AJT-9999-na.pdf Abstract Abstract The" exact="coronavirus disease 2019" post="(COVIDâ€�19) pandemic is declared a global health emergency. COVIDâ€�19"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7436575\results\search\zoonosis\results.xml">
   <result pre="to hospital with a diagnosis of interstitial pneumonia caused by" exact="coronavirus disease 2019" post="(COVIDâ€�19). After 7â€‰days, the blood tests showed a significant"/>
   <result pre="In February 2020 the World Health Organization (WHO) officially termed" exact="coronavirus disease 2019" post="(COVIDâ€�19), the infective severe acute respiratory syndrome caused by"/>
   <result pre="impending multiorgan failure.10 Furthermore, other reports showed that patients with" exact="COVID 19" post="and severe respiratory distress often develop complications such as"/>
   <result pre="N Engl J Med. 2004;351:2611â€�2618.15602021 5Warrenâ€�GashC, HaywardAC, HemingwayH, et al." exact="Influenza" post="infection and risk of acute myocardial infarction in England"/>
   <result pre="6KwongJC, SchwartzKL, CampitelliMA, et al. Acute myocardial infarction after laboratoryâ€�confirmed" exact="influenza infection." post="N Engl J Med. 2018;378(4):345â€�353. 10.1056/NEJMoa1702090.29365305 7ShiS, QinM, ShenB,"/>
   <result pre="et al. Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVIDâ€�19). JAMA Cardiol. 2020;5:81110.1001/jamacardio.2020.1017. 9TangN, LiD, WangX, SunZ. Abnormal"/>
   <result pre="2020;323:1061â€�1069. 13WuZ, McGooganJM. Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVIDâ€�19) outbreak in China: summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7438223\results\search\zoonosis\results.xml">
   <result pre="may develop type 1 diabetes mellitus in the time of" exact="Covid-19" post="infection. 2 Methods A literature search was carried out"/>
   <result pre="Italian children younger than 18Â years of age with confirmed" exact="Covid-19" post="infection, who referred to pediatric emergency departments between March"/>
   <result pre="of the disease, as reported for other infections, as Pandemic" exact="Influenza" post="A in 2009, SARS and MERS. In reverse, a"/>
   <result pre="et al. Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan China: a descriptive study. Lancet 2020;395(10223):507â€&quot;513 [44]"/>
   <result pre="Z, McGoogan JM. Characteristics of and important lesson from the" exact="Coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="adults with COVID-19 Diabetes does not increase the risk of" exact="SARS-CoV-2 infection" post="but can worsen the outcome of COVID-19. The rate"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern Med132020e20099410.1001/jamainternmed.2020.0994 6LeeP.I.HuY.L.ChenP.Y.HuangY.C.HsuehP.R.Are children less"/>
   <result pre="and a better prognosis than adultsActa Paediatr202010.1111/APA.15270 8World Health Organization." exact="Coronavirus disease 2019" post="(COVID-19): situation report 65; March 2020. https://www.who.int/docs/default-source/coronaviruses/situation-reports/20200325 -sitrep-65-covid-19.pdf. 9Italian"/>
   <result pre="age in ChinaJ Am Med Assoc202010.1001/jama.2020.2131 11HongH.WangY.ChungH.T.ChenC.J.Clinical characteristics of novel" exact="coronavirus disease 2019" post="(COVID-19) in newborns, infants and childrenPediatr Neonatol202010.1016/j.pedneo.2020.03.001 12EgloffC.Vauloup-FellousC.PiconeO.MandelbrotL.RoquesP.Evidence and"/>
   <result pre="Clin Virol202010.1016/j.jcv.2020.104447 13QiuH.WuJ.HongL.LuoY.SongQ.ChenD.Clinical and epidemiological features of 36 children with" exact="coronavirus disease 2019" post="(COVID-19) in Zhejiang, China: an observational cohort studyLancet Infect"/>
   <result pre="Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with" exact="Covid-19" post="in pediatric emergency departments in Italy. NEJM 2020, May"/>
   <result pre="Res Care82020e00145010.1136/bmjdrc-2020-001450 45ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan China: a descriptive studyLancet39510223202050751310.1016/S0140-6736(20)30211-732007143 46GuoW.LiM.DongY.ZhouH.ZhangZ.TianC.Diabetes is a"/>
   <result pre="infected with SARS-CoV-2JEI202010.1007/s-40618-020-01236-2 51WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7438224\results\search\zoonosis\results.xml">
   <result pre="dengue fever, yellow fever, Sever Acute Respiratory Syndrome (SARS), the" exact="Ebola" post="virus disease, mumps, and the Zika virus (WHO,Â 2020a)."/>
   <result pre="nurses. Epidemic and pandemics that they went through included the" exact="Ebola" post="virus disease, the Zika virus, SARS, and the H1N1/09."/>
   <result pre="Aim Methodology Results Erland etÂ al. 2017 / Norway (Europe)" exact="Ebola" post="virus disease To explore and describe midwivesâ€™ experiences of"/>
   <result pre="experiences of caring for pregnant women who were admitted to" exact="Ebola" post="centers in Sierra Leone Study design:Qualitative study with descriptive"/>
   <result pre="cross-case analysis Three themes emerged: 1â€œPersonal and public fears of" exact="Ebola" post="virus disease infection affect midwivesâ€™ professional and personal livesâ€�"/>
   <result pre="healthcare servicesâ€� JonesÂ etÂ al., 2017 / Sierra Leone (Africa)" exact="Ebola" post="virus disease To explore nursesâ€™ and midwivesâ€™ understanding of"/>
   <result pre="to continue to provide routine and emergency maternity services during" exact="Ebola" post="epidemic Study design:Hermeneutic descriptive phenomenological approach; face-to-face interviewsSample:66 midwives"/>
   <result pre="after the epidemicâ€� KollieÂ etÂ al., 2017 / Liberia (Africa)" exact="Ebola" post="virus disease To explore the experiences of nurses and"/>
   <result pre="To explore the experiences of nurses and midwives during the" exact="Ebola" post="outbreak Study design:Grounded theory method; face-to-face semi-structured interviewsSample:30 midwives"/>
   <result pre="property owner found out that she was working in an" exact="Ebola" post="center and some had their family members who avoided"/>
   <result pre="was evident from a midwife who got fired from an" exact="Ebola" post="center as she had been eager to provide better"/>
   <result pre="buckets to avoid the splashing of blood and changed the" exact="Ebola" post="facility's layout to make observations and communication with women"/>
   <result pre="Telecare196201333834610.1177/1357633x1350176724163298 ErlandE.DahlB.Midwivesâ€™ experiences of caring for pregnant women admitted to" exact="Ebola" post="centres in Sierra LeoneMidwifery552017232810.1016/j.midw.2017.08.00528915377 Faisal-CuryA.ArayaR.ZugaibM.MenezesP.R.Common mental disorders during pregnancy"/>
   <result pre="are afraid, you stayâ€™: Provision of maternity care during the" exact="Ebola" post="virus epidemic: A qualitative studyMidwifery522017192610.1016/j.midw.2017.05.00928570857 KangH.S.SonY.D.ChaeS.CorteC.Working experiences of nurses"/>
   <result pre="epidemic: A qualitative studyMidwifery522017192610.1016/j.midw.2017.05.00928570857 KangH.S.SonY.D.ChaeS.CorteC.Working experiences of nurses during the" exact="Middle East respiratory syndrome" post="outbreakInt. J. Nurs. Pract.2452018e1266410.1111/ijn.1266429851209 KimD.R.SockolL.E.SammelM.D.KellyC.MoseleyM.EppersonC.N.Elevated risk of adverse obstetric"/>
   <result pre="South KoreaAm. J. Infect. Control467201878178710.1016/j.ajic.2018.01.01229502886 KollieE.S.WinslowB.J.PothierP.GaedeD.Deciding to work during the" exact="Ebola" post="outbreak: the voices and experiences of nurses and midwives"/>
   <result pre="Organisation. (2020). Disease outbreaks. Retrieved fromhttps://www.who.int/emergencies/diseases/en/ World Health Organisation. (2020)." exact="Middle East respiratory syndrome" post="coronavirus (MERS-Cov) â€&quot; The Kingdom of Saudi Arabia. Retrieved"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7438404\results\search\zoonosis\results.xml">
   <result pre="HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1, severe acute respiratory syndrome coronavirus (SARS-CoV)," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) and, most recently, SARS-CoV-2 (Graham et al.,"/>
   <result pre="therapies able to reduce the severity of clinical outcomes of" exact="coronavirus disease 2019" post="(COVID-19) and to reduce the spread of SARS-CoV-2. Here,"/>
   <result pre="a tendency, and the drug is already used to treat" exact="Influenza" post="viruses. Corsticosteroids (dexamethasone) NE Host factors (controlling immune response)"/>
   <result pre="it is reasonable to suggest that TACE inhibitors could hinder" exact="SARS-CoV infection." post="In this context, TAPI-2, a compound able to inhibit"/>
   <result pre="(Katz, 1977). Niclosamide presented antiviral activity on post-entry steps of" exact="SARS-CoV infection" post="in Vero cells, with an EC50 of 1â€&quot;3 Î¼M"/>
   <result pre="for instance, influenza A and B viruses, as well as" exact="Ebola" post="virus (EBOV) (Rossignol, 2014; Jasenosky et al., 2019), with"/>
   <result pre="an observational study with 81 patients with moderate to severe" exact="SARS-CoV-2 infection" post="(Lian et al., 2020) that demonstrated that Umifenovir neither"/>
   <result pre="have also been investigated due to their antiviral activity against" exact="Dengue" post="virus (DENV), Influenza A viruses, Chikungunya virus (CHIKV), and"/>
   <result pre="investigated due to their antiviral activity against Dengue virus (DENV)," exact="Influenza" post="A viruses, Chikungunya virus (CHIKV), and HIV (Tay et"/>
   <result pre="Al-Bari, 2017). Chloroquine was described as an entry inhibitor of" exact="SARS-CoV infection" post="in Vero cells and prevented cell-to-cell spread of the"/>
   <result pre="plasma/derivative is, in its turn, transfused into individuals with acute" exact="SARS-CoV-2 infection" post="(Garraud, 2017; Cao and Shi, 2020). Even though the"/>
   <result pre="further evaluation using in vivo systems of CoV infection, especially" exact="SARS-CoV-2 infection." post="The compounds are: NAAE, Glycyrrhizin, 2-acetamido-Î±- D-Glucopyranosylamine derivative, Tetrahydroquinoline"/>
   <result pre="2014). The development of refined and secure protocols to study" exact="SARS-CoV-2 infection" post="and its treatment options is required. Bearing in mind"/>
   <result pre="resistance to antiviral treatment, as observed for HIV, HCV, and" exact="Influenza" post="viruses (Laplante and St George, 2014; Li and Chung,"/>
   <result pre="(2014). Ribavirin and interferon therapy in patients infected with the" exact="Middle East respiratory syndrome" post="coronavirus: an observational study.Int. J. Infect. Dis.2042â€&quot;46. 10.1016/j.ijid.2013.12.00324406736 AnandK.ZiebuhrJ.WadhwaniP.MestersJ."/>
   <result pre="studies.Biosci. Trends1472â€&quot;73. 10.5582/BST.2020.0104732074550 GarraudO. (2017). Use of convalescent plasma in" exact="Ebola" post="virus infection.Transfus. Apher. Sci.5631â€&quot;34. 10.1016/j.transci.2016.12.01428094110 GautretP.LagierJ.-C.ParolaP.HoangV. T.MeddebL.MailheM.et al. (2020)."/>
   <result pre="2019-nCoV and naming it SARS-CoV-2.Nat. Microbiol.5536â€&quot;544. 10.1038/s41564-020-0695-z32123347 GÃ¶tzV.MagarL.DornfeldD.GieseS.PohlmannA.HÃ¶perD.et al. (2016)." exact="Influenza" post="A viruses escape from MxA restriction at the expense"/>
   <result pre="bovine Coronaviruses.J. Virol.864631â€&quot;4643. 10.1128/JVI.06265-1122345457 GuanW.NiZ.HuY.LiangW.OuC.HeJ.et al. (2020). Clinical characteristics of" exact="Coronavirus disease 2019" post="in China.N. Engl. J. Med.3821708â€&quot;1720. 10.1056/NEJMoa200203232109013 HagaS.NagataN.OkamuraT.YamamotoN.SataT.YamamotoN.et al. (2010)."/>
   <result pre="with chronic hepatitis C treated with interferon-Î².Hepatology181319â€&quot;1325. 10.1002/hep.18401806068244255 LaiC.-C.ShihT.-P.KoW.-C.TangH.-J.HsuehP.-R. (2020)." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitro.Cell Discov.61â€&quot;4. 10.1038/s41421-020-0156-031934347 LuG.WangQ.GaoG. F. (2015). Bat-to-human: spike"/>
   <result pre="Lond. Engl.3951033â€&quot;1034. 10.1016/S0140-6736(20)30628-0 MilletJ. K.SÃ©ronK.LabittR. N.DanneelsA.PalmerK. E.WhittakerG. R.et al. (2016)." exact="Middle East respiratory syndrome" post="coronavirus infection is inhibited by griffithsin.Antiviral Res.1331â€&quot;8. 10.1016/j.antiviral.2016.07.01127424494 MillsA."/>
   <result pre="(2016). Nitazoxanide, a new drug candidate for the treatment of" exact="Middle East respiratory syndrome" post="coronavirus.J. Infect. Public Health9227â€&quot;230. 10.1016/j.jiph.2016.04.00127095301 Ruiz-IrastorzaG.Ramos-CasalsM.Brito-ZeronP.KhamashtaM. A. (2010). Clinical"/>
   <result pre="infection in vitro and in vivo.Antiviral Res.99100â€&quot;107. 10.1016/j.antiviral.2013.04.01623648708 TakashitaE. (2020)." exact="Influenza" post="polymerase inhibitors: mechanisms of action and resistance.Cold Spring Harb."/>
   <result pre="al. (2016). Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeys.Nature531381â€&quot;385. 10.1038/nature1718026934220 WeissS. R.Navas-MartinS. (2005). Coronavirus"/>
   <result pre="Biochem.821103â€&quot;1108. 10.1093/oxfordjournals.jbchem.a131782200604 ZhaL.LiS.PanL.TefsenB.LiY.FrenchN.et al. (2020). Corticosteroid treatment of patients with" exact="coronavirus disease 2019" post="(COVID-19).Med. J. Aust.212416â€&quot;420. 10.5694/mja2.5057732266987 ZhangC.WuZ.LiJ.ZhaoH.WangG. (2020a). Cytokine release syndrome"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7439087\results\search\zoonosis\results.xml">
   <result pre="the cases of Severe Acute Respiratory Syndrome (SARS) in 2003," exact="Middle East respiratory syndrome" post="(MERS) in 2012, and COVID-19 in 2019. The pathogens"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7440033\results\search\zoonosis\results.xml">
   <result pre="long as the COVID-19 resource centre remains active. Abstract The" exact="coronavirus disease 2019" post="(COVID-19) will continue to have a significant impact on"/>
   <result pre="are learnt now for more rapid and robust containment measures." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), the viral cause of COVID-19, is"/>
   <result pre="of all cases in Nigeria. Importantly, lessons learnt during the" exact="Ebola" post="epidemic have had a significant impact on Nigeria's COVID-19"/>
   <result pre="ou pandÃ©mies de toute maladie infectieuse en Afrique. Keywords Africa" exact="Coronavirus disease 2019" post="(COVID-19) Health system preparedness Nigeria SARS-CoV-2 Mots clÃ©s Afrique"/>
   <result pre="PrÃ©paration des systÃ¨mes de santÃ© Nigeria SRAS-CoV-2 Introduction The current" exact="coronavirus disease 2019" post="(COVID-19) pandemic will not be the last global spread"/>
   <result pre="this [1], [2], [3]. Moreover, experiences with influenza, cholera and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) demonstrate that pandemics come with fear and"/>
   <result pre="in times of health emergencies. Importantly, lessons learnt during the" exact="Ebola" post="epidemic were to a significant extent leveraged upon for"/>
   <result pre="to be effective in several settings [11], [12]. Lessons from" exact="Ebola" post="epidemic inform COVID-19 response Nigeria demonstrated strong leadership and"/>
   <result pre="response Nigeria demonstrated strong leadership and well-coordinated response during the" exact="Ebola" post="epidemic after the index case arrived Lagos on 20th"/>
   <result pre="was a citizen of Liberia who lost a sister to" exact="Ebola" post="before taking a flight to Lagos, Nigeria. On arrival"/>
   <result pre="the time, which he knew he had contracted. On confirming" exact="Ebola" post="disease in Mr Sawyer as Nigeria's index case, public"/>
   <result pre="Lagos and Port Harcourt) and certain facilities were designated for" exact="Ebola" post="treatment. In addition, information dissemination in English and local"/>
   <result pre="for polio eradication were deployed to provide support for the" exact="Ebola" post="response, Global Positioning Systems (GPS) were used for real-time"/>
   <result pre="October, 2014, by the WHO that Nigeria was free of" exact="Ebola" post="transmission [7]. The success story of Ebola response in"/>
   <result pre="was free of Ebola transmission [7]. The success story of" exact="Ebola" post="response in Nigeria was possible because public health officials"/>
   <result pre="of air travels to Nigeria, the lessons learnt during the" exact="Ebola" post="outbreak have had a significant impact on the ongoing"/>
   <result pre="References 1DudasG.CarvalhoL.M.RambautA.BedfordT.MERS-CoV spillover at the camel-human interfaceElife72018e3125729336306 2HolmesE.C.DudasG.RambautA.AndersenK.G.The evolution of" exact="Ebola" post="virus: insights from the 2013â€&quot;2016 epidemicNature538201619320010.1038/nature1979027734858 3PurohitV.KudaleA.SundaramN.JosephS.SchaettiC.WeissM.G.Public health policy"/>
   <result pre="of the current seventh cholera pandemicProceedings Nat Acad Sci1132016E7730E7739 7WHOSuccessful" exact="Ebola" post="responses in Nigeria, Senegal and Mali2015WHOGeneva 8WHO. World Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441012\results\search\zoonosis\results.xml">
   <result pre="remains active. Abbreviations and Acronyms COVID-19, Coronavirus Disease 2019 EVD," exact="Ebola" post="virus disease OR, operating room PPE, personal protective equipment"/>
   <result pre="appetite, headache, fever, fatigue, and pneumoniaâ€&quot;the predominant cause of death.7" exact="Influenza" post="infected 25% of the global population, and its death"/>
   <result pre="developed during the SARS outbreak later informed response to the" exact="Middle East respiratory syndrome" post="outbreak in 2012.31 The SARS outbreak demonstrated how systemic"/>
   <result pre="enhanced PPE highlighted the importance of adaptive infection control measures." exact="Ebola" post="Background Ebola virus disease (EVD) is a clinical syndrome"/>
   <result pre="highlighted the importance of adaptive infection control measures. Ebola Background" exact="Ebola" post="virus disease (EVD) is a clinical syndrome caused by"/>
   <result pre="the first EVD cases in southeastern Guinea.33 The West Africa" exact="Ebola" post="epidemic followed, with an outbreak rapidly spreading to Guineaâ€™s"/>
   <result pre="the SARS epidemic, healthcare workers were disproportionately infected during the" exact="Ebola" post="epidemic. From the start of the outbreak through November"/>
   <result pre="to improvise at the expense of safety.38 The West Africa" exact="Ebola" post="epidemic revealed the vulnerability that surgeons in resource-poor healthcare"/>
   <result pre="recommendations were informed by lessons learned from the SARS and" exact="Ebola" post="epidemics.42 Familiar challenges continue. Similar to the Ebola epidemic,"/>
   <result pre="SARS and Ebola epidemics.42 Familiar challenges continue. Similar to the" exact="Ebola" post="epidemic, the COVID-19 pandemic poses special concern for resource-poor"/>
   <result pre="for patients undergoing surgeryâ€&quot;many of which are lessons from the" exact="Ebola" post="epidemicâ€&quot;may facilitate resumption of surgical operations. The surgical community"/>
   <result pre="protective equipment highlighted the importance of adaptive infection control measures." exact="Ebola" post="The West Africa Ebola epidemic revealed the vulnerability surgeons"/>
   <result pre="importance of adaptive infection control measures. Ebola The West Africa" exact="Ebola" post="epidemic revealed the vulnerability surgeons in resource-poor healthcare systems"/>
   <result pre="syndrome-related patientsAnesthesia6200413941398 31ParkJ.YooS.Y.KoJ.H.Infection prevention measures for surgical procedures during a" exact="Middle East respiratory syndrome" post="outbreak in a tertiary care hospital in South KoreaSci"/>
   <result pre="diseaseAvailable at:https://www.who.int/news-room/fact- sheets/detail/ebola-virus-disease2020 33collab: Centers for Disease Control and Prevention2014-2016" exact="Ebola" post="outbreak in West AfricaAvailable at:https://www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/index.html2019 34collab: World Health OrganizationEbola"/>
   <result pre="2020 35collab: Centers for Disease Control and PreventionCost of the" exact="Ebola" post="epidemicAvailable at:https://www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/cost-of-ebola.html2019 36collab: World Health OrganizationCase definition recommendations for"/>
   <result pre="Ebola epidemicAvailable at:https://www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/cost-of-ebola.html2019 36collab: World Health OrganizationCase definition recommendations for" exact="Ebola" post="or Marburg virus diseaseAvailable at:https://www.who.int/csr/resources/publications/ebola/case-definition/en/2014 37BolkanH.A.Bash-TaqiD.A.SamaiM.Ebola and indirect effects"/>
   <result pre="40collab: American College of SurgeonsSurgical protocol for possible or confirmed" exact="Ebola" post="casesAvailable at:https://www.facs.org/surgeons/ebola/surgical-protocol2014 41collab: Centers for Disease Control and PreventionEbola:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441141\results\search\zoonosis\results.xml">
   <result pre="vaccination crisis in IrelandLancet201839110135210310.1016/S0140-6736(18)30854-7 42.Aleem Z. New CDC data shows" exact="Covid-19" post="is affecting African Americans at exceptionally high rates. Vox."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441224\results\search\zoonosis\results.xml">
   <result pre="a quality evidence base during pandemics. Keywords Pandemic Clinical trial" exact="Influenza" post="H1N1 Systematic review Funding http://dx.doi.org/10.13039/100004440Wellcome Trust 107834/Z/15/Z106491/Z/14/ZHorbyPeter W. Funding"/>
   <result pre="have been severe acute respiratory virus (SARS; caused by SARS-CoV-1)," exact="Middle East respiratory syndrome" post="(MERS) and, currently, coronavirus disease 2019 (COVID-19) (caused by"/>
   <result pre="caused by SARS-CoV-1), Middle East respiratory syndrome (MERS) and, currently," exact="coronavirus disease 2019" post="(COVID-19) (caused by SARS-CoV-2) [1]. A study of the"/>
   <result pre="used to rapidly enrol patients with COVID-19. Recommendations following the" exact="Ebola" post="virus disease (EVD) epidemic in West Africa suggest that"/>
   <result pre="patients, that were open during the pandemic period. Abbreviations COVID-19" exact="Coronavirus disease 2019" post="EVD Ebola virus disease IQR Interquartile range LMICs Low-"/>
   <result pre="during the pandemic period. Abbreviations COVID-19 Coronavirus disease 2019 EVD" exact="Ebola" post="virus disease IQR Interquartile range LMICs Low- and middle-income"/>
   <result pre="disease IQR Interquartile range LMICs Low- and middle-income countries MERS" exact="Middle East respiratory syndrome" post="NAI Neuraminidase inhibitor PHEIC Public Health Emergency of International"/>
   <result pre="Med201614121210.1186/s12916-016-0760-x27989237 14.TranTHRuiz-PalaciosGMHaydenFGFarrarJPatient-oriented pandemic influenza researchLancet.200937396812085208610.1016/S0140-6736(09)61131-419541022 15.HaydenFGFarrarJPeirisJSTowards improving clinical management of" exact="Middle East respiratory syndrome" post="coronavirus infectionLancet Infect Dis201414754454610.1016/S1473-3099(14)70793-524964934 16.Grein J, Ohmagari N, Shin"/>
   <result pre="AM, Horby PW. Offering patients more: how the West Africa" exact="Ebola" post="outbreak can shape innovation in therapeutic research for emerging"/>
   <result pre="M, Bell JL, et al. Dexamethasone in hospitalized patients with" exact="Covid-19" post="- preliminary report. N Engl J Med. 2020. 21.The"/>
   <result pre="National Academies Press. Integrating clinical research into epidemic response: the" exact="Ebola" post="experience. Washington, DC: The National Academies of Sciences, Engineering,"/>
   <result pre="operational complexities of conducting a clinical treatment trial during an" exact="Ebola" post="virus disease epidemicClin Infect Dis20186691454145710.1093/cid/cix106129206908 24.Wellcome Trust and The"/>
   <result pre="from: https://acmedsci.ac.uk/file-download/38069-561595082cd83.pdf. Accessed 29 Apr 2020. 25.DunningJKennedySBAntierensAWhiteheadJCigleneckiICarsonGet al.Experimental treatment of" exact="Ebola" post="virus disease with brincidofovirPLoS One2016119e016219910.1371/journal.pone.016219927611077 26.ChengVCChanJFcollab: To KKYuenKYClinical management"/>
   <result pre="middle-income countriesEmerg Infect Dis201925112084208710.3201/eid2511.18062831625845 28.Gubareva LV, Kaiser L, Hayden FG." exact="Influenza" post="virus neuraminidase inhibitors. Lancet. 2000;355(9206):827â€&quot;35. 29.XingWHejblumGLeungGMValleronAJAnatomy of the epidemiological"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441399\results\search\zoonosis\results.xml">
   <result pre="Viewpoint discusses insights from basic science and clinical perspectives on" exact="coronavirus disease 2019" post="(COVID-19)/severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection in the brain,"/>
   <result pre="is important. In contrast to the 1918 influenza pandemic and" exact="avian flu," post="reports of encephalopathy in COVID-19 have been slow to"/>
   <result pre="are typically more dangerous for the young15. The impression that" exact="SARS-CoV-2 infection" post="was particularly pathogenic in older frail subjects has been"/>
   <result pre="infection and development of transient parkinsonism is reported54. Notably, the" exact="avian flu" post="resulted in parkinsonism in many survivors55. Other viral infections"/>
   <result pre="development of transient or, more rarely, permanent parkinsonism, including Epstein-Barr," exact="Japanese encephalitis," post="Coxsackie, West Nile, Western equine encephalomyelitis, and human immunodeficiency"/>
   <result pre="by cleaving sialic acid; (3) that the shedding pattern of" exact="SARS-CoV-2 infection" post="is different from that of SARS-CoV and more similar"/>
   <result pre="dysfunction, inflammation, and endoplasmic reticulum stress, it is possible that" exact="SARS-CoV-2 infection" post="may prompt protein misfolding and aggregation (Fig. 1)103â€&quot;105. Of"/>
   <result pre="astrocytes. The need for detailed autopsy studies As deaths from" exact="SARS-CoV-2 infection" post="continue, autopsy studies will play a key role in"/>
   <result pre="We thus expect a delay in understanding whether and how" exact="SARS-CoV-2 infection" post="specifically alters neuropathology, including in PD. Of the available"/>
   <result pre="neuropathologic alterations, the extent of involvement of the CNS in" exact="SARS-CoV-2 infection" post="cannot be inferred from only 14 brains. To establish"/>
   <result pre="cannot be inferred from only 14 brains. To establish how" exact="SARS-CoV-2 infection" post="affects the CNS, the field will require detailed neuropathologic"/>
   <result pre="leptomeningitis, encephalitis, and vasculitis. The clinical perspective Clinical implications of" exact="SARS-CoV-2 infection" post="on PD are largely speculative apart from two case"/>
   <result pre="disease patients exposed to self-isolation or b, c infection with" exact="Coronavirus disease 2019" post="virus. Conclusions There has been a large number of"/>
   <result pre="and astrocytes. In contrast to the 1918 influenza pandemic and" exact="avian flu," post="reports of encephalopathy in COVID-19 have been slow to"/>
   <result pre="ONE20138e6419823717567 8.SalamatbakhshMMobarakiKSadeghimohammadiSAhmadzadehJThe global burden of premature mortality due to the" exact="Middle East respiratory syndrome" post="(MERS) using standard expected years of life lost, 2012"/>
   <result pre="Syndr.20201440741232335367 11.ChenNet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751332007143 12.Grifoni, A. et"/>
   <result pre="26.Mao, L. et al. Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, China. JAMA Neurol.10.1001/jamaneurol.2020.1127 (2020). 27.Esposito, G. et"/>
   <result pre="F., Moll, J., Munoz, D. P. &amp;amp; Ferreira, S. T." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) and the central nervous system. Trends"/>
   <result pre="Clinical and epidemiological characteristics of 1,420 European patients with mild-to-moderate" exact="coronavirus disease 2019." post="J. Intern. Med.10.1111/joim.13089 (2020). 36.KotfisKet al.COVID-19: ICU delirium management"/>
   <result pre="with Parkinsonâ€™s diseaseMov. Disord.199271531581316552 48.ArabiYMet al.Severe neurologic syndrome associated with" exact="Middle East respiratory syndrome" post="corona virus (MERS-CoV)Infection20154349550125600929 49.YehEACollinsACohenMEDuffnerPKFadenHDetection of coronavirus in the central"/>
   <result pre="a new mechanism of action of chloroquine and hydroxychloroquine against" exact="SARS-CoV-2 infection." post="Int. J. Antimicrob. Agents.10.1016/j.ijantimicag.2020.105960 (2020). 65.Milanetti, E., Miotto, M.,"/>
   <result pre="Blood. Flow. Metab.201333132123072749 86.Pilotto, A. et al. Steroid-responsive encephalitis in" exact="Covid-19" post="disease. Ann. Neurol. 10.1002/ana.25783 (2020). 87.TipnisSRet al.A human homolog"/>
   <result pre="diseaseCompr. Physiol.2014480582624715569 119.MÃ©ndez-Guerrero, A. et al. Acute hypokinetic-rigid syndrome following" exact="SARS-CoV-2 infection." post="Neurology.10.1212/wnl.0000000000010282 (2020). 120.Rodriguez-Perez, A. I. et al. Angiotensin type"/>
   <result pre="Infect. Dis.10.3201/eid2609.201353 (2020). 143.Menter, T. et al. Post-mortem examination of" exact="COVID19" post="patients reveals diffuse alveolar damage with severe capillary congestion"/>
   <result pre="fatigue syndrome: a short reviewMicrobiol. Sci.198853663692856301 159.GuanWJet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN. Engl. J. Med.20203821708172032109013 160.Lazcano-OcampoCet al.Identifying and responding"/>
   <result pre="M. H. Amantadine disrupts lysosomal gene expression: a hypothesis for" exact="COVID19" post="treatment. Int. J. Antimicrob. Agents. 10.1016/j.ijantimicag.2020.106004 (2020). 163.Martinez-MartinPet al.Impact"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441762\results\search\zoonosis\results.xml">
   <result pre="inhibitor of RdRp and antimalarial drug chloroquine effectively inhibited the" exact="SARS-CoV-2 infection" post="inÂ vitro (M. Wang etÂ al., 2020). Hydroxychloroquine, an"/>
   <result pre="the disposition of a pharmaceutical compound within an organism COVID-19" exact="Coronavirus disease 2019" post="main protease (Mpro) a cysteine protease, the main target"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441776\results\search\zoonosis\results.xml">
   <result pre="and structureâ€&quot;activity relationship studies to identify potent approved drugs for" exact="Covid-19" post="treatment M. M. Rahman et al. Journal of Biomolecular"/>
   <result pre="respiratory syndrome coronavirus (SARS-CoV) in Guangdong, China in 2003 and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012 have shown a high fatality"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7442131\results\search\zoonosis\results.xml">
   <result pre="worldwide attention. On December 1, 2019, the first case of" exact="coronavirus disease 2019" post="(COVID-19), caused by a novel coronavirus (SARS-CoV-2), was reported"/>
   <result pre="lessons that we have learned from COVID-19 and SARS. Keywords" exact="Coronavirus disease 2019" post="(COVID-19) SARS-CoV-2 SARS Pandemic Chinese experience Background After the"/>
   <result pre="Prognosis Mortality rate 11% Lower than that of SARS SARS:" exact="Severe acute respiratory syndrome;" post="COVID-19: Coronavirus disease 2019; CRP: C-reactive protein; APTT: Activated"/>
   <result pre="than that of SARS SARS: Severe acute respiratory syndrome; COVID-19:" exact="Coronavirus disease 2019;" post="CRP: C-reactive protein; APTT: Activated partial thromboplastin time; LDH:"/>
   <result pre="both TCM and Western medicine. (5)Professor Zhong Nanshan noted that" exact="SARS-CoV-2 infection" post="does not provide immunity from one infection for life"/>
   <result pre="saving patients' lives and providing recommendations for epidemic control. SARS:" exact="Severe acute respiratory syndrome;" post="COVID-19: Coronavirus disease 2019; CT: Computed tomography; TCM: Traditional"/>
   <result pre="recommendations for epidemic control. SARS: Severe acute respiratory syndrome; COVID-19:" exact="Coronavirus disease 2019;" post="CT: Computed tomography; TCM: Traditional Chinese medicine; FDA: Food"/>
   <result pre="potential intermediate hosts of SARS-CoV-2J Med Virol926202059560110.1002/jmv.2572632100877 12GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med3821820201708172010.1056/NEJMoa200203232109013 13AzharE.I.HuiD.S.C.MemishZ.A.DrostenC.ZumlaA.The middle east respiratory"/>
   <result pre="new outbreaksNature202010.1038/d41586-020-00822-xpublished online Mar 20 23MizumotoK.KagayaK.ZarebskiA.ChowellG.Estimating the asymptomatic proportion of" exact="coronavirus disease 2019" post="(COVID-19) cases on board the Diamond Princess cruise ship,"/>
   <result pre="Respir J5552020200054732217650 27ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet39510223202050751332007143 28LeeN.HuiD.WuA.ChanP.CameronP.JoyntG.M.A major outbreak"/>
   <result pre="37AhnD.G.ShinH.J.KimM.H.LeeS.KimH.S.MyoungJ.Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel" exact="coronavirus disease 2019" post="(COVID-19)J Microbiol Biotechnol303202031332410.4014/jmb.2003.0301132238757 38LiH.ChenX.HuangH.The novel coronavirus outbreak: what can"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7443229\results\search\zoonosis\results.xml">
   <result pre="due to the production of ROS, aggravating infections caused by" exact="coronavirus disease 2019" post="(COVID-19) [34]. Mitochondria have an essential function in energy"/>
   <result pre="it too was not successful in the clinical treatment of" exact="SARS-CoV infection" post="[110]. Many antioxidant compounds show antiviral activity against SARS-CoV."/>
   <result pre="114]. Moreover, some natural antioxidants exhibit promising antiviral activity against" exact="SARS-CoV infection" post="by interfering with different targets involved in SARS-CoV replication,"/>
   <result pre="coronavirus-229E 3CLpro: 3C-like protease ABTS: 2,2â€²-Azino-bis-3-ethylbenzthiazoline-6-sulphonic acid CoVs: Coronaviruses COVID-19:" exact="Coronavirus disease 2019" post="CAT: Catalase DAD: Diffuse alveolar damage DPPH: 2,2-Diphenyl-1-picrylhydrazyl FRAP:"/>
   <result pre="protease RNS: Reactive nitrogen species ROS: Reactive oxygenated species SARS:" exact="Severe acute respiratory syndrome" post="SARS-CoV: Severe acute respiratory syndrome-coronavirus SOD: Superoxide dismutase TBARS:"/>
   <result pre="the pathogenesis mechanism, animal models and novel therapeutic interventions for" exact="Middle East respiratory syndrome" post="coronavirus infectionsFrontiers in Microbiology20191010.3389/fmicb.2019.00569 15PeirisJ. S. M.ChuC. M.ChengV. C."/>
   <result pre="229E infectionThe Journal of Infectious Diseases2008197681281610.1086/52837718269318 34TanW.AboulhosnJ.The cardiovascular burden of" exact="coronavirus disease 2019" post="(COVID-19) with a focus on congenital heart diseaseInternational Journal"/>
   <result pre="A.MomattinH.DibJ.MemishZ. A.Ribavirin and interferon therapy in patients infected with the" exact="Middle East respiratory syndrome" post="coronavirus: an observational studyInternational Journal of Infectious Diseases201420424610.1016/j.ijid.2013.12.00324406736 109FerronF.SubissiL.Silveira"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7443335\results\search\zoonosis\results.xml">
   <result pre="findings in reference to Severe Acute Respiratory Syndrome (SARS) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS). In a short span of time, it"/>
   <result pre="and bladder suggesting that these organs may be vulnerable to" exact="SARS-CoV-2 infection," post="which may help to understand the routes of infection"/>
   <result pre="routes of infection and disease manifestations [32]. However, patients with" exact="SARS-CoV-2 infection" post="primarily exhibit lesions in the lungs, despite the ACE-2"/>
   <result pre="was significantly higher than that in the patients. Infection with" exact="MERS coronavirus" post="can induce increased concentration of pro-inflammatory cytokines (tumor 616"/>
   <result pre="and clinical effects in a non-lethal rhesus macaque model of" exact="SARS-CoV-2 infection," post="(reduced pulmonary infiltrates and virus titres in broncho-alveolar lavages"/>
   <result pre="confirmation of acute stroke and PCR (polymerase chain reaction) confirmed" exact="SARS-CoV-2 infection" post="and elucidated the imaging findings, clinical characteristics, and the"/>
   <result pre="tested for antiviral activity in an experimental infection assay using" exact="Ebola" post="virus glycoprotein pseudotyped viral particles on Jurkat cells over"/>
   <result pre="technology platform, applied to develop the globally innovative vaccine against" exact="Ebola" post="virus [125] [[126], [127], [128]] 3 mRNA-1273 Lipid nanoparticle"/>
   <result pre="12 LV-SMENP-DC Modified dendritic cells (DC) with lentivirus vectors expressing" exact="Covid-19" post="minigene (SMENP) and immune-modulatory genes. Shenzhen Geno-Immune Medical Institute(NCT04276896)"/>
   <result pre="experimentally infected BALB/c mice [150] 6 Nonlinear globular G2 dendrimer" exact="Rabies" post="virus â€&quot; Adjuvanticity efficacy [151] 7 Ammonium-terminated amphiphilic Janus"/>
   <result pre="Clin. Pathol.153202042042110.1093/ajcp/aqaa02932053148 2GuoY.R.CaoQ.D.HongZ.S.TanY.Y.ChenS.D.JinH.J.Sen TanK.WangD.Y.YanY.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak- an update on the statusMil. Med. Res.7202011010.1186/s40779-020-00240-031928528"/>
   <result pre="Crit. Care Med.2012020P7P810.1164/rccm.2014P732004066 13WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="and cytokines in peripheral blood of 123 hospitalized patients with" exact="2019 novel coronavirus pneumonia" post="(NCP)MedRxiv.202010.1101/2020.02.10.200218322020.02.10.20021832 38(No Title), (n.d.). https://www.mohfw.gov.in/pdf/GuidelinesonClinicalManagementofCOVID1912020.pdf (accessed June 15, 2020)."/>
   <result pre="Remdesivir in comparison with ribavirin, Favipiravir, Oseltamivir and Umifenovir in" exact="coronavirus disease 2019" post="(COVID-19) pandemicSSRN Electron. J.202010.2139/ssrn.3569866 45VellingiriB.JayaramayyaK.IyerM.NarayanasamyA.GovindasamyV.GiridharanB.GanesanS.VenugopalA.VenkatesanD.GanesanH.RajagopalanK.RahmanP.K.S.M.ChoS.G.KumarN.S.SubramaniamM.D.COVID-19: a promising cure for"/>
   <result pre="2, 2020). 78SarkarD.S.Silver nanoparticles with bronchodilators through nebulisation to treat" exact="COVID 19" post="patientsJ. Curr. Med. Res. Opin.32020449450449â€&quot;45010.15520/jcmro.v3i04.276 79EtemadzadeM.GhamarypourA.ZabihollahiR.shabbakG.ShiraziM.SahebjameeH.VaziriA.Z.AssadiA.ArdestaniM.S.ShandizS.A.S.AghasadeghiM.R.Synthesis and evaluation of"/>
   <result pre="therapeutic drugs tracker, (n.d). https://biorender.com/covid-vaccine-tracker/details/d-0111/methylprednisolone-ciclesonide-hydrocortisone-glucocorticoids-mineralocorticoids-dexamethasone (accessed June 18, 2020). 13310" exact="Covid-19" post="candidate vaccines in clinical evaluation, (n.d). https://www.magzter.com/article/Business/BioSpectrum-Asia/10-Covid-19-Candidate-Vaccines-In-Clinical-Evaluation (accessed June"/>
   <result pre="(accessed June 18, 2020). 136Novavax to commence human trial for" exact="Covid-19" post="vaccine, (n.d.). https://www.clinicaltrialsarena.com/news/novavax-covid-19-vaccine-trial/ (accessed June 18, 2020). 137Evaluation of"/>
   <result pre="ClinicalTrials.gov, (n.d.). https://clinicaltrials.gov/ct2/show/NCT04368728?term=vaccine&amp;amp;cond=covid-19&amp;amp;draw=3 (accessed June 18, 2020). 140And Safety of" exact="Covid-19" post="Synthetic Minigene VaccineImmunity - Full Text View - ClinicalTrials.gov,"/>
   <result pre="Research Roadmap: 2019 Novel Coronavirus2020 142Arshad AliS.BalochM.AhmedN.Arshad AliA.IqbalA.The outbreak of" exact="coronavirus disease 2019" post="(COVID-19)â€&quot;an emerging global health threatJ. Infect. Public Health13202064464610.1016/j.jiph.2020.02.03332199792 143M."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7444586\results\search\zoonosis\results.xml">
   <result pre="pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries." exact="Influenza" post="Other Respir Viruses. 2013;7(5):872â€&quot;86. 10.1111/irv.1207423331969 30GilbertM, PullanoG, PinottiF, ValdanoE,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7445016\results\search\zoonosis\results.xml">
   <result pre="Comprehensive Clinical Medicine2523-8973Springer International PublishingCham pmcid: 7445016457 doi: 10.1007/s42399-020-00457-z :" exact="Covid-19" post="Managing the COVID-19 Pandemic: Research Strategies Based on the"/>
   <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. Abstract" exact="Coronavirus disease 2019" post="(COVID-19), an ongoing global health emergency, is a highly"/>
   <result pre="as asymptomatic carriers [38â€&quot;40]. The possibility for gastrointestinal involvement in" exact="SARS-CoV-2 infection" post="and feco-oral transmission has been suggested [41]. WHO has"/>
   <result pre="investigated is the genetic predisposition for an increased risk of" exact="SARS-CoV-2 infection," post="which might be due to ACE2 polymorphisms that have"/>
   <result pre="features and viral diagnosis of two cases of infection with" exact="Middle East respiratory syndrome" post="coronavirus: a report of nosocomial transmissionLancet20133812265227223727167 10.Wu F, Zhao"/>
   <result pre="severe acute respiratory syndromeAm J Pathol20071701136114717392154 16.van den BrandJMASmitsSLHaagmansBLPathogenesis of" exact="Middle East respiratory syndrome" post="coronavirusJ Pathol201523517518425294366 17.WHO. Middle East respiratory syndrome coronavirus (MERS-CoV)."/>
   <result pre="den BrandJMASmitsSLHaagmansBLPathogenesis of Middle East respiratory syndrome coronavirusJ Pathol201523517518425294366 17.WHO." exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). https://www.who.int/csr/don/12-march-2020-mers-qatar/en. 18.World-Health-Organization Statement on the second meeting"/>
   <result pre="et al. Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet. 2020. 10.1016/S01406736(20)30211-7."/>
   <result pre="33.ArabiYMArifiAABalkhyHHet al.Clinical course and outcomes of critically ill patients with" exact="Middle East respiratory syndrome" post="coronavirus infectionAnn Intern Med201416038939724474051 34.NaZDingyuZWenlingWLiXBoYJingdongSXiangZBaoyingHet al.A novel coronavirus from"/>
   <result pre="coronavirusesVirol J20151222110.1186/s12985-015-0422-126689940 55.GuoYCaoQHongZet al.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak â€&quot; an update on the statusMil Med"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7445120\results\search\zoonosis\results.xml">
   <result pre="HbA1c, Glycated hemoglobin A1c ICU, Intensive care unit COVID-19, Novel" exact="coronavirus disease 2019" post="NT-proBNP, N-terminal brain natriuretic peptide precursor SARS-CoV-2, Severe acute"/>
   <result pre="coronavirus disease 2019 NT-proBNP, N-terminal brain natriuretic peptide precursor SARS-CoV-2," exact="Severe acute respiratory syndrome" post="coronavirus 2 1 Introduction Since Dec 2019, the novel"/>
   <result pre="syndrome coronavirus 2 1 Introduction Since Dec 2019, the novel" exact="coronavirus disease 2019" post="(COVID-19) has spread rapidly around the world and infected"/>
   <result pre="previous viral epidemics, such as the outbreak of SARS-CoV-1 and" exact="Middle East respiratory syndrome" post="coronavirus [7], [8]. Similar conclusions were reported in the"/>
   <result pre="were admitted from February 3, 2020 to February 26, 2020." exact="SARS-CoV-2 infection" post="was confirmed in all patients based on reverse transcription-polymerase"/>
   <result pre="and PreventionJAMA202010.1001/jama.2020.2648 3ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet (London, England)39510223202050751310.1016/s0140-6736(20)30211-7 4ZhouF.YuT.DuR.FanG.LiuY.LiuZ.Clinical"/>
   <result pre="and reviews, e3319 (2020). doi:10.1002/dmrr.3319 10HuangR.ZhuL.XueL.LiuL.YanX.WangJ.Clinical findings of patients with" exact="coronavirus disease 2019" post="in Jiangsu province, China: A retrospective, multi-center studyPLoS NeglTrop"/>
   <result pre="COVID-19 epidemicDiabet Metabolic Syndrome143202021121210.1016/j.dsx.2020.03.002 15BadawiA.RyooS.G.Prevalence of Diabetes in the 2009" exact="Influenza" post="A (H1N1) and the Middle East Respiratory Syndrome Coronavirus:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7445369\results\search\zoonosis\results.xml">
   <result pre="[13]. Lessons from the Past Neurological complications as sequelae of" exact="influenza infection" post="have been documented for over a century. In an"/>
   <result pre="have been then associated with secondary Parkinsonisms. These include Coksackievirus;" exact="Japanese encephalitis" post="B, St. Louis, and West Nile viruses; and HIV"/>
   <result pre="paralysis, and acute flaccid myelitis. Other Coronaviruses and Neurological Disorders" exact="Severe acute respiratory syndrome" post="(SARS) is a zoonotic respiratory disease caused by a"/>
   <result pre="detected in the brain [26]. Another zoonotic disease is the" exact="Middle East respiratory syndrome" post="(MERS) that in 2012 marked the introduction of MERS-CoV,"/>
   <result pre="Effects of Vaccines A significantly increased incidence of GBS after" exact="swine flu" post="vaccination in the USA in 1976 led to a"/>
   <result pre="to explore the association between influenza vaccination and GBS [34]." exact="Influenza" post="vaccination was associated with GBS, with a relative risk"/>
   <result pre="Complications or Stochastic Findings? The increased incidence of GBS after" exact="swine flu" post="vaccination raised several claims that the vaccine was the"/>
   <result pre="Behav Immun2020Mar 30S0889-1591(20)303573 5MaoLJinHWangMHuYChenSHeQet al.Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, ChinaJAMA Neurol2020Apr 10e201127 6GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of"/>
   <result pre="2019 in Wuhan, ChinaJAMA Neurol2020Apr 10e201127 6GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med2020Apr 30382(18)17082032109013 7ChenTWuDChenHYanWYangDChenGet al.Clinical characteristics"/>
   <result pre="in Central America and Dominican Republic 2009â€&quot;2010BMC Public Health20151573426227404 20ColtartCELindseyBGhinaiIJohnsonAMHeymannDLThe" exact="Ebola" post="outbreak, 2013â€&quot;2016: old lessons for new epidemicsPhilos Trans R"/>
   <result pre="Soc Lond, B, Biol Sci2017372(1721)2016029728396469 21BilliouxBJNeurological complications and sequelae of" exact="Ebola" post="virus diseaseCurr Infect Dis Rep201719(5)1928391498 22WongGQiuXBiYFormentyPSprecherAJacobsMet al.More challenges from"/>
   <result pre="Med2005202(3)4152416043521 27SaadMOmraniASBaigKBahloulAElzeinFMatinMAet al.Clinical aspects and outcomes of 70 patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a single-center experience in Saudi ArabiaInt J"/>
   <result pre="diseaseMov Disord19927(2)15381316552 33SchonbergerLBBregmanDJSullivan-BolyaiJZKeenlysideRAZieglerDWRetailliauHFet al.Guillain-Barre syndrome following vaccination in the National" exact="Influenza" post="Immunization Program, United States, 1976â€&quot;1977Am J Epidemiol1979110(2)10523463869 34GaleottiFMassariMD'AlessandroRBeghiEChiÃ²ALogroscinoGet al.Risk"/>
   <result pre="survival?J Neurol Sci2020May 641411688932416370 43CasoVFedericoANo lockdown for neurological diseases during" exact="COVID19" post="pandemic infectionNeurol Sci202041(5)999100132270358 44KermaliMKhalsaRKPillaiKIsmailZHarkyAThe role of biomarkers in diagnosis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7446744\results\search\zoonosis\results.xml">
   <result pre="1 interferon response has been demonstrated in mice models of" exact="SARS-CoV infection" post="[22]. It is postulated that similar suppressed type 1"/>
   <result pre="may potentially increase the risk of severity and fatality of" exact="COVID 19" post="infection [59]. However, currently there is no definite evidence"/>
   <result pre="COVID-19: a systematic reviewEClinicalMedicine20202310040410.1016/j.eclinm.2020.10040432632416 14.EllinghausDDegenhardtFBujandaLButiMAlbillosAInvernizziPet al.Genomewide association study of severe" exact="Covid-19" post="with respiratory failureN Engl J Med.202010.1056/NEJMoa202028332558485 15.LatzCADeCarloCBoitanoLPngCYMPatellRConradMFet al.Blood type"/>
   <result pre="al.Reduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVID-19)Front Immunol20201182710.3389/fimmu.2020.0082732425950 25.QinCZhouLHuZZhangSYangSTaoYet al.Dysregulation of immune response in patients"/>
   <result pre="Haemost202018484484710.1111/jth.1476832073213 31.ChenNZhouMDongXQuJGongFHanYet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet20203951022350751310.1016/S0140-6736(20)30211-732007143 32.GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics"/>
   <result pre="in Wuhan, China: a descriptive studyLancet20203951022350751310.1016/S0140-6736(20)30211-732007143 32.GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med2020382181708172010.1056/NEJMoa200203232109013 33.LippiGPlebaniMHenryBMThrombocytopenia is associated with"/>
   <result pre="in ChinaN Engl J Med2020382181708172010.1056/NEJMoa200203232109013 33.LippiGPlebaniMHenryBMThrombocytopenia is associated with severe" exact="coronavirus disease 2019" post="(COVID-19) infections: a meta-analysisClin Chim Acta202050614514810.1016/j.cca.2020.03.02232178975 34.YangXYangQWangYWuYXuJYuYet al.Thrombocytopenia and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7447002\results\search\zoonosis\results.xml">
   <result pre="urine biochemical parameters in the prediction of the severity of" exact="coronavirus disease 2019." post="Clin Chem Lab Med.2020;58:1121â€&quot;1124.32286242 7.de PeeSSembaRDRole of nutrition in"/>
   <result pre="depression in 2020. Depress Anxiety.2020;37:302.32266767 43.TeamCC-RSevere outcomes among patients with" exact="coronavirus disease 2019" post="(COVID-19)â€&quot;United States, February 12-March 16, 2020. MMWR Morb Mortal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7448857\results\search\zoonosis\results.xml">
   <result pre="original work is properly cited. http://creativecommons.org/licenses/by/4.0/TEMI_9_1772676.pdf Abstract ABSTRACT The emerging" exact="SARS-CoV-2 infection" post="associated with the outbreak of viral pneumonia in China"/>
   <result pre="urgent to develop some antiviral compounds for the treatment of" exact="SARS-CoV-2 infection" post="because of its high infectivity and morbidity and its"/>
   <result pre="we tested antiviral activity of gemcitabine, lycorine and oxysophoridine against" exact="SARS-CoV-2 infection" post="in cell culture, and chloroquine was used as a"/>
   <result pre="broad spectrum antiviral agent against multiple RNA viruses which include" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV) [4],"/>
   <result pre="in vivo evaluation about the antiviral activity of gemcitabine against" exact="SARS-CoV-2 infection" post="is going to be carried out in the near"/>
   <result pre="found a new indication for oxysophoridine as a compound inhibiting" exact="SARS-CoV-2 infection" post="in cell culture. To our knowledge, this is the"/>
   <result pre="GlassPJ, HensleyLE, FriemanMB.2014Repurposing of clinically developed drugs for treatment of" exact="Middle East respiratory syndrome" post="coronavirus infection. Antimicrob Agents Chemother58:4885-93. doi: 10.1128/AAC.03036-1424841273 5KuivanenS, BespalovMM,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7449407\results\search\zoonosis\results.xml">
   <result pre="many infectious disease-related topics including influenza, misinformation about vaccination, the" exact="Ebola" post="outbreak, and pre-exposure prophylaxis [9â€&quot;12]. Within HIV specifically, social"/>
   <result pre="CIA give us the cure for AIDS before it drops" exact="Ebola" post="off for the weekend? (Misinformation) HIV (post-outbreak)Â Â Â"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7449465\results\search\zoonosis\results.xml">
   <result pre="NK cells and other Fc receptor (FcR) effector cells in" exact="SARS-CoV-2 infection," post="advantages of using animals to model COVID-19, and NK"/>
   <result pre="cell subsets in the periphery. NK cells at sites of" exact="SARS-CoV-2 infection" post="Lung NK cells account for approximately 10% to 20%"/>
   <result pre="such as nausea, vomiting, and diarrhea, are also associated with" exact="SARS-CoV-2 infection" post="with viral shedding in fecal samples [60, 61]. NK"/>
   <result pre="focusing on myeloid cells, neutralizing antibodies, and T cells in" exact="SARS-CoV-2 infection" post="while an important antiviral defense system, the NK cells,"/>
   <result pre="Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe" exact="coronavirus disease 2019" post="(COVID-19): A meta-analysis. J Med Virol. 2020 Epub 2020/04/04."/>
   <result pre="conventional NK cells is epithelial regenerative and inflammation protective during" exact="influenza infection." post="Mucosal Immunol. 2013;6(1):69â€&quot;82. Epub 2012/06/29. 10.1038/mi.2012.4922739232 54ZhouG, JuangSW, KaneKP."/>
   <result pre="BALB/c mice: CD4+ T cells are important in control of" exact="SARS-CoV infection." post="J Virol. 2010;84(3):1289â€&quot;301. Epub 2009/11/13. 10.1128/JVI.01281-0919906920 56ZhaoJ, LiK, Wohlford-LenaneC,"/>
   <result pre="FettC, ZhaoJ, et al.Rapid generation of a mouse model for" exact="Middle East respiratory syndrome." post="Proc Natl Acad Sci U S A. 2014;111(13):4970â€&quot;5. Epub"/>
   <result pre="2020 Epub 2020/02/28. 10.1002/jmv.25728 .32104915 67NetlandJ, MeyerholzDK, MooreS, CassellM, PerlmanS." exact="Severe acute respiratory syndrome" post="coronavirus infection causes neuronal death in the absence of"/>
   <result pre="85de AlwisR CS, GanES, OoiEE. Impact of Immune enhancement on" exact="Covid-19" post="polyclonal hyperimmune globulin therapy and vaccine development. EBioMedicine. 2020"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7449622\results\search\zoonosis\results.xml">
   <result pre="of a Biologically Contained Reporter System To Study Gain-of-Function H5N1" exact="Influenza" post="A Viruses with Pandemic Potential Biologically Contained Gain-of-Function H5N1"/>
   <result pre="previously been applied to study highly pathogenic viruses such as" exact="Ebola" post="virus and Omsk hemorrhagic fever virus safely at lower"/>
   <result pre="Public Health110:669â€&quot;676. doi:10.2105/AJPH.2019.305557.32267748 7.ViboudC, GraisRF, LafontBA, MillerMA, SimonsenL, collab: Multinational" exact="Influenza" post="Seasonal Mortality Study Group. 2005Multinational impact of the 1968"/>
   <result pre="TashiroM, TaubenbergerJK, ThomasPG, TrippRA, TumpeyTM, WebbyRJ, WebsterRG2013Transmission studies resume for" exact="avian flu." post="Science339:520â€&quot;521. doi:10.1126/science.1235140.23345603 34.FouchierRA, Garcia-SastreA, KawaokaY, BarclayWS, BouvierNM, BrownIH, CapuaI,"/>
   <result pre="SwayneDE, TakimotoT, TashiroM, TaubenbergerJK, ThomasPG, TrippRA, TumpeyTM, WebbyRJ, WebsterRG2012Pause on" exact="avian flu" post="transmission research. Science335:400â€&quot;401. doi:10.1126/science.335.6067.400.22282787 35.FouchierRA, Garcia-SastreA, KawaokaY2012Pause on avian"/>
   <result pre="avian flu transmission research. Science335:400â€&quot;401. doi:10.1126/science.335.6067.400.22282787 35.FouchierRA, Garcia-SastreA, KawaokaY2012Pause on" exact="avian flu" post="transmission studies. Nature481:443. doi:10.1038/481443a. 36.LipsitchM, InglesbyTV2014Moratorium on research intended"/>
   <result pre="42.HalfmannP, KimJH, EbiharaH, NodaT, NeumannG, FeldmannH, KawaokaY2008Generation of biologically contained" exact="Ebola" post="viruses. Proc Natl Acad Sci U S A105:1129â€&quot;1133. doi:10.1073/pnas.0708057105.18212124"/>
   <result pre="accelerates sequencing and vaccine production for classical and Swine origin" exact="human influenza" post="A viruses. J Virol83:10309â€&quot;10313. doi:10.1128/JVI.01109-09.19605485"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7451040\results\search\zoonosis\results.xml">
   <result pre="of Wuhan province was then associated with propagation of epidemic" exact="SARS-CoV-2 infection" post="[13]. In other parts of China, a similar disease"/>
   <result pre="pathology features of COVID-19. Mechanisms of escalating clinico-pathological consequences of" exact="SARS-CoV-2 infection." post="SARS-CoV-2 transmissibility/virulence trade-off. Curtailment Triggers for a phased approach"/>
   <result pre="pneumonia caused by SARS-CoV-2J Infect2020pii: S0163-4453(20)30100-6 6LipsitchMSwerdlowDLFinelliLDefining the Epidemiology of" exact="Covid-19" post="- Studies NeededN Engl J Med20203821194119610.1056/NEJMp200212532074416 7LauerSAGrantzKHBiQJonesFKZhengQet al.The incubation"/>
   <result pre="Studies NeededN Engl J Med20203821194119610.1056/NEJMp200212532074416 7LauerSAGrantzKHBiQJonesFKZhengQet al.The incubation period of" exact="coronavirus disease 2019" post="(COVID-19) from publicly reported confirmed cases: estimation and applicationAnn"/>
   <result pre="case dataJ Clin Med20209pii: E538.53810.3390/jcm9020538 9.LauerSAGrantzKHBiQJonesFKZhengQet al.The incubation period of" exact="coronavirus disease 2019" post="(COVID-19) from publicly reported confirmed cases: estimation and applicationAnn"/>
   <result pre="COVID-19 infection in BeijingJ Infect2020pii: S0163-4453(20)30101-8 15SpiteriGFieldingJDierckeMCampeseCEnoufVet al.First cases of" exact="coronavirus disease 2019" post="(COVID-19) in the who European region, 24 January to"/>
   <result pre="Radiol2020110.1097/RLI.000000000000067231503083 17AiTYangZHouHZhanCChenCet al.Correlation of chest CT and RT-PCR testing in" exact="coronavirus disease 2019" post="(COVID-19) in China: a report of 1014 casesRadiology20204220064210.1148/radiol.2020200642 18YanRZhangYLiYXiaLGuoYet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7451056\results\search\zoonosis\results.xml">
   <result pre="by the above-mentioned coronaviruses, the past two decades alone cumulate" exact="swine flu" post="(H1N1), several threatening versions of avian flu (H5Nx), two"/>
   <result pre="decades alone cumulate swine flu (H1N1), several threatening versions of" exact="avian flu" post="(H5Nx), two massive Ebola crises, and the expansion of"/>
   <result pre="(H1N1), several threatening versions of avian flu (H5Nx), two massive" exact="Ebola" post="crises, and the expansion of insect vector-mediated parasitic diseases"/>
   <result pre="any wrong, and might even add some protective benefit against" exact="SARS-CoV-2 infection" post="severity [36]. Brief communication Healthcare workers are fighting at"/>
   <result pre="first documented coronavirus pandemic in historyBiomed J43202032833332387617 2ChauhanS.Comprehensive review of" exact="coronavirus disease 2019" post="(COVID-19)Biomed J43202033434032788071 3CuiJ.LiF.ShiZ.L.Origin and evolution of pathogenic coronavirusesNat Rev"/>
   <result pre="development of pseudoviruses for enveloped virusesRev Med Virol282018e1963 17WelchS.R.GuerreroL.W.ChakrabartiA.K.McMullanL.K.FlintM.BluemlingG.R.Lassa and" exact="Ebola" post="virus inhibitors identified using minigenome and recombinant virus reporter"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7451121\results\search\zoonosis\results.xml">
   <result pre="old drug against today's diseases?Lancet Infect Dis3200372272710.1016/S1473-3099(03)00806-514592603 3SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19). A reviewJAMA202010.1001/jama.2020.6019[Published online April 13, 2020. Article in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7452913\results\search\zoonosis\results.xml">
   <result pre="FDA approved antiviral drugs can be subjected to repurposing against" exact="SARS-CoV-2 infection" post="after verifying the in silico results through in vitro"/>
   <result pre="repurposing these drugs against SARS-CoV-2. Abbreviations 3CLpro, 3C-like proteinase COVID-19," exact="coronavirus disease 2019" post="DOPE, discrete optimized protein energy FDA, Food and Drug"/>
   <result pre="GpppA, Guanosine-P3-adenosine-5â€²,5â€²-triphosphate GRAVY, grand average of hydropathicity GZR, Grazoprevir MERS-CoV," exact="Middle East respiratory syndrome" post="coronavirus N7-MTase, S-adenosyl methionine (SAM)-dependent (guanine-N7) methyltransferase Nsps, non-structural"/>
   <result pre="approved antiviral drugs Molecular docking Homology modelling 1 Introduction The" exact="coronavirus disease 2019" post="(COVID-19) caused by severe acute respiratory syndrome coronavirus 2"/>
   <result pre="(Chan-Yeung and Xu, 2003) and the disease caused by the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012 which emerged in Saudi Arabia"/>
   <result pre="Cidofovir CDV 60613 Acyclic nucleoside phosphonate analogues Amantadine AMT 2130" exact="Influenza" post="virus inhibitors Ribavirin RBV 37542 Rimantadine RIM 5071 Zanamivir"/>
   <result pre="replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and" exact="Middle East respiratory syndrome" post="coronavirusesAntimicrob. Agents Chemother.5820144894489824841268 AouadiW.EydouxC.CoutardB.MartinB.DebartF.VasseurJ.J.ContrerasJ.M.MoriceC.QuÃ©ratG.JungM.-L.Toward the identification of viral cap-methyltransferase"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7453465\results\search\zoonosis\results.xml">
   <result pre="SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Abstract The emergence of" exact="coronavirus disease 2019" post="(COVID-19) in December 2019 has resulted in over 20"/>
   <result pre="SARS-CoV-2 genome is organized similarly to those of SARS-CoV-1 and" exact="Middle East respiratory syndrome" post="(MERS)-CoV.4 Using phylogenetic analysis, the SARS-CoV-2 genome was demonstrated"/>
   <result pre="3 highlights the onset and progression of SARS-CoV-1, MERS-CoV, and" exact="SARS-CoV-2 infection." post="The first case of SARS-CoV-1, reported in China, resulted"/>
   <result pre="a novel antiviral drug and nucleotide analog used to treat" exact="Ebola" post="virus infection, is currently under clinical development. The mechanism"/>
   <result pre="is likely to affect susceptibility, symptoms and intervention outcomes following" exact="SARS-CoV-2 infection." post="Precautionary measures against COVID-19 The degree of spread of"/>
   <result pre="35ChenNZhouMDongX, et al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: A descriptive study. Lancet2020; 395: 507â€&quot;513.32007143"/>
   <result pre="89: 7202.25926653 44OmraniASSaadMMBaigK, et al.Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: A retrospective cohort study.Lancet Infect Dis2014; 14:"/>
   <result pre="in China. Intensive Care Med2020; 46: 837â€&quot;840.32123994 62LiJPOLamDSCChenY, et al.Novel" exact="coronavirus disease 2019" post="(COVID-19): The importance of recognising early possible ocular manifestation"/>
   <result pre="Ocul Immunol Inflamm2020; 28: 391â€&quot;395.32175797 64GuanWJNiZYHuY, et al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med2020; 382: 1708â€&quot;1720.32109013 65XiaJTongJLiuM,"/>
   <result pre="J Microbiol Immunol Infect2020; 53: 404â€&quot;412.32173241 68collab: World Health Organization." exact="Coronavirus disease 2019" post="(COVID-19) situation report 51, https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 (2020, accessed 1 August"/>
   <result pre="JAMA2020; 323: 1406â€&quot;1407. 72WuZMcGooganJM.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: Summary of a report of"/>
   <result pre="25: 278â€&quot;280.32052514 74XiongMLiangXWeiYD.Changes in blood coagulation in patients with severe" exact="coronavirus disease 2019" post="(COVIDâ€�19): A metaâ€�analysis. Br J Haematol2020; 189: 1050â€&quot;1052.32304581 75LeviMThachilJIbaT,"/>
   <result pre="76HanHYangLLiuR, et al.Prominent changes in blood coagulation of patients with" exact="SARS-CoV-2 infection." post="Clin Chem Lab Med2020; 58: 1116â€&quot;1120.32172226 77ZengQKhanKWuJ, et al.The"/>
   <result pre="et al.Real-time sequence-validated loop-mediated isothermal amplification assays for detection of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). PLoS One2015; 10: e0123126. 80ChanJFWChoiGKYTsangAKL, et al.Development"/>
   <result pre="87collab: COVID C, Team R. Severe outcomes among patients with" exact="coronavirus disease 2019" post="(COVID-19)â€&quot;United States, February 12â€&quot;March 16, 2020. MMWR Morb Mortal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7453598\results\search\zoonosis\results.xml">
   <result pre="in the last twenty years, such as Zika, Ebola, SARS," exact="bird flu," post="MERS and, more recently of course, COVID-19. The United"/>
   <result pre="Virusâ€™ CommentNDTVNew Delhi2020https://www.ndtv.com/world-news/china-says-linking-coronavirus-to-country-kind-of-stigmatisation-after-us-president-donald-trumps-co-21961223172020 23VagenaEThe fight over the imperialist system around" exact="Covid-19" post="and the outlet for workersCorona News242020https://www.corona24.news/u/2020/03/23/the-fight-over-the-imperialist-system-around-covid-19-and-the-outlet-for-workers.html3232020 24HawksworthJAudinoHClarryRThe Long View:"/>
   <result pre="global economic order change by 2050? PwC, London, 2017https://www.pwc.com/gx/en/world-2050/assets/pwc-world-in-2050-summary-report-feb-2017.pdf 25AikenVWhy" exact="Covid-19" post="is changing our perceptions of social class and riskDiscover"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7454306\results\search\zoonosis\results.xml">
   <result pre="July 2020, approximately 6 months into the pandemic of novel" exact="coronavirus disease 2019" post="(COVID-19), whether people living with HIV (PLWH) are disproportionately"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7454523\results\search\zoonosis\results.xml">
   <result pre="immune mediated multi-organ failure. severe acute respiratory syndrome coronavirus 1" exact="Middle East respiratory syndrome" post="coronavirus severe acute respiratory syndrome coronavirus 2 coronavirus disease"/>
   <result pre="East respiratory syndrome coronavirus severe acute respiratory syndrome coronavirus 2" exact="coronavirus disease 2019" post="cytokine release syndrome pneumonia acute respiratory distress syndrome acute"/>
   <result pre="BalkhyHHet al.Clinical course and outcomes of critically ill patients with" exact="Middle East respiratory syndrome" post="coronavirus infection. Ann Intern Med. 2014;160:389â€&quot;97.24474051 ArabiYM, HarthiA, HusseinJet"/>
   <result pre="Med. 2014;160:389â€&quot;97.24474051 ArabiYM, HarthiA, HusseinJet al.Severe neurologic syndrome associated with" exact="Middle East respiratory syndrome" post="corona virus (MERS-CoV). Infection. 2015;43:495â€&quot;501.25600929 BaasT, TaubenbergerJK, ChongPYet al.SARS-CoV"/>
   <result pre="Antimicrob Agents. 2020;0:48:105949. HongKH, ChoiJP, HongSHet al.Predictors of mortality in" exact="Middle East respiratory syndrome" post="(MERS). Thorax. 2018;73:286â€&quot;9.28724637 HorisbergerA, LaÂ RosaS, ZurcherJPet al.A severe"/>
   <result pre="2003;49:2108â€&quot;9.14633896 JiangF, DengL, ZhangLet al.Review of the clinical characteristics of" exact="coronavirus disease 2019" post="(COVID-19). J Gen Intern Med. 2020;35:1545â€&quot;9.32133578 JoseRJ, ManuelACOVID-19 cytokine"/>
   <result pre="PLoS Curr. 2014;6. MizumotoK, SaitohM, ChowellGet al.Estimating the risk of" exact="Middle East respiratory syndrome" post="(MERS) death during the course of the outbreak in"/>
   <result pre="OmraniAS, BaigKet al.Clinical aspects and outcomes of 70 patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a single-center experience in Saudi Arabia. J"/>
   <result pre="and cytokines in peripheral blood of 123 hospitalized patients with" exact="2019 novel coronavirus pneumonia" post="(NCP). medRxiv. 2020, 10.1101/2020.02.10.20021832. collab: World Health OrganizationConsensus Document"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7456638\results\search\zoonosis\results.xml">
   <result pre="contains supplementary material, which is available to authorized users. Keywords" exact="Influenza" post="A virus PARP Olaparib Pneumonia Cytokines Introduction Influenza is"/>
   <result pre="users. Keywords Influenza A virus PARP Olaparib Pneumonia Cytokines Introduction" exact="Influenza" post="is an acute infectious disease affecting respiratory tracts accompanied"/>
   <result pre="accompanied with different clinical manifestations ranging from wild to lethal." exact="Influenza" post="causes seasonal, unpredictable epidemics and it is now one"/>
   <result pre="virus (IAV) has caused pandemics up to now, and most" exact="human influenza" post="cases are due to the infection of two IAV"/>
   <result pre="the Animal Care and Use Committee of Cangzhou Central Hospital." exact="Influenza" post="virus The A/Font Monmouth/47(H1N1, FM1) mouse-adapted influenza virus (Chinese"/>
   <result pre="shocking and heart-wrenching facts in history, e.g., the 1918 Great" exact="Influenza" post="killed almost 1/30 of the global population only in"/>
   <result pre="Not applicable. References References 1.RambautAPybusOGNelsonMIViboudCTaubenbergerJKHolmesECThe genomic and epidemiological dynamics of" exact="human influenza" post="A virusNature20084537195615U61210.1038/nature0694518418375 2.BedfordTRileySBarrIGBroorSChadhaMCoxNJDanielsRSGunasekaranCPHurtACKelsoAKlimovALewisNSLiXYMcCauleyJWOdagiriTPotdarVRambautAShuYLSkepnerESmithDJSuchardMATashiroMWangDYXuXYLemeyPRussellCAGlobal circulation patterns of seasonal influenza viruses"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7456910\results\search\zoonosis\results.xml">
   <result pre="often in the abdomen. Similar to the severe cases of" exact="SARS-CoV-2 infection" post="in humans resulting in ARDS and over-activation of the"/>
   <result pre="immunology and treatment options. Clin Immunol. (2020) 215:108448. 10.1016/j.clim.2020.10844832353634 8.LaiC-CShihT-PKoW-CTangH-JHsuehP-R." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic"/>
   <result pre="12.ChenGWuDGuoWCaoYHuangDWangHet al.. Clinical and immunological features of severe and moderate" exact="coronavirus disease 2019." post="J Clin Invest. (2020) 130:2620â€&quot;9. 10.1172/JCI13724432217835 13.TangNBaiHChenXGongJLiDSunZ. Anticoagulant treatment"/>
   <result pre="13.TangNBaiHChenXGongJLiDSunZ. Anticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathy. J Thromb Haemost. (2020) 18:1094â€&quot;9. 10.1111/jth.1481732220112"/>
   <result pre="10.1016/S0140-6736(20)30566-332171076 16.GuoY-RCaoQ-DHongZ-STanY-YChenS-DJinH-Jet al.. The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;an update on the status. Mil Med Res."/>
   <result pre="[Epub ahead of print]. 10.1038/d41586-020-00984-832238897 26.OreshkovaNMolenaarRJVremanSHardersFOude MunninkBBHakze-van der HoningRWet al.." exact="SARS-CoV-2 infection" post="in farmed minks, the Netherlands, April and May 2020."/>
   <result pre="Respiratory Syndrome Coronavirus 2. J Virol. (2020) 94:e00411â€&quot;20. 10.1128/JVI.00411-2032238584 37.ChengVCCLauSKPWooPCYYuenKY." exact="Severe acute respiratory syndrome" post="coronavirus as an agent of emerging and reemerging infection."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7457578\results\search\zoonosis\results.xml">
   <result pre="Keywords SARS-CoV-2 coronavirus KAP survey fig-count: table-count: ref-count: page-count: Introduction" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) belongs to the coronavirus family responsible"/>
   <result pre="drugs further compounds this effect.4 After the first report of" exact="SARS-CoV-2 infection" post="from Nepal in a student who returned from Wuhan,5"/>
   <result pre="Kathmandu; 2019Available from: https://nta.gov.np/en/mis-reports/. Accessed 810, 2020. 11.collab: Kathmandupost. At" exact="Covid-19" post="helpline, thousands of calls from Nepalis looking for accurate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7457942\results\search\zoonosis\results.xml">
   <result pre="C virus RSV, Respiratory syncytial virus EV71, Enterovirus 71 DENV," exact="Dengue" post="virus COVID-19, Coronavirus disease 2019 SARS-CoV-2, Severe acute respiratory"/>
   <result pre="Respiratory syncytial virus EV71, Enterovirus 71 DENV, Dengue virus COVID-19," exact="Coronavirus disease 2019" post="SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 CHIKV, Chikungunya"/>
   <result pre="Enterovirus 71 DENV, Dengue virus COVID-19, Coronavirus disease 2019 SARS-CoV-2," exact="Severe acute respiratory syndrome" post="coronavirus 2 CHIKV, Chikungunya virus WEEV, Western equine encephalitis"/>
   <result pre="[4], Respiratory Syncytial Virus (RSV) [5], Enterovirus 71 (EV71) [6]," exact="Dengue" post="Virus (DENV) [7], Ebola Virus [8], as well as"/>
   <result pre="(RSV) [5], Enterovirus 71 (EV71) [6], Dengue Virus (DENV) [7]," exact="Ebola" post="Virus [8], as well as the recently emerging coronavirus"/>
   <result pre="[7], Ebola Virus [8], as well as the recently emerging" exact="coronavirus disease 2019" post="(COVID-19) caused by severe acute respiratory syndrome coronavirus 2"/>
   <result pre="anti-virus agents from marine microbes 2.1 Anti-influenza virus compounds Among" exact="human influenza" post="viruses, influenza A virus is the most susceptible to"/>
   <result pre="pandemics many times, such as 1918 Spanish flu pandemic [29]." exact="Influenza" post="viruses contain two functional surface glycoproteins: hemagglutinin (HA) and"/>
   <result pre="innate immune responseEmerg. Microb. Infect.72018167 8HoenenT.GrosethA.FeldmannH.Therapeutic strategies to target the" exact="Ebola" post="virus life cycleNat. Rev. Microbiol.17201959360631341272 9CaoX.COVID-19: immunopathology and its"/>
   <result pre="interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1" exact="swine flu" post="virusBiochem. Biophys. Res. Commun.386200943243619523442 30HutchinsonE.C.Influenza virusTrends Microbiol.26201880981029909041 31KimH.WebsterR.G.WebbyR.J.Influenza virus:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7458341\results\search\zoonosis\results.xml">
   <result pre=": Medical Conditions : Tropical Diseases : Neglected Tropical Diseases:" exact="Dengue Fever" post=": Medicine and Health Sciences : Medical Conditions :"/>
   <result pre="Sciences : Medical Conditions : Infectious Diseases : Viral Diseases:" exact="Dengue Fever" post=": Medicine and Health Sciences: Epidemiology : Medicine and"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : People and places : Geographical locations :"/>
   <result pre=": Immunoassays: Enzyme-Linked Immunoassays Epidemiology of dengue fever in Guatemala" exact="Dengue" post="in Guatemala Castillo SignorLeticia del CarmenConceptualizationData curationFunding acquisitionInvestigationProject administrationValidationWriting"/>
   <result pre="medium, provided the original author and source are credited.pntd.0008535.pdf Abstract" exact="Dengue fever" post="occurs worldwide and about 1% of cases progress to"/>
   <result pre="about 1% of cases progress to severe haemorrhage and shock." exact="Dengue" post="is endemic in Guatemala and its surveillance system could"/>
   <result pre="serotype adjusted by age and gender. 91,554 samples were tested." exact="Dengue" post="was confirmed by RT-qPCR, culture or NS1-ELISA in 7097"/>
   <result pre="epidemics, which is likely linked to increased immunity. Author summary" exact="Dengue" post="is the most common mosquito-borne virus, and a major"/>
   <result pre="emailing Dr Julia Martin, Head of Information Services (Julia.Martin@lstmed.ac.uk). Introduction" exact="Dengue" post="is widespread across the tropics with up to 3.97"/>
   <result pre="are similar and serological diagnostics of flaviviruses cross react [16]." exact="Dengue" post="had a low incidence and was not considered a"/>
   <result pre="displacement to receive health services. Diagnostic algorithms and case definitions" exact="Dengue" post="case definitions have changed with the advent of new"/>
   <result pre="number of samples received varied over the years (Fig 1)." exact="Dengue" post="infection was confirmed by RT-qPCR, viral culture or NS1"/>
   <result pre="by NS1 ELISA but not serotyped are designated DENV unknown." exact="Dengue" post="affected populations of all ages, with an average of"/>
   <result pre="2011 1.93 (0.57;6.46), 0.8034 * Confidence Interval ** Significant, DENV:" exact="Dengue" post="virus. Some Departments (districts) provided health services to neighbouring"/>
   <result pre="and 586.3 cases per 100,000 inhabitants in South America [22]." exact="Dengue" post="is hyperendemic, and seasonal in Guatemala with simultaneous circulation"/>
   <result pre="varied case definitions used to select the samples for screening." exact="Dengue" post="is the most prevalent mosquito-transmitted infection worldwide and causes"/>
   <result pre="Am J Trop Med Hyg. 2012;87(4):584â€&quot;93. 10.4269/ajtmh.2012.11-077023042846 18WilsonME, ChenL. H." exact="Dengue" post="in the Americas. Dengue Bulletin. 2002;26:44â€&quot;61. 19SantiagoGA, VergneE, QuilesY,"/>
   <result pre="Hyg. 2012;87(4):584â€&quot;93. 10.4269/ajtmh.2012.11-077023042846 18WilsonME, ChenL. H. Dengue in the Americas." exact="Dengue" post="Bulletin. 2002;26:44â€&quot;61. 19SantiagoGA, VergneE, QuilesY, CosmeJ, VazquezJ, MedinaJF, et"/>
   <result pre="23Ramos-CastaÃ±edaJ, Barreto dos SantosF, MartÃ­nez-VegaR, GalvÃ£o de AraujoJM, JointG, SartiE." exact="Dengue" post="in Latin America: systematic review of molecular epidemiological trends."/>
   <result pre="re-infection in Peru. PLoS Neglect Trop Dis. 2016;10(2):e0004398. 34UnoN, RossTM." exact="Dengue" post="virus and the host innate immune response. Emerg Microb"/>
   <result pre="review. Rev Panam Salud Publica. 2018;42:e11110.26633/RPSP.2018.11131093139 43Rungeâ€�RanzingerS, McCallPJ, KroegerA, HorstickO." exact="Dengue" post="disease surveillance: an updated systematic literature review. Trop Med"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7459861\results\search\zoonosis\results.xml">
   <result pre="has resulted in severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). In December 2019, a global public health"/>
   <result pre="pathogenic HCoVs, including severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), emerging from animal reservoirs, have led to"/>
   <result pre="human ACE2 receptor. Therefore, these species may be susceptible to" exact="SARS-CoV-2 infection," post="as has been shown for SARS-CoV. Although a recent"/>
   <result pre="moderate, severe and critical (Table 4) [57,76,105]. The symptoms of" exact="SARS-CoV-2 infection" post="appear after an incubation period of 1 to 14"/>
   <result pre="test compared with chest CT in 1014 patients with suspected" exact="SARS-CoV-2 infection." post="Findings indicated that the chest CT sensitivity in suspected"/>
   <result pre="inhibitory activity towards SARS-CoV-2, suggesting a promising strategy in treating" exact="SARS-CoV-2 infection," post="although further studies are required to strengthen these hypotheses"/>
   <result pre="not express ACE2 and TMPRSS2 viral receptors are insusceptible of" exact="SARS-CoV-2 infection." post="These observations are in agreement with the knowledge that"/>
   <result pre="ChAdOx1 in the past to dispense vaccines against Ebola, Chikungunya," exact="Rift Valley fever" post="and, above all, MERS. ChAdOx1, a chimpanzee-derived adenovirus vector,"/>
   <result pre="the second circle, as was previously done during the 2018" exact="Ebola" post="epidemic in the Democratic Republic of the Congo. Overall,"/>
   <result pre="ICTRP); World Health Organization (WHO). References References 1.ChanJ.F.LauS.K.WooP.C.The emerging novel" exact="Middle East respiratory syndrome" post="coronavirus: The â€œknownsâ€� and â€œunknownsâ€�J. Formos. Med. Assoc.201311237238110.1016/j.jfma.2013.05.01023883791 2.ZumlaA.ChanJ.F.AzharE.I.HuiD.S.YuenK.Y.Coronavirusesâ€&quot;Drug"/>
   <result pre="Dis.2020710.1093/ofid/ofaa105 92.ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.et al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: A descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 93.ChengZ.J.ShanJ.2019 Novel coronavirus:"/>
   <result pre="we are and what we knowInfection20204815516310.1007/s15010-020-01401-y32072569 94.LinQ.ChiuA.P.ZhaoS.HeD.Modeling the spread of" exact="Middle East respiratory syndrome" post="coronavirus in Saudi ArabiaStat. Methods Med. Res.2018271968197810.1177/096228021774644229846148 95.LipsitchM.CohenT.CooperB.RobinsJ.M.MaS.JamesL.GopalakrishnaG.ChewS.K.TanC.C.SamoreM.H.et al.Transmission"/>
   <result pre="Energy Rev.201910949951310.1016/j.rser.2019.04.059 105.WangY.WangY.ChenY.QinQ.Unique epidemiological and clinical features of the emerging" exact="2019 novel coronavirus pneumonia" post="(COVID-19) implicate special control measuresJ. Med. Virol.20201010.1002/jmv.2574832134116 106.LiQ.GuanX.WuP.WangX.ZhouL.TongY.RenR.LeungK.LauE.WongJ.Y.et al.Early"/>
   <result pre="Study GroupThe Allplex 2019-nCoV (Seegene) assay: Which performances are for" exact="SARS-CoV-2 infection" post="diagnosis? [published online ahead of print, 28 May 2020]Eur."/>
   <result pre="135.HuL.WangC.Radiological role in the detection, diagnosis and monitoring for the" exact="coronavirus disease 2019" post="(COVID-19)Eur. Rev. Med. Pharmacol. Sci.2020244523452810.26355/eurrev_202004_2103532373990 136.LiX.ZengW.LiX.ChenH.ShiL.LiX.XiangH.CaoY.ChenH.LiuC.et al.CT imaging changes"/>
   <result pre="clinical application of a rapid IgM-IgG combined antibody test for" exact="SARS-CoV-2 infection" post="diagnosisJ. Med. Virol.20201010.1002/jmv.25727 141.KohmerN.WesthausS.RÃ¼hlC.CiesekS.RabenauH.F.Brief clinical evaluation of six high-throughput"/>
   <result pre="Zhi2014392330233525244770 153.WangZ.ChenX.LuY.ChenF.ZhangW.Clinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci. Trends20201646810.5582/bst.2020.0103032037389 154.GrahamR.L.DonaldsonE.F.BaricR.S.A"/>
   <result pre="and other RNA virusesCell Res.20203018919010.1038/s41422-020-0290-032071427 181.ZhaL.LiS.PanL.TefsenB.LiY.FrenchN.ChenL.YangG.VillanuevaE.V.Corticosteroid treatment of patients with" exact="coronavirus disease 2019" post="(COVID-19)Med. J. Aust.202021241642010.5694/mja2.5057732266987 182.ZhouW.LiuY.TianD.WangC.WangS.ChengJ.HuM.FangM.GaoY.Potential benefits of precise corticosteroids therapy"/>
   <result pre="Infect. Dis.20203410161510.1016/j.tmaid.2020.10161532145386 194.SeesuayW.JittavisutthikulS.Sae-LimN.SookrungN.SakolvareeY.ChaicumpaW.Human transbodies that interfere with the functions of" exact="Ebola" post="virus VP35 protein in genome replication and transcription and"/>
   <result pre="stem cell treating acute respiratory distress syndrome induced by epidemic" exact="Influenza" post="A (H7N9) infection, a hint for COVID-19 treatmentEngineering20201010.1016/j.eng.2020.02.006 207.ZhangB.LiuR.ShiD.LiuX.ChenY.DouX.ZhuX.LuC.LiangW.LiaoL.et"/>
   <result pre="Superiore di SanitÃ , ISS). Figure 8 Schematic representation of" exact="SARS-CoV-2 infection" post="and virus-induced human immune system response. Proposed drugs directed"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7460442\results\search\zoonosis\results.xml">
   <result pre="on 10 January 2020, on Global Initiative on Sharing All" exact="Influenza" post="Data (GISAID) [37]. In China, five patients were admitted"/>
   <result pre="A positive test for IgM or IgG antibody strongly indicates" exact="SARS-CoV-2 infection." post="This approach is extremely effective in individuals 5â€&quot;10 days"/>
   <result pre="global health concernLancet202039547047310.1016/S0140-6736(20)30185-931986257 22.GuoY.-R.CaoQ.-D.HongZ.-S.TanY.-Y.ChenS.-D.JinH.-J.TanK.-S.WangD.-Y.YanY.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;An update on the statusMil. Med. Res.2020711010.1186/s40779-020-00240-031928528 23.ChakrabortyC.SharmaA.R.BhattacharyaM.SharmaG.LeeS.-S.The"/>
   <result pre="Acad. Sci. USA20201179696969810.1073/pnas.200491111732300018 48.WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: Summary of a report of"/>
   <result pre="Update on replication and pathogenesisNat. Rev. Genet.2009743945010.1038/nrmicro214719430490 57.GuanW.-J.NiZ.-Y.HuY.LiangW.-H.OuC.-Q.HeJ.-X.LiuL.ShanH.LeiC.-L.HuiD.S.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN. Engl. J. Med.20203821708172010.1056/NEJMoa200203232109013 58.MehtaP.McAuleyD.F.BrownM.SanchezE.TattersallR.S.MansonJ.J.COVID-19: Consider cytokine storm"/>
   <result pre="Cardiothorac. Imaging20202e20003410.1148/ryct.2020200034 66.WangY.WangY.ChenY.QinQ.Unique epidemiological and clinical features of the emerging" exact="2019 novel coronavirus pneumonia" post="(COVID-19) implicate special control measuresJ. Med. Virol.20209256857610.1002/jmv.2574832134116 67.PanX.-W.XuH.Z.D.ZhouW.WangL.-H.CuiX.-G.Identification of"/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): The experience of clinical immunologists from ChinaClin. Immunol.202021410839310.1016/j.clim.2020.10839332222466"/>
   <result pre="Infect. Dis.202010.1093/cid/ciaa34432221519 81.DengS.-Q.PengH.-J.Characteristics of and public health responses to the" exact="coronavirus disease 2019" post="outbreak in ChinaJ. Clin. Med.2020957510.3390/jcm902057532093211 82.YangW.YanF.Patients with RT-PCR confirmed"/>
   <result pre="and â€œUniversalâ€� vaccine developmentClin. Infect. Dis.20197074875310.1093/cid/ciz281 104.McMullanL.K.Clinical trials in an" exact="Ebola" post="outbreak seek to find an evidence-based cureEBioMedicine20205210.1016/j.ebiom.2019.102614 105.GreinJ.OhmagariN.ShinD.DiazG.AspergesE.CastagnaA.FeldtT.GreenG.GreenM.L.LescureF.-X.Compassionate Use"/>
   <result pre="online: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment(accessed on 1 May 2020) 107.DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov. Ther.202014586010.5582/ddt.2020.0101232147628 108.CaoB.WangY.WenD.LiuW.WangJ.FanG.RuanL.SongB.CaiY.WeiM.A trial of lopinavirâ€&quot;ritonavir in adults"/>
   <result pre="to inhibit the replication of the virus, previously used for" exact="Ebola" post="Clinical trials have been conducted Favipiravir Antiviral Favipiravir interacts"/>
   <result pre="Number BCG vaccine Randomized Reducing Health Care Workers Absenteeism in" exact="Covid-19" post="Pandemic Through BCG Vaccine (BCG-CORONA) Multiple sites in the"/>
   <result pre="Phase I/II Multicenter Trial of Lentiviral Minigene Vaccine (LV-SMENP) of" exact="Covid-19" post="Coronavirus Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China NCT04276896"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7461160\results\search\zoonosis\results.xml">
   <result pre="too premature to know the long-term neurological complications of the" exact="SARS-CoV-2 infection," post="and coronaviruses have not been linked so far with"/>
   <result pre="with pneumoniaJ Virol200579288489515613317 8.Al-TawfiqJAZumlaAMemishZACoronaviruses: severe acute respiratory syndrome coronavirus and" exact="Middle East respiratory syndrome" post="coronavirus in travelersCurr Opin Infect Dis201427541141725033169 9.ChenYLiuQGuoDEmerging coronaviruses: genome"/>
   <result pre="drugsScience200330056261763176712746549 12.YangXChenXBianGet al.Proteolytic processing, deubiquitinase and interferon antagonist activities of" exact="Middle East respiratory syndrome" post="coronavirus papain-like proteaseJ Gen Virol201495Pt 361462624362959 13.LinPYChouCYChangHCHsuWCChangGGCorrelation between dissociation"/>
   <result pre="patientsJ Med Virol202092655255532104915 56.MaoLJinHWangMet al.Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, ChinaJAMA Neurol2020776683690 57.PharesTWDiSanoKDStohlmanSABergmannCCProgression from IgDâ€‰+â€‰IgMâ€‰+â€‰to isotype-switched B"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7461537\results\search\zoonosis\results.xml">
   <result pre="10.1002/jmv.26464JMV26464 : Letter to the Editor: Letter to the Editor" exact="Dengue Fever" post="and COVIDâ€�19 Coâ€�Infection; A Threat to Public Health for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7462115\results\search\zoonosis\results.xml">
   <result pre="disease, which has spread so rapidly throughout the world, as" exact="coronavirus disease 2019" post="(COVID-19) [3]. The 2019 novel coronavirus (2019-nCoV) has also"/>
   <result pre="2002 in Guangdong, southern China, and the first time the" exact="Middle East respiratory syndrome" post="(MERS) coronavirus (MERS-CoV) emerged, was in 2012 in Saudi"/>
   <result pre="by electrochemical methods Target Biosensor type Nanomaterial Sample type Reference" exact="Influenza" post="virus M1 protein Electrochemical impedance Nanocrystalline boron-doped diamond Saliva"/>
   <result pre="C virus DNA Electrochemical impedance MB@SiNPs Real patient specimen [85]" exact="Dengue" post="virus DNA Voltammetric ZnO/Pt_Pd nanocomposite â€&quot; [85] HBV DNA"/>
   <result pre="[86] Avian influenza virus H5N1 gene Voltammetric MWCNTs_AuNPs â€&quot; [87]" exact="Dengue" post="type 2 virus Voltammetric Nanoporous alumina Infected Aedesaegypti Mosquito"/>
   <result pre="2 virus Voltammetric Nanoporous alumina Infected Aedesaegypti Mosquito sample [88]" exact="Influenza" post="virus Voltammetric CdS QDs Real patient samples [89] Chikungunya"/>
   <result pre="Electrochemical paper analytical device Gold shells_coated magnetic nanocubes Serum [90]" exact="Influenza" post="virus H1N1 Chronoamperometric rGO â€&quot; [91] Aptamer-Based Detection Aptamers"/>
   <result pre="alveolar lavage fluid samples were obtained from suspected cases of" exact="SARS-CoV-2 infection." post="The goal was to extract the RNA from these"/>
   <result pre="devastating outcomes of the disease could be prevented. Abbreviations SARS-CoV-2" exact="Severe acute respiratory syndrome" post="coronavirus 2 PHEIC Public health emergency of international concern"/>
   <result pre="Med20041012 SupplS88S9715577937 24.Chan-YeungMXuRHSARS: epidemiologyRespirology20038SupplS91415018127 25.LeeJChowellGJungEA dynamic compartmental model for the" exact="Middle East respiratory syndrome" post="outbreak in the Republic of Korea: a retrospective analysis"/>
   <result pre="of novel coronavirusâ€&quot;infected pneumonia. N Engl J Med. 2020;382:1199â€&quot;207. 31.WHO." exact="Coronavirus disease 2019" post="(COVID-19) Situation Report â€&quot; 23. 32.Cai, X., et al.,"/>
   <result pre="multiple viral sequences in the respiratory tract samples of suspected" exact="Middle East respiratory syndrome" post="coronavirus patients in Jakarta, Indonesia 2015â€&quot;2016Int J Infect Dis20198610210731238156"/>
   <result pre="129.LayqahLAEissaSAn electrochemical immunosensor for the corona virus associated with the" exact="Middle East respiratory syndrome" post="using an array of gold nanoparticle-modified carbon electrodesMicrochim Acta20191864224"/>
   <result pre="Disease 2019 ed. F. edition. 132.Organization, W.H., Laboratory testing for" exact="coronavirus disease 2019" post="(COVID-19) in suspected human cases: interim guidance, 2 March"/>
   <result pre="al.Human intestinal tract serves as an alternative infection route for" exact="Middle East respiratory syndrome" post="coronavirusSci Adv2017311eaao496629152574 138.DingYet al.Organ distribution of severe acute respiratory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7462603\results\search\zoonosis\results.xml">
   <result pre="hepatitis B, acquired immunodeficiency syndrome, severe acute respiratory syndrome, and" exact="coronavirus disease 2019." post="The current and potential peptide-based therapies, vaccines, and diagnostics"/>
   <result pre="respiratory syndrome SARS-CoV-1, severe acute respiratory syndrome coronavirus 1 COVID-19," exact="coronavirus disease 2019" post="SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 AMP, antimicrobial"/>
   <result pre="PCR, polymerase chain reaction qRT-PCR, quantitative real-time PCR Keywords Peptides" exact="Influenza" post="Chronic hepatitis B Acquired immunodeficiency syndrome Severe acute respiratory"/>
   <result pre="PCR Keywords Peptides Influenza Chronic hepatitis B Acquired immunodeficiency syndrome" exact="Severe acute respiratory syndrome" post="Coronavirus disease 2019 1 Introduction Viral infectious diseases have"/>
   <result pre="Chronic hepatitis B Acquired immunodeficiency syndrome Severe acute respiratory syndrome" exact="Coronavirus disease 2019" post="1 Introduction Viral infectious diseases have had a catastrophic"/>
   <result pre="diagnostic reagents to combat viral diseases is illustrated here. 2" exact="Influenza" post="Influenza (flu), a highly contagious respiratory disease caused by"/>
   <result pre="reagents to combat viral diseases is illustrated here. 2 Influenza" exact="Influenza" post="(flu), a highly contagious respiratory disease caused by influenza"/>
   <result pre="is classified into three types: influenza A, B, and C." exact="Influenza" post="types A and B are the major causes of"/>
   <result pre="of the FP peptides (FP4: RRKKWLVFFVIFYFFR) showed nanomolar efficacy for" exact="Influenza" post="A virus subtypes H1, H3, and H5 in a"/>
   <result pre="is a peptide-based molecular beacon (PEP-MB) for the detection of" exact="Influenza" post="type A using fluorescence resonance energy transfer (FRET). A"/>
   <result pre="HA binding to the peptide indicates the presence of the" exact="Influenza" post="virus [137,138]. Also, ARLPR peptide dimers can be conjugated"/>
   <result pre="detect the majority of anti-HIV-antibodies in biological samples [132]. 5" exact="Severe acute respiratory syndrome" post="Severe acute respiratory syndrome (SARS) is caused by SARS"/>
   <result pre="anti-HIV-antibodies in biological samples [132]. 5 Severe acute respiratory syndrome" exact="Severe acute respiratory syndrome" post="(SARS) is caused by SARS coronavirus 1 (SARS-CoV-1), a"/>
   <result pre="were necessary to prevent a likely future pandemic [94,150,105]. 6" exact="Coronavirus disease 2019" post="Coronavirus disease 2019 (COVID-19) is a novel infectious disease"/>
   <result pre="prevent a likely future pandemic [94,150,105]. 6 Coronavirus disease 2019" exact="Coronavirus disease 2019" post="(COVID-19) is a novel infectious disease caused by severe"/>
   <result pre="to be tested in cell-based assays and animal models of" exact="SARS-CoV-2 infection." post="Another peptide in development is EK1 (SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL), which is"/>
   <result pre="Mechanism Of Action Of Flufirvitide-3 A. Peptide Based Inhibitor Of" exact="Influenza" post="Virus2014 12BalasubramanianP.WilliamsC.ShapiroM.B.SinangilF.HigginsK.NadasA.Functional antibody response against V1V2 and V3 of"/>
   <result pre="Drug Resistance2019CDChttps://www.cdc.gov/flu/treatment/antiviralresistance.htm 29CDC Seasonal Flu Vaccine Effectiveness Studies, 2004-20192020CDC 30Estimated" exact="Influenza" post="Illnesses, Medical Visits, Hospitalizations, and Deaths in the United"/>
   <result pre="Visits, Hospitalizations, and Deaths in the United States â€&quot; 2018â€&quot;2019" exact="Influenza" post="Season2020CDC 31Influenza A Subtypes and the Species Affected2020CDC 32ChanD.C.KimP.S.HIV"/>
   <result pre="and BioNTech Announce Early Positive Update from German Phase 1/2" exact="Covid-19" post="Vaccine Study, Including First T Cell Response Data2020 161Pfizer."/>
   <result pre="161Pfizer. Pfizer And BioNTech Choose Lead mRNA Vaccine Candidate Against" exact="Covid-19" post="and Commence Pivotal Phase 2/3 Global Study2020 162PitisuttithumP.GilbertP.GurwithM.HeywardW.MartinM.van GriensvenF.Randomized,"/>
   <result pre="FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb" exact="human influenza" post="challenge studyNPJ Vaccines520202232194999 164PleguezuelosO.RobinsonS.StoloffG.A.Caparros-WanderleyW.Synthetic influenza vaccine (FLU-v) stimulates cell"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7462660\results\search\zoonosis\results.xml">
   <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. Abstract" exact="Coronavirus disease 2019" post="(COVID-19) is due to severe acute respiratory syndrome coronavirus"/>
   <result pre="â€œPrudence is the footprint of Wisdom.â€� â€&quot; Amos Bronson Alcott" exact="Coronavirus disease 2019" post="(COVID-19) is due to severe acute respiratory syndrome coronavirus"/>
   <result pre="organs, indicating that ACE2-expressing cells are the primary targets for" exact="SARS-CoV infection" post="in vivo in humans. High levels of PICs were"/>
   <result pre="limited to explore whether RAAS therapy increases the risk of" exact="SARS-CoV-2 infection" post="Small sample size 6. Guo T, et al. doi:"/>
   <result pre="illness among patients who tested positive. 12,594 patients tested for" exact="Covid-19" post="[(46.8%) positive; 1002 (17.0%) severe illness]. Î�o substantial increase"/>
   <result pre="for the use of renin-angiotensin-aldosterone system (RAAS) inhibitors in the" exact="coronavirus disease 2019" post="(COVID-19) era. It should be noted that this strategy,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7462898\results\search\zoonosis\results.xml">
   <result pre="decades, namely, severe acute respiratory distress syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). The similarities have enabled the scientists to"/>
   <result pre="COVID-19 along with severe acute respiratory distress syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS) are the third epidemic outbreaks caused by coronaviruses"/>
   <result pre="cell through exocytosis. 4 A primer on host-immune response to" exact="SARS-CoV-2 infection" post="SARS viruses utilize a number of mechanisms to evade"/>
   <result pre="and approved for treatment of other viral diseases, such as" exact="Ebola" post="virus disease and influenza, are candidates to effectively terminate"/>
   <result pre="an adenosine analogue, which was originally developed for treatment of" exact="Ebola" post="virus disease, has been approved by FDA for clinical"/>
   <result pre="vaccines, as was accomplished in the case of vaccine for" exact="Ebola" post="virus disease. It is quite remarkable that the first"/>
   <result pre="epidemics in affected countriesJ Infect802020e32ee332209383 20EllinghausDDegenhardtFBujandaLButiMAlbillosAInvernizziPGenomewide association study of severe" exact="Covid-19" post="with respiratory failureN Engl J Med2020, NEJMoa2020283 21LevantovskyRvan der"/>
   <result pre="of print). 22SnyderTMGittelmanRMKlingerMMayDHOsborneEJTaniguchiRMagnitude and dynamics of the T-cell response to" exact="SARS-CoV-2 infection" post="at both individual and population levelsmedRxiv.2020, 2020.07.31.20165647 23NguyenADavidJKMadenSKWoodMAWeederBRNelloreAHuman leukocyte"/>
   <result pre="heartCirc Res12620201443145532252591 34BujaLMWolfDAZhaoBAkkantiBMcDonaldMLelenwaLThe emerging spectrum of cardiopulmonary pathology of the" exact="coronavirus disease 2019" post="(COVID-19): report of 3 autopsies from Houston, Texas, and"/>
   <result pre="cause SARS and COVID-19Antiviral Res1802020104857 56BeigelJHTomashekKMDoddLEMehtaAKZingmanBSKalilACRemdesivir for the treatment of" exact="Covid-19" post="- preliminary reportN Engl J Med38310202099432649078 57WangYZhangDDuGDuRZhaoJJinYRemdesivir in adults"/>
   <result pre="randomised, double-blind, placebo-controlled, multicentre trialLancet39520201569157832423584 58AntinoriSCossuMVRidolfoALRechRBonazzettiCPaganiGCompassionate remdesivir treatment of severe" exact="Covid-19" post="pneumonia in intensive care unit (ICU) and Non-ICU patients:"/>
   <result pre="cytokine and chemokine profile in relation to the severity of" exact="coronavirus disease 2019" post="(COVID-19) in ChinaJ Infect Dis2225202074675432563194 66XuXHanMLiTSunWWangDFuBEffective treatment of severe"/>
   <result pre="a retrospective cohort studyLancet Rheumatol22020e474ee8432835257 69GroupRCHorbyPLimWSEmbersonJRMafhamMBellJLDexamethasone in hospitalized patients with" exact="Covid-19" post="- preliminary reportN Engl J Med2020 70EckerleLDBeckerMMHalpinRALiKVenterELuXInfidelity of SARS-CoV"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7463036\results\search\zoonosis\results.xml">
   <result pre="drug, especially in primary hospitals. During the ongoing outbreak of" exact="coronavirus disease 2019" post="(COVID-19), most patients with COVID-19 who are symptomatic have"/>
   <result pre="oseltamivir is effective in treating SARS-CoV. With the epidemic of" exact="coronavirus disease 2019" post="(COVID-19) caused by SARS-CoV-2, oseltamivir has once again become"/>
   <result pre="and key enzymes of SARS-CoV-2 are important targets for inhibiting" exact="SARS-CoV-2 infection" post="[6], [7], [8], [9], [10]. Since the SARS outbreak"/>
   <result pre="2.6.1 Study design We retrospectively analyzed 627 patients diagnosed with" exact="SARS-CoV-2 infection" post="at the Second Hospital of Wuhan, Wuhan Union Hospital,"/>
   <result pre="China. The enrollment criteria were: 1. patients were diagnosed with" exact="SARS-CoV-2 infection" post="and negative for influenza A and B nucleic acid"/>
   <result pre="2 Structural alignment analyzed by TM-align program. Protein TM-score Final" exact="Influenza" post="B neuraminidase 0.94460 In about the same fold S"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7463108\results\search\zoonosis\results.xml">
   <result pre="Alcohol Depend1998501471559649966 Becker WC, Fiellin DA (2020) When epidemics collide:" exact="coronavirus disease 2019" post="(COVID-19) and the opioid crisis. Ann Intern Med 173:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7464065\results\search\zoonosis\results.xml">
   <result pre="has been conducted to understand the molecular basis of the" exact="SARS-CoV-2 infection" post="and evolution, develop effective therapeutics, antiviral drugs, and vaccines,"/>
   <result pre="Viruses (ICTV) [1â€&quot;4], while the disease termed as an emerging" exact="coronavirus disease 2019" post="(COVID-19). Since then, this virus has spread to every"/>
   <result pre="now SARS-CoV-2 [55]. Currently, the Global Initiative on Sharing All" exact="Influenza" post="Data (GISAID) (http://www.gisaid.org), have analyzed over 75,853 full genomes"/>
   <result pre="diarrhoea [30], but even dysgeusia and anosmia [27, 78]. Moreover," exact="SARS-CoV infection" post="has been reported in the nervous tissue of experimental"/>
   <result pre="and past epidemics and pandemics situations of Ebola, Zika, Nipah," exact="swine flu," post="avian/bird flu led to make tremendous advances in science"/>
   <result pre="that happened with SARS in the 2002â€&quot;2003 outbreak and the" exact="Ebola" post="outbreak in 2014â€&quot;2015 [107]. During this outbreak, special quarantine"/>
   <result pre="There were no unique antiviral treatments available for SARS and" exact="Ebola" post="at the time of outbreaks as situations were beyond"/>
   <result pre="animal models [131, 132], siRNA candidates in viral infections like" exact="Ebola" post="have failed in clinical trials [133]. Oligonucleoside analogues like"/>
   <result pre="The same strategy of convalescent serum was used during the" exact="Ebola" post="virus outbreak in 2014â€&quot;2015 [164]. Plasma-derived from the patients"/>
   <result pre="substantially inhibit the activity of the main protease of the" exact="MERS coronavirus," post="has an excellent inhibitory activity to the main protease"/>
   <result pre="of inducing an immune response in a subject to the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) are provided. In several embodiments, the immune"/>
   <result pre="et al. [269] 2018-02-13 US9889194B Immunogenic proteins Immunogenic composition for" exact="MERS coronavirus" post="infection Described herein are immunogenic compositions for preventing infection"/>
   <result pre="infection Described herein are immunogenic compositions for preventing infection with" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) wherein the immunogenic compositions comprise at least"/>
   <result pre="33.Galasiti KankanamalageACKimYDamalankaVCRathnayakeADFehrARMehzabeenNBattaileKPLovellSLushingtonGHPerlmanSet al.Structure-guided design of potent and permeable inhibitors of" exact="MERS coronavirus" post="3CL protease that utilize a piperidine moiety as a"/>
   <result pre="Anesthesiology. 2020; 132(6):1346-1361. 83.GuoY-RCaoQ-DHongZ-STanY-YChenS-DJinH-JTanK-SWangD-YYanYThe origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak - an update on the statusMil Med"/>
   <result pre="in designing and developing vaccines, drugs, and therapies to counter" exact="Ebola" post="virusFront Immunol180320189 98.MunjalAKhandiaRDhamaKSachanSKarthikKTiwariRMalikYSKumarDSinghRKIqbalHAdvances in developing therapies to combat Zika"/>
   <result pre="Med Infect Dis20161415626879565 106.QiuHBLiXYDuBKangHYJWangYSWangFSunBTongZHThe keypoints in treatment of the critical" exact="coronavirus disease 2019" post="patient(1)Zhonghua Jie He He Hu Xi Za Zhi202043427327732087621 107.SinghRKDhamaKMalikYSRamakrishnanMAKarthikKKhandiaRTiwariRMunjalASaminathanMSachanSet"/>
   <result pre="inflammatory responses: from mechanisms to potential therapeutic toolsVirol Sin2020816 124.CasadevallAThe" exact="Ebola" post="epidemic crystallizes the potential of passive antibody therapy for"/>
   <result pre="A, Kline S et al: Remdesivir for the Treatment of" exact="Covid-19" post="â€&quot; Preliminary Report. N Engl J Med. 2020. 146.GeversSKwaMSGWijnansEvan"/>
   <result pre="C, Ustianowski A, et al. Dexamethasone in Hospitalized Patients with" exact="Covid-19" post="- Preliminary Report. N Engl J Med. 2020. 153.PatelSKSaikumarGRanaJDhamaJYatooMITiwariRRodrÃ­guez-MoralesAJDhamaKDexamethasone:"/>
   <result pre="with dromedary immune serum in an experimental animal model for" exact="Middle East respiratory syndrome" post="coronavirus infectionJ Virol201589116117612025787284 163.MaranoGVaglioSPupellaSFaccoGCatalanoLLiumbrunoGMGrazziniGConvalescent plasma: new evidence for an"/>
   <result pre="Med201319101313131724013700 172.WangZChenXLuYChenFZhangWClinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatmentBioScience Trends2020141646832037389 173.SheahanTPSimsACLeistSRSchÃ¤ferAWonJBrownAJMontgomerySAHoggABabusisDClarkeMOet"/>
   <result pre="za zhi20201001180580732234150 177.FanH-HWangL-QLiuW-LAnX-PLiuZ-DHeX-QSongL-HTongY-GRepurposing of clinically approved drugs for treatment of" exact="coronavirus disease 2019" post="in a 2019-novel coronavirus-related coronavirus modelChin Med J (Engl)202013391051105632149769"/>
   <result pre="respiratory support strategy of severe acute respiratory failure caused by" exact="SARS-CoV-2 infection" post="in childrenZhongguo Dang Dai Er Ke Za Zhi202022318319432204751 196.BaronSADevauxCColsonPRaoultDRolainJ-MTeicoplanin:"/>
   <result pre="Faster Progress for COVID-19 Vaccine Candidate. https://www.fdanews.com/articles/197765-sanofi-reports-faster-progress-for-covid-19-vaccine-candidate. 224.Heaton PM. The" exact="Covid-19" post="vaccine-development multiverse. N Engl J Med. 2020. 225.FolegattiPMBittayeMFlaxmanALopezFRBellamyDKupkeAMairCMakinsonRSheridanJRohdeCet al.Safety"/>
   <result pre="J Med. 2020. 225.FolegattiPMBittayeMFlaxmanALopezFRBellamyDKupkeAMairCMakinsonRSheridanJRohdeCet al.Safety and immunogenicity of a candidate" exact="Middle East respiratory syndrome" post="coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase"/>
   <result pre="to curtail COVID-19Int Immunopharm.202023106924 250.Ibrahim NK: Epidemiologic surveillance for controlling" exact="Covid-19" post="pandemic: challenges and implications. J Infect Public Health. 2020."/>
   <result pre="270.Jiang S DL, Zhou Y, Zhao G: Immunogenic composition for" exact="MERS coronavirus" post="infection. 2018. 271.Kyratsous C SN, Sivapalasingam S: Human antibodies"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7464173\results\search\zoonosis\results.xml">
   <result pre="in the year 2003, the influenza H1N1 pandemic in 2009," exact="Middle East respiratory syndrome" post="(MERS) in 2012, and the Zika virus in 2005,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7464234\results\search\zoonosis\results.xml">
   <result pre="all tissues and organs through the Spike (S) protein. Currently," exact="SARS-CoV-2 infection" post="is prevented by the use of masks, social distancing,"/>
   <result pre="culture method, without any clinical suspicion and/or risk factor for" exact="SARS-CoV-2 infection" post="[56]. More detailed studies will be required to confirm"/>
   <result pre="the lung and are heavily involved in the pathogenesis of" exact="SARS-CoV-2 infection." post="Blocking IL-17 could provide a novel therapeutic strategy for"/>
   <result pre="may compromise their immune systems, may increase the risk of" exact="SARS-CoV-2 infection" post="[48]. Smoking may be a negative prognostic indicator for"/>
   <result pre="and Guillain-Barre syndrome have been reported to be associated with" exact="SARS-CoV-2 infection" post="[44,79]. The neuroinvasive propensity of SARS-CoV-2 has, therefore, already"/>
   <result pre="some genetic and hormonal factors, to give more protection to" exact="SARS-CoV-2 infection" post="and make them less susceptible [62]. Studies are underway"/>
   <result pre="of symptomatic versus asymptomatic infections, highlighting the importance of asymptomatic" exact="SARS-CoV-2 infection" post="[92]. Moreover, asymptomatic individuals have shown a weaker immune"/>
   <result pre="Moreover, asymptomatic individuals have shown a weaker immune response to" exact="SARS-CoV-2 infection." post="In fact, a recent report showed that the IgG"/>
   <result pre="of Northern Italy, in which hospitals have become amplifiers of" exact="SARS-CoV-2 infection." post="If these patients were treated early with anti-inflammatory drugs"/>
   <result pre="of MERS-CoV and has been shown to be effective against" exact="SARS-CoV-2 infection," post="preventing membrane fusion [103]. Hyperimmune plasma. The use of"/>
   <result pre="in Europe: A case seriesLancet Infect. Dis.20202069770610.1016/S1473-3099(20)30200-032224310 41.HoehlS.RabenauH.BergerA.KortenbuschM.CinatlJ.BojkovaD.BehrensP.BÃ¶ddinghausB.GÃ¶tschU.NaujoksF.et al.Evidence of" exact="SARS-CoV-2 infection" post="in returning travelers from Wuhan, ChinaN. Engl. J. Med.20203821278128010.1056/NEJMc200189932069388"/>
   <result pre="(COVID-19)StatPearls PublishingTreasure Island, FL, USA2020 73.BadawiA.RyooS.G.Prevalence of comorbidities in the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV): A systematic review and meta-analysisInt. J. Infect."/>
   <result pre="95.AhnD.G.ShinH.J.KimM.H.LeeS.KimH.S.MyoungJ.KimB.T.KimS.J.Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel" exact="coronavirus disease 2019" post="(COVID-19)J. Microbiol. Biotechnol.20203031332410.4014/jmb.2003.0301132238757 96.FernerR.E.AronsonJ.K.Remdesivir in covid-19BMJ2020369m161010.1136/bmj.m161032321732 97.GreinJ.OhmagariN.ShinD.DiazG.AspergesE.CastagnaA.FeldtT.GreenG.GreenM.L.LescureF.X.et al.Compassionate use"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7464724\results\search\zoonosis\results.xml">
   <result pre="Texas, during 1965Am. J. Trop. Med. Hyg.19671667568710.4269/ajtmh.1967.16.6756053533 154.YuillT.M.HansonR.P.Serological evidence of" exact="California encephalitis" post="virus and western equine encephalitis virus in snowshoe haresZoonoses"/>
   <result pre="disease in the Australasian zoogeographic regionArch. Virol.199413644746710.1007/BF013210748031248 313.FraserJ.R.CunninghamA.L.MathewsJ.D.RiglarA.Immune Complexes and" exact="Ross River Virus Disease" post="(Epidemic Polyarthritis)Rheumatol. Int.1988811311710.1007/BF002724322845558 314.ShanksG.D.Could Ross River Virus be the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7466376\results\search\zoonosis\results.xml">
   <result pre=": Review Is Antioxidant Therapy a Useful Complementary Measure for" exact="Covid-19" post="Treatment? An Algorithm for Its Application https://orcid.org/0000-0003-1332-2888SotoMarÃ­a Elena1â€ Guarner-LansVerÃ³nica2â€"/>
   <result pre="(WHO) ranked it as a world pandemic in March. The" exact="COVID-2019" post="disease results in a severe pneumonia that leads to"/>
   <result pre="A H5N1 virus, influenza A and B viruses, Chikungunya virus," exact="Dengue" post="virus, Zika virus, the rabies virus, poliovirus, Lassa virus,"/>
   <result pre="Nipah and Hendra viruses, Crimean-Congo hemorrhagic fever virus and the" exact="Ebola" post="virus. It also inhibits the herpes simplex virus and"/>
   <result pre="associated to adverse outcomes in severe cases of influenza and" exact="SARS-CoV infection." post="In SARS, there is still inflammation after viral clearance."/>
   <result pre="virus infectionsRev. Med. Virol.201929207510.1002/rmv.2075 5.MondalS.P.CardonaC.MicrobiologÃ­a VeterinariaStanchiN.O.Inter-MÃ©dicaBuenos Aires, Argentina200797-950-555-321-12007 6.SeahI.AgrawalR.Can the" exact="coronavirus disease 2019" post="(COVID-19) affect the eyes. A review of coronaviruses and"/>
   <result pre="Little cause for concernLancet Gastroenterol. Hepatol.2020552953010.1016/S2468-1253(20)30084-432203680 32.GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.LiuL.ShanH.LeiC.L.HuiD.S.C.et al.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN. Engl. J. Med.20203821708172010.1056/NEJMoa200203232109013 33.ContiP.RonconiG.CaraffaA.Induction of pro-Inflammatory cytokines"/>
   <result pre="in Wuhan, ChinaClin. Infect. Dis.202024810.1093/cid/ciaa24832313932 35.LippiG.PlebaniM.Procalcitonin in patients with severe" exact="coronavirus disease 2019" post="(COVID-19): A meta-analysisClin. Chim. Acta202050519019110.1016/j.cca.2020.03.00432145275 36.RicciardoloF.L.CaramoriG.ItoK.CapelliA.BrunP.AbatangeloG.PapiA.ChungK.F.AdcockI.BarnesP.J.et al.Nitrosative stress in"/>
   <result pre="acids in nonenveloped virus infectionsAdv. Carbohydr. Chem. Biochem.2019766511130851744 57.SahraeiZ.ShabaniM.ShokouhiS.SaffaeiA.Aminoquinolines against" exact="coronavirus disease 2019" post="(COVID-19): Chloroquine or hydroxychloroquineInt. J. Antimicrob. Agents20205510594510.1016/j.ijantimicag.2020.10594532194152 58.GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraV.E.Hydroxychloroquine and"/>
   <result pre="identifies several candidates with anti-Ebola activitiesBiochem. Biophys. Res. Commun.202052286286831806372 62.DyerO.Two" exact="Ebola" post="treatments halve deaths in trial in DRC outbreakBMJ2019366l514010.1136/bmj.l514031409588 63.TchesnokovE.P.FengJ.Y.PorterD.P.GÃ¶tteM.Mechanism"/>
   <result pre="deaths in trial in DRC outbreakBMJ2019366l514010.1136/bmj.l514031409588 63.TchesnokovE.P.FengJ.Y.PorterD.P.GÃ¶tteM.Mechanism of inhibition of" exact="Ebola" post="virus RNA-dependent RNA polymerase by remdesivirViruses20191132610.3390/v1104032630987343 64.GordonC.J.TchesnokovE.P.FengJ.Y.PorterD.P.GotteM.The antiviral compound"/>
   <result pre="Chem.200815997100510.2174/09298670878404965818393857 71.GagarinovaV.M.Ignatâ€™evaG.S.SinitskaiaL.V.IvanovaA.M.RodinaM.A.Turâ€™evaA.V.The New Chemical Preparation Arbidol: Its Prophylactic Efficacy During" exact="Influenza" post="EpidemicsZhurnal Mikrobiol. Epidemiol. Immunobiol.199354043 72.ShusterA.M.ShumilovV.I.ShevtsovV.A.Marâ€™inG.G.KozlovV.N.Arbidol used in the prophylaxis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7466926\results\search\zoonosis\results.xml">
   <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. Abstract" exact="Severe acute respiratory syndrome" post="coronavirus 2Â (SARS-CoV-2)Â is currently causing the respiratory illness"/>
   <result pre="(SARS-CoV-2)Â is currently causing the respiratory illness termed as the" exact="coronavirus disease 2019" post="or the COVID-19 pandemic.Â Indeed, the significant increase in"/>
   <result pre="have also been focused based on the previous literatures. Keywords" exact="Influenza" post="viruses COVID-19 Pandemic History Public health Introduction Disease outbreaks,"/>
   <result pre="Canada, and in Greenland), was another outbreak caused by the" exact="Influenza" post="A virus subtype H2N2; however, recently it is thought"/>
   <result pre="reassortment event could be held between the avian-, swine- and" exact="human influenza" post="viruses, or it could be introduced by a direct"/>
   <result pre="a result of the numerous reassortments between avian-, swine-, and" exact="human influenza" post="viruses yy[20, 36â€&quot;38]. This is to be noted that"/>
   <result pre="[9]. Such an interesting mechanism between the avian- and the" exact="human influenza" post="viruses later gave rise to the 1957 and 1968"/>
   <result pre="outbreak situations [9, 23]. Regarding the preparation or development of" exact="Influenza" post="virus vaccines, a major shortfall underlies the fact that"/>
   <result pre="antigenicity to optimize the influenza vaccines has been suggested [30]." exact="Severe acute respiratory syndrome" post="(SARS) in 2002â€&quot;2003 SARS, the severe acute respiratory syndrome,"/>
   <result pre="pneumonia and acute kidney injury; and the virus was named" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) which was thought to be propagated from"/>
   <result pre="syndrome. N Engl J Med. 2003; 348(20):1953â€&quot;66. 10.1056/nejmoa030781 3.LeungYToMLamTYauSLeungOChuangSEpidemiology of" exact="human influenza" post="A(H7N9) infection in Hong KongJ Microbiol Immunol Infect201750218318810.1016/j.jmii.2015.06.00426220305 4.LinQZhaoSGaoDLouYYangSMusaSSWangMHCaiYWangWYangLHeDA"/>
   <result pre="Hong KongJ Microbiol Immunol Infect201750218318810.1016/j.jmii.2015.06.00426220305 4.LinQZhaoSGaoDLouYYangSMusaSSWangMHCaiYWangWYangLHeDA conceptual model for the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in Wuhan, China with individual reaction and"/>
   <result pre="impact of the 1957â€&quot;1959 influenza pandemicJ Infect Dis2016213573874510.1093/infdis/jiv53426908781 28.EpsteinSLPrior H1N1" exact="influenza infection" post="and susceptibility of Cleveland Family Study participants during the"/>
   <result pre="Toronto AreaJAMA200328921280110.1001/jama.289.21.joc3088512734147 37.ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYXiaJYuTZhangXZhangLEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet20203951022350751310.1016/s0140-6736(20)30211-732007143 38.ChafekarAFieldingBCMERS-CoV: understanding the"/>
   <result pre="proteins M, ORF 4a, ORF 4b, and ORF 5 of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) are potent interferon antagonistsProtein Cell201341295196110.1007/s13238-013-3096-824318862 41.PooleDNEscuderoDJGostinLOLeblangDTalbotEAResponding to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7468341\results\search\zoonosis\results.xml">
   <result pre="between important transcription factors (TFs) and their target genes upon" exact="SARS-CoV-2 infection." post="Of particular interest is the TF-regulatory relationships involved in"/>
   <result pre="Analysis to Generate Calu-3-Specific Human-SARS-CoV-2 Interactome Likely, the outcome of" exact="SARS-CoV-2 infection" post="can largely be determined by the interaction patterns of"/>
   <result pre="Significantly enriched rare disease terms of 33 CSPs in SARS," exact="Dengue fever," post="and Japanese encephalitis (pÂ &amp;lt; 0.0001) using Enrichr tool."/>
   <result pre="disease terms of 33 CSPs in SARS, Dengue fever, and" exact="Japanese encephalitis" post="(pÂ &amp;lt; 0.0001) using Enrichr tool. (G) Network representation"/>
   <result pre="CSPs might be largely relevant to modifying host response following" exact="SARS-CoV-2 infection" post="(FigureÂ 3E). Moreover, the proteins in the other two"/>
   <result pre="(PBMC) with our CSI data (Xiong etÂ al., 2020). Overall," exact="SARS-CoV-2 infection" post="exhibited largely different transcriptional signatures for BALF cells and"/>
   <result pre="33 CSPs exhibit a strong positive correlation between SARS-CoV and" exact="SARS-CoV-2 infection" post="at both 12Â h (r2Â = 0.973) and 24Â"/>
   <result pre="The expression patterns of hsa-miR-429 target genes in response to" exact="SARS-CoV-2 infection" post="at the indicated time points. The enriched pathways are"/>
   <result pre="expression analysis of cytokine-storm-related genes in response to SARS-CoV and" exact="SARS-CoV-2 infection" post="at the indicated time. â€œSee also Figures S2, S3,"/>
   <result pre="To reveal the regulatory circuitry and molecular events pertinent to" exact="SARS-CoV-2 infection," post="we performed probabilistic modeling using the iDREM (interactive Dynamic"/>
   <result pre="11 and 22 regulators are involved specifically in SARS-CoV-2 and" exact="SARS-CoV infection," post="respectively (Figures 4Dâ€&quot;4F). It is important to note that"/>
   <result pre="of the target genes of these regulators is increasing during" exact="SARS-CoV-2 infection" post="(FigureÂ 4G). Here, we also found that hsa-miR-429, which"/>
   <result pre="innate immune response, cell cycle, and signaling by interleukins during" exact="SARS-CoV-2 infection," post="is one of the significantly downregulated regulators (FigureÂ 4H)."/>
   <result pre="GATA1, CCNT2, and E2F6) that are differentially expressed in Calu-3" exact="SARS-CoV-2 infection." post="We report that six of these significant regulators (E2F1,"/>
   <result pre="that hsa-miR-429 can potentially regulate over 750 genes involved in" exact="SARS-CoV-2 infection" post="(Table S4). Intriguingly, 573 of these 752 hsa-miR-429 target"/>
   <result pre="regulate the aforementioned pathways' genes at various stages of the" exact="SARS-CoV-2 infection" post="in COVID-19 patients. Finally, we showed distinct patterns of"/>
   <result pre="Finally, we showed distinct patterns of key pathway genes in" exact="SARS-CoV-2 infection" post="when compared with SARS-CoV and other respiratory viruses. Translational"/>
   <result pre="we believe that effective and prompt therapeutic strategies for blocking" exact="SARS-CoV-2 infection" post="are not straight forward. Notably, keeping in view the"/>
   <result pre="degradative signaling pathways may be involved in the pathogenesis of" exact="SARS-CoV-2 infection," post="it is hard to select one effective drug in"/>
   <result pre="virus, hepatitis C virus, influenza virus, human papillomavirus, dengue virus," exact="Ebola" post="virus, HIV-1, and SARS-CoV (Ackerman etÂ al., 2018; Becerra"/>
   <result pre="virulence. Recently, the global posttranslational modification landscape in response to" exact="SARS-CoV-2 infection" post="indicated an increase in the phosphorylation of NUP98, a"/>
   <result pre="receptor regulation of apoptosis. Indeed, it was recently reported that" exact="SARS-CoV-2 infection" post="may cause lymphocyte apoptosis demonstrated by overall cell count"/>
   <result pre="CSPs that are potentially relevant to modifying host response following" exact="SARS-CoV-2 infection." post="These include SPECC1, DCTN2, BCL2L1, ATP6V1A, KPNA2, KPNA4, AP2M1,"/>
   <result pre="a significant CSP in our study, which is altered by" exact="SARS-CoV-2 infection" post="and plays key roles in regulating oxidative and inflammatory"/>
   <result pre="understanding of transcriptome-wide differences. Also, a detailed temporal dataset of" exact="SARS-CoV-2 infection" post="to death/recovery host transcriptome is lacking, which may provide"/>
   <result pre="(COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/index.html. ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 ChengW.ChenG.JiaH.HeX.JingZ.DDX5 RNA helicases:"/>
   <result pre="signaling pathway during development of ATLFront. Microbiol.82017268629379481 GeierM.R.GeierD.A.Respiratory conditions in" exact="coronavirus disease 2019" post="(COVID-19): important considerations regarding novel treatment strategies to reduce"/>
   <result pre="adult non-human primatesJ.Â Neuroimmunol2582013969923528659 ShuaiL.WangJ.ZhaoD.WenZ.GeJ.HeX.WangX.BuZ.Integrin beta1 promotes peripheral entry by" exact="Rabies" post="virusJ.Â Virol.942020e01819â€&quot;19 SimonisN.RualJ.F.LemmensI.BoxusM.Hirozane-KishikawaT.GatotJ.S.DricotA.HaoT.VertommenD.LegrosS.Host-pathogen interactome mapping for HTLV-1 and -2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7471937\results\search\zoonosis\results.xml">
   <result pre="the application to COVID-19 epidemicPhysica D2020132674 14DimriV.P.GanguliS.S.SrivastavaR.P.Understanding trend of the" exact="Covid-19" post="fatalities in IndiaJ. Geol. Soc. India952020637639 15FanelliD.PiazzaF.Analysis and forecast"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7472103\results\search\zoonosis\results.xml">
   <result pre="Emerging Role of Mucosal Vaccine in Preventing Infection with Avian" exact="Influenza" post="A Viruses WangTong1https://orcid.org/0000-0002-2997-922XWeiFanhua2LiuJinhua1*[1], wtong0819@163.com[2], weifanhua999@163.com *Correspondence: ljh@cau.edu.cn epub: 2020-8-8collection:"/>
   <result pre="the primordial source of AIVs infecting other animal species [1]." exact="Influenza" post="A virus (IAV) is a single-stranded negative-sense RNA virus"/>
   <result pre="losses and mutate into highly pathogenic forms as well [8]." exact="Influenza" post="viruses undergo antigen mutations through antigen drift and shift."/>
   <result pre="of AIVs infection and epidemics. 2. Host Immune Responses to" exact="Influenza" post="Viruses 2.1. Innate Immune Response to Influenza Virus The"/>
   <result pre="Immune Responses to Influenza Viruses 2.1. Innate Immune Response to" exact="Influenza" post="Virus The innate immune response constitutes the first line"/>
   <result pre="the adaptive immune response [34,35]. 2.2. Adaptive Immune Response to" exact="Influenza" post="Virus The adaptive immune response comprising humoral and cellular"/>
   <result pre="CD4+ T cells play a role in controlling the secondary" exact="influenza infection" post="that is independent of CD8+ T cells or B"/>
   <result pre="various subtypes of IAVs [57]. 2.3. Mucosal Immune Response to" exact="Influenza" post="Virus The mucosal immune system plays a crucial role"/>
   <result pre="IgA-producing cells [68]. 3. The Importance of Mucosal Immunity against" exact="Influenza" post="Virus Infection At present, the commercial vaccines against influenza"/>
   <result pre="against the viruses and identify the molecular pathogenesis related to" exact="influenza infection" post="and the working mechanism underlying normal mucosal immunization. 4."/>
   <result pre="influenza viruses. In recent years, research on the prevention of" exact="influenza infection" post="by nasal immunity has gained more and more attention."/>
   <result pre="case dataLancet Infect. Dis.201616e108e11810.1016/S1473-3099(16)00153-527211899 12.IulianoA.D.JangY.JonesJ.DavisC.T.WentworthD.E.UyekiT.M.RoguskiK.ThompsonM.G.GubarevaL.FryA.M.Increase in Human Infections with Avian" exact="Influenza" post="A(H7N9) Virus During the Fifth Epidemic China, October 2016-February"/>
   <result pre="antigenic sites of the hemagglutinin molecule analogous to those for" exact="human influenza" post="virusJ. Virol.2011858718872421734057 15.SwayneD.E.KapczynskiD.Strategies and challenges for eliciting immunity against"/>
   <result pre="in health and diseaseNat. Rev. Immunol.201616355010.1038/nri.2015.826711677 19.ChenX.LiuS.GorayaM.U.MaaroufM.HuangS.ChenJ.L.Host Immune Response to" exact="Influenza" post="A Virus InfectionFront. Immunol.2018932010.3389/fimmu.2018.0032029556226 20.KawaiT.AkiraS.The role of pattern-recognition receptors"/>
   <result pre="Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal" exact="Influenza" post="Virus ProteinsEBioMedicine2016827729010.1016/j.ebiom.2016.04.02927428437 41.IngulliE.MondinoA.KhorutsA.JenkinsM.K.In vivo detection of dendritic cell antigen"/>
   <result pre="Exp. Med.198416094194610.1084/jem.160.3.9416332171 69.RajaoD.S.PerezD.R.Universal Vaccines and Vaccine Platforms to Protect against" exact="Influenza" post="Viruses in Humans and AgricultureFront. Microbiol.2018912310.3389/fmicb.2018.0012329467737 70.SoemaP.C.KompierR.AmorijJ.P.KerstenG.F.Current and next"/>
   <result pre="in miceClin. Vaccine Immunol.201320998100710.1128/CVI.00024-1323637045 79.OkamotoS.MatsuokaS.TakenakaN.HaredyA.M.TanimotoT.GomiY.IshikawaT.AkagiT.AkashiM.OkunoY.et al.Intranasal immunization with a formalin-inactivated" exact="human influenza" post="A virus whole-virion vaccine alone and intranasal immunization with"/>
   <result pre="from mouse modelsJ. Aerosol. Med. Pulm. Drug Deliv.200821132410.1089/jamp.2007.065918518828 138.ScottL.J.CarterN.J.CurranM.P.Live Attenuated" exact="Influenza" post="Vaccine (Fluenzâ&quot;¢)Drugs20121427127910.2165/11207080-000000000-00000 139.TomodaT.MoritaH.KurashigeT.MaassabH.F.Prevention of influenza by the intranasal administration"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7472125\results\search\zoonosis\results.xml">
   <result pre="were collected and tested by One Step RT-qPCR for Zika," exact="Dengue" post="(serotypes 1â€&quot;4), Chikungunya, Mayaro and Oropouche viruses. Positive samples"/>
   <result pre="(18/20), co-infection DENV1 and DENV2 (1/20) and DENV4 (1/20). For" exact="Dengue" post="serotype 3 and for the CHIKV, ZIKV, MAYV and"/>
   <result pre="(YFV), all with a worldwide distribution [3,6,7]. Species such as" exact="Japanese Encephalitis" post="Virus (JEV), Tick-borne Encephalitis Virus (TBEV), Venezuelan Equine Encephalitis"/>
   <result pre="including the capital Porto Velho [31]. The high numbers of" exact="Dengue fever" post="in Porto Velho is a problem that has been"/>
   <result pre="in 1 April 2016. 2.4. Analyses 2.4.1. RT-qPCR for Zika," exact="Dengue" post="and Chikungunya Viral RNA was isolated from 140 ÂµL"/>
   <result pre="and DENV2 (1/20), and DENV4 (1/20) viruses being detected. For" exact="Dengue" post="serotype 3 and for the CHIKV, ZIKV, MAYV and"/>
   <result pre="VigilÃ¢ncia em SaÃºde (Health Ministry) recorded 994 probable cases of" exact="Dengue fever" post="between the years 2018 (419) and 2019 (575), with"/>
   <result pre="According to the same document, there were no deaths from" exact="Dengue" post="in the state [51]. Despite the number of probable"/>
   <result pre="Grosso do Sul, BrazilCad. Saude Publica2014301789179210.1590/0102-311X0000391425210917 31.VieiraD.S.BifanoG.D.S.HondaE.R.TadaM.S.BatistaW.C.Isolation and identification of" exact="Dengue" post="virus serotype 3 in Rondonia, BrazilVIRUS Rev. Res.20081311610.17525/vrrjournal.v13i1-2.16 32.BatistaW.C.BifanoS.DanieleP.TravaginiC.MendesM.M.D.O.M.TadaS.StabeliR.HildebrandoL.PesquisasD.TropicaisP.et"/>
   <result pre="Rondonia, BrazilVIRUS Rev. Res.20081311610.17525/vrrjournal.v13i1-2.16 32.BatistaW.C.BifanoS.DanieleP.TravaginiC.MendesM.M.D.O.M.TadaS.StabeliR.HildebrandoL.PesquisasD.TropicaisP.et al.AnÃ¡lise EpidemiolÃ³gica Molecular do VÃ­rus" exact="Dengue" post="no Estado de RondÃ´niaAvailable online: https://rededengue.fiocruz.br/images/rededengue/Analise_epidemiologica_molecular_Rondonia.pdf(accessed on 1 June"/>
   <result pre="Brasil, de 1999 a 2010Rev. Pan-AmazÃ´nica SaÃºde20112192510.5123/S2176-62232011000300003 36.RiosF.G.F.NascimentoV.A.Dalâ€™acquaD.S.V.NavecaF.G.JuliÃ£oG.R.Vertical/venereal transmission of" exact="Dengue" post="and Zika virus on field mosquitoes in the state"/>
   <result pre="disease severity and laboratory parametersBMC Infect. Dis.20161640610.1186/s12879-016-1731-827514512 58.OsanaiC.H.A Epidemia de" exact="Dengue" post="em Boa Vista, TerritÃ³rio Federal de Roraima, 1981âˆ’1982Escola Nacional"/>
   <result pre="virus type 4, Manaus, BrazilEmerg. Infect. Dis.20081466766910.3201/eid1404.07118518394292 60.WalimbeA.M.LotankarM.CeciliaD.CherianS.S.Global phylogeography of" exact="Dengue" post="type 1 and 2 viruses reveals the role of"/>
   <result pre="dengue virus type 1PLoS ONE20138e6264910.1371/journal.pone.006264923675416 64.Villabona-ArenasC.J.de Andrade ZanottoP.M.Evolutionary history of" exact="Dengue" post="virus type 4: Insights into genotype phylodynamicsInfect. Genet. Evol.20111187888510.1016/j.meegid.2011.02.00721335103"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7474329\results\search\zoonosis\results.xml">
   <result pre="coronaviruses (such as severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV)). These outbreaks have tested the limits of"/>
   <result pre="host cells [43â€&quot;45] (Fig.Â 1). Fig.Â 1 Schematic representation of" exact="SARS-CoV-2 infection" post="and the nanotechnologies tools to prevent and control COVID-19."/>
   <result pre="Med20203821199120731995857 5.ChenNZhouMDongXQuJGongFHanYet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet.202039550751332007143 6.LiuYGayleAAWilder-SmithARocklÃ¶vJThe reproductive number"/>
   <result pre="based codelivery of oseltamivir to inhibit the activity of the" exact="H1N1 Influenza" post="Virus through ROS-mediated signaling pathwaysACS Appl Mater Interfaces20168243852439327588566 69.KimJYeomMLeeTKimH-ONaWKangAet"/>
   <result pre="codelivery of oseltamivir to inhibit the activity of the H1N1" exact="Influenza" post="Virus through ROS-mediated signaling pathwaysACS Appl Mater Interfaces20168243852439327588566 69.KimJYeomMLeeTKimH-ONaWKangAet"/>
   <result pre="nanometer silver/quaternary ammonium salt composite sanitizer. CN108391673A, 2018. https://worldwide.espacenet.com/patent/search/family/063091462/publication/CN108391673A?q=CN108391673A&amp;amp;queryLang=en%3Ade%3Afr. 86.CDC." exact="Coronavirus disease 2019" post="(COVID-19)â€&quot;transmission. Centers for Disease Control and Prevention. 2020. Available"/>
   <result pre="112.LayqahLAEissaSAn electrochemical immunosensor for the corona virus associated with the" exact="Middle East respiratory syndrome" post="using an array of gold nanoparticle-modified carbon electrodesMicrochim Acta2019186224"/>
   <result pre="clinical application of a rapid IgM-IgG combined antibody test for" exact="SARS-CoV-2 infection" post="diagnosisJ Med Virol.202010.1002/jmv.2572732869863 115.CormanVMLandtOKaiserMMolenkampRMeijerAChuDKet al.Detection of 2019 novel coronavirus"/>
   <result pre="in generic microplate reader and point-of-care deviceBioRxiv.2020142373118 128.SandersJMMonogueMLJodlowskiTZCutrellJBPharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a reviewJAMA2020323181824183632282022 129.SalviRPatankarPEmerging pharmacotherapies for COVID-19Biomed Pharmacother202012811026732410772 130.GarcÃ­a-SerradillaMRiscoCPachecoBDrug"/>
   <result pre="132.GordonCJTchesnokovEPFengJYPorterDPGÃ¶tteMThe antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirusJ Biol Chem20202954773477932094225 133.AndersenPIIanevskiALysvandHVitkauskieneAOksenychVBjÃ¸rÃ¥sMet al.Discovery and development of safe-in-man"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7476354\results\search\zoonosis\results.xml">
   <result pre="Figure 1. Article selection flowchart. AIDS, acquired immunodeficiency syndrome; COVID-19," exact="coronavirus disease 2019;" post="HBV, hepatitis B virus; HCV, hepatitis C virus; HIV,"/>
   <result pre="Part I: DMARDs for severe acute respiratory syndrome coronavirus 2" exact="Coronavirus disease 2019" post="(COVID-19) is a newly emerged lethal pandemic caused by"/>
   <result pre="control arms.7â€&quot;12 Based on the inhibitory effect of azithromycin against" exact="Ebola" post="and Zika viruses in vitro, and the possibility of"/>
   <result pre="early phase of infections. In animal models of SARS and" exact="Middle East respiratory syndrome" post="(MERS), IFN-Î± and IFN-Î² showed benefit at the early"/>
   <result pre="virus; HTLV-1, human T-cellâ€&quot;lymphotrophic virus-1; IMPDH, inosine monophosphate dehydrogenase; JEV," exact="Japanese encephalitis" post="virus; MDA5, melanoma differentiation activated protein 5; MMF/MPA, mycophenolate"/>
   <result pre="integrase suppress the virus(2)â€ƒDecrease viral expression from CD4+ T cells" exact="Japanese encephalitis" post="virus Inhibit microglial activation and neuronal apoptosis Dengue virus"/>
   <result pre="cells Japanese encephalitis virus Inhibit microglial activation and neuronal apoptosis" exact="Dengue" post="virus Reduce viral RNA synthesis, intracellular envelope protein expression,"/>
   <result pre="maturation Enterovirus 71 Reduce cytopathic effects and viral protein expressions" exact="Influenza" post="virus Reverse H7N9 replication West Nile virus Anti-apoptotic properties"/>
   <result pre="properties result in neuroprotection. Reovirus Reduce apoptosis and antigen expression" exact="Rabies" post="Reduce CD3+ cells may impair the host to control"/>
   <result pre="hence cytostatic and antiviral effect by depletion of this substrate" exact="Influenza" post="virus Inhibit viral mRNA and protein expression via inhibition"/>
   <result pre="lymphotrophic virus-1; IMPDH, inosine monophosphate dehydrogenase; JAK, Janus kinase; MERS-CoV," exact="Middle East respiratory syndrome" post="coronavirus; mRNA, messenger RNA; NRTI, nucleoside analog reverse-transcriptase inhibitor;"/>
   <result pre="activation38âœ— RCT (nâ€‰=â€‰83): no efficacy39âœ— Single-arm, pilot (nâ€‰=â€‰20): not beneficial40" exact="Dengue" post="virus âœ&quot; Farias et al.41 âœ&quot; Farias et al.42"/>
   <result pre="50% improved clinically46âœ— RCT (nâ€‰=â€‰54): no significant decrease in viremia47" exact="Influenza" post="A virus âœ&quot; Fedson48 âœ&quot; Yan et al.49 âœ&quot;"/>
   <result pre="Placebo-controlled trial (nâ€‰=â€‰120): increased sustained virological response60 Flavivirus (Zika virus," exact="Dengue" post="virus, West Nile virus, Yellow fever virus) âœ&quot; Qing"/>
   <result pre="in cognitive function80âœ— RCT (nâ€‰=â€‰73): no difference in cognitive function81" exact="Japanese encephalitis" post="virus âœ&quot; Mishra and Basu82 âœ&quot; Reduce viral titers,"/>
   <result pre="mortality rate unchanged84âœ&quot; RCT (nâ€‰=â€‰281): a trend towards better outcomes85" exact="Dengue" post="virus âœ&quot; Leela et al.86 RSV âœ&quot; Bawage et"/>
   <result pre="et al.88 âœ&quot; Decrease mortality rates, clinical scores, viral titers68" exact="Influenza" post="virus âœ&quot; Josset et al.89 West Nile virus âœ&quot;"/>
   <result pre="Michaelis et al.90 Reovirus âœ&quot; Delay encephalitis onset; reduce mortality91" exact="Rabies" post="âœ— Worse, higher mortality rate92 Mycophenolate mofetil/Mycophenolic acid HIV"/>
   <result pre="delayed viral load rebound and improved control of viral replication26" exact="Influenza" post="virus âœ&quot; To et al.27 âœ&quot; All mice survived;"/>
   <result pre="herpes simplex virus; HTLV-I, human T cell lymphotrophic virus-1; MERS-CoV," exact="Middle East respiratory syndrome" post="coronavirus; MMF, mycophenolate mofetil; PCT, porphyria cutanea tarda; RCT,"/>
   <result pre="interest in the treatment of virus-induced encephalitis such as HIV," exact="Japanese encephalitis" post="virus (JEV), and reovirus. The antiviral property is not"/>
   <result pre="there was no difference in cognitive function compared with placebo.80,81" exact="Japanese encephalitis" post="virus Minocycline showed high efficacy in animal models and"/>
   <result pre="better outcomes, especially those who survived the first hospital day.85" exact="Dengue" post="virus, respiratory syncytial virus, enterovirus 71, influenza virus, West"/>
   <result pre="exacerbation of encephalomyelitis and higher mortality rate.92 Chloroquine and hydroxychloroquine" exact="Severe acute respiratory syndrome" post="coronavirus (SARS-CoV) CQ and HCQ are reported to have"/>
   <result pre="antiviral effect by depletion of the dividing CD4+ T cells.93" exact="Influenza" post="virus MMF had antiviral activity for influenza A(H1N1), A(H3N2),"/>
   <result pre="markedly reduced viral loads in lungs and all mice survived.94" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) MERS-CoV causes respiratory infection called MERS or"/>
   <result pre="2020. DOI: 10.1002/ctm2.35. 16RichardsonPGriffinITuckerC, et al.Baricitinib as potential treatment for" exact="2019-nCoV acute respiratory disease." post="Lancet2020; 395: e30â€&quot;e31.32032529 17MehtaPMcAuleyDFBrownM, et al.COVID-19: consider cytokine storm"/>
   <result pre="microglial activation, inhibits caspase 3 induction, and viral replication following" exact="Japanese encephalitis." post="J Neurochem2008; 105: 1582â€&quot;1595.18208541 83DuttaKKumawatKLNazmiA, et al.Minocycline differentially modulates"/>
   <result pre="modulates viral infection and persistence in an experimental model of" exact="Japanese encephalitis." post="J Neuroimmune Pharmacol2010; 5: 553â€&quot;565.20635157 84SinghAMehtaAKushwahaKP, et al.Minocycline trial"/>
   <result pre="Commun2017; 494: 298â€&quot;304.29017920 95ChanJFChanKHKaoRY, et al.Broad-spectrum antivirals for the emerging" exact="Middle East respiratory syndrome" post="coronavirus. J Infect2013; 67: 606â€&quot;616.24096239 96ChanJFYaoYYeungML, et al.Treatment with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7476961\results\search\zoonosis\results.xml">
   <result pre="SARS-CoV-2 Coronavirus RNA virus Respiratory disease SARS-CoV-2 inhibitors 1 Introduction" exact="Coronavirus disease 2019" post="(COVID-19) is a pandemic faced by the global community"/>
   <result pre="also exhibited potent activity against SARS-CoV-2 pseudovirus infection and live" exact="SARS-CoV-2 infection" post="in vitro with IC50 values of 15.8Â nM and"/>
   <result pre="was developed by Gilead Sciences for the treatment of the" exact="Ebola" post="virus [85]. Remdesivir is in the frontline in ongoing"/>
   <result pre="that has shown promise as a therapeutic intervention for the" exact="Ebola" post="virus [104], [105], [106], [107]. Favipiravir was shown to"/>
   <result pre="derivatives were capable of blocking the viral entry of the" exact="Ebola" post="virus, SARS-CoV, and MERS-CoV into the cell by blocking"/>
   <result pre="trial highlighted the importance of azithromycin for the management of" exact="SARS-CoV-2 infection" post="[117]. A total of 36 patients were enrolled for"/>
   <result pre="dwelled on to consider azithromycin as viable adjuvant therapy for" exact="SARS-CoV-2 infection." post="Fascinatingly, azithromycin has been reported to be active against"/>
   <result pre="been reported to be active against other RNA viruses like" exact="Ebola" post="and Zika virus in vitro[118], [119]. Further studies might"/>
   <result pre="the efficacy of dexamethasone in patients with ARDS secondary to" exact="SARS-CoV-2 infection" post="(NCT04325061). Zhou et al. demonstrated that inflammatory and pro-inflammatory"/>
   <result pre="under clinical investigation (NCT04321993) as a potential drug for treating" exact="SARS-CoV-2 infection." post="3.6 Traditional Chinese Medicine (TCM) and natural products Traditional"/>
   <result pre="Republic of China has recommended the use of TCM for" exact="Covid-19" post="since the fourth version of Diagnosis and Treatment Protocol"/>
   <result pre="of interferon-Î±2b and ribavirinSci. Rep.3201310.1038/srep01686 15ChanJ.F.W.ChanK.H.KaoR.Y.T.ToK.K.W.ZhengB.J.LiC.P.Y.LiP.T.W.DaiJ.MokF.K.Y.ChenH.HaydenF.G.YuenK.Y.Broad-spectrum antivirals for the emerging" exact="Middle East respiratory syndrome" post="coronavirusJ. Infect.67201360661610.1016/j.jinf.2013.09.02924096239 16ElshabrawyH.A.FanJ.HaddadC.S.RatiaK.BroderC.C.CaffreyM.PrabhakarB.S.Identification of a broad-spectrum antiviral small molecule"/>
   <result pre="fusogenic mechanism and identification of fusion inhibitorsLancet363200493894710.1016/S0140-6736(04)15788-715043961 26LuL.LiuQ.ZhuY.ChanK.H.QinL.LiY.WangQ.ChanJ.F.W.DuL.YuF.MaC.YeS.YuenK.Y.ZhangR.JiangS.Structure-based discovery of" exact="Middle East respiratory syndrome" post="coronavirus fusion inhibitorNat. Commun.5201410.1038/ncomms4067 27XiaS.YanL.XuW.AgrawalA.S.AlgaissiA.TsengC.T.K.WangQ.DuL.TanW.WilsonI.A.JiangS.YangB.LuL.A pan-coronavirus fusion inhibitor targeting"/>
   <result pre="endoproteasesBiochim. Biophys. Acta - Rev. Biomembr.1469200012113210.1016/S0304-4157(00)00014-9 51MilleJ.K.WhittakerG.R.Host cell entry of" exact="Middle East respiratory syndrome" post="coronavirus after two-step, furin-mediated activation of the spike proteinProc."/>
   <result pre="58GordonC.J.TchesnokovE.P.FengJ.Y.PorterD.P.GotteM.The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirusjbc.AC120.013056J. Biol. Chem.202010.1074/jbc.ac120.013056 59SubissiL.PosthumaC.C.ColletA.Zevenhoven-DobbeJ.C.GorbalenyaA.E.DecrolyE.SnijderE.J.CanardB.ImbertI.One severe acute respiratory syndrome coronavirus"/>
   <result pre="2020). 85WarrenT.K.JordanR.LoM.K.RayA.S.MackmanR.L.SolovevaV.SiegelD.PerronM.BannisterR.HuiH.C.LarsonN.StrickleyR.WellsJ.StuthmanK.S.Van TongerenS.A.GarzaN.L.DonnellyG.ShurtleffA.C.RettererC.J.GharaibehD.ZamaniR.KennyT.EatonB.P.GrimesE.WelchL.S.GombaL.WilhelmsenC.L.NicholsD.K.NussJ.E.NagleE.R.KugelmanJ.R.PalaciosG.DoerfflerE.NevilleS.CarraE.ClarkeM.O.ZhangL.LewW.RossB.WangQ.ChunK.WolfeL.BabusisD.ParkY.StrayK.M.TranchevaI.FengJ.Y.BarauskasO.XuY.WongP.BraunM.R.FlintM.McMullanL.K.ChenS.S.FearnsR.SwaminathanS.MayersD.L.SpiropoulouC.F.LeeW.A.NicholS.T.CihlarT.BavariS.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature531201638138510.1038/nature1718026934220 86GordonC.J.TchesnokovE.P.WoolnerE.PerryJ.K.FengJ.Y.PorterD.P.GotteM.Remdesivir is a direct-acting antiviral"/>
   <result pre="The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus., J. Biol. Chem. (2020). doi:10.1074/jbc.AC120.013056. 96CvetkovicR.S.GoaK.L.Lopinavir/ritonavir: A review"/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob. Agents Chemother.5820144875488410.1128/AAC.03011-1424841269 99ChanJ.F.-W.YaoY.YeungM.-L.DengW.BaoL.JiaL.LiF.XiaoC.GaoH.YuP.CaiJ.-P.ChuH.ZhouJ.ChenH.QinC.YuenK.-Y.Treatment with"/>
   <result pre="the antiviral agent T-705 (favipiravir)Mol. Pharmacol.84201361562910.1124/mol.113.08724723907213 104OestereichL.LÃ¼dtkeA.WurrS.RiegerT.MuÃ±oz-FontelaC.GÃ¼ntherS.Successful treatment of advanced" exact="Ebola" post="virus infection with T-705 (favipiravir) in a small animal"/>
   <result pre="Mentre, X. Anglaret, D. Malvy, Experimental Treatment with Favipiravir for" exact="Ebola" post="Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm"/>
   <result pre="MERS-CoV-infected rhesus macaquesNat. Med.1920131313131710.1038/nm.336224013700 112OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.AlmakhlafiG.A.AlbarrakM.M.MemishZ.A.AlbarrakA.M.Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: A retrospective cohort studyLancet Infect. Dis.1420141090109510.1016/S1473-3099(14)70920-X25278221 113ArabiY.M.ShalhoubS.MandourahY.Al-HameedF.Al-OmariA.Al"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov.620201610.1038/s41421-020-0156-032194981 127YaoX.YeF.ZhangM.CuiC.HuangB.NiuP.LiuX.ZhaoL.DongE.SongC.ZhanS.LuR.LiH.TanW.LiuD.In vitro antiviral activity and projection"/>
   <result pre="Res.11020149410310.1016/j.antiviral.2014.07.01425108173 136RossignolJ.F.Nitazoxanide, a new drug candidate for the treatment of" exact="Middle East respiratory syndrome" post="coronavirusJ. Infect. Public Health9201622723010.1016/j.jiph.2016.04.00127095301 137A.G. Canga, A.M.S. Prieto, M.J."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7478670\results\search\zoonosis\results.xml">
   <result pre="Europe PMC, consistent with existing copyright protections.medi-99-e22040.pdf Abstract Abstract Background:" exact="Coronavirus disease 2019" post="(COVID-19) is one of the infectious diseases that have"/>
   <result pre="Xie Sichuan Provincial Science and technology department2020YFS0013Chunguang Xie 1 Introduction" exact="Coronavirus disease 2019" post="is an acute respiratory infectious disease caused by the"/>
   <result pre="24,065.[6] There is no effective treatment to control the new" exact="coronavirus disease 2019" post="according to the World Health Organization (WHO) commentary.[7] According"/>
   <result pre="Paidu Tang, Qingfei Paidu Decoction, 2019 novel coronavirus disease, COVID-19," exact="coronavirus disease 2019," post="2019 novel coronavirus infection, 2019-nCoV disease. We will simply"/>
   <result pre="editing: Chunguang Xie. Abbreviations: CI = confidence interval, COVID-19 =" exact="coronavirus disease 2019," post="FEM = fixed effect model, MD = mean difference,"/>
   <result pre="al.Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as" exact="coronavirus disease 2019" post="(COVID-19) pandemic: A global health emergency. Sci Total Environ2020;138996.32371230"/>
   <result pre="United States. N Engl J Med2020;382:92936.32004427 [10]SandersJMMonogueMLJodlowskiTZet al.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19). JAMA2020;doi: 10.1001/jama.2020.6019. [11]YangYIslamMSWangJet al.Traditional Chinese medicine in the"/>
   <result pre="Biol Sci2020;16:170817.32226288 [12]DuHZHouXYMiaoYHet al.Traditional Chinese Medicine: an effective treatment for" exact="2019 novel coronavirus pneumonia" post="(NCP). Chin J Nat Med2020;18:20610.32245590 [13]ZhaoJYYanJYQuJMInterpretations of â€œdiagnosis and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7479232\results\search\zoonosis\results.xml">
   <result pre="and provoked a still ongoing and dangerous pandemic known as" exact="coronavirus disease 2019" post="(COVID-19). The SARS-CoV-2 infection has triggered an impressive amount"/>
   <result pre="and dangerous pandemic known as coronavirus disease 2019 (COVID-19). The" exact="SARS-CoV-2 infection" post="has triggered an impressive amount of clinical and experimental"/>
   <result pre="access and use convalescent plasma for the treatment of life-threatening" exact="SARS-CoV-2 infection." post="However, there is still, limited data on the sero-conversion"/>
   <result pre="there is still, limited data on the sero-conversion following the" exact="SARS-CoV-2 infection" post="as well as on its associated side effects, such"/>
   <result pre="the most certain solution to ensure a direct protection against" exact="SARS-CoV-2 infection." post="The development of vaccines for human use represents a"/>
   <result pre="use of remdesivir on a compassionate-use basis to patients with" exact="SARS-CoV-2 infection" post="receiving oxygen support, has been associated with a clinical"/>
   <result pre="(Goraya et al., 2020) but has been less documented in" exact="SARS-CoV-2 infection." post="Recently, Ziegler et al. proved that ACE2 SARS-CoV-2 receptor"/>
   <result pre="Cochrane database. Table 1 Interferon therapy in clinical evaluation in" exact="SARS-CoV-2 infection" post="(July 20, 2020). Biological treatment Study identifier number, locations"/>
   <result pre="the non-specific vaccine which has received most attention in the" exact="SARS-CoV-2 infection" post="due to its ability to boost the immunity against"/>
   <result pre="a stepping stone for the handling of future epidemics. The" exact="SARS-CoV-2 infection" post="proved once again that viruses leave a very short"/>
   <result pre="K.ZingmanB. S.KalilA. C.et al. (2020). Remdesivir for the Treatment of" exact="Covid-19" post="â€&quot; Preliminary Report. N. Engl. J. Med.4 (2), 93â€&quot;107."/>
   <result pre="al. (2019). IFN-I response timing relative to virus replication determines" exact="MERS coronavirus" post="infection outcomes. J. Clin. Invest.129 (9), 3625â€&quot;3639. 10.1172/JCI12636331355779 ChenX.ZhaoB.QuY.ChenY.XiongJ.FengY.et"/>
   <result pre="BALB/c mice: CD4+ T cells are important in control of" exact="SARS-CoV infection." post="J. Virol.84 (3), 1289â€&quot;1301. 10.1128/JVI.01281-0919906920 ContiP.RonconiG.CaraffaA.GallengaC.RossR.FrydasI.et al. (2020). Induction"/>
   <result pre="considerations with chloroquine, hydroxychloroquine and azithromycin in the management of" exact="SARS-CoV-2 infection." post="CMAJ192 (17), E4540â€&quot;E453. 10.1503/cmaj.200528 KawaseM.ShiratoK.van der HoekL.TaguchiF.MatsuyamaS. (2012). Simultaneous"/>
   <result pre="severe acute lung injury by skewing macrophage responses during acute" exact="SARS-CoV infection." post="JCI Insight4 (4), e123158. 10.1172/jci.insight.123158 MacchiagodenaM.PagliaiM.ProcacciP. (2020). Inhibition of"/>
   <result pre="Â 10.1056/NEJMoa200897532356628 RichardsonP.GriffinI.TuckerC.SmithD.OechsleO.PhelanA.et al. (2020). Baricitinib as potential treatment for" exact="2019-nCoV acute respiratory disease." post="Lancet (London England)395 (10223), e30â€&quot;e31. 10.1016/S0140-6736(20)30304-4 RogersT. F.ZhaoF.HuangD.BeutlerN.BurnsA.HeW.et al."/>
   <result pre="D. M. E.et al. (2020). A human monoclonal antibody blocking" exact="SARS-CoV-2 infection." post="Nat. Commun.11 (1), 2251. 10.1038/s41467-020-16256-y32366817 WangM.CaoR.ZhangL.YangX.LiuJ.XuM.et al. (2020). Remdesivir"/>
   <result pre="ChenX. T. (2020). Guidelines for the diagnosis and treatment of" exact="coronavirus disease 2019" post="(COVID-19) in China. Glob. Heal. Med.2 (2), 66â€&quot;72. 10.35772/ghm.2020.01015"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7479474\results\search\zoonosis\results.xml">
   <result pre="cases between 2012 and 2015, with a threefold increase [4]." exact="Influenza" post="infection may promote the progression of latent Mycobacterium tuberculosis"/>
   <result pre="especially in the healthcare setting [11, 12]. Given that both" exact="coronavirus disease 2019" post="(COVID-19) and TB become important causes of mortality worldwide"/>
   <result pre="with TB, induction of type I interferons (IFNs) determined by" exact="influenza infection" post="could be detrimental [11], impeding the immune-competent host's ability"/>
   <result pre="or severity [20, 21]. One murine model demonstrated that although" exact="influenza infection" post="increased the IFN-Î³ secretion, it had little effect on"/>
   <result pre="need to evaluate a suspected patient [28]. 4.1.1. Key Points" exact="Influenza" post="pandemic/seasonal outbreaks and other coronaviruses epidemics might have a"/>
   <result pre="similar to the one of SARS-CoV-1. Substantial evidence suggests that" exact="SARS-CoV-2 infection" post="could initiate an aggressive inflammation by increasing cytokines secretion"/>
   <result pre="and influenza, given the early stage in our understanding regarding" exact="SARS-CoV-2 infection," post="to conclude that the immunomodulatory or immune suppressive effects"/>
   <result pre="days) with TB in 23 patients, raising the suspicion that" exact="SARS-CoV-2 infection" post="might boost the development of active TB. However, this"/>
   <result pre="if healthcare workers' BCG vaccination will have any impact on" exact="SARS-CoV-2 infection" post="(BCG Vaccination to Protect Healthcare Workers against COVID-19, BRACE,"/>
   <result pre="vaccines based on S protein are also considered for preventing" exact="SARS-CoV-2 infection" post="[47, 58, 59]. Novel methods are emerging such as"/>
   <result pre="[13]. With the urge of identifying the radiological features of" exact="SARS-CoV-2 infection," post="with the community transmission present in most countries, and"/>
   <result pre="Coinfection of TB and SARS-CoV-2 may be challenging to diagnose." exact="SARS-CoV-2 infection" post="may mask the clinical and radiological active TB. Patients"/>
   <result pre="of Infectious Diseases2014209227027410.1093/infdis/jit42423935205 12OrganisationW. H.WHO Information on Tuberculosis and Pandemic" exact="Influenza" post="A (H1N1)2009Geneva, SwitzerlandWHOhttp://www9.who.int/tb/features_archive/h1n1/en/ 13LiJ.-Y.YouZ.WangQ.et al.The epidemic of 2019-novel-coronavirus (2019-nCoV)"/>
   <result pre="Stem Cell Treating Acute Respiratory Distress Syndrome Induced by Epidemic" exact="Influenza" post="A (H7N9) Infection, a Hint for COVID-19 Treatment2020Beijing, ChinaEngineering"/>
   <result pre="infection controlIntervirology2017601-2535510.1159/00047790828683463 29GuanW. J.NiZ. Y.HuY.LiangW. H.OuC. Q.HeJ. X.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaThe New England Journal of Medicine20203821708172010.1056/NEJMoa200203232109013 30TadoliniM.CodecasaL. R.GarcÃ­a-GarcÃ­aJ.-M.et"/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the Perspectives of clinical immunologists from ChinaClinical Immunology202021410.1016/j.clim.2020.108393"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7480504\results\search\zoonosis\results.xml">
   <result pre="pose a threat to public health globally in recent years." exact="Severe acute respiratory syndrome" post="(SARS) and Middle East respiratory syndrome (MERS) are two"/>
   <result pre="globally in recent years. Severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS) are two coronaviral diseases with demonstrated potential to"/>
   <result pre="of bats and their associated viruses such as Nipah and" exact="Ebola" post="viruses, along with SARS, Midde East Respiratory Syndrome (MERS),"/>
   <result pre="vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) outbreaks in the healthcare setting. Theor Biol"/>
   <result pre="J Med. 2020;382(8):727â€&quot;6. .31978945 [3]LiuW, ZhangQ, ChenJ, et alDetection of" exact="Covid-19" post="in children in early January 2020 in Wuhan, China1."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7480628\results\search\zoonosis\results.xml">
   <result pre="otherwise stated in a credit line to the data. Abstract" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) infects host cells through angiotensin converting"/>
   <result pre="2012 in the Middle East of a novel CoV called" exact="Middle East respiratory syndrome" post="CoV (MERS-CoV), it infected 857 cases with 35% mortality"/>
   <result pre="[13, 22, 23]. A key factor in the transmissibility of" exact="Covid-19" post="is the high level of SARS-CoV-2 shedding in the"/>
   <result pre="hypotension and bradycardia when this medication was used to treat" exact="Ebola" post="[45]. The safety and efficacy of remdesivir for the"/>
   <result pre="supportive therapies are being evaluated with promising results. Abbreviations SARS-CoV" exact="Severe acute respiratory syndrome" post="coronavirus COVID-19 Coronavirus disease-19 RCT Randomized controlled trials MERS"/>
   <result pre="syndrome coronavirus COVID-19 Coronavirus disease-19 RCT Randomized controlled trials MERS" exact="Middle East respiratory syndrome" post="WHO World Health Organization RO Reproductive number ACE Angiotensin"/>
   <result pre="Microbe. 2020; 10.1016/S2666-5247(20)30003-3. 27.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, China. JAMA Intern Med. 2020. 10.1001/jamainternmed.2020.0994."/>
   <result pre="10.1001/jamainternmed.2020.0994. 34.TangNBaiHChenXGongJLiDSunZAnticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathyJ Thromb Haemost2020181094109910.1111/jth.1481732220112 35.American College of Radiology."/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan. China. JAMA Intern Med. 2020. 10.1001/jamainternmed.2020.0994."/>
   <result pre="common marmosetJ Infect Dis20152121904191310.1093/infdis/jiv39226198719 45.MulanguSDoddLEDaveyRTet al.A randomized controlled trial of" exact="Ebola" post="virus disease therapeuticsN Engl J Med20193812293230310.1056/NEJMoa191099331774950 46.ShenCWangZZhaoFet al.Treatment of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7481143\results\search\zoonosis\results.xml">
   <result pre="spread across Middle Eastern countries.14 The virus was named the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) and infected 2494 individuals and caused 858"/>
   <result pre="its molecular biology as well as available advances and technology." exact="SARS-CoV-2 infection" post="is generally detected by reverse transcriptaseâ€&quot;polymerase chain reaction (RT-PCR)"/>
   <result pre="evidence that the antibodies produced will protect from a new" exact="SARS-CoV-2 infection," post="and people infected respond differently from asymptomatic infection, moving"/>
   <result pre="in the dissemination of several types of viruses such as" exact="Influenza" post="A and other CoVs, which also makes it a"/>
   <result pre="It is an adenosine analogue prodrug first developed to treat" exact="Ebola" post="(EBOV), but it presents a broad antiviral spectrum including"/>
   <result pre="efficacy has also been investigated in different countries to fight" exact="Ebola" post="and Lassa, for example. The molecular structure of the"/>
   <result pre="are several studies on the use of ritonavir/lopinavir to treat" exact="SARS-CoV-2 infection," post="once these drugs have had positive results against SARS-CoV"/>
   <result pre="of CsA to increase ACE2 shedding and, consequently, to augment" exact="SARS-CoV-2 infection" post="by increment the ACE2 upregulation.200 Furthermore, the CsA has"/>
   <result pre="is not clear whether CsA may mitigate or aggravate the" exact="SARS-CoV-2 infection," post="since there is no CsA clinical studies published up"/>
   <result pre="and replication. This compound has already shown inhibitory activity against" exact="Ebola" post="virus, MERS-CoV and SARS-CoV.202 Recent investigations have suggested teicoplanin"/>
   <result pre="Results indicated this drug as a likely therapeutic alternative against" exact="SARS-CoV-2 infection." post="An in-silico study carried out by Qiao et al.216"/>
   <result pre="al.243 a likely involvement of HCQ in iron homeostasis during" exact="SARS-CoV-2 infection," post="which is a similar mechanism to other viral infections"/>
   <result pre="with reported inhibitory activity for enterovirus infections,300 Zika virus and" exact="Ebola" post="by interfering with the process of viral replication and"/>
   <result pre="as H5N1 avian influenza,329 pandemic 2009 influenza A H1N1,330 severe" exact="Ebola" post="virus infection,331 HCoVs SARS-CoV332 and MERS-CoV.333 A possible explanation"/>
   <result pre="New York; 2015. https://doi.org/10.1007/978-1-4939-2438-7. 40JiangF.DengL.ZhangL.CaiY.CheungC.W.XiaZ.Review of the clinical characteristics of" exact="coronavirus disease 2019" post="(COVID-19)J Gen Intern Med3520201545154910.1007/s11606-020-05762-w32133578 41GandhiR.T.LynchJ.B.del RioC.Mild or moderate Covid-19NEJMcp2009249N"/>
   <result pre="Engl J Med38220202081209010.1056/NEJMoa200845732329971 43GuoY.-R.CaoQ.-D.HongZ.-S.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak â€&quot; an update on the statusMil Med"/>
   <result pre="in Wuhan, China: a retrospective cohort studyLancet39520201054106210.1016/S0140-6736(20)30566-332171076 46GuanW.NiZ.HuY.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med38220201708172010.1056/NEJMoa200203232109013 47YangX.YuY.XuJ.Clinical course and outcomes"/>
   <result pre="should be an optionLancet3952020e35e3610.1016/S0140-6736(20)30305-632035018 63OmraniA.S.SaadM.M.BaigK.Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: a retrospective cohort studyLancet Infect Dis1420141090109510.1016/S1473-3099(14)70920-X25278221 64TangT.BidonM.JaimesJ.A.WhittakerG.R.DanielS.Coronavirus"/>
   <result pre="diseases by a novel broad-spectrum nucleoside analogue BCX4430Nature508201440240510.1038/nature1302724590073 106WestoverJ.B.MathisA.TaylorR.Galidesivir limits" exact="Rift Valley fever" post="virus infection and disease in Syrian golden hamstersAntiviral Res2018156381564510.1016/j.antiviral.2018.05.013"/>
   <result pre="Biol Chem2852010343373434710.1074/jbc.M110.16180220801890 113XuH.-T.Colby-GerminarioS.P.HassounahS.A.Evaluation of Sofosbuvir (Î²-D-2â€²-deoxy-2â€²-Î±-fluoro-2â€²-Î²-C-methyluridine) as an inhibitor of" exact="Dengue" post="virus replicationSci Rep72017634510.1038/s41598-017-06612-228740124 114de Freitas CS, Higa LM, Sacramento"/>
   <result pre="Antimicrob Agents55202010595510.1016/j.ijantimicag.2020.105955 131WarrenT.K.JordanR.LoM.K.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature531201638138510.1038/nature1718026934220 132MulanguS.DoddL.E.DaveyR.T.A randomized, controlled trial of"/>
   <result pre="patients with severe Covid-19N Engl J Med38220202327233610.1056/NEJMoa200701632275812 137SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19)JAMA202010.1001/jama.2020.6019[Epub ahead of print] 138MartinD.F.KuppermannB.D.WolitzR.A.PalestineA.G.LiH.RobinsonC.A.Oral ganciclovir for patients with"/>
   <result pre="2018;46:D1074â€&quot;D1082. https://doi.org/10.1093/nar/gkx1037. 140ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751310.1016/S0140-6736(20)30211-732007143 141MontesinosP.SanzJ.CanteroS.Incidence, risk factors,"/>
   <result pre="2020; https://doi.org/10.13140/RG.2.2.34276.94083. 200CureE.KucukA.Cumhur CureM.Cyclosporine therapy in cytokine storm due to" exact="coronavirus disease 2019" post="(COVID-19)Rheumatol Int4020201177117932415310 201CampanaC.RegazziM.B.BuggiaI.MolinaroM.Clinically significant drug interactions with cyclosporinClin Pharmacokinet3019961411798906896"/>
   <result pre="L in the late endosome/lysosome and block the entry of" exact="Ebola" post="Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and severe"/>
   <result pre="in the management of HIV-1 infectionDrugs74201399125 212DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov Ther142020586032147628 213AfaghiS.TarkiF.E.RahimiF.S.Therapeutic options and critical care strategies"/>
   <result pre="cytokinesCytokine1312020155115 238RossignolJ.F.Nitazoxanide, a new drug candidate for the treatment of" exact="Middle East respiratory syndrome" post="coronavirusJ Infect Public Health9201622723027095301 239ElazarM.LiuM.McKennaS.A.The anti-hepatitis C agent nitazoxanide"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov620201632194981 248TouretF.de LamballerieX.Of chloroquine and COVID-19Antiviral Res1772020104762"/>
   <result pre="inhibit the activity of SARS CoV2 helicase: possible implications for" exact="COVID 19" post="therapeutics. OSF Preprints. 2020; https://doi.org/10.31219/osf.io/8dseq. 269GÃ¶tzV.MagarL.DornfeldD.Influenza A viruses escape"/>
   <result pre="infection by inhibiting viral translationAntiviral Res1732020104650 301YangS.XuM.LeeE.M.Emetine inhibits Zika and" exact="Ebola" post="virus infections through two molecular mechanisms: inhibiting viral replication"/>
   <result pre="antibody blocking SARS-CoV-2 infectionNat Commun112020225132366817 329ZhouB.ZhongN.GuanY.Treatment with Convalescent Plasma for" exact="Influenza" post="A (H5N1) InfectionN Engl J Med35720071450145117914053 330HungI.F.N.ToK.K.LeeC.K.Convalescent plasma treatment"/>
   <result pre="and laboratory effects of convalescent plasma therapy for patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a study protocolSpringerplus4201570926618098 334ShenC.WangZ.ZhaoF.Treatment of 5 critically"/>
   <result pre="plasma as a potential therapy for COVID-19Lancet Infect Dis20202039840032113510 336LurieN.SavilleM.HatchettR.HaltonJ.Developing" exact="Covid-19" post="vaccines at pandemic speedN Engl J Med38220201969197332227757 337GrahamR.L.DonaldsonE.F.BaricR.S.A decade"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7482434\results\search\zoonosis\results.xml">
   <result pre="the post-election unrest in Kenya in 2007,22, 23 during the" exact="Ebola" post="epidemic in Guinea in 2014,24 in acute conflict areas"/>
   <result pre="in western KenyaJ Acquir Immune Defic Syndr59201219920622027872 24LeuenbergerDHebelamouJStrahmSImpact of the" exact="Ebola" post="epidemic on general and HIV care in Macenta, Forest"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7484576\results\search\zoonosis\results.xml">
   <result pre="syndrome coronavirus (SARS-CoV) emerged in 2002â€&quot;2003. After a decade, the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) appeared, and infections continue to expand in"/>
   <result pre="to suppress SARS-CoV and MERS-CoV in vivo.27,28 It strappingly prevented" exact="SARS-CoV-2 infection" post="in a recent in vitro investigation at low-micro molar"/>
   <result pre="administration of remdesivir.29 Though remdesivir exhibits many merits for curing" exact="SARS-CoV-2 infection" post="and pneumonia, randomized controlled trials (RCTs) are still necessitated"/>
   <result pre="boosting up immunological responses, predominantly antigen-specific CD8+ T-cell-assisted responses against" exact="SARS-CoV infection" post="are documented in patent application WO2005081716.65 Immune responses, particularly"/>
   <result pre="ChenF, ZhangWClinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatment. Biosci Trend."/>
   <result pre="doi:10.1016/j.antiviral.2017.12.007.29246504 50.ChiH, ZhengX, WangX, WangC, WangH, GaiW, XiaXDNA vaccine encoding" exact="Middle East respiratory syndrome" post="coronavirus S1 protein induces protective immune responses in mice."/>
   <result pre="Patent. 2020; US20060039926A1. 2006223 [accessed 2020 614]. https://patentimages.storage.googleapis.com/b5/d4/fb/5d1a763f553801/US20060039926A1.pdf. 62.collab: WHO," exact="COVID-2019" post="(World Health Organization)Coronavirus disease (COVID-2019) situation reports. 2020 [accessed"/>
   <result pre="MuellerMA, BleickerTClinical presentation and virological assessment of hospitalized cases of" exact="coronavirus disease 2019" post="in a travel-associated transmission cluster. MedRxiv. 2020. doi:10.1101/2020.03.05.20030502. 73.ChengY,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7485819\results\search\zoonosis\results.xml">
   <result pre="Sciences : Medical Conditions : Infectious Diseases : Viral Diseases:" exact="Influenza" post=": Biology and life sciences : Organisms : Viruses"/>
   <result pre=": Organisms : Viruses : RNA viruses : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza A virus : Biology and life sciences"/>
   <result pre=": Viruses : RNA viruses : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="A virus : Biology and life sciences : Microbiology"/>
   <result pre="microbiology : Microbial pathogens : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza A virus : Medicine and health sciences"/>
   <result pre="Microbial pathogens : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="A virus : Medicine and health sciences : Pathology"/>
   <result pre="Pathogens : Microbial pathogens : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza A virus : Biology and life sciences"/>
   <result pre="Microbial pathogens : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="A virus : Biology and life sciences : Organisms"/>
   <result pre=": Organisms : Viruses : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza A virus : Biology and Life Sciences"/>
   <result pre=": Viruses : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="A virus : Biology and Life Sciences : Molecular"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Orthomyxoviruses:" exact="Influenza" post="Viruses : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Orthomyxoviruses:" exact="Influenza" post="Viruses : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Orthomyxoviruses:" exact="Influenza" post="Viruses : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Orthomyxoviruses:" exact="Influenza" post="Viruses : Biology and life sciences : Organisms :"/>
   <result pre=": Organisms : Viruses : RNA viruses : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza B virus : Biology and life sciences"/>
   <result pre=": Viruses : RNA viruses : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="B virus : Biology and life sciences : Microbiology"/>
   <result pre="microbiology : Microbial pathogens : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza B virus : Medicine and health sciences"/>
   <result pre="Microbial pathogens : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="B virus : Medicine and health sciences : Pathology"/>
   <result pre="Pathogens : Microbial pathogens : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza B virus : Biology and life sciences"/>
   <result pre="Microbial pathogens : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="B virus : Biology and life sciences : Organisms"/>
   <result pre=": Organisms : Viruses : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza B virus : Biology and Life Sciences"/>
   <result pre=": Viruses : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="B virus : Biology and Life Sciences : Veterinary"/>
   <result pre=": Organisms : Viruses : RNA viruses : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza C virus : Biology and life sciences"/>
   <result pre=": Viruses : RNA viruses : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="C virus : Biology and life sciences : Microbiology"/>
   <result pre="microbiology : Microbial pathogens : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza C virus : Medicine and health sciences"/>
   <result pre="Microbial pathogens : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="C virus : Medicine and health sciences : Pathology"/>
   <result pre="Pathogens : Microbial pathogens : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza C virus : Biology and life sciences"/>
   <result pre="Microbial pathogens : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="C virus : Biology and life sciences : Organisms"/>
   <result pre=": Organisms : Viruses : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza C virus : Medicine and Health Sciences"/>
   <result pre=": Viruses : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="C virus : Medicine and Health Sciences : Medical"/>
   <result pre=": Medical Conditions : Infectious Diseases : Viral Diseases :" exact="Influenza" post=": Animal Influenza: Swine Influenza : Biology and Life"/>
   <result pre="Diseases : Viral Diseases : Influenza : Animal Influenza: Swine" exact="Influenza" post=": Biology and Life Sciences : Zoology : Animal"/>
   <result pre="Sciences : Zoology : Animal Diseases : Animal Influenza: Swine" exact="Influenza" post=": Medicine and Health Sciences : Medical Conditions :"/>
   <result pre="Sciences : Medical Conditions : Infectious Diseases : Zoonoses: Swine" exact="Influenza" post="Development of a multiplex isothermal amplification molecular diagnosis method"/>
   <result pre="primer for the detection of two subtypes of influenza viruses:" exact="Influenza" post="A (A/H1 and A/H3) and influenza B. The detection"/>
   <result pre="influenza-associated respiratory deaths occur annually (4Â·0â€&quot;8Â·8 per 100,000 individuals) [3]." exact="Influenza" post="viruses belong to the Orthomyxoviridae family and have a"/>
   <result pre="Ethics Committee of Korea University Guro Hospital (2019GR0055). Primer design" exact="Influenza" post="A and B LAMP primer sets were designed within"/>
   <result pre="used in this study. Target Name Sequence (5`-3`) Length (mer)" exact="Influenza" post="A (segment 7 gene) INFA F3 GAC TTG AAG"/>
   <result pre="CCC ACA CTC CGG TCT TGT CTT TAG CCA 48" exact="Influenza" post="B (NP gene) INFB F3 GAG CTG CCT ATG"/>
   <result pre="TGT GGG TGT TCC CTT TGT ACG GGC CCG-BHQ1 30" exact="Influenza" post="A (M gene) RT-PCR INFA-1 CTTCTAACCGAGGTCGAAACGTA 23 RT-PCR INFA-2"/>
   <result pre="23 RT-PCR INFA-2 GGTGACAGGATTGGTCTTGTCTTTA 25 RT-PCR INFA probe [HEX]-TCAGGCCCCCTCAAAGCCGAG 21" exact="Influenza" post="B (HA gene) RT-PCR INFB-1 AAATACGGTGGATTAAATAAAAGCAA 26 RT-PCR INFB-2"/>
   <result pre="HEX and Texas red fluorescence channels was used for detecting" exact="Influenza" post="A, influenza B and internal control (actin beta), respectively."/>
   <result pre="influenza A/B/IC RT-LAMP assay, two real-time RT-PCRs, the commercial RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 (Altona Diagnostics, Hamburg, Germany) and the"/>
   <result pre="fluorescence detection at 60Â°C for 40 s. For the RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0, the thermocycling parameters were as follows:"/>
   <result pre="Blunt V2 plasmids, including the segment 7 partial sequences of" exact="Influenza" post="A, were used to test the LOD of the"/>
   <result pre="those of the WHO influenza A/B primer set and RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0. Results Optimization of the multiplex influenza"/>
   <result pre="LAMP primer set Before optimization of multiplex LAMP assay, each" exact="Influenza" post="A, B and internal control (IC, actin beta) LAMP"/>
   <result pre="were tested with clinical samples (Influenza A H1, H1N1, H3N2," exact="Influenza" post="B, human serum RNA and distilled water). All three"/>
   <result pre="compared with the WHO RT-PCR primer set and commercial RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 using serially diluted clinical influenza A/H1,"/>
   <result pre="LOD of both the WHO RT-PCR primer set and RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 for influenza A/H1 was 10âˆ’3 while"/>
   <result pre="A/B/IC RT-LAMP assay was 10âˆ’2. For influenza A/H3, the RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 assay showed the highest sensitivity (10âˆ’5),"/>
   <result pre="other two assays was 10âˆ’4. For influenza B, the RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 assay showed the highest sensitivity (10âˆ’4),"/>
   <result pre="dilutions were the lowest in the analysis of the RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0, followed by the WHO RT-PCR primer"/>
   <result pre="LAMP primer set. Monoplex RT-LAMP Multiplex influenza A/B/IC RT-LAMP Plasmid" exact="Influenza" post="A Influenza A Internal control Influenza B Ct RFU"/>
   <result pre="set. Monoplex RT-LAMP Multiplex influenza A/B/IC RT-LAMP Plasmid Influenza A" exact="Influenza" post="A Internal control Influenza B Ct RFU Ct RFU"/>
   <result pre="influenza A/B/IC RT-LAMP Plasmid Influenza A Influenza A Internal control" exact="Influenza" post="B Ct RFU Ct RFU Ct RFU Ct RFU"/>
   <result pre="Influenza B Ct RFU Ct RFU Ct RFU Ct RFU" exact="Influenza" post="A plasmid dilution sample (copies/ul) 108 9.48 21710 11.28"/>
   <result pre="101 Neg 239 Neg -5 Neg 3 Neg 46 Plasmid" exact="Influenza" post="B Influenza A Internal control Influenza B Ct RFU"/>
   <result pre="239 Neg -5 Neg 3 Neg 46 Plasmid Influenza B" exact="Influenza" post="A Internal control Influenza B Ct RFU Ct RFU"/>
   <result pre="3 Neg 46 Plasmid Influenza B Influenza A Internal control" exact="Influenza" post="B Ct RFU Ct RFU Ct RFU Ct RFU"/>
   <result pre="Influenza B Ct RFU Ct RFU Ct RFU Ct RFU" exact="Influenza" post="B plasmid dilution sample (copies/ul) 108 5.35 20471 Neg"/>
   <result pre="42 Neg 13 Neg 12 Neg 35 Plasmid Internal control" exact="Influenza" post="A Internal control Influenza B Ct RFU Ct RFU"/>
   <result pre="12 Neg 35 Plasmid Internal control Influenza A Internal control" exact="Influenza" post="B Ct RFU Ct RFU Ct RFU Ct RFU"/>
   <result pre="the multiplex influenza A/B/IC LAMP assay, World Health Organization (WHO)" exact="Influenza" post="RT-PCR, and RealStarÂ® Influenza RT-PCR Kit 2.0 for the"/>
   <result pre="LAMP assay, World Health Organization (WHO) Influenza RT-PCR, and RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 for the clinical influenza A/B samples."/>
   <result pre="for the clinical influenza A/B samples. Subtype RT-LAMP assay WHO" exact="Influenza" post="RT-PCR RealStarÂ® Influenza RT-PCR 2.0 (Altona) RNA copies (10n)"/>
   <result pre="influenza A/B samples. Subtype RT-LAMP assay WHO Influenza RT-PCR RealStarÂ®" exact="Influenza" post="RT-PCR 2.0 (Altona) RNA copies (10n) per reaction -1"/>
   <result pre="-3 -4 -5 -6 -1 -2 -3 -4 -5 -6" exact="Influenza" post="A (H1) Influenza A (H3) Influenza B Comparison of"/>
   <result pre="-6 -1 -2 -3 -4 -5 -6 Influenza A (H1)" exact="Influenza" post="A (H3) Influenza B Comparison of clinical performance between"/>
   <result pre="-3 -4 -5 -6 Influenza A (H1) Influenza A (H3)" exact="Influenza" post="B Comparison of clinical performance between the multiplex influenza"/>
   <result pre="influenza A/B/IC RT-LAMP assay, WHO RT-PCR primer set, and RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 using clinical samples To confirm the"/>
   <result pre="with those of the WHO RT-PCR primer set and RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 for 93 influenza A, 80 influenza"/>
   <result pre="the sensitivities of the WHO RT-qPCR primer set and RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 were 100% and 81.81%, respectively. The"/>
   <result pre="the sensitivities of the WHO RT-PCR primer set and RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 were 97.59% and 89.02%, respectively. The"/>
   <result pre="A/H3 clinical samples were 100% while that of the RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 was 95.12%. Overall, the WHO RT-PCR"/>
   <result pre="multiplex influenza A/B/IC RT-LAMP assay (94.62%), and finally the RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 (88.17%). The specificities of the former"/>
   <result pre="sensitivities (97.50% and 97.50%, respectively) while that of the RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 was 86.25% (Table 4). The internal"/>
   <result pre="n = 100) were 100%, whereas that of the RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 was 99% (Table 4). The sensitivity"/>
   <result pre="clinical performance between the multiplex influenza A/B/IC RT-LAMP assay, WHO" exact="Influenza" post="RT-PCR, and RealStarÂ® Influenza RT-PCR Kit 2.0 for influenza"/>
   <result pre="multiplex influenza A/B/IC RT-LAMP assay, WHO Influenza RT-PCR, and RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 for influenza A subtypes (H1N1 and"/>
   <result pre="viruses in the clinical samples. Clinical samples RT-LAMP assay WHO" exact="Influenza" post="RT-PCR RealStarÂ® Influenza RT-PCR (Altona) In A (FAM) IC"/>
   <result pre="clinical samples. Clinical samples RT-LAMP assay WHO Influenza RT-PCR RealStarÂ®" exact="Influenza" post="RT-PCR (Altona) In A (FAM) IC (Hex) In B"/>
   <result pre="influenza A/B/IC RT-LAMP assay, WHO RT-PCR primer set, and RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 (Table 5) [33, 34]. All three"/>
   <result pre="lower detection sensitivity for diluted clinical samples than the RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 but higher sensitivity for original clinical"/>
   <result pre="higher sensitivity for various influenza genetic sequences while the RealStarÂ®" exact="Influenza" post="RT-PCR Kit 2.0 had a higher sensitivity for specific"/>
   <result pre="of influenza A, B and IC (actin beta) RT-LAMP products." exact="Influenza" post="A/B virus clinical samples, non-infection human serum RNA and"/>
   <result pre="primer set (C). Lane M: DNA ladder marker, Lane 1:" exact="Influenza" post="A/H1, Lane 2: Influenza A/H1N1, Lane 3: Influenza A/H3N2,"/>
   <result pre="M: DNA ladder marker, Lane 1: Influenza A/H1, Lane 2:" exact="Influenza" post="A/H1N1, Lane 3: Influenza A/H3N2, Lane 4: Influenza B,"/>
   <result pre="Lane 1: Influenza A/H1, Lane 2: Influenza A/H1N1, Lane 3:" exact="Influenza" post="A/H3N2, Lane 4: Influenza B, Lane 5: Non-infection human"/>
   <result pre="Lane 2: Influenza A/H1N1, Lane 3: Influenza A/H3N2, Lane 4:" exact="Influenza" post="B, Lane 5: Non-infection human serum RNA and Lane"/>
   <result pre="for additional data file. References References 1BunkerD, EhnisC, ShahbaziM. Managing" exact="Influenza" post="Outbreaks Through Social Interaction on Social Media: Research Transformation"/>
   <result pre="screening of influenza virus types A, B, C and D." exact="Influenza" post="and other respiratory viruses. 2019;13(1):71â€&quot;82. Epub 2018/09/29. 10.1111/irv.1261330264926 8JiangY,"/>
   <result pre="8JiangY, TanCY, TanSY, WongMSF, ChenYF, ZhangL, et al.SAW sensor for" exact="Influenza" post="A virus detection enabled with efficient surface functionalization. Sensors"/>
   <result pre="10.1371/journal.pone.021730731107922 15TakashitaE, MoritaH, OgawaR, NakamuraK, FujisakiS, ShirakuraM, et al.Susceptibility of" exact="Influenza" post="Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil."/>
   <result pre="ZhaoJ, LiuJ, WangX, BiswasS, HewlettI. Current Approaches for Diagnosis of" exact="Influenza" post="Virus Infections in Humans. Viruses. 2016;8(4):96 Epub 2016/04/15. 10.3390/v804009627077877"/>
   <result pre="Its Application on Simultaneous Detection of All Four Serotype of" exact="Dengue" post="Viruses. Frontiers in microbiology. 2019;10:1056 Epub 2019/05/30. 10.3389/fmicb.2019.0105631139171 30YarenO,"/>
   <result pre="10.1038/s41598-018-23930-129615801 32PoonLL, LeungCS, ChanKH, LeeJH, YuenKY, GuanY, et al.Detection of" exact="human influenza" post="A viruses by loop-mediated isothermal amplification. Journal of clinical"/>
   <result pre="with Cascade Invasive Reaction and Nanoparticle Hybridization for Subtyping of" exact="Influenza" post="A Virus. Scientific reports. 2017;7:44924 Epub 2017/03/23. 10.1038/srep4492428322309 49HsiehK,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7485949\results\search\zoonosis\results.xml">
   <result pre="emerging diseases, including the H1N1 influenza pandemic (2009) and now" exact="coronavirus disease 2019" post="(COVIDâ€�19).1 Over the last several decades, as technology has"/>
   <result pre="enhancement (ADE), and earlier studies of Hâ€�IG in SARS and" exact="Middle East respiratory syndrome" post="(MERS) have not provided enough information to extrapolate to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7486771\results\search\zoonosis\results.xml">
   <result pre="in the main text. References 1collab: Centers for Disease Control," exact="Covid-19" post="forecasts: Cumulative deaths. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/forecasting-us.html. Accessed 12 August 2020. 2FergusonN.et"/>
   <result pre="113â€&quot;122 (2020). 4collab: Institut National dâ€™Etudes DÃ©mographiques, The demographics of" exact="Covid-19" post="deaths. https://dc-covid.site.ined.fr/en/. Accessed 23 May 2020. 5EdwardsR. D., TuljapurkarS.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7486822\results\search\zoonosis\results.xml">
   <result pre="7486822S2387-0206(20)30427-7 doi: 10.1016/j.medcle.2020.06.012 : Original Article Potential drugâ€&quot;drug interactions in" exact="COVID 19" post="patients in treatment with lopinavir/ritonavirâ˜†Interacciones medicamentosas potenciales en pacientes"/>
   <result pre="19 patients in treatment with lopinavir/ritonavirâ˜†Interacciones medicamentosas potenciales en pacientes" exact="COVID 19" post="en tratamiento con lopinavir/ritonavir Brandariz-NuÃ±ezDavidaâ�ŽCorreas-SanahujaMarcelobGuarcEvaaPicÃ³nRafaelaGarcÃ­aBÃ¡rbaraaGilRocÃ­oa[a], [b], â�ŽCorresponding author. pmc-release:"/>
   <result pre="Abstract Objectives To determine the prevalence of potential interactions in" exact="COVID19" post="patients receiving lopinavir/ritonavir (LPV/r). The secondary objective was to"/>
   <result pre="Cross-sectional and multicenter study with the participation of 2 hospitals." exact="COVID 19" post="patients over 18 years of age, admitted to hospital"/>
   <result pre="factors. Objetivos Determinar la prevalencia de interacciones potenciales en pacientes" exact="COVID19" post="en tratamiento con lopinavir/ritonavir (LPV/r). El objetivo secundario fue"/>
   <result pre="y multicÃ©ntrico con la participaciÃ³n 2 hospitales. Se incluyeron pacientes" exact="COVID 19" post="mayores de 18 aÃ±os, con ingreso hospitalario y en"/>
   <result pre="el nÃºmero de fÃ¡rmacos prescritos. Keywords Potential drugâ€&quot;drug interactions Lopinavir/ritonavir" exact="COVID 19" post="SARS-CoV-2 Protease inhibitor Palabras clave Interacciones medicamentosas potenciales Lopinavir/ritonavir"/>
   <result pre="19 SARS-CoV-2 Protease inhibitor Palabras clave Interacciones medicamentosas potenciales Lopinavir/ritonavir" exact="COVID 19" post="SARS-CoV-2 Inhibidor de la proteasa Introduction COVID-19 is the"/>
   <result pre="currently used in combination with LVP/r for the treatment of" exact="COVID 19," post="also prolong QT, increasing the risk of ventricular arrhythmia"/>
   <result pre="is essential for the comprehensive approach and treatment of the" exact="COVID 19" post="pandemic. Conflict of interests The authors declare no conflict"/>
   <result pre="R, GarcÃ­a B, Gil R. Interacciones medicamentosas potenciales en pacientes" exact="COVID 19" post="en tratamiento con lopinavir/ritonavir. Med Clin (Barc). 2020;155:281â€&quot;287."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7488313\results\search\zoonosis\results.xml">
   <result pre="Emerg Dis2018651664167029920971 31.collab: The Global Consortium for H5N8 and Related" exact="Influenza" post="VirusesRole for migratory wild birds in the global spread"/>
   <result pre="55.SartikaTSulandariSZeinMSASelection of Mx gene genotype as genetic marker for Avian" exact="Influenza" post="resistance in Indonesian native chickenBMC Proc20115S3721645318 56.HassananeMSHassanAAMAhmedFMEl-KomyEMRoushdyKMHassanNAIdentification of Mx"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7489051\results\search\zoonosis\results.xml">
   <result pre="(WHO) declaration of COVID-19 as a global pandemic. Abstract The" exact="coronavirus disease 2019" post="(COVID-19) caused by severe acute respiratory syndrome coronavirus 2"/>
   <result pre="Two other Î²-CoVs, severe acute respiratory syndrome CoV (SARS-CoV) and" exact="Middle East respiratory syndrome" post="CoV (MERS-CoV), have zoonotic origins and have been linked"/>
   <result pre="response, with 8454 confirmed cases and 792 deaths.6 In 2012," exact="Middle East respiratory syndrome" post="(MERS), caused by MERS-CoV, emerged in the Kingdom of"/>
   <result pre="of COVID-19. It has been thought that deaths induced by" exact="SARS-CoV-2 infection" post="are due to vigorous systemic inflammation caused by â€œcytokine"/>
   <result pre="and the SI was &amp;gt;6.46.16 FPV was 100% protective against" exact="Ebola" post="virus challenge in mice, although the EC50 in Vero"/>
   <result pre="CoV infection and might offer promising therapeutic possibilities for combating" exact="SARS-CoV-2 infection." post="Camostat (9) is a serine protease inhibitor used to"/>
   <result pre="Î¼M. Further in vivo studies of the two drugs against" exact="SARS-CoV-2 infection" post="are recommended.16 3.2.5 Inhibitors with Undefined Replication Inhibiting Mechanisms"/>
   <result pre="the house mouse CC50 50% cytotoxic concentration CoV coronavirus COVID-19" exact="coronavirus disease 2019" post="CPE cytopathogenic effect CVB3 coxsackievirus B3 GL glycyrrhizic acid"/>
   <result pre="Î² JHQGG Jinhua Qinggan granule LHQWC Lianhua Qingwen capsule MERS-CoV" exact="Middle East respiratory syndrome" post="coronavirus NHC National Health Commission NSP nonstructural protein NTPase/Hel"/>
   <result pre="Qingfei Paidu decoction and Ma Xing Shi Gan decoction against" exact="coronavirus disease 2019" post="(COVID-19): In Silico and Experimental Study. Pharmacol. Res.2020, 157,"/>
   <result pre="RavaudP.; GodeauB.; GallienS.; Costedoat-ChalumeauN.Clinical efficacy of hydroxychloroquine in patients with" exact="Covid-19" post="pneumonia who require oxygen: observational comparative study using routine"/>
   <result pre="J.2019, 14, 3962â€&quot;3968. 10.1002/asia.201900841.31389664 DongL.; HuS.; GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19). Drug Discoveries Ther.2020, 14, 58â€&quot;60. 10.5582/ddt.2020.01012. FurutaY.; GowenB."/>
   <result pre="SubbaraoK.Development of animal models against emerging coronaviruses: from SARS to" exact="MERS coronavirus." post="Virology2015, 479â€&quot;480, 247â€&quot;258. 10.1016/j.virol.2015.02.030. SunJ.; ZhuangZ.; ZhengJ.; LiK.; WongR."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7491483\results\search\zoonosis\results.xml">
   <result pre="apheresis is disrupted during the pandemic. The sudden outbreak of" exact="coronavirus disease 2019" post="(COVID-19) caused unprecedented pressure on the community and the"/>
   <result pre="the coronavirus pandemicCirculation14120201943194532310675 5WangH.YuanZ.PavelM.A.HansenS.B.The role of high cholesterol in age-related" exact="COVID19" post="lethalitybioRxiv202010.1101/2020.05.09.086249 6NguyenJ.L.YangW.ItoK.MatteT.D.ShamanJ.KinneyP.L.Seasonal influenza infections and cardiovascular disease mortalityJAMA Cardiol1201627428127438105"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7493771\results\search\zoonosis\results.xml">
   <result pre="MD pmcid: 7493771AIDS-D-20-00526 doi: 10.1097/QAD.0000000000002643 : Clinical Science: Special Section:" exact="Covid-19" post="among People Living with HIV Clinical characteristics, risk factors,"/>
   <result pre="with HIV Clinical characteristics, risk factors, and incidence of symptomatic" exact="coronavirus disease 2019" post="in a large cohort of adults living with HIV:"/>
   <result pre="It is unclear how characteristics, risk factors, and incidence of" exact="coronavirus disease 2019" post="(COVID-19) in people living with HIV (PLWH) differ from"/>
   <result pre="findings should be confirmed in larger multicenter cohort studies. Keywords" exact="coronavirus disease 2019" post="HIV prospective observational trial severe acute respiratory syndrome coronavirus"/>
   <result pre="severe acute respiratory syndrome coronavirus 2 Introduction Risk for severe" exact="coronavirus disease 2019" post="(COVID-19) increases with age, male sex, and comorbidities [1â€&quot;3]."/>
   <result pre="analyses. Results People living with HIV with symptoms suggestive of" exact="coronavirus disease 2019" post="By 10 May 2020, 62 PLWH out of 5683"/>
   <result pre="respiratory infections concomitant to SARS-CoV-2 were found. Clinical characteristics of" exact="coronavirus disease 2019" post="people living with HIV and outcome Characteristics of COVID-19"/>
   <result pre="and 35 (66%) a tenofovir-containing regimen. Table 1 Characteristics of" exact="coronavirus disease 2019" post="patients. The median (IQR) time from the onset of"/>
   <result pre="Factors associated with severity among people living with HIV with" exact="coronavirus disease 2019" post="There were six (11%) severe COVID-19 cases. They had"/>
   <result pre="antiretroviral factors significantly associated with COVID-19 severity. Factors associated with" exact="coronavirus disease 2019" post="in the people living with HIV cohort We did"/>
   <result pre="in PLWH (Table 2). Table 2 Factors associated with severe" exact="coronavirus disease 2019" post="in the Hospital Clinic Barcelona people living with HIV"/>
   <result pre="Hospital Clinic Barcelona people living with HIV cohort. Incidence of" exact="coronavirus disease 2019" post="in the people living with HIV cohort compared with"/>
   <result pre="people living with HIV cohort compared with the incidence of" exact="coronavirus disease 2019" post="in the city of Barcelona The standardized incidence rates"/>
   <result pre="the Supplementary Appendix 2. References References 1.GuanW-JNiZ-YHuYLiangW-HOuC-QHeJ-Xet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med2020; 382:17081720.32109013 2.YangJZhengYGouXPuKChenZGuoQet al.Prevalence"/>
   <result pre="print]. 9.GervasoniCMeravigliaPRivaAGiacomelliAOreniLMinisciDet al.Clinical features and outcomes of HIV patients with" exact="coronavirus disease 2019." post="Clin Infect Dis2020; ciaa579doi:10.1093/cid/ciaa579.32407467 10.VizcarraPPerez-EliasMJQueredaCMorenoAVivancosMJDrondaFet al.Description of COVID-19 in"/>
   <result pre="people living with HIV at higher risk for developing severe" exact="coronavirus disease 2019" post="(COVID-19)?. AIDS Patient Care STDS2020; 34:247248.32407127 21.World Health Organization."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7493775\results\search\zoonosis\results.xml">
   <result pre="outbreak of SARS-like illness all over the world. As the" exact="SARS-CoV-2 infection" post="pandemic proceeds, many efforts are being dedicated to the"/>
   <result pre="pathogen leading to the outbreak of SARS-like illness (later named" exact="coronavirus disease 2019" post="[COVID-19]) in China.1 As for now, COVID-19 has become"/>
   <result pre="2 (TMPRSS2).37 Hence, camostat mesylate, a TMPRSS2 inhibitor, can eliminate" exact="SARS-CoV-2 infection" post="in vitro assay. On the other hand, the heptad"/>
   <result pre="involved in a signal-dependent SARS-CoV nucleocapsid protein nucleocytoplasmic trafficking during" exact="SARS-CoV infection" post="and could affect host cell division.76â€&quot;80 Besides, the SARS-CoV"/>
   <result pre="REFERENCES 1.ChenNZhouMDongXQuJGongFHanYet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study.Lancet2020;395:507â€&quot;13.32007143 2.PillaiyarTMeenakshisundaramSManickamMRecent discovery and"/>
   <result pre="case of the index patient who caused tertiary transmission of" exact="coronavirus disease 2019" post="in Korea: the application of lopinavir/ritonavir for the treatment"/>
   <result pre="Singapore.JAMA2020;323:1488â€&quot;94.32125362 28.WangZChenXLuYChenFZhangWClinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatment.Biosci Trends2020;14:64â€&quot;8.32037389 29.CaoBWangYWenDLiuWWangJFanGet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7493780\results\search\zoonosis\results.xml">
   <result pre="Europe PMC, consistent with existing copyright protections.ca9-83-704.pdf Abstract The novel" exact="coronavirus disease 2019" post="(COVID-19), with first presentation of atypical pneumonia, has spread"/>
   <result pre="comprehensive medical support. Cardiologists Cardiomyopathy Cardiovascular diseases COVID-19 1. INTRODUCTION" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV2; also known COVID-19), which belongs to"/>
   <result pre="SARS. A preliminary data also showed that remdesivir also inhibited" exact="SARS-CoV-2 infection" post="efficiently in a human cell line.33 Remdesivir was provided"/>
   <result pre="the warning of US FDA in 2009. Antiviral drugs for" exact="influenza infection" post="were also tested. Oseltamivir showed little effect on COVID-19"/>
   <result pre="Experimental models of acute lung injury, including a model of" exact="SARS-CoV infection," post="suggest that ARBs may mitigate COVID-19 by attenuating Ang"/>
   <result pre="factor kappa B signaling pathways, which was highly activated in" exact="SARS-CoV infection." post="Several studies showed statins might have beneficial effect on"/>
   <result pre="spreading of SARS coronavirus. In vitro study showed amiodarone inhibited" exact="SARS-CoV infection" post="and spreading via altering the late compartments of the"/>
   <result pre="for patients, health care workers, and health systems during the" exact="coronavirus disease 2019" post="(COVID-19) pandemic.J Am Coll Cardiol2020;75:2352â€&quot;71.32201335 5.ClerkinKJFriedJARaikhelkarJSayerGGriffinJMMasoumiAet al.Coronavirus disease 2019"/>
   <result pre="coronaviruses on the cardiovascular system: a review.JAMA Cardiol2020Doi:10.1001/jamacardio.2020.1286. 7.BonowROFonarowGCOâ€™GaraPTYancyCWAssociation of" exact="coronavirus disease 2019" post="(COVID-19) with myocardial injury and mortality.JAMA Cardiol2020Doi:10.1001/jamacardio.2020.1105. 8.LiuPPBletASmythDLiHThe science"/>
   <result pre="infections among travellers from Wuhan, China.Euro Surveill2020;25:2000062. 14.HosseinyMKoorakiSGholamrezanezhadAReddySMyersLRadiology perspective of" exact="coronavirus disease 2019" post="(COVID-19): lessons from severe acute respiratory syndrome and middle"/>
   <result pre="east respiratory syndrome.AJR Am J Roentgenol2020;214:1â€&quot;5.31860355 15.GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China.N Engl J Med2020; 382:1708â€&quot;20.32109013 16.MadjidMMillerCCZarubaevVVMarinichIGKiselevOILobzinYVet al.Influenza epidemics"/>
   <result pre="2020Doi:10.1001/jamacardio.2020.0950. 20.GuoTFanYChenMWuXZhangLHeTet al.Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19).JAMA Cardiol2020Doi:10.1001/jamacardio.2020.1017. 21.BhatrajuPKGhassemiehBJNicholsMKimRJeromeKRNallaAKet al.COVID-19 in critically ill patients in"/>
   <result pre="pneumonia.J Thromb Haemost2020;18:844â€&quot;7.32073213 30.InciardiRMLupiLZacconeGItaliaLRaffoMTomasoniDet al.Cardiac involvement in a patient with" exact="coronavirus disease 2019" post="(COVID-19).JAMA Cardiol2020Doi:10.1001/jamacardio.2020.1096. 31.XuZShiLWangYZhangJHuangLZhangCet al.Pathological findings of COVID-19 associated with"/>
   <result pre="novel coronavirus-infected pneumonia in Wuhan, China.JAMA2020;323:1061â€&quot;9.32031570 37.DongLHuSGaoJDiscovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19).Drug Discov Ther2020;14:58â€&quot;60.32147628 38.CaiQYangMLiuDChenJShuDXiaJet al.Experimental treatment with favipiravir for"/>
   <result pre="with acute respiratory distress syndrome and death in patients With" exact="coronavirus disease 2019" post="pneumonia in Wuhan, China.JAMA Intern Med2020Doi:10.1001/jamainternmed.2020.0994. 56.FrostFJPetersenHTollestrupKSkipperBInfluenza and COPD"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7494453\results\search\zoonosis\results.xml">
   <result pre="across various countries and included people with SARS (13 studies)," exact="Ebola" post="(1), MERS (3) and COVID-19 (38). Findings suggest that"/>
   <result pre="(SARS) in China, parts of Asia and Canada in 2003," exact="Ebola" post="in West Africa in 2014 and Middle East Respiratory"/>
   <result pre="to their families (Xiang etÂ al., 2020). During the recent" exact="Ebola" post="outbreak, an unprecedented number of HCWs were infected (Fischer"/>
   <result pre="across various countries and included people with SARS (13 studies)," exact="Ebola" post="(1), MERS (3) and COVID-19 (38). Of the 55"/>
   <result pre="(21), medical students (22), and overseas medical staff (41) and" exact="Ebola" post="survivors (18) 5 months, 2014 to 2015 SCL-90-R Juan"/>
   <result pre="HCWs and other staff with direct contact or exposure to" exact="Ebola" post="patients, had a range of psychological symptoms, such as"/>
   <result pre="during the COVID-19 outbreakJ.Â Affect. Disord.276202031231532871661 BaboreA.Psychological effects of the" exact="COVID-2019" post="pandemic: perceived stress and coping strategies among healthcare professionalsPsychiatr."/>
   <result pre="mental health of frontline and non-frontline medical workers during the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: a case-control studyJ.Â Affect. Disord.275202021021532734910"/>
   <result pre="ElbayR.Y.Depression, anxiety, stress levels of physicians and associated factors in" exact="Covid-19" post="pandemicsPsychiatr. Res.2902020113130 Emergencies preparedness, response website: world health organizationAvailable"/>
   <result pre="China: a large-scale cross-sectional studyEClinicalMedicine202024 JiD.Prevalence of psychological symptoms among" exact="Ebola" post="survivors and healthcare workers during the 2014-2015 Ebola outbreak"/>
   <result pre="symptoms among Ebola survivors and healthcare workers during the 2014-2015" exact="Ebola" post="outbreak in Sierra Leone: a cross-sectional studyOncotarget8820171278428061463 JonesN.UK military"/>
   <result pre="cross-sectional studyInt J Afr Nurs Sci13202010023332837911 Psychological First Aid during" exact="Ebola" post="Virus Disease Outbreaks (Provisional Version) [online]2014World Health Organisation, CBM,"/>
   <result pre="outcomes among frontline and second-line health care workers during the" exact="coronavirus disease 2019" post="(COVID-19) pandemic in ItalyJAMA Network Open352020e2010185-e SandeshR.Impact of COVID-19"/>
   <result pre="the pandemicPsychol. Med.202012 Unprecedented Number of Medical Staff Infected with" exact="Ebola" post="[Online]2014World Health Organization;GenevaAvailable from:https://www.who.int/mediacentre/news/ebola/25-august-2014/en/ WangL.-Q.Psychological impact of coronavirus disease"/>
   <result pre="support on sleep quality of medical staff treating patients with" exact="coronavirus disease 2019" post="(COVID-19) in january and february 2020 in ChinaMed. Sci."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7496561\results\search\zoonosis\results.xml">
   <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the" exact="coronavirus disease 2019" post="(COVID-19) was first detected in Wuhan, China. Since then,"/>
   <result pre="numerous outbreaks of diseases in the past, including Ebola, cholera,Â" exact="Middle East respiratory syndrome" post="(MERS), the novel coronavirus pandemic has undoubtedly proven to"/>
   <result pre="mitigate the severity of this crisis. The specific symptomatology of" exact="coronavirus disease 2019" post="(COVID-19) has been challenging to define with the emergence"/>
   <result pre="patients, thrombocytopenia in 36.2%, and leukopenia in 33.7% people [2]." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) is a betacoronavirus belonging to the"/>
   <result pre="severe acute respiratory syndrome (SARS) outbreak in 2002 and the" exact="Middle East respiratory syndrome" post="coronavirus (MERS CoV), which caused the MERS outbreak in"/>
   <result pre="caused the MERS outbreak in 2012. The severity of the" exact="SARS-CoV-2 infection," post="when compared to that of SARS and MERS, shows"/>
   <result pre="discuss the potential for repurposing existing antiviral agents to treat" exact="SARS-CoV-2 infection" post="with their site of action as shown in Figure"/>
   <result pre="In 2017, Gilead Sciences developed RDV for the treatment of" exact="Ebola" post="virus infection. It is a broad-spectrum drug having antiviral"/>
   <result pre="for prevention and/or treatment gathered interest during the West African" exact="Ebola" post="outbreak. Various other infections caused by West Nile Virus,"/>
   <result pre="behind use: in a majority of seriously ill patients of" exact="COVID 19," post="the leading cause of death has been found to"/>
   <result pre="focussing on stopping ACE inhibitors and ARBs for patients with" exact="COVID 19." post="Data on the renin-angiotensin system (RAS) drugs acting on"/>
   <result pre="angiotensin-converting enzyme;Â SARS-CoV-2:Â severe acute respiratory syndrome coronavirus 2;Â COVID-19:Â" exact="coronavirus disease 2019" post="Intervention NCT ID No. of participants Duration Phase Sponsor"/>
   <result pre="that is the diagnostic questionPostgrad Med JColemanJJManaviKMarsonEJBotkaiAHSapeyE39239896202032522844 2Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J MedGuanWJNiZYHuYet al.17081720382202032109013 3A novel coronavirus"/>
   <result pre="COVID-19 outbreakCurr BiolZhangTWuQZhangZ1346135130202032197085 8The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak - an update on the statusMil Med"/>
   <result pre="release syndromeOncologistLeRQLiLYuanWet al.94394723201829622697 37Can we use interleukin-6 (IL-6) blockade for" exact="coronavirus disease 2019" post="(COVID-19)-induced cytokine release syndrome (CRS)?J AutoimmunLiuBLiMZhouZGuanXXiangY102452111202032291137 38Coronavirus disease 2019"/>
   <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the perspectives of clinical immunologists from ChinaClin ImmunolZhangWZhaoYZhangFet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7497732\results\search\zoonosis\results.xml">
   <result pre="Â± antivirals. The possible effectiveness and toxicity of hydroxychloroquine in" exact="Covid-19" post="disease is debated: laboratory studies showed antiviral properties (Devaux"/>
   <result pre="paradox at allInt J Obes4120171162116310.1038/ijo.2017.99 BeigelJ.H.TomashekK.M.DoddL.E.MehtaA.K.ZingmanB.S.KalilA.C.Remdesivir for the treatment of" exact="Covid-19" post="â€&quot; preliminary reportN Engl J Med202010.1056/NEJMoa2007764[Published online 22 May]"/>
   <result pre="patients with severe Covid-19N Engl J Med38220201268127732109011 GuanW.NiZ.HuY.OuC.HeJ.LiuL.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med38220201708172032109013 GuaraldiG.MeschiariM.Cozzi-LepriA.MilicJ.TonelliR.MenozziM.Tocilizumab in patients with"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov620201632194981 MehraM.R.DesaiS.S.RuschitzkaF.PatelA.N.RETRACTED: hydroxychloroquine or chloroquine with or"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern Med1807202011110.1001/jamainternmed.2020.0994 WuZ.McGooganJ.M.Characteristics of and"/>
   <result pre="ChinaJAMA Intern Med1807202011110.1001/jamainternmed.2020.0994 WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID 19) outbreak in China. Summary of a report"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7498210\results\search\zoonosis\results.xml">
   <result pre="trials. References References 1GuoY.-R.CaoQ.-D.HongZ.-S.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak- A n update on the statusMil Med"/>
   <result pre="Biophys Acta-Mol Basis Dis1866202016587832544429 5ZhangJ.LitvinovaM.WangW.Evolving epidemiology and transmission dynamics of" exact="coronavirus disease 2019" post="outside Hubei province, China: a descriptive and modelling studyLancet"/>
   <result pre="and structureâ€&quot;activity relationship studies to identify potent approved drugs for" exact="Covid-19" post="treatmentJ Biomol Struct Dyn202011110.1080/07391102.2020.1794974 36ChatterjeeS.MaityA.ChowdhuryS.In silico analysis and identification"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7498411\results\search\zoonosis\results.xml">
   <result pre="https://www.who.int/hiv/mediacentre/events/en/. SARS: https://www.who.int/csr/don/archive/disease/severe_acute_respiratory_syndrome/en/. Hemagglutinin type1 neuraminidase type 1 (H1N1): https://www.who.int/csr/don/2009_12_30/en/." exact="Middle East respiratory syndrome" post="(MERS): https://www.who.int/emergencies/mers-cov/en/. Zika virus (ZIKV): https://www.who.int/en/news-room/fact-sheets/detail/zika-virus HCV: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c. Ebola:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7498997\results\search\zoonosis\results.xml">
   <result pre="otherwise stated in a credit line to the data. Abstract" exact="Coronavirus disease 2019" post="(COVID-19) has shown high infection and mortality rates all"/>
   <result pre="as 2019 novel coronavirus (2019-nCoV), and the disease was named" exact="coronavirus disease 2019" post="(COVID-2019). The virus was renamed by the International Committee"/>
   <result pre="in China and it resulted in 774 deaths. In 2012," exact="Middle East respiratory syndrome" post="(MERS) which first emerged in Saudi Arabia resulted in"/>
   <result pre="6]. To date, there is no specific therapy to treat" exact="SARS-CoV-2 infection." post="Different drugs that were designed for other diseases including"/>
   <result pre="infections in mice model [38]. The reduced ACE2 levels following" exact="SARS-CoV infection" post="led to acute lung injury, and interestingly, the lung"/>
   <result pre="ACE2 (rhACE2) is being considered as a therapy to control" exact="SARS-CoV-2 infection." post="The idea is to use the soluble rhACE2 as"/>
   <result pre="therapy (ADT) to regulate androgen production have lowered risk for" exact="SARS-CoV-2 infection" post="compared with patients who did not receive ADT [86]."/>
   <result pre="could downregulate TMPRSS2 and this in turn could be lowering" exact="SARS-CoV-2 infection." post="It is suggested that ADT could be beneficial for"/>
   <result pre="did not affect morbidity or mortality in male mice following" exact="SARS-CoV infection" post="[63]. Based on this, it was suggested that the"/>
   <result pre="1 protein HSC Hematopoietic stem cell NTD N-terminal domain MERS" exact="Middle East respiratory syndrome" post="MGCA Meiotic germ cell antigen RBD Receptor binding domain"/>
   <result pre="MGCA Meiotic germ cell antigen RBD Receptor binding domain SARS" exact="Severe acute respiratory syndrome" post="coronavirus SRY Sex determining region Y TMPRSS2 Transmembrane protease/serine"/>
   <result pre="Factors associated with prolonged viral RNA shedding in patients with" exact="coronavirus disease 2019" post="(covid-19). Clin Infect Dis. 2020. 11.ZhengSFanJYuFFengBLouBZouQet al.Viral load dynamics"/>
   <result pre="X, Xiang YF. Can we use interleukin-6 (il-6) blockade for" exact="coronavirus disease 2019" post="(covid-19)-induced cytokine release syndrome (crs)? J Autoimmun. 2020;111. 67.WanSYiQFanSLvJZhangXGuoLet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7499567\results\search\zoonosis\results.xml">
   <result pre="Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)ftaa046.pdf Abstract ABSTRACT" exact="Influenza" post="virus and coronaviruses continue to cause pandemics across the"/>
   <result pre="do to prepare for respiratory viral threats in the future." exact="Influenza" post="virus and coronaviruses continue to cause pandemics across the"/>
   <result pre="Gustafson and Kendall 2007; Al-Muharrmi 2010) (TableÂ 1). Table 1." exact="Influenza" post="pandemics in the last 100 years. Name of the"/>
   <result pre="virus was selected (myxovirus influenza) (Smith, Andrewes and Laidlaw 1933)." exact="Influenza" post="B and C viruses were identified in 1940 and"/>
   <result pre="of deaths (hundreds) 2002â€&quot;2004 SARS outbreak 2002â€&quot;2004 SARS-CoV-1 774 2012" exact="Middle East respiratory syndrome" post="coronavirus outbreak 2012â€&quot;present MERS-CoV 862 (as of 13 January"/>
   <result pre="etÂ al. 2020). BIOLOGICAL PROPERTIES OF INFLUENZA VIRUSES AND CORONAVIRUSES" exact="Influenza" post="viruses belong to the orthomyxoviruses family (Orhtomyxoviridae, RNA viruses"/>
   <result pre="(Bouvier and Palese 2008; Spickler 2016; King etÂ al. 2018)." exact="Influenza" post="A viruses are further classified into subtypes, depending on"/>
   <result pre="SARS-CoV-2. Remdesivir, which had previously failed in clinical trials for" exact="Ebola" post="(Mulangu et al. 2019) but had also recently shown"/>
   <result pre="Discov Today. 2018;23:661â€&quot;72.29330123 BarbezangeC, JonesL, BlancHet al.Seasonal genetic drift of" exact="human influenza" post="A virus quasispecies revealed by deep sequencing. Front Microbiol."/>
   <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014;58:4875â€&quot;84.24841269"/>
   <result pre="Physiol Biophys. 2019;38:27â€&quot;38.30657458 GhoneimHE, ThomasPG, McCullersJADepletion of alveolar macrophages during" exact="influenza infection" post="facilitates bacterial superinfection. J Immunol. 2013;191:1250â€&quot;9.23804714 GibbsBF, SchmutzlerW, VollrathIBet"/>
   <result pre="virus from Oklahoma in 2011 which is distantly related to" exact="human influenza" post="C virus. PLoS Pathog. 2013;9:e1003176.23408893 HenkelM, MitznerD, HenkleinPet al.The"/>
   <result pre="recent developments. Biotarget. 2017;1:18.30957075 HolmesEC, GhedinE, MillerNet al.Whole-genome analysis of" exact="human influenza" post="A virus reveals multiple persistent lineages and reassortment among"/>
   <result pre="OlofssonS, DimockKet al.Sialic acid tissue distribution and influenza virus tropism." exact="Influenza" post="Other Respir Viruses. 2008;2:147â€&quot;54.19453419 KuszewskiK, BrydakLThe epidemiology and history"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitro. Cell Discov. 2020;6:16.32194981 LiuM, ChenF, LiuTet al.The"/>
   <result pre="LiW, HulswitRJG, WidjajaIet al.Identification of sialic acid-binding function for the" exact="Middle East respiratory syndrome" post="coronavirus spike glycoprotein. Proc Natl Acad Sci USA. 2017;114:E8508â€&quot;17.28923942"/>
   <result pre="Biol. 1995;27:109â€&quot;22.7767779 MulanguS, DoddLE, DaveyRTJr.et al.A randomized, controlled trial of" exact="Ebola" post="virus disease therapeutics. N Engl J Med. 2019;381:2293â€&quot;303.31774950 MuramotoY,"/>
   <result pre="Exp Med. 1921a;33:125â€&quot;45.19868484 OoiEE, ChewJS, LohJPet al.In vitro inhibition of" exact="human influenza" post="A virus replication by chloroquine. Virol J. 2006;3:39.16729896 OswaldNC,"/>
   <result pre="Morales-NebredaL, SelvakumarBet al.Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during" exact="influenza infection." post="J Clin Invest. 2016;126:1566â€&quot;80.26999599 PfeifferRFJDie Aetiologie der Influenza. Zeitschrift"/>
   <result pre="2019;16:69.31133031 ScholtissekC, RohdeW, VonÂ HoyningenVet al.On the origin of the" exact="human influenza" post="virus subtypes H2N2 and H3N2. Virology. 1978;87:13â€&quot;20.664248 SchrezenmeierE, DornerTMechanisms"/>
   <result pre="Flu, grippe, avian influenza, grippe aviaire, fowl plaque, swine influenza," exact="hog flu," post="pig flu, equine influenza, canine influenzaFebruary 01, 2016[cited 2020"/>
   <result pre="avian influenza, grippe aviaire, fowl plaque, swine influenza, hog flu," exact="pig flu," post="equine influenza, canine influenzaFebruary 01, 2016[cited 2020 April 07]."/>
   <result pre="important mediator of the enhanced susceptibility to pneumococcal pneumonia after" exact="influenza infection." post="J Immunol. 2004;172:7603â€&quot;9.15187140 VargaZT, RamosI, HaiRet al.The influenza virus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7500907\results\search\zoonosis\results.xml">
   <result pre="Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Soon this disease, which called" exact="coronavirus disease 2019" post="(COVID-19) by World Health Organization (WHO), promptly spreads around"/>
   <result pre="antiviral effects against variant RNA viruses such as Coronaviruses and" exact="Influenza" post="viruses. Favipiravir in the body could be metabolized to"/>
   <result pre="in Wuhan city of China in December 2019. Soon this" exact="coronavirus disease 2019" post="(COVID-19) spreads around the world and became a pandemic."/>
   <result pre="the common coldJAMA3238202070770831971553 2GuoYRCaoQDHongZSTanYYChenSDJinHJThe origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak - an update on the statusMil Med"/>
   <result pre="learned?Int J Epidemiol2020 5WuZMcGooganJM.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="Risk Manag162020595 10ChenNZhouMDongXQuJGongFHanYEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyThe Lancet395102232020507513 11GuJHanBWangJCOVID-19: Gastrointestinal"/>
   <result pre="disease-19 (COVID-19): relationship to duration of infectionRadiology2020200463 20GuanWJNiZYHuYLiangWHOuCQHeJXClinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med2020 21LanLXuDYeGXiaCWangSLiYPositive RT-PCR test results"/>
   <result pre="test results in patients recovered from COVID-19JAMA2020 22OrganizationWH.Laboratory testing for" exact="coronavirus disease 2019" post="(COVID-19) in suspected human cases: interim guidance, 2 March"/>
   <result pre="RioCMalaniPN2019 novel coronavirus-important information for cliniciansJAMA.2020 25DongLHuSGaoJDiscovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov Ther1412020586032147628 26BelhadiDPeiffer-SmadjaNLescureF-XYazdanpanahYMentrÃ©FLaouÃ©nanCA brief review of antiviral drugs"/>
   <result pre="70DiaoBWangCTanYChenXLiuYNingLReduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVID-19)Medrxiv2020 71LiGDe ClercqETherapeutic options for the 2019 novel coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7501082\results\search\zoonosis\results.xml">
   <result pre="Proteases family HPV, Human Papillomavirus HBV, Hepatitis B virus EVD," exact="Ebola" post="VirusÂ Disease ZIKV, Zika virus JEV, Japanese Encephalitis virus"/>
   <result pre="B virus EVD, Ebola VirusÂ Disease ZIKV, Zika virus JEV," exact="Japanese Encephalitis" post="virus FPV, Feline Panleukopenia virus HPAIV, Highly Pathogenic Avian"/>
   <result pre="Encephalitis virus FPV, Feline Panleukopenia virus HPAIV, Highly Pathogenic Avian" exact="Influenza" post="virus CDV, Canine Distemper virus RSV, Respiratory Syncytial virusÂ"/>
   <result pre="are located. A key discovery in understanding the mechanism of" exact="SARS-CoV-2 infection" post="concerns the role of the androgen-responsive transmembrane serine protease"/>
   <result pre="cathepsin L have also been shown to be involved in" exact="SARS-CoV-2 infection" post="[20], [11]. The formation of the S2 fragment and"/>
   <result pre="including HIV [44], Chikungunya virus [56], chronic HBV, influenza A," exact="Ebola" post="virus infection [55] and papilloma virus [57]. Recently, the"/>
   <result pre="of dec-Arg-Val-Lys-Arg-CMK as an anti-flavivirus agent (against Zika virus and" exact="Japanese encephalitis" post="virus) has been demonstrated in both mammalian cells and"/>
   <result pre="TMPRSS2: Structure-function A key discovery in understanding the mechanism of" exact="SARS-CoV-2 infection" post="concerns the role of the androgen-responsive transmembrane serine protease"/>
   <result pre="kidney, and digestive tissues, which indeed are target tissues for" exact="SARS-CoV-2 infection." post="As a matter of fact, among the clinical complications"/>
   <result pre="5C). Similarly, the Nafamostat, a structural analog of Camostat, blocks" exact="SARS-CoV-2 infection" post="of human lung cells with 15-fold higher efficiency than"/>
   <result pre="to develop drug resistance. On the other hand, as for" exact="Ebola" post="virus, although a furin cleavage site has been clearly"/>
   <result pre="(iii) the severe acute respiratory syndrome SARS-CoV, and (iv) the" exact="Middle East respiratory syndrome" post="MERS-CoV) [108]. The multiple-sequence alignment of the main proteases"/>
   <result pre="was modest and detected only in the early phase of" exact="SARS-CoV-2 infection," post="discouraging its use at the later stage of viral"/>
   <result pre="distinct sitesProc. Natl Acad. Sci. USA10620095871587610.1073/pnas.080952410619321428 32MilletJ.K.WhittakerG.R.Host cell entry of" exact="Middle East respiratory syndrome" post="coronavirus after two-step, furin-mediated activation of the spike proteinProc."/>
   <result pre="convertase FurinDevelopment1251998486348769811571 100NeumannG.FeldmannH.WatanabeS.LukashevichI.KawaokaY.Reverse genetics demonstrates that proteolytic processing of the" exact="Ebola" post="virus glycoprotein is not essential for replication in cell"/>
   <result pre="3D-QSAR studiesJ. Med. Chem.4920063485349510.1021/jm050852f16759091 127HagarM.AhmedH.A.AljohaniG.AlhaddadO.A.Investigation of some antiviral N-heterocycles as" exact="COVID 19" post="drug: molecular docking and DFT calculationsInt. J. Mol. Sci.212020e392210.3390/ijms21113922"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov.620201610.1038/s41421-020-0156-032194981 156MaC.SaccoM.D.HurstB.TownsendJ.A.HuY.SzetoT.ZhangX.TarbetB.MartyM.T.ChenY.WangJ.Boceprevir, GC-376, and calpain inhibitors II,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7501848\results\search\zoonosis\results.xml">
   <result pre="7501848S2405-8440(20)31850-8 doi: 10.1016/j.heliyon.2020.e05007e05007 : Review Article Nucleic acid-based therapy for" exact="coronavirus disease 2019" post="PiyushRavikantaRajarshiKeshavbChatterjeeAronicKhanRajnikhanrajni@gmail.comdâˆ—âˆ—RayShashikantshashikantray@mgcub.ac.ineâˆ—[a], [b], [c], [d], [e], âˆ—Corresponding author. shashikantray@mgcub.ac.in âˆ—âˆ—Corresponding"/>
   <result pre="access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). Abstract The" exact="coronavirus disease 2019" post="(COVID-19), the pandemic that originated in China has already"/>
   <result pre="Oligonucleotide Keywords Microbiology Biotechnology Molecular biology Epidemiology Virology Regenerative medicine" exact="Covid-19" post="SARS-CoV-2 Nucleic acid based therapy siRNA Ribozymes DNAzymes Aptamers"/>
   <result pre="across the globe in the past two decades; such as" exact="Severe acute respiratory syndrome" post="coronavirus (SARS-CoV) epidemic in 2002â€&quot;2003 originated in China [1],"/>
   <result pre="syndrome coronavirus (SARS-CoV) epidemic in 2002â€&quot;2003 originated in China [1]," exact="Influenza" post="A pandemic in 2009, first reported in Spain [2],"/>
   <result pre="Influenza A pandemic in 2009, first reported in Spain [2]," exact="Middle East respiratory syndrome" post="(MERS) pandemic in 2012, first identified in Saudi Arabia"/>
   <result pre="2012, first identified in Saudi Arabia and the current [3]," exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2 or COVID-19) pandemic in 2019â€&quot;2020, originating"/>
   <result pre="that could help in the control, prevention, and treatment of" exact="SARS-CoV-2 infection" post="is an urgent need to save the entire globe"/>
   <result pre="the application of these anti-viral agents in the context of" exact="SARS-CoV-2 infection." post="1.1 SARS-CoV-2 pathogenesis The entry of virus particles inside"/>
   <result pre="differs due to genetic variations from individual to individual. The" exact="SARS-CoV-2 infection" post="can be classified into two categories: initial (non-severe) and"/>
   <result pre="the initial stages, macrophages and granulocytes mediate the inflammatory responses." exact="SARS-CoV-2 infection" post="in the respiratory system has been reported to activate"/>
   <result pre="the clinical trials respectively and are showing promising effects against" exact="SARS-CoV-2 infection." post="These vaccines are targeting the spike (S) protein of"/>
   <result pre="INO-4800 are showing promising results in clinical trials in treating" exact="SARS-CoV-2 infection." post="Recent advancements in technology have provided better ways for"/>
   <result pre="small interfering RNAs in mammalian cellsJ.Â Virol.781420047523752715220426 126SandersJ.M.Pharmacologic treatments for" exact="Coronavirus disease 2019" post="(COVID-19): a reviewJAMA2020 127TangT.Coronavirus membrane fusion mechanism offers a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7503980\results\search\zoonosis\results.xml">
   <result pre="innovative concept in selecting candidate molecules for the treatment of" exact="SARS-CoV-2 infection," post="which includes molecular characteristics responsible for long-range recognition and"/>
   <result pre="treatment with ACE-inhibitors is associated with less severe disease in" exact="SARS-CoV-2 infection" post="[31]. A number of drugs selected in our study"/>
   <result pre="online: https://clinicaltrials.gov/ct2/show/NCT04330586(accessed on 14 July 2020) 23.DongL.HuS.GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19)Drug Discov.202014586010.5582/ddt.2020.01012 24.AlyM.O.Molecular Docking Reveals the Potential of Aliskiren,"/>
   <result pre="SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound with ACE2" exact="COVID19" post="Target Proteins: A Virtual Drug Repurposing StudyChemRxiv202010.26434/chemrxiv.12032712.v2 39.VermaD.KapoorS.DasS.ThakurK.Potential Inhibitors"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505219\results\search\zoonosis\results.xml">
   <result pre="10.1007/s00284-020-02213-x : Review Article Dynamic Propagation and Impact of Pandemic" exact="Influenza" post="A (2009 H1N1) in Children: A Detailed Review RatreYashwant"/>
   <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. Abstract" exact="Influenza" post="is a highly contagious respiratory infection caused by the"/>
   <result pre="overview on how children are a key contributor to pandemic" exact="Influenza" post="A (2009 H1N1) and we would like to draw"/>
   <result pre="disease prevention and a positive impact on the community. Introduction" exact="Influenza" post="virus (commonly known as â€˜flu virusâ€™ or â€˜swine flu"/>
   <result pre="gene arrangement combining the genetic material from avian, human and" exact="swine flu" post="viruses have been observed for this pandemic infection [4]."/>
   <result pre="Thus, swine play a significant role in the occurrence of" exact="swine flu" post="viruses as well as in the initiation of human"/>
   <result pre="make swine more susceptible to infected by both avian and" exact="human influenza" post="strains. IAV from swine can also infect human. Avian"/>
   <result pre="that swine act as a â€œmixing vesselâ€� for avian and" exact="human influenza" post="A viruses and that reassortant virus combination is responsible"/>
   <result pre="infection and play key role in spreading â€œhuman to humanâ€�" exact="influenza infection." post="Re-entry of human IAV H1N1 to swine may give"/>
   <result pre="have shown that the extent of infection with the pathogenic" exact="swine flu" post="virus varies from year to year in different geographical"/>
   <result pre="NA 440 336 â€‰ 4 Biochemistry and Mechanism of Infection" exact="Influenza" post="A is a negative-sense ssRNA virus with a spherical"/>
   <result pre="more precarious and pathogenic novel â€˜reassortantâ€™ Swine flu viruses [49]." exact="Influenza" post="A virus has a segmented genome with capsulated matrix"/>
   <result pre="genome [51]. Children Play a Crucial Role in Propagating Pandemic" exact="Influenza" post="It has been observed that children are highly susceptible"/>
   <result pre="schools, playground and after-school care, which increases their risk of" exact="influenza infection." post="Such behavioral observation among children contributes disproportionately to the"/>
   <result pre="behavioral observation among children contributes disproportionately to the spread of" exact="influenza infection" post="and to the amplification of the pandemic. As a"/>
   <result pre="age groups between 5 and 18Â years of age [72]." exact="Influenza" post="infection causes a socio-economic burden due to the loss"/>
   <result pre="most commonly prescribed oral drug used in seasonal influenza and" exact="swine flu" post="infections, which is highly effective for decreasing otitis media"/>
   <result pre="Vaccination is a very effective strategy for preventing and controlling" exact="influenza infection," post="particularly in the high-risk population. Infants and children are"/>
   <result pre="two main types of vaccines have been approved to control" exact="influenza infection," post="namely live attenuated influenza vaccines (LAIVs) and inactivated influenza"/>
   <result pre="between 2 and 49Â years of age, which licensed for" exact="Influenza" post="B Yamagata and Victoria lineages but are not allowed"/>
   <result pre="following people at high risk of becoming infected with H1N1" exact="swine flu." post="Children and adults more than six months of age"/>
   <result pre="who have close contact with an infected person Therapeutic Strategies" exact="Influenza" post="is a major communicable pandemic disease with a global"/>
   <result pre="children and young people. Modern methods used to eradicate pandemic" exact="influenza infection" post="include vaccines and antiviral agents such as adamantanes (rimantadine"/>
   <result pre="disease mitigation and its related complications (Table 2). Table 2" exact="Influenza" post="antiviral drugs currently available and under clinical trial [98,"/>
   <result pre="identified that children are at significantly higher risk of developing" exact="influenza infection" post="as a result of all global pandemics. Therefore, the"/>
   <result pre="pig herds led to successive reassortment events between swine and" exact="human influenza" post="A viruses, resulting in the emergence of a novel"/>
   <result pre="surveillance studyBMJ2009339b521310.1136/bmj.b521320007665 23.collab: Gilsdorf A, Poggensee G, Working Group Pandemic" exact="Influenza" post="AInfluenza A(H1N1)v in Germany: the first 10,000 casesEuro Surveill200910.2807/ese.14.34.19318"/>
   <result pre="35.CDC (2009) Surveillance for pediatric deaths associated with 2009 pandemic" exact="Influenza" post="A (H1N1) virus infection (Aprilâ€&quot;August 2009) 36.KoliouMSoteriadesESToumasiMMDemosthenousAHadjidemetriouAEpidemiological and clinical"/>
   <result pre="Zhao H, Cleary P, Bracebridge S et al. (2010) Pandemic" exact="Influenza" post="A (H1N1) 2009 and mortality in the United Kingdom:"/>
   <result pre="a pathogenic virusJ Virol201690198454846310.1128/jvi.00163-1627440882 71.DasRRSamiALodhaRJainRBroorSet al.Clinical profile and outcome of" exact="swine flu" post="in Indian childrenIndian Pediatr201148537337810.1007/s13312-011-0085-y20972300 72.BroorSKrishnanARoyDSDhakadSKaushikSet al.Dynamic patterns of circulating"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505229\results\search\zoonosis\results.xml">
   <result pre="italic;} ScientometricsScientometricsScientometrics0138-91301588-2861Springer International PublishingCham pmcid: 75052293706 doi: 10.1007/s11192-020-03706-z : Article" exact="Covid-19" post="pandemic and the unprecedented mobilisation of scholarly efforts prompted"/>
   <result pre="been like no other. The global crisis caused by the" exact="Covid-19" post="pandemic has mobilised scientific efforts at an unprecedented scale."/>
   <result pre="the healthÂ crisis affecting all aspects of life, research on" exact="Covid-19" post="seems to have become a focal point of interest"/>
   <result pre="interest across many academic disciplines. Here, scientometric aspects of the" exact="Covid-19" post="literature are analysed and contrasted with those of the"/>
   <result pre="numberÂ of citations compared to publications the two other categories." exact="Covid-19" post="studies seem to have been disseminated across a broader"/>
   <result pre="each outbreak and the magnitude of research originated from regions." exact="Covid-19" post="studies also display the involvement of authors from a"/>
   <result pre="and categorised them (Brainard 2020). Though the impact of the" exact="Covid-19" post="health crisis has marked it as a rather unique"/>
   <result pre="These two constituted the two most major coronavirus outbreaks, until" exact="Covid-19" post="came along. Similar to Covid-19, though at a much"/>
   <result pre="mainly made on the basis of the number of indexed" exact="Covid-19" post="studies in particular, as the sector of the coronavirus"/>
   <result pre="the possible overlap between the datasets on SARS, MERS and" exact="Covid-19" post="and to disentangle the three datasets from one another"/>
   <result pre="subject areas. FigureÂ 4a also shows the composition of the" exact="Covid-19" post="literature in terms of the document types, demonstrating that"/>
   <result pre="of MERS studies across Subject Areas Fig. 3 Distribution of" exact="Covid-19" post="studies across Subject Areas Fig. 4 a Distribution of"/>
   <result pre="Covid-19 studies across Subject Areas Fig. 4 a Distribution of" exact="Covid-19" post="studies across Document Types, b Temporal distribution of the"/>
   <result pre="coronavirus studies, c Temporal distribution of the SARS, MERS and" exact="Covid-19" post="studies Full records of the three datasets on SARS,"/>
   <result pre="Full records of the three datasets on SARS, MERS and" exact="Covid-19" post="were retrieved in CSV Excel format from Scopus, all"/>
   <result pre="export posed challenges for the retrieval of the SARS and" exact="Covid-19" post="datasets whose size were bigger than 2000 documents. For"/>
   <result pre="the items of each bundle separately. The extraction of the" exact="Covid-19" post="dataset, however, posed a further layer of complication. Given"/>
   <result pre="further layer of complication. Given that nearly all studies of" exact="Covid-19" post="have been published in one year, i.e. 2020, the"/>
   <result pre="of publication coinciding with the years when SARS, MERS and" exact="Covid-19" post="outbreaks took place. The first spike is related to"/>
   <result pre="decline began. The spike of coronavirus studies prompted by the" exact="Covid-19" post="outbreak, however, seem to have been occurring at a"/>
   <result pre="Fig.Â 4c, the temporal distribution of the SARS, MERS and" exact="Covid-19" post="studies have been shown separately according to the three"/>
   <result pre="are represented by the left vertical axis whereas that of" exact="Covid-19" post="is represented by the right vertical axis, while its"/>
   <result pre="The co-occurrence of keywords associated with the SARS, MERS and" exact="Covid-19" post="literatures were analysed using VOSViewer (Van Eck and Waltman"/>
   <result pre="The maps of keyword co-occurrences associated with SARS, MERS and" exact="Covid-19" post="literatures are provided in Figs. 5, 6, 7 respectively."/>
   <result pre="the MERS literature analysis. Fig. 21 is a heatmap of" exact="Covid-19" post="keyword co-occurrence and Fig.Â 22 overlays the Covid-19 map"/>
   <result pre="heatmap of Covid-19 keyword co-occurrence and Fig.Â 22 overlays the" exact="Covid-19" post="map of keywords in Fig.Â 7 with the colour-coding"/>
   <result pre="average number of citations. Given that almost all studies of" exact="Covid-19" post="are 2020 items, the colour-coding related to the average"/>
   <result pre="the title and abstract of studies on SARS, MERS and" exact="Covid-19" post="have also been presented in the â€œAppendixâ€� in Figs."/>
   <result pre="Fig. 7 The map of keyword co-occurrences associated with the" exact="Covid-19" post="literature With respect to each of the three literatures,"/>
   <result pre="the epidemics also seem to have been addressed particularly by" exact="Covid-19" post="as reflected in Cluster (i) of the Covid-19 literature."/>
   <result pre="particularly by Covid-19 as reflected in Cluster (i) of the" exact="Covid-19" post="literature. These have been reflected in terms such as"/>
   <result pre="as â€œeconomicsâ€�, â€œeconomic aspectâ€�, which have occurred frequently enough in" exact="Covid-19" post="studies to appear distinctly on the map. The presence"/>
   <result pre="the SARS and MERS maps as is it on the" exact="Covid-19" post="map. This could be explained by the greater magnitude"/>
   <result pre="explained by the greater magnitude of the societal impact of" exact="Covid-19" post="outbreak compared to SARS and MERS. The names of"/>
   <result pre="or the term â€œWuhanâ€� on the Cluster (i) of the" exact="Covid-19" post="map are quite pronounced. The occurrence of the names"/>
   <result pre="with this cohort of virology studies on SARS, MERS and" exact="Covid-19" post="are terms such as â€œvirus proteinâ€�, â€œvirus entryâ€�, â€œchemistryâ€�,"/>
   <result pre="This includes terms such as â€œhydroxychloroquineâ€� or â€œremdesivirâ€� on the" exact="Covid-19" post="map. An inspection of the maps overlaid with the"/>
   <result pre="journals Bibliographic coupling of the studies on SARS, MERS and" exact="Covid-19" post="were analysed at the level of their sources/journals. FiguresÂ"/>
   <result pre="maps of journal bibliographic coupling associated with SARS, MERS and" exact="Covid-19" post="literatures respectively. The node sizes are proportional to the"/>
   <result pre="The map of bibliographic coupling of sources associated with the" exact="Covid-19" post="literature A first-glance comparison shows that while the maps"/>
   <result pre="with SARS and MERS are well connected, connections across the" exact="Covid-19" post="map are rather sparse. Both the SARS and MERS"/>
   <result pre="and coherence, whereas, this feature is not shared by the" exact="Covid-19" post="map. The observation is understandable considering the fact that"/>
   <result pre="under development over a period of several years, whereas the" exact="Covid-19" post="literature is an emerging and evolving field. Newly published"/>
   <result pre="Covid-19 literature is an emerging and evolving field. Newly published" exact="Covid-19" post="studies do not seem to be sharing many references"/>
   <result pre="connections are relatively weak. The comparison also suggests that the" exact="Covid-19" post="studies are generally scattered across a broader variety of"/>
   <result pre="from Figs. 1, 2, 3 showing explicitly that studies of" exact="Covid-19" post="are scattered across a broader variety of subject areas"/>
   <result pre="areas (those that are deemed minor areas in relation to" exact="Covid-19" post="literature) have each published a relatively considerable number of"/>
   <result pre="two major outlets notably identifiable on all three maps. For" exact="Covid-19" post="studies in particular, journals such as Journal of Medical"/>
   <result pre="Infectious Diseases and Journal of Virology is most outstanding. For" exact="Covid-19" post="publications, the one outstanding bibliographic coupling relation is one"/>
   <result pre="of scatter and relatively cohesive clusters in relation to the" exact="Covid-19" post="literature compared to the well-defined clusters of journal citations"/>
   <result pre="the previous observation with respect to journal bibliographic coupling, the" exact="Covid-19" post="literature seems to be also much less cohesive in"/>
   <result pre="this could also be partly explained by the fact that" exact="Covid-19" post="papers are scattered across a more diverse range of"/>
   <result pre="are the ones that most stand out. Also, for the" exact="Covid-19" post="literature, three pairs of strong citation relations are identifiable:"/>
   <result pre="13 The map of strongest citation network of sources for" exact="Covid-19" post="overlaid with the colour-coding of the average citation per"/>
   <result pre="with the journals that each node represent (except for the" exact="Covid-19" post="map that has only been overlaid with the average"/>
   <result pre="This pattern for The Lancet seems to have extended to" exact="Covid-19" post="studies as well, as this journal has published a"/>
   <result pre="Virology, Science, mbio, and New England Journal of Medicine. For" exact="Covid-19" post="studies, publications of Nature, Eurosurveillance, The Lancet Infectious Diseases,"/>
   <result pre="were also analysed with respect to the SARS, MERS and" exact="Covid-19" post="literatures. Outputs of the analysis are presented in Figs."/>
   <result pre="presented in Figs. 14, 15, 16, for SARS, MERS and" exact="Covid-19" post="respectively. In each map, the size of nodes, each"/>
   <result pre="Fig. 16 The map of country co-authorships associated with the" exact="Covid-19" post="literature Comparison across the three maps of co-authorships shows"/>
   <result pre="but clearly more so with respect to the SARS and" exact="Covid-19" post="literature, diseases whose first cases were recorded in China."/>
   <result pre="United States, have been Egypt, China and United Kingdom. The" exact="Covid-19" post="map presents a considerably higher number of country names"/>
   <result pre="Italy, as a country that was highly affected by the" exact="Covid-19" post="outbreak, has been exceptionally well represented on this map"/>
   <result pre="Spain, France and Brazil as countries severely affected by the" exact="Covid-19" post="outbreak at early stages of the global spread. According"/>
   <result pre="also aimed at quantifying and analysing scientometric aspects of the" exact="Covid-19" post="literature in contrast with those of the previous major"/>
   <result pre="consistent recordings of the number of Scopus-listed publications linked to" exact="Covid-19" post="at five cross-sections of time, the last of which"/>
   <result pre="of 2020. Fig. 17 The number of studies related to" exact="Covid-19" post="indexed by Scopus at five different points in time"/>
   <result pre="coupling analysis at the level of journals demonstrated that firstly," exact="Covid-19" post="studies are scattered across a broader variety of sources"/>
   <result pre="of the SARS and MERS literatures. As the literature on" exact="Covid-19" post="further develops, more cohesive patterns of bibliographic coupling or"/>
   <result pre="SARS and MERS literatures, their presence in the literature of" exact="Covid-19" post="seem to not be distinctly notable. Instead, a great"/>
   <result pre="to not be distinctly notable. Instead, a great portion of" exact="Covid-19" post="studies have concentrated across three journals: The Lancet, The"/>
   <result pre="for example, being much more strongly represented on SARS and" exact="Covid-19" post="studies, two diseases whose origin of outbreaks were in"/>
   <result pre="represented in the MERS literature. The questions of where the" exact="Covid-19" post="literature is headed, how big it will grow in"/>
   <result pre="not be so soon before we observe a decline in" exact="Covid-19" post="research interest. Summary and conclusions Macro-syntheses of the scholarly"/>
   <result pre="citation number Fig. 22 The heatmap of keyword co-occurrence for" exact="Covid-19" post="Fig. 23 The map of keyword co-occurrence for Covid-19"/>
   <result pre="for Covid-19 Fig. 23 The map of keyword co-occurrence for" exact="Covid-19" post="overlaid with the colour-coding the average citation number Fig."/>
   <result pre="Fig. 31 The map of bibliographic coupling of sources for" exact="Covid-19" post="overlaid with the colour-coding of the average citation per"/>
   <result pre="search on 30 May 2020 when the total number of" exact="Covid-19" post="studies was sitting at 13,700. References References AlmeidaJBerryDCunninghamCHamreDHofstadMMallucciLMcintoshKTyrrellDCoronavirusesNature19682206502 AnggraeniSMaulidinaADewiMWRahmadiantiSRizkyYPCArinalhaqZFUsdiyanaDNandiyantoABDMahdi"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505701\results\search\zoonosis\results.xml">
   <result pre="members of the scientific committee on the north African countryâ€™s" exact="Covid-19" post="outbreak, Mohamed Bekkat, said that they have treated thousands"/>
   <result pre="controversy and warnings raised by the WHO. They were treating" exact="Covid-19" post="patients with chloroquine since April 8 and appear to"/>
   <result pre="the risks of secondary infections and to treat patients with" exact="Covid-19" post="has taken very seriously for Cameron. AFP and France"/>
   <result pre="for the management of all types of patients with positive" exact="Covid-19" post="tests, from asymptomatic cases to patients suffering from severe"/>
   <result pre="drugs in normal times in Cameroon is rising with the" exact="Covid-19" post="crisis. Several fake chloroquine products are circulated within the"/>
   <result pre="a million chloroquine phosphate tablets for use in severely ill" exact="Covid-19" post="patients. The largest private pharmaceutical company in the country"/>
   <result pre="that the worldwide trends of chloroquine use showed excellent results.52" exact="Covid-19" post="complicates the tracing and treatment of malaria and compromise"/>
   <result pre="very complicated. The malaria cases are much higher than current" exact="Covid-19" post="cases in the country. Like other African countries, anti-malarial"/>
   <result pre="anti-malarial drugs, chloroquine, and hydroxychloroquine are being used to treat" exact="Covid-19" post="in Zimbabwe. However, Zimbabweâ€™s doctors advised their population to"/>
   <result pre="considerations with chloroquine, hydroxychloroquine, and azithromycin in the management of" exact="SARS-CoV-2 infection." post="CMAJ. 2020;192(17):450â€&quot;453. doi:10.1503/cmaj.200528 5.RubinEJ, HarringtonDP, HoganJW, GatsonisC, BadenLR, HamelMBThe"/>
   <result pre="HarringtonDP, HoganJW, GatsonisC, BadenLR, HamelMBThe urgency of care during the" exact="Covid-19" post="pandemicâ€&quot;learning as we go. 6.TeherÃ¡nAA, CameroG, HernÃ¡ndezC, et al."/>
   <result pre="Dis. 2020;23(5):613â€&quot;619. doi:10.1111/1756-185X.1384232281213 8.SandersJM, MonogueML, JodlowskiTZ, CutrellJB. Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a review. JAMA. 2020;323(18):1824â€&quot;1836.32282022 9.McCrearyEK, PogueJM. Coronavirus disease"/>
   <result pre="coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;323(18):1824â€&quot;1836.32282022 9.McCrearyEK, PogueJM." exact="Coronavirus disease 2019" post="treatment: a review of early and emerging options. Open"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505804\results\search\zoonosis\results.xml">
   <result pre="policy makers and health authorities. Keywords Production planning Healthcare optimization" exact="Covid-19" post="1 Introduction Viruses are pathogens that replicate after penetrating"/>
   <result pre="AIDS. Of particular interest for this work is the recent" exact="Coronavirus disease 2019" post="(COVID-19) pandemic. Under particular circumstances, a virus (and the"/>
   <result pre="Eng Manag64201381583010.3926/jiem.771 41WangY.WangY.ChenY.QinQ.Unique epidemiological and clinical features of the emerging" exact="2019 novel coronavirus pneumonia" post="(COVID-19) implicate special control measuresJ Med Virol926202056857610.1002/jmv.2574832134116 42J. Woodcock,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505852\results\search\zoonosis\results.xml">
   <result pre="acute respiratory syndrome (SARS) (Rota et al., 2003) and the" exact="Middle East respiratory syndrome" post="(MERS) (Zaki et al., 2012). They have been, and"/>
   <result pre="response to the infection is of fundamental importance for fighting" exact="COVID19" post="and similar possible diseases determined by Coronaviridae. We reviewed"/>
   <result pre="(Wang &amp;amp; Eaton, 2007). Moreover, the same event happened with" exact="Middle East respiratory syndrome" post="(MERS-CoV), that started in 2015, when another beta coronavirus,"/>
   <result pre="et al., 2001), herpes simplex (Liu et al., 2004) and" exact="Ebola" post="viruses (Sakurai et al., 2015). The authors tested the"/>
   <result pre="Using text mining and database searches, the authors identified 34" exact="COVID19" post="related genes, identifying 24 disease-related human pathways and 78"/>
   <result pre="and food design is of fundamental importance to fight the" exact="COVID19" post="disease and all its side effects, to be ready"/>
   <result pre="nerolidolInternational Journal of Antimicrobial Agents486201664164610.1016/j.ijantimicag.2016.08.01727742206 SakuraiY.KolokoltsovA.A.ChenC.-C.TidwellM.W.BautaW.E.KlugbauerN.GrimmC.Wahl-SchottC.BielM.DaveyR.A.Ebola virus. Two-pore channels control" exact="Ebola" post="virus host cell entry and are drug targets for"/>
   <result pre="targets for disease treatmentScience (New York, N.Y.)3476225201599599810.1126/science.1258758 SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): A reviewJournal of the American Medical Association3231820201824183610.1001/jama.2020.601932282022 SchoemanD.FieldingB.C.Coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505936\results\search\zoonosis\results.xml">
   <result pre="are they connected?Neurochem Res200732101749175617705097 20.ArabiYMHarthiAHusseinJBouchamaAJohaniSet al.Severe neurologic syndrome associated with" exact="Middle East respiratory syndrome" post="corona virus (MERS-CoV)Infection.201543449550125600929 21.CapuronLPagnoniGDemetrashviliMWoolwineBJNemeroffCBet al.Anterior cingulate activation and error"/>
   <result pre="the immune system, and cancerLancet Oncol200451061762515465465 23.Serrano-CastroPJEstivill-TorrÃºsGCabezudo-GarcÃ­aPReyes-BuenoJACiano PetersenNet al.Impact of" exact="SARS-CoV-2 infection" post="on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?Neurologia.202035424525132364119 24.SuarezECLewisJGKrishnanRRYoungKHEnhanced"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7506176\results\search\zoonosis\results.xml">
   <result pre="be a factor limiting the occurrence of severe forms of" exact="SARS-CoV-2 infection." post="Although the spread of the SARS-CoV-2 epidemic in West"/>
   <result pre="incubation period is approximately 3â€&quot;14 days. The clinical picture of" exact="SARS-CoV-2 infection" post="is wide. It can range from an asymptomatic infection"/>
   <result pre="in order to protect the body from infection [25]. During" exact="SARS-CoV-2 infection," post="there is an excess production of cytokine causing a"/>
   <result pre="to health services. This weakness was exposed by the 2014/2015" exact="Ebola" post="virus epidemic in West Africa. This epidemic has revealed"/>
   <result pre="beginning of the epidemic, there was only one laboratory (National" exact="Influenza" post="Reference Laboratory) for confirmation of the cases for all"/>
   <result pre="the risk of developing serious or even fatal forms of" exact="SARS-CoV-2 infection" post="[51â€&quot;53]. A study on 1099 patients with COVID-19 in"/>
   <result pre="be a factor limiting the occurrence of severe forms of" exact="SARS-CoV-2 infection." post="Indeed, the epidemiological situation of COVID-19 infection in China"/>
   <result pre="COVID-19 pandemic. For example, in Burkina Faso, the epidemic of" exact="Ebola" post="virus disease has led to the creation of a"/>
   <result pre="WHO (2020) Coronavirus disease (COVID-19) Situation Report-191. 10.collab: WHO (2020)" exact="Coronavirus disease 2019" post="(COVID-19) Situation Report-26. 11.collab: WHO (2020) #Covid19 Coronavirus Disease"/>
   <result pre="medRxiv53, 11. 20.MizumotoKet al. (2020) Estimating the asymptomatic proportion of" exact="coronavirus disease 2019" post="(COVID-19) cases on board the Diamond Princess cruise ship,"/>
   <result pre="100 days. International Journal of Infectious Diseases98, 218â€&quot;224.32585282 31.Lack of" exact="Covid-19" post="testing undermines Africa's â€˜successâ€™ â€&quot; BBC Newshttps://www.bbc.com/news/world-africa-52801190 (Accessed 26"/>
   <result pre="Lancet Respiratory Medicine2600, 30116. 52.GuanWet al. (2020) Clinical characteristics of" exact="coronavirus disease 2019" post="in China. New England Journal of Medicine382, 1708â€&quot;1720. doi:"/>
   <result pre="Low ambient humidity impairs barrier function and innate resistance against" exact="influenza infection." post="Proceedings of the National Academy of Sciences of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7506210\results\search\zoonosis\results.xml">
   <result pre="and cause disease. The 2019 novel coronavirus (SARS-CoV-2), which causes" exact="Coronavirus disease 2019" post="(COVID-19), is the seventh known coronavirus to infect humans."/>
   <result pre="cause only mild to moderate upper respiratory disease in humans." exact="Severe acute respiratory syndrome" post="(SARS) is a viral respiratory illness caused by SARS-CoV,"/>
   <result pre="COVID-19 refers to the respiratory symptoms and pneumonia caused by" exact="SARS-CoV-2 infection." post="By Sep 18, 2020, according to WHO, SARS-CoV-2 had"/>
   <result pre="80R scFv can neutralize &amp;gt;50% of the testing wells from" exact="SARS-CoV infection." post="In most cases, the bivalent full-length immunoglobulin is more"/>
   <result pre="a further study, 80R IgG1 could efficiently protect mice from" exact="SARS-CoV infection," post="noting that the core of its target is aa"/>
   <result pre="SARS-CoV in vitro. The NMAb 201 completely protected mice against" exact="SARS-CoV infection" post="at a concentration of 40â€‰mg/kg. In doses as low"/>
   <result pre="the RBD of SARS-CoV S protein,23 suggesting that F26G18 neutralizes" exact="SARS-CoV infection" post="by blocking RBD-ACE2 the binding. Using hybridoma technology, 26"/>
   <result pre="(human ACE2) for binding to RBD, indicating that ab1 neutralizes" exact="SARS-CoV-2 infection" post="by blocking RBD-ACE2 binding. The ab1 IgG1 could completely"/>
   <result pre="determined by sequence alignment results. This indicates that either natural" exact="SARS-CoV-2 infection" post="or RBD-based vaccines could stimulate the quick production of"/>
   <result pre="overlap with the RBD-ACE2 binding interface, suggesting that B38 neutralizes" exact="SARS-CoV-2 infection" post="by functionally mimicking ACE2 to bind RBD and block"/>
   <result pre="with an IC50 value of 8â€‰ng/ml and potently inhibited live" exact="SARS-CoV-2 infection" post="with IC50 values of 7 and 9â€‰ng/ml, respectively. To"/>
   <result pre="neutralization assay showed that H11-H4-Fc and H11-D4-Fc could neutralize live" exact="SARS-CoV-2 infection" post="with the ND50 of 6â€‰nM and 18â€‰nM, respectively. Combining"/>
   <result pre="to S protein and exhibited synergistic neutralization effect on live" exact="SARS-CoV-2 infection." post="The use of COV2-2196 and COV2-2130 alone or in"/>
   <result pre="have IC50 in a range 0.7 ~ 9â€‰ng/ml against live" exact="SARS-CoV-2 infection." post="Among of them, 2â€&quot;15, 2â€&quot;7, 1â€&quot;57, and 1â€&quot;20 targeted"/>
   <result pre="The most potent NMAb 2â€&quot;15 could neutralize pseudotyped and live" exact="SARS-CoV-2 infection" post="with IC50 of 5â€‰ng/ml and 0.7â€‰ng/ml, respectively, by binding"/>
   <result pre="been used successfully for the treatment of patients infected with" exact="Ebola" post="virus.57 Among NMAbs we discussed, there are some NMAbs"/>
   <result pre="coronavirus (SARS-CoV-2)?PLoS Pathog.202016e100842132407364 69.ZhangJet al.Evolving epidemiology and transmission dynamics of" exact="coronavirus disease 2019" post="outside Hubei province, China: a descriptive and modelling studyLancet"/>
   <result pre="areaJAMA20032892801280912734147 71.ChenNet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751332007143"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7506363\results\search\zoonosis\results.xml">
   <result pre="Editor Few infectious diseases have posed such tremendous challenges as" exact="coronavirus disease 2019" post="(COVID-19), which had swept across 216 countries or territories"/>
   <result pre="material, TableÂ S1). Fig.Â 1 Analysis of research activities for" exact="coronavirus disease 2019" post="(COVID-19) and severe acute respiratory syndrome (SARS). Research publications"/>
   <result pre="from:https://ispmbern.github.io/covid-19/living-review/ 6COVID-Network meta-analysis (NMA)Living mapping and living systematic review of" exact="Covid-19" post="studiesAvailable from:https://covid-nma.com/ 7BeigelJ.H.TomashekK.M.DoddL.E.MehtaA.K.ZingmanB.S.KalilA.C.Remdesivir for the treatment of Covid-19â€&quot;preliminary reportNÂ"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7508045\results\search\zoonosis\results.xml">
   <result pre="that could explain the later emergence and spread of the" exact="coronavirus disease 2019" post="(COVID-19) pandemic in African countries are being discussed, including"/>
   <result pre="and the use of antimalarial drugs. Keywords Africa antimalarial drugs" exact="coronavirus disease 2019" post="malaria severe acute respiratory syndrome coronavirus 2 Introduction In"/>
   <result pre="several African countries have benefited from previous initiatives to address" exact="Ebola" post="[35,36]. For instance, the surveillance structure and screening measures"/>
   <result pre="the surveillance structure and screening measures in airports developed for" exact="Ebola" post="virus disease became pillars in the COVID-19 response in"/>
   <result pre="became pillars in the COVID-19 response in Uganda [35] and" exact="Ebola" post="standard operating procedures were updated for COVID-19 in the"/>
   <result pre="reported a significant positive correlation of the D allele with" exact="SARS-CoV-2 infection" post="prevalence and mortality rate in Asian population [79]. The"/>
   <result pre="which implies that these populations might be relatively susceptible to" exact="SARS-CoV-2 infection" post="[87]. Cross-immunity to SARS-CoV-2 Protective immune responses to viral"/>
   <result pre="rate due to COVID-19 was lower in Asian countries where" exact="Japanese encephalitis" post="immunization is recommended compared with those were the population"/>
   <result pre="challengesInt J Antimicrob Agents55202010592432081636 9Accessedhttps://www.euro.who.int/en/health-topics/health-emergencies/international-health-regulations/news/news/2020/2/2019-ncov-outbreak-is-an-emergency-of-international-concern 10Accessedhttps://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 11ChirumboloS.Might the many positive" exact="COVID19" post="subjects in Italy have been caused by resident bat-derived"/>
   <result pre="modelling studyLancet395202087187732087820 16CaboreJ.W.KaramagiH.C.KiprutoH.AsamaniJ.A.DrotiB.SeydiA.B.W.The potential effects of widespread community transmission of" exact="SARS-CoV-2 infection" post="in the World Health Organization African Region: a predictive"/>
   <result pre="36NachegaJ.B.Mbala-KingebeniP.OtshudiemaJ.MobulaL.M.PreiserW.Kallay OResponding to the challenge of the dual COVID-19 and" exact="Ebola" post="epidemics in the Democratic Republic of Congoâ€&quot;priorities for achieving"/>
   <result pre="Africans are traveling to ChinaAccessedhttps://qz.com/africa/1680094/why-chinese-are-traveling-to-africa-and-why-africans-are-traveling-to-china/ 41Accessedhttps://qz.com/africa/1865111/chinese-migrant-workers-in-africa-and-myths-of-self-segregation/ 42Accessedhttps://www.agenceecofin.com/economie/0512-52633-l-afrique-est-desormais-la-destination-touristique-de-10-des-chinois-voyageant-a-l-exterieur-50-par-an 43SpiteriG.FieldingJ.DierckeM.CampaseC.EnoufV.GaymardA.First cases of" exact="coronavirus disease 2019" post="(VOVID-19) in the WHO European region, 24 january to"/>
   <result pre="a case seriesLancet Infect Dis20202092092832422201 47Accessedhttp://www.xinhuanet.com/english/2020-03/01/c_138832869.htm 48Accessedhttps://www.thetimes.co.uk/article/hunt-for-contacts-of-coronavirus-stricken-pair-in-york-dh363qf8k 49StoecklinS.B.RollandP.SilueY.MaillesA.CampeseC.SimondonA.First cases of" exact="coronavirus disease 2019" post="(COVID-19) in France: surveillance. investigations and control measuresEro Surveill25January"/>
   <result pre="in Africa: a modelling studyBMJ Glob Heal52020e002699 60GuanW.-J.NiZ.-Y.HuY.LiangW.-H.OuC.-Q.HeJ.-X.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaNÂ Engl J Med38220201708172032109013 61WuZ.McGooganJ.M.Characteristics of and important"/>
   <result pre="Engl J Med38220201708172032109013 61WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="of print 62QiuH.WuJ.HongL.LuoY.SongQ.ChenD.Clinical and epidemiological features of 36 children with" exact="coronavirus disease 2019" post="(COVID-19) in Zhejiang, China: an observational cohort studyLancet Infect"/>
   <result pre="I/D genotypeGene758202014494432628976 79PatiA.MahtoH.PadhiS.PandaA.K.ACE deletion allele is associated with susceptibility to" exact="SARS-CoV-2 infection" post="and mortality rate: an epidemiological study in the Asian"/>
   <result pre="in Quebec, CanadaJÂ Infect Dis2020jiaa47732761209 109EscobarL.E.Molina-cruzA.Barillas-MuryC.BCG caccine protection from severe" exact="coronavirus disease 2019" post="(COVID-19)Proc Natl Acad Sci USA1172020177201772632647056 110El-GendyA.O.SaeedH.AliA.M.A.ZawbaaH.M.GomaaD.HarbH.S.Bacillus Calmetteâ€&quot;GuÃ©rin vaccine, antimalarial,"/>
   <result pre="rate in some countriesArch Acad Emerg Med82020e5432440665 114NapoliP.E.NioiM.Global Spread of" exact="coronavirus disease 2019" post="and malaria: an epidemiological paradox in the early stage"/>
   <result pre="Chem Chemother17200627528417176632 122FanH.H.WangL.Q.LiuW.L.AnX.P.LiuZ.D.HeX.Q.Repurposing of clinically approved drugs for treatment of" exact="coronavirus disease 2019" post="in a 2019-novel coronavirus (2019-nCoV) related coronavirus modelChin Med"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7508070\results\search\zoonosis\results.xml">
   <result pre="the new creations are licensed under the identical terms. The" exact="coronavirus disease 2019" post="(COVID-19), which originated from Wuhan in China, has spread"/>
   <result pre="(London, England)2020395497506 2WuPDuanFLuoCLiuQQuXLiangLet al.Characteristics of ocular findings of patients with" exact="coronavirus disease 2019" post="(COVID-19) in Hubei Province, ChinaJAMA Ophthalmol2020doi: 101001/jamaophthalmol 20201291 3JunISYHuiKKOSongboPZPerspectives"/>
   <result pre="(COVID-19) in Hubei Province, ChinaJAMA Ophthalmol2020doi: 101001/jamaophthalmol 20201291 3JunISYHuiKKOSongboPZPerspectives on" exact="coronavirus disease 2019" post="control measures for ophthalmology clinics based on a Singapore"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7508551\results\search\zoonosis\results.xml">
   <result pre="focused on the causative factors to limit emerging outbreaks like" exact="COVID 19" post="in the future. Graphical abstract Fig.Â 1. Graphical abstract"/>
   <result pre="pandemics, like Ebola, Sika, Swine flu, SARS, MERS and currently" exact="COVID 19," post="we are at greater risk in having deaths of"/>
   <result pre="and of having huge socio-economic losses [6,7]. During the 2014â€&quot;16," exact="Ebola" post="epidemic, over 11,000 deaths with approximately 28,000 infected people,"/>
   <result pre="in the repeated emergence of pandemics in the context of" exact="COVID 19." post="Although, there are several studies suggesting the pandemic emergence"/>
   <result pre="75% of emerging diseases including the major pandemics like, HIV," exact="Ebola" post="virus, Zika, avian &amp;amp; swine influenza, SARS-CoV, MERS and"/>
   <result pre="induced immune-mediated diseases and transplantation and is well documented with" exact="COVID 19" post="[41]. Lack of proper vaccinations and cross-immune protection (For"/>
   <result pre="for transmission of diseases like SARS, Ebola, SARS-CoV-2 etc [45]." exact="Ebola" post="outbreak in the Congo Basin and Gabon in 1990s"/>
   <result pre="their incubation period before symptoms develop. The global spread of" exact="COVID 19" post="was accelerated due to international airline and ship travel"/>
   <result pre="organisms naturally, and can cause diseases in man. For example," exact="Lassa fever," post="an acute viral disease found endemic in West African"/>
   <result pre="whose habitats had been destroyed for mono-cultural agricultural purposes. The" exact="Lassa fever" post="spread by contact with the feces of infected rodents"/>
   <result pre="and the H1N1 flu in Mexico. Other examples include the" exact="Ebola" post="and Nipah outbreaks that illustrated how social disruption and"/>
   <result pre="an epidemic [[87], [88], [89]]. For example, the West African" exact="Ebola" post="outbreak exposed gaps related to the timely detection of"/>
   <result pre="the earth warms, some vector populations like mosquitoes causing Malaria," exact="Dengue" post="and ticks carrying viruses causing encephalitic syndrome etc may"/>
   <result pre="wildlife vectors, that increases the risks of EIDs as in" exact="COVID 19" post="[104] where bats were the reservoir of COVID-19 and"/>
   <result pre="region to being spread globally and causing pandemics such as" exact="COVID 19" post="Interconnectedness has extensively enhanced global trade of wildlife Migration"/>
   <result pre="in the same cell and finally emergence of pandemics like" exact="COVID 19" post="Wild life is hunted and traded mainly for food"/>
   <result pre="the wild. Several outbreaks in Africa of, for example the" exact="Ebola" post="in the Congo basin and SARS in east Asian"/>
   <result pre="13GaoF.BailesE.RobertsonD.L.ChenY.RodenburgC.M.MichaelS.F.CumminsL.B.ArthurL.O.PeetersM.ShawG.M.SharpP.M.Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytesNature397671819994364419989410 14LeroyE.M.RouquetP.FormentyP.SouquiÃ¨reS.KilbourneA.FromentJ.M.BermejoM.SmitS.KareshW.SwanepoelR.ZakiS.R.Multiple" exact="Ebola" post="virus transmission events and rapid decline of central African"/>
   <result pre="22CoburnB.J.WagnerB.G.BlowerS.Modeling influenza epidemics and pandemics: insights into the future of" exact="swine flu" post="(H1N1)BMC Med.7120093019545404 23McFarlaneR.SleighA.McMichaelT.Synanthropy of wild mammals as a determinant"/>
   <result pre="of climate, landscape, and viral genetics as drivers of the" exact="Japanese encephalitis" post="virus ecologyPLoS Neglected Trop. Dis.792013e2208 35BarbourA.G.Fall and rise of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7509820\results\search\zoonosis\results.xml">
   <result pre="severe acute respiratory syndrome coronavirus (SARS) in 2002 [3] and" exact="Middle East respiratory syndrome" post="coronavirus (MERS) in 2012 [4] has confirmed that the"/>
   <result pre="after large-scale epidemics of various viruses, such as MERS and" exact="Ebola" post="virus (EBOV) [66, 67]. The results of a phase"/>
   <result pre="clinical application of a rapid IgM-IgG combined antibody test for" exact="SARS-CoV-2 infection" post="diagnosis. J Med Virol. 2020. 10.1002/jmv.25727. Published online ahead"/>
   <result pre="Group2020193149 54.WarrenTKet al.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature2016531759438138510.1038/nature1718026934220 55.HolshueMLet al.First Case of 2019"/>
   <result pre="Who Mers-Cov Research, GState of knowledge and data gaps of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in humansPLoS Curr201351 67.WongVWSet al.Treatment of severe"/>
   <result pre="p. 1â€&quot;5. 74.ReynardOet al.Identification of a new Ribonucleoside inhibitor of" exact="Ebola" post="virus replicationViruses20157126233624010.3390/v712293426633464 75.UrakovaNet al.Î²-D--Hydroxycytidine is a potent anti-alphavirus compound"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7511040\results\search\zoonosis\results.xml">
   <result pre="Agents . 2020:105949.32205204 30DongL, HuS and GaoJ.Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19).Drug Discov Ther . 2020;14:58-60.32147628 31NicastriE, PetrosilloN, BartoliTA, LeporeL,"/>
   <result pre="e00772410.1161/JAHA.117.007724.29217664 41MitraRL, GreensteinSA, EpsteinLM.An algorithm for managing QT prolongation in" exact="coronavirus disease 2019" post="(COVID-19) patients treated with either chloroquine or hydroxychloroquine in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7513902\results\search\zoonosis\results.xml">
   <result pre="safety of Jinhua Qinggan granule (JHQG) in the treatment of" exact="coronavirus disease 2019" post="(COVID-19): a protocol for systematic review and meta analysisMedicine"/>
   <result pre="CellsInfect Drug Resist201920123911392310.2147/IDR.S231908 40.KongYWuHWChenYLaiSYangZMChenJSMechanism of Tanreqing Injection on treatment of" exact="coronavirus disease 2019" post="based on network pharmacology and molecular dockingChina Chin Tradit"/>
   <result pre="Clin Chin Mater Med202036026971 68.AngLSongELeeHWLeeMSherbal medicine for the treatment of" exact="coronavirus disease 2019" post="(COVID-19): a systematic review and meta-analysis of randomized controlled"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7514029\results\search\zoonosis\results.xml">
   <result pre="Sciences : Medical Conditions : Infectious Diseases : Viral Diseases:" exact="Influenza" post=": Medicine and Health Sciences : Medical Conditions :"/>
   <result pre=": Organisms : Viruses : RNA viruses : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza A virus : Biology and life sciences"/>
   <result pre=": Viruses : RNA viruses : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="A virus : Biology and life sciences : Microbiology"/>
   <result pre="microbiology : Microbial pathogens : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza A virus : Medicine and health sciences"/>
   <result pre="Microbial pathogens : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="A virus : Medicine and health sciences : Pathology"/>
   <result pre="Pathogens : Microbial pathogens : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza A virus : Biology and life sciences"/>
   <result pre="Microbial pathogens : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="A virus : Biology and life sciences : Organisms"/>
   <result pre=": Organisms : Viruses : Viral pathogens : Orthomyxoviruses :" exact="Influenza" post="viruses: Influenza A virus : Biology and life sciences"/>
   <result pre=": Viruses : Viral pathogens : Orthomyxoviruses : Influenza viruses:" exact="Influenza" post="A virus : Biology and life sciences : Organisms"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Orthomyxoviruses:" exact="Influenza" post="Viruses : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Orthomyxoviruses:" exact="Influenza" post="Viruses : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Orthomyxoviruses:" exact="Influenza" post="Viruses : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Orthomyxoviruses:" exact="Influenza" post="Viruses : Biology and Life Sciences : Immunology :"/>
   <result pre="work was supported partially by CRIP (Center for Research on" exact="Influenza" post="Pathogenesis), an NIH-NIAID-funded Center of Excellence for Influenza Research"/>
   <result pre="Research on Influenza Pathogenesis), an NIH-NIAID-funded Center of Excellence for" exact="Influenza" post="Research and Surveillance (CEIRS) (contract HHSN272201400008C). The funders had"/>
   <result pre="the manuscript. fig-count: table-count: page-count: Introduction In todayâ€™s interconnected world," exact="human influenza" post="A viruses emerge, evolve, and spread globally, eluding host"/>
   <result pre="complex topic about which we only have a limited understanding." exact="Influenza" post="A subtypes are classified based on their surface proteins"/>
   <result pre="immunity structured by birth year that may alleviate symptoms from" exact="influenza infection." post="Fig 1 Timeline of influenza A virus circulation in"/>
   <result pre="early in life shape and limit future immune responses to" exact="influenza infection;" post="by this definition, imprinting is related to birth year."/>
   <result pre="the termâ€�Original Antigenic Sinâ€� (OAS) to describe how the first" exact="influenza infection" post="â€œgoverns the response to vaccination with other strainsâ€� [37]"/>
   <result pre="of population-level surveillance data, particularly by comparing the risk of" exact="influenza infection" post="in birth cohorts imprinted by different influenza histories (Fig"/>
   <result pre="difficult to obtain. Recent analyses of the risk of seasonal" exact="influenza infection" post="have illuminated the role of birth year imprinting at"/>
   <result pre="in susceptibility and behavioral factors that drive the risk of" exact="influenza infection" post="and propensity to seek care and, in turn, affect"/>
   <result pre="the intensity and duration of shedding and shorten chains of" exact="influenza infection," post="potentially decreasing the risk of escape variants [79]. At"/>
   <result pre="had suggested that resistance mutations would impair viral fitness [80]." exact="Influenza" post="viruses evolve resistance to antiviral drugs via multiple pathways"/>
   <result pre="(the so-called herd immunity effect). (2) By reducing opportunities for" exact="influenza infection," post="vaccination may generate pockets of unprotected individuals who are"/>
   <result pre="US government. References References 1ErbeldingEJ, et al. (2018) A Universal" exact="Influenza" post="Vaccine: The Strategic Plan for the National Institute of"/>
   <result pre="GrenfellBT (2019) Dynamic Perspectives on the Search for a Universal" exact="Influenza" post="Vaccine. J Infect Dis219(Supplement_1):S46â€&quot;S56.30715467 4CoxNJ &amp;amp; SubbaraoK (2000) Global"/>
   <result pre="Proc Natl Acad Sci U S A109(7):2573â€&quot;2578. 10.1073/pnas.120003910922308500 12KilbourneED (1987)" exact="Influenza" post="(Plenum Medical Book Co., New York and London). 13GuthmillerJJ"/>
   <result pre="infection of mice. J Virol2(8):778â€&quot;786. 10.1128/JVI.2.8.778-786.19685701819 15EichelbergerMC &amp;amp; WanH (2015)" exact="Influenza" post="neuraminidase as a vaccine antigen. Curr Top Microbiol Immunol386:275â€&quot;299."/>
   <result pre="antigen. Curr Top Microbiol Immunol386:275â€&quot;299. 10.1007/82_2014_39825033754 16ChenYQ, et al. (2018)" exact="Influenza" post="Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive"/>
   <result pre="smoldering pandemic. J Infect Dis192(2):233â€&quot;248. 10.1086/43115015962218 18EpsteinSL (2006) Prior H1N1" exact="influenza infection" post="and susceptibility of Cleveland Family Study participants during the"/>
   <result pre="of pandemic recycling on influenza-associated mortalityOptions for the Control of" exact="Influenza" post="V, International Congress Series 1263, ed KawaokaY(Elsevier), pp 791â€&quot;794."/>
   <result pre="(2016) Structure and Function Analysis of an Antibody Recognizing All" exact="Influenza" post="A Subtypes. Cell166(3):596â€&quot;608. 10.1016/j.cell.2016.05.07327453466 32SuiJ, et al. (2011) Wide"/>
   <result pre="influenza virus. Clin Vaccine Immunol21(5):737â€&quot;746. 10.1128/CVI.00790-1324648486 42MeadeP, et al. (2020)" exact="Influenza" post="Virus Infection Induces a Narrow Antibody Response in Children"/>
   <result pre="Imprinting and Editing of the Human CD4T Cell Response to" exact="Influenza" post="Virus. Front Immunol10:93210.3389/fimmu.2019.0093231134060 45SmithDJ, ForrestS, AckleyDH, &amp;amp; PerelsonAS (1999)"/>
   <result pre="influenza via childhood hemagglutinin imprinting. Science354(6313):722â€&quot;726. 10.1126/science.aag132227846599 47EpsteinSL (2018) Universal" exact="Influenza" post="Vaccines: Progress in Achieving Broad Cross-Protection In Vivo. Am"/>
   <result pre="al. (2018) Influence of Birth Cohort on Effectiveness of 2015â€&quot;2016" exact="Influenza" post="Vaccine Against Medically Attended Illness Due to 2009 Pandemic"/>
   <result pre="Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic" exact="Influenza" post="A(H1N1) Virus in the United States. J Infect Dis218(2):189â€&quot;196."/>
   <result pre="51GagnonA, et al. (2018) Pandemic Paradox: Early Life H2N2 Pandemic" exact="Influenza" post="Infection Enhanced Susceptibility to Death during the 2009 H1N1"/>
   <result pre="comparative study. J Virol. 93(21):e01150â€&quot;19. 10.1128/JVI.01150-1931434733 58CauchemezS, et al. (2012)" exact="Influenza" post="infection rates, measurement errors and the interpretation of paired"/>
   <result pre="65NIAID (2019) NIAID Announces Two Awards for Multi-Year Studies of" exact="Influenza" post="Immunity in Children. https://www.niaid.nih.gov/news-events/niaid-announces-two-awards-multi-year-studies-influenza-immunity-children 66KimJH, et al. (2016) Prior"/>
   <result pre="recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved" exact="Influenza" post="A antigens. Mol Ther22(3):668â€&quot;674. 10.1038/mt.2013.28424374965 70AntrobusRD, et al. (2014)"/>
   <result pre="72collab: Vaccitech (2020) Phase 2 Clinical Results for Vaccitechâ€™s Universal" exact="Influenza" post="A Vaccine. https://www.vaccitech.co.uk/phase-2-clinical-results-for-vaccitech-universal-influenza/ 73MorrisDH, et al. (2018) Predictive Modeling"/>
   <result pre="A Vaccine. https://www.vaccitech.co.uk/phase-2-clinical-results-for-vaccitech-universal-influenza/ 73MorrisDH, et al. (2018) Predictive Modeling of" exact="Influenza" post="Shows the Promise of Applied Evolutionary Biology. Trends Microbiol."/>
   <result pre="et al. (2017) Estimating Direct and Indirect Protective Effect of" exact="Influenza" post="Vaccination in the United States. Am J Epidemiol186(1):92â€&quot;100. 10.1093/aje/kwx03728369163"/>
   <result pre="83SimonsenL, et al. (2007) The genesis and spread of reassortment" exact="human influenza" post="A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol24(8):1811â€&quot;1820. 10.1093/molbev/msm10317522084"/>
   <result pre="mouse model. J Virol88(11):6019â€&quot;6030. 10.1128/JVI.03101-1324623430 94ChuaBY, et al. (2015) Inactivated" exact="Influenza" post="Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term"/>
   <result pre="households. N Engl J Med362(23):2175â€&quot;2184. 10.1056/NEJMoa091153020558368 96TsangTK, et al. (2015)" exact="Influenza" post="A Virus Shedding and Infectivity in Households. J Infect"/>
   <result pre="(2017) Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic" exact="Influenza" post="Virus Infections in the Community. Clin Infect Dis64(6):736â€&quot;742. 10.1093/cid/ciw84128011603"/>
   <result pre="ArinaminpathyN (2016) Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum" exact="Influenza" post="Vaccines against Conventional, Strain-Matched Vaccines. PLoS Comput Biol12(12):e100520410.1371/journal.pcbi.100520427977667 100Pan-NgumW,"/>
   <result pre="J. Exp Pathol22:91â€&quot;97. 102SchulmanJL &amp;amp; KilbourneED (1963) Experimental Transmission Of" exact="Influenza" post="Virus Infection In Mice. Ii. Some Factors Affecting The"/>
   <result pre="al. (2019) Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal" exact="Influenza" post="Virus Infection Reflects Early-Life Imprinting and Adaptation to the"/>
   <result pre="PLoS ONE4(8):e683210.1371/journal.pone.000683219718262 113BuddAP, et al. (2019) Birth Cohort Effects in" exact="Influenza" post="Surveillance Data: Evidence That First Influenza Infection Affects Later"/>
   <result pre="Birth Cohort Effects in Influenza Surveillance Data: Evidence That First" exact="Influenza" post="Infection Affects Later Influenza-Associated Illness. J Infect Dis220(5):820â€&quot;829. 10.1093/infdis/jiz20131053844"/>
   <result pre="Significance of Age Distribution of Antibody to Antigenic Variants of" exact="Influenza" post="Virus. Journal of Experimental Medicine. 98(6):641â€&quot;656. 10.1084/jem.98.6.64113109114 115FrancisT (1960)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7517057\results\search\zoonosis\results.xml">
   <result pre="2002 caused by very virulent strains of new coronaviruses [16â€&quot;18]," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012 [19], and avian influenza, such"/>
   <result pre="and A/H7N9 in China [20, 23]. Recently, major outbreaks of" exact="Ebola" post="virus disease (EVD) threatened populations in West African countries"/>
   <result pre="unprecedented pandemic caused by a new strain of coronavirus called" exact="coronavirus disease 2019" post="(COVID-19) [26]. Wolfe et al. [27] identified five stages"/>
   <result pre="subsequent wave will require the involvement of animal hosts (e.g.," exact="Ebola" post="virus, Marburg virus, monkeypox virus); the fourth is when"/>
   <result pre="geopolitical borders [2, 31]. Recently, EIDs such as COVID-19, EVD," exact="Lassa fever," post="and SARS have been an issue of global concern."/>
   <result pre="in Africa despite its link with numerous EIDs, such as" exact="Ebola" post="and Marburg [7]. The increased demand and commercialization of"/>
   <result pre="Staphylococcus aureus CDC Centers for Disease Control and Prevention COVID-19" exact="Coronavirus disease 2019" post="CTX-M Cefotaxime-M DRC The Democratic Republic of the Congo"/>
   <result pre="Democratic Republic of the Congo EIDs Emerging infectious diseases EVD" exact="Ebola" post="virus disease FWBDs Food- and water-borne diseases HIV Human"/>
   <result pre="FWBDs Food- and water-borne diseases HIV Human immunodeficiency virus MARS" exact="Middle East respiratory syndrome" post="MDR Multidrug-resistant MRSA Methicillin-resistant Staphylococcus aureus SARS Severe acute"/>
   <result pre="East respiratory syndrome MDR Multidrug-resistant MRSA Methicillin-resistant Staphylococcus aureus SARS" exact="Severe acute respiratory syndrome" post="SDGs Sustainable Development Goals TB Tuberculosis EU European Union"/>
   <result pre="and re-emerging respiratory infectionsExpert Rev Anti-Infect Ther2004240541215482205 19.World Health Organization." exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). 2019. https://www.who.int/en/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov). Accessed 26 Jul 2020. 20.World"/>
   <result pre="(MERS-CoV). 2019. https://www.who.int/en/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov). Accessed 26 Jul 2020. 20.World Health Organization." exact="Influenza" post="(avian and other zoonotic). 2018. https://www.who.int/news-room/fact-sheets/detail/influenza-(avian-and-other-zoonotic) . Accessed 26"/>
   <result pre="influenza A (H7N9) virusN Engl J Med20133681888189723577628 24.World Health Organization." exact="Ebola" post="situation report. 2016. https://apps.who.int/ebola/current-situation/ebola-situation-report-16-march-2016. Accessed 26 Jul 2020. 25.World"/>
   <result pre="report. 2016. https://apps.who.int/ebola/current-situation/ebola-situation-report-16-march-2016. Accessed 26 Jul 2020. 25.World Health Organization." exact="Ebola" post="virus disease? Democratic republic of the Congo. 2020. https://www.who.int/csr/don/12-March-2020-ebola-drc/en/."/>
   <result pre="145.VinckPPhamPNBinduKKBedfordJNillesEJInstitutional trust and misinformation in the response to the 2018â€&quot;19" exact="Ebola" post="outbreak in North Kivu, DR Congo: a population-based surveyLancet"/>
   <result pre="infectious diseasesExpert Rev Anti-Infect Ther20161454755527063349 157.Centers for Disease Control Prevention." exact="Coronavirus disease 2019" post="(COVID-2019). 2020. https://www.cdc.gov/coronavirus/2019-ncov/cdcresponse/about-COVID-19.html. Accessed 1 Sep 2020. 158.World Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7518803\results\search\zoonosis\results.xml">
   <result pre="long-term damage, means that the overall health burden caused by" exact="SARS-CoV-2 infection" post="may be under-estimated because COVID-19 patients developed cardiovascular system"/>
   <result pre="In combination with recently published medical data of patients having" exact="SARS-CoV-2 infection" post="and the latest studies, the manifestations of damage to"/>
   <result pre="Organization (WHO) declared that the novel coronavirus infection was named" exact="coronavirus disease 2019" post="(COVID-19) [1]. By March 11, 2020, more than 118,000"/>
   <result pre="also suffer from severe heart failure in the wake of" exact="SARS-CoV-2 infection" post="and eventually die of sudden cardiac death [7]. Likewise,"/>
   <result pre="may have a long-term effect on the heart [17,18]. 2.3" exact="SARS-CoV-2 infection" post="with underlying cardiovascular disease Some SARS-CoV-2 patients have chronic"/>
   <result pre="severe hypertension and cardiac insufficiency. Further analysis showed that the" exact="SARS-CoV-2 infection" post="only induced heart failure and systemic multiorgan dysfunction in"/>
   <result pre="cause stress cardiomyopathy. 4 Treatment of cardiovascular injury associated with" exact="SARS-CoV-2 infection" post="4.1 Antiviral therapy The Diagnosis and Treatment Plan of"/>
   <result pre="4.2 ACE2 as a potential target during the treatment of" exact="SARS-CoV-2 infection" post="SARS-CoV-2 mainly invades alveolar epithelial cells via ACE2 and"/>
   <result pre="ACE2 can be regarded as a potential therapeutic target for" exact="SARS-CoV-2 infection." post="These possibilities include blocking the binding between ACE2 and"/>
   <result pre="4.2.2 ACE inhibitors (ACEIs) SARS-related studies have shown that after" exact="SARS-CoV infection," post="ACE2 was downregulated in the lungs, causing ACE/ACE2 imbalance."/>
   <result pre="evidence that ACEIs and ARBs can increase the risk of" exact="SARS-CoV-2 infection" post="or cause deterioration of COVID-19 patients [62], so ACEIs"/>
   <result pre="and kidneys [65]. 4.3 Treatment of cytokine storms associated with" exact="SARS-CoV-2 infection" post="As mentioned previously, SARS-CoV-2 infection could induce overactivation of"/>
   <result pre="of cytokine storms associated with SARS-CoV-2 infection As mentioned previously," exact="SARS-CoV-2 infection" post="could induce overactivation of the immune system, resulting in"/>
   <result pre="and protecting organ function is a promising approach to treat" exact="SARS-CoV-2 infection" post="and reduce mortality. Currently, most targeted drugs for COVID-19"/>
   <result pre="(mAbs) may be used to treat cytokine storms associated with" exact="SARS-CoV-2 infection" post="[68]. Zhou et al. found that granulocyte-macrophage colony stimulating"/>
   <result pre="main methods for treating and preventing COVID-19. 4.4 Treatment of" exact="SARS-CoV-2 infection" post="with underlying cardiovascular diseases Current data show that all"/>
   <result pre="data show that all age groups are at risk of" exact="SARS-CoV-2 infection," post="and the condition is generally more severe in elderly"/>
   <result pre="improve the prognosis of patients. 6 Conclusion The outbreak of" exact="SARS-CoV-2 infection" post="has been defined as a pandemic that is seriously"/>
   <result pre="Wuhan, ChinaLancet395202049750631986264 7ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet (London, England)3952020507513 8WangD.HuB.HuC.ZhuF.LiuX.ZhangJ.Clinical"/>
   <result pre="of cardiovascular magnetic resonance imaging in patients recently recovered from" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol.2020E1E9 19Vital surveillances: the epidemiological characteristics of an"/>
   <result pre="injury signs are associated with higher and earlier mortality in" exact="coronavirus disease 2019" post="(COVID-19)medRxiv202010.1101/2020.02.26.20028589(2020.2002.2026.20028589) 37van der PollT.LeviM.Crosstalk between inflammation and coagulation: the"/>
   <result pre="and cytokines in peripheral blood of 123 hospitalized patients with" exact="2019 novel coronavirus pneumonia" post="(NCP)medRxiv202010.1101/2020.02.10.20021832(2020.2002.2010.20021832) 69ZhouY.FuB.ZhengX.WangD.ZhaoC.qiY.Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7518973\results\search\zoonosis\results.xml">
   <result pre="as the COVID-19 resource centre remains active. Abstract The ongoing" exact="coronavirus disease 2019" post="(COVID-19) pandemic threatens global health thereby causing unprecedented social,"/>
   <result pre="39 74% Disease focus SARS 4 7% MERS 20 37%" exact="COVID19" post="37 69% Note: The sum of the disease focus"/>
   <result pre="evident in the emergence and re-emergence of viral zoonosis (e.g." exact="Ebola" post="or MERS-CoV) in Sub-Saharan Africa, the Middle East, and"/>
   <result pre="the latest human coronavirus threatViruses.1020189310.3390/v10020093 12HanH.-J.YuH.YuX.-J.Evidence for zoonotic origins of" exact="Middle East respiratory syndrome" post="coronavirusJ. Gen. Virol.97201627428010.1099/jgv.0.00034226572912 13KasemS.QasimI.Al-HufofiA.HashimO.AlkararA.Abu-ObeidaA.Cross-sectional study of MERS-CoV-specific RNA and"/>
   <result pre="COVID-19 epidemicMed. Clin.154202017517710.1016/j.medcle.2020.02.001 20WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in ChinaJAMA3232020123910.1001/jama.2020.264832091533 21Center for Systems Science and"/>
   <result pre="approachOne Heal.1001242020 38HemidaM.G.AlnaeemA.Some One Health based control strategies for the" exact="Middle East respiratory syndrome" post="coronavirusOne Heal.201910010210.1016/j.onehlt.2019.100102 39ZumlaA.DarO.KockR.MuturiM.NtoumiF.KaleebuP.Taking forward a â€˜One Healthâ€™ approach for"/>
   <result pre="a â€˜One Healthâ€™ approach for turning the tide against the" exact="Middle East respiratory syndrome" post="coronavirus and other zoonotic pathogens with epidemic potentialInt. J."/>
   <result pre="to combat this pandemic virusTravel Med. Infect. Dis.37202010183010.1016/j.tmaid.2020.101830 64AlharbiN.K.Vaccines against" exact="Middle East respiratory syndrome" post="coronavirus for humans and camelsRev. Med. Virol.272017e191710.1002/rmv.1917 65DalyJ.M.Middle East"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7520644\results\search\zoonosis\results.xml">
   <result pre="syndrome coronavirus 2 SARS-CoV-2) and the disease that it causes" exact="coronavirus disease 2019" post="(COVID-19) have changed the world we know. Yet, the"/>
   <result pre="mechanisms contribute to the deteriorating effects on the organism during" exact="SARS-CoV-2 infection." post="Both humoral and cellular immune responses are involved in"/>
   <result pre="Anti-SARS-CoV-2 antibodies COVID-19 treatment Plasma therapy Core Tip: Since the" exact="coronavirus disease 2019" post="(COVID-19) results from the interaction between the severe acute"/>
   <result pre="factors and to control and regulate the pathophysiological processes during" exact="SARS-CoV-2 infection." post="Moreover, immune-mediated and humoral immune responses, immune memory, the"/>
   <result pre="reported human coronavirus members. These are HCoV-OC43, HCoV229E, SARS-CoV, HCoV-HKU1," exact="Middle East respiratory syndrome" post="corona virus (MERS-CoV), and HCoVNL63[3,4]. Over the last twenty"/>
   <result pre="into the evolution and host distribution of these SARS-CoV-2-related viruses[8,9]." exact="Coronavirus disease 2019" post="(COVID-19) is the illness associated with SARS-CoV-2 infection. The"/>
   <result pre="viruses[8,9]. Coronavirus disease 2019 (COVID-19) is the illness associated with" exact="SARS-CoV-2 infection." post="The clinical syndrome is characterized by variable symptoms, ranging"/>
   <result pre="shedding are not shown. ARDS: Acute respiratory distress syndrome; SARS-CoV-2:" exact="Severe acute respiratory syndrome" post="coronavirus 2; ACE2: Angiotensin-converting enzyme 2. SARS-CoV and SARS-CoV-2"/>
   <result pre="profile[43,45]. Some of the immunological responses that are accompanying the" exact="SARS-CoV-2 infection" post="are presented in Figure 1. CLINICAL MANIFESTATIONS OF COVIDâ€&quot;19"/>
   <result pre="of COVID-19 and the disease severity. A common complication of" exact="SARS-CoV-2 infection" post="is the development of ARDS. The latter is assumed"/>
   <result pre="aspect of the unclear immune response and immune memory regarding" exact="SARS-CoV-2 infection" post="is the desire of the world to have an"/>
   <result pre="promising targets to use in the creation of vaccines against" exact="SARS-CoV-2 infection" post="and therapy, but additional laboratory and clinical evidence are"/>
   <result pre="to the immune responses. If we accept the division of" exact="SARS-CoV-2 infection" post="into three stages, at the beginning of the infection"/>
   <result pre="3 Treatment modalities related to the immunological mechanisms observed during" exact="coronavirus disease 2019." post="ACE2: Angiotensin-converting enzyme 2; ARDS: Acute respiratory distress syndrome;"/>
   <result pre="syndrome; MHC: Major histocompatibility complex; MSCs: Mesenchymal stromal/stem cells; SARS-CoV-2:" exact="Severe acute respiratory syndrome" post="coronavirus 2. Antibody and plasma therapy are the next"/>
   <result pre="favorable results for use in patients with acute and severe" exact="SARS-CoV-2 infection." post="In addition, the development of a recombinant human monoclonal"/>
   <result pre="MSCs properties because T cells do not activate well in" exact="SARS-CoV-2 infection." post="The use of a â€œlicensing approachâ€� is being considered:"/>
   <result pre="would be of great significance for the detailed understanding of" exact="SARS-CoV-2 infection." post="Conflict-of-interest statement: The authors have no conflicts of interest."/>
   <result pre="(Manis javanica)Viruses201911 10ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYXiaJYuTZhangXZhangLEpidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751332007143 11LiuKFangYYDengYLiuWWangMFMaJPXiaoWWangYNZhongMHLiCHLiGCLiuHGClinical characteristics of"/>
   <result pre="ColdJAMA2020 17WoelfelRCormanVMGuggemosWSeilmaierMZangeSMuellerMANiemeyerDVollmarPRotheCHoelscherMBleickerTBrueninkSSchneiderJEhmannRZwirglmaierMDrostenCWendtnerCClinical presentation and virological assessment of hospitalized cases of" exact="coronavirus disease 2019" post="in a travel-associated transmission clusterMedRxiv2020 18BaiYYaoLWeiTTianFJinDYChenLWangMPresumed Asymptomatic Carrier Transmission"/>
   <result pre="Host Microbe20161918119326867177 35ChannappanavarRFehrARZhengJWohlford-LenaneCAbrahanteJEMackMSompallaeRMcCrayPBJrMeyerholzDKPerlmanSIFN-I response timing relative to virus replication determines" exact="MERS coronavirus" post="infection outcomesJ Clin Invest20191293625363931355779 36de WitEvan DoremalenNFalzaranoDMunsterVJSARS and MERS:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7524442\results\search\zoonosis\results.xml">
   <result pre="all influenza epidemics since Spanish flu in 1919 through dengue," exact="Ebola" post="to corona virus infection in 2020 [17]. CRS has"/>
   <result pre="D3 on Selected Cytokines Involved in Cytokine Storm in the" exact="Covid-19" post="Uninfected Jordanian People IP NCT04476745 Amman, Jordan A Study"/>
   <result pre="D on selected cytokines involved in cytokine storm in the" exact="Covid-19" post="(NCT04366908, NCT04476745). Reactive oxygen species may be involved in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7525249\results\search\zoonosis\results.xml">
   <result pre="10.1016/j.nmni.2020.100770100770 : Mini-Review Diagnostic approaches and potential therapeutic options for" exact="coronavirus disease 2019" post="KhanZ.12GhafoorD.23KhanA.4âˆ—âˆ—UaliyevaD.25KhanS.A.6BilalH.7KhanB.8KhanA.9SajjadW.10âˆ—[1)], [2)], [3)], [4)], [5)], [6)], [7)], [8)], [9)],"/>
   <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) emerged in Wuhan city of China"/>
   <result pre="to its contagious nature, the virus spreads rapidly and causes" exact="coronavirus disease 2019" post="(COVID-19). The global tally of COVID-19 was 28 million"/>
   <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused an outbreak of" exact="coronavirus disease 2019" post="(COVID-19) in China, has brought about serious threats to"/>
   <result pre="(more cases reported in 2004). In 2012, the appearance of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in the Arabian Peninsula caused periodic epidemics"/>
   <result pre="random-access, point-of-care molecular devices for fast and accurate diagnosis of" exact="SARS-CoV-2 infection" post="[6]. As of 19 April 2020, the US Food"/>
   <result pre="[24,25] (Fig.3 ). Fig.Â 3 Scheme of investigated antiviral against" exact="coronavirus disease 2019," post="their potential targets and mechanism of action, Names of"/>
   <result pre="of COVID-19 up to 2 September 2020 (https://www.worldometers.info/coronavirus/). Fig.Â 2" exact="Coronavirus disease 2019" post="continent-wise distribution. Potential drugs against COVID-19 Currently, there is"/>
   <result pre="RNA polymerase, was initially developed as an antiviral drug against" exact="Ebola" post="virus and Marburg virus infections. Remdesivir has potential activity"/>
   <result pre="fevers [51,52], and to some extent it is effective against" exact="Ebola" post="virus [51,53,54]. Favipiravir is one of the possible drugs"/>
   <result pre="be reliably detected [87]. A negative result cannot sort out" exact="SARS-CoV-2 infection," post="especially in people who have recently been exposed to"/>
   <result pre="necessary to develop serological tests that can accurately assess previous" exact="SARS-CoV-2 infection" post="and immunity. In some countries/regions, immunoassays are already on"/>
   <result pre="Biological Inc./Beijing Institute of Biotechnology SARS-CoV-2 Phase 2 ChiCTR2000031781Phase 1ChiCTR2000030906" exact="Ebola" post="RNA LNP-encapsulated mRNA Moderna/NIAID SARS-CoV-2 Phase 2 NCT04405076Phase 1"/>
   <result pre="vaccine Clover Biopharmaceuticals Inc./GSK/Dynavax SARS-CoV-2 Phase 1 NCT04405908 HIV, REV" exact="Influenza" post="Protein Subunit Adjuvanted recombinant protein (RBD-Dimer) Anhui Zhifei Longcom"/>
   <result pre="Abbreviations: CCHF, Crimeanâ€&quot;Congo haemorrhagic fever virus; DENV, dengue virus; EBOV," exact="Ebola" post="virus; HIV, human immunodeficiency virus; HPV, human papillomavirus; Inf"/>
   <result pre="LASV, Lassa mammarenavirus; MARV, Marburg virus; MenB, meningitis B; MERS," exact="Middle East respiratory syndrome;" post="NIPV, Nipah virus; RABV, rabies virus; REV, reticuloendothelial virus;"/>
   <result pre="receptor for the emerging human coronavirus-EMCNature4957440201325125423486063 24MilletJ.K.WhittakerG.R.Host cell entry of" exact="Middle East respiratory syndrome" post="coronavirus after two-step, furin-mediated activation of the spike proteinProc"/>
   <result pre="the spike proteinProc Natl Acad Sci USA1112014152141521925288733 25KidoH.OkumuraY.YamadaH.LeT.Q.YanoM.Proteases essential for" exact="human influenza" post="virus entry into cells and their inhibitors as potential"/>
   <result pre="antiviral against hand, foot and mouth diseaseAntivir Res149201814314929175128 43SahraeiZ.ShabaniM.ShokouhiS.SaffaeiA.Aminoquinolines against" exact="coronavirus disease 2019" post="(COVID-19): chloroquine or hydroxychloroquineInt J Antimicrob Agents55202010594532194152 44MillionM.GautretP.ColsonP.RousselY.DubourgG.ChabriereE.Clinical efficacy"/>
   <result pre="Ser B, Phys Biol Sci932017449463 53BaiC.Q.MuJ.S.KargboD.SongY.B.NiuW.K.NieW.M.Clinical and virological characteristics of" exact="Ebola" post="virus disease patients treated with favipiravir (T-705)-Sierra Leone, 2014Clin"/>
   <result pre="(T-705)-Sierra Leone, 2014Clin Infect Dis6320161288129427553371 54CorrectionExperimental treatment with favipiravir for" exact="Ebola" post="virus disease (the JIKI trial): a historically controlled, single-arm"/>
   <result pre="Sci50Si-1202061161932293834 64RossignolJ.F.Nitazoxanide, a new drug candidate for the treatment of" exact="Middle East respiratory syndrome" post="coronavirusJÂ Infect Public Health9201622723027095301 65JasenoskyL.D.CadenaC.MireC.E.BorisevichV.HaridasV.RanjbarS.The FDA-approved oral drug nitazoxanide"/>
   <result pre="FDA-approved oral drug nitazoxanide amplifies host antiviral responses and inhibits" exact="Ebola" post="virusiScience1920191279129031402258 66CalyL.DruceJ.D.CattonM.G.JansD.A.WagstaffK.M.The FDA-approved drug ivermectin inhibits the replication of"/>
   <result pre="Microbiol5320153738374926354816 83MerckxJ.WaliR.SchillerI.CayaC.GoreG.C.ChartrandC.Diagnostic accuracy of novel and traditional rapid tests for" exact="influenza infection" post="compared with reverse transcriptase polymerase chain reaction: a systematic"/>
   <result pre="Clin Microbiol4220042884288915243033 85ChenY.ChanK.H.KangY.ChenH.LukH.K.PoonR.W.AÂ sensitive and specific antigen detection assay for" exact="Middle East respiratory syndrome" post="coronavirusEmerg Microb Infect42015e26 86SheridanC.Fast, portable tests come online to"/>
   <result pre="SARS-CoV-2: an observational cohort studyLancet Infect Dis20202056557432213337 90HosseinyM.KoorakiS.GholamrezanezhadA.ReddyS.MyersL.Radiology perspective of" exact="coronavirus disease 2019" post="(COVID-19): lessons from severe acute respiratory syndrome and middle"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7527651\results\search\zoonosis\results.xml">
   <result pre="qualify as pandemics, such as severe acute respiratory syndrome (SARS)," exact="Middle East respiratory syndrome" post="(MERS), HIV, influenza A (H1N1)pdm/09 and most recently COVID-19,"/>
   <result pre="diseases such as severe acute respiratory syndrome (SARS), Ebola, Zika," exact="Middle East respiratory syndrome" post="(MERS), HIV (although technically endemic), influenza A (H1N1)pdm/09 and"/>
   <result pre="scalable preventive measure against COVID-19 and other viral respiratory infections." exact="Influenza" post="H1N1 and lung disease The two most serious impacts"/>
   <result pre="such pulmonary sequelae may be predisposed and more susceptible to" exact="influenza infection" post="and its complications, including mortality [106]. Furthermore, the temporary"/>
   <result pre="induced by TB may increase the susceptibility of patients to" exact="influenza infection." post="An excess mortality associated with influenza has been described"/>
   <result pre="but without clear distinction between both diseases, was reported [109]." exact="Influenza" post="induces a temporary increase in the susceptibility to bacterial"/>
   <result pre="symptomatic patients and their contacts can reduce the risk of" exact="SARS-CoV-2 infection" post="by limiting the spread of droplet nuclei from isolated"/>
   <result pre="surface samples at a New York City feline quarantine facility." exact="Influenza" post="Other Respir Viruses2018; 12: 613â€&quot;622. doi:10.1111/irv.1257229768714 6LeungNH, ZhouJ, ChuDK,"/>
   <result pre="influenza A/H1N1 pneumonia: primary influenza pneumonia versus concomitant/secondary bacterial pneumonia." exact="Influenza" post="Other Respir Viruses2011; 5: e535â€&quot;e543. doi:10.1111/j.1750-2659.2011.00269.x21682848 67MorensDM, TaubenbergerJK, FauciASPredominant"/>
   <result pre="et al.Epidemiological, demographic, and clinical characteristics of 47 cases of" exact="Middle East respiratory syndrome" post="coronavirus disease from Saudi Arabia: a descriptive study. Lancet"/>
   <result pre="BaigK, et al.Clinical aspects and outcomes of 70 patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a single-center experience in Saudi Arabia. Int"/>
   <result pre="et al.Clinical course and outcomes of critically ill patients with" exact="Middle East respiratory syndrome" post="coronavirus infection. Ann Intern Med2014; 160: 389â€&quot;397. doi:10.7326/M13-248624474051 82GuanWJ,"/>
   <result pre="160: 389â€&quot;397. doi:10.7326/M13-248624474051 82GuanWJ, NiZY, HuY, et al.Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med2020; 382: 1708â€&quot;1720. doi:10.1056/nejmoa200203232109013"/>
   <result pre="1054â€&quot;1062. doi:10.1016/S0140-6736(20)30566-332171076 85WuZ, McGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
   <result pre="Campaign: guidelines on the management of critically ill adults with" exact="coronavirus disease 2019" post="(COVID-19). Crit Care Med2020; 46: 854â€&quot;887. doi:10.1007/s00134-020-06022-5 87VitaccaM, NavaS,"/>
   <result pre="Dis2020; 221: 1775â€&quot;1781. doi:10.1093/infdis/jiaa11332179908 91LiuW, ZhangQ, ChenJ, et al.Detection of" exact="Covid-19" post="in children in early January 2020 in Wuhan, China."/>
   <result pre="et al.Temporal changes of CT findings in 90 patients with" exact="Covid-19" post="pneumonia: a longitudinal study. Radiology2020; 296: E55â€&quot;E64. doi:10.1148/radiol.202020084332191587 95WangW,"/>
   <result pre="and tuberculosis in patients hospitalized with respiratory illness in Thailand." exact="Influenza" post="Other Respir Viruses2013; 7: 244â€&quot;248. doi:10.1111/j.1750-2659.2012.00413.x22817684 115de PausRA, van"/>
   <result pre="doi:10.1093/cid/cis73222942202 145AkiyamaMJ, SpauldingAC, RichJDFlattening the curve for incarcerated populations â€&quot;" exact="Covid-19" post="in jails and prisons. N Engl J Med2020; 382:"/>
   <result pre="e00373-19. doi:10.1128/JCM.00373-1931142607 149AlmekhlafiGA, AlbarrakMM, MandourahY, et al.Presentation and outcome of" exact="Middle East respiratory syndrome" post="in Saudi intensive care unit patients. Crit Care2016; 20:"/>
   <result pre="212SmithAC, ThomasE, SnoswellCL, et al.Telehealth for global emergencies: Implications for" exact="coronavirus disease 2019" post="(COVID-19). J Telemed Telecare2020; 26: 309â€&quot;313. doi:10.1177/1357633X2091656732196391 213collab: Protezione"/>
   <result pre="doi:10.1016/j.cell.2020.02.05232142651 230RichardsonP, GriffinI, TuckerC, et al.Baricitinib as potential treatment for" exact="2019-nCoV acute respiratory disease." post="Lancet2020; 395: e30â€&quot;e31. doi:10.1016/S0140-6736(20)30304-432032529 231MorseJS, LalondeT, XuS, et al.Learning"/>
   <result pre="al.The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus. J Biol Chem2020; 295: 4773â€&quot;4779. doi:10.1074/jbc.AC120.01305632094225 238BustiAJ, HallRG,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7533207\results\search\zoonosis\results.xml">
   <result pre="the effects of convalescent plasma for the treatment of severe" exact="coronavirus disease 2019" post="(COVID-19). In addition to transfusion-related side effects, unexpected side"/>
   <result pre="efficacy of convalescent plasma therapy concurrently with its clinical use." exact="Coronavirus disease 2019" post="Severe acute respiratory syndrome coronavirus 2 COVID-19 serotherapy Plasma"/>
   <result pre="plasma therapy concurrently with its clinical use. Coronavirus disease 2019" exact="Severe acute respiratory syndrome" post="coronavirus 2 COVID-19 serotherapy Plasma Introduction Severe acute respiratory"/>
   <result pre="Severe acute respiratory syndrome coronavirus 2 COVID-19 serotherapy Plasma Introduction" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) infection has become a global concern,"/>
   <result pre="a global concern, and the World Health Organization (WHO) declared" exact="coronavirus disease 2019" post="(COVID-19) a Public Health Emergency of International Concern on"/>
   <result pre="syndrome coronavirus (SARS-CoV-1), and West Nile virus, and more recently," exact="Ebola" post="virus [789]. During the current COVID-19 pandemic, multiple studies"/>
   <result pre="viral load, serum cytokine response, and mortality. During the 2013" exact="Ebola" post="epidemic in West Africa, a nonrandomized study showed significantly"/>
   <result pre="who received standard treatment [13]. However, another nonrandomized study on" exact="Ebola" post="virus disease did not show the survival benefit of"/>
   <result pre="coronavirus diseases such as severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS). A study from a hospital in Hong Kong"/>
   <result pre="China Nonrandomized, non-controlled study 4 100% improved None [22] COVID-19," exact="coronavirus disease 2019." post="Although a recent systematic review showed uncertainty regarding the"/>
   <result pre="2GuanWJNiZYHuYLiangWHOuCQHeJXLiuLShanHLeiCLHuiDSCDuBLiLJZengGYuenKYChenRCTangCLWangTChenPYXiangJLiSYWangJLLiangZJPengYXWeiLLiuYHuYHPengPWangJMLiuJYChenZLiGZhengZJQiuSQLuoJYeCJZhuSYZhongNScollab: China Medical Treatment Expert Group for Covid-19Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med20203821708172032109013 3KangSJJungSIAge-related morbidity and mortality"/>
   <result pre="de CastillaDFinbergRWDierbergKTapsonVHsiehLPattersonTFParedesRSweeneyDAShortWRTouloumiGLyeDCOhmagariNOhMDRuiz-PalaciosGMBenfieldTFÃ¤tkenheuerGKortepeterMGAtmarRLCreechCBLundgrenJBabikerAGPettSNeatonJDBurgessTHBonnettTGreenMMakowskiMOsinusiANayakSLaneHCcollab: ACTT-1 Study Group MembersRemdesivir for the treatment of" exact="Covid-19" post="- preliminary reportN Engl J Med2020NEJMoa2007764 6collab: RECOVERY Collaborative"/>
   <result pre="J Med2020NEJMoa2007764 6collab: RECOVERY Collaborative GroupHorbyPLimWSEmbersonJRMafhamMBellJLLinsellLStaplinNBrightlingCUstianowskiAElmahiEPrudonBGreenCFeltonTChadwickDRegeKFeganCChappellLCFaustSNJakiTJefferyKMontgomeryARowanKJuszczakEBaillieJKHaynesRLandrayMJDexamethasone in hospitalized patients with" exact="Covid-19" post="- preliminary reportN Engl J Med2020NEJMoa2021436 7Mair-JenkinsJSaavedra-CamposMBaillieJKClearyPKhawFMLimWSMakkiSRooneyKDNguyen-Van-TamJSBeckCRcollab: Convalescent Plasma"/>
   <result pre="infectionClin Infect Dis20115244745621248066 13SahrFAnsumanaRMassaquoiTAIdrissBRSesayFRLaminJMBakerSNicolSContonBJohnsonWAbiriOTKargboOKamaraPGobaARussellJBGevaoSMEvaluation of convalescent whole blood for treating" exact="Ebola" post="virus disease in Freetown, Sierra LeoneJ Infect20177430230927867062 14van GriensvenJEdwardsTde"/>
   <result pre="GriensvenJEdwardsTde LamballerieXSempleMGGallianPBaizeSHorbyPWRaoulHMagassoubaNAntierensALomasCFayeOSallAAFransenKBuyzeJRavinettoRTiberghienPClaeysYDe CropMLynenLBahEISmithPGDelamouADe WeggheleireAHabaNcollab: Ebola-Tx ConsortiumEvaluation of convalescent plasma for" exact="Ebola" post="virus disease in GuineaN Engl J Med2016374334226735992 15ChengYWongRSooYOWongWSLeeCKNgMHChanPWongKCLeungCBChengGUse of"/>
   <result pre="in patients with coronavirus disease 2019J Infect Dis2020222384332348485 25SalazarEPerezKKAshrafMChenJCastilloBChristensenPAEubankTBernardDWEagarTNLongSWSubediSOlsenRJLevequeCSchwartzMRDeyMChavez-EastCRogersJShehabeldinAJosephDWilliamsGThomasKMasudFTalleyCDlouhyKGLopezBVHamptonCLavinderJGolliharJDMaranhaoACIppolitoGCSaavedraMOCantuCCYerramilliPPruittLMusserJMTreatment of" exact="coronavirus disease 2019" post="(COVID-19) patients with convalescent plasmaAm J Pathol20201901680169032473109 26PerottiCBaldantiFBrunoRDel FanteCSeminariECasariSPercivalleEGlinganiCMusellaVBelliatoMGarutiMMeloniFFrigatoMDi"/>
   <result pre="SabatinoAKlersyCDe DonnoGFranchiniMCovid-19 plasma task force. Mortality reduction in 46 severe" exact="Covid-19" post="patients treated with hyperimmune plasma. A proof of concept"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7533477\results\search\zoonosis\results.xml">
   <result pre="instances, viral particles and genome sequences of SARS-CoV were detected.48â€&quot;51" exact="Middle East respiratory syndrome," post="caused by MERS-CoV (in 2012), is also known to"/>
   <result pre="studies have shown neurologic involvement as the presenting feature of" exact="SARS-CoV-2 infection" post="or have reported post-infectious neurologic complications.3,42,56â€&quot;58 Broadly speaking, these"/>
   <result pre="been several studies reporting cerebrovascular events in the setting of" exact="SARS-CoV-2 infection." post="Mao etÂ al.4 reported that six out of 214"/>
   <result pre="validates this point. Out of the selected 304 patients of" exact="SARS-CoV-2 infection," post="84 (27%) showed evidences of systemic or direct cerebral"/>
   <result pre="Myopathy and SARS-CoV-2 Skeletal muscle damage (myopathy) in association with" exact="SARS-CoV-2 infection" post="has been observed to range from asymptomatic rises in"/>
   <result pre="illness neuropathy and critical illness myopathy in patients with severe" exact="SARS-CoV-2 infection" post="requiring mechanical ventilation. The use of non-depolarising neuromuscular blocking"/>
   <result pre="etÂ al.58 from Wuhan, several cases of GBS related to" exact="SARS-CoV-2 infection" post="have been reported so far.57,58,115â€&quot;120 Toscano etÂ al.115 described"/>
   <result pre="hospitals in northern Italy. All of them had a preceding" exact="SARS-CoV-2 infection," post="the interim duration ranging from 5 to 10 d.115"/>
   <result pre="it is too early to conclude any definite association between" exact="SARS-CoV-2 infection" post="and this milder variety of MFS.121 RT-PCR tests done"/>
   <result pre="needs to be given to the risk of patients contracting" exact="SARS-CoV-2 infection." post="The risk is underscored by increasing age, presence of"/>
   <result pre="respirator may be reconsidered based on availability, regional prevalence of" exact="SARS-CoV-2 infection" post="and institutional practices. As a routine, full-sleeved gown, extended"/>
   <result pre="procedures. Sixth, Mao etÂ al.4 showed that patients with severe" exact="SARS-CoV-2 infection," post="as well as those with neurologic complications, had leucocytosis,"/>
   <result pre="have evinced that epilepsy does not increase the risk of" exact="SARS-CoV-2 infection," post="lest the patient also has associated comorbidities.145,146 There are"/>
   <result pre="belong to the geriatric population and are more susceptible to" exact="SARS-CoV-2 infection," post="and sadly are often seen to not understand the"/>
   <result pre="strictly to prevent infection.141,142 Second, in those suffering from mild" exact="SARS-CoV-2 infection," post="it may be reasonable to continue treatment. Considerations for"/>
   <result pre="of the population. In addition to the growing concerns regarding" exact="SARS-CoV-2 infection" post="and its precariousness faced by the general population, older"/>
   <result pre="to completely shut oneâ€™s eyes to these conceivable problems of" exact="SARS-CoV-2 infection" post="in the long run. So how do we terminate"/>
   <result pre="Lancet2020;395(10223):497â€&quot;506.31986264 3.GuanW, NiZ, HuY, LiangW, OuC, HeJ. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med2020;382(18):1708â€&quot;20.32109013 4.MaoL, JinH, WangM,"/>
   <result pre="4.MaoL, JinH, WangM, et al.Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, China. JAMA Neurol.2020;77(6):1â€&quot;9. 5.JarttiT, JarttiL, RuuskanenO, SÃ¶derlund-VenermoM.New"/>
   <result pre="Travel Med Infect Dis2008;6(3):114â€&quot;24.18486065 16.EscaffreO, BorisevichV, RockxB.Pathogenesis of Hendra and" exact="Nipah virus infection" post="in humans. J Infect Dev Countr2013;7(04):308â€&quot;11. 17.DrexlerJ, Gloza-RauschF, GlendeJ,"/>
   <result pre="CaoQD, HongZS, et al.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak â€&quot; an update on the status. Mil"/>
   <result pre="43.VerdecchiaP, CavalliniC, SpanevelloA, AngeliF.The pivotal link between ACE2 deficiency and" exact="SARS-CoV-2 infection." post="Eur J Intern Med.2020;76:14â€&quot;20.32336612 44.VargaZ, FlammerAJ, SteigerP, et al.Endothelial"/>
   <result pre="Dis.2004;10(2):342â€&quot;4.15030709 52.KimJE, HeoJH, KimHO, et al.Neurological complications during treatment of" exact="Middle East respiratory syndrome." post="J Clin Neurol2017;13(3):227â€&quot;33.28748673 53.SaadM, OmraniA, BaigK, BahloulA, ElzeinF. Clinical"/>
   <result pre="BahloulA, ElzeinF. Clinical aspects and outcomes of 70 patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a single-center experience in Saudi Arabia. Int"/>
   <result pre="Vasc Neurol2020;svn-2020â€&quot;000431. 55.HelmsJ, KremerS, MerdjiH, et al.Neurologic features in severe" exact="SARS-CoV-2 infection." post="N Engl J Med2020;382(23):2268â€&quot;70.32294339 56.LiuK, PanM, XiaoZ, XuX.Neurological manifestations"/>
   <result pre="QuJ, GongF. Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet2020;395(10223):507â€&quot;13.32007143 60.WangD, HuB,"/>
   <result pre="MoccoJ, MajidiS, et al.Large-vessel stroke as a presenting feature of" exact="Covid-19" post="in the young. N Engl J Med2020;382(20):e60.32343504 62.GiacomelliA, PezzatiL,"/>
   <result pre="Neurol2004;251(10):1227â€&quot;31.15503102 73.ArabiYM, HarthiA, HusseinJ, et al.Severe neurologic syndrome associated with" exact="Middle East respiratory syndrome" post="corona virus (MERS-CoV). Infection.2015;43(4):495â€&quot;501.25600929 74.ChenCY, LeeCH, LiuCY, WangJH, WangLM,"/>
   <result pre="J Med.2020;382(26):2574â€&quot;6.32302082 116.ViraniA, RaboldE, HansonT, et al.Guillain-BarrÃ© syndrome associated with" exact="SARS-CoV-2 infection." post="IDCases.2020;20:e00771.32313807 117.OttavianiD, BosoF, TranquilliniE, et al.Early Guillain-BarrÃ© syndrome in"/>
   <result pre="infection. IDCases.2020;20:e00771.32313807 117.OttavianiD, BosoF, TranquilliniE, et al.Early Guillain-BarrÃ© syndrome in" exact="coronavirus disease 2019" post="(COVID-19): a case report from an Italian COVID-hospital. Neurol"/>
   <result pre="120.CoenM, JeansonG, AlmeidaLA, et al.Guillain-BarrÃ© syndrome as a complication of" exact="SARS-CoV-2 infection." post="Brain Behav Immun.2020;87:111â€&quot;2.32360440 121.GutiÃ©rrez-OrtizC, MÃ©ndezA, Rodrigo-ReyS, et al.Miller Fisher"/>
   <result pre="fingolimod. Neurol Neuroimmunol Neuroinflamm.2020;7(4):e753.32371550 129.KansagraAP, GoyalMS, HamiltonS, AlbersGW.Collateral effect of" exact="Covid-19" post="on stroke evaluation in the United States. N Engl"/>
   <result pre="NotarioL, ChapmanMG, MenonBK.Protected code stroke: hyperacute stroke management during the" exact="coronavirus disease 2019." post="COVID-19. Stroke. 2020;51(6):1891â€&quot;5.32233980 133.ZhaoJ, RuddA, LiuR.Challenges and potential solutions"/>
   <result pre="RuddA, LiuR.Challenges and potential solutions of stroke care during the" exact="coronavirus disease 2019" post="(COVID-19) outbreak. Stroke.2020;51(5):1356â€&quot;7.32228369 134.QureshiAI, Abd-AllahF, AlsenaniF, et al.Management of"/>
   <result pre="BrodieMJ, CaraballoR, et al.Keeping people with epilepsy safe during the" exact="Covid-19" post="pandemic. Neurology2020;94(23):1032â€&quot;7.32327490 146.collab: CDC COVID-19 Response Team, et al.Preliminary"/>
   <result pre="with mental health outcomes among health care workers exposed to" exact="coronavirus disease 2019." post="JAMA Netw Open. 2020;3(3):e203976.32202646 154.Mental illness, suicides rise in"/>
   <result pre="Netw Open. 2020;3(3):e203976.32202646 154.Mental illness, suicides rise in India during" exact="Covid-19" post="crisis [Internet]. RFI. 2020. Available from: http://www.rfi.fr/en/international/20200514-mental-illness-suicides-on-the-rise-in-india-during-covid-19-lockdown; accessed May"/>
   <result pre="CheungT.Joint international collaboration to combat mental health challenges during the" exact="Coronavirus disease 2019" post="pandemic. JAMA Psychiatry2020; doi: 10.1001/jamapsychiatry.2020.1057. 168.DubeyMJ, GhoshR, ChatterjeeS, BiswasP,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7534958\results\search\zoonosis\results.xml">
   <result pre="under the terms of the Creative Commons Attribution License Abstract" exact="Coronavirus disease 2019" post="(COVID-19) caused by the severe acute respiratory syndrome coronavirus"/>
   <result pre="drug discovery replication cycle drug targets fig-count: table-count: ref-count: Epidemiology" exact="Coronavirus disease 2019" post="(COVID-19) caused by the severe acute respiratory syndrome coronavirus"/>
   <result pre="in alpha coronavirus (229E, NL63) or beta coronavirus [OC43, HKU1," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV) and"/>
   <result pre="mechanism of infection - At present, the mechanisms that underlie" exact="SARS-CoV-2 infection" post="have not been directly described. Nonetheless, they seem to"/>
   <result pre="for drug repurposing candidates and compounds 1-14 under investigation against" exact="coronavirus disease 2019" post="(COVID-19). Nsp3 is the largest protein encoded by CoVs"/>
   <result pre="for drug repurposing candidates and compounds 15-29 under investigation against" exact="coronavirus disease 2019" post="(COVID-19). Spike protein (S) is a viral type I"/>
   <result pre="occurs in MERS-CoV.60 It is still unclear its role in" exact="SARS-CoV-2 infection," post="but it is speculated that the ubiquitous expression of"/>
   <result pre="the cell. Theoretically, this role may also be played in" exact="SARS-CoV-2 infection," post="as predicted by computational analysis.154 Recently, there has been"/>
   <result pre="conformations. TABLE I In silico studies of drug repurposing for" exact="coronavirus disease 2019" post="(COVID-19) Repurposed drug Previous use Predicted targets Discovery origin"/>
   <result pre="for drug repurposing candidates and compounds 30-49 under investigation against" exact="coronavirus disease 2019" post="(COVID-19). Ge and coworkers constructed a virus-related knowledge graph"/>
   <result pre="approaches), cellular in vitro and in vivo animal models of" exact="SARS-CoV-2 infection," post="are pivotal for the discovery of molecular pathways involved"/>
   <result pre="In vitro and in vivo studies of drug repurposing for" exact="coronavirus disease 2019" post="(COVID-19) Repurposed drug Previous use Targets In vitro potency"/>
   <result pre="Targets In vitro potency (EC50) Selectivity index Reference Remdesivir (8)" exact="Ebola" post="RNA polymerase 0.77 Î¼M 129.9 194 Chloroquine (20) /"/>
   <result pre="HCQ (26) is also being studied in vitro as a" exact="SARS-CoV-2 infection" post="inhibitor acting on both virus entry, as well as"/>
   <result pre="of the two compounds against an in vitro model of" exact="SARS-CoV-2 infection" post="on Vero E6 cells, demonstrated that CQ (20) is"/>
   <result pre="was more potent than CQ (20) to inhibit in vitro" exact="SARS-CoV-2 infection" post="(EC50 0.72 vs 5.47 Î¼M).196 The authors also performed"/>
   <result pre="discovery pipeline comprising in vitro, and in vivo models of" exact="SARS-CoV-2 infection" post="is particularly important to identify new antivirals for human"/>
   <result pre="Cohen, which summarised several clinical studies on drug repurposing for" exact="Covid-19" post="reported so far.44 It is worth noting that many"/>
   <result pre="by day. TABLE III Clinical studies of drug repurposing for" exact="coronavirus disease 2019" post="(COVID-19) Repurposed drug Study characteristics Estimated enrolment Dosage Characteristics"/>
   <result pre="lopinavir (1)-ritonavir (2) treatment compared to standard care in severe" exact="Covid-19" post="patients 220 Ritonavir (2)/lopinavir (1) plus interferon Phase II,"/>
   <result pre="This prodrug was already investigated in clinical trial testing for" exact="Ebola" post="virus with no effect but showed efficiency against different"/>
   <result pre="testing in SARS-CoV-2.235 A total of 199 patients confirmed severe" exact="SARS-CoV-2 infection" post="were randomly designated to be given either (1)/(2) (400"/>
   <result pre="a drug that could be used in the treatment of" exact="COVID 19" post="patients, since its anti-inflammatory activity could minimise inflammatory complications"/>
   <result pre="patients, since its anti-inflammatory activity could minimise inflammatory complications in" exact="COVID 19" post="patients. According to the platform ClinicalTrials.gov, there are 14"/>
   <result pre="most cost-effective of the three of them. In conclusion -" exact="SARS-CoV-2 infection" post="is a life-threatening disease with such a high transmission"/>
   <result pre="approved or investigational drugs that can be repurposed to treat" exact="SARS-CoV-2 infection." post="As reviewed here, over 10 targets distributed amongst distinct"/>
   <result pre="COVID-19Anaesthesia202075797697732339251 33DengYLiuWLiuKFang Y-YShangJZhouLClinical characteristics of fatal and recovered cases of" exact="coronavirus disease 2019" post="in Wuhan, China a retrospective studyChin Med J (Engl)2020133111261126732209890"/>
   <result pre="blocked by a clinically proven protease inhibitorCell20201812 66SandersJMMonogueMLJodlowskiTZCutrellJBPharmacologic treatments for" exact="Coronavirus disease 2019" post="(COVID-19)JAMA2020323181824183632282022 67BoopathiSPomaABKolandaivelP.Novel 2019 coronavirus structure, mechanism of action, antiviral"/>
   <result pre="- shared pathways with therapeutic implicationsEndocr Rev2020413457470 152StrolloRPozzilliPDPP4 inhibition: preventing" exact="SARS-CoV-2 infection" post="and/or progression of COVID-19?Diabetes Metab Res Rev202010.1002/dmrr.3330 153IacobellisGCOVID-19 and"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov202061161632194981 207McChesneyEWAnimal toxicity and pharmacokinetics of hydroxychloroquine"/>
   <result pre="double-blind, placebo-controlled, multicentre trialLancet2020395102361569157832423584 216BeigelJHTomashekKMDoddLEMehtaAKZingmanBSKalilACet al.Remdesivir for the treatment of" exact="Covid-19" post="- Preliminary reportN Engl J Med202010.1056/NEJMoa2007764 217GaoJTianZYangXBreakthrough chloroquine phosphate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7536086\results\search\zoonosis\results.xml">
   <result pre=": 100120031: Review: Review Article Convalescent plasma therapy: a promising" exact="coronavirus disease 2019" post="treatment strategy Plasma therapy a possible hope to fight"/>
   <result pre="is passing through a very difficult phase due to the" exact="coronavirus disease 2019" post="(COVID-19) pandemic, which has disrupted almost all spheres of"/>
   <result pre="used in the treatment of viral-induced diseases like SARS-CoV epidemics," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) pandemics, Ebola epidemics and H1N1 pandemic. In"/>
   <result pre="like SARS-CoV epidemics, Middle East respiratory syndrome coronavirus (MERS-CoV) pandemics," exact="Ebola" post="epidemics and H1N1 pandemic. In this review, we have"/>
   <result pre="abbreviated the novel coronavirus as SARS-CoV-2, and the new disease" exact="coronavirus disease 2019" post="as COVID-19 [4]. Coronaviruses (CoVs) belong to the family"/>
   <result pre="used by several countries to treat patients suffering from severe" exact="SARS-CoV-2 infection" post="[18,19]. CP has proved its effectiveness in neutralizing viruses"/>
   <result pre="has proved its effectiveness in neutralizing viruses like SARS-CoV, MERS-CoV," exact="Ebola" post="and H1N1. So, in this pandemic situation of COVID-19,"/>
   <result pre="immune response of individuals. Based on the differential response, the" exact="SARS-CoV-2 infection" post="is clinically categorized into mainly two stages [16]: non-severe"/>
   <result pre="to enhance antibody-dependent cellular cytotoxicity, among other effects [67]. After" exact="SARS-CoV infection," post="IgG antibodies are produced in response to the nucleoprotein"/>
   <result pre="the beginning of disease [75]. Even after 2 years of" exact="SARS-CoV infection," post="around 89% of the convalesced patients displayed neutralizing antibodies"/>
   <result pre="been shown that viral infections in the blood, such as" exact="SARS-CoV infection," post="are at their maximum during the first week of"/>
   <result pre="reported the efficacy of CP therapy in curing patients with" exact="SARS-CoV-2 infection" post="[54,85,86]. TableÂ 1 precisely enlists the CP administration in"/>
   <result pre="the clinical outcomes by neutralizing viraemia in patients with critical" exact="SARS-CoV-2 infection" post="and can serve as a promising rescue option for"/>
   <result pre="the CP was advantageous for the severely sick patients of" exact="SARS-CoV-2 infection," post="who were suffering from critical respiratory ailments. The patients"/>
   <result pre="al.2011Convalescent plasma treatment reduced mortality in patients with severe pandemic" exact="Influenza" post="A (H1N1) 2009 virus infection. Clin. Infect. Dis.52, 447â€&quot;456."/>
   <result pre="1268â€&quot;1269. (10.1056/NEJMe2002387)32109011 62GasparyanAY, MisraDP, YessirkepovM, ZimbaO2020Perspectives of immune therapy in" exact="coronavirus disease 2019." post="J. Korean Med. Sci.35, e176 (10.3346/jkms.2020.35.e176)32383371 63BenjaminRJ, McLaughlinLS2012Plasma components:"/>
   <result pre="Microbiol.4, 734â€&quot;747. (10.1038/s41564-019-0392-y)30886356 72Van GriensvenJet al.2016Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in Guinea. N. Engl. J. Med.374, 33â€&quot;42."/>
   <result pre="convalescent whole blood or plasma collected from patients recovered from" exact="Ebola" post="virus disease for transfusion, as an empirical treatment during"/>
   <result pre="lung injury following convalescent plasma transfusion in a patient with" exact="Middle East respiratory syndrome." post="Ann. Lab. Med.36, 393â€&quot;395. (10.3343/alm.2016.36.4.393)27139619 93GuptaSS, GuptaAK, ChandakP, KumariJ2020Convalescent"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7536932\results\search\zoonosis\results.xml">
   <result pre="epidemics of severe acute respiratory syndrome (SARS) in 2003 and" exact="Middle East respiratory syndrome" post="(MERS)5 in 2012, but to date there are no"/>
   <result pre="infected i.p. with EVâ€�A71â€�MZâ€�MA1. AZM dose 30â€‰mg/kg/day Zeng et al13" exact="Ebola" post="(Ebola viruses) AZM demonstrates high in vitro antiâ€�viral potency"/>
   <result pre="severe ARDS, using a propensity score analysis Kawamura et al15" exact="Influenza" post="A (Orthomyxovirus) Reduction in ILâ€�6, ILâ€�8, ILâ€�17, CXCL9, sTNF"/>
   <result pre="levels of phosphorylated TBK1 and IRF3. 2.4 Antiâ€�viral effects in" exact="Ebola" post="AZM was similarly evaluated in a drug screen for"/>
   <result pre="DeebAM, Alâ€�HameedF, et al. Macrolides in critically ill patients with" exact="Middle East respiratory syndrome." post="Int J Infect Dis. 2019;81:184â€�190.30690213 6collab: Câ€�CRCEa . Global"/>
   <result pre="Antimicrob Agents. 2019;53(4):362â€�369.30599241 14MadridPB, PanchalRG, WarrenTK, et al. Evaluation of" exact="Ebola" post="virus inhibitors for drug repurposing. ACS Infect Dis. 2015;1(7):317â€�326.27622822"/>
   <result pre="HasegawaS, SriwilaijaroenN, et al. Clarithromycin inhibits progeny virus production from" exact="human influenza" post="virusâ€�infected host cells. Biol Pharm Bull. 2008;31(2):217â€�222.18239276 42YamayaM, ShinyaK,"/>
   <result pre="or without concomitant azithromycin among hospitalized patients testing positive for" exact="coronavirus disease 2019" post="(COVIDâ€�19). JAMA Cardiol. 2020;e201834. doi:10.1001/jamacardio.2020.1834. 56MaisonnasseP, GuedjJ, ContrerasV, et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7536958\results\search\zoonosis\results.xml">
   <result pre="page-count: word-count: to the editor: The initial months of the" exact="coronavirus disease 2019" post="(COVIDâ€�19) pandemic have led to an unprecedented response from"/>
   <result pre="respiratory viral epidemics: the severe acute respiratory syndrome (SARS), the" exact="Middle East respiratory syndrome" post="(MERS) and the influenza A(H1N1)pdm09 virus pandemic. We reviewed"/>
   <result pre="1 Growth in the number of registered studies during the" exact="coronavirus disease 2019" post="(COVIDâ€�19) pandemic compared with the rise in confirmed global"/>
   <result pre="395: 1322â€&quot;1325.32247324 2LeeAY, LinMW. Rapid publishing in the era of" exact="coronavirus disease 2019" post="(COVIDâ€�19). Med J Aust2020; 212: 535â€&quot;535. https://www.mja.com.au/journâ€‹al/2020/212/11/rapid-publiâ€‹shing-era-coronâ€‹avirus-diseaâ€‹se-2019-covid-19 3SandersJM, MonogueML,"/>
   <result pre="212: 535â€&quot;535. https://www.mja.com.au/journâ€‹al/2020/212/11/rapid-publiâ€‹shing-era-coronâ€‹avirus-diseaâ€‹se-2019-covid-19 3SandersJM, MonogueML, JodlowskiTZ, CutrellJB. Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVIDâ€�19): a review. JAMA2020; 323: 1824â€&quot;1836.32282022 4LiQ, GuanX, WuP,"/>
   <result pre="1199â€&quot;1207.31995857 5GuanW, NiZ, HuY, LiangW, et al. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med2020; 382: 1708â€&quot;1720.32109013 6ThorntonJ."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7537045\results\search\zoonosis\results.xml">
   <result pre="medium, provided the original work is properly cited.file:EMBJ-9999-e106057.pdf Abstract Abstract" exact="Coronavirus disease 2019" post="(COVIDâ€�19) is caused by SARSâ€�CoVâ€�2 and has spread across"/>
   <result pre="betacoronavirus genus like other closely related viruses including SARSâ€�CoV and" exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV). Both SARSâ€�CoV and MERSâ€�CoV have caused serious"/>
   <result pre="fig-count: table-count: page-count: word-count: The EMBO Journal (2020) e10605732944968 Introduction" exact="Coronavirus disease 2019" post="(COVIDâ€�19) is a transmissible respiratory disease caused by a"/>
   <result pre="betacoronavirus genus and other closely related viruses include SARSâ€�CoV and" exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV). Both SARSâ€�CoV and MERSâ€�CoV caused serious outbreaks"/>
   <result pre="immunodeficiency virus (HIV), vesicular stomatitis virus (VSV), Zika virus (ZIKV)," exact="Ebola" post="virus (EBOV), Nipah virus (NiV), Russian springâ€�summer encephalitis virus"/>
   <result pre="trial of recombinant human interferon alpha nasal drops to prevent" exact="coronavirus disease 2019" post="in medical staff in an epidemic area. medRxiv10.1101/2020.04.11.20061473 [PREPRINT]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7540197\results\search\zoonosis\results.xml">
   <result pre="Keywords SARS-CoV-2 Tropane alkaloids Schizanthus porrigens Molecular docking 1 Introduction" exact="Coronavirus disease 2019" post="COVID-19 causes severe acute respiratory syndrome (SARS), and therefore"/>
   <result pre="design strategiesMolecules2072015133841342126205061 24M.D. Laskar, M.A. Choudhury, Search for therapeutics against" exact="COVID 19" post="targeting SARS-CoV-2 papain-like proteaseÂ : an in silico study,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7544206\results\search\zoonosis\results.xml">
   <result pre="University Press pmcid: 7544206 doi: 10.1093/nar/gkaa771gkaa771 : AcademicSubjects/SCI00010: Molecular Biology" exact="Influenza" post="A virus co-opts ERI1 exonuclease bound to histone mRNA"/>
   <result pre="or to promote the multiplication cycle of numerous RNA viruses." exact="Influenza" post="A viruses are major human pathogens that are responsible"/>
   <result pre="restrict the replication of vesicular stomatitis virus, Sindbis virus and" exact="Rift Valley fever" post="virus (11). Conversely, components of RNA decay machineries were"/>
   <result pre="Xrn1 to produce non-coding subgenomic RNAs required for pathogenicity (16)." exact="Influenza" post="A viruses (IAV) also rely on cellular proteins to"/>
   <result pre="RNA decay (RDec) processes (referred to as the ExoRDec library)." exact="Influenza" post="A virus proteins exhibited preferential targeting of RNA degradation"/>
   <result pre="an exoribonuclease activity required to maintain viral replication fidelity, while" exact="Lassa fever" post="virus nucleoprotein possesses a DEDDh exonuclease activity essential to"/>
   <result pre="not shown to be required for its role in promoting" exact="Dengue" post="virus 2 mRNA synthesis (15), suggesting that the mechanisms"/>
   <result pre="in promoting viral transcription, which are also still unknown for" exact="Dengue" post="virus, might differ. We observed a clear enrichment in"/>
   <result pre="of Medicine, Stanford, USA. Present address: Cyril Barbezange, Belgian National" exact="Influenza" post="Centre, Viral Diseases Service, Sciensano, Brussels, Belgium. References REFERENCES"/>
   <result pre="Host Microbe. 2008; 4:579â€&quot;591.19064258 17.ShawM.L., StertzS.Role of Host Genes in" exact="Influenza" post="Virus Replication. 2017; ChamSpringer151â€&quot;189. 18.PeacockT.P., SheppardC.M., StallerE., BarclayW.S.Host determinants"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7544963\results\search\zoonosis\results.xml">
   <result pre="SARS outbreak. In the absence of any suitable treatment for" exact="SARS-CoV-2 infection," post="only supportive care is being provided to the patients"/>
   <result pre="or other viral diseases are being considered for treatment of" exact="SARS-CoV-2 infection," post="as it is a new disease and lack any"/>
   <result pre="study showed that oral H1 flu tablet vaccine protects against" exact="influenza infection" post="after just one dose. Based on these results, it"/>
   <result pre="â€œBCG Vaccine for Health Care Workers (HCW) as Defense Against" exact="COVID 19" post="(BADAS)â€�.81,82 [U.S. National Library of Medicine, ClinicalTrials.gov website: https://clinicaltrials.gov/ct2/show/NCT04348370]."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7545115\results\search\zoonosis\results.xml">
   <result pre="persons who had indications for PrEP.â€� COVID-19 and HIV The" exact="coronavirus disease 2019" post="(COVID-19) pandemic due to severe acute respiratory syndrome coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7545798\results\search\zoonosis\results.xml">
   <result pre="different agents: severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012 and the current of SARS-CoV-2"/>
   <result pre="In the case of concurrent HIV and tuberculosis infection plus" exact="SARS-CoV-2 infection," post="the additional drug might cause interaction complicating the integrated"/>
   <result pre="HIV Human Immunodeficiency Virus LRTIs Lower Respiratory Tract Infections MERS-CoV" exact="Middle East respiratory syndrome" post="coronavirus MDR-TB Multidrug-resistant TB NIH National Institute of Health"/>
   <result pre="Pulmonary TB RIF Rifampicin RT-PCR Real-time polymerase chain reaction SARS-CoV" exact="Severe acute respiratory syndrome" post="coronavirus TB Tuberculosis UNAIDS The joint United Nations Programme"/>
   <result pre="impacts of control measuresAm J Epidemiol2004160650951610.1093/aje/kwh25515353409 6.LinQChiuAPZhaoSHeDModeling the spread of" exact="Middle East respiratory syndrome" post="coronavirus in Saudi ArabiaStat Methods Med Res20182771968197810.1177/096228021774644229846148 7.collab: World"/>
   <result pre="https://doi.org/10.7326/M20-3689. 28.ChenTLDaiZMoPLiXMaZSongSet al.Clinical characteristics and outcomes of older patients with" exact="coronavirus disease 2019" post="(COVID-19) in Wuhan, China (2019): a single-centered, retrospective studyJ"/>
   <result pre="Transmission Route and Sex2017 53.HongKHLeeSWKimTSHuhHJLeeJKimSYet al.Guidelines for laboratory diagnosis of" exact="coronavirus disease 2019" post="(COVID-19) in KoreaAnn Lab Med202040535136010.3343/alm.2020.40.5.35132237288 54.PiatekASVanCMAlexanderHCogginWLRehrMVanKSet al.GeneXpert for TB"/>
   <result pre="https://doi.org/10.1155/2011/562790. 74.TangNBaiHChenXGongJLiDSunZAnticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathyJ Thromb Haemost20201851094109910.1111/jth.1481732220112 75.AlhazzaniWMÃ¸ller MortenHArabiYMLoebMGongMNFanEet al.Surviving Sepsis"/>
   <result pre="campaign: guidelines on the management of critically ill adults with" exact="coronavirus disease 2019" post="(COVID-19)Intensive Care Med20204885488710.1007/s00134-020-06022-5"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7546461\results\search\zoonosis\results.xml">
   <result pre="are credited.ppat.1008902.pdf Abstract The first cluster of patients suffering from" exact="coronavirus disease 2019" post="(COVID-19) was identified on December 21, 2019, and as"/>
   <result pre="(AIDS) alone has killed an estimated 32 million [3], whilst" exact="coronavirus disease 2019" post="(COVID-19) has caused the largest global economic crisis since"/>
   <result pre="of research response: contrasting the SARS-CoV-1 and SARS-CoV-2 outbreaks. COVID-19," exact="coronavirus disease 2019;" post="PCR, polymerase chain reaction; PHEIC, Public Health Emergency of"/>
   <result pre="considered the gold standard for laboratory diagnosis of an active" exact="SARS-CoV-2 infection" post="[28], serological assays can detect historical infections and play"/>
   <result pre="during crises was highlighted as a problem during the 2014â€&quot;2016" exact="Ebola" post="outbreak [69], yet arguably a sea change has occurred"/>
   <result pre="prevention of Coronavirus Disease (COVID-19) in the healthcare setting; COVID-19," exact="coronavirus disease 2019;" post="COVID-19 CRC, COVID-19 Clinical Research Coalition; COV-IRT, COVID-19 International"/>
   <result pre="origin. Nature. 2020;579:270â€&quot;273. 10.1038/s41586-020-2012-732015507 12BaggettTP, KeyesH, SpornN, GaetaJM. Prevalence of" exact="SARS-CoV-2 infection" post="in residents of a large homeless shelter in Boston."/>
   <result pre="clinical application of a rapid IgM-IgG combined antibody test for" exact="SARS-CoV-2 infection" post="diagnosis. J Med Virol. 2020:1â€&quot;7. 32BroughtonJP, DengX, YuG, FaschingCL,"/>
   <result pre="Vaccine Tracker. Available from: https://biorender.com/covid-vaccine-tracker. 68LurieN, SavilleM, HatchettR, HaltonJ. Developing" exact="Covid-19" post="vaccines at pandemic speed. N Engl J Med. 2020."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7547609\results\search\zoonosis\results.xml">
   <result pre="made in a rush due to the rapid spread of" exact="coronavirus disease 2019" post="(COVID-19) caused by the SARS-CoV-2 and to prevent the"/>
   <result pre="of COVID-19 on inpatient paediatric care. Upcoming care delivery scenarios" exact="Coronavirus disease 2019" post="in children contributed slightly to the collapse of the"/>
   <result pre="the hospitalization rate and the incidence of complications due to" exact="SARS-CoV-2 infection" post="is lower compared to other infectious pathogens4 and to"/>
   <result pre="infection is lower compared to other infectious pathogens4 and to" exact="SARS-CoV-2 infection" post="in other age groups.5 Nevertheless, paediatricians have faced a"/>
   <result pre="prognosis than adultsActa Paediatr10920201088109532202343 6ShekerdemianL.S.MahmoodN.R.WolfeK.K.RiggsB.J.RossC.E.MckiernanC.A.Characteristics and outcomes of children with" exact="coronavirus disease 2019" post="(COVID-19) infection admitted to US and Canadian Pediatric Intensive"/>
   <result pre="of COVID-19J Hosp Med15202030831032379038 18ChopraV.TonerE.WaldhornR.WasherL.How should U.S. Hospitals prepare for" exact="coronavirus disease 2019" post="(COVID-19)?Ann Intern Med172202062162232160273 19CramP.AndersonM.L.ShaughnessyE.E.All hands on deck: learning to"/>
   <result pre="a Childrenâ€™s HospitalJ Pediatr202010.1016/j.jpeds.2020.04.060 21CavalloJ.J.DonohoD.A.FormanH.P.Hospital capacity and operations in the" exact="coronavirus disease 2019" post="(COVID-19) pandemicâ€&quot;planning for the Nth patientJAMA Health Forum12020Available from:https://jamanetwork.com/channels/health-forum/fullarticle/2763353"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7548526\results\search\zoonosis\results.xml">
   <result pre="effects achieved while treating SARS in 2003 and the current" exact="coronavirus disease 2019" post="(COVID-19) pneumonia and the history of the effective responses"/>
   <result pre="Southern Daily, Feb 25, 2020. Available at https://xw.qq.com/cmsid/20200225A0NG5B00 14.Yuan B." exact="Ebola" post="strikes, it is both a challenge and an opportunity."/>
   <result pre="Xie P, et al. Retrospective clinical study on treatment of" exact="COVID-2019" post="patients with integrated traditional Chinese and Western medicine. Chin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7549853\results\search\zoonosis\results.xml">
   <result pre="of severe acute respiratory syndrome coronavirus (SARS-CoV-1) in 2002 and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012, both of which led to"/>
   <result pre="it is unlikely that the plasma of donors without confirmed" exact="SARS-CoV-2 infection" post="contain high titers of SARS-CoV-2 neutralizing antibodies. Additionally, it"/>
   <result pre="key to reduce mortalityInt J Antimicrob AgentsZhangCWuZLiJWZhaoHWangGQ15552020 17Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J MedGuanWJNiZYHuYet al.17081720382202032109013 18Clinical characteristics of"/>
   <result pre="Campaign: guidelines on the management of critically ill adults with" exact="coronavirus disease 2019" post="(COVID-19)Crit Care MedAlhazzaniWMollerMHArabiYMet al.44046948202032058385 28Noninvasive ventilation in acute hypoxemic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7550130\results\search\zoonosis\results.xml">
   <result pre="virus (HIV) (Pike et al., 2010; Sharp and Hahn, 2010)," exact="Ebola" post="(Leroy et al., 2004), monkeypox (Lebreton et al., 2006),"/>
   <result pre="of zoonotic diseases in human populations. Several of the last" exact="Ebola" post="outbreaks in Africa were due to the handling of"/>
   <result pre="Leroy et al., 2004; Jacobsen et al., 2016). The 2014" exact="Ebola" post="epidemic in West Africa was responsible for 27,000 reported"/>
   <result pre="than 11,000 deaths (Carroll et al., 2015; Muehlenbein, 2016) although" exact="Ebola" post="virus can be way more virulent depending on the"/>
   <result pre="up to 90% of recorded mortalities: Feldmann and Geisbert, 2011)." exact="Ebola" post="virus disease was also reported in countries such as"/>
   <result pre="al., 2006; Karesh et al., 2007; Cui et al., 2019)." exact="Monkeypox" post="virus, which causes fatal illness in humans in up"/>
   <result pre="to predict SARS-CoV-1 in 2002â€&quot;2003 (Wang et al., 2006), the" exact="Middle East respiratory syndrome" post="(MERS) in 2012, the Ebola outbreak in 2014â€&quot;2015 (Troncoso,"/>
   <result pre="2006), the Middle East respiratory syndrome (MERS) in 2012, the" exact="Ebola" post="outbreak in 2014â€&quot;2015 (Troncoso, 2015; Jacobsen et al., 2016),"/>
   <result pre="global scaleConservation Letters106201771772510.1111/conl.12361 CarrollM.W.MatthewsD.A.HiscoxJ.A.ElmoreM.J.PollakisG.RambautA.HewsonR.Garcia-DorivalI.BoreJ.A.KoundounoR.Temporal and spatial analysis of the 2014-2015" exact="Ebola" post="virus outbreak in west AfricaNature524756320159710110.1038/nature1459426083749 ChaberA.L.Allebone-WebbS.LignereuxY.CunninghamA.A.MarcusR.J.The scale of illegal"/>
   <result pre="Safety Authority (EFSA)An update on the risk of transmission of" exact="Ebola" post="virus (EBOV) via the food chainEFSA J.12112014388410.2903/j.efsa.2014.3884 FauciA.S.TouchetteN.A.FolkersG.K.Emerging infectious"/>
   <result pre="HeymannD.L.ChenL.TakemiK.FidlerD.P.TapperoJ.W.ThomasM.J.KenyonT.A.FriedenT.R.YachD.NishtarS.Global health security: the wider lessons from the west Africa" exact="Ebola" post="virus disease epidemicThe Lancet385998020151884190110.1016/S0140-6736(15)60858-3 HoffmannM.BelantJ.L.ChansonJ.S.CoxN.A.LamoreuxJ.RodriguesA.S.L.SchipperJ.StuartS.N.The changing fates of the"/>
   <result pre="of emerging infectious diseases in wildlife populationsEcoHealth123201540841110.1007/s10393-015-1045-026232293 JacobsenK.H.AguirreA.BaileyC.BaranovaA.CrooksA.CroitoruA.DelamaterP.GuptaJ.Kehn-HallK.Lessons from the" exact="Ebola" post="outbreak: action items for emerging infectious disease preparedness and"/>
   <result pre="perception of disease risk among Central African communitiesAnimal Conservation94200635736310.1111/j.1469-1795.2006.00030.x LeroyE.M.RouquetP.FormentyP.SouquiereS.KillbourneA.FromentJ.M.BermejoM.SmitS.KareshW.SwanepoelR.Multiple" exact="Ebola" post="virus transmission events and rapid decline of central African"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7551028\results\search\zoonosis\results.xml">
   <result pre="[39]. The study has shown a vital key for the" exact="SARS-CoV-2 infection," post="known as the ACE-2 cell receptor, found abundantly in"/>
   <result pre="administered a combination of antiviral drugs Oseltamivir and Lopinavir/Ritonavir for" exact="Influenza" post="and HIV to a Chinese woman who was infected"/>
   <result pre="(GS-5734), an abandoned drug which was initially developed to treat" exact="Ebola" post="virus, as an antiviral drug against COVID-19 [88]. Other"/>
   <result pre="HCQ sulphate has been studied for its antiviral effect on" exact="SARS-CoV-2 infection" post="and has been compared with CQ alone for cytotoxicity"/>
   <result pre="has successfully shown that HCQ sulphate is effective in inhibiting" exact="SARS-CoV-2 infection" post="and may be a better option for consideration in"/>
   <result pre="a less toxic derivative of Chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="In VitroCell Discov.2020610.1038/s41421-020-0156-032194981 88.HarrisonC.Coronavirus puts drug repurposing on the"/>
   <result pre="Currently ongoing [101,102] Favipiravir Broad-spectrum inhibitor of viral RNA, i.e.," exact="Influenza" post="Raises serum uric acid Diarrhoea Inhibits viral RbRp in"/>
   <result pre="vitro studies [90,104] Remdesivir Antiviral activity against RNA viruses, i.e.," exact="Ebola" post="virus Abnormal liver function Renal impairment Hypotension, diarrhoea and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7551260\results\search\zoonosis\results.xml">
   <result pre="severe acute respiratory symptom (SARS) outbreak in 2002âˆ’2003 [1], and" exact="Middle East respiratory syndrome" post="coronavirus (MERS), which emerged in 2012 [2]. At the"/>
   <result pre="Betacoronaviruses, which mainly include severe acute respiratory symptoms coronavirus (SARS-CoV)," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), severe acute respiratory symptoms coronavirus 2 (SARS-CoV-2),"/>
   <result pre="activate the S protein for membrane fusion in SARS-CoV and" exact="SARS-CoV-2 infection" post="[30]. Notably, ACE2 and TMPRSS2 are also highly expressed"/>
   <result pre="suggested that the digestive system is a potential route for" exact="SARS-CoV-2 infection" post="[33,34]. 3. Antiviral Immune Responses to Coronavirus Infection The"/>
   <result pre="molecules induces an effective host cell-intrinsic antiviral defense against lethal" exact="SARS-CoV infection" post="[50]. In contrast, TLRs 7 and 8 of plasmacytoid"/>
   <result pre="which effectively reduces the severity of MHV-induced pathogenesis [58]. Nevertheless," exact="SARS-CoV infection" post="causes temporal and spatial activation of the transcriptional factor"/>
   <result pre="been recommended as potential therapeutic drugs to prevent and treat" exact="SARS-CoV-2 infection" post="[70,71,72]. Notably, excessive and prolonged IFN expression might lead"/>
   <result pre="use in clinical practice against viral infection. 3.3.2. Proinflammatory Cytokines" exact="SARS-CoV infection" post="induces upregulation of proinflammatory cytokines/chemokines, such as interleukin (IL)-1Î²,"/>
   <result pre="changes in the proinflammatory response at the early stage of" exact="SARS-CoV-2 infection." post="In this context, Ong et al. conducted daily transcriptional"/>
   <result pre="disease severity [81]. The potential ISGs exert protective functions against" exact="SARS-CoV-2 infection," post="which may explain the lower proportion of severe cases"/>
   <result pre="load has been detected at the very early phase of" exact="SARS-CoV-2 infection" post="after symptom onset [83], suggesting that the novel emerging"/>
   <result pre="is available about the roles of DCs and pDCs in" exact="SARS-CoV-2 infection." post="Thus, further investigation is required to elucidate whether the"/>
   <result pre="replication may be particularly active during the early phrase of" exact="SARS-CoV-2 infection;" post="thus, antiviral therapy could exerts its greatest effects before"/>
   <result pre="are used as therapy for dysregulated innate immune responses to" exact="SARS-CoV-2 infection." post="Currently recommended agents include corticosteroids, interleukin inhibitors, IFNs, and"/>
   <result pre="[127]. A summary of the action of these agents against" exact="SARS-CoV-2 infection" post="is shown in Table 1. Besides the pharmacologic interventions,"/>
   <result pre="the recognition of SARS-CoV-2 by full-length human ACE2Science20203671444144810.1126/science.abb276232132184 26.TeN.Vergara-AlertJ.LehmbeckerA.PerezM.HaagmansB.L.BaumgartnerW.BensaidA.SegalesJ.Co-localization of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) and dipeptidyl peptidase-4 in the respiratory tract"/>
   <result pre="Immunol.2017101581159310.1038/mi.2017.1628327617 41.LiW.HulswitR.J.G.WidjajaI.RajV.S.McBrideR.PengW.WidagdoW.TortoriciM.A.van DierenB.LangY.et al.Identification of sialic acid-binding function for the" exact="Middle East respiratory syndrome" post="coronavirus spike glycoproteinProc. Natl. Acad. Sci. USA2017114E8508E851710.1073/pnas.171259211428923942 42.JungK.SaifL.J.Goblet cell"/>
   <result pre="on Toll-like receptorsNat. Immunol.20101137338410.1038/ni.186320404851 47.NazA.ShahidF.ButtT.T.AwanF.M.AliA.MalikA.Designing multi-epitope vaccines to combat emerging" exact="coronavirus disease 2019" post="(COVID-19) by employing immuno-informatics approachFront. Immunol.202011166310.3389/fimmu.2020.0166332754160 48.MarchantD.SingheraG.K.UtokaparchS.HackettT.L.BoydJ.H.LuoZ.S.SiX.N.DorscheidD.R.McManusB.M.HegeleR.G.Toll-like receptor 4-mediated"/>
   <result pre="severe COVID-19Nat. Med.2020261070107610.1038/s41591-020-0944-y32514174 82.WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: Summary of a report of"/>
   <result pre="4, and 6 induce double-membrane vesiclesmBio20134e00524-1310.1128/mBio.00524-1323943763 92.OudshoornD.RijsK.LimpensR.GroenK.KosterA.J.SnijderE.J.KikkertM.BarcenaM.Expression and cleavage of" exact="Middle East respiratory syndrome" post="coronavirus nsp3-4 polyprotein induce the formation of double-membrane vesicles"/>
   <result pre="protease?J. Virol.2005794550455110.1128/JVI.79.7.4550-4551.200515767458 104.YangX.ChenX.BianG.TuJ.XingY.WangY.ChenZ.Proteolytic processing, deubiquitinase and interferon antagonist activities of" exact="Middle East respiratory syndrome" post="coronavirus papain-like proteaseJ. Gen. Virol.20149561462610.1099/vir.0.059014-024362959 105.XingY.ChenJ.TuJ.ZhangB.ChenX.ShiH.BakerS.C.FengL.ChenZ.The papain-like protease of"/>
   <result pre="HealthAvailable online: https://www.covid19treatmentguidelines.nih.gov(accessed on 27 August 2020) 124.SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): A reviewJAMA202010.1001/jama.2020.601932282022 125.AoubaA.BaldolliA.GeffrayL.VerdonR.BergotE.Martin-SilvaN.JustetA.Targeting the inflammatory cascade with anakinra"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov.2020610.1038/s41421-020-0156-0 134.SchoergenhoferC.JilmaB.StimpflT.KarolyiM.ZoufalyA.Pharmacokinetics of lopinavir and ritonavir in"/>
   <result pre="Discov.2020610.1038/s41421-020-0156-0 134.SchoergenhoferC.JilmaB.StimpflT.KarolyiM.ZoufalyA.Pharmacokinetics of lopinavir and ritonavir in patients hospitalized with" exact="coronavirus disease 2019" post="(COVID-19)Ann. Intern. Med.2020M20-155010.7326/M20-1550 135.GroupR.C.HorbyP.LimW.S.EmbersonJ.R.MafhamM.BellJ.L.LinsellL.StaplinN.BrightlingC.UstianowskiA.et al.Dexamethasone in hospitalized patients with"/>
   <result pre="leukocyte subpopulationsArthritis Res. Ther.20192118310.1186/s13075-019-1964-131375130 139.CaoY.WeiJ.ZouL.JiangT.WangG.ChenL.HuangL.MengF.HuangL.WangN.et al.Ruxolitinib in treatment of severe" exact="coronavirus disease 2019" post="(COVID-19): A multicenter, single-blind, randomized controlled trialJ. Allergy Clin."/>
   <result pre="red boxes. S, severe acute respiratory symptom coronavirus (SARS-CoV); M," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV); P, porcine epidemic diarrhea virus (PEDV); PD,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7551450\results\search\zoonosis\results.xml">
   <result pre="lethality of viruses such as SARS-CoV, MERS-CoV, H5N1, H7N9, and" exact="Ebola" post="[10]. In order to contribute to the treatment and"/>
   <result pre="and the virulence factors of reverse genetic manipulation system of" exact="MERS coronavirus" post="48,100 144,300 1 April 2016 31 March 2019 JP"/>
   <result pre="1 Seoul National University The development of therapeutic antibodies against" exact="Middle East respiratory syndrome" post="coronavirus and Zika virus 99,273 496,364 1 July 2016"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7551931\results\search\zoonosis\results.xml">
   <result pre="yellow fever virus, West Nile virus, tick-borne encephalitis virus, and" exact="Japanese encephalitis" post="virus [1]. The ZIKV is a mosquito-borne arbovirus, for"/>
   <result pre="Chemother.2016601955196610.1128/AAC.02183-1526729490 15.RiberC.F.HintonT.M.GajdaP.ZuwalaK.TolstrupM.StewartC.ZelikinA.N.Macromolecular Prodrugs of Ribavirin: Structure-Function Correlation as Inhibitors of" exact="Influenza" post="InfectivityMol. Pharm.20171423424110.1021/acs.molpharmaceut.6b0082628043136 16.CarlucciM.J.ScolaroL.A.DamonteE.B.Herpes simplex virus type 1 variants arising"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7553131\results\search\zoonosis\results.xml">
   <result pre="the two coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), have affected more than 10,000 people with"/>
   <result pre="observational studies that documented the clinical features and outcome of" exact="SARS-CoV-2 infection." post="In a retrospective observational study of 710 patients with"/>
   <result pre="primary cause of severe acute respiratory syndromeThe Lancet.36293802003263270 3de GrootR.J.BakerS.C.BaricR.S.Commentary:" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV): announcement of the Coronavirus Study GroupJournal of"/>
   <result pre="Wuhan, ChinaJama.2020 9ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyThe Lancet.2020 10LiG.De ClercqE.Therapeutic"/>
   <result pre="and critical care medicine1976201875776729161116 13CaoB.GaoH.ZhouB.Adjuvant Corticosteroid Treatment in Adults With" exact="Influenza" post="A (H7N9) Viral PneumoniaCrit Care Med.4462016e31832826934144 14ZhangY.SunW.SvendsenE.R.Do corticosteroids reduce"/>
   <result pre="journal of infectious diseases812004212514690777 31ZarubaevV.SlitaA.LavrentyevaI.SmirnovVProtective Activity Of Ascorbic Acid At" exact="Influenza" post="InfectionInfektsiya Immunitet.742017319326 32WilsonJXEvaluation of vitamin C for adjuvant sepsis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7557800\results\search\zoonosis\results.xml">
   <result pre="other members of the family include SARS coronavirus SAR-CoV and" exact="MERS coronavirus" post="MERS-CoV. The disease primarily affects the respiratory system with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7558548\results\search\zoonosis\results.xml">
   <result pre="of remdesivir, a nucleoside analog originally developed for the treatment" exact="Ebola" post="virus infections, has added hopeÂ to the early management"/>
   <result pre="Â the cleavage and activation of both, hemagglutininÂ (HA) of" exact="human influenza" post="viruses and the spike (S) protein of SARS-like coronaviruses"/>
   <result pre="targeting the human kinome to identify host kinases relevant for" exact="SARS-CoV infection" post="[22]. Their work alsoÂ showed other proteins that promote"/>
   <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov202061610.1038/s41421-020-0156-032194981 5.GaoJYangXBreakthrough: chloroquine phosphate has shown apparent"/>
   <result pre="or without concomitant azithromycin among hospitalized patients testing positive for" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol201910.1001/jamacardio.2020.1834 9.SalehMet al.The effect of chloroquine, hydroxychloroquine and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7561179\results\search\zoonosis\results.xml">
   <result pre="Viral Pathogens Initial Inoculation Period of Detectability (Source) Associated Disease" exact="Influenza" post="Approximately 1Â Ã—Â 104 TCID50* 2Â days [26] Influenza"/>
   <result pre="Disease Influenza Approximately 1Â Ã—Â 104 TCID50* 2Â days [26]" exact="Influenza" post="Norovirus Approximately 2Â Ã—Â 105 TCID50* 7Â days [27]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7568023\results\search\zoonosis\results.xml">
   <result pre="and individuals in long-term care facilities (Kabir et al. 2020)." exact="SARS-CoV-2 infection" post="and replication The virus relies on the ACE2 receptor"/>
   <result pre="suspected or confirmed case (https://www.cdc.gov/coronavirus/2019-ncov/community/correction-detention/guidance-correctional-detention.html). History of patients infected with" exact="coronavirus disease 2019" post="(COVID-19) can include international travel to where COVID-19 is"/>
   <result pre="J, Kim M-G, Oh Y-K, Kim YB (2017) Progress of" exact="Middle East respiratory syndrome" post="coronavirus vaccines: a patent review. Expert Opin Ther Pat"/>
   <result pre="induce coronavirus neutralizing antibodies in miceVaccine2014323169317410.1016/j.vaccine.2014.04.01624736006 Control CfD, Prevention (2014)" exact="Influenza" post="antiviral medications: summary for clinicians CurleyGFLaffyJGZhangHSlutskyASNoninvasive respiratory support for"/>
   <result pre="Lippi G, Plebani M (2020) Laboratory abnormalities in patients with" exact="COVID-2019" post="infection. 20200198 LiuYVMassareMJBarnardDLKortTNathanMWangLSmithGChimeric severe acute respiratory syndrome coronavirus (SARS-CoV)"/>
   <result pre="degradation, anti-coagulant and thrombolytic activitiesIEEE Trans Nanobioscience20161543344210.1109/TNB.2016.255916127164598 Organization WH (2020)" exact="Coronavirus disease 2019" post="(COVID-19): situation report, 72 PandaPKArulMNPatelPVermaSKLuoWRubahnH-GMishraYKSuarMAhujaRStructure-based drug designing and immunoinformatics"/>
   <result pre="and recombinant adenovirus 5 vaccines induce specific antibodies against the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). Am Assoc Immnol PÃ©rez-CasaresACesarSBrunet-GarciaLSanchez-de-ToledoJEchocardiographic evaluation of pericardial"/>
   <result pre="antibiofilm activitiesJ Clust Sci20203136738910.1007/s10876-019-01651-3 WuJWuXZengWGuoDFangZChenLHuangHLiCChest CT findings in patients with" exact="coronavirus disease 2019" post="and its relationship with clinical featuresInvestig Radiol20205525726110.1097/RLI.000000000000067032091414 Xu C,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7570423\results\search\zoonosis\results.xml">
   <result pre="2 (SARS-CoV-2), causes a pathogenic condition that has been termed" exact="coronavirus disease 2019" post="(COVID-19) and has reached pandemic proportions. As of 17"/>
   <result pre="more than 1 million lives worldwide. Accumulating evidence suggests that" exact="SARS-CoV-2 infection" post="can lead to a variety of clinical conditions, ranging"/>
   <result pre="ill patients subsequently die. Insights into the pathogenic mechanisms underlying" exact="SARS-CoV-2 infection" post="and COVID-19 progression are emerging and highlight the critical"/>
   <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the progression of" exact="coronavirus disease 2019" post="(COVID-19), focusing on the immunological hyper-response and the induction"/>
   <result pre="the expense of effective adaptive immunity, underpins the progression of" exact="coronavirus disease 2019" post="(COVID-19). In severe cases of COVID-19, massive endothelial dysfunction,"/>
   <result pre="epidemic diseases in humans: severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS) in 2003 and 2012, respectively. Severe acute respiratory"/>
   <result pre="Middle East respiratory syndrome (MERS) in 2003 and 2012, respectively." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) is a novel coronavirus that was"/>
   <result pre="of 17 September 2020, the disease caused by SARS-CoV-2, named" exact="coronavirus disease 2019" post="(COVID-19), has reached pandemic proportions, affecting more than 30"/>
   <result pre="1 SARS-CoV-2 structure, genome composition and life cycle. a |" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) is a typical betacoronavirus belonging the"/>
   <result pre="proteins, as well as several accessory proteins with unknown functions1,6." exact="SARS-CoV-2 infection" post="(Fig.Â 1c) begins when the viral spike protein attaches"/>
   <result pre="review the current understanding of the pathogenic mechanisms involved in" exact="SARS-CoV-2 infection" post="and progression of COVID-19, focusing on the critical role"/>
   <result pre="also examine emerging data in support of a role for" exact="SARS-CoV-2 infection" post="in inducing widespread endothelial damage, complement-associated blood clotting and"/>
   <result pre="that may be repurposed to treat severe cases of COVID-19." exact="SARS-CoV-2 infection" post="and COVID-19 The human-to-human transmission of SARS-CoV-2 is primarily"/>
   <result pre="targets17,18, owing to their substantial expression of ACE2 and TMPRSS2." exact="SARS-CoV-2 infection" post="induces these epithelial cells to undergo apoptotic cell death"/>
   <result pre="Kidneys, brain, heart, eye and gut can be affected by" exact="SARS-CoV-2 infection," post="potentially leading to specific disease manifestations such as anosmia"/>
   <result pre="evidence suggests that a suboptimal or unrestrained immune response during" exact="SARS-CoV-2 infection" post="drives the clinical patterns, disease severity and progression of"/>
   <result pre="viral eradication and resolution of the disease. In these patients," exact="coronavirus disease 2019" post="(COVID-19) seems to manifest as a mild disease with"/>
   <result pre="possibly individual predisposition or differences in viral loads during primary" exact="SARS-CoV-2 infection," post="some patients experience more severe disease. A maladaptive immune"/>
   <result pre="its translocation and IFN-I activation50. In support of this hypothesis," exact="SARS-CoV-2 infection" post="is associated with lower IFN-I and IFN-III levels and"/>
   <result pre="syndrome, secondary haemophagocytic lymphohistiocytosis, and consequently, the immune response to" exact="SARS-CoV-2 infection" post="was initially considered to involve a form of cytokine"/>
   <result pre="non-infected macrophages61. Moreover, use of untargeted metabolomics has shown that" exact="SARS-CoV-2 infection" post="triggers profound alterations in macrophage phenotype and function by"/>
   <result pre="lavage fluid cells from eight patients with COVID-19 suggested that" exact="SARS-CoV-2 infection" post="elicits more pronounced neutrophil infiltration than other forms of"/>
   <result pre="suggest that the rise in inflammatory cytokine levels induced by" exact="SARS-CoV-2 infection" post="might drive the depletion of T and NK cells,"/>
   <result pre="shown in a preprint study, longitudinal evaluation of patients with" exact="SARS-CoV-2 infection" post="reported a rapid decline in levels of neutralizing antibody"/>
   <result pre="SARS-CoV-2. In support of a dysregulated B cell response to" exact="SARS-CoV-2 infection," post="analyses of circulating B cells showed expansion of oligoclonal"/>
   <result pre="and adaptive immunity, including the cellular and humoral response to" exact="SARS-CoV-2 infection" post="(Fig.Â 2). These findings indicate the need for further"/>
   <result pre="suggested that children may be at a lower risk of" exact="SARS-CoV-2 infection" post="than adults owing to the lower expression of ACE2"/>
   <result pre="as a result of the severe inflammatory state caused by" exact="SARS-CoV-2 infection;" post="none of these children had underlying cardiovascular disease122. SARS-CoV-2"/>
   <result pre="reduction of ACE2 expression by endothelial cells in response to" exact="SARS-CoV-2 infection" post="leads to reduced generation of Ang 1â€&quot;7 and consequently,"/>
   <result pre="as reported by a preprint study135. Fig. 3 Effect of" exact="SARS-CoV-2 infection" post="on endothelial cell function, systemic coagulation and thrombosis. a"/>
   <result pre="on endothelial cell function, systemic coagulation and thrombosis. a |" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) directly infects endothelial cells owing to"/>
   <result pre="unrestrained activation â€&quot; for example, in the context of prolonged" exact="SARS-CoV-2 infection" post="â€&quot; can be detrimental by causing direct damage of"/>
   <result pre="can activate C1 and initiate complement activation. In patients with" exact="SARS-CoV infection," post="the development of autoantibodies against human pulmonary epithelial cells"/>
   <result pre="complement-dependent cytotoxicity143; however, whether this process is also activated following" exact="SARS-CoV-2 infection" post="is unknown. Use of an ultra-high-throughput clinical proteomic approach"/>
   <result pre="Findings from another study suggest that enhanced IgA levels during" exact="SARS-CoV-2 infection" post="might act synergistically with IgG to promote antibody-dependent cytotoxicity108."/>
   <result pre="classical pathway-mediated cytotoxicity. Although clinical insights into complement activation following" exact="SARS-CoV-2 infection" post="are limited145, the above findings indicate that unrestrained complement"/>
   <result pre="important role in outcomes following SARS-CoV-2 infection148. Indeed, patients with" exact="SARS-CoV-2 infection" post="are at an increased risk of widespread coagulation of"/>
   <result pre="involvement in COVID-19 The lungs are the main site for" exact="SARS-CoV-2 infection" post="and the first affected organ in COVID-19. However, sustained"/>
   <result pre="proteinuria and haematuria, which are often observed in patients with" exact="coronavirus disease 2019" post="(COVID-19). Infection of endothelial cells alters glomerular capillary haemostasis"/>
   <result pre="exhibit high levels of ACE2 in the apical brush border." exact="SARS-CoV-2 infection" post="leads to loss of the brush border and vacuolar"/>
   <result pre="the APOL1 â€˜riskâ€™ genotype in inducing focal segmental glomerulosclerosis following" exact="SARS-CoV-2 infection," post="as well as the role of haemodynamic factors, cardiac"/>
   <result pre="targets to prevent kidney dysfunction and/or hasten renal recovery during" exact="SARS-CoV-2 infection." post="Several non-specific mechanisms may contribute to the development of"/>
   <result pre="suggesting that they are potential SARS-CoV-2 targets173,174. ACE2 internalization following" exact="SARS-CoV-2 infection" post="could induce an imbalance in the reninâ€&quot;angiotensinâ€&quot;aldosterone system, with"/>
   <result pre="clotting and systemic microangiopathy. Antiviral therapies The first week following" exact="SARS-CoV-2 infection" post="â€&quot; during which the virus enters alveolar cells and"/>
   <result pre="considered. For example, the observed suppression of interferon responses following" exact="SARS-CoV-2 infection" post="suggests that interferon supplementation may be a potential therapeutic"/>
   <result pre="C3 is required for protection from the highly pathogenic H5N1" exact="influenza infection" post="and proper viral clearance246, suggesting that C3 inhibition may"/>
   <result pre="polyclonal antibodies from convalescent patients. Conclusions Available evidence demonstrates that" exact="SARS-CoV-2 infection" post="induces immune dysfunction, widespread endothelial injury, complement-associated coagulopathy and"/>
   <result pre="diseaseInt. J. Legal Med.2020341271127410.1007/s00414-020-02318-9 26.PernazzaAet al.Early histologic findings of pulmonary" exact="SARS-CoV-2 infection" post="detected in a surgical specimenVirchows Arch.202010.1007/s00428-020-02829-132915266 27.HuangCet al.Clinical features"/>
   <result pre="COVID-19 in Wuhan, ChinaJAMA Cardiol.2020580281010.1001/jamacardio.2020.095032211816 37.ZangRet al.TMPRSS2 and TMPRSS4 promote" exact="SARS-CoV-2 infection" post="of human small intestinal enterocytesSci. Immunol.20205eabc358210.1126/sciimmunol.abc358232404436 38.LamersMMet al.SARS-CoV-2 productively"/>
   <result pre="al.Reduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVID-19)Front. Immunol.20201182710.3389/fimmu.2020.0082732425950 75.Chen, Y. et al. The novel severe"/>
   <result pre="et al. Longitudinal evaluation and decline of antibody responses in" exact="SARS-CoV-2 infection." post="Preprint at medRxiv10.1101/2020.07.09.20148429 (2020). 97.IbarrondoFJet al.Rapid decay of anti-SARS-CoV-2"/>
   <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern. Med.202018011110.1001/jamainternmed.2019.43467070509 209.RussellBet al.Associations between"/>
   <result pre="benefit in COVID-19Lancet Rheumatol.20202e59210.1016/S2665-9913(20)30313-132929415 224.DimopoulosGet al.Favorable anakinra responses in severe" exact="Covid-19" post="patients with secondary hemophagocytic lymphohistiocytosisCell HostMicrobe202028117123.e1 225.AhnEet al.Role of"/>
   <result pre="(2020). 241.YamamotoMet al.Identification of nafamostat as a potent inhibitor of" exact="Middle East respiratory syndrome" post="coronavirus s protein-mediated membrane fusion using the split-protein-based cell-cell"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
